
<html lang="en"     class="pb-page"  data-request-id="0b847e5a-f2a3-4e4f-96f9-c99dc9f62a87"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2020.63.issue-18;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.9b02038;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="p62/SQSTM1, a Central but Unexploited Target: Advances in Its Physiological/Pathogenic Functions and Small Molecular Modulators" /></meta><meta name="dc.Creator" content="Ying  Chen" /></meta><meta name="dc.Creator" content="Qi  Li" /></meta><meta name="dc.Creator" content="Qihang  Li" /></meta><meta name="dc.Creator" content="Shuaishuai  Xing" /></meta><meta name="dc.Creator" content="Yang  Liu" /></meta><meta name="dc.Creator" content="Yijun  Liu" /></meta><meta name="dc.Creator" content="Yao  Chen" /></meta><meta name="dc.Creator" content="Wenyuan  Liu" /></meta><meta name="dc.Creator" content="Feng  Feng" /></meta><meta name="dc.Creator" content="Haopeng  Sun" /></meta><meta name="dc.Description" content="p62/SQSTM1, encoded by gene SQSTM1, is widely known as an adaptor protein of selective autophagy to promote aggregate-prone proteins for degradation. It is also a stress-induced scaffold protein in..." /></meta><meta name="Description" content="p62/SQSTM1, encoded by gene SQSTM1, is widely known as an adaptor protein of selective autophagy to promote aggregate-prone proteins for degradation. It is also a stress-induced scaffold protein in..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 23, 2020" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b02038" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b02038" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b02038" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b02038" /></link>
        
    
    

<title>p62/SQSTM1, a Central but Unexploited Target: Advances in Its Physiological/Pathogenic Functions and Small Molecular Modulators | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b02038" /></meta><meta property="og:title" content="p62/SQSTM1, a Central but Unexploited Target: Advances in Its Physiological/Pathogenic Functions and Small Molecular Modulators" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0014.jpeg" /></meta><meta property="og:description" content="p62/SQSTM1, encoded by gene SQSTM1, is widely known as an adaptor protein of selective autophagy to promote aggregate-prone proteins for degradation. It is also a stress-induced scaffold protein involved in Nrf2 activation to resist oxidative stress. Multiple domains of p62 interact with several essential pathways implicated in cell differentiation and proliferation, placing p62 at a significant position to mediate cell survival and apoptosis. The p62 protein has been suggested as a potential target in recent years, since its abnormal expression or SQSTM1 gene mutation is tightly associated with various diseases including cancer such as hepatocellular carcinoma and prostate cancer, neurodegenerative disorders such as Alzheimer’s disease and amyotrophic lateral sclerosis, atherosclerosis, and Paget’s disease of bone. In this review, we will discuss the relationship between p62 and these diseases, and we attempt to put forward novel methods for current diagnosis or therapy by regulating the p62 expression level." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b02038"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02038">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b02038&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b02038&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b02038&amp;href=/doi/10.1021/acs.jmedchem.9b02038" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 10135-10157</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01882" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.9b02126" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">p62/SQSTM1, a Central but Unexploited Target: Advances in Its Physiological/Pathogenic Functions and Small Molecular Modulators</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Ying Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ying Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ying++Chen">Ying Chen</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qi Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qi Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, China Pharmaceutical University, Nanjing 211198, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qi++Li">Qi Li</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qihang Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qihang Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, China Pharmaceutical University, Nanjing 211198, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qihang++Li">Qihang Li</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shuaishuai Xing</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shuaishuai Xing</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, China Pharmaceutical University, Nanjing 211198, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shuaishuai++Xing">Shuaishuai Xing</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yang Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yang Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, China Pharmaceutical University, Nanjing 211198, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yang++Liu">Yang Liu</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yijun Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yijun Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, China Pharmaceutical University, Nanjing 211198, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yijun++Liu">Yijun Liu</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath6">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yao Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yao Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yao++Chen">Yao Chen</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath7">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wenyuan Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wenyuan Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, China Pharmaceutical University, Nanjing 211198, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wenyuan++Liu">Wenyuan Liu</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath8">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2536-9416" title="Orcid link">http://orcid.org/0000-0002-2536-9416</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Feng Feng</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Feng Feng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, People’s Republic of China</div><div class="loa-info-affiliations-info">Jiangsu Food and Pharmaceuticals Science College, Institute of Food and Pharmaceuticals Research, Huaian 223005, People’s Republic of China</div></div><span class="conrtib-corresp"><strong>*</strong>Tel: +86-13952045795. Email: <a href="/cdn-cgi/l/email-protection#fd9b98939a8e889391949a9589bdcccbced39e9290"><span class="__cf_email__" data-cfemail="5234373c3521273c3e3b353a26126364617c313d3f">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Feng++Feng">Feng Feng</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath9">View Biography</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Haopeng Sun</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Haopeng Sun</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, China Pharmaceutical University, Nanjing 211198, People’s Republic of China</div><div class="loa-info-affiliations-info">Jiangsu Food and Pharmaceuticals Science College, Institute of Food and Pharmaceuticals Research, Huaian 223005, People’s Republic of China</div></div><span class="conrtib-corresp"><strong>*</strong>Tel: +86-13951934235. Email: <a href="/cdn-cgi/l/email-protection#681b1d06000907180d060f28595e5b460b0705"><span class="__cf_email__" data-cfemail="bdcec8d3d5dcd2cdd8d3dafd8c8b8e93ded2d0">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Haopeng++Sun">Haopeng Sun</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath10">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5109-0304" title="Orcid link">http://orcid.org/0000-0002-5109-0304</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b02038&amp;href=/doi/10.1021%2Facs.jmedchem.9b02038" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 10135–10157</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 23, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 December 2019</li><li><span class="item_label"><b>Published</b> online</span>23 April 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 September 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b02038" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02038</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10135%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYing%2BChen%252C%2BQi%2BLi%252C%2BQihang%2BLi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D18%26contentID%3Dacs.jmedchem.9b02038%26title%3Dp62%252FSQSTM1%252C%2Ba%2BCentral%2Bbut%2BUnexploited%2BTarget%253A%2BAdvances%2Bin%2BIts%2BPhysiological%252FPathogenic%2BFunctions%2Band%2BSmall%2BMolecular%2BModulators%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10157%26publicationDate%3DSeptember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b02038"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1428</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">4</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b02038" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;p62/SQSTM1, a Central but Unexploited Target: Advances in Its Physiological/Pathogenic Functions and Small Molecular Modulators&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ying&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Qi&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Qihang&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Shuaishuai&quot;,&quot;last_name&quot;:&quot;Xing&quot;},{&quot;first_name&quot;:&quot;Yang&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Yijun&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Yao&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Wenyuan&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Feng&quot;,&quot;last_name&quot;:&quot;Feng&quot;},{&quot;first_name&quot;:&quot;Haopeng&quot;,&quot;last_name&quot;:&quot;Sun&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;10135-10157&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b02038&quot;},&quot;abstract&quot;:&quot;p62/SQSTM1, encoded by gene SQSTM1, is widely known as an adaptor protein of selective autophagy to promote aggregate-prone proteins for degradation. It is also a stress-induced scaffold protein involved in Nrf2 activation to resist oxidative stress. Multiple domains of p62 interact with several essential pathways implicated in cell differentiation and proliferation, placing p62 at a significant position to mediate cell survival and apoptosis. The p62 protein has been suggested as a potential target in recent years, since its abnormal expression or SQSTM1 gene mutation is tightly associated with various diseases including cancer such as hepatocellular carcinoma and prostate cancer, neurodegenerative disorders such as Alzheimer’s disease and amyotrophic lateral sclerosis, atherosclerosis, and Paget’s disease of bone. In this review, we will discuss the relationship between p62 and these diseases, and we attempt to put forward novel methods for current diagnosis or therapy by regulating the p62 expression level&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02038&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02038" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02038&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02038" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02038&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02038" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b02038&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02038&amp;href=/doi/10.1021/acs.jmedchem.9b02038" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b02038" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b02038" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b02038%26sid%3Dliteratum%253Aachs%26pmid%3D32324396%26genre%3Darticle%26aulast%3DChen%26date%3D2020%26atitle%3Dp62%252FSQSTM1%252C%2Ba%2BCentral%2Bbut%2BUnexploited%2BTarget%253A%2BAdvances%2Bin%2BIts%2BPhysiological%252FPathogenic%2BFunctions%2Band%2BSmall%2BMolecular%2BModulators%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D18%26spage%3D10135%26epage%3D10157%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=292527" title="Autophagy">Autophagy</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/jmcmar.2020.63.issue-18/20200924/jmcmar.2020.63.issue-18.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/medium/jm9b02038_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">p62/SQSTM1, encoded by gene <i>SQSTM1</i>, is widely known as an adaptor protein of selective autophagy to promote aggregate-prone proteins for degradation. It is also a stress-induced scaffold protein involved in Nrf2 activation to resist oxidative stress. Multiple domains of p62 interact with several essential pathways implicated in cell differentiation and proliferation, placing p62 at a significant position to mediate cell survival and apoptosis. The p62 protein has been suggested as a potential target in recent years, since its abnormal expression or <i>SQSTM1</i> gene mutation is tightly associated with various diseases including cancer such as hepatocellular carcinoma and prostate cancer, neurodegenerative disorders such as Alzheimer’s disease and amyotrophic lateral sclerosis, atherosclerosis, and Paget’s disease of bone. In this review, we will discuss the relationship between p62 and these diseases, and we attempt to put forward novel methods for current diagnosis or therapy by regulating the p62 expression level.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31075" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31075" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In humans, p62/SQSTM1 is encoded by sequestosome 1<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and is also called A170 and ZIP in mouse and rat, respectively.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> p62/SQSTM1 is a stress-inducible scaffold protein, which has been recognized as a multifunctional signaling platform via regulating different domains involved in diverse cellular processes. p62 was initially isolated as an interacting partner of atypical protein kinase Cs<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> (aPKCs) or a signaling regulator residing in the late endosome–lysosome, but its emerging role as an adaptor protein of autophagy has received wide attention in recent years. This adaptor protein is not only located in the cytoplasm but also could be observed in the cell nucleus<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and autophagy-related vesicles such as autophagosomes and lysosomes.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> On the other hand, p62 is distributed in “cargoes”, waiting for degradation via autophagy or the ubiquitin–proteasome system (UPS). These obsoleting “cargoes” cover ubiquitin-marked misfolded protein aggregates, damaged, or senescent organelles,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and even invading pathogens.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Distribution of p62 in these “cargoes” lays a foundation and preparation for the subsequent selective autophagy.</div><div class="NLM_p">Although p62 is originally found as a central protein of regulating and impacting Paget’s disease of bone (PDB),<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> its central role of promoting cellular rubbish clearance is the most investigated. The central function of p62 is involved in the degradation of misfolded proteins through UPS or the autophagy-lysosome pathway. These two pathways are the major self-regulating systems to degrade misfolded protein aggregation and maintain the cellular homeostasis in eukaryotic cells. UPS is primarily responsible for the degradation of short-lived proteins and misfolded monomers,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> while autophagy is devoted to removing long-lived proteins, misfolded oligomers, and impaired organelles.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Additionally, p62 is a substrate of the autophagy degradation system.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Despite the different labor division, UPS and autophagy interrelate closely and impact mutually. The loss of autophagy may do damage to UPS because p62 accumulation caused by autophagy deficiency delays the delivery of substrate to the proteasome.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Inversely, UPS inhibition leads to the elevation of autophagic activity via promoting p62 phosphorylation caused by proteotoxic stress.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> p62 and UPS can also regulate the level of histone deacetylase 6 (HDAC6), which influences the fusion of the autophagosome and lysosome.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Taken together, p62 is a bridge between UPS and autophagy, responsible for ubiquitinated protein degradation.</div><div class="NLM_p last">Although p62 lacks inherent enzymatic activity, it acts as a multifunctional signaling hub by utilizing its various structural elements and regulating proteolytic pathways. These functions allow p62 to directly or indirectly interact with multifarious signaling pathways, which can control cell survival and death, inflammation, and metabolic reprogramming.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> These imbalances are enough to induce multiple diseases including but not limited to osteoclastogenesis, immunopathy, neurodegeneration, tumorigenesis, and metabolic diseases. Here we discuss how p62 participates in processes of selective autophagy and other significant pathways associated with tumorigenesis, neurodegenerative diseases, atherosclerosis, and PDB. Then we enumerate existing available small-molecule modulators of the p62 protein and discuss its development prospect and possibilities as a potential target.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  p62 and Its Domain</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64433" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64433" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">p62, identified as a 62 kDa protein,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> consists of six major domains (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>): (1) an N-terminal Phox1 and Bem1p (PB1) domain; (2) a zinc finger (ZZ) domain, (3) a tumor necrosis factor receptor-associated factor 6 (TRAF6)-binding (TB) motif, (4) an LC3-interacting region (LIR) domain, (5) a Keap1-interacting region (KIR) domain, (6) a C-terminal ubiquitin-associated (UBA) domain.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Precisely because of these domains, p62 makes itself a multifunctional regulator involved in several physiological and pathological processes.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/medium/jm9b02038_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Domains of p62. There are six domains on p62: N-terminal Phox1 and Bem1p (PB1) domain; zinc finger (ZZ) domain; tumor necrosis factor receptor-associated factor 6 (TRAF6)-binding (TB) motif; LC3-interacting region (LIR) domain; Keap1-interacting region (KIR) domain; C-terminal ubiquitin-associated (UBA) domain. The PB1 domain functions to promote p62 oligomerization and interaction with aPKCs and MEKK3. The ZZ domain and TB domain are associated with the NF-κB signaling pathway. The LIR domain is responsible for binding to LC3. The KIR domain is required for p62 to activate the Nrf2 pathway through competitive inhibition of Keap1. The UBA domain is responsible for the interaction between autophagosomes and ubiquitinated proteins. The UBA domain cooperates with the LIR domain to promote autophagy occurrence. NLS1/2 and NES are responsible for the nucleo-cytoplasmic shuttling of p62.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The N-terminal PB1 domain is an evolutionarily conserved dimerization motif, which mediates protein homodimer and heterodimer formation.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> p62 can self-assemble via the PB1 domain for dimerization and further oligomerization, which is critical for inclusion body formation and ubiquitinated protein accumulation.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> p62 can also realize heter-dimerization with NBR1 and other signaling molecules containing PB1 domains, such as aPKCs and mitogen-activated protein kinase kinase 3 (MEKK3).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Both aPKCs and MEKK3 regulate nuclear factor-kappa B (NF-κB) activation,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> which is involved in inflammation and immunity. Thus, the PB1 domain is significant for the protein–protein interaction, and the dysfunction of this region will lead to the failure of activating the NF-κB pathway and p62-dependent selective autophagy.</div><div class="NLM_p">The ZZ zinc finger domain of p62 functions to bind to the receptor-interacting protein (RIP, a TNFα signaling adaptor). Through interacting with RIP, p62 acts as an intermediate in the NF-κB signaling pathway combined with aPKCs.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> This domain is accounted for as a regulator of inflammation and cell death.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Yan et al. demonstrated that the absence of the ZZ domain restored the sensitivity of ovarian cancer cells to cisplatin treatment, which proposed that the ZZ domain is associated with drug resistance by inhibiting cell death.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Besides, the G155L mutation of this region is predicted to be pathogenic to ALS reported by Kwok et al.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p">The TB domain of p62 is responsible for regulating the level of TRAF6 and trigger protein polyubiquitination. TRAF6 is a lysine 63 E3 ubiquitin ligase and promotes K63 polyubiquitination of specific substrates including itself.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The TB domain of p62 interacts with TRAF6 and enhances its ubiquitin ligase activity by inducing polyubiquitination and oligomerization.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In addition, p62 participates in activating the NF-κB signaling pathway to promote the expression of inflammatory genes in conjunction with TRAF6.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The TB domain is reported to influence osteoclastogenesis,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> neurodegenerative diseases,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and Ras-induced tumorigenesis.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">The LIR domain of p62 is required for the autophagy degradation of mammalian proteins, which ensures the targeting of autophagy receptors to light chain 3 (LC3) or other autophagy gene 8 (ATG8) family proteins anchored in the phagophore membrane.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> p62 interacts with LC3 through its LIR domain to promote the formation of autophagosomes and deliver polyubiquitinated “cargoes” to autophagic degradation.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> In addition, p62 can also interact with other autophagic effector proteins like beclin-1, γ-aminobutyric acid receptor-associated protein (GABARAP), and GABARAP-like molecules through the LIR domain.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The interaction of LC3 and this domain is a key procedure of selective autophagy. Dysfunction of the LIR domain will result in the failure of p62-induced autophagy, which can aggravate the accumulation of damaged proteins in neurodegenerative diseases.</div><div class="NLM_p">The KIR domain is related to nuclear factor erythroid 2-related factor 2 (Nrf2) activation under normal conditions. Nrf2 is a basic-leucine zipper (bZIP) transcription factor and is responsible for the gene expression of antioxidant elements (AREs) and detoxifying enzymes to respond to oxidative stress and inflammation.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Keap1 is a critical medium to negatively regulate the expression of Nrf2 by promoting its ubiquitination, resulting in the rapid degradation of Nrf2 by UPS.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Under abnormal conditions, p62 can stabilize Nrf2 activation in response to oxidative stress through its KIR domain.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> p62 competes with Nrf2 to interact with Keap1 for autophagic degradation, leading to Nrf2–Keap1 dissociation and Nrf2-translocation to the nucleus. Then Nrf2 will induce the transcription of detoxification enzymes and AREs.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> From another perspective, p62 accumulation might result in the continuous activation of Nrf2 and have a detrimental effect. p62–Keap1 complexes were detected in many neoplastic cells as well as some neurodegenerative disorders.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_p">The C-terminal UBA domain of p62 can bind to ubiquitinated protein aggregates and regulate the interaction between ubiquitinated proteins and autophagosomes.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> This process is an important part of ubiquitinated proteins degradation via the autophagy-lysosomal pathway. Additionally, mutations of the UBA domain are observed in both familiar ALS and PDB patients confirmed by Teyssou et al.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Chamoux et al. also reported that mutations in the UBA region activate TRAF6-NF-κB signaling, contributing to increased osteoclastogenesis, which might be the direct cause of PDB.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p last">Besides the six main domains, there are two nuclear localization signals (NLS1/2) and a nuclear export signal (NES) responsible for the nucleo-cytoplasmic shuttling of p62. p62 can shuttle continuously between the nucleus and cytoplasm via its NLSs and NES.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> p62 is involved in the accumulation of nuclear polyubiquitinated proteins in promyelocytic leukemia bodies through inhibiting the export of nuclear proteins. Pankiv et al. suggested that p62 may also function to transport ubiquitinated “cargoes” from the nucleus to the cytosol for degradation.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">3.  p62 and Selective Autophagy</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53576" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53576" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Autophagy, the literal meaning is “self-eating”, collaborates with apoptosis (cell “self-killing”) to regulate cell survival and death.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> However, the internal cooperation and conversion mechanisms between them are not entirely clear. Autophagy is a highly conserved process and generally preserved among different species and cell types (including tumor cells) for its contribution to cell survival.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> It is essential for cells to maintain a basic and low level of autophagy activity to maintain the stabilization of homeostasis because multifarious kinds of “garbage” produced by cells, such as broken organelles and misfolded proteins, need to be removed in time.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Autophagy is able to maintain cell self-stability and devoted to degrading or removing this “garbage”. Furthermore, breakdown products of autophagy, such as fatty acids and amino acids, can be reused by cells to provide energy and build new proteins.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_p">There are three types of autophagy classified by the generation process: macroautophagy, microautophagy, and chaperone-mediated autophagy (CMA).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Macroautophagy (hereinafter referred to as autophagy) is the most studied type, which is generally characterized by the formation of a cup-shaped phagophore with a double-layer membrane.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Microautophagy is a process where lysosomes are active to phagocytose cytoplasmic components directly.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Some molecular chaperones, such as the heat shock cognate chaperone of 70 kDa (Hsp70), are requisite for CMA. Molecular chaperones play significant roles in the translocation of unfolded proteins into the lysosomal membrane.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Autophagy maintains a low level under normal cellular conditions, but it will be activated by several inducing factors including intracellular and extracellular stimulation. Intracellular stimulation contains metabolic stress, misfolded or aggregated proteins, and aging or damaged organelles. Extracellular stimulation includes nutrition deficiency, oxygen deficit, and growth factor concentration withdrawal.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Once these inductive signals are accepted by cells, autophagy-related proteins will be synthesized in quantity to prepare for autophagy. Then it forms a cup-shaped double-membrane structure named phagophore in the cytoplasm and expands continuously. Phagophores can be observed under the electron microscope directly, which is regarded as the ironclad evidence of autophagy initiation. Phagophores keep expanding, and cytoplasmic components, such as mitochondria, ribosomes, and endoplasmic reticulum fragments, will be sequestered into the “cup”. Then phagophores close the opening and form a sealed spherical autophagosome, which can also be observed under an electron microscope. The rapid mass formation of autophagosomes is a significant symbol of autophagy performance. Autolysosomes are formed by merging autophagosomes and lysosomes, where “cargoes” will be degraded. The inner membrane of autophagosomes is degraded by lysosomal enzymes to promote fusion during this period. The degradation products will be transported to the cytoplasm for reuse, while the residue will be expelled from the cell or remain in the cytoplasm (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Autophagy is a batch degradation process, and its emergency characteristic allows cells to quickly adapt to severe environments. Autophagy has two main cellular functions: detoxification through removing cellular waste and conferring resistance to nutritional stress.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Although autophagy is beneficial to cell survival under adverse conditions including metabolic stress and cellular damage, it must be stopped in time after a crisis-resolution; otherwise, its powerful ability to capture and degrade cytoplasmic components will lead to irreversible cell damage.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/medium/jm9b02038_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Process of p62-mediated selective autophagy. Misfolded protein aggregates are recruited to the UBA domain of p62. Once intracellular or extracellular stimulation signals are accepted, phagophores keep expanding and parceling cytoplasmic components. Then phagophores close the opening and form sealed spherical autophagosomes. p62 bodies interact with LC3 to promote the formation of autophagosomes. Autophagosomes combine with lysosomes to form autolysosomes and promote aggregated proteins to degradation in them.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Precisely because of the emergency feature and batch degradation pattern, autophagy has been characterized as a nonselective bulk degradation pathway induced by nutrient deprivation or other stress situations for a long time. Nevertheless, a growing body of evidence has demonstrated that autophagy also contributes to selectively degrading superfluous or damaged mitochondria (mitophagy),<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> protein aggregates (aggrephagy),<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> invading bacteria or viruses (xenophagy),<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> peroxisomes (pexophagy),<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and ribosomes (ribophagy).<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Selective autophagy is devoted to clearing abnormal organelles and protein aggregates, which are frequently pathological features of several diseases, especially neurodegenerative and metabolic diseases. Lamark et al. reported that, during the selective autophagy process, p62 functions as a “cargo” receptor of the degradation of ubiquitinated target substrates.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Intracellular protein aggregates to be degraded are labeled by ubiquitination along with p62 appearance. For example, p62 has been found in ubiquitinated protein inclusions, such as neurofibrillary tangles (NFTs) of AD and Mallory bodies (MBs) of nonalcoholic steatohepatitis (NASH).<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> p62 can promote the selective autophagy process by interacting with both ubiquitinated substrates and LC3 through its UBA and LIR domain, respectively.</div><div class="NLM_p">Since selective autophagy plays an important role in physiological or pathological processes, it is necessary to detect its level for fear of malfunction. LC3 is a recognized marker of autophagy. LC3-I (cytoplasmic LC3) will lose a small polypeptide through enzymolysis and translate to LC3-II (autophagosome membrane type) during autophagy occurrence.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Therefore, it is a viable method to evaluate the level of autophagy, which is usually called autophagy flux, by measuring the ratio of LC3-II/LC3-I under the condition of autophagy inhibitor or activator treatment. In addition, the level of p62 could reflect the level of autophagy due to the fact that p62 can be degraded as an autophagic substrate through its LIR domain binding to LC3.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> In the experiment of detecting autophagy flux by p62, effects of lysosomal activity and gene expression should also be considered. Autophagy flux can also reflect the expression of p62, and autophagy is an important factor in the control of the level of p62.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Suppression or decline of autophagy is always accompanied by the accumulation of p62. However, p62 expression is not only merely mediated by selective autophagic degradation but also regulated by UPS, which is responsible for nonselective degradation. The inhibition of UPS enhances p62 transcription as well as the accumulation of ubiquitinated proteins.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Besides, the <i>SQSTM1</i> gene transcriptional regulation is also positively stimulated by compound induction and oxidative stress associated with Nrf2. A high level of p62 or proteasome deficiency promotes the activation of Nrf2<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> and elevated Nrf2 expression also results in the transcriptional activation of the <i>SQSTM1</i> gene in return, further inducing p62 synthesis through a feed-forward loop.</div><div class="NLM_p last">It is generally considered that p62 is not only a substrate but also a “cargo” receptor for the autophagic degradation of ubiquitinated protein aggregates. Although the negative correlation between autophagy and this adaptor protein has been manifested, how p62 functions in recognizing selective autophagy substrates against ordinary “cargoes” should be deeper studied and investigated. Dysfunction of autophagy causes up-regulation of p62 and p62-containing protein aggregates, which are usually associated with neurodegenerative diseases and oncogenesis.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The connection between p62 accumulation and disease occurrence or development will be clearly demonstrated in the following paragraphs.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">4.  p62 and Tumorigenesis</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10433" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10433" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cell death and survival are two significant aspects of metabolism to maintain normal physiological activity, once blocking the balance will contribute to the occurrence of various diseases including cancer. Tumorigenesis, characterized by excessive proliferation, is a consequence of sequential mutations in genes regulating cell growth and proliferation.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Aberrant expression of p62 has been implicated in multiple forms of cancer such as human hepatocellular carcinoma (HCC),<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> pancreatic ductal adenocarcinoma (PDAC),<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> and prostate cancer (PCa).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> The relationship between p62 and different types of cancer is complex, and sometimes even contradictory. Growing lines of evidence reveal that p62 accumulation in epithelial cells is a necessary and sufficient condition to induce tumorigenesis and deterioration without other extra carcinogen stimuli,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> independent of its functions associated with autophagy. In other words, the level of p62 expression is proportional to tumor formation, and p62 is regarded as an oncogenic protein for its overexpression <i>in vivo</i>. However, the negative impacts of p62 up-regulation are not absolute in the process of the tumor. Valencia et al. reported that the down-regulation of p62 in the stroma of several tumors, especially in cancer-associated fibroblasts (CAFs), is suggested as a potential contribution to promoting cancer progression.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Here, p62 acts as a noncell-autonomous tumor suppressor by reducing inflammation in the tumor microenvironment.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Indeed, p62 dysfunction is relative to not only tumor formation and promotion but also drug resistance of therapy. Therefore, it is necessary to discuss the dual role of p62 in tumorigenesis, respectively, from different angles.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">4.1.  p62 as a Tumor Activator</h3><div class="NLM_p">Multifunctional functions of p62 make itself a potential regulator of tumorigenesis through interacting with pathways responsible for controlling the cell anabolism and catabolism. p62 accumulation contributes to cancer progression mainly through five approaches (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>): (1) selective autophagy, (2) the NF-κB signaling pathway, (3) the Nrf2 pathway, (4) the mechanistic target of the rapamycin (mTOR) pathway, (5) the oncogenic transcription factor Twist1 pathway.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/medium/jm9b02038_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Positive correlation between p62 and tumorigenesis in epithelium cells. p62 makes itself a central regulator of tumorigenesis through interacting with pathways responsible for controlling cell anabolism and catabolism. p62 accumulation contributes to cancer progression mainly associated with five approaches: (1) selective autophagy, (2) nuclear factor-κB (NF-κB) signaling pathway, (3) nuclear factor erythroid 2-related factor 2 (Nrf2) pathway, (4) mechanistic target of rapamycin (mTOR) pathway, (5) the oncogenic transcription factor Twist1 pathway.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i7" class="anchor-spacer"></div><h4 class="article-section__title" id="_i7">4.1.1.  Autophagy Dysfunction</h4><div class="NLM_p last">Eskelinen pointed out that autophagy plays a dual role in tumorigenesis.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> During the initial stage of tumorigenesis, autophagy functions as a tumor suppressor through eliminating damaged organelles, alleviating oxidative stress, and promoting oncogene-induced senescence.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> On the contrary, once the cancer has established, autophagy is pro-tumorigenic to protect cancer cells from metabolic stress, inflammation, chemotherapy-induced stresses,<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> and anoikis.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Either autophagy suppressing or promoting tumor development depends on the cancer subtype and the stage of tumor development.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> p62 is a specific autophagy substrate and fails to be normally degraded by autophagy deficiency in the tumor, which causes the accumulation of p62.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Elevated p62 expression is associated with degenerated protein aggregate accumulation and production of reactive oxygen species (ROS), inducing endoplasmic reticulum (ER) stress and DNA damage.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> These detrimental phenomena, as well as persistent activation, of Nrf2 are usually observed in autophagy impairment caused by the loss of Atg5 or Atg7 (<i>Atg5</i><sup><i>–/–</i></sup> or <i>Atg7</i><sup><i>–/–</i></sup>) in mouse liver, ultimately leading to HCC and other liver tumors.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Loss of p62 or Nrf2 is also found to succeed in suppressing tumor development in aforementioned animal models.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Additionally, Moscat et al. proposed that p62-positive aggregates impact on cell survival by activating the NF-κB pathway and cell death by caspase-activated apoptosis.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Taken together, p62 functions as an oncogenic protein to promote tumorigenesis in autophagy-defective cells and animals. It reveals a potential therapy for tumors through activating autophagy to promote p62 accumulation and degrade protein aggregates for clearance and degradation in the early stage of cancer. Nevertheless, it is noteworthy that autophagy is observed to be up-regulated in many Ras-induced cancer cell lines, and Ras-expressing <i>Atg5</i><sup><i>–/–</i></sup> or <i>Atg7</i><sup><i>–/–</i></sup> cells displayed tumor inhibition in mice compared to the control group.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> For example, malignant melanoma survives from anticancer treatments by activating autophagy to overcome drug-induced stress or cytotoxicity<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> and is prevented from anoikis, which may promote metastasis.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> For the pro-tumorigenic function of autophagy in Ras-induced cancer, it is suggested that inhibiting autophagy can augment anticancer activity and chemosensitivity in combination with conventional chemotherapy.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> The dual identity of autophagy in tumor reflects the significance of targeted therapy.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8">4.1.2.  NF-κB Pathway Activation</h4><div class="NLM_p last">The NF-κB pathway is a critical regulator of inflammation and the immune response involved in cellular survival.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> NF-κB signaling cascade induction has been regarded as a distinguishing feature of several tumors.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Activation of the NF-κB pathway is involved in promoting tumorigenesis from three aspects.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Initially, NF-κB activation promotes the production of ROS to induce DNA damage and oncogenic mutations. Then it promotes the proliferation and differentiation of tumor cells, meanwhile preventing Ras-induced cell death from p53-independent apoptosis.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Finally, NF-κB activation-induced inflammation speeds cancer deterioration and metastasis by stimulating the expression of genes responsible for promoting neoangiogenesis and cancer cell invasion.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> p62 interacts with TRAF6 to activate NF-κB activation via proinflammatory cytokines including interleukin-1 (IL-1),<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> tumor necrosis factor (TNF),<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> and nerve growth factor (NGF) receptors.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Recent studies have confirmed that the function of p62 in NF-κB activation is relevant in tumorigenesis such as lung cancer and PDAC.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Oncogenic Ras mutations are usually detected in a variety of human cancers and draw wide attention in the research of cancer. Ras is indispensable for cancer initiation and progression for its function of promoting cell survival.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Oncogenic transformation is abolished by the ablation of p62 in the endogenous Ras-induced lung cancer model, revealing p62 as a central player in Ras-induced carcinogenesis.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> A feed-forward loop between p62, NF-κB, and Ras has been illuminated to promote tumor cell survival in PDAC development.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Ras activates NF-κB by stimulating signal transduction cascades;<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> NF-κB then transcriptionally induces p62 up-regulation, which is necessary for Ras to trigger IkB kinase (IKK) and leads to further NF-κB activation in return. Once an element of this loop is disturbed, the vicious circle will be blocked and contributes to increased cell death and decreased tumorigenicity. Ras-dependent carcinogenesis development is also positively related to autophagy expression. The Ras-induced tumor is prevented by interfering with both autophagosome formation caused by autophagy deficiency and “cargo” delivery to autophagosomes caused by p62 depletion.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Autophagy disruption by FIP200 (FAK family interacting protein of 200 kDa, an essential autophagy-related protein)<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> deletion inhibits the growth of established tumors, and knockdown/knockout of p62 in established FIP200-null tumors further impedes tumor growth.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Wei et al. concluded that p62 can synergize with autophagy to obstacle established tumors growth, providing a new insight that inhibition of both p62 accumulation and autophagy up-regulation may be more effective than targeting alone for Ras-induced cancer therapy. (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9">4.1.3.  Nrf2 Pathway Activation</h4><div class="NLM_p">Oxidative stress caused by overproduction of ROS leads to cellular damage and promotes cell death.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> The Nrf2–Keap1 pathway has been reported to function as a crucial cellular defense mechanism against electrophilic and oxidative stresses.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Persistent activation of Nrf2 has been found in autophagy-deficient tumor cells as well as p62 accumulation. It has been demonstrated that overexpression of p62 increases the levels of nuclear Nrf2, ARE-luciferase, and NAD(P)H dehydrogenase quinone 1 (a target antioxidative response gene).<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Nrf2 is a key transcription factor responsible for gene expression of cytoprotective enzymes, antioxidant proteins, and phase II detoxifying enzymes to neutralize ROS and restore cellular redox balance.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> On the other hand, persistent activation Nrf2 leads to cell excessive proliferation, usually existing in uncontrolled inflammation and tumorigenesis. Keap1 is a substrate adaptor protein of a Cullin 3 (Cul3)-based ubiquitin ligase and functions to maintain a low level of Nrf2 by promoting its ubiquitination and degradation in 26S proteasome under normal conditions (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Upon induction of ROS, Nrf2 is activated to protect cells from oxidative stress through the canonical and noncanonical mechanism. In the canonical pathway, Keap1/Cul3-mediated Nrf2 degradation is blocked through modification of cysteine residues in Keap1, resulting in Nrf2 escaping from Keap1-induced ubiquitination and activation of the Nrf2-dependent cytoprotective gene. In addition to the canonical pathway, Nrf2 activation can also be achieved by several endogenous proteins such as p62 and p21, functioning as a noncanonical way to disturb the Nrf2–Keap1 interaction (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> The KIR domain of p62 competitively binds to the Kelch domain of Keap1, which is the same binding site of Nrf2, resulting in the dissociation of the Nrf2–Keap1 complex and activation of Nrf2 to induce the expression of ARE-bearing genes.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Increased Nrf2 expression also results in the transcriptional activation of the <i>SQSTM1</i> gene and increasing further p62 accumulation in turn. The positive correlation between p62 accumulation and constitutive activation of Nrf2 constitutes a feed-forward loop, which promotes cancer cell survival against various stresses caused by oxidative damage or anticancer agents. Saito T et al. reported that the accumulation of p62 is sufficient to induce the development of HCC, and cancer cells are conferred with enhanced proliferation ability and anticancer resistance through sustained Nrf2 activation.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> However, it should be pointed out that Nrf2 up-regulation is harmful to tumor treatment for its excessive reproductive capacity, but it plays a protective role in normal or damaged cells. This reminds us of the importance to develop target therapy of cancer: devoted not only to inhibit abnormal tumor cell growth but also to ensure normal cells are free from harm. It is a potential therapeutic to design and exploit p62 targeting inhibitors to reducing the overexpression of p62 and down-regulation of Nrf2 to suppress cancer cell survival and growth.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/medium/jm9b02038_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Degradation of Nrf2 activated by Keap1. Keap1 is a substrate adaptor protein of a Cullin 3 (Cul3)-based ubiquitin ligase, and it functions to maintain a low level of Nrf2 by promoting its ubiquitination and degradation in 26S proteasome under normal conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/medium/jm9b02038_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Canonical and noncanonical pathways of Nrf2 activation. Canonical pathway induced by oxidative stress or electrophiles: Keap1/Cul3-mediated Nrf2 degradation is blocked through modification of cysteine residues in Keap1, resulting in Nrf2 escaping from Keap1-induced ubiquitination and activation of the Nrf2-dependent cytoprotective gene. In the noncanonical pathway, Nrf2 activation can also be achieved by several endogenous proteins p62, functioning as a noncanonical way to disturb the Nrf2–Keap1 interaction. The KIR domain of p62 competitively binds to the Kelch domain of Keap1, which is the same binding site of Nrf2, resulting in the dissociation of the Nrf2–Keap1 complex and activation of Nrf2 to induce the expression of ARE-bearing genes and the <i>SQSTM1</i> gene, which constitutes positive feedback between p62 accumulation and Nrf2 activation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10">4.1.4.  mTOR Pathway Activation</h4><div class="NLM_p last">mTOR, belonging to the PI3K-related kinase family, is a serine/threonine protein kinase. It is a part of two distinct protein complexes in mammalian cells: mTOR complex 1 (mTORC1, consisted of mTOR, Raptor, and GβL proteins) and mTOR complex 2 (mTORC2, consisted of mTOR, Rictor, mSin1, GβL, and Protor).<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> mTORC1 is an important promoter of protein synthesis and cell growth, which is usually overexpressed in tumorigenesis.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Actually, up-regulation of mTORC1 highly accelerates cancer process by impacting on both anabolism and catabolism.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> This complex is beneficial to enhance cancer cell growth by stimulating the production of protein, lipid, and nucleotide, simultaneously inhibiting catabolic pathways such as autophagy.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> p62 has been reported to be an anti-inflammatory tumor suppressor through its regulation of the mTORC1 pathway in epithelial prostate cancer cells.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> This signaling adapter is considered as a nutrient sensor for the activation of the mTORC1 pathway in response to amino acids by interacting with Raptor and the Rags proteins.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> p62 can be phosphorylated at Thr269 and Ser272 by mitogen-activated protein kinase 3/6 (MEK3/6) and p38 delta and is driven by the PB1-containing kinase MEKK3 under amino acid stimulation.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> Then p62 interacts with Raptor, Rag proteins, and the E3-ubiquitin ligase TRAF6 to recruit mTORC1 to the lysosomal membrane and catalyze mTOR polyubiquitination. Finally, the ubiquitination driven by p62-TRAF6 under amino acid-rich conditions results in mTORC1 activation, followed by increased anabolism capacity and cell growth.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Taken together, aberrant p62 accumulation is a critical component of the mTORC1 activation in multiple human cancers, suggesting that the p62-mTORC1 cassette may be a potential target to delay cancer development. Inhibitors of p62 or mTORC1 are expected to function as suppressors of tumorigenesis. For instance, Sapanisertib is an effective oral adenosine triphosphate (ATP)-dependent mTORC1 inhibitor via exhibiting an enzymatic inhibition activity against mTOR, and it has been applied in clinical practice to anticancer.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> In addition, kinase MEKK3 inhibitors should be designed in the future for its pivotal role in p62 phosphorylation, which is required for mTORC1 activation.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11">4.1.5.  Twist1 Stabilization</h4><div class="NLM_p last">Twist1 is a core oncogenic transcription factor in regulating both early embryonic morphogenesis and cancer development and metastasis.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> It promotes the propagation and migration of cancer cells by inhibiting epithelial-cadherin<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> and facilitating epithelial-mesenchymal transition (EMT).<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Under normal circumstances, Twist1 can be degraded by both autophagy and proteasome systems. However, in autophagy-defective tumor cells, the UBA domain of p62 binds to ubiquitinated Twist1 and blocks the natural degradation of this regulator to stabilize Twist1.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Besides preventing Twist1 from degradation, p62 is also required for Twist1 up-regulation and epithelial-cadherin down-regulation in EMT induced by the epidermal growth factor (EGF)/transforming growth factor-β (TGF-β). Of note, researchers have demonstrated that p62 only promotes cancer cell propagation and migration in the presence of oncogenic protein Twist1 by conducting xenograft mouse models.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Therefore, blocking the stabilization of Twist1 induced by p62 accumulation may be a possible therapeutic strategy for the treatment of autophagy-deficient tumors. The drug combination of autophagy activators and p62 inhibitors may improve the situation of Twist1 overexpression in cancer, by promoting its clearance and inhibiting its proliferation, respectively.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">4.2.  p62 as a Tumor Suppressor</h3><div class="NLM_p">The contents above highlighted the positive correlation between p62 accumulation and cancer progression. However, Valencia et al. reported that p62 sometimes serves as an anti-inflammatory tumor suppressor in the stroma of several tumors.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> For example, in human PCa, p62 is expressed in both prostate epithelium and the stroma. It is noticeable that p62 levels have been shown to increase in the epithelial compartment of the PCa, while down-regulated in the tumor stroma compared to the normal stroma.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Besides genetic alterations within the epithelial compartment, the tumor microenvironment also attracts attention gradually for its critical role in neoplasias progression.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Although pathways between the stromal and epithelial compartments are little researched, it is imaginable that the metabolic state of the tumor stroma has a nonnegligible influence on the oncogenic capacity of the tumor epithelial compartment.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Loss of p62 in stromal cells triggers inflammation and metabolism dysfunction, which are two critical factors contributing to the tumorigenic properties of the stroma. CAFs are activated during tumor progression, as key mediators between malignant cells and the microenvironment.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> p62 deficiency in the stromal fibroblasts results in decreased mTORC1 activity, further triggering an inflammatory response. CAFs can be activated by inflammation and enhance tumor cell proliferation and invasion. Interleukin-6 (IL-6), as a proinflammatory factor, has been implicated as a key proinflammatory and protumorigenic molecule in many tumors including PCa. p62 deficiency in the PCa stroma accelerates prostate tumorigenesis in different mouse models,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> suggesting that p62 functions as a tumor suppressor in the tumor microenvironment.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> There are at least three methods for p62 to serve as an anti-inflammation and anticancerogenesis factor (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). p62 inhibits IL-6 activation in fibroblastic stromal cells by repressing ROS production.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> It has been described before that both NF-κB and Nrf2 pathways can be activated by p62 and protect cells from oxidative stress induced by ROS. Up-regulation of p62 can also activate the mTOR1 pathway to inhibit CAFs activation and blocking inflammation. p62 is a key regulator of c-malignancy myelocytomatosis (c-Myc), which is responsible for glutamine and glucose metabolism.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> It is a novel method to combine epithelial-targeted therapies with target stromal activation by enhancement of p62 expression or inhibition of inflammation.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/medium/jm9b02038_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Negative correlation between p62 and tumor stroma activation. Loss of p62 in stromal cells triggers inflammation and metabolism dysfunction, which are two critical factors contributing to the tumorigenic properties of the stroma.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The signaling adaptor p62 protein is involved in tumorigenesis through sophisticated pathways. It is overexpressed in cancer epithelial cells, while deficient in the tumor microenvironment, particularly in CAFs. The dual role of p62 suggests different potential therapeutic strategies for cancer under different conditions. For instance, the overexpression of p62 can serve as a novel prognostic marker for several tumors, such as epithelial ovarian cancer<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> and lung cancer. However, p62 activators are expected to apply in activating the tumor stroma to delay cancer development. As a whole, drug targeting should be taken into full consideration to avoid possible side effects in normal cells when designing or developing anticarcinogens.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">5.  p62 and Neurodegenerative Diseases</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36882" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36882" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Neurodegenerative diseases are syndromes marked by progressive death of neurons in the brain and spinal cord, resulting in the decline of cognitive ability and behavior disorder. Neurodegenerative diseases mainly include Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS).<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a></div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">5.1.  p62 and AD</h3><div class="NLM_p">AD, the most common form of neurodegenerative disorders, is characterized by memory loss, cognitive impairment, and behavioral abnormalities.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Two predominant pathological hallmarks of AD are extracellular β-amyloid (Aβ) neuritic plaques (NPs) and intraneuronal NFTs occurring in the entorhinal cortex and hippocampus, which are both immediate consequences of the destruction of synapses along with loss of working memory and neuronal apoptosis.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> Besides misfolded protein aggregates, both damaged mitochondria and oxidative stress are relevant to AD, PD, and HD.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> AD-like lesions were detected in both the hippocampus and cortex of the knock out mice (<i>p62</i><sup>–/–</sup>) brain, corresponding to wild-type mice.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> Actually, p62 can be considered as a potential target to treat or delay AD via at least three methods: (1) promoting clearance of toxic protein aggregates; (2) regulating the degraded function of mitophagy; (3) relieving oxidative stress (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/medium/jm9b02038_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. The relationship between p62 and AD pathologies. The decrease of p62 in AD brains is associated with β-amyloid neuritic plaques and NFTs. p62 inhibition leads to the decrease of proteasome activity and promotion of tau-hyperphosphorylation, which results in the accumulation of misfolded tau, a typical characteristic of NFTs. On the other hand, p62 absence can promote Aβ deposition by impacting the Nrf2 and mitophagy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15">5.1.1.  Misfolded Proteins Clearance</h4><div class="NLM_p last">The accumulation of misfolded proteins has been revealed as a hallmark of AD by damaging the balance of protein homeostasis and causing neurotoxicity.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Under normal conditions, misfolded malfunctioning proteins can be removed by three protective mechanisms classified by molecular size: UPS for misfolded monomer, the autophagy-lysosome pathway for most misfolded oligomers, and inclusion body formation for large oligomers.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Ubiquitin makes it an important impact in all three ways, since it marks toxic proteins for different forms of degradation. The UBA domain of p62 binds to ubiquitin-modified proteins and shuttles them to the proteasomal or autophagosomal pathways for degradation via the PB1 or LIR domain, respectively.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> NFTs pathology in AD contains accumulated hyperphosphorylated polyubiquitinated tau, which is initially discovered as a major microtubule-associated protein found in the axons of neurons. Tau is a K63-polyubiquitinated TRAF6 substrate that interacts with the UBA domain of p62 and is targeted for proteasomal degradation.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Decline of p62 expression in AD makes p62 unable to shuttle polyubiquitinated tau for clearance and contributes to the accumulation of aggregated polyubiquitinated tau. Besides disturbing ubiquitinated tau degradation, p62 absence is also directly related to tau-hyperphosphorylation,<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> which promotes abnormal aggregation of misfolded tau with decreased binding to microtubules.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> Hopefully, the elevation of the p62 level is beneficial to remove aggregated polyubiquitinated tau and in favor of reversing AD pathologic courses. Another major lesion characteristic of AD is the abundant deposition of Aβ in senile plaques of brain tissue.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> The Aβ peptide is a proteolytic fragment, containing 39–43 amino acids, derived by the β- and γ-secretase cleavage of the transmembrane amyloid precursor protein (APP).<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> Overproduction and accumulation of Aβ contribute to early onset familial AD (EOFAD).<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> Failure to remove Aβ deposits from NPs results in late-onset AD (LOAD).<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> The imbalance between production and clearance of Aβ damages the neuronal homeostasis in the brain, accompanied by progressive synaptic dysfunction and neuritic injury. Geetha et al. reported that p62 cooperating with TRAF6 inhibits Aβ-mediated neuronal death through the p75 neurotrophin receptor (p75<sup>NTR</sup>, a member of the TNF receptor superfamily).<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> NGF is a specific ligand binding to p75<sup>NTR</sup> and induces polyubiquitination to promote cell survival and differentiation.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> TRAF6 and p62 are essential for p75<sup>NTR</sup> polyubiquitination upon NGF stimulation since TRAF6 functions to polyubiquitinate substrates and p62 enhances the ubiquitin ligase activity of TRAF6, while p75<sup>NTR</sup> recruits TRAF6/p62 to activate the NF-κB pathway to mediate cell survival.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> However, Aβ can also interact with p75<sup>NTR</sup> to induce neuronal cell death by impairing the polyubiquitination process dependent on TRAF6/p62.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> It is a potential therapeutic approach to enhance TRAF6/p62 expression for that they are capable of relieving the Aβ-mediated inhibition of p75<sup>NTR</sup> polyubiquitination and restoring neuronal cells survival.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16">5.1.2.  Mitophagy Regulation</h4><div class="NLM_p last">Mitochondria are referred to as the “powerhouses” of cells, which are the primary producers of cellular energy currency ATP and a major source of ROS.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Mitophagy, one form of the selective autophagic pathway, functions as a selective scavenger to degrade impaired or superfluous mitochondria.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Mitophagy and mitochondrial biogenesis are two sides to control mitochondrial homeostasis essential for cellular function and survival.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> Nevertheless, mitophagy balance is compromised in AD neurological pathologies, which subsequently induces damaged mitochondria accumulation resulting in reduced cellular ATP levels and excessive ROS production.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> Mattson et al. reported that superfluous ROS generated by altering mitochondria can also promote the accumulation of polyubiquitinated tau aggregates.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> Additionally, increased ROS generation causes oxidative stress, a function of ROS defenses, resulting in increased γ-secretase activity to accelerate Aβ production and deposition in neurons.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> Although mitophagy is regarded to be closely correlated with neurodegeneration, its explicit mechanism has not been elucidated. One of the most studied theories is that mitophagy is mediated by PTEN-induced putative kinase protein 1 (PINK1, a mitochondria-targeted serine/threonine kinase) and Parkin (a subunit of ubiquitin E3 ligase) in mammalian cells.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Once mitochondrial damage occurs, the inner membrane potential disappears and leads to the dimerization and cross-phosphorylation of PINK1. Subsequently, Parkin is recruited by PINK1 to mitochondria, and the increased E3 ubiquitin ligase activity of Parkin contributes to the induction of mitophagy. In this process, p62 binds to Parkin-ubiquitinated mitochondrial substrates and mediates the accumulation of mitochondria reported by Ding et al.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> The relationship between PINK1, Parkin, and p62 can be summarized as the mitochondrial translocation of Parkin is controlled by functional PINK1,<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> while functional Parkin is a prerequisite for the recruitment function of p62 to clustered mitochondria.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Even so, it is still controversial about the involvement of p62 in PINK1/Parkin-mediated mitophagy. Geisler et al. found that the knockdown of <i>SQSTM1</i> resulted in the failure of mitochondrial clearance compared with the control.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Park et al. also reported that p62 can interact with choline dehydrogenase (CHDH) to recruit LC3 to impaired or superfluous mitochondria and then stimulate mitophagy.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> The above research proved that p62 is required for PINK1/Parkin-dependent mitophagy and essential for the final mitochondrial clearance.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> However, several recent studies dispute the nonsubstitutable position of p62 in mitophagy. Hollville et al. suggested that NBR1 can replace p62 to mediate mitophagy in the cytosol.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> Lazarou et al. knocked out five autophagy receptors (TAX1BP1, NDP52, NBR1, p62, and Optineurin) in HeLa cells to clarify the function of receptors during mitophagy. They manifested that both p62 and NBR1 are the dispensable receptors for PINK1/Parkin-mediated mitophagy.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> Calvo-Garrido et al. reported that p62 is not required for mitochondrial removal, and p62 absence is unrelated to mitophagy deficiency in neuroepithelial stem cells (NESCs).<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Haack et al. pointed out that p62 is involved in Parkin-induced mitochondrial clustering but is unnecessary for mitochondrial clearance.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Given the above, mitophagy can occur through a p62-independent method, and p62 is dispensable for mitophagy itself. Even though the irreplaceable position of p62 is controversial in PINK1/Parkin-mediated mitophagy, it is generally considered that p62 is associated with the perinuclear clustering of depolarized mitochondria and managing mitochondria quality control (MQC) through selective “cargo” recognition.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> Up-regulation of the p62 level to enhance the interaction between p62 and Parkin might be favorable for rebalancing mitophagy to recover normal degradation function.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17">5.1.3.  Oxidative Stress Alleviation</h4><div class="NLM_p last">Oxidative stress, an immediate consequence of ROS over generation, is a significant risk factor associated with AD as well as other aging-related diseases.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> Products of lipid and nucleic acid oxidation such as malondialdehyde (MDA), 4-hydroxynonenal (4-HNE),<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> and 8-hydroxyguanosine (8-OHG)<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> can be perceived as diagnostic biomarkers for early AD because they have been confirmed to express elevated levels in mild cognitive impairment (MCI). In the AD pathological process, oxidative stress may be induced by multiple mechanisms including inflammation, metal accumulation, hyperphosphorylated tau, and mitochondrial dysfunction mentioned before.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> Antioxidants, such as Mitoquinone (MitoQ)<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> and curcumin,<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> may be used for exerting neuron protection in AD by eliminating ROS and preventing oxidative damage. Oxidative stress can also directly damage the promoter region of p62, as an oxidative stress-induced protein,<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> and inhibit the transcriptional activity of the p62 promoter via oxidative modification of the Sp-1 (an amplicon within human p62 promoter) transcription factor binding site.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> Increased p62 expression competitively binding to Keap1 can stimulate Nrf2 to activate ARE-driven gene translation in response to oxidative stress through creating a positive feedback loop between p62 up-regulation and Nrf2 activation.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> However, several studies proved that the Keap1-Nrf2-ARE pathway can be inducted by a p62-independent method. Valencia et al. claimed that no changes of Keap1 and Nrf2 occurred in p62-deficient stromal fibroblasts. Kwon et al. also found that the Nrf2 pathway was still activated in <i>p62</i><sup><i>–/–</i></sup> mice. The Keap1–Nrf2 interaction may be blocked by other means besides binding to the KIR domain. Although the uniqueness of p62 is uncertain in this process, increased p62 expression is conducive to activating the Keap1–Nrf2–ARE pathway. Moreover, p62 itself may be capable of sensing the oxygen concentration directly, like an oxygen sensor.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Carroll et al. reported that two oxygen-sensing cysteine residues (C105 and C113) of p62 promote activation of autophagy in response to ROS-induced oxidative stress.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> p62 is able to sense the saturation of ROS, and the redox-sensitivity of p62 might be involved in facilitating efficient autophagy to maintain cellular homeostasis.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> Logically, the up-regulation of p62 is a potential defense against oxidative stress to maintain cell viability. The aforementioned deletion of the Sp-1 binding site could activate p62 through abolishing the damage of the oxidative stress-modified promoter, but this complicated method to activate p62 is infeasible in clinical use.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18">5.2.  p62 and ALS/FTD</h3><div class="NLM_p last">Although P62 accumulation promotes AD pathology progression, several missense mutations of <i>SQSTM1</i> have also been identified in patients with other adult-onset neurodegenerative diseases including ALS and frontotemporal dementia (FTD).<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> ALS is a motor neuron disease characterized by the degeneration of the brain and spinal cord motor neurons and progressive muscle weakness, finally leading to muscle paralysis.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> Kwok et al. sequenced the <i>SQSTM1</i> gene in a cohort of 61 familial ALS patients, and the P392L and G155L mutations were predicted to be pathogenic.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The P392L mutation in the UBA region is present in both familiar ALS and PDB, indicating a common pathogenic mechanism between ALS and PDB. Frontotemporal dementia (FTD) is the third most common cause of neurodegenerative dementia, after AD and PD.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> Compared with the progressive muscle paralysis of ALS, FTD affects brain regions and leads to dementia. Kunikazu et al. identified that p62 is involved in degrading the 43 kDa transactive response-DNA-binding protein (TDP-43, existing in most FTD cases).<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> ALS and FTD belong to the same clinicopathological spectrum despite different clinical symptoms. Many patients even suffer from both ALS and FTD simultaneously.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> p62 mediates the progression of ALS/FTD through three possible methods: the Keap1–Nrf2–ARE, NF-κB signaling, and autophagy pathways. Two mutations in the KIR domain (P348L and G351A) result in the failure of p62 binding to Keap1, which further fails to activate Nrf2 and fight oxidative stress.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> Both Keap1–Nrf2 signaling and oxidative stress have been observed in the post mortem tissues from ALS/FTD patients.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> p62 regulates the NF-κB signaling pathway via its PB1 and TB domain. Several mutations in the two domains have been identified in ALS/FTD patients, which indicates that defective NF-κB signaling might be a possible cause of ALS/FTD.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> Two mutations in the LIR domain (D337E and L341V) are associated with ALS/FTD, contributing to the failure of p62 interacting with LC3 and autophagic degradation.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a></div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">6.  p62 and Atherosclerosis (AS)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15746" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15746" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Atherosclerosis (AS), characterized by excessive cholesterol deposition and lipid accumulation, is the main cause of coronary heart disease, cerebral infarction, and peripheral vascular disease.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> There are three main proposed mechanisms suggested in AS pathology: dampened inflammasome/IL-1b activation, accelerated removal of protein aggregates, and particularly increased cholesterol efflux, which has become a hot spot in the research study in recent years.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> Dyslipidemia, characterized by excessive cholesterol deposition and low concentration of high-density lipoprotein, makes AS a serious public health problem, resulting in thrombus formation, myocardial infarction, stroke, and sudden cardiac death.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> Even though various AS onset hypotheses have been proposed, unequivocal curative treatments are still not available. In AS animal models, we can find that the level of p62 expression is higher than the corresponding controls.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> The phenomenon activates us to discuss the relationship between p62 protein and AS.</div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">6.1.  p62 as an AS Activator</h3><div class="NLM_p last">A growing body of evidence has demonstrated the important role of selective autophagy in AS. The disruption of macrophage autophagy in mice (<i>Atg5</i><sup><i>–/–</i></sup>) leads to an obvious increase of cholesterol crystals, the hallmark of atherosclerotic plaques, indicating the occurrence of AS.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> Autophagy plays a protective role of in vascular smooth muscle cells (VSMCs) via degrading damaged intracellular proteins, especially dysfunctional mitochondria.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> The dysfunction of autophagy in AS causes a vicious circle, where damaged materials are unable to be cleared and lead to further autophagy inhibition. p62 was observed at a high level in macrophage-rich areas of atherosclerotic aortas detected by Western blotting, consistent with autophagy dysfunction. In fact, the formation of p62-enriched polyubiquitinated aggregates has become a novel hallmark of the deficient autophagy in advancing atherosclerotic plaques.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> Therefore, we can propose a hypothesis that the abnormal increase of p62 expression may be a feature of atherosclerotic plaques under autophagy-deficient conditions and positively correlated with the progression of AS. Previous experiments have shown that the knockdown of p62 could inhibit the formation of lipid-laden foam cells and improve autophagic activity leading to increased reversal cholesterol transportation<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> and lowering lipid deposition. Both lipid-laden foam cells and excessive lipid deposition can facilitate the development and deterioration of AS in lesion plaques.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">6.2.  Possible Atheroprotective Methods</h3><div class="NLM_p last">Because of the positive relationship between the p62 level and AS, it is a potential method to treat AS by down-regulating p62 expression or enhancing autophagic activity. Autophagy normally plays a critical role in preventing the formation and development of lipid-filled foam cells in the early stage of AS. Here are three available instances of activating autophagy and inhibiting p62 to reduce AS: trehalose, green tea polyphenol (GTP), and rapamycin. Trehalose, the nonreducing natural disaccharide, has been reported as an available autophagy inducer <i>in vivo</i> and functions as an atheroprotective role through regulating autophagy and p62.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> Trehalose promotes the autophagy degradative property by inducing macrophage autophagy-lysosomal biogenesis and simulating the atheroprotective activity of macrophage TFEB overexpression, which is a dominating transcriptional activating factor of linking autophagy to lysosomal biogenesis.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> Trehalose up-regulates the activity of the autophagy-lysosome system in macrophages to achieve the objective of protecting VSMCs from AS through increased protein aggregate clearance, reduced apoptosis, and reduced IL-1B production.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> In summary, trehalose-driven atheroprotection is autophagy- and p62-dependent. It is worth mentioning that despite trehalose as a treatment for cardiovascular disease, atheroprotection has not been observed by oral administration only, but intraperitoneal administration exhibits a stable level. This reminds us that further animal experiments of trehalose evaluations should consider the method of administration. GTP, a type of flavonoid, is a polyphenol source from green tea. Consisting of epigallocatechin-3-gallate (EGCG) and catechin primarily, GTP has called widespread attention for its effect on preventing cardiovascular diseases.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> GTP inhibits atherogenesis through improving the autophagy flux in the vessel wall of apolipoprotein E-knockout mice (ApoE-knockout mice, an animal model of AS) as well as directly inhibiting the level of oxidized low-density lipoprotein (oxLDL), which induces p62 accumulation in macrophage-rich areas of atherosclerotic aortas.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> Moreover, GTP has other beneficial effects on atheroprotection, such as antioxidant function and regulation of lipid metabolism. The mechanism of GTP functioning indicates that the combined action of up-regulating autophagy to promote lipid metabolism and decreasing lipid droplets in endothelial cells may be more effective in atheroprotection than a single pathway. This suggests that a multitarget interaction is superior to a single target. Rapamycin is a well-known inhibitor of autophagy and has been reported to play a potential role in treating AS.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> The mTOR pathway enhances foam cell formation by dampening autophagy activation and could be activated during foam cell formation in turn. Silencing mTOR expression is an available therapy to slow down the initiation and progression of AS and complications by inhibiting foam cells and activating autophagy to promote reverse cholesterol transport. To sum up, up-regulating autophagy and inhibiting p62 overexpression may provide a novel strategy against AS.</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22">6.3.  Differences between AS and AD</h3><div class="NLM_p last">By comparing AS and AD, aberrant protein aggregation is a common pathogenic feature. Misfolded protein accumulation is discovered in both damaged neurons<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> and atherosclerotic plaques.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> It is evident that degrading insoluble protein aggregates is an effective approach to prevent the cell from cytotoxicity and apoptosis in various autophagy-associated diseases. It is worth noting that p62 serves diverse functions in these two diseases. p62 overexpression is a severe issue and should be degraded in advancing atherosclerotic plaques, while the up-regulation of p62 is expected to delay the AD process. Different impacts of autophagy on AS and AD may account for this contradictory phenomenon. The correlation between autophagy dysfunction and AS is explicit: autophagic activity in macrophages is inhibited by exorbitant lipid deposition, and p62 as an autophagy substrate is above the normal level. Therefore, the main duty of atheroprotection is to activate autophagy to degrade redundant p62 and other detrimental protein aggregates. Autophagy inducers or p62 inhibitors like resveratrol and XRK3F2 have been reported.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> Nevertheless, the relationship between autophagy and AD is complicated, even controversial. Some researchers believe that the mitophagy system is damaged in AD and mitophagy-inducing compounds such as rapamycin, urolithins,<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> and spermidine<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> may be possible methods of AD treatment. On the contrary, Dai et al. discovered that mitophagy is increased caused by Parkin depletion,<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> and excessive mitophagy leads to synaptic deterioration and axon degeneration.<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> Even so, p62 is distinctly decreased in different stages of neurodegeneration; it is a feasible and promising way to up-regulate p62 expression to delay AD development.</div></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">7.  p62 and Paget’s Disease of Bone (PDB)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87115" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87115" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Paget’s disease of bone (PDB) is the second most common bone disease resulting in serious bone deformity and structural weakness, which influences about 2–3% of the population over 60 years old.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> This disease was first discovered by Sir James Paget who described detailed symptoms after studying the clinical history and post-mortem findings in 1876; hence, the bone disorder was referred to as “Paget’s disease of bone”.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a></div><div id="sec7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24">7.1.  Mechanisms of PDB</h3><div class="NLM_p last">PDB has an autosomal dominant feature with genetic heterogeneity, characterized by highly localized areas of abnormal and excessive bone turnover, especially increased bone resorption accompanied by bone formation disorders with vigorous but aberrant osteoclasts (OCLs) activity.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> Normal physiological function of bone depends on the precise balance between formation and resorption controlled by osteoblasts (OBLs) and OCLs. Abnormality of OCL activity is an essential factor for focal bone lesions and PDB genesis. Multiple influencing elements of PDB via inducting OCLs overexpression have been put forward: inheritance, environmental factors, and gene mutations. Moreover, familial clustering is often observed in this lesion, with between 15 and 40% of patients having at least one affected first-degree relative.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> In spite of various elements involved in PDB genesis and evolution, the exact mechanism remains unclear currently. There is an intriguing hypothesis considering that somatic mutations in bone cells may contribute to the pathogenesis of pagetic lesions,<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> similar to somatic mutations in oncogenes and tumor suppressor genes do in tumorigenesis.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a></div></div><div id="sec7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25">7.2.  p62<sup><i>P392L</i></sup> Mutation</h3><div class="NLM_p">Hitherto, the only uncovered gene with mutations in the coding region linked to PDB is <i>SQSTM1</i>, which encodes the p62 protein, as mentioned before. Recurrent mutations lying in the UBA domain have been identified in about 25% of familial and less than 10% of sporadic cases. To explore the role of p62 mutation in PDB, predecessors have generated mice harboring a mutation causing a proline-to-leucine (P-to-L) substitution at residue 394 (the murine equivalent of human p62<sup><i>P392L</i></sup>, the most common mutation in PDB). Subsequent results demonstrated that despite the enhanced osteoclastogenic potential of both bone marrow stromal cells and OCL precursors, which developed progressive osteopenia, in p62<sup><i>P394L</i></sup> knock-in mice, these transgenic mice had histologically normal bones without pagetic bone lesions.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> Obviously, expression of the p62 predisposing mutation (p62<sup><i>P392L</i></sup>) contributes to increased OCLs activity by enhancing the capacity of associated cells or signaling pathways to support osteoclastogenesis as well as to increase new bone formation.</div><div class="NLM_p">The primary cellular defect in PDB is generally thought to reside in large numbers of hyper-multinucleated OCLs; increased OCL formation and resorption play a major pathogenic role in the undesirable bone changes, and suppression of OCL activity in PDB patients results in prolonged clinical and histological remissions. On the other hand, the p62<sup><i>P392L</i></sup> mutation is widely associated with OCL differentiation and eventually leads to increased OCL activity, common in PDB. Therefore, it is necessary to explore and reveal the mechanisms of p62<sup><i>P392L</i></sup>, stimulating OCL differentiation in PDB <i>in vivo</i>. p62<sup><i>P392L</i></sup> transduced OCL precursors exhibit higher sensitivity to the osteoclastogenic cytokines receptor activator of the NF-κB ligand (RANKL) and TNF-α than analogous bone marrow cultures in wild-type mice.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> Both RANKL and TNF-α activate signaling pathways involving p62 that ultimately lead to the activation of NF-κB, p38 mitogen-activated protein kinase (MAPK), and extracellular regulated protein kinases 1/2 (ERK1/2), which are important for OCL formation and function. The effects of RANKL on OCL differentiation are mediated by downstream effector molecules, which lead to OCL-specific gene expression. RANKL also promotes OCL survival and participation by stimulating MAPK pathways in new cycles of bone degradation.<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a> OCLs are large multinucleated cells formed through the fusion of precursors of the monocyte–macrophage lineage in response to RANKL stimulation. p62<sup><i>P392L</i></sup> mutation is involved in the RANK signaling pathway through activating the transcription factors including activator protein 1 (AP-1) and NF-κB.<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a> Besides increasing NF-κB activity via IL-1, TNF, and NGF, p62 also links TRAF6 with aPKCs to activate RANKL (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/medium/jm9b02038_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. OCL formation activated by the RANKL–RANK pathway. Increased RANK activates polyubiquitinated TRAF-6 accumulation, which recruits p62 and aPKCs. Phosphorylation of the IKK complex leads to phosphorylation of IKB, which is degraded by the proteasome and activates NF-κB to transcribe genes beneficial to OCL formation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">However, it is controversial whether p62<sup><i>P394L</i></sup> mutation in transgenic mice (equivalent to human p62<sup><i>P392L</i></sup>)<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> alone is sufficient to cause a PDB-like disorder or pagetic bone lesions. Kurihara et al. pointed out that the osteoclastogenic potential of both OCL precursors and the marrow microenvironment are increased via p62<sup><i>P394L</i></sup> mutation in knock-in mice models, but these changes caused by p62<sup><i>P394L</i></sup> mutation alone are not sufficient to create the full paget-like phenotype or induce bone lesions.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> This suggests that other genetic and environmental factors, such as paramyxoviruses, acting together with gene mutation, are also necessary for the development of PDB <i>in vivo</i>. On the contrary, Daroszewska et al. claimed that P394L mutation in the UBA domain was sufficient to cause a PDB-like disorder in mice,<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> but agreed with the opinion that environmental factors might also affect the severity and extent of PDB. The two conflicting results may attribute to different evaluation methods. On the whole, p62<sup><i>P394L</i></sup> mutation is the root cause for PDB genesis, while environmental factors are conducive to advancing PDB in mice.</div></div><div id="sec7_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26">7.3.  Possible Therapeutic Methods</h3><div class="NLM_p last">To date, there are two main methods to treat PDB clinically: medical management and surgical operations. Bisphosphonates, as antiresorptive agents, are the first choice for PDB treatment through inhibiting bone resorption specifically.<a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(181)</a> However, side effects, including hypocalcemia,<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a> renal impairment, and osteonecrosis,<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> are observed clinically after taking bisphosphonates such as alendronate, pamidronate, etc. Since human p62<sup><i>P392L</i></sup> mutation is the primary cause of PDB, it is an evolvable approach to use genetic testing and target intervention techniques for patients with p62<sup><i>P392L</i></sup> mutation fundamentally. Better effects may be received by combination with inhibitors of the RANKL–RANK–NF-κB pathway for its critical adjusting action in OCL formation and differentiation.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a></div></div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">8.  Small Molecular Modulators of p62</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67260" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67260" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">p62 is suggested to be a potential target for its close interaction with autophagy and Nrf2 regulation. This adaptor protein is detected to be abnormally expressed in various diseases as mentioned before. It is meaningful to design and exploit small molecular inhibitors and activators of p62 to alleviate disease symptoms. Although, there are still no drugs that regulate p62 on the market, some reported small molecules might be noteworthy. Several compounds influencing p62 expression have been reported by previous researchers. However, there are few small molecular drugs directly acting on p62, most influencing its level through other targets. <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> enumerates reported different types of p62 molecular modulators.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Reported Compounds Affected p62 Expression</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/medium/jm9b02038_0009.gif" alt="" id="gr9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/medium/jm9b02038_0013.gif" alt="" id="GRAPHIC-d7e1232-autogenerated" /></img><div></div></div><div class="NLM_p last">XRK3F2 is a specific ZZ-domain of the p62 inhibitor that inhibits multiple myeloma (MM) with an IC<sub>50</sub> of 4.6 μM in the human MM cell line.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> Ripasudil (K-115) is a selective ROCK inhibitor and regulates the expression of p62 in TNF-induced neurodegeneration, with IC<sub>50</sub> values of 19 and 51 nM against ROCK2 and ROCK1, respectively.<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> Both NMS-E973 and BIIB021 are selective heat shock protein 90 (Hsp90) inhibitors, which induce autophagy to degrade p62. NMS-E973 showed a DC<sub>50</sub> less than 10 nM for Hsp90 binding,<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a> and BIIB021 is an orally available inhibitor of Hsp90 with <i>K</i><sub>i</sub> of 1.7 nM.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> K67 is an inhibitor for the Keap1-phosphorylated-p62 (<i>p</i>-p62) protein–protein interaction (PPI) reported by Daisuke Yasuda et al. K67 promotes superfluous Nrf2 degradation by inhibiting the interaction between p-p62 and Keap1 with an IC<sub>50</sub> value of 1.5 μM, resulting in the suppression of tumorigenesis and anticancer drug resistance of HCC.<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> Tsuganezawa et al. utilized two-colored fluorescence correlation spectroscopy (FCS) to screen for LC3–p62 interaction inhibitors. They achieved two selected inhibitors with IC<sub>50</sub> values less than 2 μM: compound <b>1</b> and compound <b>2</b>.<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a> Sulfasalazine (SAS) is a classic inhibitor of NF-κB. SAS that can induce p62 expression may be due to promoting its degradation by autophagy.<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a> Rapamycin and Everolimus are mTOR inhibitors and induce the autophagic activity to degrade p62. Rapamycin showed an IC<sub>50</sub> of 0.1 nM in HEK293 cells,<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a> and Everolimus showed an IC<sub>50</sub> of 5–6 nM.<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> Dactolisib (NVP-BEZ235) is a dual ATP competitive inhibitor of PI3K and mTOR, with an IC<sub>50</sub> of 20.7 nM for mTOR, which can also cause changes in the expression level of LC3 and p62.<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a> Licochalcone A (LCA) is an autophagosome inducer, which can induce the increase of intracellular acidic autophagy vesicles and autophagosomes. The IC<sub>50</sub> value is 0.97 μM for UGT1A1. It can obviously induce LC3-II, beclin 1, and Atg5 protein expression, but reduce p62 protein expression, as well as mTOR phosphorylation.<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a> Resveratrol is a natural plant antitoxin with anticancer and anti-inflammatory properties, which could induce p62 expression by activating autophagy. The IC<sub>50</sub> value is 3.3 μM for DNA polymerase α.<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a> ABT-751(E 7010) is a new biocompatible microtubulin binding agent and mitoid-resistant sulfonamide compound to promote autophagy and inhibit p62, with an IC<sub>50</sub> of 1.5 μM in neuroblastoma cell lines.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> Dehydroepiandrosterone (DHEA), as an important endogenous steroid hormone, is an androgen receptor antagonist and estrogen receptor agonist. DHEA prevents linoleic acid (LA)-induced endothelial senescence by increasing the ratio of LC3-II and decreasing the level of p62 in a time- and dose-dependent manner.<a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a> (1<i>S</i>,3<i>R</i>)-RSL3 and ML-162 are two inhibitors of glutathione peroxidase 4 (GPX4), which induces the hypertrophic death of head and neck cancer (HNC) cells. In HN3-resistant (HN3-rslR) cells, (1<i>S</i>,3<i>R</i>)-RSL3 or ML-162 treatment increased expression levels of p62 and Nrf2 through inactivation of Keap1.<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a> ML-162 and (1<i>S</i>,3<i>R</i>)-RSL3 are structurally similar, but ML-162 is more potent and selective. (1<i>S</i>,3<i>R</i>)-RSL3 showed an IC<sub>50</sub> of 5.8 μM in HN3-rslR cells.<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a> ML-162 showed an IC<sub>50</sub> of 25 nM in mutant RAS oncogene-expressing cell lines.<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> Vps34-PIK-III is a selective inhibitor of an ATP competitive vacuolar protein sorting 34 (VPS34) with an IC<sub>50</sub> of 18 nM and blocks autophagy, resulting in the increase of LC3-I levels and the stabilization of autophagy substrates including p62.<a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a> VPS34 inhibitor <b>3</b> is a PIK-III analogue with an IC<sub>50</sub> of 15 nM and owns a higher inhibitory effect of VPS34.<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a> Autophinib is a selective autophagy inhibitor with an IC<sub>50</sub> of 90 nM or 40 nM for starvation- or rapamycin-induced autophagy, respectively. Besides, Autophinib is also a VPS34 inhibitor with an IC<sub>50</sub> of 19 nM. Autophinib inhibits p62 degradation via inhibition of starvation- or rapamycin-induced autophagy by targeting VPS34 in MCF7-LC3 cells.<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a> PF-4708671 is a potent cell-permeable p70 ribosomal S6 kinase 1 (S6K1) inhibitor with a <i>K</i><sub>i</sub> of 20 nM and IC<sub>50</sub> of 160 nM. S6K1 functions to regulate protein synthesis and cell growth downstream of the mTOR protein kinase.<a onclick="showRef(event, 'ref203'); return false;" href="javascript:void(0);" class="ref ref203">(203)</a> The absence of S6K1 is accompanied by the formation of p62-positive protein aggregates in muscle hypertrophy.<a onclick="showRef(event, 'ref204'); return false;" href="javascript:void(0);" class="ref ref204">(204)</a> 3-Methyladenine (3-MA) is a PI3K inhibitor and widely used as a depressor of autophagy via inhibiting class III PI3K. Treatment with 3-MA causes a significant increase in p62 expression by blocking the formation of autophagosomes.<a onclick="showRef(event, 'ref205'); return false;" href="javascript:void(0);" class="ref ref205">(205)</a> Verteporfin is a photosensitizer for photodynamic therapy to eliminate the abnormal blood vessels in the eye associated with conditions such as age-related macular degeneration. Verteporfin is identified as a YAP inhibitor by disrupting YAP–TEAD interactions. Additionally, Verteporfin is also an inhibitor of autophagosome by promoting oligomerization of p62 and proves to be tumor-selective proteotoxic in colorectal cancer. The GI<sub>50</sub> value is 228 nM in PhLO cells.<a onclick="showRef(event, 'ref206'); return false;" href="javascript:void(0);" class="ref ref206">(206)</a> Aloxistatin (E64d) is an irreversible membrane-permeable and broad-spectrum cysteine protease inhibitor, which has an inhibitory effect on inhibiting platelet aggregation. E64d attenuates the proliferation of the parathyroid hormone-induced cell <i>in vitro</i> and inhibits osteoblast differentiation. The expression of p62 is significantly enhanced by treatment with E64d.<a onclick="showRef(event, 'ref207'); return false;" href="javascript:void(0);" class="ref ref207">(207)</a> Dorsomorphin (BML-275) is a selective and cell-permeable AMPK inhibitor by competing with ATP, with a <i>K</i><sub>i</sub> of 109 nM in the absence of AMP.<a onclick="showRef(event, 'ref208'); return false;" href="javascript:void(0);" class="ref ref208">(208)</a> BML-275 can promote p62 expression and reduce the levels of LC3 and p-AMPK by inhibiting estrogen-induced cell autophagy. Cycloheximide (CHX) is an inhibitor of eukaryotic protein synthesis, and the IC<sub>50</sub> value of inhibiting protein synthesis is 532.5 nM <i>in vivo</i>.<a onclick="showRef(event, 'ref209'); return false;" href="javascript:void(0);" class="ref ref209">(209)</a> Nrf2 is activated through up-regulating p62 after treatment with CHX. Proadifen hydrochloride (SKF-525A) is a cytochrome P450 (CYP) inhibitor with an IC<sub>50</sub> of 19 μM and promotes p62 expression.<a onclick="showRef(event, 'ref210'); return false;" href="javascript:void(0);" class="ref ref210">(210)</a> Chloroquine (CQ) is an autophagy and toll-like receptors (TLRs) inhibitor, which can induce the expression of p62 by inhibiting autophagic flux.<a onclick="showRef(event, 'ref211'); return false;" href="javascript:void(0);" class="ref ref211">(211)</a></div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">9.  Discussion and Perspectives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63772" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63772" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Based on the above descriptions, p62 is suggested to be a potential target profiting by its close interaction with selective autophagy and Nrf2 regulation. This adaptor protein distributes in organs and tissues throughout the whole body. In other words, p62 is a universal regulatory protein <i>in vivo</i>. When autophagy is inhibited or cells undergo oxidative stress, the expression level of p62 is detected to be abnormal in various disease processes as mentioned before. Since its aberrant expression in illnesses, p62 can be considered as a clinical diagnostic marker for several disorders. The quantitative analysis technique of p62 should be put forward because p62 can serve as a pathological indicator. It has been expected to be a good prognostic marker for HCC and ovarian cancer. On the other hand, disease symptoms are expected to be attenuated even reversed by reregulating p62 levels. p62 accumulation, as a pathological characteristic, could act as a novel diagnostic sign and prognostic marker. p62 accumulation is frequently combined with autophagy deficiency, leading to misfolded protein aggregation, which is the significant factor of disease occurrence and development. The level of autophagy flux can be evaluated by detecting the p62 expression, and the p62 level inversely correlates with the activity of autophagy. In a manner of speaking, p62 accumulation is the reflection of autophagy dysfunction for that p62 is an autophagy substrate and can be selectively degraded. It is beneficial for symptomatic improvement by reducing the accumulation of p62 and recovering the regular degradation function of autophagy. Taken together, it is a credible corollary that p62 as a latent target is effective and feasible in the territory of disease diagnosis and treatment.</div><div class="NLM_p">In different diseases, p62 serves disparate functions, and the regulation of p62 should depend on the specific circumstances. Applying p62 to PDB treatment might be more effective compared to other traditional therapies. There are still no cure therapies for PDB currently, and the goals of treatment are to relieve pain, rectify bending deformities, and stabilize pathological fractures. p62<sup><i>P392L</i></sup> mutation is the root cause of sporadic PDB lesions. Therefore, it may be a novel therapeutic method to knock out this gene prone to mutation and solve the problem fundamentally. p62 plays a dual role in regulating tumorigenesis: it is observed to be overexpressed in tumor epithelium, while deficient in tumor stroma fibroblasts, especially in CAFs. The double impacts remind us to pay attention to the tumor tissue selectivity and pharmacy boundaries when regulating p62 expression. It is necessary to establish the standard of the p62 normal expression level, which can provide a basis for the selection of inhibitors and activators in the future. Combination drug therapy between p62 inhibitors and autophagy activators acquires a favorable curative effect in tumor metastasis. In AD, p62 is detected to be deficient, and up-regulating the expression of this protein is advantageous to slow disease progression. Therefore, the activators of p62 are requisite in this process. Compared to cancer, drugs for AD develop slowly and are blocked frequently, which makes it imperative for researchers to search for new therapeutic targets. p62 deficiency is a typical characteristic in AD, and this potential target needs enough attention. When designing p62 activators, it is imperative to take the perviousness of the blood–brain barrier (BBB) into consideration. AD is a severe neurodegenerative disorder with complex mechanisms and plenty of influencing factors. It is not enough to merely up-regulate p62 expression. There are also urgent issues demanding solutions like elevating the ability of antioxidative stress and promoting the clearance of Aβ deposition and NFTs. It is a promising and hopefully usable method to design multitarget drugs and conduct drug combination in AD therapies.</div><div class="NLM_p">Although p62 plays unique roles in physical or pathological processes, the loss of p62 is actually not lethal. The <i>p62</i><sup><i>–/–</i></sup> mice are viable, but the lifespan is shorter than wild-type controls.<a onclick="showRef(event, 'ref212'); return false;" href="javascript:void(0);" class="ref ref212">(212)</a> In humans, the loss of p62 caused damages to the central nervous system without other organs affected.<a onclick="showRef(event, 'ref139 ref213'); return false;" href="javascript:void(0);" class="ref ref139 ref213">(139,213)</a> To some extent, it reflects the safety of p62 as a therapeutic target. There may be differences between the acute and chronic modulation of p62. A few kinds of research focused on the acute modulation of p62, but the chronic absence of p62 tends to have many negative impacts. Mice deficient of p62 displayed mature-onset obesity, leptin resistance, as well as insulin resistance.<a onclick="showRef(event, 'ref214'); return false;" href="javascript:void(0);" class="ref ref214">(214)</a> The chronic absence of p62 in individuals showed significantly increased levels of phosphorylated tau and caused childhood-onset neurodegeneration.<a onclick="showRef(event, 'ref215'); return false;" href="javascript:void(0);" class="ref ref215">(215)</a></div><div class="NLM_p">Nevertheless, there are still no marketed drugs targeting p62 as a therapeutic strategy currently. It has broad research prospects of research and application to design and synthesize small molecular inhibitors and activators of p62. Besides molecules working directly on p62, exploiting PPI inhibitors between p62 and other binding proteins is also feasible and indispensable because that p62 plays its unique roles in regulating autophagy and Nrf2 expression via these pivotal binding proteins such as LC3 and Keap1. In addition, the wide distribution of p62 indicates its universality, while it also brings up a pressing problem: tissue selectivity and targeting of p62. Choosing appropriate drug carriers or developing new dosage forms may be conducive to p62 regulators reaching the lesions accurately. Selectivity is required not only for drug use in tissues but also for the design of p62-related preparations in specific regions. When designing small molecules of p62, domain selection should be taken into consideration because p62 has six domains with different functions. For example, blocking the ubiquitination process needs to act on the UBA domain. To restrain the self-oligomerization of p62, the PB1 domain should be inhibited. To regulate the Nrf2 pathway to enhance the ability against oxidative stress, it is effective to directly activate the KIR of p62. It is necessary to design novel selective preparations for different domains based on therapeutic purposes. Depending on the structural differences of the cavity of domains, it is a feasible method to discover novel selective p62 regulators by using computer-aided drug design (CADD) techniques.</div><div class="NLM_p last">Even so, there are still many unresolved issues in mechanisms of p62 functions. For instance, although the relationship between autophagy and p62 as an adaptor protein has been manifested, how p62 distinguishes or recognizes “cargoes” between conventional versus selective autophagy is still worth further research. As previously mentioned, p62 expression imbalance is just a pathological feature in certain circumstances instead of the primary cause of disease occurrence. The inherent mechanisms of p62 impacting AD, AS, and tumorigenesis processes require more and deeper exploration in the future. Similarly, the therapeutic effect via regulating p62 deserves further discussion and explanation. In terms of discovery and druggability, the demand for selectivity and targeting is very high on account of p62 extensive distribution and diversity of domains, which raises the difficulty level for drug design.</div></div><div id="sec10" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">10.  Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14753" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14753" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">p62/SQSTM1 is an acknowledged autophagy substrate whose expression quantity reflects the level of autophagic activity. With further understanding of this protein, p62 has been reported to function as a significant signaling hub in regulating several important pathways, especially in the proteolytic system and the Nrf2 pathway. The expression of this adaptor protein is observably abnormal in tumorigenesis, neurodegeneration, AS, and PDB as mentioned before. Additionally, researchers also found that adverse symptoms can be ameliorated by regulating p62 expression in HD<a onclick="showRef(event, 'ref216'); return false;" href="javascript:void(0);" class="ref ref216">(216)</a> and AS<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> model mice. Considering these two points, p62 is suggested to be a novel latent target for disease diagnosis and treatment in tumorigenesis, neurodegeneration, AS, and PDB. Up to date, there are few drugs acting on p62 on the market. It is promising to design and exploit more effective small molecular drugs or PPI inhibitors for this potential and valuable target. Although we have understood the relationships between p62, autophagy, and these diseases, the mechanisms of how this protein realize its functions require further exploration and investigation.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b02038" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37832" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37832" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Feng Feng</span> - <span class="hlFld-Affiliation affiliation">Department
of Natural Medicinal Chemistry, China Pharmaceutical
University, Nanjing 211198, People’s Republic
of China</span>; 
    <span class="hlFld-Affiliation affiliation">Jiangsu
Food and Pharmaceuticals Science College, Institute of Food and Pharmaceuticals Research, Huaian 223005, People’s Republic of China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ddbbb8b3baaea8b3b1b4bab5a99decebeef3beb2b0"><span class="__cf_email__" data-cfemail="1573707b7266607b797c727d61552423263b767a78">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haopeng Sun</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, China Pharmaceutical University, Nanjing 211198, People’s Republic of China</span>; 
    <span class="hlFld-Affiliation affiliation">Jiangsu
Food and Pharmaceuticals Science College, Institute of Food and Pharmaceuticals Research, Huaian 223005, People’s Republic of China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5109-0304" title="Orcid link">http://orcid.org/0000-0002-5109-0304</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c5b6b0abada4aab5a0aba285f4f3f6eba6aaa8"><span class="__cf_email__" data-cfemail="a8dbddc6c0c9c7d8cdc6cfe8999e9b86cbc7c5">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ying Chen</span> - <span class="hlFld-Affiliation affiliation">Department
of Natural Medicinal Chemistry, China Pharmaceutical
University, Nanjing 211198, People’s Republic
of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qi Li</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, China Pharmaceutical University, Nanjing 211198, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qihang Li</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, China Pharmaceutical University, Nanjing 211198, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuaishuai Xing</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, China Pharmaceutical University, Nanjing 211198, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yang Liu</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, China Pharmaceutical University, Nanjing 211198, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yijun Liu</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, China Pharmaceutical University, Nanjing 211198, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yao Chen</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Nanjing University of Chinese
Medicine, Nanjing 210023, People’s Republic
of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenyuan Liu</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, China Pharmaceutical University, Nanjing 211198, People’s Republic of China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2536-9416" title="Orcid link">http://orcid.org/0000-0002-2536-9416</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Feng Feng, Haopeng Sun, and Ying Chen are responsible for writing the whole passage. Qi Li, Qihang Li, Shuaishuai Xing, and Yao Chen were charge of checking and revision, and others were made by Wenyuan Liu, Yijun Liu, and Yang Liu.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78888" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78888" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Ying Chen</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=BIO-d7e2076-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Ying Chen</b> graduated in Pharmacy at the China Pharmaceutical University and received her Bachelor’s degree in 2019. She is pursuing a Master’s degree at the China Pharmaceutical University, in the research group of Prof. F. Feng. Her research focuses on the design and synthesis of small molecules targeting Alzheimer’s disease.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Qi Li</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=BIO-d7e2081-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Qi Li</b> graduated in Pharmacy at the China Pharmaceutical University in 2016. She advanced her Ph.D. study in medicinal chemistry, China Pharmaceutical University, in the research group of Associate Professor Haopeng Sun. Her research focuses on the design and synthesis of small molecules targeting the neurodegenerative disease.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Qihang Li</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=BIO-d7e2086-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Qihang Li</b> graduated in Pharmacy at the China Pharmaceutical University and received his Bachelor’s degree in 2017. He is pursuing a Master’s degree under the supervision of Associate Professor Haopeng Sun. His research is focused on the discovery of novel small molecules in the field of neurodegenerative diseases using computer-aided drug design.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Shuaishuai Xing</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=BIO-d7e2091-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Shuaishuai Xing</b> majored in Pharmaceutical Engineering at the Hefei University of Technology and got his Bachelor’s degree in 2018. In the same year, he started to pursue his Master’s degree by following Associate Professor Haopeng Sun. His research focuses on the design and structural optimization of small molecules targeting Alzheimer’s disease.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Yang Liu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=BIO-d7e2096-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Yang Liu</b> is studying pharmacy at the China Pharmaceutical University, and in 2019, she continued her Master’s study in medicinal chemistry at the same school. Her postgraduate studies will be taught by Associate Professor Haopeng Sun in the field of neuroprotection against inflammation and oxidative stress.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Yijun Liu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=BIO-d7e2101-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Yijun Liu</b> is a postgraduate studying medicinal chemistry at China Pharmaceutical University for her Master’s study. Her postgraduate studies will be taught by Associate Professor Haopeng Sun in the field of neuroprotection against inflammation and oxidative stress.</p></figure></div><div class="bio" rid="ath7"><figure id="ath7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Yao Chen</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=BIO-d7e2106-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Yao Chen</b> graduated in Pharmacy at the China Pharmaceutical University in 2006. She received her Ph.D. in 2012 in Medicinal Chemistry guided by Prof. Y. H. Zhang, with a thesis about the design, synthesis, and bioevaluation of new compounds targeting Alzheimer’s disease. In 2013, she became a Lecturer of Nanjing University of Chinese Medicine, China. So far, she has published 13 papers in medicinal chemistry journals, including the Journal of Medicinal Chemistry. Her major research interests include the design and optimization of small molecules targeting neurodegenerative diseases.</p></figure></div><div class="bio" rid="ath8"><figure id="ath8" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Wenyuan Liu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=BIO-d7e2112-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Wenyuan Liu</b> graduated in Chemistry at the Shaanxi Normal University in 1991. She received her Ph.D. in 2004 in Pharmaceutical Analysis, supervised by Prof. Z. X. Zhang. She studied at the University of California, San Diego, as a visiting scholar in 2008. In 2010, she was promoted to Professor of Pharmaceutical Analysis, at the China Pharmaceutical University. So far, she has published more than 50 research papers in the Journal of Chromatography A, Journal of Chromatography B, Journal of Pharmaceutical, and Biomedical Analysis, etc. Her major research interests include the analysis of pharmaceutical instruments.</p></figure></div><div class="bio" rid="ath9"><figure id="ath9" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Feng Feng</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=BIO-d7e2117-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Feng Feng</b> graduated in Chemistry at the Shaanxi Normal University in 1991. He received his Ph.D. in 2001 in Pharmacy, with a thesis about natural products with antitumor activities supervised by Prof. S. X. Zhao. He studied at the University of California, Irvine, as a visiting scholar in 2005. In 2010, he was promoted to Professor of Natural Medicinal Chemistry at the China Pharmaceutical University. So far, he has published more than 70 papers on journals indexed by the Science Citation Index. His major research interests include extraction and isolation of chemical constituents from natural medicines, structural modification of active compositions, and drug analysis <i>in vivo</i>. In addition, he is focusing on the prevention and treatment of cancer and neurodegenerative agents.</p></figure></div><div class="bio" rid="ath10"><figure id="ath10" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Haopeng Sun</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=BIO-d7e2125-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Haopeng Sun</b> graduated in Pharmacy at the China Pharmaceutical University in 2006. He received his Ph.D. in 2011 in medicinal chemistry, with a thesis about the structural optimization and mechanism study of a natural product. His advisor was Prof. Q. D. You. In 2014, he was promoted to Associate Professor of Medicinal Chemistry at the China Pharmaceutical University. So far, he has published more than 110 papers in peer-review journals indexed by Science Citation Index. His major research interests include the design, synthesis, and biological evaluation of small-molecule bioactive compounds, in particular, agents targeting neurodegenerative diseases. In addition, he is focusing on the field of anticancer and anti-inflammatory agents.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71270" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71270" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We gratefully thank the support from the grants (81573281, 81872728, and 81973207) of the National Natural Science Foundation of China (BK20191411), Natural Science Foundation, Jiangsu Province. We thank the support from the “Double First-Class” Initiative Innovation team project of China Pharmaceutical University (CPU2018GF11 and CPU2018GY34) and Jiangsu Qinglan Project (Yao Chen).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">aPKCs</td><td class="NLM_def"><p class="first last">atypical protein kinase Cs</p></td></tr><tr><td class="NLM_term">UPS</td><td class="NLM_def"><p class="first last">ubiquitin–proteasome system</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Paget’s disease of bone</p></td></tr><tr><td class="NLM_term">HDAC6</td><td class="NLM_def"><p class="first last">histone deacetylase 6</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">PB1</td><td class="NLM_def"><p class="first last">Phox1 and Bem1p</p></td></tr><tr><td class="NLM_term">ZZ</td><td class="NLM_def"><p class="first last">zinc finger</p></td></tr><tr><td class="NLM_term">TRAF6</td><td class="NLM_def"><p class="first last">tumor necrosis factor receptor-associated factor 6</p></td></tr><tr><td class="NLM_term">TB</td><td class="NLM_def"><p class="first last">tumor necrosis factor receptor-associated factor 6-binding</p></td></tr><tr><td class="NLM_term">LIR</td><td class="NLM_def"><p class="first last">LC3-interacting region</p></td></tr><tr><td class="NLM_term">KIR</td><td class="NLM_def"><p class="first last">Keap1-interacting region</p></td></tr><tr><td class="NLM_term">UBA</td><td class="NLM_def"><p class="first last">ubiquitin-associated</p></td></tr><tr><td class="NLM_term">NF-κB</td><td class="NLM_def"><p class="first last">nuclear factor-kappa B</p></td></tr><tr><td class="NLM_term">NLSs</td><td class="NLM_def"><p class="first last">nuclear localization signals</p></td></tr><tr><td class="NLM_term">NES</td><td class="NLM_def"><p class="first last">nuclear export signals</p></td></tr><tr><td class="NLM_term">LC3</td><td class="NLM_def"><p class="first last">light chain 3</p></td></tr><tr><td class="NLM_term">ATG8</td><td class="NLM_def"><p class="first last">autophagy gene 8</p></td></tr><tr><td class="NLM_term">GABARAP</td><td class="NLM_def"><p class="first last">γ-aminobutyric acid receptor-associated protein</p></td></tr><tr><td class="NLM_term">Nrf2</td><td class="NLM_def"><p class="first last">nuclear factor erythroid 2-related factor 2</p></td></tr><tr><td class="NLM_term">bZIP</td><td class="NLM_def"><p class="first last">basic-leucine zipper</p></td></tr><tr><td class="NLM_term">AREs</td><td class="NLM_def"><p class="first last">antioxidant elements</p></td></tr><tr><td class="NLM_term">CMA</td><td class="NLM_def"><p class="first last">chaperone-mediated autophagy</p></td></tr><tr><td class="NLM_term">Hsp70</td><td class="NLM_def"><p class="first last">heat shock cognate chaperone of 70 kDa</p></td></tr><tr><td class="NLM_term">NFTs</td><td class="NLM_def"><p class="first last">neurofibrillary tangles</p></td></tr><tr><td class="NLM_term">MBs</td><td class="NLM_def"><p class="first last">Mallory bodies</p></td></tr><tr><td class="NLM_term">NASH</td><td class="NLM_def"><p class="first last">nonalcoholic steatohepatitis</p></td></tr><tr><td class="NLM_term">HCC</td><td class="NLM_def"><p class="first last">human hepatocellular carcinoma</p></td></tr><tr><td class="NLM_term">PDAC</td><td class="NLM_def"><p class="first last">pancreatic ductal adenocarcinoma</p></td></tr><tr><td class="NLM_term">CAFs</td><td class="NLM_def"><p class="first last">cancer-associated fibroblasts</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mechanistic target of rapamycin</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">endoplasmic reticulum</p></td></tr><tr><td class="NLM_term">IL-1</td><td class="NLM_def"><p class="first last">interleukin-1</p></td></tr><tr><td class="NLM_term">TNF</td><td class="NLM_def"><p class="first last">tumor necrosis factor</p></td></tr><tr><td class="NLM_term">NGF</td><td class="NLM_def"><p class="first last">nerve growth factor</p></td></tr><tr><td class="NLM_term">IKK</td><td class="NLM_def"><p class="first last">IkB kinase</p></td></tr><tr><td class="NLM_term">Cul3</td><td class="NLM_def"><p class="first last">Cullin 3</p></td></tr><tr><td class="NLM_term">MEK3/6</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase 3/6</p></td></tr><tr><td class="NLM_term">MEKK3</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase kinases 3</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">EMT</td><td class="NLM_def"><p class="first last">epithelial-mesenchymal transition</p></td></tr><tr><td class="NLM_term">EGF</td><td class="NLM_def"><p class="first last">epidermal growth factor</p></td></tr><tr><td class="NLM_term">TGF-β</td><td class="NLM_def"><p class="first last">transforming growth factor-β</p></td></tr><tr><td class="NLM_term">PCa</td><td class="NLM_def"><p class="first last">prostate cancer</p></td></tr><tr><td class="NLM_term">IL-6</td><td class="NLM_def"><p class="first last">interleukin-6</p></td></tr><tr><td class="NLM_term">Myc</td><td class="NLM_def"><p class="first last">malignancy myelocytomatosis</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid β</p></td></tr><tr><td class="NLM_term">NPs</td><td class="NLM_def"><p class="first last">neuritic plaques</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinson’s disease</p></td></tr><tr><td class="NLM_term">HD</td><td class="NLM_def"><p class="first last">Huntington’s disease</p></td></tr><tr><td class="NLM_term">ALS</td><td class="NLM_def"><p class="first last">amyotrophic lateral sclerosis</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">EOFAD</td><td class="NLM_def"><p class="first last">early onset familial AD</p></td></tr><tr><td class="NLM_term">LOAD</td><td class="NLM_def"><p class="first last">late-onset AD</p></td></tr><tr><td class="NLM_term">PINK1</td><td class="NLM_def"><p class="first last">PTEN-induced putative kinase protein 1</p></td></tr><tr><td class="NLM_term">CHDH</td><td class="NLM_def"><p class="first last">choline dehydrogenase</p></td></tr><tr><td class="NLM_term">NESCs</td><td class="NLM_def"><p class="first last">neuroepithelial stem cells</p></td></tr><tr><td class="NLM_term">MQC</td><td class="NLM_def"><p class="first last">mitochondria quality control</p></td></tr><tr><td class="NLM_term">MDA</td><td class="NLM_def"><p class="first last">malondialdehyde</p></td></tr><tr><td class="NLM_term">4-HNE</td><td class="NLM_def"><p class="first last">4-hydroxynonenal</p></td></tr><tr><td class="NLM_term">8-OHG</td><td class="NLM_def"><p class="first last">8-hydroxyguanosine</p></td></tr><tr><td class="NLM_term">MCI</td><td class="NLM_def"><p class="first last">mild cognitive impairment</p></td></tr><tr><td class="NLM_term">MitoQ</td><td class="NLM_def"><p class="first last">Mitoquinone</p></td></tr><tr><td class="NLM_term">FTD</td><td class="NLM_def"><p class="first last">frontotemporal dementia</p></td></tr><tr><td class="NLM_term">AS</td><td class="NLM_def"><p class="first last">atherosclerosis</p></td></tr><tr><td class="NLM_term">VSMCs</td><td class="NLM_def"><p class="first last">vascular smooth muscle cells</p></td></tr><tr><td class="NLM_term">GTP</td><td class="NLM_def"><p class="first last">green tea polyphenol</p></td></tr><tr><td class="NLM_term">EGCG</td><td class="NLM_def"><p class="first last">epigallocatechin-3-gallate</p></td></tr><tr><td class="NLM_term">ApoE</td><td class="NLM_def"><p class="first last">apolipoprotein E</p></td></tr><tr><td class="NLM_term">oxLDL</td><td class="NLM_def"><p class="first last">oxidized low-density lipoprotein</p></td></tr><tr><td class="NLM_term">OCLs</td><td class="NLM_def"><p class="first last">osteoclastsOBLs, osteoblasts</p></td></tr><tr><td class="NLM_term">P-to-L</td><td class="NLM_def"><p class="first last">proline-to-leucine</p></td></tr><tr><td class="NLM_term">RANKL</td><td class="NLM_def"><p class="first last">receptor activator of NF-κB ligand</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">ERK1/2</td><td class="NLM_def"><p class="first last">extracellular regulated protein kinases 1/2 (ERK1/2)</p></td></tr><tr><td class="NLM_term">AP-1</td><td class="NLM_def"><p class="first last">activator protein 1</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">50% inhibitory concentration</p></td></tr><tr><td class="NLM_term">Hsp90</td><td class="NLM_def"><p class="first last">heat shock protein 90</p></td></tr><tr><td class="NLM_term"><i>p</i>-p62</td><td class="NLM_def"><p class="first last">phosphorylated-p62 (<i>p</i>-p62)</p></td></tr><tr><td class="NLM_term">PPI</td><td class="NLM_def"><p class="first last">protein–protein interaction</p></td></tr><tr><td class="NLM_term">FCS</td><td class="NLM_def"><p class="first last">fluorescence correlation spectroscopy</p></td></tr><tr><td class="NLM_term">SAS</td><td class="NLM_def"><p class="first last">sulfasalazine</p></td></tr><tr><td class="NLM_term">LCA</td><td class="NLM_def"><p class="first last">licochalcone A</p></td></tr><tr><td class="NLM_term">DEHA</td><td class="NLM_def"><p class="first last">dehydroepiandrosterone</p></td></tr><tr><td class="NLM_term">LA</td><td class="NLM_def"><p class="first last">linoleic acid</p></td></tr><tr><td class="NLM_term">GPX4</td><td class="NLM_def"><p class="first last">glutathione peroxidase 4</p></td></tr><tr><td class="NLM_term">HNC</td><td class="NLM_def"><p class="first last">head and neck cancer</p></td></tr><tr><td class="NLM_term">VPS34</td><td class="NLM_def"><p class="first last">vacuolar protein sorting 34</p></td></tr><tr><td class="NLM_term">S6K1</td><td class="NLM_def"><p class="first last">S6 kinase 1</p></td></tr><tr><td class="NLM_term">3-MA</td><td class="NLM_def"><p class="first last">3-methyladenine</p></td></tr><tr><td class="NLM_term">CHX</td><td class="NLM_def"><p class="first last">cycloheximide</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">CQ</td><td class="NLM_def"><p class="first last">chloroquine</p></td></tr><tr><td class="NLM_term">TLRs</td><td class="NLM_def"><p class="first last">toll-like receptors</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">CADD</td><td class="NLM_def"><p class="first last">computer-aided drug design.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60863" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60863" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 216 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vadlamudi, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, J.</span></span> <span> </span><span class="NLM_article-title">Genomic structure and promoter analysis of the p62 gene encoding a non-proteasomal multiubiquitin chain binding protein</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>435</i></span> (<span class="NLM_issue">2–3</span>),  <span class="NLM_fpage">138</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(98)01021-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2FS0014-5793%2898%2901021-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=9762895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADyaK1cXmt1emt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=435&publication_year=1998&pages=138-142&issue=2%E2%80%933&author=R.+K.+Vadlamudiauthor=J.+Shin&title=Genomic+structure+and+promoter+analysis+of+the+p62+gene+encoding+a+non-proteasomal+multiubiquitin+chain+binding+protein&doi=10.1016%2FS0014-5793%2898%2901021-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Genomic structure and promoter analysis of the p62 gene encoding a non-proteasomal multiubiquitin chain binding protein</span></div><div class="casAuthors">Vadlamudi, Ratna K.; Shin, Jaekyoon</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">435</span>
        (<span class="NLM_cas:issue">2,3</span>),
    <span class="NLM_cas:pages">138-142</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">P62 is a novel immediate early response gene encoding a ubiquitin chain binding protein.  To investigate the mechanism of p62 gene expression, we isolated and characterized the 20 kb long human p62 gene.  The p62 gene contains seven introns and eight exons.  The splice sites conformed to the GT/AG rule, except introns 6 and 7 which used the unusual GC dinucleotides.  The p62 promoter is TATA-less, and 357 nucleotides of the 5'-flanking region contain basic machineries for transcription.  A reporter gene linked to 1800 nucleotides of the 5'-flanking region was rapidly activated by various extracellular signals.  The presence of a CpG island as well as multiple binding sites for SP-1, AP-1, NF-κB, and Ets-1 family in the promoter region supports the regulated activation of the p62 gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrONVdfwR7D8rVg90H21EOLACvtfcHk0lj2K22qgizhug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmt1emt70%253D&md5=c98a838ae8018c6fc0bfcfe5034d2f7d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2898%2901021-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252898%252901021-7%26sid%3Dliteratum%253Aachs%26aulast%3DVadlamudi%26aufirst%3DR.%2BK.%26aulast%3DShin%26aufirst%3DJ.%26atitle%3DGenomic%2520structure%2520and%2520promoter%2520analysis%2520of%2520the%2520p62%2520gene%2520encoding%2520a%2520non-proteasomal%2520multiubiquitin%2520chain%2520binding%2520protein%26jtitle%3DFEBS%2520Lett.%26date%3D1998%26volume%3D435%26issue%3D2%25E2%2580%25933%26spage%3D138%26epage%3D142%26doi%3D10.1016%2FS0014-5793%2898%2901021-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Joung, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strominger, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, J.</span></span> <span> </span><span class="NLM_article-title">Molecular cloning of a phosphotyrosine-independent ligand of the p56(lck) SH2 domain</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5991</span>– <span class="NLM_lpage">5995</span>, <span class="refDoi"> DOI: 10.1073/pnas.93.12.5991</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1073%2Fpnas.93.12.5991" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=8650207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADyaK28Xjs1Ojsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=5991-5995&issue=12&author=I.+Joungauthor=J.+L.+Stromingerauthor=J.+Shin&title=Molecular+cloning+of+a+phosphotyrosine-independent+ligand+of+the+p56%28lck%29+SH2+domain&doi=10.1073%2Fpnas.93.12.5991"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning of a phosphotyrosine-independent ligand of the p56lck SH2 domain</span></div><div class="casAuthors">Joung, Insil; Strominger, Jack L.; Shin, Jaekyoon</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5991-5995</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A novel human cDNA encoding a cytosolic 62-kDa protein (p62) that binds to the Src homol. 2 (SH2) domain of p56lck in a phosphotyrosine-independent manner has been cloned.  The cDNA is composed of 2074 nucleotides with an open reading frame encoding 440 amino acids.  Northern anal. suggests that p62 is expressed ubiquitously in all tissues examd.  P62 is not homologous to any known protein in the data base.  However, it contains a cysteine-rich region resembling a zinc finger motif, a potential G-protein-binding region, a PEST motif, and several potential phosphorylation sites.  Using T7-epitope tagged p62 expression in HeLa cells, the expressed protein was shown to bind to the lck SH2 domain.  Deletion of the N-terminal 50 amino acids abolished binding, but mutagenesis of the single tyrosine residue in this region had no effect on binding.  Thus, the cloned cDNA indeed encodes the p62 protein, which is a phosphotyrosine-independent ligand for the lck SH2 domain.  Its binding mechanism is unique with respect to binding modes of other known ligands for SH2 domains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplpLz4fO-ldLVg90H21EOLACvtfcHk0lj2K22qgizhug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xjs1Ojsb8%253D&md5=6ffa8d26a71fbe0dc1f42355d0c5c293</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.12.5991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.12.5991%26sid%3Dliteratum%253Aachs%26aulast%3DJoung%26aufirst%3DI.%26aulast%3DStrominger%26aufirst%3DJ.%2BL.%26aulast%3DShin%26aufirst%3DJ.%26atitle%3DMolecular%2520cloning%2520of%2520a%2520phosphotyrosine-independent%2520ligand%2520of%2520the%2520p56%2528lck%2529%2520SH2%2520domain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26issue%3D12%26spage%3D5991%26epage%3D5995%26doi%3D10.1073%2Fpnas.93.12.5991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Carcer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandoval, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span> <span> </span><span class="NLM_article-title">Localization of atypical protein kinase C isoforms into lysosome-targeted endosomes through interaction with p62</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">3069</span>– <span class="NLM_lpage">3080</span>, <span class="refDoi"> DOI: 10.1128/MCB.18.5.3069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1128%2FMCB.18.5.3069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=9566925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADyaK1cXis1GmsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1998&pages=3069-3080&issue=5&author=P.+Sanchezauthor=G.+De+Carcerauthor=I.+V.+Sandovalauthor=J.+Moscatauthor=M.+T.+Diaz-Meco&title=Localization+of+atypical+protein+kinase+C+isoforms+into+lysosome-targeted+endosomes+through+interaction+with+p62&doi=10.1128%2FMCB.18.5.3069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Localization of atypical protein kinase C isoforms into lysosome-targeted endosomes through interaction with p62</span></div><div class="casAuthors">Sanchez, Pilar; De Carcer, Guillermo; Sandoval, Ignacio V.; Moscat, Jorge; Diaz-Meco, Maria T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">3069-3080</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">An increasing no. of independent studies indicate that the atypical protein kinase C (PKC) isoforms (aPKCs) are critically involved in the control of cell proliferation and survival.  The aPKCs are targets of important lipid mediators such as ceramide and the products of the PI 3-kinase.  In addn., the aPKCs have been shown to interact with Ras and with two novel proteins, LIP (lambda-interacting protein; a selective activator of λ/ιPKC) and the product of par-4 (a gene induced during apoptosis), which is an inhibitor of both λ/ιPKC and ζPKC.  LIP and Par-4 interact with the zinc finger domain of the aPKCs where the lipid mediators have been shown to bind.  Here we report the identification of p62, a previously described phosphotyrosine-independent p56lck SH2-interacting protein, as a mol. that interacts potently with the V1 domain of λ/ιPKC and, albeit with lower affinity, with ζPKC.  We also show in this study that ectopically expressed p62 colocalizes perfectly with both λ/ιPKC and ζPKC.  Interestingly, the endogenous p62, like the ectopically expressed protein, displays a punctate vesicular pattern and clearly colocalizes with endogenous λ/ιPKC and endogenous ζPKC.  P62 colocalizes with Rab7 and partially with lamp-1 and limp-II as well as with the epidermal growth factor (EGF) receptor in activated cells, but not with Rab5 or the transferrin receptor.  Of functional relevance, expression of dominant neg. λ/ιPKC, but not of the wild-type enzyme, severely impairs the endocytic membrane transport of the EGF receptor with no effect on the transferrin receptor.  These findings strongly suggest that the aPKCs are anchored by p62 in the lysosome-targeted endosomal compartment, which seems crit. for the control of the growth factor receptor trafficking.  This is particularly relevant in light of the role played by the aPKCs in mitogenic cell signaling events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9LrgrrgM2ObVg90H21EOLACvtfcHk0lj2K22qgizhug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXis1GmsL4%253D&md5=3c5639bc44206a280e82433614e09099</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1128%2FMCB.18.5.3069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.18.5.3069%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez%26aufirst%3DP.%26aulast%3DDe%2BCarcer%26aufirst%3DG.%26aulast%3DSandoval%26aufirst%3DI.%2BV.%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26atitle%3DLocalization%2520of%2520atypical%2520protein%2520kinase%2520C%2520isoforms%2520into%2520lysosome-targeted%2520endosomes%2520through%2520interaction%2520with%2520p62%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1998%26volume%3D18%26issue%3D5%26spage%3D3069%26epage%3D3080%26doi%3D10.1128%2FMCB.18.5.3069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pikkarainen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartikainen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soininen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alafuzoff, I.</span></span> <span> </span><span class="NLM_article-title">Distribution and pattern of pathology in subjects with familial or sporadic late-onset cerebellar ataxia as assessed by p62/sequestosome immunohistochemistry</span>. <i>Cerebellum</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">720</span>– <span class="NLM_lpage">731</span>, <span class="refDoi"> DOI: 10.1007/s12311-011-0281-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1007%2Fs12311-011-0281-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21544590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVyrtrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=720-731&issue=4&author=M.+Pikkarainenauthor=P.+Hartikainenauthor=H.+Soininenauthor=I.+Alafuzoff&title=Distribution+and+pattern+of+pathology+in+subjects+with+familial+or+sporadic+late-onset+cerebellar+ataxia+as+assessed+by+p62%2Fsequestosome+immunohistochemistry&doi=10.1007%2Fs12311-011-0281-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution and Pattern of Pathology in Subjects with Familial or Sporadic Late-Onset Cerebellar Ataxia as Assessed by p62/Sequestosome Immunohistochemistry</span></div><div class="casAuthors">Pikkarainen, Maria; Hartikainen, Paeivi; Soininen, Hilkka; Alafuzoff, Irina</div><div class="citationInfo"><span class="NLM_cas:title">Cerebellum</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">720-731</span>CODEN:
                <span class="NLM_cas:coden">CERECF</span>;
        ISSN:<span class="NLM_cas:issn">1473-4222</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We investigated whether ubiquitin-binding protein p62/sequestosome-1 could be utilized to evaluate the pathol. seen in patients with a clin. diagnosis of progressive late-onset cerebellar ataxia (LOCA). p62-immunoreactive (IR) lesions were assessed by means of immunohistochem. in the brains of six LOCA cases, one with the spinocerebellar ataxia type 1 mutation (SCA1), ages at death ranging from 46 to 56 years.  All cases fulfilled the criteria of olivopontocerebellar atrophy (OPCA), i.e., displaying cell loss in the predilection brain areas.  One case, genetics unknown, exhibited p62-IR neuronal intranuclear inclusions (NIs).  Similar NIs were labeled with the 1C2 antibody that recognizes proteins contg. large polyglutamine stretches.  In this case, also fused in sarcoma-IR NIs were seen.  In the remaining LOCA cases, including the case with the SCA1 mutation, different kinds of nuclear and cytoplasmic p62 and 1C2 labeling but no NIs were seen.  The immunoreactivity and distribution of lesions while applying p62 and 1C2 immunohistochem. varied in our six LOCA cases fulfilling the criteria of OPCA.  In all cases except in the SCA1, diffuse nuclear p62 labeling was seen, not previously reported in SCA or other neurodegenerative disorders.  Due to the variability noted here as well as the limited no. of cases, no assessment of progression and distributional pattern of pathol. could be conducted.  Based on a literature search, it is apparent that there is a need for clinico-pathol.-genetical studies of LOCA, esp. to obtain a deeper understanding of the regional distribution and progression of pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqScYxAb8-UurVg90H21EOLACvtfcHk0lhwRU9hd_fvhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVyrtrvK&md5=4fa0cac68d24f00173e85ce43c372ae0</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs12311-011-0281-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12311-011-0281-2%26sid%3Dliteratum%253Aachs%26aulast%3DPikkarainen%26aufirst%3DM.%26aulast%3DHartikainen%26aufirst%3DP.%26aulast%3DSoininen%26aufirst%3DH.%26aulast%3DAlafuzoff%26aufirst%3DI.%26atitle%3DDistribution%2520and%2520pattern%2520of%2520pathology%2520in%2520subjects%2520with%2520familial%2520or%2520sporadic%2520late-onset%2520cerebellar%2520ataxia%2520as%2520assessed%2520by%2520p62%252Fsequestosome%2520immunohistochemistry%26jtitle%3DCerebellum%26date%3D2011%26volume%3D10%26issue%3D4%26spage%3D720%26epage%3D731%26doi%3D10.1007%2Fs12311-011-0281-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamark, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isakson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brech, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overvatn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenmark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjorkoy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansen, T.</span></span> <span> </span><span class="NLM_article-title">p62/SQSTM1 and ALFY interact to facilitate the formation of p62 bodies/ALIS and their degradation by autophagy</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">330</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.4161/auto.6.3.11226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.4161%2Fauto.6.3.11226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20168092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1WjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=330-344&issue=3&author=T.+H.+Clausenauthor=T.+Lamarkauthor=P.+Isaksonauthor=K.+Finleyauthor=K.+B.+Larsenauthor=A.+Brechauthor=A.+Overvatnauthor=H.+Stenmarkauthor=G.+Bjorkoyauthor=A.+Simonsenauthor=T.+Johansen&title=p62%2FSQSTM1+and+ALFY+interact+to+facilitate+the+formation+of+p62+bodies%2FALIS+and+their+degradation+by+autophagy&doi=10.4161%2Fauto.6.3.11226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">P62/SQSTM1 and ALFY interact to facilitate the formation of p62 bodies/ALIS and their degradation by autophagy</span></div><div class="casAuthors">Clausen, Terje Hoeyvarde; Lamark, Trond; Isakson, Pauline; Finley, Kim; Larsen, Kenneth Bowitz; Brech, Andreas; Oevervatn, Aud; Stenmark, Harald; Bjoerkoey, Geir; Simonsen, Anne; Johansen, Terje</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">330-344</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8627</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Accumulation of ubiquitinated proteins in cytoplasmic and/or nuclear inclusions is a hallmark of several diseases assocd. with premature cell death.  SQSTM1/p62 is known to bind ubiquitinated substrates and aid their aggregation and degrdn. by macroautophagy.  We show here that p62 is required to recruit the large phosphoinositide-binding protein ALFY to cytoplasmic p62 bodies generated upon amino acid starvation or puromycin-treatment.  ALFY, as well as p62, is required for formation and autophagic degrdn. of cytoplasmic ubiquitin-pos. inclusions.  Moreover, both p62 and ALFY localize to nuclear promyleocytic leukemia (PML) bodies.  The Drosophila p62 homolog Ref(2) P accumulates in ubiquitinated inclusions in the brain of flies carrying mutations in the ALFY homolog Blue cheese, demonstrating that ALFY is required for autophagic degrdn. of p62-assocd. ubiquitinated proteins in vivo.  We conclude that p62 and ALFY interact to organize misfolded, ubiquitinated proteins into protein bodies that become degraded by autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa7Du1RQygUrVg90H21EOLACvtfcHk0lhwRU9hd_fvhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1WjtLo%253D&md5=9e1a29fc05e68ab7f2e62f027b1cf026</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.4161%2Fauto.6.3.11226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.6.3.11226%26sid%3Dliteratum%253Aachs%26aulast%3DClausen%26aufirst%3DT.%2BH.%26aulast%3DLamark%26aufirst%3DT.%26aulast%3DIsakson%26aufirst%3DP.%26aulast%3DFinley%26aufirst%3DK.%26aulast%3DLarsen%26aufirst%3DK.%2BB.%26aulast%3DBrech%26aufirst%3DA.%26aulast%3DOvervatn%26aufirst%3DA.%26aulast%3DStenmark%26aufirst%3DH.%26aulast%3DBjorkoy%26aufirst%3DG.%26aulast%3DSimonsen%26aufirst%3DA.%26aulast%3DJohansen%26aufirst%3DT.%26atitle%3Dp62%252FSQSTM1%2520and%2520ALFY%2520interact%2520to%2520facilitate%2520the%2520formation%2520of%2520p62%2520bodies%252FALIS%2520and%2520their%2520degradation%2520by%2520autophagy%26jtitle%3DAutophagy%26date%3D2010%26volume%3D6%26issue%3D3%26spage%3D330%26epage%3D344%26doi%3D10.4161%2Fauto.6.3.11226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bjorkoy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamark, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brech, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Outzen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perander, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overvatn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenmark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansen, T.</span></span> <span> </span><span class="NLM_article-title">p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>171</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">603</span>– <span class="NLM_lpage">614</span>, <span class="refDoi"> DOI: 10.1083/jcb.200507002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1083%2Fjcb.200507002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=16286508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BD2MnitVWktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2005&pages=603-614&issue=4&author=G.+Bjorkoyauthor=T.+Lamarkauthor=A.+Brechauthor=H.+Outzenauthor=M.+Peranderauthor=A.+Overvatnauthor=H.+Stenmarkauthor=T.+Johansen&title=p62%2FSQSTM1+forms+protein+aggregates+degraded+by+autophagy+and+has+a+protective+effect+on+huntingtin-induced+cell+death&doi=10.1083%2Fjcb.200507002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death</span></div><div class="casAuthors">Bjorkoy Geir; Lamark Trond; Brech Andreas; Outzen Heidi; Perander Maria; Overvatn Aud; Stenmark Harald; Johansen Terje</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of cell biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">603-14</span>
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    </div><div class="casAbstract">Autophagic degradation of ubiquitinated protein aggregates is important for cell survival, but it is not known how the autophagic machinery recognizes such aggregates.  In this study, we report that polymerization of the polyubiquitin-binding protein p62/SQSTM1 yields protein bodies that either reside free in the cytosol and nucleus or occur within autophagosomes and lysosomal structures.  Inhibition of autophagy led to an increase in the size and number of p62 bodies and p62 protein levels.  The autophagic marker light chain 3 (LC3) colocalized with p62 bodies and co-immunoprecipitated with p62, suggesting that these two proteins participate in the same complexes.  The depletion of p62 inhibited recruitment of LC3 to autophagosomes under starvation conditions.  Strikingly, p62 and LC3 formed a shell surrounding aggregates of mutant huntingtin.  Reduction of p62 protein levels or interference with p62 function significantly increased cell death that was induced by the expression of mutant huntingtin.  We suggest that p62 may, via LC3, be involved in linking polyubiquitinated protein aggregates to the autophagy machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTI4TfVb2IG0H6oPH0mYWL1fW6udTcc2eZiQC8-NXEsMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MnitVWktw%253D%253D&md5=458c088f5526eadc05be25594a183747</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200507002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200507002%26sid%3Dliteratum%253Aachs%26aulast%3DBjorkoy%26aufirst%3DG.%26aulast%3DLamark%26aufirst%3DT.%26aulast%3DBrech%26aufirst%3DA.%26aulast%3DOutzen%26aufirst%3DH.%26aulast%3DPerander%26aufirst%3DM.%26aulast%3DOvervatn%26aufirst%3DA.%26aulast%3DStenmark%26aufirst%3DH.%26aulast%3DJohansen%26aufirst%3DT.%26atitle%3Dp62%252FSQSTM1%2520forms%2520protein%2520aggregates%2520degraded%2520by%2520autophagy%2520and%2520has%2520a%2520protective%2520effect%2520on%2520huntingtin-induced%2520cell%2520death%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2005%26volume%3D171%26issue%3D4%26spage%3D603%26epage%3D614%26doi%3D10.1083%2Fjcb.200507002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dang, C. V.</span></span> <span> </span><span class="NLM_article-title">MYC on the path to cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>149</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.cell.2012.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22464321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVehu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2012&pages=22-35&issue=1&author=C.+V.+Dang&title=MYC+on+the+path+to+cancer&doi=10.1016%2Fj.cell.2012.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">MYC on the Path to Cancer</span></div><div class="casAuthors">Dang, Chi V.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-35</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The MYC oncogene contributes to the genesis of many human cancers.  Recent insights into its expression and function have led to therapeutic opportunities.  MYC's activation by bromodomain proteins could be inhibited by drug-like mols., resulting in tumor inhibition in vivo.  Tumor growth can also be curbed by pharmacol. uncoupling bioenergetic pathways involving glucose or glutamine metab. from Myc-induced cellular biomass accumulation.  Other approaches to halt Myc on the path to cancer involve targeting Myc-Max dimerization or Myc-induced microRNA expression.  Here the richness of our understanding of MYC is reviewed, highlighting new biol. insights and opportunities for cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8ebUAbjLhmbVg90H21EOLACvtfcHk0lhpbYA2GpoYXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVehu78%253D&md5=5b0131f36c845e16dc9a736034483109</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DC.%2BV.%26atitle%3DMYC%2520on%2520the%2520path%2520to%2520cancer%26jtitle%3DCell%26date%3D2012%26volume%3D149%26issue%3D1%26spage%3D22%26epage%3D35%26doi%3D10.1016%2Fj.cell.2012.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hocking, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, G. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daroszewska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangion, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olavesen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cundy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wuyts, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Hul, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ralston, S. H.</span></span> <span> </span><span class="NLM_article-title">Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget’s disease</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">2735</span>– <span class="NLM_lpage">2739</span>, <span class="refDoi"> DOI: 10.1093/hmg/11.22.2735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1093%2Fhmg%2F11.22.2735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=12374763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVSjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2002&pages=2735-2739&issue=22&author=L.+J.+Hockingauthor=G.+J.+A.+Lucasauthor=A.+Daroszewskaauthor=J.+Mangionauthor=M.+Olavesenauthor=T.+Cundyauthor=G.+C.+Nicholsonauthor=L.+Wardauthor=S.+T.+Bennettauthor=W.+Wuytsauthor=W.+Van+Hulauthor=S.+H.+Ralston&title=Domain-specific+mutations+in+sequestosome+1+%28SQSTM1%29+cause+familial+and+sporadic+Paget%E2%80%99s+disease&doi=10.1093%2Fhmg%2F11.22.2735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease</span></div><div class="casAuthors">Hocking, Lynne J.; Lucas, Gavin J. A.; Daroszewska, Anna; Mangion, Jon; Olavesen, Mark; Cundy, Tim; Nicholson, Geoff C.; Ward, Lynley; Bennett, Simon T.; Wuyts, Wim; Van Hul, Wim; Ralston, Stuart H.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2735-2739</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Paget's disease of bone (PDB) is a common disorder characterized by focal abnormalities of increased and disorganized bone turnover.  Genetic factors are important in the pathogenesis of PDB, and in previous studies, the authors and others identified a locus for familial PDB by genome-wide search on 5q35-qter (PDB3).  The gene encoding sequestosome 1 (SQSTM1/p62) maps to within the PDB3 crit. region, and recent studies have identified a proline-leucine amino acid change at codon 392 of SQSTM1 (P392L) in French-Canadian patients with PDB.  The authors conducted mutation screening of positional candidate genes in the PDB3 locus in patients with PDB, and also identified mutations in the gene encoding SQSTM1 as a common cause of familial and sporadic PDB.  Three different mutations were found, all affecting the highly conserved ubiquitin-binding domain.  The most common mutation was the P392L change in exon 8, which was found in 13 of 68 families (19.1%).  Another mutation, a T insertion that introduces a stop codon at position 396 in exon 8, was found in four (5.8%) families.  A third mutation affecting the splice donor site in intron 7 was found in one (1.5%) family.  The P392L mutation was also found in 15 of 168 (8.9%) of patients with sporadic PDB and 0 of 160 of age- and sex-matched controls (P<0.0001).  These studies confirm that mutations affecting the ubiquitin-binding domain of SQSTM1 are a common cause of familial and sporadic Paget's disease of bone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIN4hRKTDlJLVg90H21EOLACvtfcHk0lhpbYA2GpoYXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVSjsL8%253D&md5=d7af34ca6549df760787245bb6538c33</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F11.22.2735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F11.22.2735%26sid%3Dliteratum%253Aachs%26aulast%3DHocking%26aufirst%3DL.%2BJ.%26aulast%3DLucas%26aufirst%3DG.%2BJ.%2BA.%26aulast%3DDaroszewska%26aufirst%3DA.%26aulast%3DMangion%26aufirst%3DJ.%26aulast%3DOlavesen%26aufirst%3DM.%26aulast%3DCundy%26aufirst%3DT.%26aulast%3DNicholson%26aufirst%3DG.%2BC.%26aulast%3DWard%26aufirst%3DL.%26aulast%3DBennett%26aufirst%3DS.%2BT.%26aulast%3DWuyts%26aufirst%3DW.%26aulast%3DVan%2BHul%26aufirst%3DW.%26aulast%3DRalston%26aufirst%3DS.%2BH.%26atitle%3DDomain-specific%2520mutations%2520in%2520sequestosome%25201%2520%2528SQSTM1%2529%2520cause%2520familial%2520and%2520sporadic%2520Paget%25E2%2580%2599s%2520disease%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2002%26volume%3D11%26issue%3D22%26spage%3D2735%26epage%3D2739%26doi%3D10.1093%2Fhmg%2F11.22.2735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigneron, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labbe, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorca, T.</span></span> <span> </span><span class="NLM_article-title">The anaphase-promoting complex: a key factor in the regulation of cell cycle</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">314</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1207973</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fsj.onc.1207973" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=15678131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2MXnsFShsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=314-325&issue=3&author=A.+Castroauthor=C.+Bernisauthor=S.+Vigneronauthor=J.+C.+Labbeauthor=T.+Lorca&title=The+anaphase-promoting+complex%3A+a+key+factor+in+the+regulation+of+cell+cycle&doi=10.1038%2Fsj.onc.1207973"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The anaphase-promoting complex: a key factor in the regulation of cell cycle</span></div><div class="casAuthors">Castro, Anna; Bernis, Cyril; Vigneron, Suzanne; Labbe, Jean-Claude; Lorca, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">314-325</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Events controlling cell division are governed by the degrdn. of different regulatory proteins by the ubiquitin-dependent pathway.  In this pathway, the attachment of a polyubiquitin chain to a substrate by a ubiquitin ligase targets this substrate for degrdn. by the 26S proteasome.  Two different ubiquitin ligases play an important role in the cell cycle: the SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC).  Here, the authors describe the present knowledge about the APC.  The authors pay particular attention to the latest results concerning APC structure, APC regulation, and substrate recognition, and discuss the implications of these findings in an understanding of APC function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmv8lwu3_qbrVg90H21EOLACvtfcHk0lgJYmGbwQbRrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXnsFShsg%253D%253D&md5=c8c304a9928c3ba05cbd93b516f4fe77</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207973%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DBernis%26aufirst%3DC.%26aulast%3DVigneron%26aufirst%3DS.%26aulast%3DLabbe%26aufirst%3DJ.%2BC.%26aulast%3DLorca%26aufirst%3DT.%26atitle%3DThe%2520anaphase-promoting%2520complex%253A%2520a%2520key%2520factor%2520in%2520the%2520regulation%2520of%2520cell%2520cycle%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26issue%3D3%26spage%3D314%26epage%3D325%26doi%3D10.1038%2Fsj.onc.1207973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klionsky, D. J.</span></span> <span> </span><span class="NLM_article-title">Eaten alive: a history of macroautophagy</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">814</span>– <span class="NLM_lpage">822</span>, <span class="refDoi"> DOI: 10.1038/ncb0910-814</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fncb0910-814" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20811353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSju7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=814-822&issue=9&author=Z.+F.+Yangauthor=D.+J.+Klionsky&title=Eaten+alive%3A+a+history+of+macroautophagy&doi=10.1038%2Fncb0910-814"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Eaten alive: a history of macroautophagy</span></div><div class="casAuthors">Yang, Zhifen; Klionsky, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">814-822</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Macroautophagy (hereafter autophagy), or 'self-eating', is a conserved cellular pathway that controls protein and organelle degrdn., and has essential roles in survival, development and homeostasis.  Autophagy is also integral to human health and is involved in physiol., development, lifespan and a wide range of diseases, including cancer, neurodegeneration and microbial infection.  Although research on this topic began in the late 1950s, substantial progress in the mol. study of autophagy has taken place during only the past 15 years.  This review traces the key findings that led to our current mol. understanding of this complex process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ_iZJ3YUoHrVg90H21EOLACvtfcHk0lgJYmGbwQbRrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSju7zE&md5=a20abac7db3f20eac668c41052413397</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fncb0910-814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb0910-814%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%2BF.%26aulast%3DKlionsky%26aufirst%3DD.%2BJ.%26atitle%3DEaten%2520alive%253A%2520a%2520history%2520of%2520macroautophagy%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2010%26volume%3D12%26issue%3D9%26spage%3D814%26epage%3D822%26doi%3D10.1038%2Fncb0910-814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rusten, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenmark, H.</span></span> <span> </span><span class="NLM_article-title">p62, an autophagy hero or culprit?</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">209</span>, <span class="refDoi"> DOI: 10.1038/ncb0310-207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fncb0310-207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20190829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFemsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=207-209&issue=3&author=T.+E.+Rustenauthor=H.+Stenmark&title=p62%2C+an+autophagy+hero+or+culprit%3F&doi=10.1038%2Fncb0310-207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">p62, an autophagy hero or culprit?</span></div><div class="casAuthors">Rusten, Tor Erik; Stenmark, Harald</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207-209</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The p62 protein recognizes toxic cellular waste, which is then scavenged by a sequestration process known as self-eating or autophagy.  Lack of autophagy leads to accumulation of p62, which is not good for liver cells, as it induces a cellular stress response that leads to disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDTvJsqrkhz7Vg90H21EOLACvtfcHk0lgJYmGbwQbRrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFemsLo%253D&md5=8c8db4932b3c53a0e576e2cda62fcc20</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fncb0310-207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb0310-207%26sid%3Dliteratum%253Aachs%26aulast%3DRusten%26aufirst%3DT.%2BE.%26aulast%3DStenmark%26aufirst%3DH.%26atitle%3Dp62%252C%2520an%2520autophagy%2520hero%2520or%2520culprit%253F%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2010%26volume%3D12%26issue%3D3%26spage%3D207%26epage%3D209%26doi%3D10.1038%2Fncb0310-207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korolchuk, V. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansilla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menzies, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinsztein, D. C.</span></span> <span> </span><span class="NLM_article-title">Autophagy inhibition compromises degradation of ubiquitin–proteasome pathway substrates</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">517</span>– <span class="NLM_lpage">527</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2009.01.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.molcel.2009.01.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19250912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltFSnu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2009&pages=517-527&issue=4&author=V.+I.+Korolchukauthor=A.+Mansillaauthor=F.+M.+Menziesauthor=D.+C.+Rubinsztein&title=Autophagy+inhibition+compromises+degradation+of+ubiquitin%E2%80%93proteasome+pathway+substrates&doi=10.1016%2Fj.molcel.2009.01.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates</span></div><div class="casAuthors">Korolchuk, Viktor I.; Mansilla, Alicia; Menzies, Fiona M.; Rubinsztein, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">517-527</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The two main routes that cells use for degrading intracellular proteins are the ubiquitin-proteasome and autophagy-lysosome pathways, which have been thought to have largely distinct clients.  Here, we show that autophagy inhibition increases levels of proteasome substrates.  This is largely due to p62 (also called A170/SQSTM1) accumulation after autophagy inhibition.  Excess p62 inhibits the clearance of ubiquitinated proteins destined for proteasomal degrdn. by delaying their delivery to the proteasome's proteases.  Our data show that autophagy inhibition, which was previously believed to only affect long-lived proteins, will also compromise the ubiquitin-proteasome system.  This will lead to increased levels of short-lived regulatory proteins, like p53, as well as the accumulation of aggregation-prone proteins, with predicted deleterious consequences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw5rr6zXQN6bVg90H21EOLACvtfcHk0lgfxtGPYqLKkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltFSnu7Y%253D&md5=b184b0dedbf7b2cedea3f76687aebe85</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2009.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2009.01.021%26sid%3Dliteratum%253Aachs%26aulast%3DKorolchuk%26aufirst%3DV.%2BI.%26aulast%3DMansilla%26aufirst%3DA.%26aulast%3DMenzies%26aufirst%3DF.%2BM.%26aulast%3DRubinsztein%26aufirst%3DD.%2BC.%26atitle%3DAutophagy%2520inhibition%2520compromises%2520degradation%2520of%2520ubiquitin%25E2%2580%2593proteasome%2520pathway%2520substrates%26jtitle%3DMol.%2520Cell%26date%3D2009%26volume%3D33%26issue%3D4%26spage%3D517%26epage%3D527%26doi%3D10.1016%2Fj.molcel.2009.01.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachenmayer, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, Z.</span></span> <span> </span><span class="NLM_article-title">Proteotoxic stress induces phosphorylation of p62/SQSTM1 by ULK1 to regulate selective autophagic clearance of protein aggregates</span>. <i>PLoS Genet.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">e1004987</span>, <span class="refDoi"> DOI: 10.1371/journal.pgen.1004987</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1371%2Fjournal.pgen.1004987" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=25723488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28XltlCns74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=e1004987&issue=2&author=J.+Limauthor=M.+L.+Lachenmayerauthor=S.+Wuauthor=W.+Liuauthor=M.+Kunduauthor=R.+Wangauthor=M.+Komatsuauthor=Y.+J.+Ohauthor=Y.+Zhaoauthor=Z.+Yue&title=Proteotoxic+stress+induces+phosphorylation+of+p62%2FSQSTM1+by+ULK1+to+regulate+selective+autophagic+clearance+of+protein+aggregates&doi=10.1371%2Fjournal.pgen.1004987"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Proteotoxic stress induces phosphorylation of p62/SQSTM1 by ULK1 to regulate selective autophagic clearance of protein aggregates</span></div><div class="casAuthors">Lim, Junghyun; Lenard, Lachenmayer M.; Wu, Shuai; Liu, Wenchao; Kundu, Mondira; Wang, Rong; Komatsu, Masaaki; Oh, Young J.; Zhao, Yanxiang; Yue, Zhenyu</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Genetics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e1004987/1-e1004987/28</span>CODEN:
                <span class="NLM_cas:coden">PGLEB5</span>;
        ISSN:<span class="NLM_cas:issn">1553-7404</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Disruption of proteostasis, or protein homeostasis, is often assocd. with aberrant accumulation of misfolded proteins or protein aggregates.  Autophagy offers protection to cells by removing toxic protein aggregates and injured organelles in response to proteotoxic stress.  However, the exact mechanism whereby autophagy recognizes and degrades misfolded or aggregated proteins has yet to be elucidated.  Mounting evidence demonstrates the selectivity of autophagy, which is mediated through autophagy receptor proteins (e.g. p62/SQSTM1) linking autophagy cargos and autophagosomes.  Here we report that proteotoxic stress imposed by the proteasome inhibition or expression of polyglutamine expanded huntingtin (polyQ-Htt) induces p62 phosphorylation at its ubiquitin-assocn. (UBA) domain that regulates its binding to ubiquitinated proteins.We find that autophagy-related kinase ULK1 phosphorylates p62 at a novel phosphorylation site S409 in UBA domain.  Interestingly, phosphorylation of p62 by ULK1 does not occur upon nutrient starvation, in spite of its role in canonical autophagy signaling.  ULK1 also phosphorylates S405, while S409 phosphorylation critically regulates S405 phosphorylation.  We find that S409 phosphorylation destabilizes the UBA dimer interface, and increases binding affinity of p62 to ubiquitin.  Furthermore, lack of S409 phosphorylation causes accumulation of p62, aberrant localization of autophagy proteins and inhibition of the clearance of ubiquitinated proteins or polyQ-Htt.  Therefore, our data provide mechanistic insights into the regulation of selective autophagy by ULK1 and p62 upon proteotoxic stress.  Our study suggests a potential novel drug target in developing autophagy-based therapeutics for the treatment of proteinopathies including Huntington' disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGQyUcPSyWcrVg90H21EOLACvtfcHk0lgfxtGPYqLKkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltlCns74%253D&md5=ebbcdae749c70ff1b1ec31ee3a690fb8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pgen.1004987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pgen.1004987%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DJ.%26aulast%3DLachenmayer%26aufirst%3DM.%2BL.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DKundu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DOh%26aufirst%3DY.%2BJ.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DYue%26aufirst%3DZ.%26atitle%3DProteotoxic%2520stress%2520induces%2520phosphorylation%2520of%2520p62%252FSQSTM1%2520by%2520ULK1%2520to%2520regulate%2520selective%2520autophagic%2520clearance%2520of%2520protein%2520aggregates%26jtitle%3DPLoS%2520Genet.%26date%3D2015%26volume%3D11%26issue%3D2%26spage%3De1004987%26doi%3D10.1371%2Fjournal.pgen.1004987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibenhener, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderilla-Barbosa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, M. C.</span></span> <span> </span><span class="NLM_article-title">SQSTM1/p62 interacts with HDAC6 and regulates deacetylase activity</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">e76016</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0076016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1371%2Fjournal.pone.0076016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=24086678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOrsLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e76016&issue=9&author=J.+Yanauthor=M.+L.+Seibenhenerauthor=L.+Calderilla-Barbosaauthor=M.+T.+Diaz-Mecoauthor=J.+Moscatauthor=J.+X.+Jiangauthor=M.+W.+Wootenauthor=M.+C.+Wooten&title=SQSTM1%2Fp62+interacts+with+HDAC6+and+regulates+deacetylase+activity&doi=10.1371%2Fjournal.pone.0076016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">SQSTM1/p62 interacts with HDAC6 and regulates deacetylase activity</span></div><div class="casAuthors">Yan, Jin; Seibenhener, Michael Lamar; Calderilla-Barbosa, Luis; Diaz-Meco, Maria-Theresa; Moscat, Jorge; Jiang, Jianxiong; Wooten, Marie W.; Wooten, Michael C.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e76016</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Protein aggregates can form in the cytoplasm of the cell and are accumulated at aggresomes localized to the microtubule organizing center (MTOC) where they are subsequently degraded by autophagy.  In this process, aggregates are engulfed into autophagosomes which subsequently fuse with lysosomes for protein degrdn.  A member of the class II histone deacetylase family, histone deacetylase 6(HDAC6) has been shown to be involved in both aggresome formation and the fusion of autophagosomes with lysosomes making it an attractive target to regulate protein aggregation.  The scaffolding protein sequestosome 1(SQSTM1)/p62 has also been shown to regulate accumulation and autophagic clearance of protein aggregates.  Recent studies have revealed colocalization of HDAC6 and p62 to ubiquitinated mitochondria, as well as, ubiquitinated protein aggregates assocd. with the E3 ubiquitin ligase TRIM50.  HDAC6 deacetylase activity is required for aggresome formation and can be regulated by protein interaction with HDAC6.  Due to their colocalization at ubiquitinated protein aggregates, we sought to examine if p62 specifically interacted with HDAC6 and if so, if this interaction had any effect on HDAC6 activity and/or the physiol. function of cortactin-F-actin assembly.  We succeeded in identifying and mapping the direct interaction between HDAC6 and p62.  We further show that this interaction regulates HDAC6 deacetylase activity.  Data are presented demonstrating that the absence of p62 results in hyperactivation of HDAC6 and deacetylation of α-tubulin and cortactin.  Further, upon induction of protein misfolding we show that p62 is required for perinuclear co-localization of cortactin-F-actin assemblies.  Thus, our findings indicate that p62 plays a key role in regulating the recruitment of F-actin network assemblies to the MTOC, a crit. cellular function that is required for successful autophagic clearance of protein aggregates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpExnTVUcFzirVg90H21EOLACvtfcHk0lgfxtGPYqLKkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOrsLjE&md5=d9025bf2bb345b9300a728c6b492e456</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0076016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0076016%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DSeibenhener%26aufirst%3DM.%2BL.%26aulast%3DCalderilla-Barbosa%26aufirst%3DL.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DJ.%2BX.%26aulast%3DWooten%26aufirst%3DM.%2BW.%26aulast%3DWooten%26aufirst%3DM.%2BC.%26atitle%3DSQSTM1%252Fp62%2520interacts%2520with%2520HDAC6%2520and%2520regulates%2520deacetylase%2520activity%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D9%26spage%3De76016%26doi%3D10.1371%2Fjournal.pone.0076016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Long, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H. T.</span></span> <span> </span><span class="NLM_article-title">Multifunctional p62 effects underlie diverse metabolic diseases</span>. <i>Trends Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">818</span>– <span class="NLM_lpage">830</span>, <span class="refDoi"> DOI: 10.1016/j.tem.2017.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.tem.2017.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=28966079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFeqtr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=818-830&issue=11&author=M.+Longauthor=X.+Liauthor=L.+Liauthor=M.+Dodsonauthor=D.+D.+Zhangauthor=H.+T.+Zheng&title=Multifunctional+p62+effects+underlie+diverse+metabolic+diseases&doi=10.1016%2Fj.tem.2017.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional p62 Effects Underlie Diverse Metabolic Diseases</span></div><div class="casAuthors">Long, Min; Li, Xing; Li, Li; Dodson, Matthew; Zhang, Donna D.; Zheng, Hongting</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">818-830</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">P62, a protein capable of binding both ubiquitin and autophagy substrates, is well established as a key regulator in cancer and neurodegenerative diseases.  Recently, there has been accumulating evidence that p62 is also a pivotal regulator in metabolic diseases, such as obesity, T2DM, NAFLD, metabolic bone disease, gout and thyroid disease.  This review summarizes the emerging role of p62 on these diseases by considering its functional domains, phenotypes in genetically modified animals, clin. obsd. alterations, and its effects on downstream metabolic signaling pathways.  At the same time, we highlight the need to explore the roles played by p62 in the gastrointestinal environment and immune system, and the extent to which its elevated expression may confer protection against metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_BlrVQz9ZbrVg90H21EOLACvtfcHk0lj3vFmLVxC5Zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFeqtr3E&md5=a1fabfc182d851f6283db0ed0caaa67a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2017.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2017.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DDodson%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26aulast%3DZheng%26aufirst%3DH.%2BT.%26atitle%3DMultifunctional%2520p62%2520effects%2520underlie%2520diverse%2520metabolic%2520diseases%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2017%26volume%3D28%26issue%3D11%26spage%3D818%26epage%3D830%26doi%3D10.1016%2Fj.tem.2017.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Martin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span> <span> </span><span class="NLM_article-title">p62/SQSTM1-steering the cell through health and disease</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>131</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">jcs222836</span>, <span class="refDoi"> DOI: 10.1242/jcs.222836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1242%2Fjcs.222836" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=30397181" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2018&pages=jcs222836&issue=21&author=P.+Sanchez-Martinauthor=M.+Komatsu&title=p62%2FSQSTM1-steering+the+cell+through+health+and+disease&doi=10.1242%2Fjcs.222836"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1242%2Fjcs.222836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.222836%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez-Martin%26aufirst%3DP.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3Dp62%252FSQSTM1-steering%2520the%2520cell%2520through%2520health%2520and%2520disease%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2018%26volume%3D131%26issue%3D21%26spage%3Djcs222836%26doi%3D10.1242%2Fjcs.222836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span> <span> </span><span class="NLM_article-title">The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway</span>. <i>EMBO journal</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1576</span>– <span class="NLM_lpage">1586</span>, <span class="refDoi"> DOI: 10.1093/emboj/19.7.1576</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1093%2Femboj%2F19.7.1576" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD3cXislymt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=1576-1586&issue=7&author=L.+Sanzauthor=M.+T.+Diaz-Mecoauthor=H.+Nakanoauthor=J.+Moscat&title=The+atypical+PKC-interacting+protein+p62+channels+NF-kappaB+activation+by+the+IL-1-TRAF6+pathway&doi=10.1093%2Femboj%2F19.7.1576"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The atypical PKC-interacting protein p62 channels NF-κB activation by the IL-1-TRAF6 pathway</span></div><div class="casAuthors">Sanz, Laura; Diaz-Meco, Maria T.; Nakano, Hiroyasu; Moscat, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1576-1586</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The atypical protein kinase C (aPKC)-interacting protein, p62, has previously been shown to interact with RIP, linking these kinases to NF-κB activation by tumor necrosis factor α (TNFα).  The aPKCs have been implicated in the activation of IKKβ in TNFα-stimulated cells and have been shown to be activated in response to interleukin-1 (IL-1).  Here the authors demonstrate that the inhibition of the aPKCs or the down-regulation of p62 severely abrogates NF-κB activation by IL-1 and TRAF6, suggesting that both proteins are crit. intermediaries in this pathway.  Consistent with this the authors show that p62 selectively interacts with the TRAF domain of TRAF6 but not that of TRAF5 or TRAF2 in co-transfection expts.  The binding of endogenous p62 to TRAF6 is stimulus dependent, reinforcing the notion that this is a physiol. relevant interaction.  Furthermore, the authors demonstrate that the N-terminal domain of TRAF6, which is required for signaling, interacts with ζPKC in a dimerization-dependent manner.  Together, these results indicate that p62 is an important intermediary not only in TNFα but also in IL-1 signaling to NF-κB via the specific adapters RIP and TRAF6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrytjcrhYe9zbVg90H21EOLACvtfcHk0lj3vFmLVxC5Zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXislymt7s%253D&md5=dcfc651bfcb5c031a7058464fee50f62</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F19.7.1576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F19.7.1576%26sid%3Dliteratum%253Aachs%26aulast%3DSanz%26aufirst%3DL.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DNakano%26aufirst%3DH.%26aulast%3DMoscat%26aufirst%3DJ.%26atitle%3DThe%2520atypical%2520PKC-interacting%2520protein%2520p62%2520channels%2520NF-kappaB%2520activation%2520by%2520the%2520IL-1-TRAF6%2520pathway%26jtitle%3DEMBO%2520journal%26date%3D2000%26volume%3D19%26issue%3D7%26spage%3D1576%26epage%3D1586%26doi%3D10.1093%2Femboj%2F19.7.1576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumanomidou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sou, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ezaki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kominami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamane, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span> <span> </span><span class="NLM_article-title">Structural basis for sorting mechanism of p62 in selective autophagy</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span> (<span class="NLM_issue">33</span>),  <span class="NLM_fpage">22847</span>– <span class="NLM_lpage">22857</span>, <span class="refDoi"> DOI: 10.1074/jbc.M802182200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1074%2Fjbc.M802182200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18524774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsVKmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=22847-22857&issue=33&author=Y.+Ichimuraauthor=T.+Kumanomidouauthor=Y.+S.+Souauthor=T.+Mizushimaauthor=J.+Ezakiauthor=T.+Uenoauthor=E.+Kominamiauthor=T.+Yamaneauthor=K.+Tanakaauthor=M.+Komatsu&title=Structural+basis+for+sorting+mechanism+of+p62+in+selective+autophagy&doi=10.1074%2Fjbc.M802182200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Sorting Mechanism of p62 in Selective Autophagy</span></div><div class="casAuthors">Ichimura, Yoshinobu; Kumanomidou, Taichi; Sou, Yu-shin; Mizushima, Tsunehiro; Ezaki, Junji; Ueno, Takashi; Kominami, Eiki; Yamane, Takashi; Tanaka, Keiji; Komatsu, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">22847-22857</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Impairment of autophagic degrdn. of the ubiquitin- and LC3-binding protein "p62" leads to the formation of cytoplasmic inclusion bodies.  However, little is known about the sorting mechanism of p62 to autophagic degrdn.  Here we identified a motif of murine p62 consisting of 11 amino acids (Ser334-Ser344) contg. conserved acidic and hydrophobic residues across species, as an LC3 recognition sequence (LRS).  The crystal structure of the LC3-LRS complex at 1.56Å resoln. revealed interaction of Trp340 and Leu343 of p62 with different hydrophobic pockets on the ubiquitin fold of LC3.  In vivo analyses demonstrated that p62 mutants lacking LC3 binding ability accumulated without entrapping into autophagosomes in the cytoplasm and subsequently formed ubiquitin-pos. inclusion bodies as in autophagy-deficient cells.  These results demonstrate that the intracellular level of p62 is tightly regulated by autophagy through the direct interaction of LC3 with p62 and reveal that selective turnover of p62 via autophagy controls inclusion body formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqriqJXuar6ObVg90H21EOLACvtfcHk0lj9A61a6njkaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsVKmt7o%253D&md5=6066759d89a4a3bd321c9ca77bae7c5b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M802182200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M802182200%26sid%3Dliteratum%253Aachs%26aulast%3DIchimura%26aufirst%3DY.%26aulast%3DKumanomidou%26aufirst%3DT.%26aulast%3DSou%26aufirst%3DY.%2BS.%26aulast%3DMizushima%26aufirst%3DT.%26aulast%3DEzaki%26aufirst%3DJ.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DKominami%26aufirst%3DE.%26aulast%3DYamane%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3DStructural%2520basis%2520for%2520sorting%2520mechanism%2520of%2520p62%2520in%2520selective%2520autophagy%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26issue%3D33%26spage%3D22847%26epage%3D22857%26doi%3D10.1074%2Fjbc.M802182200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimple, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siderovski, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, G. L.</span></span> <span> </span><span class="NLM_article-title">PB1 domain interaction of p62/sequestosome 1 and MEKK3 regulates NF-kappaB activation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">2077</span>– <span class="NLM_lpage">2089</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.065102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1074%2Fjbc.M109.065102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19903815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjsVSqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=2077-2089&issue=3&author=K.+Nakamuraauthor=A.+J.+Kimpleauthor=D.+P.+Siderovskiauthor=G.+L.+Johnson&title=PB1+domain+interaction+of+p62%2Fsequestosome+1+and+MEKK3+regulates+NF-kappaB+activation&doi=10.1074%2Fjbc.M109.065102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">PB1 Domain Interaction of p62/Sequestosome 1 and MEKK3 Regulates NF-κB Activation</span></div><div class="casAuthors">Nakamura, Kazuhiro; Kimple, Adam J.; Siderovski, David P.; Johnson, Gary L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">2077-2089</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">P62/Sequestosome 1 is a scaffold protein involved in the regulation of autophagy, trafficking of proteins to the proteasome, and activation of NF-κB.  P62 encodes an N-terminal PB1 domain in addn. to the ZZ domain, TRAF6-binding domain, LC3 interaction region, and ubiquitin-assocd. domain, each crit. for the physiol. function of p62.  PB1 domains have a β-grasp topol. where the front end of one PB1 domain binds the back end of a second PB1 domain.  The p62 PB1 domain homodimerizes as well as heterodimerizes with other PB1 domains.  The front end of the PB1 domain in p62 binds the PB1 domain of atypical protein kinases C, the MAPK kinase, MEK5, and the NBR1 protein.  Other than its role in homodimerization, the rear end acidic cluster region of the p62 PB1 domain had no previous defined binding partners.  Herein, we demonstrate that the rear end acidic cluster region of the p62 PB1 domain binds the front end basic region of the MAPK kinase kinase, MEKK3.  P62 and MEKK3 co-localize in speckles or aggregates that are centers for organizing TRAF6-regulated NF-κB signaling and the assembly of polyubiquinated proteins sorting to sequestosomes and proteasomes.  The p62-MEKK3 complex binds TRAF6, which regulates the ubiquitination of the IKK complex and NF-κB activation.  P62 is required for the assocn. of MEKK3 with TRAF6, and short hairpin RNA knockdown of p62 inhibits IL-1 and MEKK3 activation of NF-κB.  The rear end acidic cluster of the p62 PB1 domain is used to organize cytosolic aggregates or speckles-assocd. TRAF6-p62-MEKK3 complex for control of NF-κB activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS5Q3e_FG82rVg90H21EOLACvtfcHk0lj8_wme6Ro7cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjsVSqsg%253D%253D&md5=dca7f975296dcfa2273d2845b20b0a8d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.065102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.065102%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DKimple%26aufirst%3DA.%2BJ.%26aulast%3DSiderovski%26aufirst%3DD.%2BP.%26aulast%3DJohnson%26aufirst%3DG.%2BL.%26atitle%3DPB1%2520domain%2520interaction%2520of%2520p62%252Fsequestosome%25201%2520and%2520MEKK3%2520regulates%2520NF-kappaB%2520activation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26issue%3D3%26spage%3D2077%26epage%3D2089%26doi%3D10.1074%2Fjbc.M109.065102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ofengeim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">736</span>, <span class="refDoi"> DOI: 10.1038/nrm3683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fnrm3683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=24129419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1WmsL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=727-736&issue=11&author=D.+Ofengeimauthor=J.+Yuan&title=Regulation+of+RIP1+kinase+signalling+at+the+crossroads+of+inflammation+and+cell+death&doi=10.1038%2Fnrm3683"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death</span></div><div class="casAuthors">Ofengeim, Dimitry; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">727-736</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Receptor-interacting protein 1 (RIP1) kinase has emerged as a key upstream regulator that controls inflammatory signaling as well as the activation of multiple cell death pathways, including apoptosis and necroptosis.  The ability of RIP1 to modulate these key cellular events is tightly controlled by ubiquitylation, deubiquitylation, and the interaction of RIP1 with a class of ubiquitin receptors.  The modification of RIP1 may thus provide a unique 'ubiquitin code' that dets. whether a cell activates nuclear factor-κB (NF-κB) to promote inflammatory signaling or induces cell death by apoptosis or necroptosis.  Targeting RIP1 might be a novel therapeutic strategy for the treatment of both acute and chronic human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEaxoFDmOcn7Vg90H21EOLACvtfcHk0lj8_wme6Ro7cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1WmsL%252FE&md5=4a21fb85ca9c564082d2faedc1c60cf1</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrm3683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3683%26sid%3Dliteratum%253Aachs%26aulast%3DOfengeim%26aufirst%3DD.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DRegulation%2520of%2520RIP1%2520kinase%2520signalling%2520at%2520the%2520crossroads%2520of%2520inflammation%2520and%2520cell%2520death%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2013%26volume%3D14%26issue%3D11%26spage%3D727%26epage%3D736%26doi%3D10.1038%2Fnrm3683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L. K.</span></span> <span> </span><span class="NLM_article-title">p62/SQSTM1 as an oncotarget mediates cisplatin resistance through activating RIP1-NF-kappaB pathway in human ovarian cancer cells</span>. <i>Cancer science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>108</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1405</span>– <span class="NLM_lpage">1413</span>, <span class="refDoi"> DOI: 10.1111/cas.13276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1111%2Fcas.13276" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=28498503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVGntLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2017&pages=1405-1413&issue=7&author=X.+Y.+Yanauthor=Y.+Zhangauthor=J.+J.+Zhangauthor=L.+C.+Zhangauthor=Y.+N.+Liuauthor=Y.+Wuauthor=Y.+N.+Xueauthor=S.+Y.+Luauthor=J.+Suauthor=L.+K.+Sun&title=p62%2FSQSTM1+as+an+oncotarget+mediates+cisplatin+resistance+through+activating+RIP1-NF-kappaB+pathway+in+human+ovarian+cancer+cells&doi=10.1111%2Fcas.13276"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">p62/SQSTM1 as an oncotarget mediates cisplatin resistance through activating RIP1-NF-κB pathway in human ovarian cancer cells</span></div><div class="casAuthors">Yan, Xiao-Yu; Zhang, Yu; Zhang, Juan-Juan; Zhang, Li-Chao; Liu, Ya-Nan; Wu, Yao; Xue, Ya-Nan; Lu, Sheng-Yao; Su, Jing; Sun, Lian-Kun</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1405-1413</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Platinum-based therapeutic strategies have been widely used in ovarian cancer treatment.  However, drug resistance has greatly limited therapeutic efficacy.  Recently, tolerance to cisplatin has been attributed to other factors unrelated to DNA. p62 (also known as SQSTM1) functions as a multifunctional hub participating in tumorigenesis and may be a therapeutic target.  Our previous study showed that p62 was overexpressed in drug-resistant ovarian epithelial carcinoma and its inhibition increased the sensitivity to cisplatin.  In this study, we demonstrate that the activity of the NF-κB signaling pathway and K63-linked ubiquitination of RIP1 was higher in cisplatin-resistant ovarian (SKOV3/DDP) cells compared with parental cells.  In addn., cisplatin resistance could be reversed by inhibiting the expression of p62 using siRNA.  Furthermore, deletion of the ZZ domain of p62 that interacts with RIP1 in SKOV3 cells markedly decreased K63-linked ubiquitination of RIP1 and inhibited the activation of the NF-κB signaling pathway.  Moreover, loss of the ZZ domain from p62 led to poor proliferative capacity and high levels of apoptosis in SKOV3 cells and made them more sensitive to cisplatin treatment.  Collectively, we provide evidence that p62 is implicated in the activation of NF-κB signaling that is partly dependent on RIP1. p62 promotes cell proliferation and inhibits apoptosis thus mediating drug resistance in ovarian cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZvEM9J3RUg7Vg90H21EOLACvtfcHk0lgVSj0P_rMuUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVGntLbL&md5=750746b2c920bb418afc86232741476c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fcas.13276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.13276%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DX.%2BY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DL.%2BC.%26aulast%3DLiu%26aufirst%3DY.%2BN.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DY.%2BN.%26aulast%3DLu%26aufirst%3DS.%2BY.%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DL.%2BK.%26atitle%3Dp62%252FSQSTM1%2520as%2520an%2520oncotarget%2520mediates%2520cisplatin%2520resistance%2520through%2520activating%2520RIP1-NF-kappaB%2520pathway%2520in%2520human%2520ovarian%2520cancer%2520cells%26jtitle%3DCancer%2520science%26date%3D2017%26volume%3D108%26issue%3D7%26spage%3D1405%26epage%3D1413%26doi%3D10.1111%2Fcas.13276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwok, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Belleroche, J. S.</span></span> <span> </span><span class="NLM_article-title">Sequestosome-1 (SQSTM1) sequence variants in ALS cases in the UK: prevalence and coexistence of SQSTM1 mutations in ALS kindred with PDB</span>. <i>Eur. J. Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">492</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1038/ejhg.2013.184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fejhg.2013.184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=23942205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktlGlt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=492-496&issue=4&author=C.+T.+Kwokauthor=A.+Morrisauthor=J.+S.+de+Belleroche&title=Sequestosome-1+%28SQSTM1%29+sequence+variants+in+ALS+cases+in+the+UK%3A+prevalence+and+coexistence+of+SQSTM1+mutations+in+ALS+kindred+with+PDB&doi=10.1038%2Fejhg.2013.184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Sequestosome-1 (SQSTM1) sequence variants in ALS cases in the UK: prevalence and coexistence of SQSTM1 mutations in ALS kindred with PDB</span></div><div class="casAuthors">Kwok, Chun T.; Morris, Alex; de Belleroche, Jacqueline S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">492-496</span>CODEN:
                <span class="NLM_cas:coden">EJHGEU</span>;
        ISSN:<span class="NLM_cas:issn">1018-4813</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in the SQSTM1 gene have been reported to be assocd. with amyotrophic lateral sclerosis (ALS).  We sought to det. the frequency of these mutations in a UK familial ALS (FALS) cohort.  Sequences of all eight exons of the SQSTM1 gene were analyzed in index cases from 61 different FALS kindred lacking known FALS mutations.  Six exonic variants c.463G>A, p.(Glu155Lys), c.822G>C, p.(Glu274Asp), c.888G>T, p.(=), c.954C>T, p.(=), c.1038G>A, p.(=) and c.1175C>T, p.  (Pro392Leu) were identified in five FALS index cases, three of which were non-synonymous and three were synonymous.  One index case harbored three variants (c.822G>C, c.888G>T and c.954C>T), and a second index case harbored two variants (c.822G>C and c.954C>T).  Only the p.(Pro392Leu) and p.(Glu155Lys) mutations were predicted to be pathogenic.  In one p.(Pro392Leu) kindred, the carrier developed both ALS and Paget's disease of bone (PDB), and, in the p.(Glu155Lys) kindred, the father of the proband developed PDB.  All p.(Pro392Leu) carriers were heterozygous for a previously reported founder haplotype for PDB, where this mutation has an established causal effect.  The frequency of the p.(Pro392Leu) mutation in this UK FALS cohort was 2.3% and 0.97% overall including three previously screened FALS cohorts.  Our results confirm the presence of the p.(Pro392Leu) SQSTM1 mutation in FALS.  This mutation is the most common SQSTM1 mutation found in ALS to date, and a likely pathogenicity is supported by having an established causal role in PDB.  The occurrence of the same mutation in ALS and PDB is indicative of a common pathogenic pathway that converges on protein homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozWZMgJFrGL7Vg90H21EOLACvtfcHk0lgVSj0P_rMuUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktlGlt78%253D&md5=bb5e2764204efbae60ac1d9f64e91c25</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fejhg.2013.184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fejhg.2013.184%26sid%3Dliteratum%253Aachs%26aulast%3DKwok%26aufirst%3DC.%2BT.%26aulast%3DMorris%26aufirst%3DA.%26aulast%3Dde%2BBelleroche%26aufirst%3DJ.%2BS.%26atitle%3DSequestosome-1%2520%2528SQSTM1%2529%2520sequence%2520variants%2520in%2520ALS%2520cases%2520in%2520the%2520UK%253A%2520prevalence%2520and%2520coexistence%2520of%2520SQSTM1%2520mutations%2520in%2520ALS%2520kindred%2520with%2520PDB%26jtitle%3DEur.%2520J.%2520Hum.%2520Genet.%26date%3D2014%26volume%3D22%26issue%3D4%26spage%3D492%26epage%3D496%26doi%3D10.1038%2Fejhg.2013.184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Joazeiro, C. A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissman, A. M.</span></span> <span> </span><span class="NLM_article-title">RING finger proteins: mediators of ubiquitin ligase activity</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>102</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">549</span>– <span class="NLM_lpage">552</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)00077-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2FS0092-8674%2800%2900077-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=11007473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFWit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=549-552&issue=5&author=C.+A.+P.+Joazeiroauthor=A.+M.+Weissman&title=RING+finger+proteins%3A+mediators+of+ubiquitin+ligase+activity&doi=10.1016%2FS0092-8674%2800%2900077-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">RING finger proteins: mediators of ubiquitin ligase activity</span></div><div class="casAuthors">Joazeiro, Claudio A. P.; Weissman, Allan M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">549-552</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review with 20 refs.  Ubiquitination is a highly regulated and common cellular process with ubiquitin protein ligases (E3) as central players.  RING finger proteins represent the largest class of E3s to date.  Whether RING fingers are primarily modules that mediate ubiquitination and other protein modifications or if they have other discrete functions should soon become apparent.  Mammalian genomes encode hundreds of RING finger proteins.  Extrapolating from in vitro studies, we predict that many of these have the capacity to interact with E2s and to potentially mediate ubiquitination.  It remains to be detd. how many of these will be bona fide E3s for heterologous substrates, targets for ubiquitination, or both.  The no. of potential E3s is further enhanced by the combinatorial assocn. of certain RING finger proteins with other proteins that provide docking sites for substrates.  The field of intracellular protein degrdn. now leaves the era where mediators of substrate-specific ubiquitination were scarce and enters a new and exciting phase where databases provide us with a large no. of candidate E3s awaiting characterization.  Each has the potential to help us understand how cells orchestrate the complexities of rapidly regulating protein levels and activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGstCtpScUhrVg90H21EOLACvtfcHk0lhnXmlU9qFKOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFWit7s%253D&md5=92fc04f47883e83d39cb491d6fa26834</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2900077-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252900077-5%26sid%3Dliteratum%253Aachs%26aulast%3DJoazeiro%26aufirst%3DC.%2BA.%2BP.%26aulast%3DWeissman%26aufirst%3DA.%2BM.%26atitle%3DRING%2520finger%2520proteins%253A%2520mediators%2520of%2520ubiquitin%2520ligase%2520activity%26jtitle%3DCell%26date%3D2000%26volume%3D102%26issue%3D5%26spage%3D549%26epage%3D552%26doi%3D10.1016%2FS0092-8674%2800%2900077-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geetha, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibenhener, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span> <span> </span><span class="NLM_article-title">The p62 scaffold regulates nerve growth factor-induced NF-kappa B activation by influencing TRAF6 polyubiquitination</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span> (<span class="NLM_issue">42</span>),  <span class="NLM_fpage">35625</span>– <span class="NLM_lpage">35629</span>, <span class="refDoi"> DOI: 10.1074/jbc.C500237200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1074%2Fjbc.C500237200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=16079148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFWmurrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=35625-35629&issue=42&author=M.+W.+Wootenauthor=T.+Geethaauthor=M.+L.+Seibenhenerauthor=J.+R.+Babuauthor=M.+T.+Diaz-Mecoauthor=J.+Moscat&title=The+p62+scaffold+regulates+nerve+growth+factor-induced+NF-kappa+B+activation+by+influencing+TRAF6+polyubiquitination&doi=10.1074%2Fjbc.C500237200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The p62 scaffold regulates nerve growth factor-induced NF-κB activation by influencing TRAF6 polyubiquitination</span></div><div class="casAuthors">Wooten, Marie W.; Geetha, Thangiah; Seibenhener, M. Lamar; Babu, J. Ramesh; Diaz-Meco, Maria T.; Moscat, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">35625-35629</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Sequestosome 1/p62 is a scaffolding protein with several interaction modules that include a PB1 dimerization domain, a TRAF6 (tumor necrosis factor receptor-assocd. factor 6) binding site, and a ubiquitin-assocg. (UBA) domain.  Here, we report that p62 functions to facilitate K63-polyubiquitination of TRAF6 and thereby mediates nerve growth factor-induced activation of the NF-κB pathway.  In brain of p62 knock-out mice we did not recover polyubiquitinated TRAF6.  The UBA domain binds polyubiquitin chains and deletion of p62-UBA domain or mutation of F406V within the ubiquitin binding pocket of the UBA domain abolished TRAF6 polyubiquitination.  Likewise, deletion of p62 N-terminal dimerization domain or the TRAF6 binding site had similar effects on both polyubiquitination and oligomerization of TRAF6.  Nerve growth factor treatment of PC12 cells induced TRAF6 polyubiquitination along with formation of a p62-TRAF6-IKKβ-PKCι signal complex, while inhibition of the p62/TRAF6 interaction had an opposite effect.  These results provide evidence for a mechanism whereby p62 serves to regulate the NF-κB pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhHtx2OlREorVg90H21EOLACvtfcHk0lhnXmlU9qFKOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFWmurrE&md5=b0b847082ba014a13bf74838eb5420db</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C500237200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C500237200%26sid%3Dliteratum%253Aachs%26aulast%3DWooten%26aufirst%3DM.%2BW.%26aulast%3DGeetha%26aufirst%3DT.%26aulast%3DSeibenhener%26aufirst%3DM.%2BL.%26aulast%3DBabu%26aufirst%3DJ.%2BR.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DMoscat%26aufirst%3DJ.%26atitle%3DThe%2520p62%2520scaffold%2520regulates%2520nerve%2520growth%2520factor-induced%2520NF-kappa%2520B%2520activation%2520by%2520influencing%2520TRAF6%2520polyubiquitination%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26issue%3D42%26spage%3D35625%26epage%3D35629%26doi%3D10.1074%2Fjbc.C500237200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chamoux, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McManus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laberge, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roux, S.</span></span> <span> </span><span class="NLM_article-title">Involvement of kinase PKC-zeta in the p62/p62(P392L)-driven activation of NF-kappaB in human osteoclasts</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1832</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">475</span>– <span class="NLM_lpage">484</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2012.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.bbadis.2012.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCgtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1832&publication_year=2013&pages=475-484&issue=3&author=E.+Chamouxauthor=S.+McManusauthor=G.+Labergeauthor=M.+Bissonauthor=S.+Roux&title=Involvement+of+kinase+PKC-zeta+in+the+p62%2Fp62%28P392L%29-driven+activation+of+NF-kappaB+in+human+osteoclasts&doi=10.1016%2Fj.bbadis.2012.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of kinase PKC-zeta in the p62/p62P392L-driven activation of NF-κB in human osteoclasts</span></div><div class="casAuthors">Chamoux, Estelle; McManus, Stephen; Laberge, Gino; Bisson, Martine; Roux, Sophie</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1832</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">475-484</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Mutations of the gene encoding sequestosome1 (SQSTM1/p62), clustering in or near the UBA domain, have been described in Paget's disease of bone (PDB); among these the P392L substitution is the most prevalent.  Protein p62 mediates several cell functions, including the control of NF-κB signaling, and autophagy.  This scaffolding protein interacts with atypical PKCζ in the RANKL-induced signaling complex.  We have previously shown that osteoclasts (OCs) overexpressing the p62P392L variant were in a constitutively activated state, presenting activated kinase p-PKCζ/λ and activated NF-κB prior to RANKL stimulation.  In the present study, we investigated the relationships between PKCζ and NF-κB activation in human OCs transfected with p62 variants.  We showed that PKCζ and p-PKCζ/λ colocalize with p62, and that PKCζ is involved in the RANKL-induced NF-κB activation and in the RANKL-independent activation of NF-κB obsd. in p62P392L-transfected cells.  We also obsd. a basal and RANKL-induced increase in IκBα levels in the presence of the p62P392L mutation that contrasted with the NF-κB activation.  In this study we propose that PKCζ plays a role in the activation of NF-κB by acting as a p65 (RelA) kinase at Ser536, independently of IκBα; this alternative pathway could be used preferentially in the presence of the p62P392L mutation, which may hinder the ubiquitin-proteasome pathway.  Overall, our results highlight the importance of p62-assocd. PKCζ in the overactive state of pagetic OCs and in the activation of NF-κB, particularly in the presence of the p62P392L mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoToi0wa789mrVg90H21EOLACvtfcHk0lhnXmlU9qFKOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCgtLk%253D&md5=c381b983a8c6e13aa85a5c28a411c0a6</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2012.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2012.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DChamoux%26aufirst%3DE.%26aulast%3DMcManus%26aufirst%3DS.%26aulast%3DLaberge%26aufirst%3DG.%26aulast%3DBisson%26aufirst%3DM.%26aulast%3DRoux%26aufirst%3DS.%26atitle%3DInvolvement%2520of%2520kinase%2520PKC-zeta%2520in%2520the%2520p62%252Fp62%2528P392L%2529-driven%2520activation%2520of%2520NF-kappaB%2520in%2520human%2520osteoclasts%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2013%26volume%3D1832%26issue%3D3%26spage%3D475%26epage%3D484%26doi%3D10.1016%2Fj.bbadis.2012.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bloom, G. S.</span></span> <span> </span><span class="NLM_article-title">Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis</span>. <i>JAMA neurology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">505</span>– <span class="NLM_lpage">508</span>, <span class="refDoi"> DOI: 10.1001/jamaneurol.2013.5847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1001%2Fjamaneurol.2013.5847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=24493463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BC2cvhslWmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=505-508&issue=4&author=G.+S.+Bloom&title=Amyloid-beta+and+tau%3A+the+trigger+and+bullet+in+Alzheimer+disease+pathogenesis&doi=10.1001%2Fjamaneurol.2013.5847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis</span></div><div class="casAuthors">Bloom George S</div><div class="citationInfo"><span class="NLM_cas:title">JAMA neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">505-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The defining features of Alzheimer disease (AD) include conspicuous changes in both brain histology and behavior.  The AD brain is characterized microscopically by the combined presence of 2 classes of abnormal structures, extracellular amyloid plaques and intraneuronal neurofibrillary tangles, both of which comprise highly insoluble, densely packed filaments.  The soluble building blocks of these structures are amyloid-β (Aβ) peptides for plaques and tau for tangles.  Amyloid-β peptides are proteolytic fragments of the transmembrane amyloid precursor protein, whereas tau is a brain-specific, axon-enriched microtubule-associated protein.  The behavioral symptoms of AD correlate with the accumulation of plaques and tangles, and they are a direct consequence of the damage and destruction of synapses that mediate memory and cognition.  Synapse loss can be caused by the failure of live neurons to maintain functional axons and dendrites or by neuron death.  During the past dozen years, a steadily accumulating body of evidence has indicated that soluble forms of Aβ and tau work together, independently of their accumulation into plaques and tangles, to drive healthy neurons into the diseased state and that hallmark toxic properties of Aβ require tau.  For instance, acute neuron death, delayed neuron death following ectopic cell cycle reentry, and synaptic dysfunction are triggered by soluble, extracellular Aβ species and depend on soluble, cytoplasmic tau.  Therefore, Aβ is upstream of tau in AD pathogenesis and triggers the conversion of tau from a normal to a toxic state, but there is also evidence that toxic tau enhances Aβ toxicity via a feedback loop.  Because soluble toxic aggregates of both Aβ and tau can self-propagate and spread throughout the brain by prionlike mechanisms, successful therapeutic intervention for AD would benefit from detecting these species before plaques, tangles, and cognitive impairment become evident and from interfering with the destructive biochemical pathways that they initiate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSz_gqDeA-SdD0O18WR3iAofW6udTcc2eZBHUIYsgkFALntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvhslWmsA%253D%253D&md5=a12c1fb9fb6f57c471009a3b30573fb3</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1001%2Fjamaneurol.2013.5847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjamaneurol.2013.5847%26sid%3Dliteratum%253Aachs%26aulast%3DBloom%26aufirst%3DG.%2BS.%26atitle%3DAmyloid-beta%2520and%2520tau%253A%2520the%2520trigger%2520and%2520bullet%2520in%2520Alzheimer%2520disease%2520pathogenesis%26jtitle%3DJAMA%2520neurology%26date%3D2014%26volume%3D71%26issue%3D4%26spage%3D505%26epage%3D508%26doi%3D10.1001%2Fjamaneurol.2013.5847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span> <span> </span><span class="NLM_article-title">TRAF6 promoted the metastasis of esophageal squamous cell carcinoma</span>. <i>Tumor Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">715</span>– <span class="NLM_lpage">721</span>, <span class="refDoi"> DOI: 10.1007/s13277-013-1098-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1007%2Fs13277-013-1098-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGjtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=715-721&issue=1&author=Q.+Hanauthor=F.+Yaoauthor=C.+Zhongauthor=H.+Zhao&title=TRAF6+promoted+the+metastasis+of+esophageal+squamous+cell+carcinoma&doi=10.1007%2Fs13277-013-1098-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">TRAF6 promoted the metastasis of esophageal squamous cell carcinoma</span></div><div class="casAuthors">Han, Qingqi; Yao, Feng; Zhong, Chenxi; Zhao, Heng</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">715-721</span>CODEN:
                <span class="NLM_cas:coden">TUMBEA</span>;
        ISSN:<span class="NLM_cas:issn">1010-4283</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Esophageal cancer is one of the most aggressive malignancies and has been ranked as the sixth leading cause of cancer-related death in the world.  It is very urgent to find new therapeutic targets.  Although tumor necrosis factor receptor-assocd. factor 6 (TRAF6) was initially identified as an adaptor for NF-κB signaling, recently it has been found to be involved in cancer by modulating various signaling pathways.  In the previous study, we have found that TRAF6 promoted the growth of esophageal squamous cell carcinoma (ESCC) cell in vitro and in vivo.  However, the effects of TRAF6 on the migration and metastasis of ESCC cells are poorly understood.  Here, we found that TRAF6 promoted migration and metastasis of ESCC cells through modulating Ras signaling.  Overexpression of TRAF6 promoted the migration of ESCC cells and immortalized esophageal epithelial cells, while knock down the expression of TRAF6 inhibited the migration and metastasis of ESCC cells in vitro and in vivo.  Mech., TRAF6 binds Ras with its N-terminal and activated Ras signaling.  Taken together, TRAF6 played an important role in the metastasis of ESCC and might be a promising therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9-0iCeZ1UwLVg90H21EOLACvtfcHk0lgxqnbDN1lbHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGjtbw%253D&md5=e5a133848689d41740042fdb8c540a6a</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs13277-013-1098-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13277-013-1098-z%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DQ.%26aulast%3DYao%26aufirst%3DF.%26aulast%3DZhong%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DH.%26atitle%3DTRAF6%2520promoted%2520the%2520metastasis%2520of%2520esophageal%2520squamous%2520cell%2520carcinoma%26jtitle%3DTumor%2520Biol.%26date%3D2014%26volume%3D35%26issue%3D1%26spage%3D715%26epage%3D721%26doi%3D10.1007%2Fs13277-013-1098-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Birgisdottir, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamark, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansen, T.</span></span> <span> </span><span class="NLM_article-title">The LIR motif-crucial for selective autophagy</span>. <i>Journal of cell science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>126</i></span> (<span class="NLM_issue">Pt 15</span>),  <span class="NLM_fpage">3237</span>– <span class="NLM_lpage">3247</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=23908376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFajur%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2013&pages=3237-3247&issue=Pt+15&author=A.+B.+Birgisdottirauthor=T.+Lamarkauthor=T.+Johansen&title=The+LIR+motif-crucial+for+selective+autophagy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The LIR motif - crucial for selective autophagy</span></div><div class="casAuthors">Birgisdottir, Aasa Birna; Lamark, Trond; Johansen, Terje</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3237-3247</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  (Macro)autophagy is a fundamental degrdn. process for macromols. and organelles of vital importance for cell and tissue homeostasis.  Autophagy research has gained a strong momentum in recent years because of its relevance to cancer, neurodegenerative diseases, muscular dystrophy, lipid storage disorders, development, ageing and innate immunity.  Autophagy has traditionally been thought of as a bulk degrdn. process that is mobilized upon nutritional starvation to replenish the cell with building blocks and keep up with the energy demand.  This view has recently changed dramatically following an array of papers describing various forms of selective autophagy.  A main driving force has been the discovery of specific autophagy receptors that sequester cargo into forming autophagosomes (phagophores).  At the heart of this selectivity lies the LC3-interacting region (LIR) motif, which ensures the targeting of autophagy receptors to LC3 (or other ATG8 family proteins) anchored in the phagophore membrane.  LIR-contg. proteins include cargo receptors, members of the basal autophagy app., proteins assocd. with vesicles and of their transport, Rab GTPase-activating proteins (GAPs) and specific signaling proteins that are degraded by selective autophagy.  Here, we comment on these new insights and focus on the interactions of LIR-contg. proteins with members of the ATG8 protein family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaWI8Ij9ZBkrVg90H21EOLACvtfcHk0lhqnc5cHGqrZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFajur%252FK&md5=37d7a374da7d515bc5cca5558261eb01</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBirgisdottir%26aufirst%3DA.%2BB.%26aulast%3DLamark%26aufirst%3DT.%26aulast%3DJohansen%26aufirst%3DT.%26atitle%3DThe%2520LIR%2520motif-crucial%2520for%2520selective%2520autophagy%26jtitle%3DJournal%2520of%2520cell%2520science%26date%3D2013%26volume%3D126%26issue%3DPt%252015%26spage%3D3237%26epage%3D3247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kominami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span> <span> </span><span class="NLM_article-title">Selective turnover of p62/A170/SQSTM1 by autophagy</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1063</span>– <span class="NLM_lpage">1066</span>, <span class="refDoi"> DOI: 10.4161/auto.6826</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.4161%2Fauto.6826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18776737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtlaktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=1063-1066&issue=8&author=Y.+Ichimuraauthor=E.+Kominamiauthor=K.+Tanakaauthor=M.+Komatsu&title=Selective+turnover+of+p62%2FA170%2FSQSTM1+by+autophagy&doi=10.4161%2Fauto.6826"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Selective turnover of p62/A170/SQSTM1 by autophagy</span></div><div class="casAuthors">Ichimura, Yoshinobu; Kominami, Eiki; Tanaka, Keiji; Komatsu, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1063-1066</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8627</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  Loss of autophagy causes liver injury, cardiomyopathy and neurodegeneration, assocd. with the formation of ubiquitin-pos. inclusion bodies.  However, the pathogenic mechanism and mol. machinery involved in inclusion formation are not fully understood.  We recently identified a ubiquitin-binding protein, p62/A170/SQSTM1, as a mol. involved in inclusion formation.  P62 interacts with LC3 which regulates autophagosome formation, through an 11 amino acid sequence rich in acidic and hydrophobic residues, named the LC3-recognition sequence (LRS), and the LC3-p62 complex is degraded by autophagy.  Furthermore, structural anal. reveals an interaction of Trp-340 and Leu-343 of p62 with different hydrophobic pockets in the ubiquitin-fold of LC3.  P62 mutants, defective in binding the LRS, escape efficient turnover by autophagy, forming ubiquitin- and p62-pos. inclusions.  Importantly, such ubiquitin- and p62-pos. inclusions are identified in various human diseases, implying the involvement of autophagy in their pathogenic mechanisms.  Our reports identify an important role for autophagy in the selective turnover of p62, and demonstrate that in addn. to the essential role of LC3 in autophagosome formation, LC3 is also involved in sorting autophagy-specific substrate(s).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLpHsCGMqL1rVg90H21EOLACvtfcHk0lhqnc5cHGqrZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtlaktQ%253D%253D&md5=1904742d6716c203b1c5093cd65628fa</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.4161%2Fauto.6826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.6826%26sid%3Dliteratum%253Aachs%26aulast%3DIchimura%26aufirst%3DY.%26aulast%3DKominami%26aufirst%3DE.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3DSelective%2520turnover%2520of%2520p62%252FA170%252FSQSTM1%2520by%2520autophagy%26jtitle%3DAutophagy%26date%3D2008%26volume%3D4%26issue%3D8%26spage%3D1063%26epage%3D1066%26doi%3D10.4161%2Fauto.6826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cha, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, J. S.</span></span> <span> </span><span class="NLM_article-title">Expression of autophagy-related proteins in hurthle cell neoplasm is different from that in follicular neoplasm</span>. <i>Dis. Markers</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1155/2017/1372387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1155%2F2017%2F1372387" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=1-8&author=Y.+J.+Chaauthor=H.+M.+Kimauthor=J.+S.+Koo&title=Expression+of+autophagy-related+proteins+in+hurthle+cell+neoplasm+is+different+from+that+in+follicular+neoplasm&doi=10.1155%2F2017%2F1372387"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1155%2F2017%2F1372387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2017%252F1372387%26sid%3Dliteratum%253Aachs%26aulast%3DCha%26aufirst%3DY.%2BJ.%26aulast%3DKim%26aufirst%3DH.%2BM.%26aulast%3DKoo%26aufirst%3DJ.%2BS.%26atitle%3DExpression%2520of%2520autophagy-related%2520proteins%2520in%2520hurthle%2520cell%2520neoplasm%2520is%2520different%2520from%2520that%2520in%2520follicular%2520neoplasm%26jtitle%3DDis.%2520Markers%26date%3D2017%26volume%3D2017%26spage%3D1%26epage%3D8%26doi%3D10.1155%2F2017%2F1372387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishayee, A.</span></span> <span> </span><span class="NLM_article-title">Nrf2-mediated redox signaling in arsenic carcinogenesis: a review</span>. <i>Arch. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>87</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1007/s00204-012-0920-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1007%2Fs00204-012-0920-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22914984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1emsbfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2013&pages=383-396&issue=2&author=D.+Sinhaauthor=J.+Biswasauthor=A.+Bishayee&title=Nrf2-mediated+redox+signaling+in+arsenic+carcinogenesis%3A+a+review&doi=10.1007%2Fs00204-012-0920-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2-mediated redox signaling in arsenic carcinogenesis: a review</span></div><div class="casAuthors">Sinha, Dona; Biswas, Jaydip; Bishayee, Anupam</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Toxicology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">383-396</span>CODEN:
                <span class="NLM_cas:coden">ARTODN</span>;
        ISSN:<span class="NLM_cas:issn">0340-5761</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Arsenic is a ubiquitous toxic metalloid whose natural leaching from geogenic resources of earth's crust into groundwater has become a dreadful health hazard to millions of people across the globe.  Arsenic has been documented as a top most potent human carcinogen by Agency of Toxic Substances and Disease Registry.  There have been a no. of schools of opinions regarding the underlying mechanism of arsenic-induced carcinogenicity, but the theory of oxidative stress generated by arsenic has gained much importance.  Imbalance in the cellular redox state and its assocd. complications have been closely assocd. with nuclear factor-erythroid 2-related factor 2 (Nrf2), a basic-leucine zipper transcription factor that activates the antioxidant responsive element and electrophilic responsive element, thereby upregulating the expression of a variety of downstream genes.  This review has been framed on the lines of differential mol. responses of Nrf2 on arsenic exposure as well as the chemopreventive strategy which may be improvised to regulate Nrf2 in order to combat arsenic-induced oxidative stress and its long-term carcinogenic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbBd2dQk9ac7Vg90H21EOLACvtfcHk0lg_X-zC279y2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1emsbfP&md5=d3bdbb06e64c1ac797ff06d66743a180</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs00204-012-0920-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00204-012-0920-5%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DD.%26aulast%3DBiswas%26aufirst%3DJ.%26aulast%3DBishayee%26aufirst%3DA.%26atitle%3DNrf2-mediated%2520redox%2520signaling%2520in%2520arsenic%2520carcinogenesis%253A%2520a%2520review%26jtitle%3DArch.%2520Toxicol.%26date%3D2013%26volume%3D87%26issue%3D2%26spage%3D383%26epage%3D396%26doi%3D10.1007%2Fs00204-012-0920-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span> <span> </span><span class="NLM_article-title">Reasonably activating Nrf2: a long-term, effective and controllable strategy for neurodegenerative diseases</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>185</i></span>,  <span class="NLM_fpage">111862</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.111862</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.ejmech.2019.111862" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=31735576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFOlsL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2020&pages=111862&author=Q.+Liauthor=S.+Xingauthor=Y.+Chenauthor=Q.+Liaoauthor=Q.+Liauthor=Y.+Liuauthor=S.+Heauthor=F.+Fengauthor=Y.+Chenauthor=J.+Zhangauthor=W.+Liuauthor=Q.+Guoauthor=Y.+Sunauthor=H.+Sun&title=Reasonably+activating+Nrf2%3A+a+long-term%2C+effective+and+controllable+strategy+for+neurodegenerative+diseases&doi=10.1016%2Fj.ejmech.2019.111862"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Reasonably activating Nrf2: A long-term, effective and controllable strategy for neurodegenerative diseases</span></div><div class="casAuthors">Li, Qi; Xing, Shuaishuai; Chen, Ying; Liao, Qinghong; Li, Qihang; Liu, Yang; He, Siyu; Feng, Feng; Chen, Yao; Zhang, Jie; Liu, Wenyuan; Guo, Qinglong; Sun, Yuan; Sun, Haopeng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111862</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative diseases are a variety of debilitating and fatal disorder in central nervous system (CNS).  Besides targeting neuronal activity by influencing neurotransmitters or their corresponding receptors, modulating the underlying processes that lead to cell death, such as oxidative stress and mitochondrial dysfunction, should also be emphasized as an assistant strategy for neurodegeneration therapy.  Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) has been closely verified to be related to anti-inflammation and oxidative stress, rationally regulating its belonging pathway and activating Nrf2 is emphasized to be a potential treatment approach.  There have existed multiple Nrf2 activators with different mechanisms and diverse structures, but those applied for neuro-disorders are still limited.  On the basis of research arrangement and compd. summary, the authors put forward the limitations of existing Nrf2 activators for neurodegenerative diseases and their future developing directions in enhancing the blood-brain barrier permeability to make Nrf2 activators function in CNS and designing Nrf2-based multitarget-directed ligands to affect multiple nodes in pathol. of neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpaN0Pbk65J7Vg90H21EOLACvtfcHk0lg_X-zC279y2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFOlsL%252FK&md5=c8062f0b9652b7fec2f6678f4f7378cb</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.111862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.111862%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DXing%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLiao%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DFeng%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DH.%26atitle%3DReasonably%2520activating%2520Nrf2%253A%2520a%2520long-term%252C%2520effective%2520and%2520controllable%2520strategy%2520for%2520neurodegenerative%2520diseases%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D185%26spage%3D111862%26doi%3D10.1016%2Fj.ejmech.2019.111862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamark, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjottem, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awuh, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overvatn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansen, T.</span></span> <span> </span><span class="NLM_article-title">p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span> (<span class="NLM_issue">29</span>),  <span class="NLM_fpage">22576</span>– <span class="NLM_lpage">22591</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.118976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1074%2Fjbc.M110.118976" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20452972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1WntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=22576-22591&issue=29&author=A.+Jainauthor=T.+Lamarkauthor=E.+Sjottemauthor=K.+B.+Larsenauthor=J.+A.+Awuhauthor=A.+Overvatnauthor=M.+McMahonauthor=J.+D.+Hayesauthor=T.+Johansen&title=p62%2FSQSTM1+is+a+target+gene+for+transcription+factor+NRF2+and+creates+a+positive+feedback+loop+by+inducing+antioxidant+response+element-driven+gene+transcription&doi=10.1074%2Fjbc.M110.118976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription</span></div><div class="casAuthors">Jain, Ashish; Lamark, Trond; Sjottem, Eva; Bowitz Larsen, Kenneth; Atesoh Awuh, Jane; Overvatn, Aud; McMahon, Michael; Hayes, John D.; Johansen, Terje</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">22576-22591</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The p62/SQSTM1 (sequestosome 1) protein, which acts as a cargo receptor for autophagic degrdn. of ubiquitinated targets, is up-regulated by various stressors.  Induction of the p62 gene by oxidative stress is mediated by NF-E2-related factor 2 (NRF2) and, at the same time, p62 protein contributes to the activation of NRF2, but hitherto the mechanisms involved were not known.  Herein, we have mapped an antioxidant response element (ARE) in the p62 promoter that is responsible for its induction by oxidative stress via NRF2.  Chromatin immunopptn. and gel mobility-shift assays verified that NRF2 binds to this cis-element in vivo and in vitro.  Also, p62 docks directly onto the Kelch-repeat domain of Kelch-like ECH-assocd. protein 1 (KEAP1), via a motif designated the KEAP1 interacting region (KIR), thereby blocking binding between KEAP1 and NRF2 that leads to ubiquitylation and degrdn. of the transcription factor.  The KIR motif in p62 is located immediately C-terminal to the LC3-interacting region (LIR) and resembles the ETGE motif utilized by NRF2 for its interaction with KEAP1.  KIR is required for p62 to stabilize NRF2, and inhibition of KEAP1 by p62 occurs from a cytoplasmic location within the cell.  The LIR and KIR motifs cannot be engaged simultaneously by LC3 and KEAP1, but because p62 is polymeric the interaction between KEAP1 and p62 leads to accumulation of KEAP1 in p62 bodies, which is followed by autophagic degrdn. of KEAP1.  Our data explain how p62 contributes to activation of NRF2 target genes in response to oxidative stress through creating a pos. feedback loop.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgqJXJvye3yrVg90H21EOLACvtfcHk0lhLW9w2LzNM2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1WntLg%253D&md5=707de1a603fba64ec0d631b575bd6c99</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.118976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.118976%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DA.%26aulast%3DLamark%26aufirst%3DT.%26aulast%3DSjottem%26aufirst%3DE.%26aulast%3DLarsen%26aufirst%3DK.%2BB.%26aulast%3DAwuh%26aufirst%3DJ.%2BA.%26aulast%3DOvervatn%26aufirst%3DA.%26aulast%3DMcMahon%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DJohansen%26aufirst%3DT.%26atitle%3Dp62%252FSQSTM1%2520is%2520a%2520target%2520gene%2520for%2520transcription%2520factor%2520NRF2%2520and%2520creates%2520a%2520positive%2520feedback%2520loop%2520by%2520inducing%2520antioxidant%2520response%2520element-driven%2520gene%2520transcription%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26issue%3D29%26spage%3D22576%26epage%3D22591%26doi%3D10.1074%2Fjbc.M110.118976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span> <span> </span><span class="NLM_article-title">Activation of p62/SQSTM1-Keap1-nuclear factor erythroid 2-related factor 2 pathway in cancer</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">210</span>, <span class="refDoi"> DOI: 10.3389/fonc.2018.00210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.3389%2Ffonc.2018.00210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=29930914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252Fgs1GgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=210&author=Y.+Ichimuraauthor=M.+Komatsu&title=Activation+of+p62%2FSQSTM1-Keap1-nuclear+factor+erythroid+2-related+factor+2+pathway+in+cancer&doi=10.3389%2Ffonc.2018.00210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of p62/SQSTM1-Keap1-Nuclear Factor Erythroid 2-Related Factor 2 Pathway in Cancer</span></div><div class="casAuthors">Ichimura Yoshinobu; Komatsu Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">210</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">Autophagy and the Keap1-Nrf2 system are major cellular defense mechanisms against metabolic and oxidative stress.  These two systems are linked via phosphorylation of the ubiquitin binding autophagy receptor protein p62/SQSTM1 in the p62-Keap1-Nrf2 pathway.  The p62-Keap1-Nrf2 pathway plays a protective role in normal cells; however, recent studies indicate that this pathway induces tumorigenesis of pre-malignant cells, and promotes the growth and drug resistance of tumor cells via metabolic reprogramming mediated by Nrf2 activation.  These findings suggest that impairment of autophagy is involved in the acquisition of malignancy and maintenance of tumors, and furthermore, that p62/SQSTM1 could be a potential target for chemotherapy in cancers that harbor excess p62.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTviYn3QVqG6dHxxy173TfNfW6udTcc2ebE7QjvCgPwIrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252Fgs1GgsQ%253D%253D&md5=73a86b286e267b612bb101089809078b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2018.00210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2018.00210%26sid%3Dliteratum%253Aachs%26aulast%3DIchimura%26aufirst%3DY.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3DActivation%2520of%2520p62%252FSQSTM1-Keap1-nuclear%2520factor%2520erythroid%25202-related%2520factor%25202%2520pathway%2520in%2520cancer%26jtitle%3DFront.%2520Oncol.%26date%3D2018%26volume%3D8%26spage%3D210%26doi%3D10.3389%2Ffonc.2018.00210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sofola-Adesakin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatliff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez Perez-Nievas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snoeren, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocheme, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adcott, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khericha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo-Quan, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noble, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partridge, L.</span></span> <span> </span><span class="NLM_article-title">Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer’s disease</span>. <i>PLoS Genet.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">e1006593</span>, <span class="refDoi"> DOI: 10.1371/journal.pgen.1006593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1371%2Fjournal.pgen.1006593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=28253260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1aitrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=e1006593&issue=3&author=F.+Kerrauthor=O.+Sofola-Adesakinauthor=D.+K.+Ivanovauthor=J.+Gatliffauthor=B.+Gomez+Perez-Nievasauthor=H.+C.+Bertrandauthor=P.+Martinezauthor=R.+Callardauthor=I.+Snoerenauthor=H.+M.+Cochemeauthor=J.+Adcottauthor=M.+Kherichaauthor=J.+I.+Castillo-Quanauthor=G.+Wellsauthor=W.+Nobleauthor=J.+Thorntonauthor=L.+Partridge&title=Direct+Keap1-Nrf2+disruption+as+a+potential+therapeutic+target+for+Alzheimer%E2%80%99s+disease&doi=10.1371%2Fjournal.pgen.1006593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease</span></div><div class="casAuthors">Kerr, Fiona; Sofola-Adesakin, Oyinkan; Ivanov, Dobril K.; Gatliff, Jemma; Perez-Nievas, Beatriz Gomez; Bertrand, Helene C.; Martinez, Pedro; Callard, Rebecca; Snoeren, Inge; Cocheme, Helena M.; Adcott, Jennifer; Khericha, Mobina; Castillo-Quan, JorgeIvan; Wells, Geoffrey; Noble, Wendy; Thornton, Janet; Partridge, Linda</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Genetics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e1006593/1-e1006593/30</span>CODEN:
                <span class="NLM_cas:coden">PGLEB5</span>;
        ISSN:<span class="NLM_cas:issn">1553-7404</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Nrf2, a transcriptional activator of cell protection genes, is an attractive therapeutic target for the prevention of neurodegenerative diseases, including Alzheimer's disease (AD).  Current Nrf2 activators, however, may exert toxicity and pathway over-activation can induce detrimental effects.  An understanding of the mechanisms mediating Nrf2 inhibition in neurodegenerative conditions may therefore direct the design of drugs targeted for the prevention of these diseases with minimal side-effects.  Our study provides the first in vivo evidence that specific inhibition of Keap1, a neg. regulator of Nrf2, can prevent neuronal toxicity in response to the AD-initiating Aβ42 peptide, in correlation with Nrf2 activation.  Comparatively, lithium, an inhibitor of the Nrf2 suppressor GSK-3, prevented Aβ42 toxicity by mechanisms independent of Nrf2.  A new direct inhibitor of the Keap1-Nrf2 binding domain also prevented synaptotoxicity mediated by naturally-derived Aβ oligomers in mouse cortical neurons.  Overall, our findings highlight Keap1 specifically as an efficient target for the reactivation of Nrf2 in AD, and support the further investigation of direct Keap1 inhibitors for the prevention of neurodegeneration in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaPjD0cuk13rVg90H21EOLACvtfcHk0lhbaGcOb6kCkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1aitrzO&md5=0bb45ee28b645cb153bcdb3a6758d489</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pgen.1006593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pgen.1006593%26sid%3Dliteratum%253Aachs%26aulast%3DKerr%26aufirst%3DF.%26aulast%3DSofola-Adesakin%26aufirst%3DO.%26aulast%3DIvanov%26aufirst%3DD.%2BK.%26aulast%3DGatliff%26aufirst%3DJ.%26aulast%3DGomez%2BPerez-Nievas%26aufirst%3DB.%26aulast%3DBertrand%26aufirst%3DH.%2BC.%26aulast%3DMartinez%26aufirst%3DP.%26aulast%3DCallard%26aufirst%3DR.%26aulast%3DSnoeren%26aufirst%3DI.%26aulast%3DCocheme%26aufirst%3DH.%2BM.%26aulast%3DAdcott%26aufirst%3DJ.%26aulast%3DKhericha%26aufirst%3DM.%26aulast%3DCastillo-Quan%26aufirst%3DJ.%2BI.%26aulast%3DWells%26aufirst%3DG.%26aulast%3DNoble%26aufirst%3DW.%26aulast%3DThornton%26aufirst%3DJ.%26aulast%3DPartridge%26aufirst%3DL.%26atitle%3DDirect%2520Keap1-Nrf2%2520disruption%2520as%2520a%2520potential%2520therapeutic%2520target%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPLoS%2520Genet.%26date%3D2017%26volume%3D13%26issue%3D3%26spage%3De1006593%26doi%3D10.1371%2Fjournal.pgen.1006593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cohen-Kaplan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livneh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabre, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziv, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciechanover, A.</span></span> <span> </span><span class="NLM_article-title">p62- and ubiquitin-dependent stress-induced autophagy of the mammalian 26S proteasome</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">47</span>),  <span class="NLM_fpage">E7490</span>– <span class="NLM_lpage">E7499</span>, <span class="refDoi"> DOI: 10.1073/pnas.1615455113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1073%2Fpnas.1615455113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27791183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1ykurjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=E7490-E7499&issue=47&author=V.+Cohen-Kaplanauthor=I.+Livnehauthor=N.+Avniauthor=B.+Fabreauthor=T.+Zivauthor=Y.+T.+Kwonauthor=A.+Ciechanover&title=p62-+and+ubiquitin-dependent+stress-induced+autophagy+of+the+mammalian+26S+proteasome&doi=10.1073%2Fpnas.1615455113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">p62- and ubiquitin-dependent stress-induced autophagy of the mammalian 26S proteasome</span></div><div class="casAuthors">Cohen-Kaplan, Victoria; Livneh, Ido; Avni, Noa; Fabre, Bertrand; Ziv, Tamar; Kwon, Yong Tae; Ciechanover, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">E7490-E7499</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The ubiquitin-proteasome system and autophagy are the two main proteolytic systems involved in, among other functions, the maintenance of cell integrity by eliminating misfolded and damaged proteins and organelles.  Both systems remove their targets after their conjugation with ubiquitin.  An interesting, yet incompletely understood problem relates to the fate of the components of the two systems.  Here we provide evidence that amino acid starvation enhances polyubiquitination on specific sites of the proteasome, a modification essential for its targeting to the autophagic machinery.  The uptake of the ubiquitinated proteasome is mediated by its interaction with the ubiquitin-assocd. domain of p62/SQSTM1, a process that also requires interaction with LC3.  Importantly, deletion of the PB1 domain of p62, which is important for the targeting of ubiquitinated substrates to the proteasome, has no effect on stress-induced autophagy of this proteolytic machinery, suggesting that the domain of p62 that binds to the proteasome dets. the function of p62 in either targeting substrates to the proteasome or targeting the proteasome to autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6eNef2mWtg7Vg90H21EOLACvtfcHk0lgZJ5-Z0cIGJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1ykurjE&md5=7defe031e853828cc64fb0e88e1adde3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1615455113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1615455113%26sid%3Dliteratum%253Aachs%26aulast%3DCohen-Kaplan%26aufirst%3DV.%26aulast%3DLivneh%26aufirst%3DI.%26aulast%3DAvni%26aufirst%3DN.%26aulast%3DFabre%26aufirst%3DB.%26aulast%3DZiv%26aufirst%3DT.%26aulast%3DKwon%26aufirst%3DY.%2BT.%26aulast%3DCiechanover%26aufirst%3DA.%26atitle%3Dp62-%2520and%2520ubiquitin-dependent%2520stress-induced%2520autophagy%2520of%2520the%2520mammalian%252026S%2520proteasome%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26issue%3D47%26spage%3DE7490%26epage%3DE7499%26doi%3D10.1073%2Fpnas.1615455113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teyssou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebon, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boillee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doukoure, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bataillon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sazdovitch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cazeneuve, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meininger, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeGuern, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salachas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seilhean, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millecamps, S.</span></span> <span> </span><span class="NLM_article-title">Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>125</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">522</span>, <span class="refDoi"> DOI: 10.1007/s00401-013-1090-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1007%2Fs00401-013-1090-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=23417734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltFCmsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2013&pages=511-522&issue=4&author=E.+Teyssouauthor=T.+Takedaauthor=V.+Lebonauthor=S.+Boilleeauthor=B.+Doukoureauthor=G.+Bataillonauthor=V.+Sazdovitchauthor=C.+Cazeneuveauthor=V.+Meiningerauthor=E.+LeGuernauthor=F.+Salachasauthor=D.+Seilheanauthor=S.+Millecamps&title=Mutations+in+SQSTM1+encoding+p62+in+amyotrophic+lateral+sclerosis%3A+genetics+and+neuropathology&doi=10.1007%2Fs00401-013-1090-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology</span></div><div class="casAuthors">Teyssou, Elisa; Takeda, Takahiro; Lebon, Vincent; Boillee, Severine; Doukoure, Brahima; Bataillon, Guillaume; Sazdovitch, Veronique; Cazeneuve, Cecile; Meininger, Vincent; LeGuern, Eric; Salachas, Francois; Seilhean, Danielle; Millecamps, Stephanie</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">511-522</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Mutations in SQSTM1 encoding the sequestosome 1/p62 protein have recently been identified in familial and sporadic cases of amyotrophic lateral sclerosis (ALS). p62 is a component of the ubiquitin inclusions detected in degenerating neurons in ALS patients.  We sequenced SQSTM1 in 90 French patients with familial ALS (FALS) and 74 autopsied ALS cases with sporadic ALS (SALS).  We identified, at the heterozygote state, one missense c.1175C>T, p.Pro392Leu (exon 8) in one of our FALS and one substitution in intron 7 (the c.1165+1G>A, previously called IVS7+1 G-A, A390X) affecting the exon 7 splicing site in one SALS.  These mutations that are located in the ubiquitin-assocd. domain (UBA domain) of the p62 protein have already been described in Paget's disease and ALS patients carrying these mutations had both concomitant Paget's disease.  However, we also identified two novel missense mutations in two SALS: the c.259A>G, p.Met87Val in exon 2 and the c.304A>G, p.Lys102Glu in exon 3.  These mutations that were not detected in 360 control subjects are possibly pathogenic.  Neuropathol. anal. of three patients carrying SQSTM1 variants revealed the presence of large round p62 inclusions in motor neurons, and immunoblot anal. showed an increased p62 and TDP-43 protein levels in the spinal cord.  Our results confirm that SQSTM1 gene mutations could be the cause or genetic susceptibility factor of ALS in some patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4iSkSmw3nE7Vg90H21EOLACvtfcHk0lgZJ5-Z0cIGJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltFCmsrs%253D&md5=005a974be4718f328aa965545387ee96</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs00401-013-1090-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-013-1090-0%26sid%3Dliteratum%253Aachs%26aulast%3DTeyssou%26aufirst%3DE.%26aulast%3DTakeda%26aufirst%3DT.%26aulast%3DLebon%26aufirst%3DV.%26aulast%3DBoillee%26aufirst%3DS.%26aulast%3DDoukoure%26aufirst%3DB.%26aulast%3DBataillon%26aufirst%3DG.%26aulast%3DSazdovitch%26aufirst%3DV.%26aulast%3DCazeneuve%26aufirst%3DC.%26aulast%3DMeininger%26aufirst%3DV.%26aulast%3DLeGuern%26aufirst%3DE.%26aulast%3DSalachas%26aufirst%3DF.%26aulast%3DSeilhean%26aufirst%3DD.%26aulast%3DMillecamps%26aufirst%3DS.%26atitle%3DMutations%2520in%2520SQSTM1%2520encoding%2520p62%2520in%2520amyotrophic%2520lateral%2520sclerosis%253A%2520genetics%2520and%2520neuropathology%26jtitle%3DActa%2520Neuropathol.%26date%3D2013%26volume%3D125%26issue%3D4%26spage%3D511%26epage%3D522%26doi%3D10.1007%2Fs00401-013-1090-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pankiv, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamark, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruun, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overvatn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjorkoy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansen, T.</span></span> <span> </span><span class="NLM_article-title">Nucleocytoplasmic shuttling of p62/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">5941</span>– <span class="NLM_lpage">5953</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.039925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1074%2Fjbc.M109.039925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20018885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFCqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=5941-5953&issue=8&author=S.+Pankivauthor=T.+Lamarkauthor=J.+A.+Bruunauthor=A.+Overvatnauthor=G.+Bjorkoyauthor=T.+Johansen&title=Nucleocytoplasmic+shuttling+of+p62%2FSQSTM1+and+its+role+in+recruitment+of+nuclear+polyubiquitinated+proteins+to+promyelocytic+leukemia+bodies&doi=10.1074%2Fjbc.M109.039925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleocytoplasmic Shuttling of p62/SQSTM1 and Its Role in Recruitment of Nuclear Polyubiquitinated Proteins to Promyelocytic Leukemia Bodies</span></div><div class="casAuthors">Pankiv, Serhiy; Lamark, Trond; Bruun, Jack-Ansgar; Overvatn, Aud; Bjorkoy, Geir; Johansen, Terje</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">5941-5953</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">P62, also known as sequestosome1 1 (SQSTM1), A170, or ZIP, is a multifunctional protein implicated in several signal transduction pathways.  P62 is induced by various forms of cellular stress, is degraded by autophagy, and acts as a cargo receptor for autophagic degrdn. of ubiquitinated targets.  It is also suggested to shuttle ubiquitinated proteins for proteasomal degrdn. p62 is commonly found in cytosolic protein inclusions in patients with protein aggregopathies, it is up-regulated in several forms of human tumors, and mutations in the gene are linked to classical adult onset Paget disease of the bone.  To this end, p62 has generally been considered to be a cytosolic protein, and little attention has been paid to possible nuclear roles of this protein.  Here, we present evidence that p62 shuttles continuously between nuclear and cytosolic compartments at a high rate.  The protein is also found in nuclear promyelocytic leukemia bodies.  We show that p62 contains two nuclear localization signals and a nuclear export signal.  Our data suggest that the nucleocytoplasmic shuttling of p62 is modulated by phosphorylations at or near the most important nuclear localization signal, NLS2.  The aggregation of p62 in cytosolic bodies also regulates the transport of p62 between the compartments.  We found p62 to be essential for accumulation of polyubiquitinated proteins in promyelocytic leukemia bodies upon inhibition of nuclear protein export.  Furthermore, p62 contributed to the assembly of proteasome-contg. degradative compartments in the vicinity of nuclear aggregates contg. polyglutamine-expanded Ataxin1Q84 and to the degrdn. of Ataxin1Q84.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptGR-BHB6FfrVg90H21EOLACvtfcHk0lg6vwvBQ7pDFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFCqs74%253D&md5=7aaa907fcd81f5b204b5ad0150dc42d9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.039925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.039925%26sid%3Dliteratum%253Aachs%26aulast%3DPankiv%26aufirst%3DS.%26aulast%3DLamark%26aufirst%3DT.%26aulast%3DBruun%26aufirst%3DJ.%2BA.%26aulast%3DOvervatn%26aufirst%3DA.%26aulast%3DBjorkoy%26aufirst%3DG.%26aulast%3DJohansen%26aufirst%3DT.%26atitle%3DNucleocytoplasmic%2520shuttling%2520of%2520p62%252FSQSTM1%2520and%2520its%2520role%2520in%2520recruitment%2520of%2520nuclear%2520polyubiquitinated%2520proteins%2520to%2520promyelocytic%2520leukemia%2520bodies%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26issue%3D8%26spage%3D5941%26epage%3D5953%26doi%3D10.1074%2Fjbc.M109.039925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yorimitsu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klionsky, D. J.</span></span> <span> </span><span class="NLM_article-title">Autophagy: molecular machinery for self-eating</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1542</span>– <span class="NLM_lpage">1552</span>, <span class="refDoi"> DOI: 10.1038/sj.cdd.4401765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fsj.cdd.4401765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=16247502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCjt7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=1542-1552&author=T.+Yorimitsuauthor=D.+J.+Klionsky&title=Autophagy%3A+molecular+machinery+for+self-eating&doi=10.1038%2Fsj.cdd.4401765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy: molecular machinery for self-eating</span></div><div class="casAuthors">Yorimitsu, T.; Klionsky, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">Suppl. 2</span>),
    <span class="NLM_cas:pages">1542-1552</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Autophagy is a highly conserved process in eukaryotes in which the cytoplasm, including excess or aberrant organelles, is sequestered into double-membrane vesicles and delivered to the degradative organelle, the lysosome/vacuole, for breakdown and eventual recycling of the resulting macromols.  This process has an important role in various biol. events such as adaptation to changing environmental conditions, cellular remodeling during development and differentiation, and detn. of lifespan.  Auto-phagy is also involved in preventing certain types of disease, although it may contribute to some pathologies.  Recent studies have identified many components that are required to drive this complicated cellular process.  Auto-phagy-related genes were first identified in yeast, but homologs are found in all eukaryotes.  Analyses in a range of model systems have provided huge advances toward understanding the mol. basis of autophagy.  Here we review our current knowledge on the machinery and mol. mechanism of autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgAFRsUOGNrbVg90H21EOLACvtfcHk0lg6vwvBQ7pDFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCjt7%252FJ&md5=669805b0c9c4af98c9a6dd484ff81f1f</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4401765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4401765%26sid%3Dliteratum%253Aachs%26aulast%3DYorimitsu%26aufirst%3DT.%26aulast%3DKlionsky%26aufirst%3DD.%2BJ.%26atitle%3DAutophagy%253A%2520molecular%2520machinery%2520for%2520self-eating%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2005%26volume%3D12%26spage%3D1542%26epage%3D1552%26doi%3D10.1038%2Fsj.cdd.4401765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waguri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizushima, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwata, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ezaki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamazaki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iemura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natsume, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanagawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uwayama, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warabi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kominami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span> <span> </span><span class="NLM_article-title">Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>131</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1149</span>– <span class="NLM_lpage">1163</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.10.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.cell.2007.10.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18083104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksFGnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=1149-1163&issue=6&author=M.+Komatsuauthor=S.+Waguriauthor=M.+Koikeauthor=Y.+Souauthor=T.+Uenoauthor=T.+Haraauthor=N.+Mizushimaauthor=J.+Iwataauthor=J.+Ezakiauthor=S.+Murataauthor=J.+Hamazakiauthor=Y.+Nishitoauthor=S.+Iemuraauthor=T.+Natsumeauthor=T.+Yanagawaauthor=J.+Uwayamaauthor=E.+Warabiauthor=H.+Yoshidaauthor=T.+Ishiiauthor=A.+Kobayashiauthor=M.+Yamamotoauthor=Z.+Yueauthor=Y.+Uchiyamaauthor=E.+Kominamiauthor=K.+Tanaka&title=Homeostatic+levels+of+p62+control+cytoplasmic+inclusion+body+formation+in+autophagy-deficient+mice&doi=10.1016%2Fj.cell.2007.10.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice</span></div><div class="casAuthors">Komatsu, Masaaki; Waguri, Satoshi; Koike, Masato; Sou, Yu-shin; Ueno, Takashi; Hara, Taichi; Mizushima, Noboru; Iwata, Jun-ichi; Ezaki, Junji; Murata, Shigeo; Hamazaki, Jun; Nishito, Yasumasa; Iemura, Shun-ichiro; Natsume, Tohru; Yanagawa, Toru; Uwayama, Junya; Warabi, Eiji; Yoshida, Hiroshi; Ishii, Tetsuro; Kobayashi, Akira; Yamamoto, Masayuki; Yue, Zhenyu; Uchiyama, Yasuo; Kominami, Eiki; Tanaka, Keiji</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1149-1163</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Inactivation of constitutive autophagy results in formation of cytoplasmic protein inclusions and leads to liver injury and neurodegeneration, but the details of abnormalities related to impaired autophagy are largely unknown.  Here we used mouse genetic analyses to define the roles of autophagy in the aforementioned events.  We report that the ubiquitin- and LC3-binding protein "p62" regulates the formation of protein aggregates and is removed by autophagy.  Thus, genetic ablation of p62 suppressed the appearance of ubiquitin-pos. protein aggregates in hepatocytes and neurons, indicating that p62 plays an important role in inclusion body formation.  Moreover, loss of p62 markedly attenuated liver injury caused by autophagy deficiency, whereas it had little effect on neuronal degeneration.  Our findings highlight the unexpected role of homeostatic level of p62, which is regulated by autophagy, in controlling intracellular inclusion body formation, and indicate that the pathol. process assocd. with autophagic deficiency is cell-type specific.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRUqqGdziagrVg90H21EOLACvtfcHk0liEpAVB35tOWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksFGnsg%253D%253D&md5=7b3e77dd70d33df65b4010d91a90fce9</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.10.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.10.035%26sid%3Dliteratum%253Aachs%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DWaguri%26aufirst%3DS.%26aulast%3DKoike%26aufirst%3DM.%26aulast%3DSou%26aufirst%3DY.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DMizushima%26aufirst%3DN.%26aulast%3DIwata%26aufirst%3DJ.%26aulast%3DEzaki%26aufirst%3DJ.%26aulast%3DMurata%26aufirst%3DS.%26aulast%3DHamazaki%26aufirst%3DJ.%26aulast%3DNishito%26aufirst%3DY.%26aulast%3DIemura%26aufirst%3DS.%26aulast%3DNatsume%26aufirst%3DT.%26aulast%3DYanagawa%26aufirst%3DT.%26aulast%3DUwayama%26aufirst%3DJ.%26aulast%3DWarabi%26aufirst%3DE.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DA.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DYue%26aufirst%3DZ.%26aulast%3DUchiyama%26aufirst%3DY.%26aulast%3DKominami%26aufirst%3DE.%26aulast%3DTanaka%26aufirst%3DK.%26atitle%3DHomeostatic%2520levels%2520of%2520p62%2520control%2520cytoplasmic%2520inclusion%2520body%2520formation%2520in%2520autophagy-deficient%2520mice%26jtitle%3DCell%26date%3D2007%26volume%3D131%26issue%3D6%26spage%3D1149%26epage%3D1163%26doi%3D10.1016%2Fj.cell.2007.10.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, E.</span></span> <span> </span><span class="NLM_article-title">Autophagy and metabolism</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>330</i></span> (<span class="NLM_issue">6009</span>),  <span class="NLM_fpage">1344</span>– <span class="NLM_lpage">1348</span>, <span class="refDoi"> DOI: 10.1126/science.1193497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1126%2Fscience.1193497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21127245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVyrsbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=1344-1348&issue=6009&author=J.+D.+Rabinowitzauthor=E.+White&title=Autophagy+and+metabolism&doi=10.1126%2Fscience.1193497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy and metabolism</span></div><div class="casAuthors">Rabinowitz, Joshua D.; White, Eileen</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">6009</span>),
    <span class="NLM_cas:pages">1344-1348</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Autophagy is a process of self-cannibalization.  Cells capture their own cytoplasm and organelles and consume them in lysosomes.  The resulting breakdown products are inputs to cellular metab., through which they are used to generate energy and to build new proteins and membranes.  Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones.  In starvation, it provides an internal source of nutrients for energy generation and, thus, survival.  A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases.  It does have a downside, however; cancer cells exploit it to survive in nutrient-poor tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpREWU_wFW6GLVg90H21EOLACvtfcHk0liEpAVB35tOWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVyrsbbE&md5=4b6ed3a623cbef8df1241579e15632fa</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1126%2Fscience.1193497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1193497%26sid%3Dliteratum%253Aachs%26aulast%3DRabinowitz%26aufirst%3DJ.%2BD.%26aulast%3DWhite%26aufirst%3DE.%26atitle%3DAutophagy%2520and%2520metabolism%26jtitle%3DScience%26date%3D2010%26volume%3D330%26issue%3D6009%26spage%3D1344%26epage%3D1348%26doi%3D10.1126%2Fscience.1193497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mizushima, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span> <span> </span><span class="NLM_article-title">Autophagy: renovation of cells and tissues</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>147</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">728</span>– <span class="NLM_lpage">741</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.10.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.cell.2011.10.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22078875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVKgsLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2011&pages=728-741&issue=4&author=N.+Mizushimaauthor=M.+Komatsu&title=Autophagy%3A+renovation+of+cells+and+tissues&doi=10.1016%2Fj.cell.2011.10.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy: Renovation of Cells and Tissues</span></div><div class="casAuthors">Mizushima, Noboru; Komatsu, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">728-741</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Autophagy is the major intracellular degrdn. system by which cytoplasmic materials are delivered to and degraded in the lysosome.  However, the purpose of autophagy is not the simple elimination of materials, but instead, autophagy serves as a dynamic recycling system that produces new building blocks and energy for cellular renovation and homeostasis.  Here we provide a multidisciplinary review of our current understanding of autophagy's role in metabolic adaptation, intracellular quality control, and renovation during development and differentiation.  We also explore how recent mouse models in combination with advances in human genetics are providing key insights into how the impairment or activation of autophagy contributes to pathogenesis of diverse diseases, from neurodegenerative diseases such as Parkinson disease to inflammatory disorders such as Crohn disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphHJHJXZsr6bVg90H21EOLACvtfcHk0lhl8T_QiYiMeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVKgsLnN&md5=c749750db767f05549db0b22ec5068c7</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.10.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.10.026%26sid%3Dliteratum%253Aachs%26aulast%3DMizushima%26aufirst%3DN.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3DAutophagy%253A%2520renovation%2520of%2520cells%2520and%2520tissues%26jtitle%3DCell%26date%3D2011%26volume%3D147%26issue%3D4%26spage%3D728%26epage%3D741%26doi%3D10.1016%2Fj.cell.2011.10.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ammar, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y.</span></span> <span> </span><span class="NLM_article-title">Crosstalk between macroautophagy and chaperone-mediated autophagy: implications for the treatment of neurological diseases</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1284</span>– <span class="NLM_lpage">1296</span>, <span class="refDoi"> DOI: 10.1007/s12035-014-8933-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1007%2Fs12035-014-8933-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=25330936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSqsLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2015&pages=1284-1296&issue=3&author=H.+J.+Wuauthor=S.+Chenauthor=A.+B.+Ammarauthor=J.+Xuauthor=Q.+Wuauthor=K.+Panauthor=J.+M.+Zhangauthor=Y.+Hong&title=Crosstalk+between+macroautophagy+and+chaperone-mediated+autophagy%3A+implications+for+the+treatment+of+neurological+diseases&doi=10.1007%2Fs12035-014-8933-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Crosstalk Between Macroautophagy and Chaperone-Mediated Autophagy: Implications for the Treatment of Neurological Diseases</span></div><div class="casAuthors">Wu, Haijian; Chen, Sheng; Ammar, Al-Baadani; Xu, Jie; Wu, Qun; Pan, Kum; Zhang, Jianmin; Hong, Yuan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1284-1296</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Macroautophagy and chaperone-mediated autophagy (CMA) are two important subtypes of autophagy that play a crit. role in cellular quality control under physiol. and pathol. conditions.  Despite the marked differences between these two autophagic pathways, macroautophagy and CMA are intimately connected with each other during the autophagy-lysosomal degrdn. process, in particular, in the setting of neurol. illness.  Macroautophagy serves as a backup mechanism to removal of malfunctioning proteins (i.e., aberrant α-synuclein) from the cytoplasm when CMA is compromised, and vice versa.  The mol. mechanisms underlying the conversation between macroautophagy and CMA are being clarified.  Herein, we survey current overviews concg. on the complex interactions between macroautophagy and CMA, and present therapeutic potentials through utilization and manipulation of macroautophagy-CMA crosstalk in the treatment of neurol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_Jt28FSSLy7Vg90H21EOLACvtfcHk0lhl8T_QiYiMeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSqsLjJ&md5=239453df2be7fb599bf17f0d818d2db8</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1007%2Fs12035-014-8933-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-014-8933-0%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DH.%2BJ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DAmmar%26aufirst%3DA.%2BB.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DPan%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DJ.%2BM.%26aulast%3DHong%26aufirst%3DY.%26atitle%3DCrosstalk%2520between%2520macroautophagy%2520and%2520chaperone-mediated%2520autophagy%253A%2520implications%2520for%2520the%2520treatment%2520of%2520neurological%2520diseases%26jtitle%3DMol.%2520Neurobiol.%26date%3D2015%26volume%3D52%26issue%3D3%26spage%3D1284%26epage%3D1296%26doi%3D10.1007%2Fs12035-014-8933-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kunz, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, A.</span></span> <span> </span><span class="NLM_article-title">Determination of four sequential stages during microautophagy in vitro</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">9987</span>– <span class="NLM_lpage">9996</span>, <span class="refDoi"> DOI: 10.1074/jbc.M307905200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1074%2Fjbc.M307905200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=14679207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitlygsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=9987-9996&issue=11&author=J.+B.+Kunzauthor=H.+Schwarzauthor=A.+Mayer&title=Determination+of+four+sequential+stages+during+microautophagy+in+vitro&doi=10.1074%2Fjbc.M307905200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of four sequential stages during microautophagy in vitro</span></div><div class="casAuthors">Kunz, Joachim B.; Schwarz, Heinz; Mayer, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">9987-9996</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Microautophagy is the transfer of cytosolic components into the lysosome by direct invagination of the lysosomal membrane and subsequent budding of vesicles into the lysosomal lumen.  This process is topol. equiv. to membrane invagination during multivesicular body formation and to the budding of enveloped viruses.  Vacuoles are lysosomal compartments of yeasts.  Vacuolar membrane invagination can be reconstituted in vitro with purified yeast vacuoles, serving as a model system for budding of vesicles into the lumen of an organelle.  Using this in vitro system, we defined different reaction states.  We identified inhibitors of microautophagy in vitro and used them as tools for kinetic anal.  This allowed us to characterize 4 biochem. distinguishable steps of the reaction.  We propose that these correspond to sequential stages of vacuole invagination and vesicle scission.  Formation of vacuolar invaginations was slow and temp.-dependent, whereas the final scission of the vesicle from a preformed invagination was fast and proceeded even on ice.  Our observations suggest that the formation of invaginations rather than the scission of vesicles is the rate-limiting step of the overall reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJxw7fw4uIl7Vg90H21EOLACvtfcHk0lhSbQ_wNA7p1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitlygsr0%253D&md5=cd24c51cf20e31bcb3f917f634312377</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M307905200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M307905200%26sid%3Dliteratum%253Aachs%26aulast%3DKunz%26aufirst%3DJ.%2BB.%26aulast%3DSchwarz%26aufirst%3DH.%26aulast%3DMayer%26aufirst%3DA.%26atitle%3DDetermination%2520of%2520four%2520sequential%2520stages%2520during%2520microautophagy%2520in%2520vitro%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26issue%3D11%26spage%3D9987%26epage%3D9996%26doi%3D10.1074%2Fjbc.M307905200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terlecky, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plant, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dice, J. F.</span></span> <span> </span><span class="NLM_article-title">A role for a 70-kilodalton heat shock protein in lysosomal degradation of intracellular proteins</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>246</i></span> (<span class="NLM_issue">4928</span>),  <span class="NLM_fpage">382</span>– <span class="NLM_lpage">385</span>, <span class="refDoi"> DOI: 10.1126/science.2799391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1126%2Fscience.2799391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=2799391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADyaK3cXivFei" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=1989&pages=382-385&issue=4928&author=H.+L.+Chiangauthor=S.+R.+Terleckyauthor=C.+P.+Plantauthor=J.+F.+Dice&title=A+role+for+a+70-kilodalton+heat+shock+protein+in+lysosomal+degradation+of+intracellular+proteins&doi=10.1126%2Fscience.2799391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A role for a 70-kilodaton heat shock protein in lysosomal degradation of intracellular proteins</span></div><div class="casAuthors">Chiang, Hui Ling; Terlecky, Stanley R.; Plant, Charles P.; Dice, J. Fred</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">246</span>
        (<span class="NLM_cas:issue">4928</span>),
    <span class="NLM_cas:pages">382-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A 73-kilodalton (kD) intracellular protein was found to bind to peptide regions that target intracellular proteins for lysosomal degrdn. in response to serum withdrawal.  This protein crossreacted with a monoclonal antibody raised to a member of the 70-kD heat shock protein (hsp70) family, and sequences of 2 internal peptides of the 73-kD protein confirm that it is a member of this family.  In response to serum withdrawal, the intracellular concn. of the 73-kD protein increased severalfold.  In the presence of ATP and MgCl2 the 73-kD protein enhanced protein degrdn. in 2 different cell-free assays for lysosomal proteolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8lZiH72r-DrVg90H21EOLACvtfcHk0lhSbQ_wNA7p1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXivFei&md5=81aebe3c75135c1167ede6ba3ac2e12f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1126%2Fscience.2799391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.2799391%26sid%3Dliteratum%253Aachs%26aulast%3DChiang%26aufirst%3DH.%2BL.%26aulast%3DTerlecky%26aufirst%3DS.%2BR.%26aulast%3DPlant%26aufirst%3DC.%2BP.%26aulast%3DDice%26aufirst%3DJ.%2BF.%26atitle%3DA%2520role%2520for%2520a%252070-kilodalton%2520heat%2520shock%2520protein%2520in%2520lysosomal%2520degradation%2520of%2520intracellular%2520proteins%26jtitle%3DScience%26date%3D1989%26volume%3D246%26issue%3D4928%26spage%3D382%26epage%3D385%26doi%3D10.1126%2Fscience.2799391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinet, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Meyer, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andries, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kockx, M. M.</span></span> <span> </span><span class="NLM_article-title">In situ detection of starvation-induced autophagy</span>. <i>J. Histochem. Cytochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1369/jhc.5A6743.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1369%2Fjhc.5A6743.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=16148314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD28XitlOlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=85-96&issue=1&author=W.+Martinetauthor=G.+R.+De+Meyerauthor=L.+Andriesauthor=A.+G.+Hermanauthor=M.+M.+Kockx&title=In+situ+detection+of+starvation-induced+autophagy&doi=10.1369%2Fjhc.5A6743.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">In situ detection of starvation-induced autophagy</span></div><div class="casAuthors">Martinet, Wim; De Meyer, Guido R. Y.; Andries, Luc; Herman, Arnold G.; Kockx, Mark M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-96</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    
            (<span class="NLM_cas:orgname">Histochemical Society, Inc.</span>)
        </div><div class="casAbstract">Autophagy is a regulated bulk degrdn. process involved in many different human pathologies.  Transmission electron microscopy (TEM) is currently the only reliable method for monitoring autophagy in situ.  Because TEM is labor intensive, the authors questioned whether useful marker proteins can be found for unambiguous detection of autophagy in tissue via routinely used colorimetric, immunohistochem., or fluorescent techniques.  Starved Hep G2 hepatocytes and nutrient-deprived liver tissue were used as a model for the initiation of autophagy.  The findings indicate that starvation-induced autophagy in Hep G2 cells was assocd. neither with differential mRNA gene expression nor with changes in the expression level of known autophagy-related proteins.  On the contrary, both transcription and translation were inhibited, suggesting that the identification of autophagy-specific biomarkers for tissue is highly compromised.  Light chain 3 (LC3) protein, which is an attractive marker of autophagosomes, revealed a relatively low expression level in tissue and cultured cells, but could be detected via immunohistochem. in liver from GFP-LC3 transgenic mice.  The no. of LC3 immunopos. dot-like structures was significantly upregulated in liver tissue from nutrient-deprived GFP-LC3 mice as compared with nonstarved control tissue.  Apparently, LC3 immunostaining can be used as an alternative detection method for autophagy in situ, but only when this protein is overexpressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8_vy2GGsXXrVg90H21EOLACvtfcHk0lhSbQ_wNA7p1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitlOlug%253D%253D&md5=d86097d1b1e7d6159cf4ee8902921a54</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1369%2Fjhc.5A6743.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1369%252Fjhc.5A6743.2005%26sid%3Dliteratum%253Aachs%26aulast%3DMartinet%26aufirst%3DW.%26aulast%3DDe%2BMeyer%26aufirst%3DG.%2BR.%26aulast%3DAndries%26aufirst%3DL.%26aulast%3DHerman%26aufirst%3DA.%2BG.%26aulast%3DKockx%26aufirst%3DM.%2BM.%26atitle%3DIn%2520situ%2520detection%2520of%2520starvation-induced%2520autophagy%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D2006%26volume%3D54%26issue%3D1%26spage%3D85%26epage%3D96%26doi%3D10.1369%2Fjhc.5A6743.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mizushima, N.</span></span> <span> </span><span class="NLM_article-title">Autophagy: process and function</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">2861</span>– <span class="NLM_lpage">2873</span>, <span class="refDoi"> DOI: 10.1101/gad.1599207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1101%2Fgad.1599207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18006683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmsrjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=2861-2873&issue=22&author=N.+Mizushima&title=Autophagy%3A+process+and+function&doi=10.1101%2Fgad.1599207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy: process and function</span></div><div class="casAuthors">Mizushima, Noboru</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2861-2873</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  Autophagy is an intracellular degrdn. system that delivers cytoplasmic constituents to the lysosome.  Despite its simplicity, recent progress has demonstrated that autophagy plays a wide variety of physiol. and pathophysiol. roles, which are sometimes complex.  Autophagy consists of several sequential steps-sequestration, transport to lysosomes, degrdn., and utilization of degrdn. products-and each step may exert different function.  In this review, the process of autophagy is summarized, and the role of autophagy is discussed in a process-based manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjLQ6AXbG19rVg90H21EOLACvtfcHk0lhBOiihH5-fZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmsrjP&md5=a55a6956ae9fc41b7067753459f90ca5</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1101%2Fgad.1599207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1599207%26sid%3Dliteratum%253Aachs%26aulast%3DMizushima%26aufirst%3DN.%26atitle%3DAutophagy%253A%2520process%2520and%2520function%26jtitle%3DGenes%2520Dev.%26date%3D2007%26volume%3D21%26issue%3D22%26spage%3D2861%26epage%3D2873%26doi%3D10.1101%2Fgad.1599207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, Z.</span></span> <span> </span><span class="NLM_article-title">SQSTM1/p62 loss reverses the inhibitory effect of sunitinib on autophagy independent of AMPK signaling</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">11087</span>, <span class="refDoi"> DOI: 10.1038/s41598-019-47597-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fs41598-019-47597-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=31366950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BB3MvjsVemtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=11087&issue=1&author=B.+Houauthor=G.+Wangauthor=Q.+Gaoauthor=Y.+Weiauthor=C.+Zhangauthor=Y.+Wangauthor=Y.+Huoauthor=H.+Yangauthor=X.+Jiangauthor=Z.+Xi&title=SQSTM1%2Fp62+loss+reverses+the+inhibitory+effect+of+sunitinib+on+autophagy+independent+of+AMPK+signaling&doi=10.1038%2Fs41598-019-47597-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">SQSTM1/p62 loss reverses the inhibitory effect of sunitinib on autophagy independent of AMPK signaling</span></div><div class="casAuthors">Hou Bolin; Gao Quan; Wei Yanjie; Zhang Caining; Wang Yange; Jiang Xuejun; Hou Bolin; Gao Quan; Wei Yanjie; Zhang Caining; Wang Yange; Wang Gang; Xi Zhijun; Huo Yuqing; Yang Huaiyi</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11087</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Sunitinib (ST), a multitargeted receptor tyrosine kinase inhibitor, has been demonstrated to be effective for the treatment of renal carcinoma.  It has been reported that ST is involved in the mediation of autophagy; however, its regulatory role in the autophagic process remains controversial.  Furthermore, the mechanism by which activated AMP-activated protein kinase (AMPK) negatively regulates autophagy remains nearly unexplored.  In the present study, we revealed that ST inhibited AMPK activity and regulated autophagy in a cell type- and dose-dependent manner.  In a number of cell lines, ST was demonstrated to inhibit H2O2-induced autophagy and the phosphorylation of acetyl-CoA carboxylase (ACC), whereas alone it could block the autophagic flux concurrent with increased expression of p62.  An immunoprecipitation assay revealed that LC3 directly interacted with p62, whereas ST increased punctate LC3 staining, which was well colocalized with p62.  Taken together, we reveal a previously unnoticed pathway for ST to regulate the autophagic process, and p62, although often utilized as a substrate in autophagy, plays a critical role in regulating the inhibition of ST in both basal and induced autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwPdPrOAUoaR0LsK7uFuY7fW6udTcc2eZKW0ho8AmvMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MvjsVemtQ%253D%253D&md5=5819caa869b4e944c1b4515f2239c475</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-47597-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-47597-4%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHuo%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DXi%26aufirst%3DZ.%26atitle%3DSQSTM1%252Fp62%2520loss%2520reverses%2520the%2520inhibitory%2520effect%2520of%2520sunitinib%2520on%2520autophagy%2520independent%2520of%2520AMPK%2520signaling%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26issue%3D1%26spage%3D11087%26doi%3D10.1038%2Fs41598-019-47597-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Youle, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narendra, D. P.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of mitophagy</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1038/nrm3028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fnrm3028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21179058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2murvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=9-14&issue=1&author=R.+J.+Youleauthor=D.+P.+Narendra&title=Mechanisms+of+mitophagy&doi=10.1038%2Fnrm3028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of mitophagy</span></div><div class="casAuthors">Youle, Richard J.; Narendra, Derek P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-14</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Autophagy not only recycles intracellular components to compensate for nutrient deprivation but also selectively eliminates organelles to regulate their no. and maintain quality control.  Mitophagy, the specific autophagic elimination of mitochondria, has been identified in yeast, mediated by autophagy-related 32 (Atg32), and in mammals during red blood cell differentiation, mediated by NIP3-like protein X (NIX; also known as BNIP3L).  Moreover, mitophagy is regulated in many metazoan cell types by parkin and PTEN-induced putative kinase protein 1 (PINK1), and mutations in the genes encoding these proteins have been linked to forms of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreUxmIhSOkeLVg90H21EOLACvtfcHk0lgSj-Av_75gyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2murvF&md5=8b3cd10ebef89f08c561485c4b81caa1</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fnrm3028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3028%26sid%3Dliteratum%253Aachs%26aulast%3DYoule%26aufirst%3DR.%2BJ.%26aulast%3DNarendra%26aufirst%3DD.%2BP.%26atitle%3DMechanisms%2520of%2520mitophagy%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2011%26volume%3D12%26issue%3D1%26spage%3D9%26epage%3D14%26doi%3D10.1038%2Fnrm3028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, E.</span></span> <span> </span><span class="NLM_article-title">Kinetics of protein aggregates disposal by aggrephagy</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>588</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1016/bs.mie.2016.09.084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fbs.mie.2016.09.084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=28237105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmslSntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=588&publication_year=2017&pages=245-281&author=S.+Tanauthor=E.+Wong&title=Kinetics+of+protein+aggregates+disposal+by+aggrephagy&doi=10.1016%2Fbs.mie.2016.09.084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics of protein aggregates disposal by aggrephagy</span></div><div class="casAuthors">Tan, S.; Wong, E.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">588</span>
        (<span class="NLM_cas:issue">Molecular Characterization of Autophagic Responses, Part B</span>),
    <span class="NLM_cas:pages">245-281</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Macroautophagy has generated considerable interest because of its ability to recognize and target protein inclusions found prevalent in neurodegenerative diseases to lysosomes for elimination.  Pharmacol. upregulation of macroautophagy to remove disease-linked aggresomes has been reported to slow down disease progression and to improve survivability in many neurodegenerative models.  Despite its bulk removal mechanism, we now know that there are selective forms of autophagy.  Defect in selective autophagy represents a prominent cause of autophagic failures in many disorders.  Aggrephagy refers to the selective degrdn. of protein aggregates by macroautophagy.  In this chapter, we will review the mechanisms and factors that govern the selectivity of protein aggregates for disposal by macroautophagy.  This understanding is paramount for us to develop therapeutic approaches to enhance specific cargo targeting in addn. to general upregulation of macroautophagy for mitigating disease progression.  In addn., we will provide an overview of the different exptl. models of protein inclusions, as well as the microscopy and biochem. techniques used to quant. analyze the abundance of protein inclusions and the kinetics of their turnovers by macroautophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMs1xLraah8LVg90H21EOLACvtfcHk0lgSj-Av_75gyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmslSntL0%253D&md5=4ad9e7ab5f18ac447b6c61d47246492c</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fbs.mie.2016.09.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.mie.2016.09.084%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DE.%26atitle%3DKinetics%2520of%2520protein%2520aggregates%2520disposal%2520by%2520aggrephagy%26jtitle%3DMethods%2520Enzymol.%26date%3D2017%26volume%3D588%26spage%3D245%26epage%3D281%26doi%3D10.1016%2Fbs.mie.2016.09.084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seranova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, D.</span></span> <span> </span><span class="NLM_article-title">Selective autophagy and xenophagy in infection and disease</span>. <i>Front. Cell Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">147</span>, <span class="refDoi"> DOI: 10.3389/fcell.2018.00147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.3389%2Ffcell.2018.00147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=30483501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BB3crlsV2ktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=147&author=V.+Sharmaauthor=S.+Vermaauthor=E.+Seranovaauthor=S.+Sarkarauthor=D.+Kumar&title=Selective+autophagy+and+xenophagy+in+infection+and+disease&doi=10.3389%2Ffcell.2018.00147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Autophagy and Xenophagy in Infection and Disease</span></div><div class="casAuthors">Sharma Vartika; Verma Surbhi; Kumar Dhiraj; Seranova Elena; Sarkar Sovan</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in cell and developmental biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">147</span>
        ISSN:<span class="NLM_cas:issn">2296-634X</span>.
    </div><div class="casAbstract">Autophagy, a cellular homeostatic process, which ensures cellular survival under various stress conditions, has catapulted to the forefront of innate defense mechanisms during intracellular infections.  The ability of autophagy to tag and target intracellular pathogens toward lysosomal degradation is central to this key defense function.  However, studies involving the role and regulation of autophagy during intracellular infections largely tend to ignore the housekeeping function of autophagy.  A growing number of evidences now suggest that the housekeeping function of autophagy, rather than the direct pathogen degradation function, may play a decisive role to determine the outcome of infection and immunological balance.  We discuss herein the studies that establish the homeostatic and anti-inflammatory function of autophagy, as well as role of bacterial effectors in modulating and coopting these functions.  Given that the core autophagy machinery remains largely the same across diverse cargos, how selectivity plays out during intracellular infection remains intriguing.  We explore here, the contrasting role of autophagy adaptors being both selective as well as pleotropic in functions and discuss whether E3 ligases could bring in the specificity to cargo selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQeDGPEbJxSCNyzdcP07UmufW6udTcc2eZqNyNMDLZ2U7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3crlsV2ktg%253D%253D&md5=9000fe59d94df8e1c00fd99e0247b1fa</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.3389%2Ffcell.2018.00147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffcell.2018.00147%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DV.%26aulast%3DVerma%26aufirst%3DS.%26aulast%3DSeranova%26aufirst%3DE.%26aulast%3DSarkar%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DD.%26atitle%3DSelective%2520autophagy%2520and%2520xenophagy%2520in%2520infection%2520and%2520disease%26jtitle%3DFront.%2520Cell%2520Dev.%2520Biol.%26date%3D2018%26volume%3D6%26spage%3D147%26doi%3D10.3389%2Ffcell.2018.00147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oku, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, Y.</span></span> <span> </span><span class="NLM_article-title">Pexophagy in Pichia pastoris</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>451</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">228</span>, <span class="refDoi"> DOI: 10.1016/S0076-6879(08)03215-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2FS0076-6879%2808%2903215-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19185723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1Wjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=451&publication_year=2008&pages=217-228&author=M.+Okuauthor=Y.+Sakai&title=Pexophagy+in+Pichia+pastoris&doi=10.1016%2FS0076-6879%2808%2903215-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Pexophagy in Pichia pastoris</span></div><div class="casAuthors">Oku, Masahide; Sakai, Yasuyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">451</span>
        (<span class="NLM_cas:issue">Autophagy: Lower Eukaryotes and Nonmammalian Systems, Part A</span>),
    <span class="NLM_cas:pages">217-228</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  The peroxisome is an organelle whose quantity is tightly regulated in response to changes in metabolic status, and much knowledge has been accumulated regarding its dynamics.  The turnover of peroxisomes through autophagic pathways, termed pexophagy, has been esp. studied in several methylotrophic yeast strains capable of growth on methanol as a sole carbon source, which led to the identification of factors involved in pexophagy.  In the methylotrophic yeast Pichia pastoris, several types of membrane dynamics during pexophagy can be visualized simultaneously under live cell imaging.  The decrease of abundant peroxisomal proteins in the cell lysate can be used as a convenient indicator of the completion of pexophagy.  In combination, these methods provide basic information for further anal. of pexophagy at the mol. level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryDxR5FNNS3LVg90H21EOLACvtfcHk0liEFdS2SezG_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1Wjt7w%253D&md5=089851473383cf304e845e210343e22e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2808%2903215-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252808%252903215-1%26sid%3Dliteratum%253Aachs%26aulast%3DOku%26aufirst%3DM.%26aulast%3DSakai%26aufirst%3DY.%26atitle%3DPexophagy%2520in%2520Pichia%2520pastoris%26jtitle%3DMethods%2520Enzymol.%26date%3D2008%26volume%3D451%26spage%3D217%26epage%3D228%26doi%3D10.1016%2FS0076-6879%2808%2903215-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MacIntosh, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassham, D. C.</span></span> <span> </span><span class="NLM_article-title">The connection between ribophagy, autophagy and ribosomal RNA decay</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">662</span>– <span class="NLM_lpage">663</span>, <span class="refDoi"> DOI: 10.4161/auto.7.6.15447</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.4161%2Fauto.7.6.15447" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21460615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38Xks1ymtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=662-663&issue=6&author=G.+C.+MacIntoshauthor=D.+C.+Bassham&title=The+connection+between+ribophagy%2C+autophagy+and+ribosomal+RNA+decay&doi=10.4161%2Fauto.7.6.15447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The connection between ribophagy, autophagy and ribosomal RNA decay</span></div><div class="casAuthors">MacIntosh, Gustavo C.; Bassham, Diane C.</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">662-663</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8627</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  Ribosomes are essential components of all cells.  A large body of knowledge has been accumulated regarding ribosome synthesis and assembly; however, the pathways of normal ribosome turnover, esp. rRNA decay, are not known.  Some information on ribosome recycling derives from studies on starved yeast cells that use a specialized type of autophagy, called ribophagy, to differentially target ribosomes for degrdn.  We found that Arabidopsis RNS2, a conserved RNase of the RNase T2 family, is necessary for normal decay of rRNA.  Mutants lacking RNS2 activity have longer-lived rRNA, accumulate RNA in the vacuole and show constitutive macroautophagy.  Thus, it is clear that normal rRNA decay is necessary to maintain cellular homeostasis.  These phenotypes and the subcellular localization of RNS2 in the endoplasmic reticulum and the vacuole suggest that RNS2 participates in a ribophagy-like mechanism that targets ribosomes for recycling under normal growth conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8pFmpYKJIxrVg90H21EOLACvtfcHk0liEFdS2SezG_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xks1ymtQ%253D%253D&md5=8a118f84e1f53c704dfe7fa9c6416d23</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.4161%2Fauto.7.6.15447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.7.6.15447%26sid%3Dliteratum%253Aachs%26aulast%3DMacIntosh%26aufirst%3DG.%2BC.%26aulast%3DBassham%26aufirst%3DD.%2BC.%26atitle%3DThe%2520connection%2520between%2520ribophagy%252C%2520autophagy%2520and%2520ribosomal%2520RNA%2520decay%26jtitle%3DAutophagy%26date%3D2011%26volume%3D7%26issue%3D6%26spage%3D662%26epage%3D663%26doi%3D10.4161%2Fauto.7.6.15447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamark, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dikic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansen, T.</span></span> <span> </span><span class="NLM_article-title">NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets</span>. <i>Cell Cycle</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">1986</span>– <span class="NLM_lpage">1990</span>, <span class="refDoi"> DOI: 10.4161/cc.8.13.8892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.4161%2Fcc.8.13.8892" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19502794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFykuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1986-1990&issue=13&author=T.+Lamarkauthor=V.+Kirkinauthor=I.+Dikicauthor=T.+Johansen&title=NBR1+and+p62+as+cargo+receptors+for+selective+autophagy+of+ubiquitinated+targets&doi=10.4161%2Fcc.8.13.8892"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets</span></div><div class="casAuthors">Lamark, Trond; Kirkin, Vladimir; Dikic, Ivan; Johansen, Terje</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1986-1990</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1538-4101</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  Autophagy is an evolutionary conserved cell survival process for the degrdn. of long-lived proteins, damaged organelles, and protein aggregates.  Mammalian proteins p62 and NBR1 are selectively degraded by autophagy and can act as cargo receptors or adaptors for the autophagic degrdn. of ubiquitinated substrates.  Despite differing in size and primary sequence, both proteins share a similar domain architecture contg. an N-terminal PB1 domain, a LIR motif interacting with ATG8 family proteins, and a C-terminal UBA domain interacting with ubiquitin.  The LIR motif is essential for their autophagic degrdn., indicating that ATG8 family proteins are responsible for the docking of p62 and NBR1 to nucleating autophagosomes.  Proteins p62 and NBR1 cooperate in the sequestration of misfolded and ubiquitinated proteins in p62 bodies and are both required for their degrdn. by autophagy.  Here, the authors discuss the role of p62 and NBR1 in degrdn. of ubiquitinated cargoes and the putative role of LIR as a general motif for docking of proteins to ATG8 family proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH9ltW91qxNrVg90H21EOLACvtfcHk0lj8QcjVbSbjng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFykuw%253D%253D&md5=325f743e80c3ce93415662822d1fc683</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.4161%2Fcc.8.13.8892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.8.13.8892%26sid%3Dliteratum%253Aachs%26aulast%3DLamark%26aufirst%3DT.%26aulast%3DKirkin%26aufirst%3DV.%26aulast%3DDikic%26aufirst%3DI.%26aulast%3DJohansen%26aufirst%3DT.%26atitle%3DNBR1%2520and%2520p62%2520as%2520cargo%2520receptors%2520for%2520selective%2520autophagy%2520of%2520ubiquitinated%2520targets%26jtitle%3DCell%2520Cycle%26date%3D2009%26volume%3D8%26issue%3D13%26spage%3D1986%26epage%3D1990%26doi%3D10.4161%2Fcc.8.13.8892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strnad, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zatloukal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stumptner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulaksiz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denk, H.</span></span> <span> </span><span class="NLM_article-title">Mallory-Denk-bodies: lessons from keratin-containing hepatic inclusion bodies</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>1782</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">764</span>– <span class="NLM_lpage">774</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2008.08.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.bbadis.2008.08.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCntb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1782&publication_year=2008&pages=764-774&issue=12&author=P.+Strnadauthor=K.+Zatloukalauthor=C.+Stumptnerauthor=H.+Kulaksizauthor=H.+Denk&title=Mallory-Denk-bodies%3A+lessons+from+keratin-containing+hepatic+inclusion+bodies&doi=10.1016%2Fj.bbadis.2008.08.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Mallory-Denk-bodies: Lessons from keratin-containing hepatic inclusion bodies</span></div><div class="casAuthors">Strnad, P.; Zatloukal, K.; Stumptner, C.; Kulaksiz, H.; Denk, H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1782</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">764-774</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Inclusion bodies are characteristic morphol. features of various neuronal, muscular and other human disorders.  They share common mol. constituents such as p62, chaperones and proteasome subunits.  The proteins within aggregates are misfolded with increased β-sheet structure, they are heavily phosphorylated, ubiquitinylated and partially degraded.  Furthermore, involvement of proteasomal system represents a common feature of virtually all inclusions.  Multiple aggregates contain intermediate filament proteins as their major constituents.  Among them, Mallory-Denk bodies (MDBs) are the best studied.  MDBs represent hepatic inclusions obsd. in diverse chronic liver diseases such as alc. and non-alc. steatohepatitis, chronic cholestasis, metabolic disorders and hepatocellular neoplasms.  MDBs are induced in mice fed griseofulvin or 3,5-diethoxycarbonyl-1,4-dihydrocollidine and resolve after discontinuation of toxin administration.  The availability of a drug-induced model makes MDBs a unique tool for studying inclusion formation.  Our review summarizes the recent advances gained from this model and shows how they relate to observations in other aggregates.  The MDB formation-underlying mechanisms include protein misfolding, chaperone alterations, disproportional protein expression with keratin 8 > keratin 18 levels and subsequent keratin 8 crosslinking via transglutaminase. p62 presence is crucial for MDB formation.  Proteasome inhibitors ppt. MDB formation, whereas stimulation of autophagy with rapamycin attenuates their formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG0R0PfzKloLVg90H21EOLACvtfcHk0lj8QcjVbSbjng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCntb%252FE&md5=a1230e0d263a507879b4de689026ff05</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2008.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2008.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DStrnad%26aufirst%3DP.%26aulast%3DZatloukal%26aufirst%3DK.%26aulast%3DStumptner%26aufirst%3DC.%26aulast%3DKulaksiz%26aufirst%3DH.%26aulast%3DDenk%26aufirst%3DH.%26atitle%3DMallory-Denk-bodies%253A%2520lessons%2520from%2520keratin-containing%2520hepatic%2520inclusion%2520bodies%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2008%26volume%3D1782%26issue%3D12%26spage%3D764%26epage%3D774%26doi%3D10.1016%2Fj.bbadis.2008.08.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aparicio, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espino, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bejarano, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallardo-Soler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salido, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pariente, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pena, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tapia, J. A.</span></span> <span> </span><span class="NLM_article-title">Autophagy-related proteins are functionally active in human spermatozoa and may be involved in the regulation of cell survival and motility</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">33647</span>, <span class="refDoi"> DOI: 10.1038/srep33647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fsrep33647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27633131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFentL3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=33647&author=I.+M.+Aparicioauthor=J.+Espinoauthor=I.+Bejaranoauthor=A.+Gallardo-Solerauthor=M.+L.+Campoauthor=G.+M.+Salidoauthor=J.+A.+Parienteauthor=F.+J.+Penaauthor=J.+A.+Tapia&title=Autophagy-related+proteins+are+functionally+active+in+human+spermatozoa+and+may+be+involved+in+the+regulation+of+cell+survival+and+motility&doi=10.1038%2Fsrep33647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy-related proteins are functionally active in human spermatozoa and may be involved in the regulation of cell survival and motility</span></div><div class="casAuthors">Aparicio, I. M.; Espino, J.; Bejarano, I.; Gallardo-Soler, A.; Campo, M. L.; Salido, G. M.; Pariente, J. A.; Pena, F. J.; Tapia, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">33647</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Macroautophagy (hereafter autophagy) is an evolutionarily highly conserved cellular process that participates in the maintenance of intracellular homeostasis through the degrdn. of most long-lived proteins and entire organelles.  Autophagy participates in some reproductive events; however, there are not reports regarding the role of autophagy in the regulation of sperm physiol.  Hence, the aim of this study was to investigate whether autophagy-related proteins are present and functionally active in human spermatozoa.  Proteins related to autophagy/mitophagy process (LC3, Atg5, Atg16, Beclin 1, p62, m-TOR, AMPKα 1/2, and PINK1) were present in human spermatozoa.  LC3 colocalized with p62 in the middle piece of the spermatozoa.  Autophagy activation induced a significant increase in motility and a decrease in PINK1, TOM20 expression and caspase 3/7 activation.  In contrast, autophagy inhibition resulted in decreased motility, viability, ATP and intracellular calcium concn. whereas PINK1, TOM20 expression, AMPK phosphorylation and caspase 3/7 activation were significantly increased.  In conclusion our results show that autophagy related proteins and upstream regulators are present and functional in human spermatozoa.  Modification of mitochondrial proteins expression after autophagy activation/inhibition may be indicating that a specialized form of autophagy named mitophagy may be regulating sperm function such as motility and viability and may be cooperating with apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3Mou1PHTnqrVg90H21EOLACvtfcHk0lj8QcjVbSbjng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFentL3J&md5=c347a38b4b4bc460dccb9f42942d3c8c</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fsrep33647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep33647%26sid%3Dliteratum%253Aachs%26aulast%3DAparicio%26aufirst%3DI.%2BM.%26aulast%3DEspino%26aufirst%3DJ.%26aulast%3DBejarano%26aufirst%3DI.%26aulast%3DGallardo-Soler%26aufirst%3DA.%26aulast%3DCampo%26aufirst%3DM.%2BL.%26aulast%3DSalido%26aufirst%3DG.%2BM.%26aulast%3DPariente%26aufirst%3DJ.%2BA.%26aulast%3DPena%26aufirst%3DF.%2BJ.%26aulast%3DTapia%26aufirst%3DJ.%2BA.%26atitle%3DAutophagy-related%2520proteins%2520are%2520functionally%2520active%2520in%2520human%2520spermatozoa%2520and%2520may%2520be%2520involved%2520in%2520the%2520regulation%2520of%2520cell%2520survival%2520and%2520motility%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D33647%26doi%3D10.1038%2Fsrep33647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamark, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overvatn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harneshaug, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjorkoy, G.</span></span> <span> </span><span class="NLM_article-title">A reporter cell system to monitor autophagy based on p62/SQSTM1</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">784</span>– <span class="NLM_lpage">793</span>, <span class="refDoi"> DOI: 10.4161/auto.6.6.12510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.4161%2Fauto.6.6.12510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20574168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFCqsrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=784-793&issue=6&author=K.+B.+Larsenauthor=T.+Lamarkauthor=A.+Overvatnauthor=I.+Harneshaugauthor=T.+Johansenauthor=G.+Bjorkoy&title=A+reporter+cell+system+to+monitor+autophagy+based+on+p62%2FSQSTM1&doi=10.4161%2Fauto.6.6.12510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">A reporter cell system to monitor autophagy based on p62/SQSTM1</span></div><div class="casAuthors">Larsen, Kenneth Bowitz; Lamark, Trond; Oevervam, Aud; Harneshaug, Ingvill; Johansen, Terje; Bjoerkoey, Geir</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">784-793</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8627</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Macroautophagy (hereafter referred to as autophagy) is a catabolic pathway to isolate and transport cytosolic components to the lysosome for degrdn.  Recently, autophagy receptors, like p62/SQSTM1 and NBR1, which phys. link autophagic cargo to ATG8/MAP1-LC3/GABARAP family members located on the forming autophagic membranes, have been identified.  To identify conditions or compds. that affect autophagy, cell systems that efficiently report on autophagic flux are required.  Here we describe reporter cell systems based on induced expression of GFP-p62, GFP-NBR1 or GFP-LC3B.  The degrdn. of the fusion proteins was followed after promoter shut-off by flow cytometry of live cells.  All three fusion proteins were degraded at a basal rate by autophagy.  Surprisingly, the basal degrdn. rate varied for the three reporter fusion proteins.  GFP-LC3B was the most stable protein.  GFP-NBR1 was most efficiently degraded under basal conditions while degrdn. of GFP-p62 displayed the strongest response to amino acid starvation.  GFP-p62 was found to perform the best of the tested reporters.  Single cell anal. of autophagic flux by flow cytometry allows ests. of heterogeneous cell populations.  The feasibility of this approach was demonstrated using transient overexpression of a dominant neg. ULK1 kinase and siRNA-mediated knockdown of LC3B to inhibit autophagic degrdn. of GFP-p62.  The inducible GFP-p62 cell system allows quantification by several approaches and will be useful in screening for compds. or conditions that affect the rate of autophagy.  Inducers of autophagy can be identified using rich medium whereas inhibitors are identified under starvation conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0X0ToS2A15LVg90H21EOLACvtfcHk0lipPMpRzXDIPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFCqsrrI&md5=c8c9021cd2de1b7b1413de0766cad06f</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.4161%2Fauto.6.6.12510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.6.6.12510%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DK.%2BB.%26aulast%3DLamark%26aufirst%3DT.%26aulast%3DOvervatn%26aufirst%3DA.%26aulast%3DHarneshaug%26aufirst%3DI.%26aulast%3DJohansen%26aufirst%3DT.%26aulast%3DBjorkoy%26aufirst%3DG.%26atitle%3DA%2520reporter%2520cell%2520system%2520to%2520monitor%2520autophagy%2520based%2520on%2520p62%252FSQSTM1%26jtitle%3DAutophagy%26date%3D2010%26volume%3D6%26issue%3D6%26spage%3D784%26epage%3D793%26doi%3D10.4161%2Fauto.6.6.12510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rusten, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenmark, H.</span></span> <span> </span><span class="NLM_article-title">p62, an autophagy hero or culprit?</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">209</span>, <span class="refDoi"> DOI: 10.1038/ncb0310-207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fncb0310-207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20190829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFemsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=207-209&issue=3&author=T.+E.+Rustenauthor=H.+Stenmark&title=p62%2C+an+autophagy+hero+or+culprit%3F&doi=10.1038%2Fncb0310-207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">p62, an autophagy hero or culprit?</span></div><div class="casAuthors">Rusten, Tor Erik; Stenmark, Harald</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207-209</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The p62 protein recognizes toxic cellular waste, which is then scavenged by a sequestration process known as self-eating or autophagy.  Lack of autophagy leads to accumulation of p62, which is not good for liver cells, as it induces a cellular stress response that leads to disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDTvJsqrkhz7Vg90H21EOLACvtfcHk0lipPMpRzXDIPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFemsLo%253D&md5=8c8db4932b3c53a0e576e2cda62fcc20</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fncb0310-207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb0310-207%26sid%3Dliteratum%253Aachs%26aulast%3DRusten%26aufirst%3DT.%2BE.%26aulast%3DStenmark%26aufirst%3DH.%26atitle%3Dp62%252C%2520an%2520autophagy%2520hero%2520or%2520culprit%253F%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2010%26volume%3D12%26issue%3D3%26spage%3D207%26epage%3D209%26doi%3D10.1038%2Fncb0310-207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choe, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. K.</span></span> <span> </span><span class="NLM_article-title">Enhanced p62 expression through impaired proteasomal degradation is involved in caspase-1 activation in monosodium urate crystal-induced interleukin-1b expression</span>. <i>Rheumatology (Oxford, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1043</span>– <span class="NLM_lpage">1053</span>, <span class="refDoi"> DOI: 10.1093/rheumatology/ket474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1093%2Frheumatology%2Fket474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=24587486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotF2qsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=1043-1053&issue=6&author=J.+Y.+Choeauthor=H.+Y.+Jungauthor=K.+Y.+Parkauthor=S.+K.+Kim&title=Enhanced+p62+expression+through+impaired+proteasomal+degradation+is+involved+in+caspase-1+activation+in+monosodium+urate+crystal-induced+interleukin-1b+expression&doi=10.1093%2Frheumatology%2Fket474"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced p62 expression through impaired proteasomal degradation is involved in caspase-1 activation in monosodium urate crystal-induced interleukin-1β expression</span></div><div class="casAuthors">Choe, Jung-Yoon; Jung, Hyun-Young; Park, Ki-Yeun; Kim, Seong-Kyu</div><div class="citationInfo"><span class="NLM_cas:title">Rheumatology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1043-1053</span>CODEN:
                <span class="NLM_cas:coden">RUMAFK</span>;
        ISSN:<span class="NLM_cas:issn">1462-0324</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objective. Evidence for the role of autophagy in the regulation of inflammation, esp. IL-1β expression in response to monosodium urate (MSU) crystals, is presented.  This study investigated the role of p62, a selective autophagy receptor in autophagy, in IL-1β prodn. in MSU crystal-induced inflammation.  Methods. IL-1β, TNF-α and IL-6 mRNA expression was measured by quant. real-time PCR (qRT-PCR).  Autophagy-related mols. such as p62, Cullin-3, microtubule-assocd. protein 1 light-chain 3 (LC3) I/II, ubiquitin, caspase-1 and mitogen-activated protein kinase (MAPK)-related proteins were measured by immunoblotting.  Small interfering RNAs (siRNAs) for Atg16L1, IL-1β and p62 were used to silence each target gene.  Results. MSU crystals accelerate the process of autophagosome formation and also induce impairment of proteasomal degrdn., resulting in p62 accumulation in autophagy.  Enhanced p62 accumulation by MSU crystals leads to IL-1β expression through activation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK), but not p38, of the MAPK pathway and is also involved in activation of caspase-1 in inflammasomes.  Impaired autophagosome formation by Atg16L1 siRNA significantly amplified p62 levels, thereby producing enhanced inflammatory responses, including overexpression of IL-1β under stimulation of MSU crystals.  IL-1β also induces p62 protein, and blocking IL-1β under stimulation of MSU crystals greatly reduced p62 levels.  Conclusion. This study demonstrates that enhanced p62 expression through impaired proteasomal degrdn. by MSU crystals plays a crucial role in caspase-1 activation in MSU crystal-induced IL-1β prodn. p62 is required for activation of inflammasomes during acute inflammation in gout.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolm2_Jdipsp7Vg90H21EOLACvtfcHk0lhKqyn1HYP0-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotF2qsLk%253D&md5=67a2fbcc23af60e5f63488a875fdfcdb</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2Fket474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252Fket474%26sid%3Dliteratum%253Aachs%26aulast%3DChoe%26aufirst%3DJ.%2BY.%26aulast%3DJung%26aufirst%3DH.%2BY.%26aulast%3DPark%26aufirst%3DK.%2BY.%26aulast%3DKim%26aufirst%3DS.%2BK.%26atitle%3DEnhanced%2520p62%2520expression%2520through%2520impaired%2520proteasomal%2520degradation%2520is%2520involved%2520in%2520caspase-1%2520activation%2520in%2520monosodium%2520urate%2520crystal-induced%2520interleukin-1b%2520expression%26jtitle%3DRheumatology%2520%2528Oxford%252C%2520U.%2520K.%2529%26date%3D2014%26volume%3D53%26issue%3D6%26spage%3D1043%26epage%3D1053%26doi%3D10.1093%2Frheumatology%2Fket474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Umemura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamachika, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Font-Burgada, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramaniam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghunandan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linares, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reina-Campos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umemura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valasek, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">p62, upregulated during preneoplasia, induces hepatocellular carcinogenesis by maintaining survival of stressed HCC-initiating cells</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">935</span>– <span class="NLM_lpage">948</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2016.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.ccell.2016.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27211490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28Xotlentro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2016&pages=935-948&issue=6&author=A.+Umemuraauthor=F.+Heauthor=K.+Taniguchiauthor=H.+Nakagawaauthor=S.+Yamachikaauthor=J.+Font-Burgadaauthor=Z.+Y.+Zhongauthor=S.+Subramaniamauthor=S.+Raghunandanauthor=A.+Duranauthor=J.+F.+Linaresauthor=M.+Reina-Camposauthor=S.+Umemuraauthor=M.+A.+Valasekauthor=E.+Sekiauthor=K.+Yamaguchiauthor=K.+Koikeauthor=Y.+Itohauthor=M.+T.+Diaz-Mecoauthor=J.+Moscatauthor=M.+Karin&title=p62%2C+upregulated+during+preneoplasia%2C+induces+hepatocellular+carcinogenesis+by+maintaining+survival+of+stressed+HCC-initiating+cells&doi=10.1016%2Fj.ccell.2016.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells</span></div><div class="casAuthors">Umemura, Atsushi; He, Feng; Taniguchi, Koji; Nakagawa, Hayato; Yamachika, Shinichiro; Font-Burgada, Joan; Zhong, Zhenyu; Subramaniam, Shankar; Raghunandan, Sindhu; Duran, Angeles; Linares, Juan F.; Reina-Campos, Miguel; Umemura, Shiori; Valasek, Mark A.; Seki, Ekihiro; Yamaguchi, Kanji; Koike, Kazuhiko; Itoh, Yoshito; Diaz-Meco, Maria T.; Moscat, Jorge; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">935-948</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">P62 is a ubiquitin-binding autophagy receptor and signaling protein that accumulates in premalignant liver diseases and most hepatocellular carcinomas (HCCs).  Although p62 was proposed to participate in the formation of benign adenomas in autophagy-deficient livers, its role in HCC initiation was not explored.  Here we show that p62 is necessary and sufficient for HCC induction in mice and that its high expression in non-tumor human liver predicts rapid HCC recurrence after curative ablation.  High p62 expression is needed for activation of NRF2 and mTORC1, induction of c-Myc, and protection of HCC-initiating cells from oxidative stress-induced death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG3PmjQwQ86bVg90H21EOLACvtfcHk0lhKqyn1HYP0-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xotlentro%253D&md5=c8b15119ef52aacdc15ea7a9a3ee39e2</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2016.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2016.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DUmemura%26aufirst%3DA.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DTaniguchi%26aufirst%3DK.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DYamachika%26aufirst%3DS.%26aulast%3DFont-Burgada%26aufirst%3DJ.%26aulast%3DZhong%26aufirst%3DZ.%2BY.%26aulast%3DSubramaniam%26aufirst%3DS.%26aulast%3DRaghunandan%26aufirst%3DS.%26aulast%3DDuran%26aufirst%3DA.%26aulast%3DLinares%26aufirst%3DJ.%2BF.%26aulast%3DReina-Campos%26aufirst%3DM.%26aulast%3DUmemura%26aufirst%3DS.%26aulast%3DValasek%26aufirst%3DM.%2BA.%26aulast%3DSeki%26aufirst%3DE.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DKoike%26aufirst%3DK.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3Dp62%252C%2520upregulated%2520during%2520preneoplasia%252C%2520induces%2520hepatocellular%2520carcinogenesis%2520by%2520maintaining%2520survival%2520of%2520stressed%2520HCC-initiating%2520cells%26jtitle%3DCancer%2520Cell%26date%3D2016%26volume%3D29%26issue%3D6%26spage%3D935%26epage%3D948%26doi%3D10.1016%2Fj.ccell.2016.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linares, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvez, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wikenheiser, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span> <span> </span><span class="NLM_article-title">The signaling adaptor p62 is an important NF-kappa B mediator in tumorigenesis</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2008.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.ccr.2008.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18394557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkslSjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=343-354&issue=4&author=A.+Duranauthor=J.+F.+Linaresauthor=A.+S.+Galvezauthor=K.+Wikenheiserauthor=J.+M.+Floresauthor=M.+T.+Diaz-Mecoauthor=J.+Moscat&title=The+signaling+adaptor+p62+is+an+important+NF-kappa+B+mediator+in+tumorigenesis&doi=10.1016%2Fj.ccr.2008.02.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The signaling adaptor p62 is an important NF-κB mediator in tumorigenesis</span></div><div class="casAuthors">Duran, Angeles; Linares, Juan F.; Galvez, Anita S.; Wikenheiser, Kathryn; Flores, Juana M.; Diaz-Meco, Maria T.; Moscat, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">343-354</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The balance between cell death and survival, two crit. aspects of oncogenic transformation, dets. the outcome of tumorigenesis.  Nuclear factor-κB (NF-κB) is a crit. regulator of survival; it is induced by the oncogene Ras and, when inhibited, accounts for the cell death response of Ras-transformed cells.  Here, we show that the signaling adaptor p62 is induced by Ras, its levels are increased in human tumors, and it is required for Ras-induced survival and transformation.  P62-/- mice are resistant to Ras-induced lung adenocarcinomas.  P62 is necessary for Ras to trigger IκB kinase (IKK) through the polyubiquitination of tumor necrosis factor (TNF) receptor-assocd. factor 6 (TRAF6), and its deficiency produces increased reactive oxygen species (ROS) levels, which account for the enhanced cell death and reduced tumorigenicity of Ras in the absence of p62.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3t40xqHjHH7Vg90H21EOLACvtfcHk0liA6XHPmrZBPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkslSjtrY%253D&md5=a3557942b123db5fa13abd7a2b2a7713</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2008.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2008.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DDuran%26aufirst%3DA.%26aulast%3DLinares%26aufirst%3DJ.%2BF.%26aulast%3DGalvez%26aufirst%3DA.%2BS.%26aulast%3DWikenheiser%26aufirst%3DK.%26aulast%3DFlores%26aufirst%3DJ.%2BM.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DMoscat%26aufirst%3DJ.%26atitle%3DThe%2520signaling%2520adaptor%2520p62%2520is%2520an%2520important%2520NF-kappa%2520B%2520mediator%2520in%2520tumorigenesis%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D13%26issue%3D4%26spage%3D343%26epage%3D354%26doi%3D10.1016%2Fj.ccr.2008.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torigoe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asanuma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hisasue, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, N.</span></span> <span> </span><span class="NLM_article-title">Cytosolic overexpression of p62 sequestosome 1 in neoplastic prostate tissue</span>. <i>Histopathology</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2559.2005.02313.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1111%2Fj.1365-2559.2005.02313.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=16405664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FitVSqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2006&pages=157-161&issue=2&author=H.+Kitamuraauthor=T.+Torigoeauthor=H.+Asanumaauthor=S.+I.+Hisasueauthor=K.+Suzukiauthor=T.+Tsukamotoauthor=M.+Satohauthor=N.+Sato&title=Cytosolic+overexpression+of+p62+sequestosome+1+in+neoplastic+prostate+tissue&doi=10.1111%2Fj.1365-2559.2005.02313.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Cytosolic overexpression of p62 sequestosome 1 in neoplastic prostate tissue</span></div><div class="casAuthors">Kitamura H; Torigoe T; Asanuma H; Hisasue S-I; Suzuki K; Tsukamoto T; Satoh M; Sato N</div><div class="citationInfo"><span class="NLM_cas:title">Histopathology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-61</span>
        ISSN:<span class="NLM_cas:issn">0309-0167</span>.
    </div><div class="casAbstract">AIMS:  To investigate the expression of p62 in various prostatic tissues, and to demonstrate different immunohistochemical patterns of p62 expression in distinct pathological entities of the prostate.  The p62 sequestosome 1 (SQSTM1) gene product is a multifunctional protein with ubiquitous expression in normal adult tissue.  METHODS AND RESULTS:  Overexpression of p62 was detected in prostate cancer cell lines and tissues by reverse transcriptase-polymerase chain reaction.  Immunohistochemical staining for p62 was performed on 73 cases of paraffin-embedded prostatic tissue. p62 was negative or weakly positive only in the nucleus (pattern N) of prostatic gland epithelium in nine normal and hyperplastic prostate specimens, whilst most cancerous tissue showed intense, uniform staining for p62 in the cytoplasm (pattern C).  Of the prostate cancer specimens, 91% showed positive pattern C immunoreactivity.  Of the cases with high-grade prostatic intraepithelial neoplasia (PIN) around cancer, 77% showed pattern C.  However, in specimens from the patients without prostate cancer PIN displayed pattern C in only 32% of cases.  Western blot analysis showed that all cancer cell lines expressed p62 in the cytoplasm but there was little nuclear expression.  CONCLUSION:  Cytosolic overexpression of p62 is a novel immunohistochemical characteristic in prostatic adenocarcinoma and high-grade PIN, suggesting that p62 might be a novel marker for prostatic malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS4Q809cHSgjXl8icjszYl0fW6udTcc2ea81z8IfzVPJLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FitVSqug%253D%253D&md5=6de7425cd1be440743ae5c76ffc17948</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2559.2005.02313.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2559.2005.02313.x%26sid%3Dliteratum%253Aachs%26aulast%3DKitamura%26aufirst%3DH.%26aulast%3DTorigoe%26aufirst%3DT.%26aulast%3DAsanuma%26aufirst%3DH.%26aulast%3DHisasue%26aufirst%3DS.%2BI.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DSatoh%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DN.%26atitle%3DCytosolic%2520overexpression%2520of%2520p62%2520sequestosome%25201%2520in%2520neoplastic%2520prostate%2520tissue%26jtitle%3DHistopathology%26date%3D2006%26volume%3D48%26issue%3D2%26spage%3D157%26epage%3D161%26doi%3D10.1111%2Fj.1365-2559.2005.02313.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signoretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beroukhim, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lizotte, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liberzon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bair, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamayo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsherniak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabak, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hakimi, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciriello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sander, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaelin, W. G.</span></span> <span> </span><span class="NLM_article-title">SQSTM1 is a pathogenic target of 5q copy number gains in kidney cancer</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">738</span>– <span class="NLM_lpage">750</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2013.10.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.ccr.2013.10.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=24332042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFyltrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=738-750&issue=6&author=L.+J.+Liauthor=C.+Shenauthor=E.+Nakamuraauthor=K.+Andoauthor=S.+Signorettiauthor=R.+Beroukhimauthor=G.+S.+Cowleyauthor=P.+Lizotteauthor=E.+Liberzonauthor=S.+Bairauthor=D.+E.+Rootauthor=P.+Tamayoauthor=A.+Tsherniakauthor=S.+C.+Chengauthor=B.+Tabakauthor=A.+Jacobsenauthor=A.+A.+Hakimiauthor=N.+Schultzauthor=G.+Cirielloauthor=C.+Sanderauthor=J.+J.+Hsiehauthor=W.+G.+Kaelin&title=SQSTM1+is+a+pathogenic+target+of+5q+copy+number+gains+in+kidney+cancer&doi=10.1016%2Fj.ccr.2013.10.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">SQSTM1 Is a Pathogenic Target of 5q Copy Number Gains in Kidney Cancer</span></div><div class="casAuthors">Li, Lianjie; Shen, Chuan; Nakamura, Eijiro; Ando, Kiyohiro; Signoretti, Sabina; Beroukhim, Rameen; Cowley, Glenn S.; Lizotte, Patrick; Liberzon, Ella; Bair, Steven; Root, David E.; Tamayo, Pablo; Tsherniak, Aviad; Cheng, Su-Chun; Tabak, Barbara; Jacobsen, Anders; Hakimi, A. Ari; Schultz, Nikolaus; Ciriello, Giovanni; Sander, Chris; Hsieh, James J.; Kaelin, William G., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">738-750</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Clear cell renal cell carcinoma (ccRCC) is the most common form of kidney cancer and is often linked to loss of chromosome 3p, which harbors the VHL tumor suppressor gene, loss of chromosome 14q, which includes HIF1A, and gain of chromosome 5q.  The relevant target(s) on chromosome 5q is not known.  Here, we show that 5q amplification leads to overexpression of the SQSTM1 oncogene in ccRCC lines and tumors.  Overexpression of SQSTM1 in ccRCC lines promoted resistance to redox stress and increased soft agar growth, while downregulation of SQSTM1 decreased resistance to redox stress, impaired cellular fitness, and decreased tumor formation.  Therefore, the selection pressure to amplify 5q in ccRCC is driven, at least partly, by SQSTM1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDLybjFnYTMrVg90H21EOLACvtfcHk0ljFQb6CTi-77w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFyltrzM&md5=0d9e0bf2b9be24a33e2ecd7c082fa58f</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2013.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2013.10.025%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%2BJ.%26aulast%3DShen%26aufirst%3DC.%26aulast%3DNakamura%26aufirst%3DE.%26aulast%3DAndo%26aufirst%3DK.%26aulast%3DSignoretti%26aufirst%3DS.%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DCowley%26aufirst%3DG.%2BS.%26aulast%3DLizotte%26aufirst%3DP.%26aulast%3DLiberzon%26aufirst%3DE.%26aulast%3DBair%26aufirst%3DS.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DTamayo%26aufirst%3DP.%26aulast%3DTsherniak%26aufirst%3DA.%26aulast%3DCheng%26aufirst%3DS.%2BC.%26aulast%3DTabak%26aufirst%3DB.%26aulast%3DJacobsen%26aufirst%3DA.%26aulast%3DHakimi%26aufirst%3DA.%2BA.%26aulast%3DSchultz%26aufirst%3DN.%26aulast%3DCiriello%26aufirst%3DG.%26aulast%3DSander%26aufirst%3DC.%26aulast%3DHsieh%26aufirst%3DJ.%2BJ.%26aulast%3DKaelin%26aufirst%3DW.%2BG.%26atitle%3DSQSTM1%2520is%2520a%2520pathogenic%2520target%2520of%25205q%2520copy%2520number%2520gains%2520in%2520kidney%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2013%26volume%3D24%26issue%3D6%26spage%3D738%26epage%3D750%26doi%3D10.1016%2Fj.ccr.2013.10.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valencia, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu-Baker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat-Pardos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reina-Campos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castilla, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metallo, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span> <span> </span><span class="NLM_article-title">Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2014.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.ccr.2014.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=25002027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFans7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2014&pages=121-135&issue=1&author=T.+Valenciaauthor=J.+Y.+Kimauthor=S.+Abu-Bakerauthor=J.+Moscat-Pardosauthor=C.+S.+Ahnauthor=M.+Reina-Camposauthor=A.+Duranauthor=E.+A.+Castillaauthor=C.+M.+Metalloauthor=M.+T.+Diaz-Mecoauthor=J.+Moscat&title=Metabolic+reprogramming+of+stromal+fibroblasts+through+p62-mTORC1+signaling+promotes+inflammation+and+tumorigenesis&doi=10.1016%2Fj.ccr.2014.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic Reprogramming of Stromal Fibroblasts through p62-mTORC1 Signaling Promotes Inflammation and Tumorigenesis</span></div><div class="casAuthors">Valencia, Tania; Kim, Ji Young; Abu-Baker, Shadi; Moscat-Pardos, Jorge; Ahn, Christopher S.; Reina-Campos, Miguel; Duran, Angeles; Castilla, Elias A.; Metallo, Christian M.; Diaz-Meco, Maria T.; Moscat, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">121-135</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The tumor microenvironment plays a crit. role in cancer progression, but the precise mechanisms by which stromal cells influence the epithelium are poorly understood.  Here we show that p62 levels were reduced in the stroma of several tumors and that its loss in the tumor microenvironment or stromal fibroblasts resulted in increased tumorigenesis of epithelial prostate cancer cells.  The mechanism involves the regulation of cellular redox through an mTORC1/c-Myc pathway of stromal glucose and amino acid metab., resulting in increased stromal IL-6 prodn., which is required for tumor promotion in the epithelial compartment.  Thus, p62 is an anti-inflammatory tumor suppressor that acts through the modulation of metab. in the tumor stroma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFR7mW_cF9IbVg90H21EOLACvtfcHk0ljFQb6CTi-77w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFans7rL&md5=8448e9f8c287d7db07c690150e5f1215</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2014.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2014.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DValencia%26aufirst%3DT.%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DAbu-Baker%26aufirst%3DS.%26aulast%3DMoscat-Pardos%26aufirst%3DJ.%26aulast%3DAhn%26aufirst%3DC.%2BS.%26aulast%3DReina-Campos%26aufirst%3DM.%26aulast%3DDuran%26aufirst%3DA.%26aulast%3DCastilla%26aufirst%3DE.%2BA.%26aulast%3DMetallo%26aufirst%3DC.%2BM.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DMoscat%26aufirst%3DJ.%26atitle%3DMetabolic%2520reprogramming%2520of%2520stromal%2520fibroblasts%2520through%2520p62-mTORC1%2520signaling%2520promotes%2520inflammation%2520and%2520tumorigenesis%26jtitle%3DCancer%2520Cell%26date%3D2014%26volume%3D26%26issue%3D1%26spage%3D121%26epage%3D135%26doi%3D10.1016%2Fj.ccr.2014.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span> <span> </span><span class="NLM_article-title">p62 in cancer: signaling adaptor beyond autophagy</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>167</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">606</span>– <span class="NLM_lpage">609</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.09.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.cell.2016.09.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27768885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslCrsrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2016&pages=606-609&issue=3&author=J.+Moscatauthor=M.+Karinauthor=M.+T.+Diaz-Meco&title=p62+in+cancer%3A+signaling+adaptor+beyond+autophagy&doi=10.1016%2Fj.cell.2016.09.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">p62 in Cancer: Signaling Adaptor Beyond Autophagy</span></div><div class="casAuthors">Moscat, Jorge; Karin, Michael; Diaz-Meco, Maria T.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">606-609</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Adaptor proteins participate in selective autophagy, which is crit. for cellular detoxification and stress relief.  However, new evidence supports an autophagy-independent key role of the adaptor p62 (encoded by the gene Sqstm1) in signaling functions central to tumor initiation in the epithelium and suppression of tumor progression in the stroma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfCL87hjyvcbVg90H21EOLACvtfcHk0lhmz4XGjhqz6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslCrsrjL&md5=cb962ea1adfd7935b4fbe0eba4b7049b</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.09.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.09.030%26sid%3Dliteratum%253Aachs%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DKarin%26aufirst%3DM.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26atitle%3Dp62%2520in%2520cancer%253A%2520signaling%2520adaptor%2520beyond%2520autophagy%26jtitle%3DCell%26date%3D2016%26volume%3D167%26issue%3D3%26spage%3D606%26epage%3D609%26doi%3D10.1016%2Fj.cell.2016.09.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eskelinen, E. L.</span></span> <span> </span><span class="NLM_article-title">The dual role of autophagy in cancer</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">294</span>– <span class="NLM_lpage">300</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2011.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.coph.2011.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21498118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVaisbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=294-300&issue=4&author=E.+L.+Eskelinen&title=The+dual+role+of+autophagy+in+cancer&doi=10.1016%2Fj.coph.2011.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">The dual role of autophagy in cancer</span></div><div class="casAuthors">Eskelinen, Eeva-Liisa</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">294-300</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Autophagy is a mechanism for the degrdn. of cytoplasmic material, damaged organelles and aggregate-prone proteins in lysosomes.  Recent evidence indicates that autophagy is a tumor suppressor mechanism, which is connected to its role in the clearance of the scaffold protein p62/SQSTM1 and prevention of oxidative stress and genomic instability.  However, since autophagy is a survival mechanism, cancer cells can also exploit it to survive nutrient limitation and hypoxia that often occur in solid tumors.  Tumor cells can also upregulate autophagy as a response to cancer treatment, and recent studies show that inhibition of autophagy can enhance the killing of tumor cells after treatment.  Interestingly, the FK506-binding protein 51 plays a role in the autophagy-linked radiation resistance of malignant melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqperDgYUp4kLVg90H21EOLACvtfcHk0lhmz4XGjhqz6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVaisbfF&md5=ff1fedd9f6f59b5cac7f594c65f87681</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2011.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2011.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DEskelinen%26aufirst%3DE.%2BL.%26atitle%3DThe%2520dual%2520role%2520of%2520autophagy%2520in%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2011%26volume%3D11%26issue%3D4%26spage%3D294%26epage%3D300%26doi%3D10.1016%2Fj.coph.2011.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debnath, J.</span></span> <span> </span><span class="NLM_article-title">Autophagy and tumorigenesis</span>. <i>Semin. Immunopathol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1007/s00281-010-0213-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1007%2Fs00281-010-0213-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20589500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FivVahsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2010&pages=383-396&issue=4&author=S.+Royauthor=J.+Debnath&title=Autophagy+and+tumorigenesis&doi=10.1007%2Fs00281-010-0213-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy and tumorigenesis</span></div><div class="casAuthors">Roy Srirupa; Debnath Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in immunopathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">383-96</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autophagy, a catabolic process involved in the sequestration and lysosomal degradation of cytoplasmic contents, is crucial for cellular homeostasis.  The current literature supports that autophagy plays diverse roles in the development, maintenance, and progression of tumors.  While genetic evidence indicates autophagy functions as a tumor suppressor mechanism, it is also apparent that autophagy can promote the survival of established tumors under stress conditions and in response to chemotherapy.  In this review, we discuss the mechanisms and the evidence underlying these multifaceted roles of autophagy in tumorigenesis, the prospects for targeting autophagy in cancer therapy, and overview the potential markers that may be utilized to reliably detect autophagy in clinical settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSRZ1BYMyXusI2y4bB4mnvYfW6udTcc2eaJeFNTuJVnrbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FivVahsg%253D%253D&md5=102223a7cdb6068f9431aef06e87c0cc</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1007%2Fs00281-010-0213-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00281-010-0213-0%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DDebnath%26aufirst%3DJ.%26atitle%3DAutophagy%2520and%2520tumorigenesis%26jtitle%3DSemin.%2520Immunopathol.%26date%3D2010%26volume%3D32%26issue%3D4%26spage%3D383%26epage%3D396%26doi%3D10.1007%2Fs00281-010-0213-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, T. D.</span></span> <span> </span><span class="NLM_article-title">Autophagy modulation: a prudent approach in cancer treatment?</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>82</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">913</span>– <span class="NLM_lpage">922</span>, <span class="refDoi"> DOI: 10.1007/s00280-018-3669-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1007%2Fs00280-018-3669-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=30182146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Gks7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2018&pages=913-922&issue=6&author=E.+Bishopauthor=T.+D.+Bradshaw&title=Autophagy+modulation%3A+a+prudent+approach+in+cancer+treatment%3F&doi=10.1007%2Fs00280-018-3669-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy modulation: a prudent approach in cancer treatment?</span></div><div class="casAuthors">Bishop, Eleanor; Bradshaw, Tracey D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">913-922</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Autophagy is a tightly controlled process comprising lysosomal degrdn. and recycling of cellular proteins and organelles.  In cancer, its paradoxical dual role of cytoprotection and cytotoxicity is context-dependent and controversial.  Autophagy primarily acts as a mechanism of tumor suppression, by maintenance of genomic integrity and prevention of proliferation and inflammation.  This, combined with immune-surveillance capabilities and autophagy's implicated role in cell death, acts to prevent tumor initiation.  However, established tumors exploit autophagy to survive cellular stresses in the hostile tumor microenvironment.  This can lead to therapy resistance, one of the biggest challenges facing current anti-cancer approaches.  Autophagy modulation is an exciting area of clin. development, attempting to harness this fundamental process as an anti-cancer strategy.  Autophagy induction could potentially prevent tumor formation and enhance anti-cancer immune responses.  In addn., drug-induced autophagy could be used to kill cancer cells, particularly those in which the apoptotic machinery is defective.  Conversely, autophagy inhibition may help to sensitize resistant cancer cells to conventional chemotherapies and specifically target autophagy-addicted tumors.  Currently, hydroxychloroquine is in phase I and II clin. trials in combination with several std. chemotherapies, whereas direct, deliberate autophagy induction remains to be tested clin.  More comprehensive understanding of the roles of autophagy throughout different stages of carcinogenesis has potential to guide development of novel therapeutic strategies to eradicate cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGIViCqA2AKLVg90H21EOLACvtfcHk0ljOAcC81ZxTOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Gks7%252FE&md5=a1655951f3c69f959b2acc6b35fe00d4</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1007%2Fs00280-018-3669-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-018-3669-6%26sid%3Dliteratum%253Aachs%26aulast%3DBishop%26aufirst%3DE.%26aulast%3DBradshaw%26aufirst%3DT.%2BD.%26atitle%3DAutophagy%2520modulation%253A%2520a%2520prudent%2520approach%2520in%2520cancer%2520treatment%253F%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2018%26volume%3D82%26issue%3D6%26spage%3D913%26epage%3D922%26doi%3D10.1007%2Fs00280-018-3669-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fung, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lock, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debnath, J.</span></span> <span> </span><span class="NLM_article-title">Induction of autophagy during extracellular matrix detachment promotes cell survival</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">797</span>– <span class="NLM_lpage">806</span>, <span class="refDoi"> DOI: 10.1091/mbc.e07-10-1092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1091%2Fmbc.e07-10-1092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18094039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslemsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=797-806&issue=3&author=C.+Fungauthor=R.+Lockauthor=S.+Z.+Gaoauthor=E.+Salasauthor=J.+Debnath&title=Induction+of+autophagy+during+extracellular+matrix+detachment+promotes+cell+survival&doi=10.1091%2Fmbc.e07-10-1092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of autophagy during extracellular matrix detachment promotes cell survival</span></div><div class="casAuthors">Fung, Christopher; Lock, Rebecca; Gao, Sizhen; Salas, Eduardo; Debnath, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">797-806</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1939-4586</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Autophagy has been proposed to promote cell death during lumen formation in three-dimensional mammary epithelial acini because numerous autophagic vacuoles are obsd. in the dying central cells during morphogenesis.  Because these central cells die due to extracellular matrix (ECM) deprivation (anoikis), we have directly interrogated how matrix detachment regulates autophagy.  Detachment induces autophagy in both nontumorigenic epithelial lines and in primary epithelial cells.  RNA interference-mediated depletion of autophagy regulators (ATGs) inhibits detachment-induced autophagy, enhances apoptosis, and reduces clonogenic recovery after anoikis.  Remarkably, matrix-detached cells still exhibit autophagy when apoptosis is blocked by Bcl-2 overexpression, and ATG depletion reduces the clonogenic survival of Bcl-2-expressing cells after detachment.  Finally, stable redn. of ATG5 or ATG7 in MCF-10A acini enhances luminal apoptosis during morphogenesis and fails to elicit long-term luminal filling, even when combined with apoptotic inhibition mediated by Bcl-2 overexpression.  Thus, autophagy promotes epithelial cell survival during anoikis, including detached cells harboring antiapoptotic lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCt94oDcCXZLVg90H21EOLACvtfcHk0li3pVZv25Vanw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslemsr8%253D&md5=5480fd837a9490e92d80b9eeb2e5ec15</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1091%2Fmbc.e07-10-1092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.e07-10-1092%26sid%3Dliteratum%253Aachs%26aulast%3DFung%26aufirst%3DC.%26aulast%3DLock%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DS.%2BZ.%26aulast%3DSalas%26aufirst%3DE.%26aulast%3DDebnath%26aufirst%3DJ.%26atitle%3DInduction%2520of%2520autophagy%2520during%2520extracellular%2520matrix%2520detachment%2520promotes%2520cell%2520survival%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2008%26volume%3D19%26issue%3D3%26spage%3D797%26epage%3D806%26doi%3D10.1091%2Fmbc.e07-10-1092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amaravadi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimmelman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, E.</span></span> <span> </span><span class="NLM_article-title">Recent insights into the function of autophagy in cancer</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">1913</span>– <span class="NLM_lpage">1930</span>, <span class="refDoi"> DOI: 10.1101/gad.287524.116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1101%2Fgad.287524.116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27664235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlWiu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=1913-1930&issue=17&author=R.+Amaravadiauthor=A.+C.+Kimmelmanauthor=E.+White&title=Recent+insights+into+the+function+of+autophagy+in+cancer&doi=10.1101%2Fgad.287524.116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Recent insights into the function of autophagy in cancer</span></div><div class="casAuthors">Amaravadi, Ravi; Kimmelman, Alec C.; White, Eileen</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1913-1930</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Macroautophagy (referred to here as autophagy) is induced by starvation to capture and degrade intracellular proteins and organelles in lysosomes, which recycles intracellular components to sustain metab. and survival.  Autophagy also plays a major homeostatic role in controlling protein and organelle quality and quantity.  Dysfunctional autophagy contributes to many diseases.  In cancer, autophagy can be neutral, tumor-suppressive, or tumor-promoting in different contexts.  Large-scale genomic anal. of human cancers indicates that the loss or mutation of core autophagy genes is uncommon, whereas oncogenic events that activate autophagy and lysosomal biogenesis have been identified.  Autophagic flux, however, is difficult to measure in human tumor samples, making functional assessment of autophagy problematic in a clin. setting.  Autophagy impacts cellular metab., the proteome, and organelle nos. and quality, which alter cell functions in diverse ways.  Moreover, autophagy influences the interaction between the tumor and the host by promoting stress adaptation and suppressing activation of innate and adaptive immune responses.  Addnl., autophagy can promote a cross-talk between the tumor and the stroma, which can support tumor growth, particularly in a nutrient-limited microenvironment.  Thus, the role of autophagy in cancer is detd. by nutrient availability, microenvironment stress, and the presence of an immune system.  Here we discuss recent developments in the role of autophagy in cancer, in particular how autophagy can promote cancer through suppressing p53 and preventing energy crisis, cell death, senescence, and an anti-tumor immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZVHFFZf5sjbVg90H21EOLACvtfcHk0ljsPsHUJj422w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlWiu70%253D&md5=d0bbf76e801f31613d5e8f56f8d69d2b</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1101%2Fgad.287524.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.287524.116%26sid%3Dliteratum%253Aachs%26aulast%3DAmaravadi%26aufirst%3DR.%26aulast%3DKimmelman%26aufirst%3DA.%2BC.%26aulast%3DWhite%26aufirst%3DE.%26atitle%3DRecent%2520insights%2520into%2520the%2520function%2520of%2520autophagy%2520in%2520cancer%26jtitle%3DGenes%2520Dev.%26date%3D2016%26volume%3D30%26issue%3D17%26spage%3D1913%26epage%3D1930%26doi%3D10.1101%2Fgad.287524.116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bjorkoy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamark, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brech, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Outzen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perander, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overvatn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenmark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansen, T.</span></span> <span> </span><span class="NLM_article-title">p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>171</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">603</span>– <span class="NLM_lpage">614</span>, <span class="refDoi"> DOI: 10.1083/jcb.200507002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1083%2Fjcb.200507002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=16286508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BD2MnitVWktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2005&pages=603-614&issue=4&author=G.+Bjorkoyauthor=T.+Lamarkauthor=A.+Brechauthor=H.+Outzenauthor=M.+Peranderauthor=A.+Overvatnauthor=H.+Stenmarkauthor=T.+Johansen&title=p62%2FSQSTM1+forms+protein+aggregates+degraded+by+autophagy+and+has+a+protective+effect+on+huntingtin-induced+cell+death&doi=10.1083%2Fjcb.200507002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death</span></div><div class="casAuthors">Bjorkoy Geir; Lamark Trond; Brech Andreas; Outzen Heidi; Perander Maria; Overvatn Aud; Stenmark Harald; Johansen Terje</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of cell biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">603-14</span>
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    </div><div class="casAbstract">Autophagic degradation of ubiquitinated protein aggregates is important for cell survival, but it is not known how the autophagic machinery recognizes such aggregates.  In this study, we report that polymerization of the polyubiquitin-binding protein p62/SQSTM1 yields protein bodies that either reside free in the cytosol and nucleus or occur within autophagosomes and lysosomal structures.  Inhibition of autophagy led to an increase in the size and number of p62 bodies and p62 protein levels.  The autophagic marker light chain 3 (LC3) colocalized with p62 bodies and co-immunoprecipitated with p62, suggesting that these two proteins participate in the same complexes.  The depletion of p62 inhibited recruitment of LC3 to autophagosomes under starvation conditions.  Strikingly, p62 and LC3 formed a shell surrounding aggregates of mutant huntingtin.  Reduction of p62 protein levels or interference with p62 function significantly increased cell death that was induced by the expression of mutant huntingtin.  We suggest that p62 may, via LC3, be involved in linking polyubiquitinated protein aggregates to the autophagy machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTI4TfVb2IG0H6oPH0mYWL1fW6udTcc2ea5s6qufmuh_7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MnitVWktw%253D%253D&md5=458c088f5526eadc05be25594a183747</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200507002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200507002%26sid%3Dliteratum%253Aachs%26aulast%3DBjorkoy%26aufirst%3DG.%26aulast%3DLamark%26aufirst%3DT.%26aulast%3DBrech%26aufirst%3DA.%26aulast%3DOutzen%26aufirst%3DH.%26aulast%3DPerander%26aufirst%3DM.%26aulast%3DOvervatn%26aufirst%3DA.%26aulast%3DStenmark%26aufirst%3DH.%26aulast%3DJohansen%26aufirst%3DT.%26atitle%3Dp62%252FSQSTM1%2520forms%2520protein%2520aggregates%2520degraded%2520by%2520autophagy%2520and%2520has%2520a%2520protective%2520effect%2520on%2520huntingtin-induced%2520cell%2520death%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2005%26volume%3D171%26issue%3D4%26spage%3D603%26epage%3D614%26doi%3D10.1083%2Fjcb.200507002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inami, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waguri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hino, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwadate, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span> <span> </span><span class="NLM_article-title">Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>193</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1083/jcb.201102031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1083%2Fjcb.201102031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21482715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltlGjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2011&pages=275-284&issue=2&author=Y.+Inamiauthor=S.+Waguriauthor=A.+Sakamotoauthor=T.+Kounoauthor=K.+Nakadaauthor=O.+Hinoauthor=S.+Watanabeauthor=J.+Andoauthor=M.+Iwadateauthor=M.+Yamamotoauthor=M.+S.+Leeauthor=K.+Tanakaauthor=M.+Komatsu&title=Persistent+activation+of+Nrf2+through+p62+in+hepatocellular+carcinoma+cells&doi=10.1083%2Fjcb.201102031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells</span></div><div class="casAuthors">Inami, Yoshihiro; Waguri, Satoshi; Sakamoto, Ayako; Kouno, Tsuguka; Nakada, Kazuto; Hino, Okio; Watanabe, Sumio; Ando, Jin; Iwadate, Manabu; Yamamoto, Masayuki; Lee, Myung-Shik; Tanaka, Keiji; Komatsu, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-284</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Suppression of autophagy is always accompanied by marked accumulation of p62, a selective autophagy substrate.  Because p62 interacts with the Nrf2-binding site on Keap1, which is a Cullin 3-based ubiquitin ligase adapter protein, autophagy deficiency causes competitive inhibition of the Nrf2-Keap1 interaction, resulting in stabilization of Nrf2 followed by transcriptional activation of Nrf2 target genes.  Herein, we show that liver-specific autophagy-deficient mice harbor adenomas linked to both the formation of p62- and Keap1-pos. cellular aggregates and induction of Nrf2 targets.  Importantly, similar aggregates were identified in more than 25% of human hepatocellular carcinomas (HCC), and induction of Nrf2 target genes was recognized in most of these tumors.  Gene targeting of p62 in an HCC cell line markedly abrogates the anchorage-independent growth, whereas forced expression of p62, but not a Keap1 interaction-defective mutant, resulted in recovery of the growth defect.  These results indicate the involvement of persistent activation of Nrf2 through the accumulation of p62 in hepatoma development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3R8QJbqjBu7Vg90H21EOLACvtfcHk0liWD-NyrH1pwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltlGjtro%253D&md5=94996fb80dafd1637ce0299209a1db60</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201102031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201102031%26sid%3Dliteratum%253Aachs%26aulast%3DInami%26aufirst%3DY.%26aulast%3DWaguri%26aufirst%3DS.%26aulast%3DSakamoto%26aufirst%3DA.%26aulast%3DKouno%26aufirst%3DT.%26aulast%3DNakada%26aufirst%3DK.%26aulast%3DHino%26aufirst%3DO.%26aulast%3DWatanabe%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DJ.%26aulast%3DIwadate%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3DPersistent%2520activation%2520of%2520Nrf2%2520through%2520p62%2520in%2520hepatocellular%2520carcinoma%2520cells%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2011%26volume%3D193%26issue%3D2%26spage%3D275%26epage%3D284%26doi%3D10.1083%2Fjcb.201102031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waguri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eishi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hino, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizushima, N.</span></span> <span> </span><span class="NLM_article-title">Autophagy-deficient mice develop multiple liver tumors</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">795</span>– <span class="NLM_lpage">800</span>, <span class="refDoi"> DOI: 10.1101/gad.2016211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1101%2Fgad.2016211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21498569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltlKntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=795-800&issue=8&author=A.+Takamuraauthor=M.+Komatsuauthor=T.+Haraauthor=A.+Sakamotoauthor=C.+Kishiauthor=S.+Waguriauthor=Y.+Eishiauthor=O.+Hinoauthor=K.+Tanakaauthor=N.+Mizushima&title=Autophagy-deficient+mice+develop+multiple+liver+tumors&doi=10.1101%2Fgad.2016211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy-deficient mice develop multiple liver tumors</span></div><div class="casAuthors">Takamura, Akito; Komatsu, Masaaki; Hara, Taichi; Sakamoto, Ayako; Kishi, Chieko; Waguri, Satoshi; Eishi, Yoshinobu; Hino, Okio; Tanaka, Keiji; Mizushima, Noboru</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">795-800</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Autophagy is a major pathway for degrdn. of cytoplasmic proteins and organelles, and has been implicated in tumor suppression.  Here, we report that mice with systemic mosaic deletion of Atg5 and liver-specific Atg7-/- mice develop benign liver adenomas.  These tumor cells originate autophagy-deficient hepatocytes and show mitochondrial swelling, p62 accumulation, and oxidative stress and genomic damage responses.  The size of the Atg7-/- liver tumors is reduced by simultaneous deletion of p62.  These results suggest that autophagy is important for the suppression of spontaneous tumorigenesis through a cell-intrinsic mechanism, particularly in the liver, and that p62 accumulation contributes to tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDoU81LkM8lbVg90H21EOLACvtfcHk0liWD-NyrH1pwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltlKntrY%253D&md5=5fff0dac8440745e12db5d1d53643cb3</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1101%2Fgad.2016211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.2016211%26sid%3Dliteratum%253Aachs%26aulast%3DTakamura%26aufirst%3DA.%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DA.%26aulast%3DKishi%26aufirst%3DC.%26aulast%3DWaguri%26aufirst%3DS.%26aulast%3DEishi%26aufirst%3DY.%26aulast%3DHino%26aufirst%3DO.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DMizushima%26aufirst%3DN.%26atitle%3DAutophagy-deficient%2520mice%2520develop%2520multiple%2520liver%2520tumors%26jtitle%3DGenes%2520Dev.%26date%3D2011%26volume%3D25%26issue%3D8%26spage%3D795%26epage%3D800%26doi%3D10.1101%2Fgad.2016211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span> <span> </span><span class="NLM_article-title">p62 at the crossroads of autophagy, apoptosis, and cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>137</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1001</span>– <span class="NLM_lpage">1004</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2009.05.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.cell.2009.05.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19524504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1eiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2009&pages=1001-1004&issue=6&author=J.+Moscatauthor=M.+T.+Diaz-Meco&title=p62+at+the+crossroads+of+autophagy%2C+apoptosis%2C+and+cancer&doi=10.1016%2Fj.cell.2009.05.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">p62 at the crossroads of autophagy, apoptosis, and cancer</span></div><div class="casAuthors">Moscat, Jorge; Diaz-Meco, Maria T.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1001-1004</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The signaling adaptor p62 is a multidomain protein implicated in the activation of the transcription factor NF-κB.  Recent findings link p62 activity to the extrinsic apoptosis pathway, and Mathew, R., et al. (2009) now show that the modulation of p62 by autophagy is a key factor in tumorigenesis.  These findings place p62 at crit. decision points that control cell death and survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohw1jilj8gS7Vg90H21EOLACvtfcHk0lifmKq9_To20w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1eiurs%253D&md5=e276456de2e89eadba0c222dce7091a1</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2009.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2009.05.023%26sid%3Dliteratum%253Aachs%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26atitle%3Dp62%2520at%2520the%2520crossroads%2520of%2520autophagy%252C%2520apoptosis%252C%2520and%2520cancer%26jtitle%3DCell%26date%3D2009%26volume%3D137%26issue%3D6%26spage%3D1001%26epage%3D1004%26doi%3D10.1016%2Fj.cell.2009.05.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strohecker, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karsli-Uzunbas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamphorst, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemons, J. M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karantza, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coller, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiPaola, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelinas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, E.</span></span> <span> </span><span class="NLM_article-title">Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">460</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1101/gad.2016311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1101%2Fgad.2016311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21317241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslCisbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=460-470&issue=5&author=J.+Y.+Guoauthor=H.+Y.+Chenauthor=R.+Mathewauthor=J.+Fanauthor=A.+M.+Stroheckerauthor=G.+Karsli-Uzunbasauthor=J.+J.+Kamphorstauthor=G.+H.+Chenauthor=J.+M.+S.+Lemonsauthor=V.+Karantzaauthor=H.+A.+Collerauthor=R.+S.+DiPaolaauthor=C.+Gelinasauthor=J.+D.+Rabinowitzauthor=E.+White&title=Activated+Ras+requires+autophagy+to+maintain+oxidative+metabolism+and+tumorigenesis&doi=10.1101%2Fgad.2016311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis</span></div><div class="casAuthors">Guo, Jessie Yanxiang; Chen, Hsin-Yi; Mathew, Robin; Fan, Jing; Strohecker, Anne M.; Karsli-Uzunbas, Gizem; Kamphorst, Jurre J.; Chen, Guanghua; Lemons, Johanna M. S.; Karantza, Vassiliki; Coller, Hilary A.; DiPaola, Robert S.; Gelinas, Celine; Rabinowitz, Joshua D.; White, Eileen</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">460-470</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Autophagy is a catabolic pathway used by cells to support metab. in response to starvation and to clear damaged proteins and organelles in response to stress.  We report here that expression of a H-rasV12 or K-rasV12 oncogene up-regulates basal autophagy, which is required for tumor cell survival in starvation and in tumorigenesis.  In Ras-expressing cells, defective autophagosome formation or cargo delivery causes accumulation of abnormal mitochondria and reduced oxygen consumption.  Autophagy defects also lead to tricarboxylic acid (TCA) cycle metabolite and energy depletion in starvation.  As mitochondria sustain viability of Ras-expressing cells in starvation, autophagy is required to maintain the pool of functional mitochondria necessary to support growth of Ras-driven tumors.  Human cancer cell lines bearing activating mutations in Ras commonly have high levels of basal autophagy, and, in a subset of these, down-regulating the expression of essential autophagy proteins impaired cell growth.  As cancers with Ras mutations have a poor prognosis, this "autophagy addiction" suggests that targeting autophagy and mitochondrial metab. are valuable new approaches to treat these aggressive cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqplDyIfMVeurVg90H21EOLACvtfcHk0lifmKq9_To20w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslCisbg%253D&md5=bdebf93e1369906637436152bc11ea6e</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1101%2Fgad.2016311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.2016311%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DJ.%2BY.%26aulast%3DChen%26aufirst%3DH.%2BY.%26aulast%3DMathew%26aufirst%3DR.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DStrohecker%26aufirst%3DA.%2BM.%26aulast%3DKarsli-Uzunbas%26aufirst%3DG.%26aulast%3DKamphorst%26aufirst%3DJ.%2BJ.%26aulast%3DChen%26aufirst%3DG.%2BH.%26aulast%3DLemons%26aufirst%3DJ.%2BM.%2BS.%26aulast%3DKarantza%26aufirst%3DV.%26aulast%3DColler%26aufirst%3DH.%2BA.%26aulast%3DDiPaola%26aufirst%3DR.%2BS.%26aulast%3DGelinas%26aufirst%3DC.%26aulast%3DRabinowitz%26aufirst%3DJ.%2BD.%26aulast%3DWhite%26aufirst%3DE.%26atitle%3DActivated%2520Ras%2520requires%2520autophagy%2520to%2520maintain%2520oxidative%2520metabolism%2520and%2520tumorigenesis%26jtitle%3DGenes%2520Dev.%26date%3D2011%26volume%3D25%26issue%3D5%26spage%3D460%26epage%3D470%26doi%3D10.1101%2Fgad.2016311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mcafee, Q. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathanson, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaravadi, R. K.</span></span> <span> </span><span class="NLM_article-title">Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3478</span>– <span class="NLM_lpage">3489</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-10-2372</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1158%2F1078-0432.CCR-10-2372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21325076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtVGitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=3478-3489&issue=10&author=X.+H.+Maauthor=S.+Piaoauthor=D.+Wangauthor=Q.+W.+Mcafeeauthor=K.+L.+Nathansonauthor=J.+J.+Lumauthor=L.+Z.+Liauthor=R.+K.+Amaravadi&title=Measurements+of+tumor+cell+autophagy+predict+invasiveness%2C+resistance+to+chemotherapy%2C+and+survival+in+melanoma&doi=10.1158%2F1078-0432.CCR-10-2372"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma</span></div><div class="casAuthors">Ma, Xiao-Hong; Piao, Sheng-Fu; Wang, Dan; McAfee, Quentin W.; Nathanson, Katherine L.; Lum, Julian J.; Li, Lin Z.; Amaravadi, Ravi K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3478-3489</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Autophagy consists of lysosome-dependent degrdn. of cytoplasmic contents sequestered by autophagic vesicles (AV).  The role of autophagy in detg. tumor aggressiveness and response to therapy in melanoma was investigated.  Autophagy was measured in tumor biopsies obtained from metastatic melanoma patients enrolled on a phase II trial of temozolomide and sorafenib and correlated to clin. outcome.  These results were compared with autophagy measurements in aggressive and indolent melanoma cells grown in two- and three-dimensional (3D) culture and as xenograft tumors.  The effects of autophagy inhibition with either hydroxychloroquine or inducible shRNA (short hairpin RNA) against the autophagy gene ATG5 were assessed in three-dimensional spheroids.  Patients whose tumors had a high autophagic index were less likely to respond to treatment and had a shorter survival compared with those with a low autophagic index.  Differences in autophagy were less evident in aggressive and indolent melanoma cells grown in monolayer culture.  In contrast, autophagy was increased in aggressive compared with indolent melanoma xenograft tumors.  This difference was recapitulated when aggressive and indolent melanoma cells were grown as spheroids.  Autophagy inhibition with either hydroxychloroquine or inducible shRNA against ATG5 resulted in cell death in aggressive melanoma spheroids, and significantly augmented temozolomide-induced cell death.  Thus, autophagy is a potential prognostic factor and therapeutic target in melanoma.  Three-dimensional culture mimics the tumor microenvironment better than monolayer culture and is an appropriate model for studying therapeutic combinations involving autophagy modulators.  Autophagy inhibition should be tested clin. in patients with melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoUQqsbQHdbbVg90H21EOLACvtfcHk0lhY41H5fCcwiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtVGitLo%253D&md5=d12631fc7f68e0ba648c6f210ba9dc92</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-10-2372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-10-2372%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DX.%2BH.%26aulast%3DPiao%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DMcafee%26aufirst%3DQ.%2BW.%26aulast%3DNathanson%26aufirst%3DK.%2BL.%26aulast%3DLum%26aufirst%3DJ.%2BJ.%26aulast%3DLi%26aufirst%3DL.%2BZ.%26aulast%3DAmaravadi%26aufirst%3DR.%2BK.%26atitle%3DMeasurements%2520of%2520tumor%2520cell%2520autophagy%2520predict%2520invasiveness%252C%2520resistance%2520to%2520chemotherapy%252C%2520and%2520survival%2520in%2520melanoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26issue%3D10%26spage%3D3478%26epage%3D3489%26doi%3D10.1158%2F1078-0432.CCR-10-2372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amaravadi, R.</span></span> <span> </span><span class="NLM_article-title">Autophagy can contribute to cell death when combining targeted therapy</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">2097</span>– <span class="NLM_lpage">2098</span>, <span class="refDoi"> DOI: 10.4161/cbt.8.21.10416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.4161%2Fcbt.8.21.10416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotVWksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=2097-2098&issue=21&author=R.+Amaravadi&title=Autophagy+can+contribute+to+cell+death+when+combining+targeted+therapy&doi=10.4161%2Fcbt.8.21.10416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy can contribute to cell death when combining targeted therapy</span></div><div class="casAuthors">Amaravadi, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2097-2100</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  The research Martin et al. (2009) entitled, 'Inhibitin of MCL-1 enhances Lapatinib toxicity and overcomes Lapatinib resistance via BAK-dependent autophagy' is reviewed with commentary and refs.  The authors characterized the synergistic cell death found in colon and breast cancer cells treated with the ErbB1/2 inhibitor lapatinib and the BCL-2 family inhibitor obatoclax.  Surprisingly, they were unable to find evidence of caspase activation in cells treated with this combination and that inhibition of caspase function with z-VAD modestly enhanced cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq77Wbl1379bVg90H21EOLACvtfcHk0lhY41H5fCcwiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotVWksLo%253D&md5=29b65b45b5b988a2c0aaded0b9f57c35</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.4161%2Fcbt.8.21.10416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.8.21.10416%26sid%3Dliteratum%253Aachs%26aulast%3DAmaravadi%26aufirst%3DR.%26atitle%3DAutophagy%2520can%2520contribute%2520to%2520cell%2520death%2520when%2520combining%2520targeted%2520therapy%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2009%26volume%3D8%26issue%3D21%26spage%3D2097%26epage%3D2098%26doi%3D10.4161%2Fcbt.8.21.10416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sundaram, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugarajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S. V.</span></span> <span> </span><span class="NLM_article-title">Mutant p62(P392L) stimulation of osteoclast differentiation in Paget’s disease of bone</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>152</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4180</span>– <span class="NLM_lpage">4189</span>, <span class="refDoi"> DOI: 10.1210/en.2011-1225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1210%2Fen.2011-1225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21878516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOrtb%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2011&pages=4180-4189&issue=11&author=K.+Sundaramauthor=S.+Shanmugarajanauthor=D.+S.+Raoauthor=S.+V.+Reddy&title=Mutant+p62%28P392L%29+stimulation+of+osteoclast+differentiation+in+Paget%E2%80%99s+disease+of+bone&doi=10.1210%2Fen.2011-1225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone</span></div><div class="casAuthors">Sundaram, Kumaran; Shanmugarajan, Srinivasan; Rao, D. Sudhaker; Reddy, Sakamuri V.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4180-4189</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Paget's disease of the bone (PDB) is an autosomal dominant trait with genetic heterogeneity, characterized by abnormal osteoclastogenesis.  Sequestosome 1 (p62) is a scaffold protein that plays an important role in receptor activator of nuclear factor κB (RANK) signaling essential for osteoclast (OCL) differentiation.  P62P392L mutation in the ubiquitin-assocd. (UBA) domain is widely assocd. with PDB; however, the mechanisms by which p62P392L stimulate OCL differentiation in PDB are not completely understood.  Deubiquitinating enzyme cylindromatosis (CYLD) has been shown to neg. regulate RANK ligand-RANK signaling essential for OCL differentiation.  Here, we report that CYLD binds with the p62 wild-type (p62WT), non-UBA mutant (p62A381V) but not with the UBA mutant (p62P392L) in OCL progenitor cells.  Also, p62P392L induces expression of c-Fos (2.8-fold) and nuclear factor of activated T cells c1 (6.0-fold) transcription factors crit. for OCL differentiation.  Furthermore, p62P392L expression results in accumulation of polyubiquitinated TNF receptor-assocd. factor (TRAF)6 and elevated levels of phospho-IκB during OCL differentiation.  Retroviral transduction of p62P392L/CYLD short hairpin RNA significantly increased TRAP pos. multinucleated OCL formation/bone resorption activity in mouse bone marrow cultures.  Thus, the p62P392L mutation abolished CYLD interaction and enhanced OCL development/bone resorption activity in PDB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnCnqE4OKW37Vg90H21EOLACvtfcHk0ljlqbKRd8Itqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOrtb%252FL&md5=a814ce703028c713f5d09e2c6499f006</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1210%2Fen.2011-1225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2011-1225%26sid%3Dliteratum%253Aachs%26aulast%3DSundaram%26aufirst%3DK.%26aulast%3DShanmugarajan%26aufirst%3DS.%26aulast%3DRao%26aufirst%3DD.%2BS.%26aulast%3DReddy%26aufirst%3DS.%2BV.%26atitle%3DMutant%2520p62%2528P392L%2529%2520stimulation%2520of%2520osteoclast%2520differentiation%2520in%2520Paget%25E2%2580%2599s%2520disease%2520of%2520bone%26jtitle%3DEndocrinology%26date%3D2011%26volume%3D152%26issue%3D11%26spage%3D4180%26epage%3D4189%26doi%3D10.1210%2Fen.2011-1225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benhar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levitzki, A.</span></span> <span> </span><span class="NLM_article-title">ROS, stress-activated kinases and stress signaling in cancer</span>. <i>EMBO Rep.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">420</span>– <span class="NLM_lpage">425</span>, <span class="refDoi"> DOI: 10.1093/embo-reports/kvf094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1093%2Fembo-reports%2Fkvf094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=11991946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD38Xkt1Srurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=420-425&issue=5&author=M.+Benharauthor=D.+Engelbergauthor=A.+Levitzki&title=ROS%2C+stress-activated+kinases+and+stress+signaling+in+cancer&doi=10.1093%2Fembo-reports%2Fkvf094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">ROS, stress-activated kinases and stress signaling in cancer</span></div><div class="casAuthors">Benhar, Moran; Engelberg, David; Levitzki, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Reports</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">420-425</span>CODEN:
                <span class="NLM_cas:coden">ERMEAX</span>;
        ISSN:<span class="NLM_cas:issn">1469-221X</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Anticancer therapy is frequently efficient in early stages of the disease, whereas advanced tumors are usually resistant to the same treatments.  The mol. basis for this change is not entirely understood.  Many anticancer agents are DNA- or cytoskeleton-damaging drugs that show some specificity towards dividing cells.  However, recent studies show that these agents also activate stress-signaling cascades that may play a role in eliciting the obsd. therapeutic effects.  We discuss recent findings that suggest that induction of stress signaling in oncogenically transformed cells is integrated into apoptotic pathways.  Reactive oxygen species (ROS) and stress-activated protein kinases (SAPKs), which are potentiated in recently transformed cells, emerge as key effectors of cell death.  In advanced tumors, however, these agents are down-regulated and, consequently, death signaling is suppressed.  Such changes in ROS and SAPK activity levels during the course of tumor development may underlie the changes in responsiveness to anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu2fW7Q64Nn7Vg90H21EOLACvtfcHk0ljlqbKRd8Itqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xkt1Srurs%253D&md5=953ebe8ec80b47b51259187976f36c6f</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1093%2Fembo-reports%2Fkvf094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fembo-reports%252Fkvf094%26sid%3Dliteratum%253Aachs%26aulast%3DBenhar%26aufirst%3DM.%26aulast%3DEngelberg%26aufirst%3DD.%26aulast%3DLevitzki%26aufirst%3DA.%26atitle%3DROS%252C%2520stress-activated%2520kinases%2520and%2520stress%2520signaling%2520in%2520cancer%26jtitle%3DEMBO%2520Rep.%26date%3D2002%26volume%3D3%26issue%3D5%26spage%3D420%26epage%3D425%26doi%3D10.1093%2Fembo-reports%2Fkvf094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grivennikov, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greten, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">Immunity, inflammation, and cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>140</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">883</span>– <span class="NLM_lpage">899</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2010.01.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.cell.2010.01.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20303878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSgu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2010&pages=883-899&issue=6&author=S.+I.+Grivennikovauthor=F.+R.+Gretenauthor=M.+Karin&title=Immunity%2C+inflammation%2C+and+cancer&doi=10.1016%2Fj.cell.2010.01.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Immunity, inflammation, and cancer</span></div><div class="casAuthors">Grivennikov, Sergei I.; Greten, Florian R.; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">883-899</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Inflammatory responses play decisive roles at different stages of tumor development, including initiation, promotion, malignant conversion, invasion, and metastasis.  Inflammation also affects immune surveillance and responses to therapy.  Immune cells that infiltrate tumors engage in an extensive and dynamic crosstalk with cancer cells, and some of the mol. events that mediate this dialog have been revealed.  This review outlines the principal mechanisms that govern the effects of inflammation and immunity on tumor development and discusses attractive new targets for cancer therapy and prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSKC7HKir8HLVg90H21EOLACvtfcHk0ljlqbKRd8Itqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSgu7g%253D&md5=5d554f70b26c479b72d934a462ac2086</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.01.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.01.025%26sid%3Dliteratum%253Aachs%26aulast%3DGrivennikov%26aufirst%3DS.%2BI.%26aulast%3DGreten%26aufirst%3DF.%2BR.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DImmunity%252C%2520inflammation%252C%2520and%2520cancer%26jtitle%3DCell%26date%3D2010%26volume%3D140%26issue%3D6%26spage%3D883%26epage%3D899%26doi%3D10.1016%2Fj.cell.2010.01.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, B. P.</span></span> <span> </span><span class="NLM_article-title">Inflammation: a driving force speeds cancer metastasis</span>. <i>Cell Cycle</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">3267</span>– <span class="NLM_lpage">3273</span>, <span class="refDoi"> DOI: 10.4161/cc.8.20.9699</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.4161%2Fcc.8.20.9699" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19770594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvVequ70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=3267-3273&issue=20&author=Y.+Wuauthor=B.+P.+Zhou&title=Inflammation%3A+a+driving+force+speeds+cancer+metastasis&doi=10.4161%2Fcc.8.20.9699"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation: a driving force speeds cancer metastasis</span></div><div class="casAuthors">Wu, Yadi; Zhou, Binhua P.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3267-3273</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1538-4101</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  It has been increasingly recognized that tumor microenvironment plays an important role in carcinogenesis.  Inflammatory component is present and contributes to tumor proliferation, angiogenesis, metastasis and resistance to hormonal and chemotherapy.  This review highlights the role of inflammation in the tumor metastasis.  We focus on the function of proinflammatory factors, particularly cytokines during tumor metastasis.  Understanding of the mechanisms by which inflammation contributes to metastasis will lead to innovative approach for treating cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroJxib1pSWH7Vg90H21EOLACvtfcHk0liprHfzJ3VBSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvVequ70%253D&md5=910e480c0b4aca668d7e6f945c9fef01</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.4161%2Fcc.8.20.9699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.8.20.9699%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DB.%2BP.%26atitle%3DInflammation%253A%2520a%2520driving%2520force%2520speeds%2520cancer%2520metastasis%26jtitle%3DCell%2520Cycle%26date%3D2009%26volume%3D8%26issue%3D20%26spage%3D3267%26epage%3D3273%26doi%3D10.4161%2Fcc.8.20.9699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span> <span> </span><span class="NLM_article-title">The atypical PKC-interacting protein p62 channels NF-kappa B activation by the IL-1-TRAF6 pathway</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1576</span>– <span class="NLM_lpage">1586</span>, <span class="refDoi"> DOI: 10.1093/emboj/19.7.1576</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1093%2Femboj%2F19.7.1576" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10747026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD3cXislymt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=1576-1586&issue=7&author=L.+Sanzauthor=M.+T.+Diaz-Mecoauthor=H.+Nakanoauthor=J.+Moscat&title=The+atypical+PKC-interacting+protein+p62+channels+NF-kappa+B+activation+by+the+IL-1-TRAF6+pathway&doi=10.1093%2Femboj%2F19.7.1576"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">The atypical PKC-interacting protein p62 channels NF-κB activation by the IL-1-TRAF6 pathway</span></div><div class="casAuthors">Sanz, Laura; Diaz-Meco, Maria T.; Nakano, Hiroyasu; Moscat, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1576-1586</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The atypical protein kinase C (aPKC)-interacting protein, p62, has previously been shown to interact with RIP, linking these kinases to NF-κB activation by tumor necrosis factor α (TNFα).  The aPKCs have been implicated in the activation of IKKβ in TNFα-stimulated cells and have been shown to be activated in response to interleukin-1 (IL-1).  Here the authors demonstrate that the inhibition of the aPKCs or the down-regulation of p62 severely abrogates NF-κB activation by IL-1 and TRAF6, suggesting that both proteins are crit. intermediaries in this pathway.  Consistent with this the authors show that p62 selectively interacts with the TRAF domain of TRAF6 but not that of TRAF5 or TRAF2 in co-transfection expts.  The binding of endogenous p62 to TRAF6 is stimulus dependent, reinforcing the notion that this is a physiol. relevant interaction.  Furthermore, the authors demonstrate that the N-terminal domain of TRAF6, which is required for signaling, interacts with ζPKC in a dimerization-dependent manner.  Together, these results indicate that p62 is an important intermediary not only in TNFα but also in IL-1 signaling to NF-κB via the specific adapters RIP and TRAF6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrytjcrhYe9zbVg90H21EOLACvtfcHk0liprHfzJ3VBSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXislymt7s%253D&md5=dcfc651bfcb5c031a7058464fee50f62</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F19.7.1576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F19.7.1576%26sid%3Dliteratum%253Aachs%26aulast%3DSanz%26aufirst%3DL.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DNakano%26aufirst%3DH.%26aulast%3DMoscat%26aufirst%3DJ.%26atitle%3DThe%2520atypical%2520PKC-interacting%2520protein%2520p62%2520channels%2520NF-kappa%2520B%2520activation%2520by%2520the%2520IL-1-TRAF6%2520pathway%26jtitle%3DEMBO%2520J.%26date%3D2000%26volume%3D19%26issue%3D7%26spage%3D1576%26epage%3D1586%26doi%3D10.1093%2Femboj%2F19.7.1576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ea, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Z. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pineda, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. J. J.</span></span> <span> </span><span class="NLM_article-title">Activation of IKK by TNF alpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2006.03.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.molcel.2006.03.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=16603398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkt1Gmtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2006&pages=245-257&issue=2&author=C.+K.+Eaauthor=L.+Dengauthor=Z.+P.+Xiaauthor=G.+Pinedaauthor=Z.+J.+J.+Chen&title=Activation+of+IKK+by+TNF+alpha+requires+site-specific+ubiquitination+of+RIP1+and+polyubiquitin+binding+by+NEMO&doi=10.1016%2Fj.molcel.2006.03.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO</span></div><div class="casAuthors">Ea, Chee-Kwee; Deng, Li; Xia, Zong-Ping; Pineda, Gabriel; Chen, Zhijian J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">245-257</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The receptor interacting protein kinase 1 (RIP1) is essential for the activation of nuclear factor κB (NF-κB) by tumor necrosis factor α (TNFα).  Here, we present evidence that TNFα induces the polyubiquitination of RIP1 at Lys-377 and that this polyubiquitination is required for the activation of IκB kinase (IKK) and NF-κB.  A point mutation of RIP1 at Lys-377 (K377R) abolishes its polyubiquitination as well as its ability to restore IKK activation in a RIP1-deficient cell line.  The K377R mutation of RIP1 also prevents the recruitment of TAK1 and IKK complexes to TNF receptor.  Interestingly, polyubiquitinated RIP1 recruits IKK through the binding between the polyubiquitin chains and NEMO, a regulatory subunit of the IKK complex.  Mutations of NEMO that disrupt its polyubiquitin binding also abolish IKK activation.  These results reveal the biochem. mechanism underlying the essential signaling function of NEMO and provide direct evidence that signal-induced site-specific ubiquitination of RIP1 is required for IKK activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXSt-Dp_VcZLVg90H21EOLACvtfcHk0ljmBG4ZDKt63w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkt1Gmtb8%253D&md5=47308469a366c3b9f648e76f60702a3e</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2006.03.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2006.03.026%26sid%3Dliteratum%253Aachs%26aulast%3DEa%26aufirst%3DC.%2BK.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DXia%26aufirst%3DZ.%2BP.%26aulast%3DPineda%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DZ.%2BJ.%2BJ.%26atitle%3DActivation%2520of%2520IKK%2520by%2520TNF%2520alpha%2520requires%2520site-specific%2520ubiquitination%2520of%2520RIP1%2520and%2520polyubiquitin%2520binding%2520by%2520NEMO%26jtitle%3DMol.%2520Cell%26date%3D2006%26volume%3D22%26issue%3D2%26spage%3D245%26epage%3D257%26doi%3D10.1016%2Fj.molcel.2006.03.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ling, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Q. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemischka, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiao, P. J.</span></span> <span> </span><span class="NLM_article-title">Kras(G12D)-induced IKK2/beta/NF-kappa B activation by IL-1 alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">120</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2011.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.ccr.2011.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22264792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1SktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=105-120&issue=1&author=J.+H.+Lingauthor=Y.+A.+Kangauthor=R.+Y.+Zhaoauthor=Q.+H.+Xiaauthor=D.+F.+Leeauthor=Z.+Changauthor=J.+Liauthor=B.+L.+Pengauthor=J.+B.+Flemingauthor=H.+M.+Wangauthor=J.+S.+Liuauthor=I.+R.+Lemischkaauthor=M.+C.+Hungauthor=P.+J.+Chiao&title=Kras%28G12D%29-induced+IKK2%2Fbeta%2FNF-kappa+B+activation+by+IL-1+alpha+and+p62+feedforward+loops+is+required+for+development+of+pancreatic+ductal+adenocarcinoma&doi=10.1016%2Fj.ccr.2011.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">KrasG12D-Induced IKK2/β/NF-κB Activation by IL-1α and p62 Feedforward Loops Is Required for Development of Pancreatic Ductal Adenocarcinoma</span></div><div class="casAuthors">Ling, Jianhua; Kang, Ya-an; Zhao, Ruiying; Xia, Qianghua; Lee, Dung-Fang; Chang, Zhe; Li, Jin; Peng, Bailu; Fleming, Jason B.; Wang, Huamin; Liu, Jinsong; Lemischka, Ihor R.; Hung, Mien-Chie; Chiao, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-120</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Summary: Constitutive Kras and NF-κB activation is identified as signature alterations in pancreatic ductal adenocarcinoma (PDAC).  However, how NF-κB is activated in PDAC is not yet understood.  Here, we report that pancreas-targeted IKK2/β inactivation inhibited NF-κB activation and PDAC development in KrasG12D and KrasG12D;Ink4a/ArfF/F mice, demonstrating a mechanistic link between IKK2/β and KrasG12D in PDAC inception.  Our findings reveal that KrasG12D-activated AP-1 induces IL-1α, which, in turn, activates NF-κB and its target genes IL-1α and p62, to initiate IL-1α/p62 feedforward loops for inducing and sustaining NF-κB activity.  Furthermore, IL-1α overexpression correlates with Kras mutation, NF-κB activity, and poor survival in PDAC patients.  Therefore, our findings demonstrate the mechanism by which IKK2/β/NF-κB is activated by KrasG12D through dual feedforward loops of IL-1α/p62.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocWOU6Ouq2SbVg90H21EOLACvtfcHk0ljmBG4ZDKt63w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1SktLY%253D&md5=7a739c3f1d43dfa62e31ce6af3bc2151</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2011.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2011.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DJ.%2BH.%26aulast%3DKang%26aufirst%3DY.%2BA.%26aulast%3DZhao%26aufirst%3DR.%2BY.%26aulast%3DXia%26aufirst%3DQ.%2BH.%26aulast%3DLee%26aufirst%3DD.%2BF.%26aulast%3DChang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DB.%2BL.%26aulast%3DFleming%26aufirst%3DJ.%2BB.%26aulast%3DWang%26aufirst%3DH.%2BM.%26aulast%3DLiu%26aufirst%3DJ.%2BS.%26aulast%3DLemischka%26aufirst%3DI.%2BR.%26aulast%3DHung%26aufirst%3DM.%2BC.%26aulast%3DChiao%26aufirst%3DP.%2BJ.%26atitle%3DKras%2528G12D%2529-induced%2520IKK2%252Fbeta%252FNF-kappa%2520B%2520activation%2520by%2520IL-1%2520alpha%2520and%2520p62%2520feedforward%2520loops%2520is%2520required%2520for%2520development%2520of%2520pancreatic%2520ductal%2520adenocarcinoma%26jtitle%3DCancer%2520Cell%26date%3D2012%26volume%3D21%26issue%3D1%26spage%3D105%26epage%3D120%26doi%3D10.1016%2Fj.ccr.2011.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mayo, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cogswell, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">RogersGraham, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Der, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, A. S.</span></span> <span> </span><span class="NLM_article-title">Requirement of NF-kappa B activation to suppress p53-independent apoptosis induced by oncogenic Ras</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>278</i></span> (<span class="NLM_issue">5344</span>),  <span class="NLM_fpage">1812</span>– <span class="NLM_lpage">1815</span>, <span class="refDoi"> DOI: 10.1126/science.278.5344.1812</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1126%2Fscience.278.5344.1812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=9388187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADyaK2sXnvFCksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=1997&pages=1812-1815&issue=5344&author=M.+W.+Mayoauthor=C.+Y.+Wangauthor=P.+C.+Cogswellauthor=K.+S.+RogersGrahamauthor=S.+W.+Loweauthor=C.+J.+Derauthor=A.+S.+Baldwin&title=Requirement+of+NF-kappa+B+activation+to+suppress+p53-independent+apoptosis+induced+by+oncogenic+Ras&doi=10.1126%2Fscience.278.5344.1812"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras</span></div><div class="casAuthors">Mayo, Marty W.; Wang, Cun-Yu; Cogswell, Patricia C.; Rogers-Graham, Kelley S.; Lowe, Scott W.; Der, Channing J.; Baldwin, Albert S., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">5344</span>),
    <span class="NLM_cas:pages">1812-1815</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The ras proto-oncogene is frequently mutated in human tumors and functions to chronically stimulate signal transduction cascades resulting in the synthesis or activation of specific transcription factors, including Ets, c-Myc, c-Jun, and nuclear factor kappa B (NF-κB).  These Ras-responsive transcription factors are required for transformation, but the mechanisms by which these proteins facilitate oncogenesis have not been fully established.  Oncogenic Ras was shown to initiate a p53-independent apoptotic response that was suppressed through the activation of NF-κB.  These results provide an explanation for the requirement of NF-κB for Ras-mediated oncogenesis and provide evidence that Ras-transformed cells are susceptible to apoptosis even if they do not express the p53 tumor-suppressor gene product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYP4VmisJ6cLVg90H21EOLACvtfcHk0liIL9dQnJCpwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnvFCksLo%253D&md5=8334214d8287e8b744db9f9cf41dba36</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1126%2Fscience.278.5344.1812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.278.5344.1812%26sid%3Dliteratum%253Aachs%26aulast%3DMayo%26aufirst%3DM.%2BW.%26aulast%3DWang%26aufirst%3DC.%2BY.%26aulast%3DCogswell%26aufirst%3DP.%2BC.%26aulast%3DRogersGraham%26aufirst%3DK.%2BS.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26aulast%3DDer%26aufirst%3DC.%2BJ.%26aulast%3DBaldwin%26aufirst%3DA.%2BS.%26atitle%3DRequirement%2520of%2520NF-kappa%2520B%2520activation%2520to%2520suppress%2520p53-independent%2520apoptosis%2520induced%2520by%2520oncogenic%2520Ras%26jtitle%3DScience%26date%3D1997%26volume%3D278%26issue%3D5344%26spage%3D1812%26epage%3D1815%26doi%3D10.1126%2Fscience.278.5344.1812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teramoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikegawa, S.</span></span> <span> </span><span class="NLM_article-title">Truncating mutations of RB1CC1 in human breast cancer</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1038/ng911</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fng911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=12068296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvVGmtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2002&pages=285-288&issue=3&author=T.+Chanoauthor=K.+Kontaniauthor=K.+Teramotoauthor=H.+Okabeauthor=S.+Ikegawa&title=Truncating+mutations+of+RB1CC1+in+human+breast+cancer&doi=10.1038%2Fng911"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Truncating mutations of RB1CC1 in human breast cancer</span></div><div class="casAuthors">Chano, Tokuhiro; Kontani, Keiichi; Teramoto, Koji; Okabe, Hidetoshi; Ikegawa, Shiro</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">285-288</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The protein RB1CC1 (retinoblastoma 1 (RB1)-inducible coiled-coil 1) has been identified as a key regulator of the tumor-suppressor gene RB1.  RB1CC1 is localized in the nucleus and has been proposed to be a transcription factor because of its nuclear localization signal, leucine zipper motif and coiled-coil structure.  The gene RB1CC1 is localized to a region of chromosome 8q11 (ref. 2) contg. several loci of putative tumor-suppressor genes; however, its role in human cancers remains to be detd.  Here we report that 20% (7 of 35) of primary breast cancers examd. contained mutations in RB1CC1, including nine large interstitial deletions predicted to yield markedly truncated RB1CC1 proteins.  Wildtype RB1CC1 and RB1 were absent or significantly less abundant than normal in the seven cancers with mutations in RB1CC1, but were abundant in cancers without such mutations.  In all seven cancers, both RB1CC1 alleles were inactivated; two showed compd. heterozygous deletions.  Thus, RB1CC1 is frequently mutated in breast cancer and shows characteristics of a classical tumor-suppressor gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIEG9VJWui7rVg90H21EOLACvtfcHk0liIL9dQnJCpwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvVGmtLg%253D&md5=2c02a1ccdaf8ce683a2f7d1396c5d56d</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1038%2Fng911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng911%26sid%3Dliteratum%253Aachs%26aulast%3DChano%26aufirst%3DT.%26aulast%3DKontani%26aufirst%3DK.%26aulast%3DTeramoto%26aufirst%3DK.%26aulast%3DOkabe%26aufirst%3DH.%26aulast%3DIkegawa%26aufirst%3DS.%26atitle%3DTruncating%2520mutations%2520of%2520RB1CC1%2520in%2520human%2520breast%2520cancer%26jtitle%3DNat.%2520Genet.%26date%3D2002%26volume%3D31%26issue%3D3%26spage%3D285%26epage%3D288%26doi%3D10.1038%2Fng911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croce, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, J. L.</span></span> <span> </span><span class="NLM_article-title">p62/SQSTM1 synergizes with autophagy for tumor growth in vivo</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1204</span>– <span class="NLM_lpage">1216</span>, <span class="refDoi"> DOI: 10.1101/gad.237354.113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1101%2Fgad.237354.113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=24888590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVSktLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=1204-1216&issue=11&author=H.+J.+Weiauthor=C.+R.+Wangauthor=C.+M.+Croceauthor=J.+L.+Guan&title=p62%2FSQSTM1+synergizes+with+autophagy+for+tumor+growth+in+vivo&doi=10.1101%2Fgad.237354.113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">p62/SQSTM1 synergizes with autophagy for tumor growth in vivo</span></div><div class="casAuthors">Wei, Huijun; Wang, Chenran; Croce, Carlo M.; Guan, Jun-Lin</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1204-1216</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Autophagy is crucial for cellular homeostasis and plays important roles in tumorigenesis.  FIP200 (FAK family-interacting protein of 200 kDa) is an essential autophagy gene required for autophagy induction, functioning in the ULK1-ATG13-FIP200 complex.  Our previous studies showed that conditional knockout of FIP200 significantly suppressed mammary tumorigenesis, which was accompanied by accumulation of p62 in tumor cells.  However, it is not clear whether FIP200 is also required for maintaining tumor growth and how the increased p62 level affects the growth in autophagy-deficient FIP200-null tumors in vivo.  Here, we describe a new system to delete FIP200 in transformed mouse embryonic fibroblasts as well as mammary tumor cells following their transplantation and show that ablation of FIP200 significantly reduced growth of established tumors in vivo.  Using similar strategies, we further showed that either p62 knockdown or p62 deficiency in established FIP200-null tumors dramatically impaired tumor growth.  The stimulation of tumor growth by p62 accumulation in FIP200-null tumors is assocd. with the up-regulated activation of the NF-κB pathway by p62.  Last, we showed that overexpression of the autophagy master regulator TFEBS142A increased the growth of established tumors, which correlated with the increased autophagy of the tumor cells.  Together, our studies demonstrate that p62 and autophagy synergize to promote tumor growth, suggesting that inhibition of both pathways could be more effective than targeting either alone for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIXxNl_tfXxbVg90H21EOLACvtfcHk0liHOXRKynW67A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVSktLjO&md5=8a65e0ca2c7e220914196534b45e5d12</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1101%2Fgad.237354.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.237354.113%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DH.%2BJ.%26aulast%3DWang%26aufirst%3DC.%2BR.%26aulast%3DCroce%26aufirst%3DC.%2BM.%26aulast%3DGuan%26aufirst%3DJ.%2BL.%26atitle%3Dp62%252FSQSTM1%2520synergizes%2520with%2520autophagy%2520for%2520tumor%2520growth%2520in%2520vivo%26jtitle%3DGenes%2520Dev.%26date%3D2014%26volume%3D28%26issue%3D11%26spage%3D1204%26epage%3D1216%26doi%3D10.1101%2Fgad.237354.113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halliwell, B.</span></span> <span> </span><span class="NLM_article-title">Biochemistry of oxidative stress</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1147</span>– <span class="NLM_lpage">1150</span>, <span class="refDoi"> DOI: 10.1042/BST0351147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1042%2FBST0351147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=17956298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1eru7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=1147-1150&author=B.+Halliwell&title=Biochemistry+of+oxidative+stress&doi=10.1042%2FBST0351147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemistry of oxidative stress</span></div><div class="casAuthors">Halliwell, B.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1147-1150</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The terms 'antioxidant', 'oxidative stress' and 'oxidative damage' are widely used but rarely defined.  This brief review attempts to define them and to examine the ways in which oxidative stress and oxidative damage can affect cell behavior both in vivo and in cell culture, using cancer as an example.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLxO3HqpB1I7Vg90H21EOLACvtfcHk0liHOXRKynW67A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1eru7vN&md5=5e4a8281ddbed9d2bc398df36eea4d6b</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1042%2FBST0351147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0351147%26sid%3Dliteratum%253Aachs%26aulast%3DHalliwell%26aufirst%3DB.%26atitle%3DBiochemistry%2520of%2520oxidative%2520stress%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2007%26volume%3D35%26spage%3D1147%26epage%3D1150%26doi%3D10.1042%2FBST0351147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1101/gad.13.1.76</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1101%2Fgad.13.1.76" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=9887101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADyaK1MXnvF2qsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=76-86&issue=1&author=K.+Itohauthor=N.+Wakabayashiauthor=Y.+Katohauthor=T.+Ishiiauthor=K.+Igarashiauthor=J.+D.+Engelauthor=M.+Yamamoto&title=Keap1+represses+nuclear+activation+of+antioxidant+responsive+elements+by+Nrf2+through+binding+to+the+amino-terminal+Neh2+domain&doi=10.1101%2Fgad.13.1.76"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain</span></div><div class="casAuthors">Itoh, Ken; Wakabayashi, Nobunao; Katoh, Yasutake; Ishii, Tetsuro; Igarashi, Kazuhiko; Engel, James Douglas; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">76-86</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Transcription factor Nrf2 is essential for the antioxidant responsive element 〈ARE〉-mediated induction of phase II detoxifying and oxidative stress enzyme genes.  Detailed anal. of differential Nrf2 activity displayed in transfected cell lines ultimately led to the identification of a new protein, which we named Keap1, that suppresses Nrf2 transcriptional activity by specific binding to its evolutionarily conserved amino-terminal regulatory domain.  The closest homolog of Keap1 is a Drosophila actin-binding protein called Kelch, implying that Keap1 might be a Nrf2 cytoplasmic effector.  We then showed that electrophilic agents antagonize Keap1 inhibition of Nrf2 activity in vivo, allowing Nrf2 to traverse from the cytoplasm to the nucleus and potentiate the ARE response.  We postulate that Keap1 and Nrf2 constitute a crucial cellular sensor for oxidative stress, and together mediate a key step in the signaling pathway that leads to transcriptional activation by this novel Nrf2 nuclear shuttling mechanism.  The activation of Nrf2 leads in turn to the induction of phase II enzyme and antioxidative stress genes in response to electrophiles and reactive oxygen species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQy--aOMXTI7Vg90H21EOLACvtfcHk0ljsZUqC9KvDpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnvF2qsg%253D%253D&md5=1f6cdf6615b03719dedbffe01d0be2ec</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1101%2Fgad.13.1.76&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.13.1.76%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DWakabayashi%26aufirst%3DN.%26aulast%3DKatoh%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DIgarashi%26aufirst%3DK.%26aulast%3DEngel%26aufirst%3DJ.%2BD.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DKeap1%2520represses%2520nuclear%2520activation%2520of%2520antioxidant%2520responsive%2520elements%2520by%2520Nrf2%2520through%2520binding%2520to%2520the%2520amino-terminal%2520Neh2%2520domain%26jtitle%3DGenes%2520Dev.%26date%3D1999%26volume%3D13%26issue%3D1%26spage%3D76%26epage%3D86%26doi%3D10.1101%2Fgad.13.1.76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kern, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luesch, H.</span></span> <span> </span><span class="NLM_article-title">A genomic screen for activators of the antioxidant response element</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5205</span>– <span class="NLM_lpage">5210</span>, <span class="refDoi"> DOI: 10.1073/pnas.0700898104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1073%2Fpnas.0700898104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=17360324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=5205-5210&issue=12&author=Y.+X.+Liuauthor=J.+T.+Kernauthor=J.+R.+Walkerauthor=J.+A.+Johnsonauthor=P.+G.+Schultzauthor=H.+Luesch&title=A+genomic+screen+for+activators+of+the+antioxidant+response+element&doi=10.1073%2Fpnas.0700898104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">A genomic screen for activators of the antioxidant response element</span></div><div class="casAuthors">Liu, Yanxia; Kern, Jonathan T.; Walker, John R.; Johnson, Jeffrey A.; Schultz, Peter G.; Luesch, Hendrik</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5205-5210</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The antioxidant response element (ARE) is a cis-acting regulatory enhancer element found in the 5' flanking region of many phase II detoxification enzymes.  Up-regulation of ARE-dependent target genes is known to have neuroprotective effects; yet, the mechanism of activation is largely unknown.  By screening an arrayed collection of ≈15,000 full-length expression cDNAs in the human neuroblastoma cell line IMR-32 with an ARE-luciferase reporter, the authors have identified several cDNAs not previously assocd. with ARE activation.  A subset of cDNAs, encoding sequestosome 1 (SQSTM1) and dipeptidylpeptidase 3 (DPP3), activated the ARE in primary mouse-derived cortical neurons.  Overexpression of SQSTM1 and DPP3 in IMR-32 cells stimulated NF-E2-related factor 2 (NRF2) nuclear translocation and led to increased levels of NAD(P)H:quinone oxidoreductase 1, a protein which is transcriptionally regulated by the ARE.  When transfected into IMR-3z neuroblastoma cells that were depleted of transcription factor NRF2 by RNA interference, SQSTM1 and DPP3 were unable to activate the ARE or induce NAD(P)H:quinone oxidoreductase 1 expression, indicating that the ARE activation upon ectopic expression of these cDNAs is mediated by NRF2.  Studies with pharmacol. inhibitors indicated that 1-phosphatidylinositol 3-kinase and protein kinase C signaling are essential for activity.  Overexpression of these cDNAs conferred partial resistance to hydrogen peroxide or rotenone-induced toxicity, consistent with the induction of antioxidant and phase II detoxification enzymes, which can protect from oxidative stress.  This work and other such studies may provide mechanisms for activating the ARE in the absence of general oxidative stress and a yet-unexploited therapeutic approach to degenerative diseases and aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq85UPgBaWMfLVg90H21EOLACvtfcHk0ljsZUqC9KvDpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFCgtb4%253D&md5=e2eca2643b63eaeb65478d69832dee48</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0700898104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0700898104%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%2BX.%26aulast%3DKern%26aufirst%3DJ.%2BT.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DJohnson%26aufirst%3DJ.%2BA.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DLuesch%26aufirst%3DH.%26atitle%3DA%2520genomic%2520screen%2520for%2520activators%2520of%2520the%2520antioxidant%2520response%2520element%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26issue%3D12%26spage%3D5205%26epage%3D5210%26doi%3D10.1073%2Fpnas.0700898104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">Mechanistic studies of the Nrf2–Keap1 signaling pathway</span>. <i>Drug Metab. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">769</span>– <span class="NLM_lpage">789</span>, <span class="refDoi"> DOI: 10.1080/03602530600971974</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1080%2F03602530600971974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=17145701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCnur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2006&pages=769-789&issue=4&author=D.+D.+Zhang&title=Mechanistic+studies+of+the+Nrf2%E2%80%93Keap1+signaling+pathway&doi=10.1080%2F03602530600971974"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic studies of the Nrf2-Keap1 signaling pathway</span></div><div class="casAuthors">Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">769-789</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A review.  Since eukaryotic cells constantly encounter various environmental insults, they have evolved defense mechanisms to cope with toxicant- and carcinogen-induced oxidative stress or electrophiles.  One of the most important cellular defense mechanisms against oxidative stress or electrophiles is mediated by the transcription factor Nrf2.  Under the basal condition, Nrf2-dependent transcription is repressed by a neg. regulator Keap1.  When cells are exposed to oxidative stress, electrophiles, or chemopreventive agents, Nrf2 escapes Keap1-mediated repression and activates antioxidant responsive element (ARE)-dependent gene expression to maintain cellular redox homeostasis.  Beyond its antioxidant function, Nrf2 has recently been recognized as a key factor regulating an array of genes that defend cells against the deleterious effects of environmental insults.  Since this Nrf2-dependent cellular defense response is able to protect multi-organs or multi-tissues, activation of Nrf2 has been implicated in conferring protection against many human diseases, including cancer, neurodegenerative diseases, cardiovascular diseases, acute and chronic lung injury, autoimmune diseases, and inflammation.  Therefore, understanding of Nrf2 regulation is crucial in the development of drugs for therapeutic intervention.  This review will discuss recent progress in the field of the Nrf2-Keap1 signaling pathway, with emphasis on the mechanistic studies of Nrf2 regulation by Keap1, oxidative stress, or chemopreventive compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5xfCSnwdvUrVg90H21EOLACvtfcHk0lj_SrI1YeWzww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCnur%252FP&md5=7fc5c44bb9897739fe437679b6d21cf4</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1080%2F03602530600971974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F03602530600971974%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DMechanistic%2520studies%2520of%2520the%2520Nrf2%25E2%2580%2593Keap1%2520signaling%2520pathway%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2006%26volume%3D38%26issue%3D4%26spage%3D769%26epage%3D789%26doi%3D10.1080%2F03602530600971974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span> <span> </span><span class="NLM_article-title">Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">21592</span>– <span class="NLM_lpage">21600</span>, <span class="refDoi"> DOI: 10.1074/jbc.M300931200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1074%2Fjbc.M300931200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=12682069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksVems7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=21592-21600&issue=24&author=M.+McMahonauthor=K.+Itohauthor=M.+Yamamotoauthor=J.+D.+Hayes&title=Keap1-dependent+proteasomal+degradation+of+transcription+factor+Nrf2+contributes+to+the+negative+regulation+of+antioxidant+response+element-driven+gene+expression&doi=10.1074%2Fjbc.M300931200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression</span></div><div class="casAuthors">McMahon, Michael; Itoh, Ken; Yamamoto, Masayuki; Hayes, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">21592-21600</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Keap1 is a neg. regulator of Nrf2, a bZIP transcription factor that mediates adaptation to oxidative stress.  Previous studies suggested this neg. regulation is a consequence of Keap1 controlling the subcellular distribution of Nrf2.  We now report that Keap1 also controls the total cellular level of Nrf2 protein.  In the RL34 non-transformed rat liver cell line, Nrf2 was found to accumulate rapidly in response to oxidative stress caused by treatment with sulforaphane, and the accumulation resulted from inhibition of proteasomal-mediated degrdn. of the bZIP protein.  By heterologously expressing in COS1 cells epitope-tagged Nrf2 and an Nrf2ΔETGE mutant lacking the Keap1-binding site, in both the presence and absence of Keap1 we demonstrate that Nrf2 is subject to ubiquitination and proteasomal degrdn. independently of both Keap1 and the redox environment of the cell.  In oxidatively stressed cells, this is the sole mechanism responsible for Nrf2 degrdn.  However, under homeostatic conditions Nrf2 is subject to a substantially more rapid mode of proteasomal degrdn. than it is in oxidatively stressed cells, and this rapid turnover of Nrf2 requires it to interact with Keap1.  Within Nrf2, the N-terminal Neh2 domain is identified as the redox-sensitive degron.  These data suggest that Keap1 neg. regulates Nrf2 by both enhancing its rate of proteasomal degrdn. and altering its subcellular distribution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomAhRj4GOmc7Vg90H21EOLACvtfcHk0lj_SrI1YeWzww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksVems7g%253D&md5=2810bf0fbf74c433b9fed9fa956a6f02</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M300931200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M300931200%26sid%3Dliteratum%253Aachs%26aulast%3DMcMahon%26aufirst%3DM.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26atitle%3DKeap1-dependent%2520proteasomal%2520degradation%2520of%2520transcription%2520factor%2520Nrf2%2520contributes%2520to%2520the%2520negative%2520regulation%2520of%2520antioxidant%2520response%2520element-driven%2520gene%2520expression%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26issue%3D24%26spage%3D21592%26epage%3D21600%26doi%3D10.1074%2Fjbc.M300931200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannink, M.</span></span> <span> </span><span class="NLM_article-title">Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">8137</span>– <span class="NLM_lpage">8151</span>, <span class="refDoi"> DOI: 10.1128/MCB.23.22.8137-8151.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1128%2FMCB.23.22.8137-8151.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=14585973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVKjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=8137-8151&issue=22&author=D.+D.+Zhangauthor=M.+Hannink&title=Distinct+cysteine+residues+in+Keap1+are+required+for+Keap1-dependent+ubiquitination+of+Nrf2+and+for+stabilization+of+Nrf2+by+chemopreventive+agents+and+oxidative+stress&doi=10.1128%2FMCB.23.22.8137-8151.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress</span></div><div class="casAuthors">Zhang, Donna D.; Hannink, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8137-8151</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A common feature of diverse chemopreventive agents is the ability to activate expression of a genetic program that protects cells from reactive chem. species that if left unchecked would cause mutagenic DNA damage.  The bZIP transcription factor Nrf2 has emerged as a key regulator of this cancer-preventive genetic program.  Nrf2 is normally sequestered in the cytoplasm by a protein known as Keap1.  Chemopreventive agents allow Nrf2 to escape from Keap1-mediated repression, although the mol. mechanism(s) responsible for activation of Nrf2 is not understood.  In this report, we demonstrate that Keap1 does not passively sequester Nrf2 in the cytoplasm but actively targets Nrf2 for ubiquitination and degrdn. by the proteasome under basal culture conditions.  We have identified two crit. cysteine residues in Keap1, C273 and C288, that are required for Keap1-dependent ubiquitination of Nrf2.  Both sulforaphane, a chemopreventive isothiocyanate, and oxidative stress enable Nrf2 to escape Keap1-dependent degrdn., leading to stabilization of Nrf2, increased nuclear localization of Nrf2, and activation of Nrf2-dependent cancer-protective genes.  We have identified a third cysteine residue in Keap1, C151, that is uniquely required for inhibition of Keap1-dependent degrdn. of Nrf2 by sulforaphane and oxidative stress.  This cysteine residue is also required for a novel posttranslational modification to Keap1 that is induced by oxidative stress.  We propose that Keap1 is a component of a novel E3 ubiquitin ligase complex that is specifically targeted for inhibition by both chemopreventive agents and oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqys54qQ6MlRLVg90H21EOLACvtfcHk0lgkKEJKZlq9ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVKjtr4%253D&md5=9287849578d0a6b7a6d52b67e3c65190</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1128%2FMCB.23.22.8137-8151.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.23.22.8137-8151.2003%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%2BD.%26aulast%3DHannink%26aufirst%3DM.%26atitle%3DDistinct%2520cysteine%2520residues%2520in%2520Keap1%2520are%2520required%2520for%2520Keap1-dependent%2520ubiquitination%2520of%2520Nrf2%2520and%2520for%2520stabilization%2520of%2520Nrf2%2520by%2520chemopreventive%2520agents%2520and%2520oxidative%2520stress%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2003%26volume%3D23%26issue%3D22%26spage%3D8137%26epage%3D8151%26doi%3D10.1128%2FMCB.23.22.8137-8151.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villeneuve, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">3275</span>– <span class="NLM_lpage">3285</span>, <span class="refDoi"> DOI: 10.1128/MCB.00248-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1128%2FMCB.00248-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20421418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptVegu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=3275-3285&issue=13&author=A.+Lauauthor=X.+J.+Wangauthor=F.+Zhaoauthor=N.+F.+Villeneuveauthor=T.+D.+Wuauthor=T.+Jiangauthor=Z.+Sunauthor=E.+Whiteauthor=D.+D.+Zhang&title=A+noncanonical+mechanism+of+Nrf2+activation+by+autophagy+deficiency%3A+direct+interaction+between+Keap1+and+p62&doi=10.1128%2FMCB.00248-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62</span></div><div class="casAuthors">Lau, Alexandria; Wang, Xiao-Jun; Zhao, Fei; Villeneuve, Nicole F.; Wu, Tongde; Jiang, Tao; Sun, Zheng; White, Eileen; Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3275-3285</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">In response to stress, cells can utilize several cellular processes, such as autophagy, which is a bulklysosomal degrdn. pathway, to mitigate damages and increase the chances of cell survival.  Deregulation of autophagy causes upregulation of p62 and the formation of p62-contg. aggregates, which are assocd. with neurodegenerative diseases and cancer.  The Nrf2-Keap1 pathway functions as a crit. regulator of the cell's defense mechanism against oxidative stress by controlling the expression of many cellular protective proteins.  Under basal conditions, Nrf2 is ubiquitinated by the Keap1-Cul3-E3 ubiquitin ligase complex and targeted to the 26S proteasome for degrdn.  Upon induction, the activity of the E3 ubiquitin ligase is inhibited through the modification of cysteine residues in Keap1, resulting in the stabilization and activation of Nrf2.  In this current study, we identified the direct interaction between p62 and Keap1 and the residues required for the interaction have been mapped to 349-DPSTGE-354 in p62 and three arginines in the Kelch domain of Keap1.  Accumulation of endogenous p62 or ectopic expression of p62 sequesters Keap1 into aggregates, resulting in the inhibition of Keap1-mediated Nrf2 ubiquitination and its subsequent degrdn. by the proteasome.  In contrast, overexpression of mutated p62, which loses its ability to interact with Keap1, had no effect on Nrf2 stability, demonstrating that p62-mediated Nrf2 upregulation is Keap1 dependent.  These findings demonstrate that autophagy deficiency activates the Nrf2 pathway in a noncanonical cysteine-independent mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBD8Dknwp7p7Vg90H21EOLACvtfcHk0lgkKEJKZlq9ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptVegu7k%253D&md5=fd52e7053b0fd9bbcb4c3c8d8df91ee4</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1128%2FMCB.00248-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00248-10%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DVilleneuve%26aufirst%3DN.%2BF.%26aulast%3DWu%26aufirst%3DT.%2BD.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DWhite%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DA%2520noncanonical%2520mechanism%2520of%2520Nrf2%2520activation%2520by%2520autophagy%2520deficiency%253A%2520direct%2520interaction%2520between%2520Keap1%2520and%2520p62%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2010%26volume%3D30%26issue%3D13%26spage%3D3275%26epage%3D3285%26doi%3D10.1128%2FMCB.00248-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirose, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagahashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukutomi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uemura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obata, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pi, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mashino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waguri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span> <span> </span><span class="NLM_article-title">p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">12030</span>, <span class="refDoi"> DOI: 10.1038/ncomms12030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fncomms12030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27345495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFSisLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12030&author=T.+Saitoauthor=Y.+Ichimuraauthor=K.+Taguchiauthor=T.+Suzukiauthor=T.+Mizushimaauthor=K.+Takagiauthor=Y.+Hiroseauthor=M.+Nagahashiauthor=T.+Isoauthor=T.+Fukutomiauthor=M.+Ohishiauthor=K.+Endoauthor=T.+Uemuraauthor=Y.+Nishitoauthor=S.+Okudaauthor=M.+Obataauthor=T.+Kounoauthor=R.+Imamuraauthor=Y.+Tadaauthor=R.+Obataauthor=D.+Yasudaauthor=K.+Takahashiauthor=T.+Fujimuraauthor=J.+B.+Piauthor=M.+S.+Leeauthor=T.+Uenoauthor=T.+Oheauthor=T.+Mashinoauthor=T.+Wakaiauthor=H.+Kojimaauthor=T.+Okabeauthor=T.+Naganoauthor=H.+Motohashiauthor=S.+Waguriauthor=T.+Sogaauthor=M.+Yamamotoauthor=K.+Tanakaauthor=M.+Komatsu&title=p62%2FSqstm1+promotes+malignancy+of+HCV-positive+hepatocellular+carcinoma+through+Nrf2-dependent+metabolic+reprogramming&doi=10.1038%2Fncomms12030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming</span></div><div class="casAuthors">Saito, Tetsuya; Ichimura, Yoshinobu; Taguchi, Keiko; Suzuki, Takafumi; Mizushima, Tsunehiro; Takagi, Kenji; Hirose, Yuki; Nagahashi, Masayuki; Iso, Tetsuro; Fukutomi, Toshiaki; Ohishi, Maki; Endo, Keiko; Uemura, Takefumi; Nishito, Yasumasa; Okuda, Shujiro; Obata, Miki; Kouno, Tsuguka; Imamura, Riyo; Tada, Yukio; Obata, Rika; Yasuda, Daisuke; Takahashi, Kyoko; Fujimura, Tsutomu; Pi, Jingbo; Lee, Myung-Shik; Ueno, Takashi; Ohe, Tomoyuki; Mashino, Tadahiko; Wakai, Toshifumi; Kojima, Hirotatsu; Okabe, Takayoshi; Nagano, Tetsuo; Motohashi, Hozumi; Waguri, Satoshi; Soga, Tomoyoshi; Yamamoto, Masayuki; Tanaka, Keiji; Komatsu, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12030</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">P62/Sqstm1 is a multifunctional protein involved in cell survival, growth and death, that is degraded by autophagy.  Amplification of the p62/Sqstm1 gene, and aberrant accumulation and phosphorylation of p62/Sqstm1, have been implicated in tumor development.  Herein, we reveal the mol. mechanism of p62/Sqstm1-dependent malignant progression, and suggest that mol. targeting of p62/Sqstm1 represents a potential chemotherapeutic approach against hepatocellular carcinoma (HCC).  Phosphorylation of p62/Sqstm1 at Ser349 directs glucose to the glucuronate pathway, and glutamine towards glutathione synthesis through activation of the transcription factor Nrf2.  These changes provide HCC cells with tolerance to anti-cancer drugs and proliferation potency.  Phosphorylated p62/Sqstm1 accumulates in tumor regions pos. for hepatitis C virus (HCV).  An inhibitor of phosphorylated p62-dependent Nrf2 activation suppresses the proliferation and anticancer agent tolerance of HCC.  Our data indicate that this Nrf2 inhibitor could be used to make cancer cells less resistant to anticancer drugs, esp. in HCV-pos. HCC patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWPpd-6mfs2rVg90H21EOLACvtfcHk0ljaYErqnj5wPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFSisLzF&md5=859f788e0e5ac3e5ed46eeee9da47490</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1038%2Fncomms12030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12030%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DT.%26aulast%3DIchimura%26aufirst%3DY.%26aulast%3DTaguchi%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMizushima%26aufirst%3DT.%26aulast%3DTakagi%26aufirst%3DK.%26aulast%3DHirose%26aufirst%3DY.%26aulast%3DNagahashi%26aufirst%3DM.%26aulast%3DIso%26aufirst%3DT.%26aulast%3DFukutomi%26aufirst%3DT.%26aulast%3DOhishi%26aufirst%3DM.%26aulast%3DEndo%26aufirst%3DK.%26aulast%3DUemura%26aufirst%3DT.%26aulast%3DNishito%26aufirst%3DY.%26aulast%3DOkuda%26aufirst%3DS.%26aulast%3DObata%26aufirst%3DM.%26aulast%3DKouno%26aufirst%3DT.%26aulast%3DImamura%26aufirst%3DR.%26aulast%3DTada%26aufirst%3DY.%26aulast%3DObata%26aufirst%3DR.%26aulast%3DYasuda%26aufirst%3DD.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DFujimura%26aufirst%3DT.%26aulast%3DPi%26aufirst%3DJ.%2BB.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DOhe%26aufirst%3DT.%26aulast%3DMashino%26aufirst%3DT.%26aulast%3DWakai%26aufirst%3DT.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DNagano%26aufirst%3DT.%26aulast%3DMotohashi%26aufirst%3DH.%26aulast%3DWaguri%26aufirst%3DS.%26aulast%3DSoga%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3Dp62%252FSqstm1%2520promotes%2520malignancy%2520of%2520HCV-positive%2520hepatocellular%2520carcinoma%2520through%2520Nrf2-dependent%2520metabolic%2520reprogramming%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12030%26doi%3D10.1038%2Fncomms12030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wullschleger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loewith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, M. N.</span></span> <span> </span><span class="NLM_article-title">TOR signaling in growth and metabolism</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>124</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">471</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.01.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.cell.2006.01.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=16469695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslaqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2006&pages=471&issue=3&author=S.+Wullschlegerauthor=R.+Loewithauthor=M.+N.+Hall&title=TOR+signaling+in+growth+and+metabolism&doi=10.1016%2Fj.cell.2006.01.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">TOR signaling in growth and metabolism</span></div><div class="casAuthors">Wullschleger, Stephan; Loewith, Robbie; Hall, Michael N.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">471-484</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The target of rapamycin (TOR) is a conserved Ser/Thr kinase that regulates cell growth and metab. in response to environmental cues.  Here, highlighting contributions from studies in model organisms, we review mammalian TOR complexes and the signaling branches they mediate.  TOR is part of two distinct multiprotein complexes, TOR complex 1 (TORC1), which is sensitive to rapamycin, and TORC2, which is not.  The physiol. consequences of mammalian TORC1 dysregulation suggest that inhibitors of mammalian TOR may be useful in the treatment of cancer, cardiovascular disease, autoimmunity, and metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdwzZ5NGx9YrVg90H21EOLACvtfcHk0lgKFHCRYaWIew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslaqs74%253D&md5=d8128a86651c824e725f56b90cafb88d</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DWullschleger%26aufirst%3DS.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DHall%26aufirst%3DM.%2BN.%26atitle%3DTOR%2520signaling%2520in%2520growth%2520and%2520metabolism%26jtitle%3DCell%26date%3D2006%26volume%3D124%26issue%3D3%26spage%3D471%26doi%3D10.1016%2Fj.cell.2006.01.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Martin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span> <span> </span><span class="NLM_article-title">p62/SQSTM1: ’Jack of all trades’ in health and cancer</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>286</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1111/febs.14712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1111%2Ffebs.14712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=30499183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFCit7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2019&pages=8-23&issue=1&author=P.+Sanchez-Martinauthor=T.+Saitoauthor=M.+Komatsu&title=p62%2FSQSTM1%3A+%E2%80%99Jack+of+all+trades%E2%80%99+in+health+and+cancer&doi=10.1111%2Ffebs.14712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">p62/SQSTM1: 'Jack of all trades' in health and cancer</span></div><div class="casAuthors">Sanchez-Martin, Pablo; Saito, Tetsuya; Komatsu, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-23</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  P62 is a stress-inducible protein able to change among binding partners, cellular localizations and form liq. droplet structures in a context-dependent manner.  This protein is mainly defined as a cargo receptor for selective autophagy, a process that allows the degrdn. of detrimental and unnecessary components through the lysosome.  Besides this role, its ability to interact with multiple binding partners allows p62 to act as a main regulator of the activation of the Nrf2, mTORC1, and NF-κB signaling pathways, linking p62 to the oxidative defense system, nutrient sensing, and inflammation, resp.  In the present review, we will present the mol. mechanisms behind the control p62 exerts over these pathways, their interconnection and how their deregulation contributes to cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprneSTDEcvP7Vg90H21EOLACvtfcHk0lgKFHCRYaWIew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFCit7bE&md5=276c34df5107d61d4c837157725d09a2</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1111%2Ffebs.14712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.14712%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez-Martin%26aufirst%3DP.%26aulast%3DSaito%26aufirst%3DT.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3Dp62%252FSQSTM1%253A%2520%25E2%2580%2599Jack%2520of%2520all%2520trades%25E2%2580%2599%2520in%2520health%2520and%2520cancer%26jtitle%3DFEBS%2520J.%26date%3D2019%26volume%3D286%26issue%3D1%26spage%3D8%26epage%3D23%26doi%3D10.1111%2Ffebs.14712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amanchy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linares, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu-Baker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porollo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span> <span> </span><span class="NLM_article-title">p62 is a key regulator of nutrient sensing in the mTORC1 pathway</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">146</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2011.06.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.molcel.2011.06.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21981924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12gtrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2011&pages=134-146&issue=1&author=A.+Duranauthor=R.+Amanchyauthor=J.+F.+Linaresauthor=J.+Joshiauthor=S.+Abu-Bakerauthor=A.+Porolloauthor=M.+Hansenauthor=J.+Moscatauthor=M.+T.+Diaz-Meco&title=p62+is+a+key+regulator+of+nutrient+sensing+in+the+mTORC1+pathway&doi=10.1016%2Fj.molcel.2011.06.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">p62 is a key regulator of nutrient sensing in the mTORC1 pathway</span></div><div class="casAuthors">Duran, Angeles; Amanchy, Ramars; Linares, Juan F.; Joshi, Jayashree; Abu-Baker, Shadi; Porollo, Aleksey; Hansen, Malene; Moscat, Jorge; Diaz-Meco, Maria T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-146</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Signaling adaptor p62 is a crit. mediator of important cellular functions, owing to its ability to establish interactions with various signaling intermediaries.  Here, the authors identify raptor as an interacting partner of p62.  Thus, p62 is an integral part of the mTORC1 complex and is necessary to mediate amino acid signaling for the activation of S6K1 and 4EBP1.  Protein p62 interacted in an amino acid-dependent manner with mTOR and raptor.  In addn., p62 bound to Rags proteins and favored the formation of the active Rag heterodimer that was further stabilized by raptor.  Interestingly, p62 colocalized with Rags at the lysosomal compartment and was required for the interaction of mTOR with Rag GTPases in vivo and for translocation of the mTORC1 complex to the lysosome, a crucial step for mTOR activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr3IRKDm5MzbVg90H21EOLACvtfcHk0lgKFHCRYaWIew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12gtrrL&md5=a32a6d560b5c336a3fa7371145829a37</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2011.06.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2011.06.038%26sid%3Dliteratum%253Aachs%26aulast%3DDuran%26aufirst%3DA.%26aulast%3DAmanchy%26aufirst%3DR.%26aulast%3DLinares%26aufirst%3DJ.%2BF.%26aulast%3DJoshi%26aufirst%3DJ.%26aulast%3DAbu-Baker%26aufirst%3DS.%26aulast%3DPorollo%26aufirst%3DA.%26aulast%3DHansen%26aufirst%3DM.%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26atitle%3Dp62%2520is%2520a%2520key%2520regulator%2520of%2520nutrient%2520sensing%2520in%2520the%2520mTORC1%2520pathway%26jtitle%3DMol.%2520Cell%26date%3D2011%26volume%3D44%26issue%3D1%26spage%3D134%26epage%3D146%26doi%3D10.1016%2Fj.molcel.2011.06.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linares, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yajima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasparakis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span> <span> </span><span class="NLM_article-title">K63 polyubiquitination and activation of mTOR by the p62-TRAF6 complex in nutrient-activated cells</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2013.06.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.molcel.2013.06.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=23911927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1WrsbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2013&pages=283-296&issue=3&author=J.+F.+Linaresauthor=A.+Duranauthor=T.+Yajimaauthor=M.+Pasparakisauthor=J.+Moscatauthor=M.+T.+Diaz-Meco&title=K63+polyubiquitination+and+activation+of+mTOR+by+the+p62-TRAF6+complex+in+nutrient-activated+cells&doi=10.1016%2Fj.molcel.2013.06.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">K63 Polyubiquitination and Activation of mTOR by the p62-TRAF6 Complex in Nutrient-Activated Cells</span></div><div class="casAuthors">Linares, Juan F.; Duran, Angeles; Yajima, Tomoko; Pasparakis, Manolis; Moscat, Jorge; Diaz-Meco, Maria T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">283-296</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The ability of cells to respond to changes in nutrient availability is crit. for an adequate control of metabolic homeostasis.  Mammalian target of rapamycin complex 1 (mTORC1) is a central complex kinase in these processes.  The signaling adaptor p62 binds raptor, and integral component of the mTORC1 pathway. p62 interacts with TNF receptor assocd. factor 6 (TRAF6) and is required for mTORC1 translocation to the lysosome and its subsequent activation.  Here we show that TRAF6 is recruited to and activates mTORC1 through p62 in amino acid-stimulated cells.  We also show that TRAF6 is necessary for the translocation of mTORC1 to the lysosomes and that the TRAF6-catalyzed K63 ubiquitination of mTOR regulates mTORC1 activation by amino acids.  TRAF6, through its interaction with p62 and activation of mTORC1, modulates autophagy and is an important mediator in cancer cell proliferation.  Interfering with the p62-TRAF6 interaction serves to modulate autophagy and nutrient sensing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjV20DGgD_ArVg90H21EOLACvtfcHk0lh7NedhMhrcnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1WrsbzM&md5=84ab95fe040ea47c6ca7fbcd10064ea6</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2013.06.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2013.06.020%26sid%3Dliteratum%253Aachs%26aulast%3DLinares%26aufirst%3DJ.%2BF.%26aulast%3DDuran%26aufirst%3DA.%26aulast%3DYajima%26aufirst%3DT.%26aulast%3DPasparakis%26aufirst%3DM.%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26atitle%3DK63%2520polyubiquitination%2520and%2520activation%2520of%2520mTOR%2520by%2520the%2520p62-TRAF6%2520complex%2520in%2520nutrient-activated%2520cells%26jtitle%3DMol.%2520Cell%26date%3D2013%26volume%3D51%26issue%3D3%26spage%3D283%26epage%3D296%26doi%3D10.1016%2Fj.molcel.2013.06.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linares, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reina-Campos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aza-Blanc, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span> <span> </span><span class="NLM_article-title">Amino acid activation of mTORC1 by a PB1-domain-driven kinase complex cascade</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1339</span>– <span class="NLM_lpage">1352</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2015.07.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.celrep.2015.07.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=26279575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCis7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=1339-1352&issue=8&author=J.+F.+Linaresauthor=A.+Duranauthor=M.+Reina-Camposauthor=P.+Aza-Blancauthor=A.+Camposauthor=J.+Moscatauthor=M.+T.+Diaz-Meco&title=Amino+acid+activation+of+mTORC1+by+a+PB1-domain-driven+kinase+complex+cascade&doi=10.1016%2Fj.celrep.2015.07.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Amino Acid Activation of mTORC1 by a PB1-Domain-Driven Kinase Complex Cascade</span></div><div class="casAuthors">Linares, Juan F.; Duran, Angeles; Reina-Campos, Miguel; Aza-Blanc, Pedro; Campos, Alex; Moscat, Jorge; Diaz-Meco, Maria T.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1339-1352</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The mTORC1 complex is central to the cellular response to changes in nutrient availability.  The signaling adaptor p62 contributes to mTORC1 activation in response to amino acids and interacts with TRAF6, which is required for the translocation of mTORC1 to the lysosome and the subsequent K63 polyubiquitination and activation of mTOR.  However, the signal initiating these p62-driven processes was previously unknown.  Here, we show that p62 is phosphorylated via a cascade that includes MEK3/6 and p38δ and is driven by the PB1-contg. kinase MEKK3.  This phosphorylation results in the recruitment of TRAF6 to p62, the ubiquitination and activation of mTOR, and the regulation of autophagy and cell proliferation.  Genetic inactivation of MEKK3 or p38δ mimics that of p62 in that it leads to inhibited growth of PTEN-deficient prostate organoids.  Anal. of human prostate cancer samples showed upregulation of these three components of the pathway, which correlated with enhanced mTORC1 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquKKMXLubHmrVg90H21EOLACvtfcHk0lh7NedhMhrcnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCis7jK&md5=33e74d5f17399dc1b2576d836a28235b</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2015.07.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2015.07.045%26sid%3Dliteratum%253Aachs%26aulast%3DLinares%26aufirst%3DJ.%2BF.%26aulast%3DDuran%26aufirst%3DA.%26aulast%3DReina-Campos%26aufirst%3DM.%26aulast%3DAza-Blanc%26aufirst%3DP.%26aulast%3DCampos%26aufirst%3DA.%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26atitle%3DAmino%2520acid%2520activation%2520of%2520mTORC1%2520by%2520a%2520PB1-domain-driven%2520kinase%2520complex%2520cascade%26jtitle%3DCell%2520Rep.%26date%3D2015%26volume%3D12%26issue%3D8%26spage%3D1339%26epage%3D1352%26doi%3D10.1016%2Fj.celrep.2015.07.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Misra, U. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzo, S. V.</span></span> <span> </span><span class="NLM_article-title">Epac1-induced cellular proliferation in prostate cancer cells is mediated by B-Raf/ERK and mTOR signaling cascades</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>108</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">998</span>– <span class="NLM_lpage">1011</span>, <span class="refDoi"> DOI: 10.1002/jcb.22333</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1002%2Fjcb.22333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19725049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSqs7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2009&pages=998-1011&issue=4&author=U.+K.+Misraauthor=S.+V.+Pizzo&title=Epac1-induced+cellular+proliferation+in+prostate+cancer+cells+is+mediated+by+B-Raf%2FERK+and+mTOR+signaling+cascades&doi=10.1002%2Fjcb.22333"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Epac1-induced cellular proliferation in prostate cancer cells is mediated by B-Raf/ERK and mTOR signaling cascades</span></div><div class="casAuthors">Misra, Uma Kant; Pizzo, Salvatore Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">998-1011</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">CAMP-dependent, PKA-independent effects on cell proliferation are mediated by cAMP binding to EPAC and activation of Rap signaling.  In this report, we employed the analog 8-CPT-2-O-Me-cAMP to study binding to EPAC and subsequent activation of B-Raf/ERK and mTOR signaling in human cancer cells.  This compd. significantly stimulated DNA synthesis, protein synthesis, and cellular proliferation of human 1-LN prostate cancer cells.  By study of phosphorylation-dependent activation, we demonstrate that EPAC-mediated cellular effects require activation of the B-Raf/ERK and mTOR signaling cascades.  RNAi directed against EPAC gene expression as well as inhibitors of ERK, PI 3-kinase, and mTOR were employed to further demonstrate the role of these pathways in regulating prostate cancer cell proliferation.  These studies were then extended to several other human prostate cancer cell lines and melanoma cells with comparable results.  We conclude that B-Raf/ERK and mTOR signaling play an essential role in cAMP-dependent, but PKA-independent, proliferation of cancer cells.  © 2009 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXCJ8M-WxUq7Vg90H21EOLACvtfcHk0ljy1Aa395rc8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSqs7rE&md5=93e02f2ef1411c1bf30ec209a9ff1e7f</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1002%2Fjcb.22333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.22333%26sid%3Dliteratum%253Aachs%26aulast%3DMisra%26aufirst%3DU.%2BK.%26aulast%3DPizzo%26aufirst%3DS.%2BV.%26atitle%3DEpac1-induced%2520cellular%2520proliferation%2520in%2520prostate%2520cancer%2520cells%2520is%2520mediated%2520by%2520B-Raf%252FERK%2520and%2520mTOR%2520signaling%2520cascades%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2009%26volume%3D108%26issue%3D4%26spage%3D998%26epage%3D1011%26doi%3D10.1002%2Fjcb.22333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donaher, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaswamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itzykson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Come, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savagner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gitelman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>117</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">927</span>– <span class="NLM_lpage">939</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2004.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.cell.2004.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=15210113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsFWnu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2004&pages=927-939&issue=7&author=J.+Yangauthor=S.+A.+Maniauthor=J.+L.+Donaherauthor=S.+Ramaswamyauthor=R.+A.+Itzyksonauthor=C.+Comeauthor=P.+Savagnerauthor=I.+Gitelmanauthor=A.+Richardsonauthor=R.+A.+Weinberg&title=Twist%2C+a+master+regulator+of+morphogenesis%2C+plays+an+essential+role+in+tumor+metastasis&doi=10.1016%2Fj.cell.2004.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis</span></div><div class="casAuthors">Yang, Jing; Mani, Sendurai A.; Donaher, Joana Liu; Ramaswamy, Sridhar; Itzykson, Raphael A.; Come, Christophe; Savagner, Pierre; Gitelman, Inna; Richardson, Andrea; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">927-939</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Metastasis is a multistep process during which cancer cells disseminate from the site of primary tumors and establish secondary tumors in distant organs.  In a search for key regulators of metastasis in a murine breast tumor model, the authors have found that the transcription factor Twist, a master regulator of embryonic morphogenesis, plays an essential role in metastasis.  Suppression of Twist expression in highly metastatic mammary carcinoma cells specifically inhibits their ability to metastasize from the mammary gland to the lung.  Ectopic expression of Twist results in loss of E-cadherin-mediated cell-cell adhesion, activation of mesenchymal markers, and induction of cell motility, suggesting that Twist contributes to metastasis by promoting an epithelial-mesenchymal transition (EMT).  In human breast cancers, high level of Twist expression is correlated with invasive lobular carcinoma, a highly infiltrating tumor type assocd. with loss of E-cadherin expression.  These results establish a mechanistic link between Twist, EMT, and tumor metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqPNT4BFZTkLVg90H21EOLACvtfcHk0ljy1Aa395rc8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsFWnu7w%253D&md5=6a2f4793b4ba770f8bd08c8e5aa5a08e</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2004.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2004.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DMani%26aufirst%3DS.%2BA.%26aulast%3DDonaher%26aufirst%3DJ.%2BL.%26aulast%3DRamaswamy%26aufirst%3DS.%26aulast%3DItzykson%26aufirst%3DR.%2BA.%26aulast%3DCome%26aufirst%3DC.%26aulast%3DSavagner%26aufirst%3DP.%26aulast%3DGitelman%26aufirst%3DI.%26aulast%3DRichardson%26aufirst%3DA.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DTwist%252C%2520a%2520master%2520regulator%2520of%2520morphogenesis%252C%2520plays%2520an%2520essential%2520role%2520in%2520tumor%2520metastasis%26jtitle%3DCell%26date%3D2004%26volume%3D117%26issue%3D7%26spage%3D927%26epage%3D939%26doi%3D10.1016%2Fj.cell.2004.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Onder, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lander, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3645</span>– <span class="NLM_lpage">3654</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-2938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1158%2F0008-5472.CAN-07-2938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18483246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvVOitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=3645-3654&issue=10&author=T.+T.+Onderauthor=P.+B.+Guptaauthor=S.+A.+Maniauthor=J.+Yangauthor=E.+S.+Landerauthor=R.+A.+Weinberg&title=Loss+of+E-cadherin+promotes+metastasis+via+multiple+downstream+transcriptional+pathways&doi=10.1158%2F0008-5472.CAN-07-2938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional Pathways</span></div><div class="casAuthors">Onder, Tamer T.; Gupta, Piyush B.; Mani, Sendurai A.; Yang, Jing; Lander, Eric S.; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3645-3654</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Loss of the epithelial adhesion mol. E-cadherin is thought to enable metastasis by disrupting intercellular contacts-an early step in metastatic dissemination.  To further investigate the mol. basis of this notion, we use two methods to inhibit E-cadherin function that distinguish between E-cadherin's cell-cell adhesion and intracellular signaling functions.  Whereas the disruption of cell-cell contacts alone does not enable metastasis, the loss of E-cadherin protein does, through induction of an epithelial-to-mesenchymal transition, invasiveness, and anoikis resistance.  We find the E-cadherin binding partner β-catenin to be necessary, but not sufficient, for induction of these phenotypes.  In addn., gene expression anal. shows that E-cadherin loss results in the induction of multiple transcription factors, at least one of which, Twist, is necessary for E-cadherin loss-induced metastasis.  These findings indicate that E-cadherin loss in tumors contributes to metastatic dissemination by inducing wide-ranging transcriptional and functional changes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgx7f9E65UQbVg90H21EOLACvtfcHk0ljBZ07mJxZojg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvVOitLw%253D&md5=39cac4d757b2560460ffa04a19359624</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-2938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-2938%26sid%3Dliteratum%253Aachs%26aulast%3DOnder%26aufirst%3DT.%2BT.%26aulast%3DGupta%26aufirst%3DP.%2BB.%26aulast%3DMani%26aufirst%3DS.%2BA.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DLoss%2520of%2520E-cadherin%2520promotes%2520metastasis%2520via%2520multiple%2520downstream%2520transcriptional%2520pathways%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26issue%3D10%26spage%3D3645%26epage%3D3654%26doi%3D10.1158%2F0008-5472.CAN-07-2938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ming, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorburn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span> <span> </span><span class="NLM_article-title">Regulation of cell proliferation and migration by p62 through stabilization of Twist1</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">9241</span>– <span class="NLM_lpage">9246</span>, <span class="refDoi"> DOI: 10.1073/pnas.1322913111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1073%2Fpnas.1322913111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=24927592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVamurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=9241-9246&issue=25&author=L.+Qiangauthor=B.+Z.+Zhaoauthor=M.+Mingauthor=N.+Wangauthor=T.+C.+Heauthor=S.+Hwangauthor=A.+Thorburnauthor=Y.+He&title=Regulation+of+cell+proliferation+and+migration+by+p62+through+stabilization+of+Twist1&doi=10.1073%2Fpnas.1322913111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of cell proliferation and migration by p62 through stabilization of Twist1</span></div><div class="casAuthors">Qiang, Lei; Zhao, Baozhong; Ming, Mei; Wang, Ning; He, Tong-Chuan; Hwang, Seungmin; Thorburn, Andrew; He, Yu-Ying</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">9241-9246</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The selective autophagy substrate p62 serves as a mol. link between autophagy and cancer.  Suppression of autophagy causes p62 accumulation and thereby contributes to tumorigenesis.  Here we demonstrate that autophagy deficiency promotes cell proliferation and migration through p62-dependent stabilization of the oncogenic transcription factor Twist1.  P62 binds to Twist1 and inhibits degrdn. of Twist1.  In mice, p62 up-regulation promotes tumor cell growth and metastasis in a Twist1-dependent manner.  Our findings demonstrate that Twist1 is a key downstream effector of p62 in regulation of cell proliferation and migration and suggest that targeting p62-mediated Twist1 stabilization is a promising therapeutic strategy for prevention and treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXXGY8lVZUc7Vg90H21EOLACvtfcHk0ljBZ07mJxZojg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVamurs%253D&md5=f791b236837c29b55739138da6f0d6fd</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1322913111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1322913111%26sid%3Dliteratum%253Aachs%26aulast%3DQiang%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DB.%2BZ.%26aulast%3DMing%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DT.%2BC.%26aulast%3DHwang%26aufirst%3DS.%26aulast%3DThorburn%26aufirst%3DA.%26aulast%3DHe%26aufirst%3DY.%26atitle%3DRegulation%2520of%2520cell%2520proliferation%2520and%2520migration%2520by%2520p62%2520through%2520stabilization%2520of%2520Twist1%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26issue%3D25%26spage%3D9241%26epage%3D9246%26doi%3D10.1073%2Fpnas.1322913111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ammirante, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grivennikov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nedospasov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">B-cell-derived lymphotoxin promotes castration-resistant prostate cancer</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>464</i></span> (<span class="NLM_issue">7286</span>),  <span class="NLM_fpage">302</span>– <span class="NLM_lpage">305</span>, <span class="refDoi"> DOI: 10.1038/nature08782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fnature08782" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20220849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFSnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=464&publication_year=2010&pages=302-305&issue=7286&author=M.+Ammiranteauthor=J.+L.+Luoauthor=S.+Grivennikovauthor=S.+Nedospasovauthor=M.+Karin&title=B-cell-derived+lymphotoxin+promotes+castration-resistant+prostate+cancer&doi=10.1038%2Fnature08782"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">B-cell-derived lymphotoxin promotes castration-resistant prostate cancer</span></div><div class="casAuthors">Ammirante, Massimo; Luo, Jun-Li; Grivennikov, Sergei; Nedospasov, Sergei; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">464</span>
        (<span class="NLM_cas:issue">7286</span>),
    <span class="NLM_cas:pages">302-305</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Prostate cancer (CaP) progresses from prostatic intraepithelial neoplasia through locally invasive adenocarcinoma to castration-resistant metastatic carcinoma.  Although radical prostatectomy, radiation and androgen ablation are effective therapies for androgen-dependent CaP, metastatic castration-resistant CaP is a major complication with high mortality.  Androgens stimulate growth and survival of prostate epithelium and early CaP.  Although most patients initially respond to androgen ablation, many develop castration-resistant CaP within 12-18 mo.  Despite extensive studies, the mechanisms underlying the emergence of castration-resistant CaP remain poorly understood and their elucidation is crit. for developing improved therapies.  Curiously, castration-resistant CaP remains androgen-receptor dependent, and potent androgen-receptor antagonists induce tumor regression in castrated mice.  The role of inflammation in castration-resistant CaP has not been addressed, although it was reported that intrinsic NF-κB activation supports its growth.  Inflammation is a localized protective reaction to injury or infection, but it also has a pathogenic role in many diseases, including cancer.  Whereas acute inflammation is crit. for host defense, chronic inflammation contributes to tumorigenesis and metastatic progression.  The inflammation-responsive IκB kinase (IKK)-β and its target NF-κB have important tumor-promoting functions within malignant cells and inflammatory cells.  The latter, including macrophages and lymphocytes, are important elements of the tumor microenvironment, but the mechanisms underlying their recruitment remain obscure, although they are thought to depend on chemokine and cytokine prodn.  We found that CaP progression is assocd. with inflammatory infiltration and activation of IKK-α, which stimulates metastasis by an NF-κB-independent, cell autonomous mechanism.  Here we show that androgen ablation causes infiltration of regressing androgen-dependent tumors with leukocytes, including B cells, in which IKK-β activation results in prodn. of cytokines that activate IKK-α and STAT3 in CaP cells to enhance hormone-free survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqYc1rD0xf_bVg90H21EOLACvtfcHk0ljlUuuCacpmug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFSnurs%253D&md5=17531b68980797adcf09a3a0eaed0694</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1038%2Fnature08782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08782%26sid%3Dliteratum%253Aachs%26aulast%3DAmmirante%26aufirst%3DM.%26aulast%3DLuo%26aufirst%3DJ.%2BL.%26aulast%3DGrivennikov%26aufirst%3DS.%26aulast%3DNedospasov%26aufirst%3DS.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DB-cell-derived%2520lymphotoxin%2520promotes%2520castration-resistant%2520prostate%2520cancer%26jtitle%3DNature%26date%3D2010%26volume%3D464%26issue%3D7286%26spage%3D302%26epage%3D305%26doi%3D10.1038%2Fnature08782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lisanti, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Outschoorn, U. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotgia, F.</span></span> <span> </span><span class="NLM_article-title">Oncogenes induce the cancer-associated fibroblast phenotype metabolic symbiosis and ″fibroblast addiction″ are new therapeutic targets for drug discovery</span>. <i>Cell Cycle</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">2723</span>– <span class="NLM_lpage">2732</span>, <span class="refDoi"> DOI: 10.4161/cc.25695</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.4161%2Fcc.25695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=23860382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlGiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=2723-2732&issue=17&author=M.+P.+Lisantiauthor=U.+E.+Martinez-Outschoornauthor=F.+Sotgia&title=Oncogenes+induce+the+cancer-associated+fibroblast+phenotype+metabolic+symbiosis+and+%E2%80%B3fibroblast+addiction%E2%80%B3+are+new+therapeutic+targets+for+drug+discovery&doi=10.4161%2Fcc.25695"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and "fibroblast addiction" are new therapeutic targets for drug discovery</span></div><div class="casAuthors">Lisanti, Michael P.; Martinez-Outschoorn, Ubaldo E.; Sotgia, Federica</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2723-2732</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1538-4101</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  Metabolic coupling, between mitochondria in cancer cells and catabolism in stromal fibroblasts, promotes tumor growth, recurrence, metastasis, and predicts anticancer drug resistance.  Catabolic fibroblasts donate the necessary fuels (such as L-lactate, ketones, glutamine, other amino acids, and fatty acids) to anabolic cancer cells, to metabolize via their TCA cycle and oxidative phosphorylation (OXPHOS).  This provides a simple mechanism by which metabolic energy and biomass are transferred from the host microenvironment to cancer cells.  Recently, we showed that catabolic metab. and "glycolytic reprogramming" in the tumor microenvironment are orchestrated by oncogene activation and inflammation, which originates in epithelial cancer cells.  Oncogenes drive the onset of the cancer-assocd. fibroblast phenotype in adjacent normal fibroblasts via paracrine oxidative stress.  This oncogene-induced transition to malignancy is "mirrored" by a loss of caveolin-1 (Cav-1) and an increase in MCT4 in adjacent stromal fibroblasts, functionally reflecting catabolic metab. in the tumor microenvironment.  Virtually identical findings were obtained using BRCA1-deficient breast and ovarian cancer cells.  Thus, oncogene activation (RAS, NFkB, TGF-β) and/or tumor suppressor loss (BRCA1) have similar functional effects on adjacent stromal fibroblasts, initiating "metabolic symbiosis" and the cancer-assocd. fibroblast phenotype.  New therapeutic strategies that metabolically uncouple oxidative cancer cells from their glycolytic stroma or modulate oxidative stress could be used to target this lethal subtype of cancers.  Targeting "fibroblast addiction" in primary and metastatic tumor cells may expose a crit. Achilles' heel, leading to disease regression in both sporadic and familial cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBKmBjE3IJ6rVg90H21EOLACvtfcHk0ljlUuuCacpmug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlGiu7k%253D&md5=186b118769295e05673196170e1a5aa2</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.4161%2Fcc.25695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.25695%26sid%3Dliteratum%253Aachs%26aulast%3DLisanti%26aufirst%3DM.%2BP.%26aulast%3DMartinez-Outschoorn%26aufirst%3DU.%2BE.%26aulast%3DSotgia%26aufirst%3DF.%26atitle%3DOncogenes%2520induce%2520the%2520cancer-associated%2520fibroblast%2520phenotype%2520metabolic%2520symbiosis%2520and%2520%25E2%2580%25B3fibroblast%2520addiction%25E2%2580%25B3%2520are%2520new%2520therapeutic%2520targets%2520for%2520drug%2520discovery%26jtitle%3DCell%2520Cycle%26date%3D2013%26volume%3D12%26issue%3D17%26spage%3D2723%26epage%3D2732%26doi%3D10.4161%2Fcc.25695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barron, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, D. R.</span></span> <span> </span><span class="NLM_article-title">The reactive stroma microenvironment and prostate cancer progression</span>. <i>Endocr.-Relat. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">R187</span>– <span class="NLM_lpage">R204</span>, <span class="refDoi"> DOI: 10.1530/ERC-12-0085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1530%2FERC-12-0085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22930558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=R187-R204&issue=6&author=D.+A.+Barronauthor=D.+R.+Rowley&title=The+reactive+stroma+microenvironment+and+prostate+cancer+progression&doi=10.1530%2FERC-12-0085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">The reactive stroma microenvironment and prostate cancer progression</span></div><div class="casAuthors">Barron, David A.; Rowley, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine-Related Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">R187-R204</span>CODEN:
                <span class="NLM_cas:coden">ERCAE9</span>;
        ISSN:<span class="NLM_cas:issn">1351-0088</span>.
    
            (<span class="NLM_cas:orgname">BioScientifica Ltd.</span>)
        </div><div class="casAbstract">A review.  Reactive stroma initiates during early prostate cancer development and coevolves with prostate cancer progression.  Previous studies have defined the key markers of reactive stroma and have established that reactive stroma biol. influences prostate tumorigenesis and progression.  The stem/progenitor cells of origin and the mechanisms that regulate their recruitment and activation to myofibroblasts or carcinoma-assocd. fibroblasts are essentially unknown.  Key regulatory factors have been identified, including transforming growth factor β, interleukin-8, fibroblast growth factors, connective tissue growth factor, wingless homologs-Wnts, and stromal cell-derived factor-1, among others.  The biol. of reactive stroma in cancer is similar to the more predictable biol. of the stroma compartment during wound repair at sites where the epithelial barrier function is breached and a stromal response is generated.  The coevolution of reactive stroma and the biol. of how reactive stroma-carcinoma interactions regulate cancer progression and metastasis are targets for new therapeutic approaches.  Such approaches are strategically designed to inhibit cancer progression by uncoupling the reactive stroma niche.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTdUu1u3Zar7Vg90H21EOLACvtfcHk0lhiP3fLJeXctA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCitL4%253D&md5=758fd1a1ff0b2f4ca7f7e6cb642a3fd7</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1530%2FERC-12-0085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1530%252FERC-12-0085%26sid%3Dliteratum%253Aachs%26aulast%3DBarron%26aufirst%3DD.%2BA.%26aulast%3DRowley%26aufirst%3DD.%2BR.%26atitle%3DThe%2520reactive%2520stroma%2520microenvironment%2520and%2520prostate%2520cancer%2520progression%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D2012%26volume%3D19%26issue%3D6%26spage%3DR187%26epage%3DR204%26doi%3D10.1530%2FERC-12-0085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reina-Campos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valencia, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castilla, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschop, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span> <span> </span><span class="NLM_article-title">Adipocyte p62/SQSTM1 suppresses tumorigenesis through opposite regulations of metabolism in adipose tissue and tumor</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">770</span>– <span class="NLM_lpage">784</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2018.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.ccell.2018.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=29634950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntlCit7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=770-784&issue=4&author=J.+Huangauthor=A.+Duranauthor=M.+Reina-Camposauthor=T.+Valenciaauthor=E.+A.+Castillaauthor=T.+D.+Mullerauthor=M.+H.+Tschopauthor=J.+Moscatauthor=M.+T.+Diaz-Meco&title=Adipocyte+p62%2FSQSTM1+suppresses+tumorigenesis+through+opposite+regulations+of+metabolism+in+adipose+tissue+and+tumor&doi=10.1016%2Fj.ccell.2018.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Adipocyte p62/SQSTM1 Suppresses Tumorigenesis through Opposite Regulations of Metabolism in Adipose Tissue and Tumor</span></div><div class="casAuthors">Huang, Jianfeng; Duran, Angeles; Reina-Campos, Miguel; Valencia, Tania; Castilla, Elias A.; Muller, Timo D.; Tschop, Matthias H.; Moscat, Jorge; Diaz-Meco, Maria T.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">770-784.e6</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Obesity is a leading risk factor for cancer.  However, understanding the crosstalk between adipocytes and tumor cells in vivo, independently of dietary contributions, is a major gap in the field.  Here we used a prostate cancer (PCa) mouse model in which the signaling adaptor p62/Sqstm1 is selectively inactivated in adipocytes.  P62 loss in adipocytes results in increased osteopontin secretion, which mediates tumor fatty acid oxidn. and invasion, leading to aggressive metastatic PCa in vivo.  Furthermore, p62 deficiency triggers in adipocytes a general shutdown of energy-utilizing pathways through mTORC1 inhibition, which supports nutrient availability for cancer cells.  This reveals a central role of adipocyte's p62 in the symbiotic adipose tissue-tumor collaboration that enables cancer metabolic fitness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXV3tsNfRWPrVg90H21EOLACvtfcHk0lhiP3fLJeXctA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntlCit7c%253D&md5=9415b6ef75ba3e64d6c5b99d13ad77f3</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2018.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2018.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DDuran%26aufirst%3DA.%26aulast%3DReina-Campos%26aufirst%3DM.%26aulast%3DValencia%26aufirst%3DT.%26aulast%3DCastilla%26aufirst%3DE.%2BA.%26aulast%3DMuller%26aufirst%3DT.%2BD.%26aulast%3DTschop%26aufirst%3DM.%2BH.%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26atitle%3DAdipocyte%2520p62%252FSQSTM1%2520suppresses%2520tumorigenesis%2520through%2520opposite%2520regulations%2520of%2520metabolism%2520in%2520adipose%2520tissue%2520and%2520tumor%26jtitle%3DCancer%2520Cell%26date%3D2018%26volume%3D33%26issue%3D4%26spage%3D770%26epage%3D784%26doi%3D10.1016%2Fj.ccell.2018.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iwadate, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirasawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inazawa, J.</span></span> <span> </span><span class="NLM_article-title">High expression of SQSTM1/p62 protein is associated with poor prognosis in epithelial ovarian cancer</span>. <i>Acta Histochem. Cytochem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">301</span>, <span class="refDoi"> DOI: 10.1267/ahc.14048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1267%2Fahc.14048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=25859063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BC2MjivVaiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2014&pages=295-301&issue=6&author=R.+Iwadateauthor=J.+Inoueauthor=H.+Tsudaauthor=M.+Takanoauthor=K.+Furuyaauthor=A.+Hirasawaauthor=D.+Aokiauthor=J.+Inazawa&title=High+expression+of+SQSTM1%2Fp62+protein+is+associated+with+poor+prognosis+in+epithelial+ovarian+cancer&doi=10.1267%2Fahc.14048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">High Expression of SQSTM1/p62 Protein Is Associated with Poor Prognosis in Epithelial Ovarian Cancer</span></div><div class="casAuthors">Iwadate Reiko; Inoue Jun; Tsuda Hitoshi; Takano Masashi; Furuya Kenichi; Hirasawa Akira; Aoki Daisuke; Inazawa Johji</div><div class="citationInfo"><span class="NLM_cas:title">Acta histochemica et cytochemica</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">295-301</span>
        ISSN:<span class="NLM_cas:issn">0044-5991</span>.
    </div><div class="casAbstract">High expression of SQSTM1/p62 (p62) protein, which functions as a hub for various cellular signaling pathways, has been detected in several human cancers.  However, the clinicopathological impact of high p62 expression is largely unknown in epithelial ovarian cancer (EOC).  Here, the expression level of p62 in primary EOCs (n=266) was assessed by immunohistochemistry, and its clinical significance was analyzed.  Univariate and multivariate analyses were used to determine the impact of p62 expression on overall survival. p62 was expressed in the cytoplasm (Cyto) and/or nucleus (Nuc) in primary EOCs, and an expression subtype (Cyto(High)/Nuc(Low)), showing high expression in the cytoplasm but low expression in the nucleus, was significantly correlated with serous carcinoma (P<0.001), advanced stage (P=0.005), presence of residual tumor (P<0.001), and low overall survival rate (P=0.013).  Furthermore, in serous carcinomas (n=107), the p62 Cyto(High)/Nuc(Low) subtype was significantly correlated with low overall survival rate (P=0.019) as an independent factor (P=0.044).  Thus, our findings suggest that high expression of cytoplasmic p62 may be a novel prognostic biomarker in EOC, particularly in serous carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS1SMGX3K8vvf69nzq6467DfW6udTcc2ebPjZlNvXQtPrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MjivVaiug%253D%253D&md5=aceb769a8f66b7a6948e04cd282d865b</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1267%2Fahc.14048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1267%252Fahc.14048%26sid%3Dliteratum%253Aachs%26aulast%3DIwadate%26aufirst%3DR.%26aulast%3DInoue%26aufirst%3DJ.%26aulast%3DTsuda%26aufirst%3DH.%26aulast%3DTakano%26aufirst%3DM.%26aulast%3DFuruya%26aufirst%3DK.%26aulast%3DHirasawa%26aufirst%3DA.%26aulast%3DAoki%26aufirst%3DD.%26aulast%3DInazawa%26aufirst%3DJ.%26atitle%3DHigh%2520expression%2520of%2520SQSTM1%252Fp62%2520protein%2520is%2520associated%2520with%2520poor%2520prognosis%2520in%2520epithelial%2520ovarian%2520cancer%26jtitle%3DActa%2520Histochem.%2520Cytochem.%26date%3D2014%26volume%3D47%26issue%3D6%26spage%3D295%26epage%3D301%26doi%3D10.1267%2Fahc.14048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choonara, Y. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillay, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">du Toit, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naidoo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ndesendo, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibambo, S. R.</span></span> <span> </span><span class="NLM_article-title">Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2510</span>– <span class="NLM_lpage">2557</span>, <span class="refDoi"> DOI: 10.3390/ijms10062510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.3390%2Fijms10062510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19582217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Sltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=2510-2557&issue=6&author=Y.+E.+Choonaraauthor=V.+Pillayauthor=L.+C.+du+Toitauthor=G.+Modiauthor=D.+Naidooauthor=V.+M.+Ndesendoauthor=S.+R.+Sibambo&title=Trends+in+the+molecular+pathogenesis+and+clinical+therapeutics+of+common+neurodegenerative+disorders&doi=10.3390%2Fijms10062510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders</span></div><div class="casAuthors">Choonara, Yahya E.; Pillay, Viness; du Toit, Lisa C.; Modi, Girish; Naidoo, Dinesh; Ndesendo, Valence M. K.; Sibambo, Sibongile R.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2510-2557</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  The term neurodegenerative disorders, encompasses a variety of underlying conditions, sporadic and/or familial and are characterized by the persistent loss of neuronal subtypes.  These disorders can disrupt mol. pathways, synapses, neuronal subpopulations and local circuits in specific brain regions, as well as higher-order neural networks.  Abnormal network activities may result in a vicious cycle, further impairing the integrity and functions of neurons and synapses, for example, through aberrant excitation or inhibition.  The most common neurodegenerative disorders are Alzheimer's disease, Parkinson's disease, Amyotrophic Lateral Sclerosis and Huntington's disease.  The mol. features of these disorders have been extensively researched and various unique neurotherapeutic interventions have been developed.  However, there is an enormous coercion to integrate the existing knowledge in order to intensify the reliability with which neurodegenerative disorders can be diagnosed and treated.  The objective of this review article is therefore to assimilate these disorders' in terms of their neuropathol., neurogenetics, etiol., trends in pharmacol. treatment, clin. management, and the use of innovative neurotherapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD3RZrWfcYerVg90H21EOLACvtfcHk0libih9_X_03ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Sltbk%253D&md5=7717a9dee003850082028e1b10bc3910</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.3390%2Fijms10062510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms10062510%26sid%3Dliteratum%253Aachs%26aulast%3DChoonara%26aufirst%3DY.%2BE.%26aulast%3DPillay%26aufirst%3DV.%26aulast%3Ddu%2BToit%26aufirst%3DL.%2BC.%26aulast%3DModi%26aufirst%3DG.%26aulast%3DNaidoo%26aufirst%3DD.%26aulast%3DNdesendo%26aufirst%3DV.%2BM.%26aulast%3DSibambo%26aufirst%3DS.%2BR.%26atitle%3DTrends%2520in%2520the%2520molecular%2520pathogenesis%2520and%2520clinical%2520therapeutics%2520of%2520common%2520neurodegenerative%2520disorders%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2009%26volume%3D10%26issue%3D6%26spage%3D2510%26epage%3D2557%26doi%3D10.3390%2Fijms10062510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease is a synaptic failure</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>298</i></span> (<span class="NLM_issue">5594</span>),  <span class="NLM_fpage">789</span>– <span class="NLM_lpage">791</span>, <span class="refDoi"> DOI: 10.1126/science.1074069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1126%2Fscience.1074069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=12399581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD38XotFSnur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=789-791&issue=5594&author=D.+J.+Selkoe&title=Alzheimer%E2%80%99s+disease+is+a+synaptic+failure&doi=10.1126%2Fscience.1074069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's Disease Is a Synaptic Failure</span></div><div class="casAuthors">Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5594</span>),
    <span class="NLM_cas:pages">789-791</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  In its earliest clin. phase, Alzheimer's disease characteristically produces a remarkably pure impairment of memory.  Mounting evidence suggests that this syndrome begins with subtle alterations of hippocampal synaptic efficacy prior to frank neuronal degeneration, and that the synaptic dysfunction is caused by diffusible oligomeric assemblies of the amyloid β protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsFVFyrx-gM7Vg90H21EOLACvtfcHk0libih9_X_03ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotFSnur0%253D&md5=5927195bd25a2d0fdf1663972f32a139</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1126%2Fscience.1074069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1074069%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520is%2520a%2520synaptic%2520failure%26jtitle%3DScience%26date%3D2002%26volume%3D298%26issue%3D5594%26spage%3D789%26epage%3D791%26doi%3D10.1126%2Fscience.1074069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bloom, G. S.</span></span> <span> </span><span class="NLM_article-title">Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis</span>. <i>Jama Neurol</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">505</span>– <span class="NLM_lpage">508</span>, <span class="refDoi"> DOI: 10.1001/jamaneurol.2013.5847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1001%2Fjamaneurol.2013.5847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=24493463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BC2cvhslWmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=505-508&issue=4&author=G.+S.+Bloom&title=Amyloid-beta+and+tau%3A+the+trigger+and+bullet+in+Alzheimer+disease+pathogenesis&doi=10.1001%2Fjamaneurol.2013.5847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis</span></div><div class="casAuthors">Bloom George S</div><div class="citationInfo"><span class="NLM_cas:title">JAMA neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">505-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The defining features of Alzheimer disease (AD) include conspicuous changes in both brain histology and behavior.  The AD brain is characterized microscopically by the combined presence of 2 classes of abnormal structures, extracellular amyloid plaques and intraneuronal neurofibrillary tangles, both of which comprise highly insoluble, densely packed filaments.  The soluble building blocks of these structures are amyloid-β (Aβ) peptides for plaques and tau for tangles.  Amyloid-β peptides are proteolytic fragments of the transmembrane amyloid precursor protein, whereas tau is a brain-specific, axon-enriched microtubule-associated protein.  The behavioral symptoms of AD correlate with the accumulation of plaques and tangles, and they are a direct consequence of the damage and destruction of synapses that mediate memory and cognition.  Synapse loss can be caused by the failure of live neurons to maintain functional axons and dendrites or by neuron death.  During the past dozen years, a steadily accumulating body of evidence has indicated that soluble forms of Aβ and tau work together, independently of their accumulation into plaques and tangles, to drive healthy neurons into the diseased state and that hallmark toxic properties of Aβ require tau.  For instance, acute neuron death, delayed neuron death following ectopic cell cycle reentry, and synaptic dysfunction are triggered by soluble, extracellular Aβ species and depend on soluble, cytoplasmic tau.  Therefore, Aβ is upstream of tau in AD pathogenesis and triggers the conversion of tau from a normal to a toxic state, but there is also evidence that toxic tau enhances Aβ toxicity via a feedback loop.  Because soluble toxic aggregates of both Aβ and tau can self-propagate and spread throughout the brain by prionlike mechanisms, successful therapeutic intervention for AD would benefit from detecting these species before plaques, tangles, and cognitive impairment become evident and from interfering with the destructive biochemical pathways that they initiate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSz_gqDeA-SdD0O18WR3iAofW6udTcc2eZNzRkJrscQzLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvhslWmsA%253D%253D&md5=a12c1fb9fb6f57c471009a3b30573fb3</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1001%2Fjamaneurol.2013.5847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjamaneurol.2013.5847%26sid%3Dliteratum%253Aachs%26aulast%3DBloom%26aufirst%3DG.%2BS.%26atitle%3DAmyloid-beta%2520and%2520tau%253A%2520the%2520trigger%2520and%2520bullet%2520in%2520Alzheimer%2520disease%2520pathogenesis%26jtitle%3DJama%2520Neurol%26date%3D2014%26volume%3D71%26issue%3D4%26spage%3D505%26epage%3D508%26doi%3D10.1001%2Fjamaneurol.2013.5847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">East, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campanella, M.</span></span> <span> </span><span class="NLM_article-title">Mitophagy and the therapeutic clearance of damaged mitochondria for neuroprotection</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">382</span>– <span class="NLM_lpage">387</span>, <span class="refDoi"> DOI: 10.1016/j.biocel.2016.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.biocel.2016.08.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27586258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFWiur%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=382-387&author=D.+A.+Eastauthor=M.+Campanella&title=Mitophagy+and+the+therapeutic+clearance+of+damaged+mitochondria+for+neuroprotection&doi=10.1016%2Fj.biocel.2016.08.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Mitophagy and the therapeutic clearance of damaged mitochondria for neuroprotection</span></div><div class="casAuthors">East, Daniel A.; Campanella, Michelangelo</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">382-387</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Mitochondria are the foremost producers of the cellular energy currency ATP.  They are also a significant source of reactive oxygen species and an important buffer of intracellular calcium.  Mitochondrial retrograde signals regulate energy homeostasis and pro-survival elements whereas anterograde stimuli can trigger programmed cell death.  Maintenance of a healthy, functional mitochondria network is therefore essential, and several mechanisms of mitochondrial quality control have been described.  Mitochondrial dysfunction is linked to several neurodegenerative conditions including Parkinson, and Huntingdon diseases as well as Amyotrophic lateral sclerosis.  Understanding the mechanisms governing mitochondrial quality control may reveal novel strategies for pharmacol. intervention and disease therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRFDFcGXuZbbVg90H21EOLACvtfcHk0lia_2k_HwR9fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFWiur%252FN&md5=1edd00e2b8fb1e55e005bace7931bf35</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2016.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2016.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DEast%26aufirst%3DD.%2BA.%26aulast%3DCampanella%26aufirst%3DM.%26atitle%3DMitophagy%2520and%2520the%2520therapeutic%2520clearance%2520of%2520damaged%2520mitochondria%2520for%2520neuroprotection%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2016%26volume%3D79%26spage%3D382%26epage%3D387%26doi%3D10.1016%2Fj.biocel.2016.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Babu, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibenhener, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strom, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemppainen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, M. W.</span></span> <span> </span><span class="NLM_article-title">Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">120</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2008.05340.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1111%2Fj.1471-4159.2008.05340.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18346206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1Ohu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2008&pages=107-120&issue=1&author=J.+R.+Babuauthor=M.+L.+Seibenhenerauthor=J.+M.+Pengauthor=A.+L.+Stromauthor=R.+Kemppainenauthor=N.+Coxauthor=H.+N.+Zhuauthor=M.+C.+Wootenauthor=M.+T.+Diaz-Mecoauthor=J.+Moscatauthor=M.+W.+Wooten&title=Genetic+inactivation+of+p62+leads+to+accumulation+of+hyperphosphorylated+tau+and+neurodegeneration&doi=10.1111%2Fj.1471-4159.2008.05340.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic inactivation of p62 leads to accumulation of hyper-phosphorylated tau and neurodegeneration</span></div><div class="casAuthors">Babu, J. Ramesh; Seibenhener, M. Lamar; Peng, Junmin; Strom, Anna-Lena; Kemppainen, Robert; Cox, Nancy; Zhu, Haining; Wooten, Michael C.; Diaz-Meco, Maria T.; Moscat, Jorge; Wooten, Marie W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">107-120</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The signaling adapter p62 plays a coordinating role in mediating phosphorylation and ubiquitin-dependent trafficking of interacting proteins.  However, there is little known about the physiol. role of this protein in brain.  Here, we report age-dependent constitutive activation of glycogen synthase kinase 3β, protein kinase B, mitogen-activated protein kinase, and c-Jun-N-terminal kinase in adult p62-/- mice resulting in hyperphosphorylated tau, neurofibrillary tangles, and neurodegeneration.  Biochem. fractionation of p62-/- brain led to recovery of aggregated K63-ubiquitinated tau.  Loss of p62 was manifested by increased anxiety, depression, loss of working memory, and reduced serum brain-derived neurotrophic factor levels.  Our findings reveal a novel role for p62 as a chaperone that regulates tau soly. thereby preventing tau aggregation.  This study provides a clear demonstration of an Alzheimer-like phenotype in a mouse model in the absence of expression of human genes carrying mutations in amyloid-beta protein precursor, presenilin 1, or tau.  Thus, these findings provide new insight into manifestation of sporadic Alzheimer disease and the impact of obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqctPwjnpXAg7Vg90H21EOLACvtfcHk0ljXa1h7DrwOSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1Ohu7k%253D&md5=56d5b60e29220ad7fdcc50d7a698f6d2</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05340.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05340.x%26sid%3Dliteratum%253Aachs%26aulast%3DBabu%26aufirst%3DJ.%2BR.%26aulast%3DSeibenhener%26aufirst%3DM.%2BL.%26aulast%3DPeng%26aufirst%3DJ.%2BM.%26aulast%3DStrom%26aufirst%3DA.%2BL.%26aulast%3DKemppainen%26aufirst%3DR.%26aulast%3DCox%26aufirst%3DN.%26aulast%3DZhu%26aufirst%3DH.%2BN.%26aulast%3DWooten%26aufirst%3DM.%2BC.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DWooten%26aufirst%3DM.%2BW.%26atitle%3DGenetic%2520inactivation%2520of%2520p62%2520leads%2520to%2520accumulation%2520of%2520hyperphosphorylated%2520tau%2520and%2520neurodegeneration%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D106%26issue%3D1%26spage%3D107%26epage%3D120%26doi%3D10.1111%2Fj.1471-4159.2008.05340.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soto, C.</span></span> <span> </span><span class="NLM_article-title">Unfolding the role of protein misfolding in neurodegenerative diseases</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1038/nrn1007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fnrn1007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=12511861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=49-60&issue=1&author=C.+Soto&title=Unfolding+the+role+of+protein+misfolding+in+neurodegenerative+diseases&doi=10.1038%2Fnrn1007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Unfolding the role of protein misfolding in neurodegenerative diseases</span></div><div class="casAuthors">Soto, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-60</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recent evidence indicates that diverse neurodegenerative diseases might have a common cause and pathol. mechanism - the misfolding, aggregation and accumulation of proteins in the brain, resulting in neuronal apoptosis.  Studies from different disciplines strongly support this hypothesis and indicate that a common therapy for these devastating disorders might be possible.  The aim of this article is to review the literature on the mol. mechanism of protein misfolding and aggregation, its role in neurodegeneration and the potential targets for therapeutic intervention in neurodegenerative diseases.  Many questions still need to be answered and future research in this field will result in exciting new discoveries that might impact other areas of biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt-G4N2FMUNbVg90H21EOLACvtfcHk0ljXa1h7DrwOSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlY%253D&md5=08a612ce6947fd846bb0d469fa747bef</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1038%2Fnrn1007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1007%26sid%3Dliteratum%253Aachs%26aulast%3DSoto%26aufirst%3DC.%26atitle%3DUnfolding%2520the%2520role%2520of%2520protein%2520misfolding%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2003%26volume%3D4%26issue%3D1%26spage%3D49%26epage%3D60%26doi%3D10.1038%2Fnrn1007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attarwala, I. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X. Q.</span></span> <span> </span><span class="NLM_article-title">SQSTM1/p62: a potential target for neurodegenerative disease</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2094</span>– <span class="NLM_lpage">2114</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00516</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00516" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtl2rur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=2094-2114&issue=5&author=S.+F.+Maauthor=I.+Y.+Attarwalaauthor=X.+Q.+Xie&title=SQSTM1%2Fp62%3A+a+potential+target+for+neurodegenerative+disease&doi=10.1021%2Facschemneuro.8b00516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">SQSTM1/p62: A Potential Target for Neurodegenerative Disease</span></div><div class="casAuthors">Ma, Shifan; Attarwala, Insiya; Xie, Xiangqun</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2094-2114</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative diseases, characterized by a progressive loss of brain function, affect the lives of millions of individuals worldwide.  The complexity of the brain poses a challenge for scientists who are trying to map the biochem. and physiol. pathways in order to identify areas of pathol. errors.  Brain samples of patients with neurodegenerative diseases have been shown to contain large amts. of misfolded and abnormally aggregated proteins, resulting in dysfunction in certain brain centers.  Removal of these abnormal mols. is essential in maintaining protein homeostasis and overall neuron health.  Macroautophagy is the major route by which cells achieve this.  Administration of certain autophagy-enhancing compds. has been shown to provide therapeutic effects for individuals with neurodegenerative conditions.  SQSTM1/p62 is a scaffold protein closely involved in the macroautophagy process.  P62 functions to anchor the ubiquitinated proteins to the autophagosome membrane, promoting degrdn. of unwanted mols.  Modulators targeting p62 to induce autophagy and promote its protective pathways for aggregate protein clearance have high potential in the treatment of these conditions.  Addnl., causal relationships have been found between errors in regulation of SQSTM1/p62 and the development of a variety of neurodegenerative disorders, including Alzheimer's, Parkinson's, Huntington's, Amyotrophic lateral sclerosis, and Frontotemporal lobar degeneration.  Furthermore, SQSTM1/p62 also serves as a signaling hub for multiple pathways assocd. with neurodegeneration, providing a potential therapeutic target in the treatment of neurodegenerative diseases.  However, rational design of a p62-oriented autophagy modulator that can balance the neg. and pos. functions of multiple domains in p62 requires further efforts in the exploration of the protein structure and pathol. basis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSNzt9o2QeTrVg90H21EOLACvtfcHk0lheRWkhYT9DWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtl2rur4%253D&md5=719eb875d2f58b8e8156c06c3df90778</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00516%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DS.%2BF.%26aulast%3DAttarwala%26aufirst%3DI.%2BY.%26aulast%3DXie%26aufirst%3DX.%2BQ.%26atitle%3DSQSTM1%252Fp62%253A%2520a%2520potential%2520target%2520for%2520neurodegenerative%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26issue%3D5%26spage%3D2094%26epage%3D2114%26doi%3D10.1021%2Facschemneuro.8b00516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. F.</span></span> <span> </span><span class="NLM_article-title">p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation</span>. <i>Cell. Mol. Biol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">29</span>, <span class="refDoi"> DOI: 10.1186/s11658-016-0031-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1186%2Fs11658-016-0031-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=28536631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsVSmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=29&author=W.+J.+Liuauthor=L.+Yeauthor=W.+F.+Huangauthor=L.+J.+Guoauthor=Z.+G.+Xuauthor=H.+L.+Wuauthor=C.+Yangauthor=H.+F.+Liu&title=p62+links+the+autophagy+pathway+and+the+ubiqutin-proteasome+system+upon+ubiquitinated+protein+degradation&doi=10.1186%2Fs11658-016-0031-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">P62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation</span></div><div class="casAuthors">Liu, Wei Jing; Ye, Lin; Huang, Wei Fang; Guo, Lin Jie; Xu, Zi Gan; Wu, Hong Luan; Yang, Chen; Liu, Hua Feng</div><div class="citationInfo"><span class="NLM_cas:title">Cellular & Molecular Biology Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">29/1-29/14</span>CODEN:
                <span class="NLM_cas:coden">CMBLFF</span>;
        ISSN:<span class="NLM_cas:issn">1689-1392</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">The ubiquitin-proteasome system (UPS) and autophagy are two distinct and interacting proteolytic systems.  They play crit. roles in cell survival under normal conditions and during stress.  An increasing body of evidence indicates that ubiquitinated cargoes are important markers of degrdn. p62, a classical receptor of autophagy, is a multifunctional protein located throughout the cell and involved in many signal transduction pathways, including the Keap1-Nrf2 pathway.  It is involved in the proteasomal degrdn. of ubiquitinated proteins.  When the cellular p62 level is manipulated, the quantity and location pattern of ubiquitinated proteins change with a considerable impact on cell survival.  Altered p62 levels can even lead to some diseases.  The proteotoxic stress imposed by proteasome inhibition can activate autophagy through p62 phosphorylation.  A deficiency in autophagy may compromise the ubiquitin-proteasome system, since overabundant p62 delays delivery of the proteasomal substrate to the proteasome despite proteasomal catalytic activity being unchanged.  In addn., p62 and the proteasome can modulate the activity of HDAC6 deacetylase, thus influencing the autophagic degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9as-ehXGDY7Vg90H21EOLACvtfcHk0lheRWkhYT9DWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsVSmsbk%253D&md5=50e9a4781bb48f49fe7b9d5943c5d618</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1186%2Fs11658-016-0031-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs11658-016-0031-z%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%2BJ.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DW.%2BF.%26aulast%3DGuo%26aufirst%3DL.%2BJ.%26aulast%3DXu%26aufirst%3DZ.%2BG.%26aulast%3DWu%26aufirst%3DH.%2BL.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DH.%2BF.%26atitle%3Dp62%2520links%2520the%2520autophagy%2520pathway%2520and%2520the%2520ubiqutin-proteasome%2520system%2520upon%2520ubiquitinated%2520protein%2520degradation%26jtitle%3DCell.%2520Mol.%2520Biol.%2520Lett.%26date%3D2016%26volume%3D21%26spage%3D29%26doi%3D10.1186%2Fs11658-016-0031-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Babu, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geetha, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, M. W.</span></span> <span> </span><span class="NLM_article-title">Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>94</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">192</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2005.03181.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1111%2Fj.1471-4159.2005.03181.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=15953362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvFCksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2005&pages=192-203&issue=1&author=J.+R.+Babuauthor=T.+Geethaauthor=M.+W.+Wooten&title=Sequestosome+1%2Fp62+shuttles+polyubiquitinated+tau+for+proteasomal+degradation&doi=10.1111%2Fj.1471-4159.2005.03181.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation</span></div><div class="casAuthors">Babu, Jeganathan Ramesh; Geetha, Thangiah; Wooten, Marie W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">192-203</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Inclusions isolated from several neurodegenerative diseases, including Alzheimer's disease (AD), are characterized by ubiquitin-pos. proteinaceous aggregates.  Employing confocal and immunoelectron microscopy, we find that the ubiquitin-assocg. protein sequestosome1/p62, co-localizes to aggregates isolated from AD but not control brain, along with the E3 ubiquitin ligase, TRAF6.  This interaction could be recapitulated by co-transfection in HEK293 cells.  Employing both in vitro and in vivo approaches, tau was found to be a substrate of the TRAF6, possessing lysine 63 polyubiquitin chains.  Moreover, tau recovered from brain of TRAF6 knockout mice, compared with wild type, was not ubiquitinated.  Tau degrdn. took place through the ubiquitin-proteasome pathway and was dependent upon either the K63-polyubiquitin chains or upon p62.  In brain lysates of p62 knockout mice, tau fails to co-interact with Rpt1, a proteasomal subunit, thereby indicating a requirement for p62 shuttling of tau to the proteasome.  Our results demonstrate that p62 interacts with K63-polyubiquitinated tau through its UBA domain and serves a novel role in regulating tau proteasomal degrdn.  We propose a model whereby either a decline in p62 expression or a decrease in proteasome activity may contribute to accumulation of insol./aggregated K63-polyubiquitinated tau.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxggL6oD-wILVg90H21EOLACvtfcHk0lheRWkhYT9DWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvFCksbY%253D&md5=1cba213bc86a63595bd3c9ea92d7e34d</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2005.03181.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2005.03181.x%26sid%3Dliteratum%253Aachs%26aulast%3DBabu%26aufirst%3DJ.%2BR.%26aulast%3DGeetha%26aufirst%3DT.%26aulast%3DWooten%26aufirst%3DM.%2BW.%26atitle%3DSequestosome%25201%252Fp62%2520shuttles%2520polyubiquitinated%2520tau%2520for%2520proteasomal%2520degradation%26jtitle%3DJ.%2520Neurochem.%26date%3D2005%26volume%3D94%26issue%3D1%26spage%3D192%26epage%3D203%26doi%3D10.1111%2Fj.1471-4159.2005.03181.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaidi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundkeiqbal, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, K.</span></span> <span> </span><span class="NLM_article-title">Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer-disease</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>91</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5562</span>– <span class="NLM_lpage">5566</span>, <span class="refDoi"> DOI: 10.1073/pnas.91.12.5562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1073%2Fpnas.91.12.5562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=8202528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADyaK2c3mtFKhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=5562-5566&issue=12&author=A.+D.+Alonsoauthor=T.+Zaidiauthor=I.+Grundkeiqbalauthor=K.+Iqbal&title=Role+of+abnormally+phosphorylated+tau+in+the+breakdown+of+microtubules+in+Alzheimer-disease&doi=10.1073%2Fpnas.91.12.5562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease</span></div><div class="casAuthors">Alonso A C; Zaidi T; Grundke-Iqbal I; Iqbal K</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5562-6</span>
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The microtubule assembly-promoting activity of different pools of tau protein isolated from Alzheimer disease (AD) and control brains and the effect of dephosphorylation on this activity were studied.  Tau isolated from a 2.5% perchloric extract of AD brain had almost the same activity as that obtained from control brain, and this activity did not change significantly on dephosphorylation.  Abnormally phosphorylated tau (AD P-tau) isolated from brain homogenate of AD patients had little activity, and upon dephosphorylation with alkaline phosphatase, its activity increased to approximately the same level as the acid-soluble tau.  Addition of AD P-tau to a mixture of normal tau and tubulin inhibited microtubule assembly.  AD P-tau bound to normal tau but not to tubulin.  These studies suggest that the abnormal phosphorylation of tau might be responsible for the breakdown of microtubules in affected neurons in AD not only because the altered protein has little microtubule-promoting activity but also because it interacts with normal tau, making the latter unavailable for promoting the assembly of tubulin into microtubules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5nJ1wCLFdwrZpSb_XWfMrfW6udTcc2ebRid97UrBGbrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c3mtFKhtA%253D%253D&md5=4b73493ac98f48a1d5b6976104bd5ca3</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.12.5562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.12.5562%26sid%3Dliteratum%253Aachs%26aulast%3DAlonso%26aufirst%3DA.%2BD.%26aulast%3DZaidi%26aufirst%3DT.%26aulast%3DGrundkeiqbal%26aufirst%3DI.%26aulast%3DIqbal%26aufirst%3DK.%26atitle%3DRole%2520of%2520abnormally%2520phosphorylated%2520tau%2520in%2520the%2520breakdown%2520of%2520microtubules%2520in%2520Alzheimer-disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26issue%3D12%26spage%3D5562%26epage%3D5566%26doi%3D10.1073%2Fpnas.91.12.5562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">Medicine-the amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>297</i></span> (<span class="NLM_issue">5580</span>),  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1126/science.1072994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&issue=5580&author=J.+Hardyauthor=D.+J.+Selkoe&title=Medicine-the+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+progress+and+problems+on+the+road+to+therapeutics&doi=10.1126%2Fscience.1072994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0ljTM1x3YKn2hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DMedicine-the%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26issue%3D5580%26spage%3D353%26epage%3D356%26doi%3D10.1126%2Fscience.1072994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geetha, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGregor, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh, J.</span></span> <span> </span><span class="NLM_article-title">TRAF6 and p62 inhibit amyloid beta-induced neuronal death through p75 neurotrophin receptor</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1289</span>– <span class="NLM_lpage">1293</span>, <span class="refDoi"> DOI: 10.1016/j.neuint.2012.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.neuint.2012.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=23017601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs12ksbvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=1289-1293&issue=8&author=T.+Geethaauthor=C.+Zhengauthor=W.+C.+McGregorauthor=B.+D.+Whiteauthor=M.+T.+Diaz-Mecoauthor=J.+Moscatauthor=J.+Ramesh&title=TRAF6+and+p62+inhibit+amyloid+beta-induced+neuronal+death+through+p75+neurotrophin+receptor&doi=10.1016%2Fj.neuint.2012.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">TRAF6 and p62 inhibit amyloid β-induced neuronal death through p75 neurotrophin receptor</span></div><div class="casAuthors">Geetha, Thangiah; Zheng, Chen; McGregor, Wade C.; Douglas White, B.; Diaz-Meco, Maria T.; Moscat, Jorge; Babu, Jeganathan Ramesh</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1289-1293</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Amyloid β (Aβ) aggregates are the primary component of senile plaques in Alzheimer disease (AD) patient's brain.  Aβ is known to bind p75 neurotrophin receptor (p75NTR) and mediates Aβ-induced neuronal death.  Recently, we showed that NGF leads to p75NTR polyubiquitination, which promotes neuronal cell survival.  Here, we demonstrate that Aβ stimulation impaired the p75NTR polyubiquitination.  TRAF6 and p62 are required for polyubiquitination of p75NTR on NGF stimulation.  Interestingly, we found that overexpression of TRAF6/p62 restored p75NTR polyubiquitination upon Aβ/NGF treatment.  Aβ significantly reduced NF-κB activity by attenuating the interaction of p75NTR with IKKβ. p75NTR increased NF-κB activity by recruiting TRAF6/p62, which thereby mediated cell survival.  These findings indicate that TRAF6/p62 abrogated the Aβ-mediated inhibition of p75NTR polyubiquitination and restored neuronal cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbVMszTf9ngbVg90H21EOLACvtfcHk0ljTM1x3YKn2hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs12ksbvL&md5=e4060f807da58fbda95ad4c2afeecf64</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2012.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2012.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DGeetha%26aufirst%3DT.%26aulast%3DZheng%26aufirst%3DC.%26aulast%3DMcGregor%26aufirst%3DW.%2BC.%26aulast%3DWhite%26aufirst%3DB.%2BD.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DRamesh%26aufirst%3DJ.%26atitle%3DTRAF6%2520and%2520p62%2520inhibit%2520amyloid%2520beta-induced%2520neuronal%2520death%2520through%2520p75%2520neurotrophin%2520receptor%26jtitle%3DNeurochem.%2520Int.%26date%3D2012%26volume%3D61%26issue%3D8%26spage%3D1289%26epage%3D1293%26doi%3D10.1016%2Fj.neuint.2012.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brendza, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bales, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzman, D. M.</span></span> <span> </span><span class="NLM_article-title">Role of apoE/Abeta interactions in Alzheimer’s disease: insights from transgenic mouse models</span>. <i>Mol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.1038/sj.mp.4001006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fsj.mp.4001006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=11840304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BD387jvVaktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2002&pages=132-135&issue=2&author=R.+P.+Brendzaauthor=K.+R.+Balesauthor=S.+M.+Paulauthor=D.+M.+Holtzman&title=Role+of+apoE%2FAbeta+interactions+in+Alzheimer%E2%80%99s+disease%3A+insights+from+transgenic+mouse+models&doi=10.1038%2Fsj.mp.4001006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Role of apoE/Abeta interactions in Alzheimer's disease: insights from transgenic mouse models</span></div><div class="casAuthors">Brendza R P; Bales K R; Paul S M; Holtzman D M</div><div class="citationInfo"><span class="NLM_cas:title">Molecular psychiatry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">132-5</span>
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQvX8euXtprFOQ4Pl9hzjQhfW6udTcc2ebRid97UrBGbrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387jvVaktA%253D%253D&md5=f8b151eb9a16f6e74c60d3bfcb21a73f</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4001006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4001006%26sid%3Dliteratum%253Aachs%26aulast%3DBrendza%26aufirst%3DR.%2BP.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DPaul%26aufirst%3DS.%2BM.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26atitle%3DRole%2520of%2520apoE%252FAbeta%2520interactions%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520insights%2520from%2520transgenic%2520mouse%2520models%26jtitle%3DMol.%2520Psychiatry%26date%3D2002%26volume%3D7%26issue%3D2%26spage%3D132%26epage%3D135%26doi%3D10.1038%2Fsj.mp.4001006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whitfield, J. F.</span></span> <span> </span><span class="NLM_article-title">The road to load late-onset Alzheimer’s disease and a possible way to block it</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1257</span>– <span class="NLM_lpage">1260</span>, <span class="refDoi"> DOI: 10.1517/14728222.11.10.1257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1517%2F14728222.11.10.1257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=17907956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSgsbjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=1257-1260&issue=10&author=J.+F.+Whitfield&title=The+road+to+load+late-onset+Alzheimer%E2%80%99s+disease+and+a+possible+way+to+block+it&doi=10.1517%2F14728222.11.10.1257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">The road to load late-onset Alzheimer's disease and a possible way to block it</span></div><div class="casAuthors">Whitfield, James F.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1257-1260</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The ageing brain becomes increasingly less able to destroy or eject toxic amyloid (A) β42 peptide byproducts of normal neuronal activity that consequently accumulate to induce Alzheimer's disease (AD).  Therefore, the various components of the Aβ-clearing machinery are prime targets for AD therapeutics.  In this connection, there are reports that taking statins to lower circulating cholesterol to prevent cardiovascular disease can also prevent late-onset AD (LOAD) the most common form of the disease.  However, it seems unlikely that statins would prevent LOAD by lowering the very long-lived brain cholesterol that is controlled independently from the very much shorter-lived circulating cholesterol.  In fact, reducing the ability of the brain astrocytes to make cholesterol for their closely assocd. neuron clients' synaptogenesis could damage the brain rather than protect it.  However, a plausible way statins might prevent LOAD is to target a main component of the clearance machinery, low-d. lipoprotein receptor-related protein 1 (LRP1), the brain's powerful Aβ-efflux driver.  This is indicated by a reported ability of micromolar concns. of lovastatin and simvastatin to strongly stimulate brain vascular endothelial cells to make this Aβ ejector.  Therefore, if this holds up, taking a statin over the years would prevent the normal decline of LRP1 in the ageing brain and a LOAD-driving accumulation of Aβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVVpuLv-ZGHrVg90H21EOLACvtfcHk0lj9j7qQN8x13w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSgsbjO&md5=0e60abd1ed0368305562bef0a541b213</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1517%2F14728222.11.10.1257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.11.10.1257%26sid%3Dliteratum%253Aachs%26aulast%3DWhitfield%26aufirst%3DJ.%2BF.%26atitle%3DThe%2520road%2520to%2520load%2520late-onset%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520a%2520possible%2520way%2520to%2520block%2520it%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2007%26volume%3D11%26issue%3D10%26spage%3D1257%26epage%3D1260%26doi%3D10.1517%2F14728222.11.10.1257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geetha, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unroe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sycheva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kluess, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, J. R.</span></span> <span> </span><span class="NLM_article-title">Polyubiquitination of the neurotrophin receptor p75 directs neuronal cell survival</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>421</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">286</span>– <span class="NLM_lpage">290</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2012.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.bbrc.2012.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22503986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFygur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2012&pages=286-290&issue=2&author=T.+Geethaauthor=C.+Zhengauthor=B.+Unroeauthor=M.+Sychevaauthor=H.+Kluessauthor=J.+R.+Babu&title=Polyubiquitination+of+the+neurotrophin+receptor+p75+directs+neuronal+cell+survival&doi=10.1016%2Fj.bbrc.2012.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Polyubiquitination of the neurotrophin receptor p75 directs neuronal cell survival</span></div><div class="casAuthors">Geetha, Thangiah; Zheng, Chen; Unroe, Bradford; Sycheva, Marina; Kluess, Heidi; Babu, Jeganathan Ramesh</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">421</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">286-290</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Specific binding of nerve growth factor (NGF) to p75 neurotrophin receptor (p75NTR) leads to p75NTR polyubiquitination and its subsequent interaction with TRAF6 resulting in neuronal cell survival.  However, when the binding of NGF to p75NTR was blocked with p75 antiserum, p75NTR polyubiquitination and neuronal cell survival were impaired.  Results showed that tyrosine phosphorylation of p75NTR increased the polyubiquitination of p75NTR and contributed to the obsd. apparent neuroprotective effects.  Similar to p75NTR polyubiquitination, interaction of TRAF6 with p75NTR was NGF/tyrosine phosphorylation dependent suggesting that TRAF6 might function as an E3 ubiquitin ligase.  In sum, the results show that specific binding of NGF to p75NTR mediates neuronal cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsFKFBdVd847Vg90H21EOLACvtfcHk0lj9j7qQN8x13w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFygur8%253D&md5=01cd2f471fb0f884aa4cc51d93403a5e</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2012.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2012.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DGeetha%26aufirst%3DT.%26aulast%3DZheng%26aufirst%3DC.%26aulast%3DUnroe%26aufirst%3DB.%26aulast%3DSycheva%26aufirst%3DM.%26aulast%3DKluess%26aufirst%3DH.%26aulast%3DBabu%26aufirst%3DJ.%2BR.%26atitle%3DPolyubiquitination%2520of%2520the%2520neurotrophin%2520receptor%2520p75%2520directs%2520neuronal%2520cell%2520survival%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2012%26volume%3D421%26issue%3D2%26spage%3D286%26epage%3D290%26doi%3D10.1016%2Fj.bbrc.2012.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mamidipudi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, M. W.</span></span> <span> </span><span class="NLM_article-title">Identification of interleukin 1 receptor-associated kinase as a conserved component in the p75-neurotrophin receptor activation of nuclear factor-kappa B</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>277</i></span> (<span class="NLM_issue">31</span>),  <span class="NLM_fpage">28010</span>– <span class="NLM_lpage">28018</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109730200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1074%2Fjbc.M109730200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=12034707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvFKgtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=28010-28018&issue=31&author=V.+Mamidipudiauthor=X.+X.+Liauthor=M.+W.+Wooten&title=Identification+of+interleukin+1+receptor-associated+kinase+as+a+conserved+component+in+the+p75-neurotrophin+receptor+activation+of+nuclear+factor-kappa+B&doi=10.1074%2Fjbc.M109730200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of interleukin 1 receptor-associated kinase as a conserved component in the p75-neurotrophin receptor activation of nuclear factor-κB</span></div><div class="casAuthors">Mamidipudi, Vidya; Li, Xiaoxia; Wooten, Marie W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">28010-28018</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The neurotrophin nerve growth factor (NGF) supports neuronal survival by activating the transcription factor nuclear factor-κB (NF-κB).  The authors report here, for the first time, the identification of p75-assocd. kinase that mediates NGF-driven NF-κB activation.  Using co-immunopptn., they demonstrate an NGF-dependent assocn. of interleukin 1 receptor-assocd. kinase (IRAK) with the p75 neurotrophin receptor in PC12 cells.  The authors' results reveal that IRAK is recruited to the p75-NGF receptor leading to formation of a complex between IRAK, atypical protein kinase C interacting protein, p62, and TRAF6.  Activation of NF-κB occurs predominantly through the p75 receptor, and TrkA activity suppresses NF-κB activation and retards IκBβ degrdn.  In addn., the authors obsd. a requirement for the kinase activity of IRAK in mediating NGF-induced NF-κB activation, recruitment of the adapter protein p62 to the p75 receptor, and cell survival.  Moreover, p75-IRAK-mediated κB activation and the recruitment of IKKβ, but not IKKα, to the receptor require p62.  The authors' data thus provide novel information regarding the proximal components involved in p75 receptor signaling and underscore the importance of the atypical PKC interacting protein p62 in this process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPWw9vYNnG2LVg90H21EOLACvtfcHk0lj9j7qQN8x13w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvFKgtLY%253D&md5=03ef477fadf5369c6e6535249a0a1daa</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109730200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109730200%26sid%3Dliteratum%253Aachs%26aulast%3DMamidipudi%26aufirst%3DV.%26aulast%3DLi%26aufirst%3DX.%2BX.%26aulast%3DWooten%26aufirst%3DM.%2BW.%26atitle%3DIdentification%2520of%2520interleukin%25201%2520receptor-associated%2520kinase%2520as%2520a%2520conserved%2520component%2520in%2520the%2520p75-neurotrophin%2520receptor%2520activation%2520of%2520nuclear%2520factor-kappa%2520B%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26issue%3D31%26spage%3D28010%26epage%3D28018%26doi%3D10.1074%2Fjbc.M109730200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adriaanse, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greig, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cader, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohr, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, E. F.</span></span> <span> </span><span class="NLM_article-title">Mitophagy and Alzheimer’s disease: cellular and molecular mechanisms</span>. <i>Trends Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1016/j.tins.2017.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.tins.2017.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=28190529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitFeitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2017&pages=151-166&issue=3&author=J.+S.+Kerrauthor=B.+A.+Adriaanseauthor=N.+H.+Greigauthor=M.+P.+Mattsonauthor=M.+Z.+Caderauthor=V.+A.+Bohrauthor=E.+F.+Fang&title=Mitophagy+and+Alzheimer%E2%80%99s+disease%3A+cellular+and+molecular+mechanisms&doi=10.1016%2Fj.tins.2017.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Mitophagy and Alzheimer's Disease: Cellular and Molecular Mechanisms</span></div><div class="casAuthors">Kerr, Jesse S.; Adriaanse, Bryan A.; Greig, Nigel H.; Mattson, Mark P.; Cader, M. Zameel; Bohr, Vilhelm A.; Fang, Evandro F.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Neurosciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">151-166</span>CODEN:
                <span class="NLM_cas:coden">TNSCDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-2236</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Neurons affected in Alzheimer's disease (AD) experience mitochondrial dysfunction and a bioenergetic deficit that occurs early and promotes the disease-defining amyloid beta peptide (Aβ) and Tau pathologies.  Emerging findings suggest that the autophagy/lysosome pathway that removes damaged mitochondria (mitophagy) is also compromised in AD, resulting in the accumulation of dysfunctional mitochondria.  Results in animal and cellular models of AD and in patients with sporadic late-onset AD suggest that impaired mitophagy contributes to synaptic dysfunction and cognitive deficits by triggering Aβ and Tau accumulation through increases in oxidative damage and cellular energy deficits; these, in turn, impair mitophagy.  Interventions that bolster mitochondrial health and/or stimulate mitophagy may therefore forestall the neurodegenerative process in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_-MRZbZ4Y1bVg90H21EOLACvtfcHk0liVkBvIH0ra1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitFeitb8%253D&md5=3365c23656a7890481e1553fd018808f</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2017.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2017.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DKerr%26aufirst%3DJ.%2BS.%26aulast%3DAdriaanse%26aufirst%3DB.%2BA.%26aulast%3DGreig%26aufirst%3DN.%2BH.%26aulast%3DMattson%26aufirst%3DM.%2BP.%26aulast%3DCader%26aufirst%3DM.%2BZ.%26aulast%3DBohr%26aufirst%3DV.%2BA.%26aulast%3DFang%26aufirst%3DE.%2BF.%26atitle%3DMitophagy%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520cellular%2520and%2520molecular%2520mechanisms%26jtitle%3DTrends%2520Neurosci.%26date%3D2017%26volume%3D40%26issue%3D3%26spage%3D151%26epage%3D166%26doi%3D10.1016%2Fj.tins.2017.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamat, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyles, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagi, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagi, N.</span></span> <span> </span><span class="NLM_article-title">Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease</span>. <i>Cell Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>70</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">707</span>– <span class="NLM_lpage">719</span>, <span class="refDoi"> DOI: 10.1007/s12013-014-0006-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1007%2Fs12013-014-0006-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=24807843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXns1aisrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2014&pages=707-719&issue=2&author=P.+K.+Kamatauthor=A.+Kalaniauthor=P.+Kylesauthor=S.+C.+Tyagiauthor=N.+Tyagi&title=Autophagy+of+mitochondria%3A+a+promising+therapeutic+target+for+neurodegenerative+disease&doi=10.1007%2Fs12013-014-0006-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy of Mitochondria: A Promising Therapeutic Target for Neurodegenerative Disease</span></div><div class="casAuthors">Kamat, Pradip K.; Kalani, Anuradha; Kyles, Philip; Tyagi, Suresh C.; Tyagi, Neetu</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">707-719</span>CODEN:
                <span class="NLM_cas:coden">CBBIFV</span>;
        ISSN:<span class="NLM_cas:issn">1085-9195</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The autophagic process is the only known mechanism for mitochondrial turnover and it has been speculated that dysfunction of autophagy may result in mitochondrial error and cellular stress.  Emerging investigations have provided new understanding of how autophagy of mitochondria (also known as mitophagy) is assocd. with cellular oxidative stress and its impact on neurodegeneration.  This impaired autophagic function may be considered as a possible mechanism in the pathogenesis of several neurodegenerative disorders including Parkinson's disease, Alzheimer's disease, multiple sclerosis, amyotrophic lateral sclerosis, and Huntington disease.  It can be suggested that autophagy dysfunction along with oxidative stress is considered main events in neurodegenerative disorders.  New therapeutic approaches have now begun to target mitochondria as a potential drug target.  This review discusses evidence supporting the notion that oxidative stress and autophagy are intimately assocd. with neurodegenerative disease pathogenesis.  This review also explores new approaches that can prevent mitochondrial dysfunction, improve neurodegenerative etiol., and also offer possible cures to the aforementioned neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoryIgB2Eg6l7Vg90H21EOLACvtfcHk0liVkBvIH0ra1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXns1aisrk%253D&md5=9961e5ffde3e6397bb21d1bd53a79271</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1007%2Fs12013-014-0006-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12013-014-0006-5%26sid%3Dliteratum%253Aachs%26aulast%3DKamat%26aufirst%3DP.%2BK.%26aulast%3DKalani%26aufirst%3DA.%26aulast%3DKyles%26aufirst%3DP.%26aulast%3DTyagi%26aufirst%3DS.%2BC.%26aulast%3DTyagi%26aufirst%3DN.%26atitle%3DAutophagy%2520of%2520mitochondria%253A%2520a%2520promising%2520therapeutic%2520target%2520for%2520neurodegenerative%2520disease%26jtitle%3DCell%2520Biochem.%2520Biophys.%26date%3D2014%26volume%3D70%26issue%3D2%26spage%3D707%26epage%3D719%26doi%3D10.1007%2Fs12013-014-0006-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleichmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A.</span></span> <span> </span><span class="NLM_article-title">Mitochondria in neuroplasticity and neurological disorders</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">748</span>– <span class="NLM_lpage">766</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2008.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.neuron.2008.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19081372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFahs7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=748-766&issue=5&author=M.+P.+Mattsonauthor=M.+Gleichmannauthor=A.+Cheng&title=Mitochondria+in+neuroplasticity+and+neurological+disorders&doi=10.1016%2Fj.neuron.2008.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria in neuroplasticity and neurological disorders</span></div><div class="casAuthors">Mattson, Mark P.; Gleichmann, Marc; Cheng, Aiwu</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">748-766</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Mitochondrial electron transport generates the ATP that is essential for the excitability and survival of neurons, and the protein phosphorylation reactions that mediate synaptic signaling and related long-term changes in neuronal structure and function.  Mitochondria are highly dynamic organelles that divide, fuse, and move purposefully within axons and dendrites.  Major functions of mitochondria in neurons include the regulation of Ca2+ and redox signaling, developmental and synaptic plasticity, and the arbitration of cell survival and death.  The importance of mitochondria in neurons is evident in the neurol. phenotypes in rare diseases caused by mutations in mitochondrial genes.  Mitochondria-mediated oxidative stress, perturbed Ca2+ homeostasis, and apoptosis may also contribute to the pathogenesis of prominent neurol. diseases including Alzheimer's, Parkinson's, and Huntington's diseases; stroke; amyotrophic lateral sclerosis; and psychiatric disorders.  Advances in understanding the mol. and cell biol. of mitochondria are leading to novel approaches for the prevention and treatment of neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVB5rd26j-rLVg90H21EOLACvtfcHk0liVkBvIH0ra1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFahs7rI&md5=66667579021bc8125d1b4796f44ff131</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2008.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2008.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DMattson%26aufirst%3DM.%2BP.%26aulast%3DGleichmann%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DA.%26atitle%3DMitochondria%2520in%2520neuroplasticity%2520and%2520neurological%2520disorders%26jtitle%3DNeuron%26date%3D2008%26volume%3D60%26issue%3D5%26spage%3D748%26epage%3D766%26doi%3D10.1016%2Fj.neuron.2008.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waeg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, K.</span></span> <span> </span><span class="NLM_article-title">4-hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau</span>. <i>NeuroReport</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">9–10</span>),  <span class="NLM_fpage">2275</span>– <span class="NLM_lpage">2281</span>, <span class="refDoi"> DOI: 10.1097/00001756-199707070-00036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1097%2F00001756-199707070-00036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=9243625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADyaK2sXlt1Wgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=2275-2281&issue=9%E2%80%9310&author=M.+P.+Mattsonauthor=W.+M.+Fuauthor=G.+Waegauthor=K.+Uchida&title=4-hydroxynonenal%2C+a+product+of+lipid+peroxidation%2C+inhibits+dephosphorylation+of+the+microtubule-associated+protein+tau&doi=10.1097%2F00001756-199707070-00036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">4-Hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau</span></div><div class="casAuthors">Mattson, Mark P.; Fu, Weiming; Waeg, Georg; Uchida, Koji</div><div class="citationInfo"><span class="NLM_cas:title">NeuroReport</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">2275-2281</span>CODEN:
                <span class="NLM_cas:coden">NERPEZ</span>;
        ISSN:<span class="NLM_cas:issn">0959-4965</span>.
    
            (<span class="NLM_cas:orgname">Rapid Science Publishers</span>)
        </div><div class="casAbstract">In Alzheimer's disease (AD) the microtubule-assocd. protein tau is excessively phosphorylated in degenerating neurons, but the mechanisms underlying the increased phosphorylation are unknown.  Recent findings suggest that oxidative stress, and membrane lipid peroxidn. in particular, contributes to the neurodegenerative process in AD.  The authors now report that following exposure of cultured rat hippocampal neurons to 4-hydroxynonenal (HNE), an aldehydic product of membrane lipid peroxidn., tau is resistant to dephosphorylation.  Immunocytochem. and Western blot analyses using phosphorylation-sensitive tau antibodies showed that HNE treatment causes a moderate increase in basal levels of tau phosphorylation, and prevents tau dephosphorylation by alk. phosphatase in neurons pretreated with the phosphatase inhibitor okadaic acid.  Studies with anti-HNE antibodies showed that HNE binds directly to tau, and that HNE immunoreactivity localizes to cell bodies and axons, cell compartments that contain tau.  These data suggest a role for HNE in altered tau phosphorylation and neurofibrillary degeneration in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmD64H-HG0A7Vg90H21EOLACvtfcHk0liVkBvIH0ra1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlt1Wgtro%253D&md5=0955162536d5897a86c1291ab9e338fc</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1097%2F00001756-199707070-00036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-199707070-00036%26sid%3Dliteratum%253Aachs%26aulast%3DMattson%26aufirst%3DM.%2BP.%26aulast%3DFu%26aufirst%3DW.%2BM.%26aulast%3DWaeg%26aufirst%3DG.%26aulast%3DUchida%26aufirst%3DK.%26atitle%3D4-hydroxynonenal%252C%2520a%2520product%2520of%2520lipid%2520peroxidation%252C%2520inhibits%2520dephosphorylation%2520of%2520the%2520microtubule-associated%2520protein%2520tau%26jtitle%3DNeuroReport%26date%3D1997%26volume%3D8%26issue%3D9%25E2%2580%259310%26spage%3D2275%26epage%3D2281%26doi%3D10.1097%2F00001756-199707070-00036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gwon, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arumugam, T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baik, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyun, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dann, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markesbery, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jo, D. G.</span></span> <span> </span><span class="NLM_article-title">Oxidative lipid modification of nicastrin enhances amyloidogenic γ-secretase activity in Alzheimer’s disease</span>. <i>Aging Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">559</span>– <span class="NLM_lpage">568</span>, <span class="refDoi"> DOI: 10.1111/j.1474-9726.2012.00817.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1111%2Fj.1474-9726.2012.00817.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22404891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OrtrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=559-568&issue=4&author=A.+R.+Gwonauthor=J.+S.+Parkauthor=T.+V.+Arumugamauthor=Y.+K.+Kwonauthor=S.+L.+Chanauthor=S.+H.+Kimauthor=S.+H.+Baikauthor=S.+Yangauthor=Y.+K.+Yunauthor=Y.+Choiauthor=S.+Kimauthor=S.+C.+Tangauthor=D.+H.+Hyunauthor=A.+W.+Chengauthor=C.+E.+Dannauthor=M.+Bernierauthor=J.+Leeauthor=W.+R.+Markesberyauthor=M.+P.+Mattsonauthor=D.+G.+Jo&title=Oxidative+lipid+modification+of+nicastrin+enhances+amyloidogenic+%CE%B3-secretase+activity+in+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fj.1474-9726.2012.00817.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative lipid modification of nicastrin enhances amyloidogenic γ-secretase activity in Alzheimer's disease</span></div><div class="casAuthors">Gwon, A.-Ryeong; Park, Jong-Sung; Arumugam, Thiruma V.; Kwon, Yong-Kook; Chan, Sic L.; Kim, Seol-Hee; Baik, Sang-Ha; Yang, Sunghee; Yun, Young-Kwang; Choi, Yuri; Kim, Saerom; Tang, Sung-Chun; Hyun, Dong-Hoon; Cheng, Aiwu; Dann, Charles E., III; Bernier, Michel; Lee, Jaewon; Markesbery, William R.; Mattson, Mark P.; Jo, Dong-Gyu</div><div class="citationInfo"><span class="NLM_cas:title">Aging Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">559-568</span>CODEN:
                <span class="NLM_cas:coden">ACGECQ</span>;
        ISSN:<span class="NLM_cas:issn">1474-9718</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The cause of elevated level of amyloid β-peptide (Aβ42) in common late-onset sporadic [Alzheimer's disease (AD)] has not been established.  Here, we show that the membrane lipid peroxidn. product 4-hydroxynonenal (HNE) is assocd. with amyloid and neurodegenerative pathologies in AD and that it enhances γ-secretase activity and Aβ42 prodn. in neurons.  The γ-secretase substrate receptor, nicastrin, was found to be modified by HNE in cultured neurons and in brain specimens from patients with AD, in which HNE-nicastrin levels were found to be correlated with increased γ-secretase activity and Aβ plaque burden.  Furthermore, HNE modification of nicastrin enhanced its binding to the γ-secretase substrate, amyloid precursor protein (APP) C99.  In addn., the stimulation of γ-secretase activity and Aβ42 prodn. by HNE were blocked by an HNE-scavenging histidine analog in a 3xTgAD mouse model of AD.  These findings suggest a specific mol. mechanism by which oxidative stress increases Aβ42 prodn. in AD and identify HNE as a novel therapeutic target upstream of the γ-secretase cleavage of APP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuYry6s13U0bVg90H21EOLACvtfcHk0liRyRxeUr0-uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OrtrvJ&md5=69a79fbdf10318113609622f5c1a566a</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1111%2Fj.1474-9726.2012.00817.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1474-9726.2012.00817.x%26sid%3Dliteratum%253Aachs%26aulast%3DGwon%26aufirst%3DA.%2BR.%26aulast%3DPark%26aufirst%3DJ.%2BS.%26aulast%3DArumugam%26aufirst%3DT.%2BV.%26aulast%3DKwon%26aufirst%3DY.%2BK.%26aulast%3DChan%26aufirst%3DS.%2BL.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DBaik%26aufirst%3DS.%2BH.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DYun%26aufirst%3DY.%2BK.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DS.%2BC.%26aulast%3DHyun%26aufirst%3DD.%2BH.%26aulast%3DCheng%26aufirst%3DA.%2BW.%26aulast%3DDann%26aufirst%3DC.%2BE.%26aulast%3DBernier%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMarkesbery%26aufirst%3DW.%2BR.%26aulast%3DMattson%26aufirst%3DM.%2BP.%26aulast%3DJo%26aufirst%3DD.%2BG.%26atitle%3DOxidative%2520lipid%2520modification%2520of%2520nicastrin%2520enhances%2520amyloidogenic%2520%25CE%25B3-secretase%2520activity%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAging%2520Cell%26date%3D2012%26volume%3D11%26issue%3D4%26spage%3D559%26epage%3D568%26doi%3D10.1111%2Fj.1474-9726.2012.00817.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eiyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, K.</span></span> <span> </span><span class="NLM_article-title">PINK1/Parkin-mediated mitophagy in mammalian cells</span>. <i>Curr. Opin. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1016/j.ceb.2015.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.ceb.2015.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=25697963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2msrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2015&pages=95-101&author=A.+Eiyamaauthor=K.+Okamoto&title=PINK1%2FParkin-mediated+mitophagy+in+mammalian+cells&doi=10.1016%2Fj.ceb.2015.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">PINK1/Parkin-mediated mitophagy in mammalian cells</span></div><div class="casAuthors">Eiyama, Akinori; Okamoto, Koji</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">95-101</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Mitochondria-specific autophagy (mitophagy) is a fundamental process crit. for maintaining mitochondrial fitness in a myriad of cell types.  Particularly, mitophagy contributes to mitochondrial quality control by selectively eliminating dysfunctional mitochondria.  In mammalian cells, the Ser/Thr kinase PINK1 and the E3 ubiquitin ligase Parkin act cooperatively in sensing mitochondrial functional state and marking damaged mitochondria for disposal via the autophagy pathway.  Notably, ubiquitin and deubiquitinases play vital roles in modulating Parkin activity and mitophagy efficiency.  In this review, we highlight recent breakthroughs addressing the key issues of how PINK1 activates Parkin in response to mitochondrial malfunction, how Parkin localizes specifically to impaired mitochondria, and how ubiquitination and deubiquitination regulate PINK1/Parkin-mediated mitophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5bIcK20R-CLVg90H21EOLACvtfcHk0liRyRxeUr0-uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2msrg%253D&md5=6973e43c653a7c9b7f53fe6a5ddf7a6f</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2015.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2015.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DEiyama%26aufirst%3DA.%26aulast%3DOkamoto%26aufirst%3DK.%26atitle%3DPINK1%252FParkin-mediated%2520mitophagy%2520in%2520mammalian%2520cells%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2015%26volume%3D33%26spage%3D95%26epage%3D101%26doi%3D10.1016%2Fj.ceb.2015.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, W. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolz, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, G. W.,  2nd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, X. M.</span></span> <span> </span><span class="NLM_article-title">Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span> (<span class="NLM_issue">36</span>),  <span class="NLM_fpage">27879</span>– <span class="NLM_lpage">27890</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.119537</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1074%2Fjbc.M110.119537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20573959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVOnsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=27879-27890&issue=36&author=W.+X.+Dingauthor=H.+M.+Niauthor=M.+Liauthor=Y.+Liaoauthor=X.+Chenauthor=D.+B.+Stolzauthor=G.+W.+Dornauthor=X.+M.+Yin&title=Nix+is+critical+to+two+distinct+phases+of+mitophagy%2C+reactive+oxygen+species-mediated+autophagy+induction+and+Parkin-ubiquitin-p62-mediated+mitochondrial+priming&doi=10.1074%2Fjbc.M110.119537"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Nix Is Critical to Two Distinct Phases of Mitophagy, Reactive Oxygen Species-mediated Autophagy Induction and Parkin-Ubiquitin-p62-mediated Mitochondrial Priming</span></div><div class="casAuthors">Ding, Wen-Xing; Ni, Hong-Min; Li, Min; Liao, Yong; Chen, Xiaoyun; Stolz, Donna B.; Dorn, Gerald W., II; Yin, Xiao-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">27879-27890</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Damaged mitochondria can be eliminated by autophagy, i.e. mitophagy, which is important for cellular homeostasis and cell survival.  Despite the fact that a no. of factors have been found to be important for mitophagy in mammalian cells, their individual roles in the process had not been clearly defined.  Parkin is a ubiquitin-protein isopeptide ligase able to translocate to the mitochondria that are to be removed.  We showed here in a chem. hypoxia model of mitophagy induced by an uncoupler, carbonyl cyanide m-chlorophenylhydrazone (CCCP) that Parkin translocation resulted in mitochondrial ubiquitination and p62 recruitment to the mitochondria.  Small inhibitory RNA-mediated knockdown of p62 significantly diminished mitochondrial recognition by the autophagy machinery and the subsequent elimination.  Thus Parkin, ubiquitin, and p62 function in prepg. mitochondria for mitophagy, here referred to as mitochondrial priming.  However, these mols. were not required for the induction of autophagy machinery.  Neither Parkin nor p62 seemed to affect autophagy induction by CCCP.  Instead, we found that Nix was required for the autophagy induction.  Nix promoted CCCP-induced mitochondrial depolarization and reactive oxygen species generation, which inhibited mTOR signaling and activated autophagy.  Nix also contributed to mitochondrial priming by controlling the mitochondrial translocation of Parkin, although reactive oxygen species generation was not involved in this step.  Deletion of the C-terminal membrane targeting sequence but not mutations in the BH3 domain disabled Nix for these functions.  Our work thus distinguished the mol. events responsible for the different phases of mitophagy and placed Nix upstream of the events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRn-oM4221XbVg90H21EOLACvtfcHk0lh0YP18QPDbtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVOnsL3L&md5=db8f958e70449e2f0ec670485ade07fe</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.119537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.119537%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DW.%2BX.%26aulast%3DNi%26aufirst%3DH.%2BM.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DStolz%26aufirst%3DD.%2BB.%26aulast%3DDorn%26aufirst%3DG.%2BW.%26aulast%3DYin%26aufirst%3DX.%2BM.%26atitle%3DNix%2520is%2520critical%2520to%2520two%2520distinct%2520phases%2520of%2520mitophagy%252C%2520reactive%2520oxygen%2520species-mediated%2520autophagy%2520induction%2520and%2520Parkin-ubiquitin-p62-mediated%2520mitochondrial%2520priming%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26issue%3D36%26spage%3D27879%26epage%3D27890%26doi%3D10.1074%2Fjbc.M110.119537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, J.</span></span> <span> </span><span class="NLM_article-title">PINK1 controls mitochondrial localization of Parkin through direct phosphorylation</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>377</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">975</span>– <span class="NLM_lpage">980</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2008.10.104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.bbrc.2008.10.104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18957282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVais7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2008&pages=975-980&issue=3&author=Y.+Kimauthor=J.+Parkauthor=S.+Kimauthor=S.+Songauthor=S.+K.+Kwonauthor=S.+H.+Leeauthor=T.+Kitadaauthor=J.+M.+Kimauthor=J.+Chung&title=PINK1+controls+mitochondrial+localization+of+Parkin+through+direct+phosphorylation&doi=10.1016%2Fj.bbrc.2008.10.104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">PINK1 controls mitochondrial localization of Parkin through direct phosphorylation</span></div><div class="casAuthors">Kim, Yongsung; Park, Jeehye; Kim, Sunhong; Song, Saera; Kwon, Seok-Kyu; Lee, Sang-Hee; Kitada, Tohru; Kim, Jin-Man; Chung, Jongkyeong</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">377</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">975-980</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">PTEN-induced putative kinase 1 (PINK1) and Parkin, encoded by their resp. genes assocd. with Parkinson's disease (PD), are linked in a common pathway involved in the protection of mitochondrial integrity and function.  However, the mechanism of their interaction at the biochem. level has not been investigated yet.  Using both mammalian and Drosophila systems, we here demonstrate that the PINK1 kinase activity is required for its function in mitochondria.  PINK1 regulates the localization of Parkin to the mitochondria in its kinase activity-dependent manner.  In detail, Parkin phosphorylation by PINK1 on its linker region promotes its mitochondrial translocation, and the RING1 domain of Parkin is crit. for this occurrence.  These results demonstrate the biochem. relationship between PINK1, Parkin, and the mitochondria and thereby suggest the possible mechanism of PINK-Parkin-assocd. PD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRqdn2wR6BKLVg90H21EOLACvtfcHk0lh0YP18QPDbtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVais7jP&md5=3d3dee4bb7cc5f7f84821cf3509e0013</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2008.10.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2008.10.104%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DSong%26aufirst%3DS.%26aulast%3DKwon%26aufirst%3DS.%2BK.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DKitada%26aufirst%3DT.%26aulast%3DKim%26aufirst%3DJ.%2BM.%26aulast%3DChung%26aufirst%3DJ.%26atitle%3DPINK1%2520controls%2520mitochondrial%2520localization%2520of%2520Parkin%2520through%2520direct%2520phosphorylation%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2008%26volume%3D377%26issue%3D3%26spage%3D975%26epage%3D980%26doi%3D10.1016%2Fj.bbrc.2008.10.104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geisler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmstrom, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skujat, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiesel, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothfuss, O. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahle, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springer, W.</span></span> <span> </span><span class="NLM_article-title">PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">131</span>, <span class="refDoi"> DOI: 10.1038/ncb2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fncb2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20098416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=119-131&issue=2&author=S.+Geislerauthor=K.+M.+Holmstromauthor=D.+Skujatauthor=F.+C.+Fieselauthor=O.+C.+Rothfussauthor=P.+J.+Kahleauthor=W.+Springer&title=PINK1%2FParkin-mediated+mitophagy+is+dependent+on+VDAC1+and+p62%2FSQSTM1&doi=10.1038%2Fncb2012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1</span></div><div class="casAuthors">Geisler, Sven; Holmstroem, Kira M.; Skujat, Diana; Fiesel, Fabienne C.; Rothfuss, Oliver C.; Kahle, Philipp J.; Springer, Wolfdieter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-131</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Parkinson's disease is the most common neurodegenerative movement disorder.  Mutations in PINK1 and PARKIN are the most frequent causes of recessive Parkinson's disease.  However, their mol. contribution to pathogenesis remains unclear.  Here, we reveal important mechanistic steps of a PINK1/Parkin-directed pathway linking mitochondrial damage, ubiquitylation and autophagy in non-neuronal and neuronal cells.  PINK1 kinase activity and its mitochondrial localization sequence are prerequisites to induce translocation of the E3 ligase Parkin to depolarized mitochondria.  Subsequently, Parkin mediates the formation of two distinct poly-ubiquitin chains, linked through Lys 63 and Lys 27.  In addn., the autophagic adaptor p62/SQSTM1 is recruited to mitochondrial clusters and is essential for the clearance of mitochondria.  Strikingly, we identified VDAC1 (voltage-dependent anion channel 1) as a target for Parkin-mediated Lys 27 poly-ubiquitylation and mitophagy.  Moreover, pathogenic Parkin mutations interfere with distinct steps of mitochondrial translocation, ubiquitylation and/or final clearance through mitophagy.  Thus, our data provide functional links between PINK1, Parkin and the selective autophagy of mitochondria, which is implicated in the pathogenesis of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBWQl05xlFk7Vg90H21EOLACvtfcHk0lh0YP18QPDbtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCqtbs%253D&md5=0f96bb285620e7c6852332b4cc5ca917</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1038%2Fncb2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2012%26sid%3Dliteratum%253Aachs%26aulast%3DGeisler%26aufirst%3DS.%26aulast%3DHolmstrom%26aufirst%3DK.%2BM.%26aulast%3DSkujat%26aufirst%3DD.%26aulast%3DFiesel%26aufirst%3DF.%2BC.%26aulast%3DRothfuss%26aufirst%3DO.%2BC.%26aulast%3DKahle%26aufirst%3DP.%2BJ.%26aulast%3DSpringer%26aufirst%3DW.%26atitle%3DPINK1%252FParkin-mediated%2520mitophagy%2520is%2520dependent%2520on%2520VDAC1%2520and%2520p62%252FSQSTM1%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2010%26volume%3D12%26issue%3D2%26spage%3D119%26epage%3D131%26doi%3D10.1038%2Fncb2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y. K.</span></span> <span> </span><span class="NLM_article-title">Choline dehydrogenase interacts with SQSTM1/p62 to recruit LC3 and stimulate mitophagy</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1906</span>– <span class="NLM_lpage">1920</span>, <span class="refDoi"> DOI: 10.4161/auto.32177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.4161%2Fauto.32177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=25483962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVKhsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=1906-1920&issue=11&author=S.+Parkauthor=S.+G.+Choiauthor=S.+M.+Yooauthor=J.+H.+Sonauthor=Y.+K.+Jung&title=Choline+dehydrogenase+interacts+with+SQSTM1%2Fp62+to+recruit+LC3+and+stimulate+mitophagy&doi=10.4161%2Fauto.32177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Choline dehydrogenase interacts with SQSTM1/p62 to recruit LC3 and stimulate mitophagy</span></div><div class="casAuthors">Park, Sungwoo; Choi, Seon-Guk; Yoo, Seung-Min; Son, Jin H.; Jung, Yong-Keun</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1906-1920, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8627</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">CHDH (choline dehydrogenase) is an enzyme catalyzing the dehydrogenation of choline to betaine aldehyde in mitochondria.  Apart from this well-known activity, we report here a pivotal role of CHDH in mitophagy.  Knockdown of CHDH expression impairs CCCP-induced mitophagy and PARK2/parkin-mediated clearance of mitochondria in mammalian cells, including HeLa cells and SN4741 dopaminergic neuronal cells.  Conversely, overexpression of CHDH accelerates PARK2-mediated mitophagy.  CHDH is found on both the outer and inner membranes of mitochondria in resting cells.  Interestingly, upon induction of mitophagy, CHDH accumulates on the outer membrane in a mitochondrial potential-dependent manner.  We found that CHDH is not a substrate of PARK2 but interacts with SQSTM1 independently of PARK2 to recruit SQSTM1 into depolarized mitochondria.  The FB1 domain of CHDH is exposed to the cytosol and is required for the interaction with SQSTM1, and overexpression of the FB1 domain only in cytosol reduces CCCP-induced mitochondrial degrdn. via competitive interaction with SQSTM1.  In addn., CHDH, but not the CHDH FB1 deletion mutant, forms a ternary protein complex with SQSTM1 and MAP1LC3 (LC3), leading to loading of LC3 onto the damaged mitochondria via SQSTM1.  Further, CHDH is crucial to the mitophagy induced by MPP+ in SN4741 cells.  Overall, our results suggest that CHDH is required for PARK2-mediated mitophagy for the recruitment of SQSTM1 and LC3 onto the mitochondria for cargo recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsh1_bUpx9H7Vg90H21EOLACvtfcHk0lhq94f6ky_aSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVKhsrw%253D&md5=04f8288cbfac5444cca641349382817b</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.4161%2Fauto.32177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.32177%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DS.%2BG.%26aulast%3DYoo%26aufirst%3DS.%2BM.%26aulast%3DSon%26aufirst%3DJ.%2BH.%26aulast%3DJung%26aufirst%3DY.%2BK.%26atitle%3DCholine%2520dehydrogenase%2520interacts%2520with%2520SQSTM1%252Fp62%2520to%2520recruit%2520LC3%2520and%2520stimulate%2520mitophagy%26jtitle%3DAutophagy%26date%3D2014%26volume%3D10%26issue%3D11%26spage%3D1906%26epage%3D1920%26doi%3D10.4161%2Fauto.32177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hollville, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullen, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. J.</span></span> <span> </span><span class="NLM_article-title">Bcl-2 family proteins participate in mitochondrial quality control by regulating Parkin/PINK1-dependent mitophagy</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">451</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2014.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.molcel.2014.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=24999239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFSgtLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=451-466&issue=3&author=E.+Hollvilleauthor=R.+G.+Carrollauthor=S.+P.+Cullenauthor=S.+J.+Martin&title=Bcl-2+family+proteins+participate+in+mitochondrial+quality+control+by+regulating+Parkin%2FPINK1-dependent+mitophagy&doi=10.1016%2Fj.molcel.2014.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Bcl-2 Family Proteins Participate in Mitochondrial Quality Control by Regulating Parkin/PINK1-Dependent Mitophagy</span></div><div class="casAuthors">Hollville, Emilie; Carroll, Richard G.; Cullen, Sean P.; Martin, Seamus J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">451-466</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Mitophagy facilitates the selective elimination of impaired or depolarized mitochondria through targeting the latter to autophagosomes.  Parkin becomes localized to depolarized mitochondria in a PINK1-dependent manner and polyubiquitinates multiple mitochondrial outer membrane proteins.  This permits ubiquitin-binding proteins (e.g., p62 and NBR1) to target impaired mitochondria to autophagosomes via Atg8/LC3II.  Bcl-2 family proteins regulate mitochondrial outer membrane permeabilization during apoptosis and can also influence macroautophagy via interactions with Beclin-1.  Here, we show that Parkin-dependent mitophagy is antagonized by prosurvival members of the Bcl-2 family (e.g., Bcl-xL and Mcl-1) in a Beclin-1-independent manner.  Bcl-2 proteins suppressed mitophagy through inhibition of Parkin translocation to depolarized mitochondria.  Consistent with this, Parkin translocation to mitochondria was enhanced by BH3-only proteins or a BH3-only mimetic.  Taken together with their role as regulators of apoptosis-assocd. mitochondrial permeabilization, as well as mitochondrial fission/fusion dynamics, this suggests that Bcl-2 family proteins act as global regulators of mitochondrial homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVoXI2PTy1U7Vg90H21EOLACvtfcHk0lhq94f6ky_aSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFSgtLzN&md5=9f9b9cabdeba877038feec258b168750</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2014.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2014.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DHollville%26aufirst%3DE.%26aulast%3DCarroll%26aufirst%3DR.%2BG.%26aulast%3DCullen%26aufirst%3DS.%2BP.%26aulast%3DMartin%26aufirst%3DS.%2BJ.%26atitle%3DBcl-2%2520family%2520proteins%2520participate%2520in%2520mitochondrial%2520quality%2520control%2520by%2520regulating%2520Parkin%252FPINK1-dependent%2520mitophagy%26jtitle%3DMol.%2520Cell%26date%3D2014%26volume%3D55%26issue%3D3%26spage%3D451%26epage%3D466%26doi%3D10.1016%2Fj.molcel.2014.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lazarou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sliter, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kane, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarraf, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sideris, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogel, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youle, R. J.</span></span> <span> </span><span class="NLM_article-title">The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>524</i></span> (<span class="NLM_issue">7565</span>),  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1038/nature14893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fnature14893" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=26266977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlaju73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=524&publication_year=2015&pages=309-314&issue=7565&author=M.+Lazarouauthor=D.+A.+Sliterauthor=L.+A.+Kaneauthor=S.+A.+Sarrafauthor=C.+Wangauthor=J.+L.+Burmanauthor=D.+P.+Siderisauthor=A.+I.+Fogelauthor=R.+J.+Youle&title=The+ubiquitin+kinase+PINK1+recruits+autophagy+receptors+to+induce+mitophagy&doi=10.1038%2Fnature14893"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy</span></div><div class="casAuthors">Lazarou, Michael; Sliter, Danielle A.; Kane, Lesley A.; Sarraf, Shireen A.; Wang, Chunxin; Burman, Jonathon L.; Sideris, Dionisia P.; Fogel, Adam I.; Youle, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">524</span>
        (<span class="NLM_cas:issue">7565</span>),
    <span class="NLM_cas:pages">309-314</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein aggregates and damaged organelles are tagged with ubiquitin chains to trigger selective autophagy.  To initiate mitophagy, the ubiquitin kinase PINK1 phosphorylates ubiquitin to activate the ubiquitin ligase parkin, which builds ubiquitin chains on mitochondrial outer membrane proteins, where they act to recruit autophagy receptors.  Using genome editing to knockout five autophagy receptors in HeLa cells, here we show that two receptors previously linked to xenophagy, NDP52 and optineurin, are the primary receptors for PINK1- and parkin-mediated mitophagy.  PINK1 recruits NDP52 and optineurin, but not p62, to mitochondria to activate mitophagy directly, independently of parkin.  Once recruited to mitochondria, NDP52 and optineurin recruit the autophagy factors ULK1, DFCP1 and WIPI1 to focal spots proximal to mitochondria, revealing a function for these autophagy receptors upstream of LC3.  This supports a new model in which PINK1-generated phospho-ubiquitin serves as the autophagy signal on mitochondria, and parkin then acts to amplify this signal.  This work also suggests direct and broader roles for ubiquitin phosphorylation in other autophagy pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6G4G5jmlFQLVg90H21EOLACvtfcHk0lhq94f6ky_aSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlaju73P&md5=690c30ae72f33bec1622e7cc0686618a</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1038%2Fnature14893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14893%26sid%3Dliteratum%253Aachs%26aulast%3DLazarou%26aufirst%3DM.%26aulast%3DSliter%26aufirst%3DD.%2BA.%26aulast%3DKane%26aufirst%3DL.%2BA.%26aulast%3DSarraf%26aufirst%3DS.%2BA.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DBurman%26aufirst%3DJ.%2BL.%26aulast%3DSideris%26aufirst%3DD.%2BP.%26aulast%3DFogel%26aufirst%3DA.%2BI.%26aulast%3DYoule%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520ubiquitin%2520kinase%2520PINK1%2520recruits%2520autophagy%2520receptors%2520to%2520induce%2520mitophagy%26jtitle%3DNature%26date%3D2015%26volume%3D524%26issue%3D7565%26spage%3D309%26epage%3D314%26doi%3D10.1038%2Fnature14893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calvo-Garrido, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maffezzini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schober, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemente, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhlin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kele, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stranneheim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesko, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruhn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svenningsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wedell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freyer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wredenberg, A.</span></span> <span> </span><span class="NLM_article-title">SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation</span>. <i>Stem Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">696</span>– <span class="NLM_lpage">711</span>, <span class="refDoi"> DOI: 10.1016/j.stemcr.2019.01.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.stemcr.2019.01.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=30827875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktFOrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2019&pages=696-711&issue=4&author=J.+Calvo-Garridoauthor=C.+Maffezziniauthor=F.+A.+Schoberauthor=P.+Clementeauthor=E.+Uhlinauthor=M.+Keleauthor=H.+Stranneheimauthor=N.+Leskoauthor=H.+Bruhnauthor=P.+Svenningssonauthor=A.+Falkauthor=A.+Wedellauthor=C.+Freyerauthor=A.+Wredenberg&title=SQSTM1%2Fp62-directed+metabolic+reprogramming+is+essential+for+normal+neurodifferentiation&doi=10.1016%2Fj.stemcr.2019.01.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">SQSTM1/p62-Directed Metabolic Reprogramming Is Essential for Normal Neurodifferentiation</span></div><div class="casAuthors">Calvo-Garrido, Javier; Maffezzini, Camilla; Schober, Florian A.; Clemente, Paula; Uhlin, Elias; Kele, Malin; Stranneheim, Henrik; Lesko, Nicole; Bruhn, Helene; Svenningsson, Per; Falk, Anna; Wedell, Anna; Freyer, Christoph; Wredenberg, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Stem Cell Reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">696-711</span>CODEN:
                <span class="NLM_cas:coden">SCRTFL</span>;
        ISSN:<span class="NLM_cas:issn">2213-6711</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Neurodegenerative disorders are an increasingly common and irreversible burden on society, often affecting the aging population, but their etiol. and disease mechanisms are poorly understood.  Studying monogenic neurodegenerative diseases with known genetic cause provides an opportunity to understand cellular mechanisms also affected in more complex disorders.  We recently reported that loss-of-function mutations in the autophagy adaptor protein SQSTM1/p62 lead to a slowly progressive neurodegenerative disease presenting in childhood.  To further elucidate the neuronal involvement, we studied the cellular consequences of loss of p62 in a neuroepithelial stem cell (NESC) model and differentiated neurons derived from reprogrammed p62 patient cells or by CRISPR/Cas9-directed gene editing in NESCs.  Transcriptomic and proteomic analyses suggest that p62 is essential for neuronal differentiation by controlling the metabolic shift from aerobic glycolysis to oxidative phosphorylation required for neuronal maturation.  This shift is blocked by the failure to sufficiently downregulate lactate dehydrogenase expression due to the loss of p62, possibly through impaired Hif-1α downregulation and increased sensitivity to oxidative stress.  The findings imply an important role for p62 in neuronal energy metab. and particularly in the regulation of the shift between glycolysis and oxidative phosphorylation required for normal neurodifferentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq60DJCavx23rVg90H21EOLACvtfcHk0ljXuYlDIe7Lvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktFOrsL8%253D&md5=123ef7ee5098f234a1ac3d143268624e</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.stemcr.2019.01.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stemcr.2019.01.023%26sid%3Dliteratum%253Aachs%26aulast%3DCalvo-Garrido%26aufirst%3DJ.%26aulast%3DMaffezzini%26aufirst%3DC.%26aulast%3DSchober%26aufirst%3DF.%2BA.%26aulast%3DClemente%26aufirst%3DP.%26aulast%3DUhlin%26aufirst%3DE.%26aulast%3DKele%26aufirst%3DM.%26aulast%3DStranneheim%26aufirst%3DH.%26aulast%3DLesko%26aufirst%3DN.%26aulast%3DBruhn%26aufirst%3DH.%26aulast%3DSvenningsson%26aufirst%3DP.%26aulast%3DFalk%26aufirst%3DA.%26aulast%3DWedell%26aufirst%3DA.%26aulast%3DFreyer%26aufirst%3DC.%26aulast%3DWredenberg%26aufirst%3DA.%26atitle%3DSQSTM1%252Fp62-directed%2520metabolic%2520reprogramming%2520is%2520essential%2520for%2520normal%2520neurodifferentiation%26jtitle%3DStem%2520Cell%2520Rep.%26date%3D2019%26volume%3D12%26issue%3D4%26spage%3D696%26epage%3D711%26doi%3D10.1016%2Fj.stemcr.2019.01.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haack, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignatius, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvo-Garrido, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iuso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isohanni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maffezzini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonnqvist, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suomalainen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kremer, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berutti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paucar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svenningsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stranneheim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandberg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wedell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurian, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayflick, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venco, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiranti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strom, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dichgans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvath, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holinski-Feder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freyer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meitinger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokisch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senderek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wredenberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klopstock, T.</span></span> <span> </span><span class="NLM_article-title">Absence of the autophagy adaptor SQSTM1/p62 causes childhood-onset neurodegeneration with ataxia, dystonia, and gaze palsy</span>. <i>Am. J. Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">743</span>, <span class="refDoi"> DOI: 10.1016/j.ajhg.2016.06.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.ajhg.2016.06.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27545679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlyjtLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2016&pages=735-743&issue=3&author=T.+B.+Haackauthor=E.+Ignatiusauthor=J.+Calvo-Garridoauthor=A.+Iusoauthor=P.+Isohanniauthor=C.+Maffezziniauthor=T.+Lonnqvistauthor=A.+Suomalainenauthor=M.+Gorzaauthor=L.+S.+Kremerauthor=E.+Grafauthor=M.+Hartigauthor=R.+Beruttiauthor=M.+Paucarauthor=P.+Svenningssonauthor=H.+Stranneheimauthor=G.+Brandbergauthor=A.+Wedellauthor=M.+A.+Kurianauthor=S.+A.+Hayflickauthor=P.+Vencoauthor=V.+Tirantiauthor=T.+M.+Stromauthor=M.+Dichgansauthor=R.+Horvathauthor=E.+Holinski-Federauthor=C.+Freyerauthor=T.+Meitingerauthor=H.+Prokischauthor=J.+Senderekauthor=A.+Wredenbergauthor=C.+J.+Carrollauthor=T.+Klopstock&title=Absence+of+the+autophagy+adaptor+SQSTM1%2Fp62+causes+childhood-onset+neurodegeneration+with+ataxia%2C+dystonia%2C+and+gaze+palsy&doi=10.1016%2Fj.ajhg.2016.06.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Absence of the Autophagy Adaptor SQSTM1/p62 Causes Childhood-Onset Neurodegeneration with Ataxia, Dystonia, and Gaze Palsy</span></div><div class="casAuthors">Haack, Tobias B.; Ignatius, Erika; Calvo-Garrido, Javier; Iuso, Arcangela; Isohanni, Pirjo; Maffezzini, Camilla; Loennqvist, Tuula; Suomalainen, Anu; Gorza, Matteo; Kremer, Laura S.; Graf, Elisabeth; Hartig, Monika; Berutti, Riccardo; Paucar, Martin; Svenningsson, Per; Stranneheim, Henrik; Brandberg, Goeran; Wedell, Anna; Kurian, Manju A.; Hayflick, Susan A.; Venco, Paola; Tiranti, Valeria; Strom, Tim M.; Dichgans, Martin; Horvath, Rita; Holinski-Feder, Elke; Freyer, Christoph; Meitinger, Thomas; Prokisch, Holger; Senderek, Jan; Wredenberg, Anna; Carroll, Christopher J.; Klopstock, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">735-743</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">SQSTM1 (sequestosome 1; also known as p62) encodes a multidomain scaffolding protein involved in various key cellular processes, including the removal of damaged mitochondria by its function as a selective autophagy receptor.  Heterozygous variants in SQSTM1 have been assocd. with Paget disease of the bone and might contribute to neurodegeneration in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).  Using exome sequencing, we identified three different biallelic loss-of-function variants in SQSTM1 in nine affected individuals from four families with a childhood- or adolescence-onset neurodegenerative disorder characterized by gait abnormalities, ataxia, dysarthria, dystonia, vertical gaze palsy, and cognitive decline.  We confirmed absence of the SQSTM1/p62 protein in affected individuals' fibroblasts and found evidence of a defect in the early response to mitochondrial depolarization and autophagosome formation.  Our findings expand the SQSTM1-assocd. phenotypic spectrum and lend further support to the concept of disturbed selective autophagy pathways in neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgFtjHBGoA77Vg90H21EOLACvtfcHk0ljXuYlDIe7Lvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlyjtLrJ&md5=91f1addb3e2ed8ae628a042db1337a4d</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.ajhg.2016.06.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajhg.2016.06.026%26sid%3Dliteratum%253Aachs%26aulast%3DHaack%26aufirst%3DT.%2BB.%26aulast%3DIgnatius%26aufirst%3DE.%26aulast%3DCalvo-Garrido%26aufirst%3DJ.%26aulast%3DIuso%26aufirst%3DA.%26aulast%3DIsohanni%26aufirst%3DP.%26aulast%3DMaffezzini%26aufirst%3DC.%26aulast%3DLonnqvist%26aufirst%3DT.%26aulast%3DSuomalainen%26aufirst%3DA.%26aulast%3DGorza%26aufirst%3DM.%26aulast%3DKremer%26aufirst%3DL.%2BS.%26aulast%3DGraf%26aufirst%3DE.%26aulast%3DHartig%26aufirst%3DM.%26aulast%3DBerutti%26aufirst%3DR.%26aulast%3DPaucar%26aufirst%3DM.%26aulast%3DSvenningsson%26aufirst%3DP.%26aulast%3DStranneheim%26aufirst%3DH.%26aulast%3DBrandberg%26aufirst%3DG.%26aulast%3DWedell%26aufirst%3DA.%26aulast%3DKurian%26aufirst%3DM.%2BA.%26aulast%3DHayflick%26aufirst%3DS.%2BA.%26aulast%3DVenco%26aufirst%3DP.%26aulast%3DTiranti%26aufirst%3DV.%26aulast%3DStrom%26aufirst%3DT.%2BM.%26aulast%3DDichgans%26aufirst%3DM.%26aulast%3DHorvath%26aufirst%3DR.%26aulast%3DHolinski-Feder%26aufirst%3DE.%26aulast%3DFreyer%26aufirst%3DC.%26aulast%3DMeitinger%26aufirst%3DT.%26aulast%3DProkisch%26aufirst%3DH.%26aulast%3DSenderek%26aufirst%3DJ.%26aulast%3DWredenberg%26aufirst%3DA.%26aulast%3DCarroll%26aufirst%3DC.%2BJ.%26aulast%3DKlopstock%26aufirst%3DT.%26atitle%3DAbsence%2520of%2520the%2520autophagy%2520adaptor%2520SQSTM1%252Fp62%2520causes%2520childhood-onset%2520neurodegeneration%2520with%2520ataxia%252C%2520dystonia%252C%2520and%2520gaze%2520palsy%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2016%26volume%3D99%26issue%3D3%26spage%3D735%26epage%3D743%26doi%3D10.1016%2Fj.ajhg.2016.06.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okatsu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saisho, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimanuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shitara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sou, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, N.</span></span> <span> </span><span class="NLM_article-title">p62/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria</span>. <i>Genes Cells</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">887</span>– <span class="NLM_lpage">900</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2443.2010.01426.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1111%2Fj.1365-2443.2010.01426.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20604804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVCltbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=887-900&issue=8&author=K.+Okatsuauthor=K.+Saishoauthor=M.+Shimanukiauthor=K.+Nakadaauthor=H.+Shitaraauthor=Y.+S.+Souauthor=M.+Kimuraauthor=S.+Satoauthor=N.+Hattoriauthor=M.+Komatsuauthor=K.+Tanakaauthor=N.+Matsuda&title=p62%2FSQSTM1+cooperates+with+Parkin+for+perinuclear+clustering+of+depolarized+mitochondria&doi=10.1111%2Fj.1365-2443.2010.01426.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">p62/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria</span></div><div class="casAuthors">Okatsu, Kei; Saisho, Keiko; Shimanuki, Midori; Nakada, Kazuto; Shitara, Hiroshi; Sou, Yu-shin; Kimura, Mayumi; Sato, Shigeto; Hattori, Nobutaka; Komatsu, Masaaki; Tanaka, Keiji; Matsuda, Noriyuki</div><div class="citationInfo"><span class="NLM_cas:title">Genes to Cells</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">887-900</span>CODEN:
                <span class="NLM_cas:coden">GECEFL</span>;
        ISSN:<span class="NLM_cas:issn">1356-9597</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">PINK1 and Parkin were first identified as the causal genes responsible for familial forms of early-onset Parkinson's disease (PD), a prevalent neurodegenerative disorder.  PINK1 encodes a mitochondrial serine/threonine protein kinase, whereas Parkin encodes an ubiquitin-protein ligase.  PINK1 and Parkin cooperate to maintain mitochondrial integrity; however, the detailed mol. mechanism of how Parkin-catalyzed ubiquitylation results in mitochondrial integrity remains an enigma.  In this study, we show that Parkin-catalyzed K63-linked polyubiquitylation of depolarized mitochondria resulted in ubiquitylated mitochondria being transported along microtubules to cluster in the perinuclear region, which was interfered by pathogenic mutations of Parkin.  In addn., p62/SQSTM1 (hereafter referred to as p62) was recruited to depolarized mitochondria after Parkin-directed ubiquitylation.  Intriguingly, deletion of p62 in mouse embryonic fibroblasts resulted in a gross loss of mitochondrial perinuclear clustering but did not hinder mitochondrial degrdn.  Thus, p62 is required for ubiquitylation-dependent clustering of damaged mitochondria, which resembles p62-mediated 'aggresome' formation of misfolded/unfolded proteins after ubiquitylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8c1s0HG6dqrVg90H21EOLACvtfcHk0lg4lWr2yJiu7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVCltbrP&md5=f44a45c8f2cd33b365e00645c581c7ca</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2443.2010.01426.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2443.2010.01426.x%26sid%3Dliteratum%253Aachs%26aulast%3DOkatsu%26aufirst%3DK.%26aulast%3DSaisho%26aufirst%3DK.%26aulast%3DShimanuki%26aufirst%3DM.%26aulast%3DNakada%26aufirst%3DK.%26aulast%3DShitara%26aufirst%3DH.%26aulast%3DSou%26aufirst%3DY.%2BS.%26aulast%3DKimura%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DHattori%26aufirst%3DN.%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DMatsuda%26aufirst%3DN.%26atitle%3Dp62%252FSQSTM1%2520cooperates%2520with%2520Parkin%2520for%2520perinuclear%2520clustering%2520of%2520depolarized%2520mitochondria%26jtitle%3DGenes%2520Cells%26date%3D2010%26volume%3D15%26issue%3D8%26spage%3D887%26epage%3D900%26doi%3D10.1111%2Fj.1365-2443.2010.01426.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butterfield, D. A.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress in neurodegenerative disorders</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">11–12</span>),  <span class="NLM_fpage">1971</span>– <span class="NLM_lpage">1973</span>, <span class="refDoi"> DOI: 10.1089/ars.2006.8.1971</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1089%2Fars.2006.8.1971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=17034342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVKntb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=1971-1973&issue=11%E2%80%9312&author=D.+A.+Butterfield&title=Oxidative+stress+in+neurodegenerative+disorders&doi=10.1089%2Fars.2006.8.1971"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress in Neurodegenerative Disorders</span></div><div class="casAuthors">Butterfield, D. Allan</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11 & 12</span>),
    <span class="NLM_cas:pages">1971-1973</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  The topics discussed include: introduction and overview; causes and consequences of oxidative stress; and oxidative damage and neurodegenerative disorders.  Future studies and perspectives are also given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQeCr46_yPVrVg90H21EOLACvtfcHk0lg4lWr2yJiu7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVKntb7P&md5=303629ed4cfc0e100d6339dbd2108aa9</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1089%2Fars.2006.8.1971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2006.8.1971%26sid%3Dliteratum%253Aachs%26aulast%3DButterfield%26aufirst%3DD.%2BA.%26atitle%3DOxidative%2520stress%2520in%2520neurodegenerative%2520disorders%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2006%26volume%3D8%26issue%3D11%25E2%2580%259312%26spage%3D1971%26epage%3D1973%26doi%3D10.1089%2Fars.2006.8.1971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butterfield, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perluigi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Marco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coccia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sultana, R.</span></span> <span> </span><span class="NLM_article-title">Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>397</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1016/j.neulet.2005.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.neulet.2005.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=16413966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD28XisFOqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=397&publication_year=2006&pages=170-173&issue=3&author=D.+A.+Butterfieldauthor=T.+Reedauthor=M.+Perluigiauthor=C.+De+Marcoauthor=R.+Cocciaauthor=C.+Ciniauthor=R.+Sultana&title=Elevated+protein-bound+levels+of+the+lipid+peroxidation+product%2C+4-hydroxy-2-nonenal%2C+in+brain+from+persons+with+mild+cognitive+impairment&doi=10.1016%2Fj.neulet.2005.12.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment</span></div><div class="casAuthors">Butterfield, D. Allan; Reed, Tanea; Perluigi, Marzia; De Marco, Carlo; Coccia, Raffaella; Cini, Chiara; Sultana, Rukhsana</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">397</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">170-173</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Oxidative damage is a feature of many age-related neurodegenerative diseases, including Alzheimer's disease (AD).  4-Hydroxy-2-nonenal (HNE) is a highly reactive product of the free radical-mediated lipid peroxidn. of unsatd. lipids, particularly arachidonic acid, in cellular membranes.  In the present study we show for the first time in brain obtained at short postmortem intervals that the levels of HNE are elevated in mild cognitive impairment (MCI) hippocampus and inferior parietal lobules compared to those of control brain.  Thus, increased levels of HNE in MCI brain implicate lipid peroxidn. as an early event in AD pathophysiol. and also suggest that the pharmacol. intervention to prevent lipid peroxidn. at the MCI stage or earlier may be a promising therapeutic strategy to delay or prevent progression to AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeee3vur7beLVg90H21EOLACvtfcHk0liUeXARR_p7_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisFOqsrk%253D&md5=ab2855b494f197c5831b68fc5b39317c</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2005.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2005.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DButterfield%26aufirst%3DD.%2BA.%26aulast%3DReed%26aufirst%3DT.%26aulast%3DPerluigi%26aufirst%3DM.%26aulast%3DDe%2BMarco%26aufirst%3DC.%26aulast%3DCoccia%26aufirst%3DR.%26aulast%3DCini%26aufirst%3DC.%26aulast%3DSultana%26aufirst%3DR.%26atitle%3DElevated%2520protein-bound%2520levels%2520of%2520the%2520lipid%2520peroxidation%2520product%252C%25204-hydroxy-2-nonenal%252C%2520in%2520brain%2520from%2520persons%2520with%2520mild%2520cognitive%2520impairment%26jtitle%3DNeurosci.%2520Lett.%26date%3D2006%26volume%3D397%26issue%3D3%26spage%3D170%26epage%3D173%26doi%3D10.1016%2Fj.neulet.2005.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mecocci, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macgarvey, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, M. F.</span></span> <span> </span><span class="NLM_article-title">Oxidative damage to mitochondrial-DNA is increased in Alzheimers-disease</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">747</span>– <span class="NLM_lpage">751</span>, <span class="refDoi"> DOI: 10.1002/ana.410360510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1002%2Fana.410360510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=7979220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADyaK2M%252FmvF2nsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1994&pages=747-751&issue=5&author=P.+Mecocciauthor=U.+Macgarveyauthor=M.+F.+Beal&title=Oxidative+damage+to+mitochondrial-DNA+is+increased+in+Alzheimers-disease&doi=10.1002%2Fana.410360510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease</span></div><div class="casAuthors">Mecocci P; MacGarvey U; Beal M F</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">747-51</span>
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">Oxidative damage to DNA may play a role in both normal aging and in neurodegenerative diseases.  We examined whether Alzheimer's disease (AD) is associated with increased oxidative damage to nDNA and mtDNA in postmortem brain tissue.  We measured the oxidized nucleoside, 8-hydroxy-2'-deoxyguanosine (OH8dG), in DNA isolated from three regions of cerebral cortex and cerebellum in 13 AD and 13 age-matched controls.  There was a significant threefold increase in the amount of OH8dG in mtDNA in parietal cortex of AD patients compared with controls.  In the entire group of samples there was a small significant increase in oxidative damage to nDNA and a highly significant threefold increase in oxidative damage to mtDNA in AD compared with age-matched controls.  These results confirm that mitochondrial DNA is particularly sensitive to oxidative damage, and they show that there is increased oxidative damage to DNA in AD, which may contribute to the neurodegenerative process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTIhMoEIAbG5Jp6t8nS6Nc3fW6udTcc2eYHRj1C5aHr8rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252FmvF2nsA%253D%253D&md5=f4708b4825a3eec3d86b1f1ab9884dca</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1002%2Fana.410360510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410360510%26sid%3Dliteratum%253Aachs%26aulast%3DMecocci%26aufirst%3DP.%26aulast%3DMacgarvey%26aufirst%3DU.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DOxidative%2520damage%2520to%2520mitochondrial-DNA%2520is%2520increased%2520in%2520Alzheimers-disease%26jtitle%3DAnn.%2520Neurol.%26date%3D1994%26volume%3D36%26issue%3D5%26spage%3D747%26epage%3D751%26doi%3D10.1002%2Fana.410360510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanagawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawane, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seita, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannai, S.</span></span> <span> </span><span class="NLM_article-title">Murine peritoneal macrophages induce a novel 60-kDa protein with structural similarity to a tyrosine kinase p56(lck)-associated protein in response to oxidative stress</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>226</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">456</span>– <span class="NLM_lpage">460</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1996.1377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1006%2Fbbrc.1996.1377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=8806656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADyaK28Xls1yit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=1996&pages=456-460&issue=2&author=T.+Ishiiauthor=T.+Yanagawaauthor=T.+Kawaneauthor=K.+Yukiauthor=J.+Seitaauthor=H.+Yoshidaauthor=S.+Bannai&title=Murine+peritoneal+macrophages+induce+a+novel+60-kDa+protein+with+structural+similarity+to+a+tyrosine+kinase+p56%28lck%29-associated+protein+in+response+to+oxidative+stress&doi=10.1006%2Fbbrc.1996.1377"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Murine peritoneal macrophages induce a novel 60-kDa protein with structural similarity to a tyrosine kinase p56lck-associated protein in response to oxidative stress</span></div><div class="casAuthors">Ishii, Tetsuro; Yanagawa, Yoru; Kawane, Tetsuya; Yuki, Koichi; Seita, Jun; Yoshida, Hiroshi; Bannai, Shiro</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">456-460</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Using differential screening we have cloned a cDNA encoding a novel oxidative stress protein designated A170 from murine peritoneal macrophages.  It has a Zn-finger domain, a PEST domain and several potential phosphorylation sites for kinases.  Treatments with oxidative stress agents such as di-Et maleate and paraquat increased a 2.0-kilobase A170 mRNA about twofold in the macrophages after 12 h in culture.  However, H2O2 or glucose/glucose oxidase did not increase the level of the A170 mRNA.  Using an A170-specific antibody we have detected in the macrophages a 60-kDa protein that was induced 5 to 10 h after the addn. of the oxidative stress agents.  A search of sequence databases revealed that the A170 protein is roughly 90% identical to a human protein that binds to the Src homol. 2 domain of the T-cell-specific tyrosine kinase p56lck.  These features suggest that the A170 protein plays a significant role in oxidative stress-responsive signal transduction in macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosnqKmPU_Ve7Vg90H21EOLACvtfcHk0liUeXARR_p7_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xls1yit7o%253D&md5=de5965e2445982d0e146a905fb5c526b</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1996.1377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1996.1377%26sid%3Dliteratum%253Aachs%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DYanagawa%26aufirst%3DT.%26aulast%3DKawane%26aufirst%3DT.%26aulast%3DYuki%26aufirst%3DK.%26aulast%3DSeita%26aufirst%3DJ.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DBannai%26aufirst%3DS.%26atitle%3DMurine%2520peritoneal%2520macrophages%2520induce%2520a%2520novel%252060-kDa%2520protein%2520with%2520structural%2520similarity%2520to%2520a%2520tyrosine%2520kinase%2520p56%2528lck%2529-associated%2520protein%2520in%2520response%2520to%2520oxidative%2520stress%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1996%26volume%3D226%26issue%3D2%26spage%3D456%26epage%3D460%26doi%3D10.1006%2Fbbrc.1996.1377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M. P.</span></span> <span> </span><span class="NLM_article-title">Animal and human studies with the mitochondria-targeted antioxidant MitoQ</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1201</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1111/j.1749-6632.2010.05627.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1111%2Fj.1749-6632.2010.05627.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20649545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFegsLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1201&publication_year=2010&pages=96-103&author=R.+A.+J.+Smithauthor=M.+P.+Murphy&title=Animal+and+human+studies+with+the+mitochondria-targeted+antioxidant+MitoQ&doi=10.1111%2Fj.1749-6632.2010.05627.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Animal and human studies with the mitochondria-targeted antioxidant mitoQ</span></div><div class="casAuthors">Smith, Robin A. J.; Murphy, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1201</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">96-103</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  As mitochondrial oxidative damage contributes to a wide range of human diseases, antioxidants designed to be accumulated by mitochondria in vivo have been developed.  The most extensively studied of these mitochondria-targeted antioxidants is MitoQ, which contains the antioxidant quinone moiety covalently attached to a lipophilic triphenylphosphonium cation.  MitoQ has now been used in a range of in vivo studies in rats and mice and in two phase II human trials.  Here, we review what has been learned from these animal and human studies with MitoQ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN1QYo6EVyf7Vg90H21EOLACvtfcHk0ljj9I3X_7I6TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFegsLrF&md5=e11dd288b96d56da2e229eb8052c8479</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.2010.05627.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.2010.05627.x%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DR.%2BA.%2BJ.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26atitle%3DAnimal%2520and%2520human%2520studies%2520with%2520the%2520mitochondria-targeted%2520antioxidant%2520MitoQ%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2010%26volume%3D1201%26spage%3D96%26epage%3D103%26doi%3D10.1111%2Fj.1749-6632.2010.05627.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baum, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, C. W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, S. K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwok, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lui, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsoh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, H. F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goggins, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zee, B. C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, C. Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mok, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, M. S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ip, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, C. Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, I. H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mok, V.</span></span> <span> </span><span class="NLM_article-title">Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease</span>. <i>J. Clin. Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">113</span>, <span class="refDoi"> DOI: 10.1097/jcp.0b013e318160862c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1097%2Fjcp.0b013e318160862c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18204357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BD1c7gtlansw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=110-113&issue=1&author=L.+Baumauthor=C.+W.+K.+Lamauthor=S.+K.+K.+Cheungauthor=T.+Kwokauthor=V.+Luiauthor=J.+Tsohauthor=L.+Lamauthor=V.+Leungauthor=E.+Huiauthor=C.+Ngauthor=J.+Wooauthor=H.+F.+K.+Chiuauthor=W.+B.+Gogginsauthor=B.+C.+Y.+Zeeauthor=K.+F.+Chengauthor=C.+Y.+S.+Fongauthor=A.+Wongauthor=H.+Mokauthor=M.+S.+S.+Chowauthor=P.+C.+Hoauthor=S.+P.+Ipauthor=C.+S.+Hoauthor=X.+W.+Yuauthor=C.+Y.+L.+Laiauthor=M.+H.+Chanauthor=S.+Szetoauthor=I.+H.+S.+Chanauthor=V.+Mok&title=Six-month+randomized%2C+placebo-controlled%2C+double-blind%2C+pilot+clinical+trial+of+curcumin+in+patients+with+Alzheimer+disease&doi=10.1097%2Fjcp.0b013e318160862c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease</span></div><div class="casAuthors">Baum Larry; Lam Christopher Wai Kei; Cheung Stanley Kwok-Kuen; Kwok Timothy; Lui Victor; Tsoh Joshua; Lam Linda; Leung Vivian; Hui Elsie; Ng Chelsia; Woo Jean; Chiu Helen Fung Kum; Goggins William B; Zee Benny Chung-Ying; Cheng King Fai; Fong Carmen Yuet Shim; Wong Adrian; Mok Hazel; Chow Moses Sing Sum; Ho Ping Chuen; Ip Siu Po; Ho Chung Shun; Yu Xiong Wen; Lai Caroline Yau Lin; Chan Ming-Houng; Szeto Samuel; Chan Iris Hiu Shuen; Mok Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical psychopharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">110-3</span>
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTPfhPvTevf1Ptos8R3JUhXfW6udTcc2eb8HknzNVYpq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7gtlansw%253D%253D&md5=b0b7fb02c9ec4f0213f6176415aa9a5d</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1097%2Fjcp.0b013e318160862c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252Fjcp.0b013e318160862c%26sid%3Dliteratum%253Aachs%26aulast%3DBaum%26aufirst%3DL.%26aulast%3DLam%26aufirst%3DC.%2BW.%2BK.%26aulast%3DCheung%26aufirst%3DS.%2BK.%2BK.%26aulast%3DKwok%26aufirst%3DT.%26aulast%3DLui%26aufirst%3DV.%26aulast%3DTsoh%26aufirst%3DJ.%26aulast%3DLam%26aufirst%3DL.%26aulast%3DLeung%26aufirst%3DV.%26aulast%3DHui%26aufirst%3DE.%26aulast%3DNg%26aufirst%3DC.%26aulast%3DWoo%26aufirst%3DJ.%26aulast%3DChiu%26aufirst%3DH.%2BF.%2BK.%26aulast%3DGoggins%26aufirst%3DW.%2BB.%26aulast%3DZee%26aufirst%3DB.%2BC.%2BY.%26aulast%3DCheng%26aufirst%3DK.%2BF.%26aulast%3DFong%26aufirst%3DC.%2BY.%2BS.%26aulast%3DWong%26aufirst%3DA.%26aulast%3DMok%26aufirst%3DH.%26aulast%3DChow%26aufirst%3DM.%2BS.%2BS.%26aulast%3DHo%26aufirst%3DP.%2BC.%26aulast%3DIp%26aufirst%3DS.%2BP.%26aulast%3DHo%26aufirst%3DC.%2BS.%26aulast%3DYu%26aufirst%3DX.%2BW.%26aulast%3DLai%26aufirst%3DC.%2BY.%2BL.%26aulast%3DChan%26aufirst%3DM.%2BH.%26aulast%3DSzeto%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DI.%2BH.%2BS.%26aulast%3DMok%26aufirst%3DV.%26atitle%3DSix-month%2520randomized%252C%2520placebo-controlled%252C%2520double-blind%252C%2520pilot%2520clinical%2520trial%2520of%2520curcumin%2520in%2520patients%2520with%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D2008%26volume%3D28%26issue%3D1%26spage%3D110%26epage%3D113%26doi%3D10.1097%2Fjcp.0b013e318160862c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, M. W.</span></span> <span> </span><span class="NLM_article-title">Oxidative damage to the promoter region of SQSTM1/p62 is common to neurodegenerative disease</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">302</span>– <span class="NLM_lpage">310</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2009.05.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.nbd.2009.05.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19481605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotFCgtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2009&pages=302-310&issue=2&author=Y.+F.+Duauthor=M.+C.+Wootenauthor=M.+W.+Wooten&title=Oxidative+damage+to+the+promoter+region+of+SQSTM1%2Fp62+is+common+to+neurodegenerative+disease&doi=10.1016%2Fj.nbd.2009.05.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative damage to the promoter region of SQSTM1/p62 is common to neurodegenerative disease</span></div><div class="casAuthors">Du, Yifeng; Wooten, Michael C.; Wooten, Marie W.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">302-310</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recently we reported that declined SQSTM1/p62 expression in Alzheimer disease brain was age-correlated with oxidative damage to the p62 promoter.  The objective of this study was to examine whether oxidative damage to the p62 promoter is common to DNA recovered from brain of individuals with neurodegenerative disease.  Increased 8-OHdG staining was obsd. in brain sections from Alzheimer's disease (AD), Parkinson disease (PD), Huntington disease (HD), Frontotemporal dementia (FTD), and Pick's disease compared to control subjects.  In parallel, the p62 promoter exhibited elevated oxidative damage in samples from various diseases compared to normal brain, and damage was neg. correlated with p62 expression in FTD samples.  Oxidative damage to the p62 promoter induced by H2O2 treatment decreased its transcriptional activity.  In keeping with this observation, the transcriptional activity of a Sp-1 element deletion mutant displayed reduced stimulus-induced activity.  These findings reveal that oxidative damage to the p62 promoter decreased its transcriptional activity and might therefore account for decreased expression of p62.  Altogether these results suggest that pharmacol. means to increase p62 expression may be beneficial in delaying the onset of neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA_-iE4eJ1l7Vg90H21EOLACvtfcHk0lhDpW1NsoY-yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotFCgtL0%253D&md5=96782e2b993c732f81a18d8a6655d6ab</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2009.05.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2009.05.015%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DY.%2BF.%26aulast%3DWooten%26aufirst%3DM.%2BC.%26aulast%3DWooten%26aufirst%3DM.%2BW.%26atitle%3DOxidative%2520damage%2520to%2520the%2520promoter%2520region%2520of%2520SQSTM1%252Fp62%2520is%2520common%2520to%2520neurodegenerative%2520disease%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2009%26volume%3D35%26issue%3D2%26spage%3D302%26epage%3D310%26doi%3D10.1016%2Fj.nbd.2009.05.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamark, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjottem, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awuh, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overvatn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansen, T.</span></span> <span> </span><span class="NLM_article-title">p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span> (<span class="NLM_issue">29</span>),  <span class="NLM_fpage">22576</span>– <span class="NLM_lpage">22591</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.118976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1074%2Fjbc.M110.118976" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20452972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1WntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=22576-22591&issue=29&author=A.+Jainauthor=T.+Lamarkauthor=E.+Sjottemauthor=K.+B.+Larsenauthor=J.+A.+Awuhauthor=A.+Overvatnauthor=M.+McMahonauthor=J.+D.+Hayesauthor=T.+Johansen&title=p62%2FSQSTM1+is+a+target+gene+for+transcription+factor+NRF2+and+creates+a+positive+feedback+loop+by+inducing+antioxidant+response+element-driven+gene+transcription&doi=10.1074%2Fjbc.M110.118976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription</span></div><div class="casAuthors">Jain, Ashish; Lamark, Trond; Sjottem, Eva; Bowitz Larsen, Kenneth; Atesoh Awuh, Jane; Overvatn, Aud; McMahon, Michael; Hayes, John D.; Johansen, Terje</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">22576-22591</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The p62/SQSTM1 (sequestosome 1) protein, which acts as a cargo receptor for autophagic degrdn. of ubiquitinated targets, is up-regulated by various stressors.  Induction of the p62 gene by oxidative stress is mediated by NF-E2-related factor 2 (NRF2) and, at the same time, p62 protein contributes to the activation of NRF2, but hitherto the mechanisms involved were not known.  Herein, we have mapped an antioxidant response element (ARE) in the p62 promoter that is responsible for its induction by oxidative stress via NRF2.  Chromatin immunopptn. and gel mobility-shift assays verified that NRF2 binds to this cis-element in vivo and in vitro.  Also, p62 docks directly onto the Kelch-repeat domain of Kelch-like ECH-assocd. protein 1 (KEAP1), via a motif designated the KEAP1 interacting region (KIR), thereby blocking binding between KEAP1 and NRF2 that leads to ubiquitylation and degrdn. of the transcription factor.  The KIR motif in p62 is located immediately C-terminal to the LC3-interacting region (LIR) and resembles the ETGE motif utilized by NRF2 for its interaction with KEAP1.  KIR is required for p62 to stabilize NRF2, and inhibition of KEAP1 by p62 occurs from a cytoplasmic location within the cell.  The LIR and KIR motifs cannot be engaged simultaneously by LC3 and KEAP1, but because p62 is polymeric the interaction between KEAP1 and p62 leads to accumulation of KEAP1 in p62 bodies, which is followed by autophagic degrdn. of KEAP1.  Our data explain how p62 contributes to activation of NRF2 target genes in response to oxidative stress through creating a pos. feedback loop.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgqJXJvye3yrVg90H21EOLACvtfcHk0lhDpW1NsoY-yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1WntLg%253D&md5=707de1a603fba64ec0d631b575bd6c99</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.118976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.118976%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DA.%26aulast%3DLamark%26aufirst%3DT.%26aulast%3DSjottem%26aufirst%3DE.%26aulast%3DLarsen%26aufirst%3DK.%2BB.%26aulast%3DAwuh%26aufirst%3DJ.%2BA.%26aulast%3DOvervatn%26aufirst%3DA.%26aulast%3DMcMahon%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DJohansen%26aufirst%3DT.%26atitle%3Dp62%252FSQSTM1%2520is%2520a%2520target%2520gene%2520for%2520transcription%2520factor%2520NRF2%2520and%2520creates%2520a%2520positive%2520feedback%2520loop%2520by%2520inducing%2520antioxidant%2520response%2520element-driven%2520gene%2520transcription%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26issue%3D29%26spage%3D22576%26epage%3D22591%26doi%3D10.1074%2Fjbc.M110.118976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otten, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manni, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanatos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menzies, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jurk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenneth, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passos, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attems, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veal, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teyssou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seilhean, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millecamps, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eskelinen, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronowska, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinsztein, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korolchuk, V. I.</span></span> <span> </span><span class="NLM_article-title">Oxidation of SQSTM1/p62 mediates the link between redox state and protein homeostasis</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">256</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02746-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fs41467-017-02746-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=29343728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BC1Mvhs12rsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=256&issue=1&author=B.+Carrollauthor=E.+G.+Ottenauthor=D.+Manniauthor=R.+Stefanatosauthor=F.+M.+Menziesauthor=G.+R.+Smithauthor=D.+Jurkauthor=N.+Kennethauthor=S.+Wilkinsonauthor=J.+F.+Passosauthor=J.+Attemsauthor=E.+A.+Vealauthor=E.+Teyssouauthor=D.+Seilheanauthor=S.+Millecampsauthor=E.+L.+Eskelinenauthor=A.+K.+Bronowskaauthor=D.+C.+Rubinszteinauthor=A.+Sanzauthor=V.+I.+Korolchuk&title=Oxidation+of+SQSTM1%2Fp62+mediates+the+link+between+redox+state+and+protein+homeostasis&doi=10.1038%2Fs41467-017-02746-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidation of SQSTM1/p62 mediates the link between redox state and protein homeostasis</span></div><div class="casAuthors">Carroll Bernadette; Otten Elsje G; Manni Diego; Stefanatos Rhoda; Smith Graham R; Jurk Diana; Kenneth Niall; Passos Joao F; Veal Elizabeth A; Sanz Alberto; Korolchuk Viktor I; Menzies Fiona M; Rubinsztein David C; Smith Graham R; Wilkinson Simon; Attems Johannes; Teyssou Elisa; Seilhean Danielle; Millecamps Stephanie; Seilhean Danielle; Eskelinen Eeva-Liisa; Bronowska Agnieszka K; Rubinsztein David C</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">256</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cellular homoeostatic pathways such as macroautophagy (hereinafter autophagy) are regulated by basic mechanisms that are conserved throughout the eukaryotic kingdom.  However, it remains poorly understood how these mechanisms further evolved in higher organisms.  Here we describe a modification in the autophagy pathway in vertebrates, which promotes its activity in response to oxidative stress.  We have identified two oxidation-sensitive cysteine residues in a prototypic autophagy receptor SQSTM1/p62, which allow activation of pro-survival autophagy in stress conditions.  The Drosophila p62 homologue, Ref(2)P, lacks these oxidation-sensitive cysteine residues and their introduction into the protein increases protein turnover and stress resistance of flies, whereas perturbation of p62 oxidation in humans may result in age-related pathology.  We propose that the redox-sensitivity of p62 may have evolved in vertebrates as a mechanism that allows activation of autophagy in response to oxidative stress to maintain cellular homoeostasis and increase cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7izekEYEuo9NTrvPZP1IpfW6udTcc2eY-az3bU_4dc7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mvhs12rsQ%253D%253D&md5=6fcf378990f79016d342f2be482191f3</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02746-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02746-z%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DB.%26aulast%3DOtten%26aufirst%3DE.%2BG.%26aulast%3DManni%26aufirst%3DD.%26aulast%3DStefanatos%26aufirst%3DR.%26aulast%3DMenzies%26aufirst%3DF.%2BM.%26aulast%3DSmith%26aufirst%3DG.%2BR.%26aulast%3DJurk%26aufirst%3DD.%26aulast%3DKenneth%26aufirst%3DN.%26aulast%3DWilkinson%26aufirst%3DS.%26aulast%3DPassos%26aufirst%3DJ.%2BF.%26aulast%3DAttems%26aufirst%3DJ.%26aulast%3DVeal%26aufirst%3DE.%2BA.%26aulast%3DTeyssou%26aufirst%3DE.%26aulast%3DSeilhean%26aufirst%3DD.%26aulast%3DMillecamps%26aufirst%3DS.%26aulast%3DEskelinen%26aufirst%3DE.%2BL.%26aulast%3DBronowska%26aufirst%3DA.%2BK.%26aulast%3DRubinsztein%26aufirst%3DD.%2BC.%26aulast%3DSanz%26aufirst%3DA.%26aulast%3DKorolchuk%26aufirst%3DV.%2BI.%26atitle%3DOxidation%2520of%2520SQSTM1%252Fp62%2520mediates%2520the%2520link%2520between%2520redox%2520state%2520and%2520protein%2520homeostasis%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26issue%3D1%26spage%3D256%26doi%3D10.1038%2Fs41467-017-02746-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rea, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majcher, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Searle, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layfield, R.</span></span> <span> </span><span class="NLM_article-title">SQSTM1 mutations-bridging Paget disease of bone and ALS/FTLD</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>325</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">37</span>, <span class="refDoi"> DOI: 10.1016/j.yexcr.2014.01.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.yexcr.2014.01.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=24486447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitlelsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2014&pages=27-37&issue=1&author=S.+L.+Reaauthor=V.+Majcherauthor=M.+S.+Searleauthor=R.+Layfield&title=SQSTM1+mutations-bridging+Paget+disease+of+bone+and+ALS%2FFTLD&doi=10.1016%2Fj.yexcr.2014.01.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">SQSTM1 mutations - Bridging Paget disease of bone and ALS/FTLD</span></div><div class="casAuthors">Rea, Sarah L.; Majcher, Veronika; Searle, Mark S.; Layfield, Rob</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-37</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Paget disease of bone (PDB) is a skeletal disorder common in Western Europe but extremely rare in the Indian subcontinent and Far East.  The condition has a strong genetic element with mutations affecting the SQSTM1 gene, encoding the p62 protein, frequently identified.  Recently SQSTM1 mutations have also been reported in a small no. of patients with amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD), neurodegenerative disorders in which significant coexistence with PDB has not been previously recognized.  Although several SQSTM1 mutations are common to both ALS/FTLD and PDB, many are ALS/FTLD-specific.  The p62 protein regulates various cellular processes including NF-κB signaling and autophagy pathways.  Here we consider how knowledge of the impact of PDB-assocd. SQSTM1 mutations (several of which are now known to be relevant for ALS/FTLD) on these pathways, as well as the locations of the mutations within the p62 primary sequence, may provide new insights into ALS/FTLD disease mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO-5Xu7HQbtLVg90H21EOLACvtfcHk0ljkJhVth1TEdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitlelsrg%253D&md5=3ee0dc16a76c9009d7994bdb48cb0c00</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2014.01.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2014.01.020%26sid%3Dliteratum%253Aachs%26aulast%3DRea%26aufirst%3DS.%2BL.%26aulast%3DMajcher%26aufirst%3DV.%26aulast%3DSearle%26aufirst%3DM.%2BS.%26aulast%3DLayfield%26aufirst%3DR.%26atitle%3DSQSTM1%2520mutations-bridging%2520Paget%2520disease%2520of%2520bone%2520and%2520ALS%252FFTLD%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2014%26volume%3D325%26issue%3D1%26spage%3D27%26epage%3D37%26doi%3D10.1016%2Fj.yexcr.2014.01.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sabatelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zollino, M.</span></span> <span> </span><span class="NLM_article-title">Clinical and genetic heterogeneity of amyotrophic lateral sclerosis</span>. <i>Clin. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>83</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">408</span>– <span class="NLM_lpage">416</span>, <span class="refDoi"> DOI: 10.1111/cge.12117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1111%2Fcge.12117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=23379621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosFKktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2013&pages=408-416&issue=5&author=M.+Sabatelliauthor=A.+Conteauthor=M.+Zollino&title=Clinical+and+genetic+heterogeneity+of+amyotrophic+lateral+sclerosis&doi=10.1111%2Fcge.12117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical and genetic heterogeneity of amyotrophic lateral sclerosis</span></div><div class="casAuthors">Sabatelli, M.; Conte, A.; Zollino, M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Genetics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">408-416</span>CODEN:
                <span class="NLM_cas:coden">CLGNAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-9163</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Although clin. picture of amyotrophic lateral sclerosis (ALS) is a stereotypical one, resulting from combination of signs secondary to dysfunction of both upper motor neuron (UMN) and lower motor neuron (LMN), clin. heterogeneity is a consistent feature of the disease.  Age of onset, relative mix of UMN and LMN signs, duration of the disease and assocn. with other conditions are major factors contributing to variable clin. phenotypes.  Genetically, familial forms of ALS are assocd. with a large no. of pleiotropic genes whose mutations impair different biochem. pathways, resulting in overlapping clin. and pathol. phenotypes.  Over the last few years contribution of large- and low-effect genes to sporadic ALS is increasingly recognized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptYRLkwkK7NbVg90H21EOLACvtfcHk0ljkJhVth1TEdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosFKktrg%253D&md5=d3dc82de3f58c7159bc05b31c9933610</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1111%2Fcge.12117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcge.12117%26sid%3Dliteratum%253Aachs%26aulast%3DSabatelli%26aufirst%3DM.%26aulast%3DConte%26aufirst%3DA.%26aulast%3DZollino%26aufirst%3DM.%26atitle%3DClinical%2520and%2520genetic%2520heterogeneity%2520of%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DClin.%2520Genet.%26date%3D2013%26volume%3D83%26issue%3D5%26spage%3D408%26epage%3D416%26doi%3D10.1111%2Fcge.12117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panegyres, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frencham, K.</span></span> <span> </span><span class="NLM_article-title">Course and causes of suspected dementia in young adults: a longitudinal study</span>. <i>American journal of Alzheimer’s disease and other dementias</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1177/1533317506295887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1177%2F1533317506295887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=17534002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BD2szit1KntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=48-56&issue=1&author=P.+K.+Panegyresauthor=K.+Frencham&title=Course+and+causes+of+suspected+dementia+in+young+adults%3A+a+longitudinal+study&doi=10.1177%2F1533317506295887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Course and causes of suspected dementia in young adults: a longitudinal study</span></div><div class="casAuthors">Panegyres Peter K; Frencham Kate</div><div class="citationInfo"><span class="NLM_cas:title">American journal of Alzheimer's disease and other dementias</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-56</span>
        ISSN:<span class="NLM_cas:issn">1533-3175</span>.
    </div><div class="casAbstract">The authors performed a prospective, unbiased analysis of a cohort of young patients assessed consecutively with the question of dementia.  The onset of patients' cognitive symptoms was prior to the age of 65 years.  A study group of 226 patients was followed for a mean duration of 4.59 +/- 2.23 years (1 SD; range, 0.04-7.86 years).  The diagnoses were established using published diagnostic criteria.  A diagnosis of dementia was made in 112 patients (49.56%).  Psychiatric disease was the most common diagnosis in those who did not have dementia (24.3%) followed by frontotemporal lobar degeneration (19.0%), Alzheimer's disease (11.9%), patients with cognitive symptoms who obtained normal neuropsychometric profiles (10.6%), nonneurological disorders (eg, obstructive sleep apnea [8.4%]), neurological disorders (eg, Parkinson's disease [4.9%]), and mild cognitive impairment (4.9%).  The frequencies of frontotemporal lobar degeneration and psychiatric disease were higher than Alzheimer's disease, unlike in older populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRIkI5T8Ht0zZPlX7E30qdzfW6udTcc2ebGHqMVP2MMfLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2szit1KntQ%253D%253D&md5=7866ac4ecf15f5a9fd5c99780c51ed6e</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1177%2F1533317506295887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1533317506295887%26sid%3Dliteratum%253Aachs%26aulast%3DPanegyres%26aufirst%3DP.%2BK.%26aulast%3DFrencham%26aufirst%3DK.%26atitle%3DCourse%2520and%2520causes%2520of%2520suspected%2520dementia%2520in%2520young%2520adults%253A%2520a%2520longitudinal%2520study%26jtitle%3DAmerican%2520journal%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520other%2520dementias%26date%3D2007%26volume%3D22%26issue%3D1%26spage%3D48%26epage%3D56%26doi%3D10.1177%2F1533317506295887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanji, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakita, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, K.</span></span> <span> </span><span class="NLM_article-title">p62/sequestosome 1 binds to TDP-43 in brains with frontotemporal lobar degeneration with TDP-43 inclusions</span>. <i>J. Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>90</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2034</span>– <span class="NLM_lpage">2042</span>, <span class="refDoi"> DOI: 10.1002/jnr.23081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1002%2Fjnr.23081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22674379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvFOqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2012&pages=2034-2042&issue=10&author=K.+Tanjiauthor=H.+X.+Zhangauthor=F.+Moriauthor=A.+Kakitaauthor=H.+Takahashiauthor=K.+Wakabayashi&title=p62%2Fsequestosome+1+binds+to+TDP-43+in+brains+with+frontotemporal+lobar+degeneration+with+TDP-43+inclusions&doi=10.1002%2Fjnr.23081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">p62/sequestosome 1 binds to TDP-43 in brains with frontotemporal lobar degeneration with TDP-43 inclusions</span></div><div class="casAuthors">Tanji, Kunikazu; Zhang, Hai-Xin; Mori, Fumiaki; Kakita, Akiyoshi; Takahashi, Hitoshi; Wakabayashi, Koichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2034-2042</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Ubiquitin-pos. cytoplasmic inclusions are consistently found in various neurodegenerative diseases.  As with ubiquitin, anti-p62/SQSTM1 (referred to as p62) antibody clearly immunostains these inclusions.  P62 has a ubiquitin-assocd. domain at the carboxyl terminus and thereby interacts with ubiquitinated and misfolded proteins.  Here we immunopptd. endogenous p62 in the cerebral cortex from patients with frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) and found that p62 coimmunopptd. several proteins, including TDP-43, which is a major disease protein in FTLD-TDP.  Unexpectedly, p62 immunopptd. a smaller amt. of TDP-43 in FTLD-TDP compared with controls.  Further analyses showed that p62 physiol. binds to TDP-43 and likely is involved in degrdn. of TDP-43 with 35-kDa, but not full-length TDP-43.  Our results suggest that the interaction of TDP-43 and p62 is disrupted and may participate in the pathogenesis of TDP-43 proteinopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcIxUxWxvmBbVg90H21EOLACvtfcHk0lhrhfm71qq0Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvFOqs74%253D&md5=3c8535b5959d73d8b7ad0cebb4a8ab83</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1002%2Fjnr.23081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.23081%26sid%3Dliteratum%253Aachs%26aulast%3DTanji%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DH.%2BX.%26aulast%3DMori%26aufirst%3DF.%26aulast%3DKakita%26aufirst%3DA.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DWakabayashi%26aufirst%3DK.%26atitle%3Dp62%252Fsequestosome%25201%2520binds%2520to%2520TDP-43%2520in%2520brains%2520with%2520frontotemporal%2520lobar%2520degeneration%2520with%2520TDP-43%2520inclusions%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2012%26volume%3D90%26issue%3D10%26spage%3D2034%26epage%3D2042%26doi%3D10.1002%2Fjnr.23081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alegre-Abarrategui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade-Martins, R.</span></span> <span> </span><span class="NLM_article-title">RNA dysfunction and aggrephagy at the centre of an amyotrophic lateral sclerosis/frontotemporal dementia disease continuum</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>136</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1345</span>– <span class="NLM_lpage">1360</span>, <span class="refDoi"> DOI: 10.1093/brain/awt030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1093%2Fbrain%2Fawt030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=23474849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BC3svks1aitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2013&pages=1345-1360&issue=5&author=M.+Thomasauthor=J.+Alegre-Abarrateguiauthor=R.+Wade-Martins&title=RNA+dysfunction+and+aggrephagy+at+the+centre+of+an+amyotrophic+lateral+sclerosis%2Ffrontotemporal+dementia+disease+continuum&doi=10.1093%2Fbrain%2Fawt030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">RNA dysfunction and aggrephagy at the centre of an amyotrophic lateral sclerosis/frontotemporal dementia disease continuum</span></div><div class="casAuthors">Thomas Matthew; Alegre-Abarrategui Javier; Wade-Martins Richard</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">Pt 5</span>),
    <span class="NLM_cas:pages">1345-60</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Amyotrophic lateral sclerosis and frontotemporal dementia form two poles of a genetically, pathologically and clinically-related disease continuum.  Analysis of the genes and proteins at the heart of this continuum highlights dysfunction of RNA processing and aggrephagy as crucial disease-associated pathways.  TAR DNA binding protein and fused in sarcoma (FUS) are both RNA processing proteins whose dysfunction impacts on global cellular RNA regulation.  The recent discovery that expression of repeat expansions in the C9orf72 gene may induce RNA foci that could sequester RNA binding proteins such as TAR DNA binding protein and FUS highlights a further possibly important mechanism of RNA dysfunction in disease.  Furthermore, sequestration of key RNA binding proteins may also play an important role in sporadic disease due to the association of TAR DNA binding protein and FUS with stress granules.  In a further functional convergence, ubiquilin 2, p62, valosin-containing protein and optineurin are all linked to aggrephagy, a cargo-specific subtype of autophagy important for degrading ubiquitinated target proteins through the lysosome.  Notably these two key pathways interact; TAR DNA binding protein and FUS bind and regulate key aggrephagy-related genes whereas dysfunction of aggrephagy leads to cytoplasmic relocalization and aggregation of TAR DNA binding protein.  The convergence of amyotrophic lateral sclerosis and frontotemporal dementia linked genes into these two pathways highlights RNA dysfunction and aggrephagy as promising areas for drug discovery.  In this review we discuss the importance of each of these pathways and suggest mechanisms by which they may cause both sporadic and familial disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSss4OwtmZ9cO2mnZh2OgS0fW6udTcc2ea53HIyOQgVnrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svks1aitg%253D%253D&md5=63a673f902456b6437deb417b0f21846</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawt030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawt030%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DAlegre-Abarrategui%26aufirst%3DJ.%26aulast%3DWade-Martins%26aufirst%3DR.%26atitle%3DRNA%2520dysfunction%2520and%2520aggrephagy%2520at%2520the%2520centre%2520of%2520an%2520amyotrophic%2520lateral%2520sclerosis%252Ffrontotemporal%2520dementia%2520disease%2520continuum%26jtitle%3DBrain%26date%3D2013%26volume%3D136%26issue%3D5%26spage%3D1345%26epage%3D1360%26doi%3D10.1093%2Fbrain%2Fawt030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goode, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rea, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sultana, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Searle, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layfield, R.</span></span> <span> </span><span class="NLM_article-title">ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling</span>. <i>Mol. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1016/j.mcn.2016.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.mcn.2016.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27554286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVeltbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=52-58&author=A.+Goodeauthor=S.+Reaauthor=M.+Sultanaauthor=B.+Shawauthor=M.+S.+Searleauthor=R.+Layfield&title=ALS-FTLD+associated+mutations+of+SQSTM1+impact+on+Keap1-Nrf2+signalling&doi=10.1016%2Fj.mcn.2016.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling</span></div><div class="casAuthors">Goode, Alice; Rea, Sarah; Sultana, Melanie; Shaw, Barry; Searle, Mark S.; Layfield, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">52-58</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The transcription factor Nrf2 and its repressor protein Keap1 play key roles in the regulation of antioxidant stress responses and both Keap1-Nrf2 signalling and oxidative stress have been implicated in the pathogenesis of the ALS-FTLD spectrum of neurodegenerative disorders.  The Keap1-binding partner and autophagy receptor SQSTM1/p62 has also recently been linked genetically to ALS-FTLD, with some missense mutations identified in patients mapping within or close to its Keap1-interacting region (KIR, residues 347-352).  Here we report the effects on protein function of four different disease assocd. mutations of SQSTM1/p62 which affect the KIR region.  Only mutations mapping precisely to the KIR (P348L and G351A) were assocd. with a loss of Keap1 binding in co-immunopptns. comparable to wild-type SQSTM1/p62.  These selective effects on Keap1 recognition were entirely rational based on protein structural models.  Consistent with impaired Keap1 binding, the P348L and G351A KIR mutants showed reduced ability to activate Nrf2 signalling compared to wild-type SQSTM1/p62 in antioxidant response element (ARE)-luciferase reporter assays.  The results suggest that SQSTM1 mutations within the KIR of SQSTM1/p62 contribute to etiol. of some cases of ALS-FTLD through a mechanism involving aberrant expression or regulation of oxidative response genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2W4RjD3vbDbVg90H21EOLACvtfcHk0lhrhfm71qq0Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVeltbrE&md5=2dba8b692d85da668b6ab80b78833a59</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2Fj.mcn.2016.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcn.2016.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DGoode%26aufirst%3DA.%26aulast%3DRea%26aufirst%3DS.%26aulast%3DSultana%26aufirst%3DM.%26aulast%3DShaw%26aufirst%3DB.%26aulast%3DSearle%26aufirst%3DM.%2BS.%26aulast%3DLayfield%26aufirst%3DR.%26atitle%3DALS-FTLD%2520associated%2520mutations%2520of%2520SQSTM1%2520impact%2520on%2520Keap1-Nrf2%2520signalling%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2016%26volume%3D76%26spage%3D52%26epage%3D58%26doi%3D10.1016%2Fj.mcn.2016.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarlette, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krampfl, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grothe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhoff, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dengler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petri, S.</span></span> <span> </span><span class="NLM_article-title">Nuclear erythroid 2-related factor 2-antioxidative response element signaling pathway in motor cortex and spinal cord in amyotrophic lateral sclerosis</span>. <i>J. Neuropathol. Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1055</span>– <span class="NLM_lpage">1062</span>, <span class="refDoi"> DOI: 10.1097/NEN.0b013e31818b4906</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1097%2FNEN.0b013e31818b4906" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18957896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVeqtLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2008&pages=1055-1062&issue=11&author=A.+Sarletteauthor=K.+Krampflauthor=C.+Grotheauthor=N.+Neuhoffauthor=R.+Denglerauthor=S.+Petri&title=Nuclear+erythroid+2-related+factor+2-antioxidative+response+element+signaling+pathway+in+motor+cortex+and+spinal+cord+in+amyotrophic+lateral+sclerosis&doi=10.1097%2FNEN.0b013e31818b4906"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear erythroid 2-related factor 2-antioxidative response element signaling pathway in motor cortex and spinal cord in amyotrophic lateral sclerosis</span></div><div class="casAuthors">Sarlette, Alexander; Krampfl, Klaus; Grothe, Claudia; von Neuhoff, Nils; Dengler, Reinhard; Petri, Susanne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuropathology & Experimental Neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1055-1062</span>CODEN:
                <span class="NLM_cas:coden">JNENAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Oxidative stress and inflammation are important pathogenetic mechanisms in amyotrophic lateral sclerosis (ALS).  Nuclear erythroid 2-related factor 2 (Nrf2) is a basic region leucine-zipper transcription factor that binds to the antioxidant response element, thereby regulating the expression of many genes that are involved in cellular antioxidant and anti-inflammatory defense.  Under normal conditions, Nrf2 activation is inhibited by Kelch-like ECH-assocd. protein 1 (Keap1).  We investigated the potential involvement of the Nrf2/antioxidant response element signaling pathway in the selective degeneration of motor neurons in ALS.  Nrf2 and Keap1 expression was analyzed in primary motor cortex and spinal cord postmortem tissue samples from ALS patients and controls by in situ hybridization histochem., quant. real-time polymerase chain reaction, immunohistochem., and Western blot anal.  In ALS samples, there was a redn. of Nrf2 mRNA and protein expression in neurons, whereas Keap1 mRNA expression was increased in the motor cortex.  These results suggest that alterations in this signaling cascade occur in motor neurons in ALS and that they may contribute to chronic motor neuron degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM5tN7GW_yB7Vg90H21EOLACvtfcHk0lhhu3xqjtKuOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVeqtLbL&md5=aa15024d516b888e48107915db34be09</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1097%2FNEN.0b013e31818b4906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FNEN.0b013e31818b4906%26sid%3Dliteratum%253Aachs%26aulast%3DSarlette%26aufirst%3DA.%26aulast%3DKrampfl%26aufirst%3DK.%26aulast%3DGrothe%26aufirst%3DC.%26aulast%3DNeuhoff%26aufirst%3DN.%26aulast%3DDengler%26aufirst%3DR.%26aulast%3DPetri%26aufirst%3DS.%26atitle%3DNuclear%2520erythroid%25202-related%2520factor%25202-antioxidative%2520response%2520element%2520signaling%2520pathway%2520in%2520motor%2520cortex%2520and%2520spinal%2520cord%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D2008%26volume%3D67%26issue%3D11%26spage%3D1055%26epage%3D1062%26doi%3D10.1097%2FNEN.0b013e31818b4906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ning, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, X. R.</span></span> <span> </span><span class="NLM_article-title">Oxidized low-density lipoprotein-induced p62/SQSTM1 accumulation in THP-1-derived macrophages promotes IL-18 secretion and cell death</span>. <i>Exp. Ther. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">5417</span>– <span class="NLM_lpage">5423</span>, <span class="refDoi"> DOI: 10.3892/etm.2017.5221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.3892%2Fetm.2017.5221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=29285070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitV2jsb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=5417-5423&issue=6&author=H.+F.+Ningauthor=D.+Liuauthor=X.+C.+Yuauthor=X.+R.+Guan&title=Oxidized+low-density+lipoprotein-induced+p62%2FSQSTM1+accumulation+in+THP-1-derived+macrophages+promotes+IL-18+secretion+and+cell+death&doi=10.3892%2Fetm.2017.5221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidized low-density lipoprotein-induced p62/SQSTM1 accumulation in THP-1-derived macrophages promotes IL-18 secretion and cell death</span></div><div class="casAuthors">Ning, Haofeng; Liu, Dan; Yu, Xiaochen; Guan, Xiuru</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Therapeutic Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">5417-5423</span>CODEN:
                <span class="NLM_cas:coden">ETMXA2</span>;
        ISSN:<span class="NLM_cas:issn">1792-1015</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Macrophage autophagy has a protective role in the development of atherosclerosis; however, it turns dysfunctional in advanced lesions with an increase in p62/sequestosome-1 protein.  Little is known about the role and significance of p62 accumulation in atherosclerosis.  The present study investigated the assocn. between p62 expression and the process of foam cell formation.  Foam cell models were established through incubation of THP-1-derived macrophages with oxidized low-d. lipoprotein, and the process of foam cell formation was detected by Oil red O staining.  Furthermore, the dynamic change of p62 expression was detected by western blotting and quant. polymerase chain reaction.  Addnl., using gene silencing techniques, the roles of p62 in foam cells were investigated with ELISA, MTT and flow cytometry.  The results indicated that besides serving as a marker of autophagy deficiency, the p62 protein could also mediate inflammation and cytotoxicity in advanced foam cells.  Addnl., the implication of p62 in autophagy inhibition and foam cell formation makes it a key atherogenic factor under autophagy-deficient conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6Fx8df4TqDLVg90H21EOLACvtfcHk0lhhu3xqjtKuOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitV2jsb3F&md5=1ad88ded2c113b39222a8ae88e127fa6</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.3892%2Fetm.2017.5221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fetm.2017.5221%26sid%3Dliteratum%253Aachs%26aulast%3DNing%26aufirst%3DH.%2BF.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DX.%2BC.%26aulast%3DGuan%26aufirst%3DX.%2BR.%26atitle%3DOxidized%2520low-density%2520lipoprotein-induced%2520p62%252FSQSTM1%2520accumulation%2520in%2520THP-1-derived%2520macrophages%2520promotes%2520IL-18%2520secretion%2520and%2520cell%2520death%26jtitle%3DExp.%2520Ther.%2520Med.%26date%3D2017%26volume%3D14%26issue%3D6%26spage%3D5417%26epage%3D5423%26doi%3D10.3892%2Fetm.2017.5221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Razani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ting, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virgin, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenkovich, C. F.</span></span> <span> </span><span class="NLM_article-title">Autophagy links inflammasomes to atherosclerotic progression</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">534</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2012.02.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.cmet.2012.02.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22440612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38Xkt1ynurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=534-544&issue=4&author=B.+Razaniauthor=C.+Fengauthor=T.+Colemanauthor=R.+Emanuelauthor=H.+T.+Wenauthor=S.+Hwangauthor=J.+P.+Tingauthor=H.+W.+Virginauthor=M.+B.+Kastanauthor=C.+F.+Semenkovich&title=Autophagy+links+inflammasomes+to+atherosclerotic+progression&doi=10.1016%2Fj.cmet.2012.02.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy Links Inflammasomes to Atherosclerotic Progression</span></div><div class="casAuthors">Razani, Babak; Feng, Chu; Coleman, Trey; Emanuel, Roy; Wen, Haitao; Hwang, Seungmin; Ting, Jenny P.; Virgin, Herbert W.; Kastan, Michael B.; Semenkovich, Clay F.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">534-544</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">We investigated the role of autophagy in atherosclerosis.  During plaque formation in mice, autophagic markers colocalized predominantly with macrophages (m.vphi.).  Atherosclerotic aortas had elevated levels of p62, suggesting that dysfunctional autophagy is characteristic of plaques.  To det. whether autophagy directly influences atherogenesis, we characterized Beclin-1 heterozygous-null and m.vphi.-specific ATG5-null (ATG5-m.vphi.KO) mice, commonly used models of autophagy haploinsufficiency and deficiency, resp.  Haploinsufficent Beclin-1 mice had no atherosclerotic phenotype, but ATG5-m.vphi.KO mice had increased plaques, suggesting an essential role for basal levels of autophagy in atheroprotection.  Defective autophagy is assocd. with proatherogenic inflammasome activation.  Classic inflammasome markers were robustly induced in ATG5-null m.vphi., esp. when coincubated with cholesterol crystals.  Moreover, cholesterol crystals appear to be increased in ATG5-m.vphi.KO plaques, suggesting a potentially vicious cycle of crystal formation and inflammasome activation in autophagy-deficient plaques.  These results show that autophagy becomes dysfunctional in atherosclerosis and its deficiency promotes atherosclerosis in part through inflammasome hyperactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_L9XEDatPTrVg90H21EOLACvtfcHk0lhhu3xqjtKuOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xkt1ynurc%253D&md5=605c29c85e01000b894ea8bcecb428ff</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2012.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2012.02.011%26sid%3Dliteratum%253Aachs%26aulast%3DRazani%26aufirst%3DB.%26aulast%3DFeng%26aufirst%3DC.%26aulast%3DColeman%26aufirst%3DT.%26aulast%3DEmanuel%26aufirst%3DR.%26aulast%3DWen%26aufirst%3DH.%2BT.%26aulast%3DHwang%26aufirst%3DS.%26aulast%3DTing%26aufirst%3DJ.%2BP.%26aulast%3DVirgin%26aufirst%3DH.%2BW.%26aulast%3DKastan%26aufirst%3DM.%2BB.%26aulast%3DSemenkovich%26aufirst%3DC.%2BF.%26atitle%3DAutophagy%2520links%2520inflammasomes%2520to%2520atherosclerotic%2520progression%26jtitle%3DCell%2520Metab.%26date%3D2012%26volume%3D15%26issue%3D4%26spage%3D534%26epage%3D544%26doi%3D10.1016%2Fj.cmet.2012.02.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span> <span> </span><span class="NLM_article-title">Green tea polyphenol treatment attenuates atherosclerosis in high-fat diet-fed apolipoprotein E-knockout mice via alleviating dyslipidemia and up-regulating autophagy</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">e0181666</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0181666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1371%2Fjournal.pone.0181666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=28777810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1cXps1GgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0181666&issue=8&author=S.+Dingauthor=J.+Jiangauthor=P.+Yuauthor=G.+Zhangauthor=G.+Zhangauthor=X.+Liu&title=Green+tea+polyphenol+treatment+attenuates+atherosclerosis+in+high-fat+diet-fed+apolipoprotein+E-knockout+mice+via+alleviating+dyslipidemia+and+up-regulating+autophagy&doi=10.1371%2Fjournal.pone.0181666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Green tea polyphenol treatment attenuates atherosclerosis in high-fat diet-fed apolipoprotein E-knockout mice via alleviating dyslipidemia and up-regulating autophagy</span></div><div class="casAuthors">Ding, Shibin; Jiang, Jinjin; Yu, Pengxin; Zhang, Guofu; Zhang, Guanghui; Liu, Xiaoting</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e0181666/1-e0181666/18</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Green tea polyphenol (GTP) is a polyphenol source from green tea that has drawn wide attention owing to epidemiol. evidence of its beneficial effects in the prevention of cardiovascular disease; the underlying mol. mechanisms of these effects are not well understood.  This study aimed to investigate the effects of GTP treatment on autophagy regulation in the vessel wall and lipid metab. of HFD-fed male ApoE-knockout mice.  Methods: Adult male ApoE-knockout mice (n = 30) fed with a high-fat diet (HFD) were treated with either vehicle or GTP (3.2 or 6.4 g/L) administered via drinking water for 15 wk, and C57BL/6J mice fed with std. chow diet (STD) were used as the control group.  Metabolic parameters, expression of key mRNAs and proteins of hepatic lipid metab. and autophagy in the vessel wall of mice were detd. after the 15-wk treatment.  Results: A HFD induced atherosclerosis formation and lipid metab. disorders as well as reduced autophagy expression in the vessel wall of ApoE-knockout mice, but GTP treatment alleviated the lipid metab. disorders, decreased the oxLDL levels in serum, and increased the mRNA and protein expressions of hepatic PPARa and autophagy markers (LC3, Beclin1 and p62) in the vessel wall of ApoE-knockout mice.  Conclusions: Our findings suggest that GTP supplementation showed marked suppression of atherogenesis through improved lipid metab. as well as through a direct impact on oxLDL and autophagy flux in the vessel wall.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUsHEVkvw0uLVg90H21EOLACvtfcHk0lh5kzSRd3VkyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXps1GgsQ%253D%253D&md5=428489c6aef52110f077cb1184652cd1</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0181666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0181666%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DGreen%2520tea%2520polyphenol%2520treatment%2520attenuates%2520atherosclerosis%2520in%2520high-fat%2520diet-fed%2520apolipoprotein%2520E-knockout%2520mice%2520via%2520alleviating%2520dyslipidemia%2520and%2520up-regulating%2520autophagy%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26issue%3D8%26spage%3De0181666%26doi%3D10.1371%2Fjournal.pone.0181666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bravo-San Pedro, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span> <span> </span><span class="NLM_article-title">Autophagy and mitophagy in cardiovascular disease</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>120</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1812</span>– <span class="NLM_lpage">1824</span>, <span class="refDoi"> DOI: 10.1161/CIRCRESAHA.117.311082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1161%2FCIRCRESAHA.117.311082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=28546358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotlOku74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2017&pages=1812-1824&issue=11&author=J.+M.+Bravo-San+Pedroauthor=G.+Kroemerauthor=L.+Galluzzi&title=Autophagy+and+mitophagy+in+cardiovascular+disease&doi=10.1161%2FCIRCRESAHA.117.311082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy and Mitophagy in Cardiovascular Disease</span></div><div class="casAuthors">Bravo-San Pedro, Jose Manuel; Kroemer, Guido; Galluzzi, Lorenzo</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1812-1824</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Autophagy contributes to the maintenance of intracellular homeostasis in most cells of cardiovascular origin, including cardiomyocytes, endothelial cells, and arterial smooth muscle cells.  Mitophagy is an autophagic response that specifically targets damaged, and hence potentially cytotoxic, mitochondria.  As these organelles occupy a crit. position in the bioenergetics of the cardiovascular system, mitophagy is particularly important for cardiovascular homeostasis in health and disease.  Consistent with this notion, genetic defects in autophagy or mitophagy have been shown to exacerbate the propensity of lab. animals to spontaneously develop cardiodegenerative disorders.  Moreover, pharmacol. or genetic maneuvers that alter the autophagic or mitophagic flux have been shown to influence disease outcome in rodent models of several cardiovascular conditions, such as myocardial infarction, various types of cardiomyopathy, and atherosclerosis.  In this review, we discuss the intimate connection between autophagy, mitophagy, and cardiovascular disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDOFBCqUaNi7Vg90H21EOLACvtfcHk0lh5kzSRd3VkyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotlOku74%253D&md5=f8dda092f990b5e9163c6e04688def9f</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.117.311082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.117.311082%26sid%3Dliteratum%253Aachs%26aulast%3DBravo-San%2BPedro%26aufirst%3DJ.%2BM.%26aulast%3DKroemer%26aufirst%3DG.%26aulast%3DGalluzzi%26aufirst%3DL.%26atitle%3DAutophagy%2520and%2520mitophagy%2520in%2520cardiovascular%2520disease%26jtitle%3DCirc.%2520Res.%26date%3D2017%26volume%3D120%26issue%3D11%26spage%3D1812%26epage%3D1824%26doi%3D10.1161%2FCIRCRESAHA.117.311082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sergin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokes, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehestani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micevych, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javaheri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballabio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epelman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weihl, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diwan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zayed, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Razani, B.</span></span> <span> </span><span class="NLM_article-title">Exploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">15750</span>, <span class="refDoi"> DOI: 10.1038/ncomms15750</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fncomms15750" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=28589926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpsVCltbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=15750&author=I.+Serginauthor=T.+D.+Evansauthor=X.+Y.+Zhangauthor=S.+Bhattacharyaauthor=C.+J.+Stokesauthor=E.+Songauthor=S.+Aliauthor=B.+Dehestaniauthor=K.+B.+Hollowayauthor=P.+S.+Micevychauthor=A.+Javaheriauthor=J.+R.+Crowleyauthor=A.+Ballabioauthor=J.+D.+Schillingauthor=S.+Epelmanauthor=C.+C.+Weihlauthor=A.+Diwanauthor=D.+P.+Fanauthor=M.+A.+Zayedauthor=B.+Razani&title=Exploiting+macrophage+autophagy-lysosomal+biogenesis+as+a+therapy+for+atherosclerosis&doi=10.1038%2Fncomms15750"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis</span></div><div class="casAuthors">Sergin, Ismail; Evans, Trent D.; Zhang, Xiangyu; Bhattacharya, Somashubhra; Stokes, Carl J.; Song, Eric; Ali, Sahl; Dehestani, Babak; Holloway, Karyn B.; Micevych, Paul S.; Javaheri, Ali; Crowley, Jan R.; Ballabio, Andrea; Schilling, Joel D.; Epelman, Slava; Weihl, Conrad C.; Diwan, Abhinav; Fan, Daping; Zayed, Mohamed A.; Razani, Babak</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15750</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Macrophages specialize in removing lipids and debris present in the atherosclerotic plaque.  However, plaque progression renders macrophages unable to degrade exogenous atherogenic material and endogenous cargo including dysfunctional proteins and organelles.  Here we show that a decline in the autophagy-lysosome system contributes to this as evidenced by a derangement in key autophagy markers in both mouse and human atherosclerotic plaques.  By augmenting macrophage TFEB, the master transcriptional regulator of autophagy-lysosomal biogenesis, we can reverse the autophagy dysfunction of plaques, enhance aggrephagy of p62-enriched protein aggregates and blunt macrophage apoptosis and pro-inflammatory IL-1β levels, leading to reduced atherosclerosis.  In order to harness this degradative response therapeutically, we also describe a natural sugar called trehalose as an inducer of macrophage autophagy-lysosomal biogenesis and show trehalose's ability to recapitulate the atheroprotective properties of macrophage TFEB overexpression.  Our data support this practical method of enhancing the degradative capacity of macrophages as a therapy for atherosclerotic vascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGy35mHMN5J7Vg90H21EOLACvtfcHk0ljq-lioZRDOZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpsVCltbc%253D&md5=68f279a21821f7abb8fd7688061f84c2</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1038%2Fncomms15750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms15750%26sid%3Dliteratum%253Aachs%26aulast%3DSergin%26aufirst%3DI.%26aulast%3DEvans%26aufirst%3DT.%2BD.%26aulast%3DZhang%26aufirst%3DX.%2BY.%26aulast%3DBhattacharya%26aufirst%3DS.%26aulast%3DStokes%26aufirst%3DC.%2BJ.%26aulast%3DSong%26aufirst%3DE.%26aulast%3DAli%26aufirst%3DS.%26aulast%3DDehestani%26aufirst%3DB.%26aulast%3DHolloway%26aufirst%3DK.%2BB.%26aulast%3DMicevych%26aufirst%3DP.%2BS.%26aulast%3DJavaheri%26aufirst%3DA.%26aulast%3DCrowley%26aufirst%3DJ.%2BR.%26aulast%3DBallabio%26aufirst%3DA.%26aulast%3DSchilling%26aufirst%3DJ.%2BD.%26aulast%3DEpelman%26aufirst%3DS.%26aulast%3DWeihl%26aufirst%3DC.%2BC.%26aulast%3DDiwan%26aufirst%3DA.%26aulast%3DFan%26aufirst%3DD.%2BP.%26aulast%3DZayed%26aufirst%3DM.%2BA.%26aulast%3DRazani%26aufirst%3DB.%26atitle%3DExploiting%2520macrophage%2520autophagy-lysosomal%2520biogenesis%2520as%2520a%2520therapy%2520for%2520atherosclerosis%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D15750%26doi%3D10.1038%2Fncomms15750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Settembre, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Malta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polito, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Arencibia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetrini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdin, S. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huynh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colella, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sardiello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinsztein, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballabio, A.</span></span> <span> </span><span class="NLM_article-title">TFEB links autophagy to lysosomal biogenesis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>332</i></span> (<span class="NLM_issue">6036</span>),  <span class="NLM_fpage">1429</span>– <span class="NLM_lpage">1433</span>, <span class="refDoi"> DOI: 10.1126/science.1204592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1126%2Fscience.1204592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21617040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntlOltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2011&pages=1429-1433&issue=6036&author=C.+Settembreauthor=C.+Di+Maltaauthor=V.+A.+Politoauthor=M.+Garcia-Arencibiaauthor=F.+Vetriniauthor=S.+Erdinauthor=S.+U.+Erdinauthor=T.+Huynhauthor=D.+Medinaauthor=P.+Colellaauthor=M.+Sardielloauthor=D.+C.+Rubinszteinauthor=A.+Ballabio&title=TFEB+links+autophagy+to+lysosomal+biogenesis&doi=10.1126%2Fscience.1204592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">TFEB Links Autophagy to Lysosomal Biogenesis</span></div><div class="casAuthors">Settembre, Carmine; Di Malta, Chiara; Polito, Vinicia Assunta; Arencibia, Moises Garcia; Vetrini, Francesco; Erdin, Serkan; Erdin, Serpil Uckac; Huynh, Tuong; Medina, Diego; Colella, Pasqualina; Sardiello, Marco; Rubinsztein, David C.; Ballabio, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">6036</span>),
    <span class="NLM_cas:pages">1429-1433</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Autophagy is a cellular catabolic process that relies on the cooperation of autophagosomes and lysosomes.  During starvation, the cell expands both compartments to enhance degrdn. processes.  We found that starvation activates a transcriptional program that controls major steps of the autophagic pathway, including autophagosome formation, autophagosome-lysosome fusion, and substrate degrdn.  The transcription factor EB (TFEB), a master gene for lysosomal biogenesis, coordinated this program by driving expression of autophagy and lysosomal genes.  Nuclear localization and activity of TFEB were regulated by serine phosphorylation mediated by the extracellular signal-regulated kinase 2, whose activity was tuned by the levels of extracellular nutrients.  Thus, a mitogen-activated protein kinase-dependent mechanism regulates autophagy by controlling the biogenesis and partnership of two distinct cellular organelles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAFC-etIDsorVg90H21EOLACvtfcHk0ljq-lioZRDOZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntlOltLw%253D&md5=ee36a38543a0f2fd156f6ba49d81fc04</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1126%2Fscience.1204592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1204592%26sid%3Dliteratum%253Aachs%26aulast%3DSettembre%26aufirst%3DC.%26aulast%3DDi%2BMalta%26aufirst%3DC.%26aulast%3DPolito%26aufirst%3DV.%2BA.%26aulast%3DGarcia-Arencibia%26aufirst%3DM.%26aulast%3DVetrini%26aufirst%3DF.%26aulast%3DErdin%26aufirst%3DS.%26aulast%3DErdin%26aufirst%3DS.%2BU.%26aulast%3DHuynh%26aufirst%3DT.%26aulast%3DMedina%26aufirst%3DD.%26aulast%3DColella%26aufirst%3DP.%26aulast%3DSardiello%26aufirst%3DM.%26aulast%3DRubinsztein%26aufirst%3DD.%2BC.%26aulast%3DBallabio%26aufirst%3DA.%26atitle%3DTFEB%2520links%2520autophagy%2520to%2520lysosomal%2520biogenesis%26jtitle%3DScience%26date%3D2011%26volume%3D332%26issue%3D6036%26spage%3D1429%26epage%3D1433%26doi%3D10.1126%2Fscience.1204592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sergin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Razani, B.</span></span> <span> </span><span class="NLM_article-title">TFEB and trehalose drive the macrophage autophagy-lysosome system to protect against atherosclerosis</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">724</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1080/15548627.2018.1434373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1080%2F15548627.2018.1434373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=29394113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1cXks1Khur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=724-726&issue=4&author=T.+D.+Evansauthor=S.+J.+Jeongauthor=X.+Y.+Zhangauthor=I.+Serginauthor=B.+Razani&title=TFEB+and+trehalose+drive+the+macrophage+autophagy-lysosome+system+to+protect+against+atherosclerosis&doi=10.1080%2F15548627.2018.1434373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">TFEB and trehalose drive the macrophage autophagy-lysosome system to protect against atherosclerosis</span></div><div class="casAuthors">Evans, Trent D.; Jeong, Se-Jin; Zhang, Xiangyu; Sergin, Ismail; Razani, Babak</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">724-726</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8635</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">In the atherosclerotic plaque, macrophages are the key catabolic workhorse responsible for clearing lipid and dead cell debris.  To survive the highly proinflammatory and lipotoxic plaque environment, macrophages must adopt strategies for maintaining tight homeostasis and self-renewal.  Macroautophagy/autophagy is a pro-survival cellular pathway wherein damaged or excess cellular cargoes are encapsulated by a double-membrane compartment and delivered to the lysosome for hydrolysis.  Previously, macrophage-specific autophagy deficiency has been shown to be atherogenic through several complementary mechanisms including hyperactivation of the inflammasome, defective efferocytosis, accumulation of cytotoxic protein aggregates, and impaired lipid degrdn.  Conversely, in a recent study we hypothesized that enhancing the macrophage autophagy-lysosomal system through genetic or pharmacol. means could protect against atherosclerosis.  We demonstrated that TFEB, a transcription factor master regulator of autophagy and lysosome biogenesis, coordinately enhances the function of this system to reduce atherosclerotic plaque burden.  Further, we characterized the disaccharide trehalose as a novel inducer of TFEB with similar atheroprotective effects.  Overall, these findings mechanistically interrogate the importance and therapeutic promise of a functional autophagy-lysosome degrdn. system in plaque macrophage biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOmCFOsPwqEbVg90H21EOLACvtfcHk0ljq-lioZRDOZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXks1Khur0%253D&md5=144ab8c714b1d83bc8595ccf96bb907e</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1080%2F15548627.2018.1434373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15548627.2018.1434373%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DT.%2BD.%26aulast%3DJeong%26aufirst%3DS.%2BJ.%26aulast%3DZhang%26aufirst%3DX.%2BY.%26aulast%3DSergin%26aufirst%3DI.%26aulast%3DRazani%26aufirst%3DB.%26atitle%3DTFEB%2520and%2520trehalose%2520drive%2520the%2520macrophage%2520autophagy-lysosome%2520system%2520to%2520protect%2520against%2520atherosclerosis%26jtitle%3DAutophagy%26date%3D2018%26volume%3D14%26issue%3D4%26spage%3D724%26epage%3D726%26doi%3D10.1080%2F15548627.2018.1434373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L. F.</span></span> <span> </span><span class="NLM_article-title">mTOR enhances foam cell formation by suppressing the autophagy pathway</span>. <i>DNA Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">198</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1089/dna.2013.2164</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1089%2Fdna.2013.2164" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=24512183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltVSlsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=198-204&issue=4&author=X.+C.+Wangauthor=L.+X.+Liauthor=X.+L.+Niuauthor=X.+Y.+Dangauthor=P.+Liauthor=L.+Quauthor=X.+J.+Biauthor=Y.+X.+Gaoauthor=Y.+F.+Huauthor=M.+X.+Liauthor=W.+H.+Qiaoauthor=Z.+Pengauthor=L.+F.+Pan&title=mTOR+enhances+foam+cell+formation+by+suppressing+the+autophagy+pathway&doi=10.1089%2Fdna.2013.2164"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">mTOR enhances foam cell formation by suppressing the autophagy pathway</span></div><div class="casAuthors">Wang, Xiaochuang; Li, Lingxia; Niu, Xiaolin; Dang, Xiaoyan; Li, Ping; Qu, Li; Bi, Xiaoju; Gao, Yanxia; Hu, Yanfen; Li, Manxiang; Qiao, Wanhai; Peng, Zhuo; Pan, Longfei</div><div class="citationInfo"><span class="NLM_cas:title">DNA and Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">198-204</span>CODEN:
                <span class="NLM_cas:coden">DCEBE8</span>;
        ISSN:<span class="NLM_cas:issn">1044-5498</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Recently, autophagy has drawn more attention in cardiovascular disease as it has important roles in lipid metab.  Mammalian target of rapamycin (mTOR) is a key regulator of autophagy; however, its effect on atherosclerosis and the underlying mechanism remains undefined.  In this study, an obvious upregulation of mTOR and p-mTOR protein was obsd. in macrophage-derived foam cells.  Blocking mTOR expression with specific small interference RNA (siRNA) dramatically suppressed foam cell formation, accompanied by a decrease of lipid deposition.  Further mechanistic anal. indicated that suppressing mTOR expression significantly upregulated autophagic marker LC3 expression and downregulated autophagy substrate p62 levels, indicating that mTOR silencing triggered autophagosome formation.  Moreover, blocking mTOR expression obviously accelerated neutral lipid delivery to lysosome and cholesterol efflux from foam cells, implying that mTOR could induce macrophage foam cell formation by suppressing autophagic pathway.  Further, mTOR silencing significantly upregulated ULK1 expression, which was accounted for mTOR-induced foam cell formation via autophagic pathway as treatment with ULK1 siRNA dampened LC3-II levels and increased p62 expression, concomitant with lipid accumulation and decreased cholesterol efflux from foam cells.  Together, our data provide an insight into how mTOR accelerates the pathol. process of atherosclerosis.  Accordingly, blocking mTOR levels may be a promising therapeutic agent against atherosclerotic complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo31-E62U1vhLVg90H21EOLACvtfcHk0lhUyb7_LyzMXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltVSlsro%253D&md5=b10be0dca1b74a0469570e026731c498</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1089%2Fdna.2013.2164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fdna.2013.2164%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BC.%26aulast%3DLi%26aufirst%3DL.%2BX.%26aulast%3DNiu%26aufirst%3DX.%2BL.%26aulast%3DDang%26aufirst%3DX.%2BY.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DQu%26aufirst%3DL.%26aulast%3DBi%26aufirst%3DX.%2BJ.%26aulast%3DGao%26aufirst%3DY.%2BX.%26aulast%3DHu%26aufirst%3DY.%2BF.%26aulast%3DLi%26aufirst%3DM.%2BX.%26aulast%3DQiao%26aufirst%3DW.%2BH.%26aulast%3DPeng%26aufirst%3DZ.%26aulast%3DPan%26aufirst%3DL.%2BF.%26atitle%3DmTOR%2520enhances%2520foam%2520cell%2520formation%2520by%2520suppressing%2520the%2520autophagy%2520pathway%26jtitle%3DDNA%2520Cell%2520Biol.%26date%3D2014%26volume%3D33%26issue%3D4%26spage%3D198%26epage%3D204%26doi%3D10.1089%2Fdna.2013.2164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yancey, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerome, W. G.</span></span> <span> </span><span class="NLM_article-title">Lysosomal sequestration of free and esterified cholesterol from oxidized low density lipoprotein in macrophages of different species</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1349</span>– <span class="NLM_lpage">1361</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=9684737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADyaK1cXkslOqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=1349-1361&issue=7&author=P.+G.+Yanceyauthor=W.+G.+Jerome&title=Lysosomal+sequestration+of+free+and+esterified+cholesterol+from+oxidized+low+density+lipoprotein+in+macrophages+of+different+species"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomal sequestration of free and esterified cholesterol from oxidized low density lipoprotein in macrophages of different species</span></div><div class="casAuthors">Yancey, Patricia G.; Jerome, W. Gray</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1349-1361</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">Lipid Research, Inc.</span>)
        </div><div class="casAbstract">Macrophage foam cells of atherosclerotic lesions store lipid in lysosomes and cytoplasmic inclusions.  Oxidized low d. lipoprotein (oxLDL) has been proposed to be the atherogenic particle responsible for the free and esterified cholesterol stores in macrophages.  Currently, however, there is a paucity of data showing that oxLDL can induce much cholesterol accumulation in cells.  The present studies compare the ability of mildly oxLDL (TBARS = 5 to 10 nmols/mg LDL protein) with acetylated LDL (acLDL) to induce free cholesterol (FC) and esterified cholesterol (EC) accumulation in pigeon, THP-1, and mouse macrophages.  Mildly oxLDL stimulated high levels of loading comparable to acLDL where the cellular cholesterol concns. ranged from 160 to 420 μg/mg cell protein with EC accounting for 52-80% of the cholesterol.  Pigeon and THP-1 macrophages stored most (60-90%) of oxLDL cholesterol (both FC and EC) in lysosomes, and the bulk (64-88%) of acLDL cholesterol in cytoplasmic inclusions.  Consistent with lysosomal accumulation, cholesterol esterification was 75% less in THP-1 macrophages enriched with oxLDL cholesterol compared with acLDL.  Furthermore, addn. of an acyl-CoA:cholesterol acyltransferase inhibitor did not significantly affect either cholesterol loading or the percent distribution of FC and EC in THP-1 and pigeon cells incubated with oxLDL.  Surprisingly, mouse macrophages stored most of oxLDL (71%) and acLDL (83%) cholesterol within cytoplasmic inclusions.  Also, in mouse macrophages, esterification paralleled cholesterol loading, and was 3-fold more in oxLDL treated cells compared with acLDL treated cells.  Inhibition of ACAT led to a 62% and 90% redn. in the %EC in oxLDL and acLDL treated mouse macrophages, resp.  The results demonstrate that mildly oxidized low d. lipoprotein (oxLDL) stimulates macrophage foam cell formation and lipid engorgement of lysosomes.  However, the fate of oxLDL cholesterol markedly differs in macrophages of different species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGGYIi9_eGOrVg90H21EOLACvtfcHk0lhjIcG1R8_-BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkslOqtLY%253D&md5=9a4bd00b731395b8aa2d3c35c0a480c3</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYancey%26aufirst%3DP.%2BG.%26aulast%3DJerome%26aufirst%3DW.%2BG.%26atitle%3DLysosomal%2520sequestration%2520of%2520free%2520and%2520esterified%2520cholesterol%2520from%2520oxidized%2520low%2520density%2520lipoprotein%2520in%2520macrophages%2520of%2520different%2520species%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D1998%26volume%3D39%26issue%3D7%26spage%3D1349%26epage%3D1361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adamik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silbermann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roodman, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galson, D. L.</span></span> <span> </span><span class="NLM_article-title">XRK3F2 inhibition of p62-ZZ domain signaling rescues myeloma-induced GFI1-driven epigenetic repression of the Runx2 gene in pre-osteoblasts to overcome differentiation suppression</span>. <i>Front. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">344</span>, <span class="refDoi"> DOI: 10.3389/fendo.2018.00344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.3389%2Ffendo.2018.00344" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=30008697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252Fot1Ggsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=344&author=J.+Adamikauthor=R.+Silbermannauthor=S.+Marinoauthor=Q.+Sunauthor=J.+L.+Andersonauthor=D.+Zhouauthor=X.+Q.+Xieauthor=G.+D.+Roodmanauthor=D.+L.+Galson&title=XRK3F2+inhibition+of+p62-ZZ+domain+signaling+rescues+myeloma-induced+GFI1-driven+epigenetic+repression+of+the+Runx2+gene+in+pre-osteoblasts+to+overcome+differentiation+suppression&doi=10.3389%2Ffendo.2018.00344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">XRK3F2 Inhibition of p62-ZZ Domain Signaling Rescues Myeloma-Induced GFI1-Driven Epigenetic Repression of the Runx2 Gene in Pre-osteoblasts to Overcome Differentiation Suppression</span></div><div class="casAuthors">Adamik Juraj; Sun Quanhong; Galson Deborah L; Silbermann Rebecca; Marino Silvia; Anderson Judith L; Zhou Dan; Roodman G David; Silbermann Rebecca; Xie Xiang-Qun; Roodman G David</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in endocrinology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">344</span>
        ISSN:<span class="NLM_cas:issn">1664-2392</span>.
    </div><div class="casAbstract">Multiple myeloma bone disease (MMBD) is characterized by non-healing lytic bone lesions that persist even after a patient has achieved a hematologic remission.  We previously reported that p62 (sequestosome-1) in bone marrow stromal cells (BMSC) is critical for the formation of MM-induced signaling complexes that mediate OB suppression.  Importantly, XRK3F2, an inhibitor of the p62-ZZ domain, blunted MM-induced Runx2 suppression in vitro, and induced new bone formation and remodeling in the presence of tumor in vivo.  Additionally, we reported that MM cells induce the formation of repressive chromatin on the Runx2 gene in BMSC via direct binding of the transcriptional repressor GFI1, which recruits the histone modifiers, histone deacetylase 1 (HDAC1) and Enhancer of zeste homolog 2 (EZH2).  In this study we investigated the mechanism by which blocking p62-ZZ domain-dependent signaling prevents MM-induced suppression of Runx2 in BMSC.  XRK3F2 prevented MM-induced upregulation of Gfi1 and repression of the Runx2 gene when present in MM-preOB co-cultures.  We also show that p62-ZZ-domain blocking by XRK3F2 also prevented MM conditioned media and TNF plus IL7-mediated Gfi1 mRNA upregulation and the concomitant Runx2 repression, indicating that XRK3F2's prevention of p62-ZZ domain signaling within preOB is involved in the response.  Chromatin immunoprecipitation (ChIP) analyses revealed that XRK3F2 decreased MM-induced GFI1 occupancy at the Runx2-P1 promoter and prevented recruitment of HDAC1, thus preserving the transcriptionally permissive chromatin mark H3K9ac on Runx2 and allowing osteogenic differentiation.  Furthermore, treatment of MM-exposed preOB with XRK3F2 after MM removal decreased GFI1 enrichment at Runx2-P1 and rescued MM-induced suppression of Runx2 mRNA and its downstream osteogenic gene targets together with increased osteogenic differentiation.  Further, primary BMSC (hBMSC) from MM patients (MM-hBMSC) had little ability to increase H3K9ac on the Runx2 promoter in osteogenic conditions when compared to hBMSC from healthy donors (HD).  XRK3F2 treatment enriched Runx2 gene H3K9ac levels in MM-hBMSC to the level observed in HD-hBMSC, but did not alter HD-hBMSC H3K9ac.  Importantly, XRK3F2 treatment of long-term MM-hBMSC cultures rescued osteogenic differentiation and mineralization.  Our data show that blocking p62-ZZ domain-dependent signaling with XRK3F2 can reverse epigenetic-based mechanisms of MM-induced Runx2 suppression and promote osteogenic differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRGlHTC1_71lyA3UY9EwTNrfW6udTcc2ebpn8U4imPlJrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252Fot1Ggsg%253D%253D&md5=f1463cc7140b5b7ac5400a676e902e14</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.3389%2Ffendo.2018.00344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffendo.2018.00344%26sid%3Dliteratum%253Aachs%26aulast%3DAdamik%26aufirst%3DJ.%26aulast%3DSilbermann%26aufirst%3DR.%26aulast%3DMarino%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DAnderson%26aufirst%3DJ.%2BL.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DXie%26aufirst%3DX.%2BQ.%26aulast%3DRoodman%26aufirst%3DG.%2BD.%26aulast%3DGalson%26aufirst%3DD.%2BL.%26atitle%3DXRK3F2%2520inhibition%2520of%2520p62-ZZ%2520domain%2520signaling%2520rescues%2520myeloma-induced%2520GFI1-driven%2520epigenetic%2520repression%2520of%2520the%2520Runx2%2520gene%2520in%2520pre-osteoblasts%2520to%2520overcome%2520differentiation%2520suppression%26jtitle%3DFront.%2520Endocrinol.%26date%3D2018%26volume%3D9%26spage%3D344%26doi%3D10.3389%2Ffendo.2018.00344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouchiroud, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreux, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsyuba, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moullan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolet-dit-Felix, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jha, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo Sasso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huzard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aebischer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rinsch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auwerx, J.</span></span> <span> </span><span class="NLM_article-title">Urolithin A induces mitophagy and prolongs lifespan in C-elegans and increases muscle function in rodents</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">879</span>– <span class="NLM_lpage">888</span>, <span class="refDoi"> DOI: 10.1038/nm.4132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fnm.4132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27400265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Klsr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=879-888&issue=8&author=D.+Ryuauthor=L.+Mouchiroudauthor=P.+A.+Andreuxauthor=E.+Katsyubaauthor=N.+Moullanauthor=A.+A.+Nicolet-dit-Felixauthor=E.+G.+Williamsauthor=P.+Jhaauthor=G.+Lo+Sassoauthor=D.+Huzardauthor=P.+Aebischerauthor=C.+Sandiauthor=C.+Rinschauthor=J.+Auwerx&title=Urolithin+A+induces+mitophagy+and+prolongs+lifespan+in+C-elegans+and+increases+muscle+function+in+rodents&doi=10.1038%2Fnm.4132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents</span></div><div class="casAuthors">Ryu, Dongryeol; Mouchiroud, Laurent; Andreux, Penelope A.; Katsyuba, Elena; Moullan, Norman; Nicolet-dit-Felix, Amandine A.; Williams, Evan G.; Jha, Pooja; Lo Sasso, Giuseppe; Huzard, Damien; Aebischer, Patrick; Sandi, Carmen; Rinsch, Chris; Auwerx, Johan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">879-888</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The biol. effects of urolithins remain poorly characterized, despite wide-spread human exposure via the dietary consumption of their metabolic precursors, the ellagitannins, which are found in the pomegranate fruit, as well as in nuts and berries.  We identified urolithin A (UA) as a first-in-class natural compd. that induces mitophagy both in vitro and in vivo following oral consumption.  In C. elegans, UA prevented the accumulation of dysfunctional mitochondria with age and extended lifespan.  Likewise, UA prolonged normal activity during aging in C. elegans, including mobility and pharyngeal pumping, while maintaining mitochondrial respiratory capacity.  These effects translated to rodents, where UA improved exercise capacity in two different mouse models of age-related decline of muscle function, as well as in young rats.  Our findings highlight the health benefits of urolithin A and its potential application in strategies to improve mitochondrial and muscle function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcwLkJYGaEsbVg90H21EOLACvtfcHk0liWGdZ3BTjV3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Klsr7F&md5=d74556b7cf4106974fff66f9508d39c0</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1038%2Fnm.4132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4132%26sid%3Dliteratum%253Aachs%26aulast%3DRyu%26aufirst%3DD.%26aulast%3DMouchiroud%26aufirst%3DL.%26aulast%3DAndreux%26aufirst%3DP.%2BA.%26aulast%3DKatsyuba%26aufirst%3DE.%26aulast%3DMoullan%26aufirst%3DN.%26aulast%3DNicolet-dit-Felix%26aufirst%3DA.%2BA.%26aulast%3DWilliams%26aufirst%3DE.%2BG.%26aulast%3DJha%26aufirst%3DP.%26aulast%3DLo%2BSasso%26aufirst%3DG.%26aulast%3DHuzard%26aufirst%3DD.%26aulast%3DAebischer%26aufirst%3DP.%26aulast%3DSandi%26aufirst%3DC.%26aulast%3DRinsch%26aufirst%3DC.%26aulast%3DAuwerx%26aufirst%3DJ.%26atitle%3DUrolithin%2520A%2520induces%2520mitophagy%2520and%2520prolongs%2520lifespan%2520in%2520C-elegans%2520and%2520increases%2520muscle%2520function%2520in%2520rodents%26jtitle%3DNat.%2520Med.%26date%3D2016%26volume%3D22%26issue%3D8%26spage%3D879%26epage%3D888%26doi%3D10.1038%2Fnm.4132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morselli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennetzen, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Megalou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benit, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rustin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Criollo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepp, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malik, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiuri, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horio, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Otin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavernarakis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madeo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span> <span> </span><span class="NLM_article-title">Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>192</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">615</span>– <span class="NLM_lpage">629</span>, <span class="refDoi"> DOI: 10.1083/jcb.201008167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1083%2Fjcb.201008167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21339330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXislGjs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2011&pages=615-629&issue=4&author=E.+Morselliauthor=G.+Marinoauthor=M.+V.+Bennetzenauthor=T.+Eisenbergauthor=E.+Megalouauthor=S.+Schroederauthor=S.+Cabreraauthor=P.+Benitauthor=P.+Rustinauthor=A.+Criolloauthor=O.+Keppauthor=L.+Galluzziauthor=S.+S.+Shenauthor=S.+A.+Malikauthor=M.+C.+Maiuriauthor=Y.+Horioauthor=C.+Lopez-Otinauthor=J.+S.+Andersenauthor=N.+Tavernarakisauthor=F.+Madeoauthor=G.+Kroemer&title=Spermidine+and+resveratrol+induce+autophagy+by+distinct+pathways+converging+on+the+acetylproteome&doi=10.1083%2Fjcb.201008167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome</span></div><div class="casAuthors">Morselli, Eugenia; Marino, Guillermo; Bennetzen, Martin V.; Eisenberg, Tobias; Megalou, Evgenia; Schroeder, Sabrina; Cabrera, Sandra; Benit, Paule; Rustin, Pierre; Criollo, Alfredo; Kepp, Oliver; Galluzzi, Lorenzo; Shen, Shensi; Malik, Shoaib Ahmad; Maiuri, Maria Chiara; Horio, Yoshiyuki; Lopez-Otin, Carlos; Andersen, Jens S.; Tavernarakis, Nektarios; Madeo, Frank; Kroemer, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">615-629</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Autophagy protects organelles, cells, and organisms against several stress conditions.  Induction of autophagy by resveratrol requires the NAD-dependent deacetylase sirtuin 1 (SIRT1).  In this paper, it is shown that the acetylase inhibitor spermidine stimulates autophagy independent of SIRT1 in human and yeast cells as well as in nematodes.  Although resveratrol and spermidine ignite autophagy through distinct mechanisms, these compds. stimulate convergent pathways that culminate in concordant modifications of the acetylproteome.  Both agents favor convergent deacetylation and acetylation reactions in the cytosol and in the nucleus, resp.  Both resveratrol and spermidine were able to induce autophagy in cytoplasts (enucleated cells).  Moreover, a cytoplasm-restricted mutant of SIRT1 could stimulate autophagy, suggesting that cytoplasmic deacetylation reactions dictate the autophagic cascade.  At doses at which neither resveratrol nor spermidine stimulated autophagy alone, these agents synergistically induced autophagy.  Altogether, these data underscore the importance of an autophagy regulatory network of antagonistic deacetylases and acetylases that can be pharmacol. manipulated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_JpR-msDh9rVg90H21EOLACvtfcHk0liWGdZ3BTjV3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXislGjs7c%253D&md5=1bb33c4b97898af83c744a9d7078672b</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201008167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201008167%26sid%3Dliteratum%253Aachs%26aulast%3DMorselli%26aufirst%3DE.%26aulast%3DMarino%26aufirst%3DG.%26aulast%3DBennetzen%26aufirst%3DM.%2BV.%26aulast%3DEisenberg%26aufirst%3DT.%26aulast%3DMegalou%26aufirst%3DE.%26aulast%3DSchroeder%26aufirst%3DS.%26aulast%3DCabrera%26aufirst%3DS.%26aulast%3DBenit%26aufirst%3DP.%26aulast%3DRustin%26aufirst%3DP.%26aulast%3DCriollo%26aufirst%3DA.%26aulast%3DKepp%26aufirst%3DO.%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DS.%2BS.%26aulast%3DMalik%26aufirst%3DS.%2BA.%26aulast%3DMaiuri%26aufirst%3DM.%2BC.%26aulast%3DHorio%26aufirst%3DY.%26aulast%3DLopez-Otin%26aufirst%3DC.%26aulast%3DAndersen%26aufirst%3DJ.%2BS.%26aulast%3DTavernarakis%26aufirst%3DN.%26aulast%3DMadeo%26aufirst%3DF.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DSpermidine%2520and%2520resveratrol%2520induce%2520autophagy%2520by%2520distinct%2520pathways%2520converging%2520on%2520the%2520acetylproteome%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2011%26volume%3D192%26issue%3D4%26spage%3D615%26epage%3D629%26doi%3D10.1083%2Fjcb.201008167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dai, C. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. Y.</span></span> <span> </span><span class="NLM_article-title">p53 and mitochondrial dysfunction: novel insight of neurodegenerative diseases</span>. <i>J. Bioenerg. Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">337</span>– <span class="NLM_lpage">347</span>, <span class="refDoi"> DOI: 10.1007/s10863-016-9669-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1007%2Fs10863-016-9669-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27422544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFyntr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2016&pages=337-347&issue=4&author=C.+Q.+Daiauthor=T.+T.+Luoauthor=S.+C.+Luoauthor=J.+Q.+Wangauthor=S.+M.+Wangauthor=Y.+H.+Baiauthor=Y.+L.+Yangauthor=Y.+Y.+Wang&title=p53+and+mitochondrial+dysfunction%3A+novel+insight+of+neurodegenerative+diseases&doi=10.1007%2Fs10863-016-9669-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">p53 and mitochondrial dysfunction: novel insight of neurodegenerative diseases</span></div><div class="casAuthors">Dai, Chun-Qiu; Luo, Ting-Ting; Luo, Shi-Cheng; Wang, Jia-Qi; Wang, Sheng-Ming; Bai, Yun-Hu; Yang, Yan-Ling; Wang, Ya-Yun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bioenergetics and Biomembranes</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">337-347</span>CODEN:
                <span class="NLM_cas:coden">JBBID4</span>;
        ISSN:<span class="NLM_cas:issn">0145-479X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Mitochondria are organelles responsible for vital cell functions. p53 is a transcription factor that regulates the DNA stability and cell growth normality.  Recent studies revealed that p53 can influence mitochondrial function changing from normal condition to abnormal condition under different stress levels.  In normal state, p53 can maintain mitochondrial respiration through transactivation of SCO2.  When stress stimuli presents, SCO2 overexpresses and leads to ROS generation.  ROS promotes p53 inducing MALM (Mieap-induced accumulation of lysosome-like organelles within mitochondria) to repair dysfunctional mitochondria and MIV (Mieap-induced vacuole) to accomplish damaged mitochondria degrdn.  If stress or damage is irreversible, p53 will translocate to mitochondria, leading into apoptosis or necrosis.  Neurodegenerative diseases including Parkinson's disease, Huntington's disease and Alzheimer's disease are still lack of clear explanations of mechanisms, but more studies have revealed the functional relationship between mitochondria and p53 towards the pathol. development of these diseases.  In this review, we discuss that p53 plays the vital role in the function of mitochondria in the aspect of pathol. change metab.  We also analyze these diseases with novel targeted treating mols. which are related to p53 and mitochondria, hoping to present novel therapies in future clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQrS3qP7UaOLVg90H21EOLACvtfcHk0liWGdZ3BTjV3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFyntr3E&md5=120cf7df72c9fdd26bf21f474a8fa69e</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1007%2Fs10863-016-9669-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10863-016-9669-5%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DC.%2BQ.%26aulast%3DLuo%26aufirst%3DT.%2BT.%26aulast%3DLuo%26aufirst%3DS.%2BC.%26aulast%3DWang%26aufirst%3DJ.%2BQ.%26aulast%3DWang%26aufirst%3DS.%2BM.%26aulast%3DBai%26aufirst%3DY.%2BH.%26aulast%3DYang%26aufirst%3DY.%2BL.%26aulast%3DWang%26aufirst%3DY.%2BY.%26atitle%3Dp53%2520and%2520mitochondrial%2520dysfunction%253A%2520novel%2520insight%2520of%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Bioenerg.%2520Biomembr.%26date%3D2016%26volume%3D48%26issue%3D4%26spage%3D337%26epage%3D347%26doi%3D10.1007%2Fs10863-016-9669-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodolfo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campello, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecconi, F.</span></span> <span> </span><span class="NLM_article-title">Mitophagy in neurodegenerative diseases</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">156</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1016/j.neuint.2017.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.neuint.2017.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=28797885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlegsL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2018&pages=156-166&author=C.+Rodolfoauthor=S.+Campelloauthor=F.+Cecconi&title=Mitophagy+in+neurodegenerative+diseases&doi=10.1016%2Fj.neuint.2017.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Mitophagy in neurodegenerative diseases</span></div><div class="casAuthors">Rodolfo, Carlo; Campello, Silvia; Cecconi, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">156-166</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neurodegenerative diseases, such as Parkinson's disease (PD), Alzheimer's disease (AD), Huntington's disease (HD), and Amyotrophic Lateral Sclerosis (ALS), are a complex "family" of pathologies, characterised by the progressive loss of neurons and/or neuronal functions, leading to severe phys. and cognitive inabilities in affected patients.  These syndromes, despite differences in the causative events, the onset, and the progression of the disease, share as common features the presence of aggregate-prone neuro-toxic proteins, in the form of aggresomes and/or inclusion bodies, perturbing cellular homeostasis and neuronal function (Popovic et al., 2014), and the presence of dysfunctional mitochondria.  The removal of protein aggregates and of damaged organelles, through the ubiquitin-proteasome system (UPS) and/or the autophagy/lysosome machinery, is a crucial step for the maintenance of neuronal homeostasis.  Indeed, their impairment has been reported as assocd. with the development of these diseases.  In this review, we focus on the role played by mitophagy, a specialised form of autophagy, in the onset and progression of major neurodegenerative diseases, as well as on possible therapeutic approaches involving mitophagy modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMll-LZSDLzbVg90H21EOLACvtfcHk0lg1x6CFC6Hq1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlegsL7O&md5=0ec4f311ea91b69f187ef039d51b1f0e</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2017.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2017.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DRodolfo%26aufirst%3DC.%26aulast%3DCampello%26aufirst%3DS.%26aulast%3DCecconi%26aufirst%3DF.%26atitle%3DMitophagy%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNeurochem.%2520Int.%26date%3D2018%26volume%3D117%26spage%3D156%26epage%3D166%26doi%3D10.1016%2Fj.neuint.2017.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paget, J.</span></span> <span> </span><span class="NLM_article-title">An address on certain points in the pathology of syphilis</span>. <i>British medical journal</i> <span class="NLM_year" style="font-weight: bold;">1876</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">790</span>),  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1136/bmj.1.790.215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1136%2Fbmj.1.790.215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20748114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BC3MzgvFersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1876&pages=215-217&issue=790&author=J.+Paget&title=An+address+on+certain+points+in+the+pathology+of+syphilis&doi=10.1136%2Fbmj.1.790.215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">An Address on Certain Points in the Pathology of Syphilis</span></div><div class="casAuthors">Paget J</div><div class="citationInfo"><span class="NLM_cas:title">British medical journal</span>
        (<span class="NLM_cas:date">1876</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">790</span>),
    <span class="NLM_cas:pages">215-7</span>
        ISSN:<span class="NLM_cas:issn">0007-1447</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR2ftheHkOrAVWTCLT8lX9SfW6udTcc2eb6Qr9myDwFMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MzgvFersw%253D%253D&md5=bb7c59f8663ff73808af3d1dc543d3e2</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1136%2Fbmj.1.790.215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.1.790.215%26sid%3Dliteratum%253Aachs%26aulast%3DPaget%26aufirst%3DJ.%26atitle%3DAn%2520address%2520on%2520certain%2520points%2520in%2520the%2520pathology%2520of%2520syphilis%26jtitle%3DBritish%2520medical%2520journal%26date%3D1876%26volume%3D1%26issue%3D790%26spage%3D215%26epage%3D217%26doi%3D10.1136%2Fbmj.1.790.215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cundy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, I. R.</span></span> <span> </span><span class="NLM_article-title">Paget’s disease of bone</span>. <i>Clin. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.clinbiochem.2011.09.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.clinbiochem.2011.09.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22024254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFaktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2012&pages=43-48&issue=1%E2%80%932&author=T.+Cundyauthor=I.+R.+Reid&title=Paget%E2%80%99s+disease+of+bone&doi=10.1016%2Fj.clinbiochem.2011.09.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Paget's disease of bone</span></div><div class="casAuthors">Cundy, Tim; Reid, Ian R.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">43-48</span>CODEN:
                <span class="NLM_cas:coden">CLBIAS</span>;
        ISSN:<span class="NLM_cas:issn">0009-9120</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Objectives: To review recent advance in understanding the causation and management of Paget's disease.  Design and methods: We review recent publications concerning the etiol. of the disease and the use of biochem. markers of bone turnover in diagnosis and treatment.  Results: Epidemiol. studies suggest that Paget's disease is decreasing in prevalence and severity (implying that environmental factors are important) but there is also strong evidence of a genetic predisposition particularly through the SQSTM1 gene.  Genome-wide assocn. studies have identified polymorphisms at several other loci that are assocd. with the disease.  Plasma alk. phosphatase activity (ALP) is widely used, but less helpful in patients with disease of limited extent.  Of the newer markers, plasma procollagen-1 N-peptide (PINP) performs best.  Treatment with potent bisphosphonates usually produces long-term remission.  Conclusions: Both genetic and environmental factors appear to be important in the etiol. of Paget's disease.  Effective long-term disease suppression can be achieved with bisphosphonate treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9whOwKtg6b7Vg90H21EOLACvtfcHk0lg1x6CFC6Hq1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFaktw%253D%253D&md5=a91cc54a42ca40e5656daeb8103648aa</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1016%2Fj.clinbiochem.2011.09.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinbiochem.2011.09.026%26sid%3Dliteratum%253Aachs%26aulast%3DCundy%26aufirst%3DT.%26aulast%3DReid%26aufirst%3DI.%2BR.%26atitle%3DPaget%25E2%2580%2599s%2520disease%2520of%2520bone%26jtitle%3DClin.%2520Biochem.%26date%3D2012%26volume%3D45%26issue%3D1%25E2%2580%25932%26spage%3D43%26epage%3D48%26doi%3D10.1016%2Fj.clinbiochem.2011.09.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebaldt, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C.</span></span> <span> </span><span class="NLM_article-title">Analysis of environmental factors in familial versus sporadic Paget’s disease of bone-the new England registry for Paget’s disease of bone</span>. <i>J. Bone Miner. Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1519</span>– <span class="NLM_lpage">1524</span>, <span class="refDoi"> DOI: 10.1359/jbmr.2003.18.8.1519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1359%2Fjbmr.2003.18.8.1519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=12929942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BD3szpt1GjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=1519-1524&issue=8&author=M.+Setonauthor=H.+K.+Choiauthor=M.+F.+Hansenauthor=R.+J.+Sebaldtauthor=C.+Cooper&title=Analysis+of+environmental+factors+in+familial+versus+sporadic+Paget%E2%80%99s+disease+of+bone-the+new+England+registry+for+Paget%E2%80%99s+disease+of+bone&doi=10.1359%2Fjbmr.2003.18.8.1519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of environmental factors in familial versus sporadic Paget's disease of bone--the New England Registry for Paget's Disease of Bone</span></div><div class="casAuthors">Seton Margaret; Choi Hyon K; Hansen Marc F; Sebaldt Rolf J; Cooper Cyrus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1519-24</span>
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    </div><div class="casAbstract">UNLABELLED:  A registry for Paget's Disease (PD) was created to study the environmental and familial features of this disorder.  This study examines the first 202 people enrolled.  Those with a family history of PD (20%) suffered earlier deformity and fracture, and tended to have grandparents born abroad.  These findings suggest heritage is important in PD; the role of environment remains unclear.  INTRODUCTION:  The New England Registry for Paget's Disease of Bone is a database that was created to explore the distribution and determinants of disease frequency.  METHODS:  Using a case-series design, we explored the association of environmental factors in expression of the disease, comparing those patients with familial Paget's disease to those with sporadic Paget's disease (PD).  RESULTS AND CONCLUSIONS:  Analysis of the first 202 patients enrolled in the registry revealed a positive family history (FH) in 41 (20%).  Significant findings in this cohort included an earlier age of onset (51 years FH+ versus 59 years FH-, p < 0.05), a trend to a higher incidence of bone deformity (49% versus 33%, p < 0.1), and an increased fracture rate (27% versus 11%, p < 0.05).  Persons with a FH of PD were less likely to record the United States or Canada as their grandparents' birthplace (p < 0.01), and sibships tended to be larger (p < 0.05).  A history of measles infection, childhood exposure to pets, milk ingestion, year of immigration to the United States, birth order, level of education, and functional status did not distinguish the two groups.  The database confirms the high prevalence of familial PD and supports the theory that heritable factors are important in the pathogenesis of this focal disorder of bone metabolism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTaViPOWMEqbJp6t8nS6Nc3fW6udTcc2eY9yQcO64JG77ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3szpt1GjsA%253D%253D&md5=79c909a047dab313c2828b45bac567de</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.2003.18.8.1519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.2003.18.8.1519%26sid%3Dliteratum%253Aachs%26aulast%3DSeton%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DH.%2BK.%26aulast%3DHansen%26aufirst%3DM.%2BF.%26aulast%3DSebaldt%26aufirst%3DR.%2BJ.%26aulast%3DCooper%26aufirst%3DC.%26atitle%3DAnalysis%2520of%2520environmental%2520factors%2520in%2520familial%2520versus%2520sporadic%2520Paget%25E2%2580%2599s%2520disease%2520of%2520bone-the%2520new%2520England%2520registry%2520for%2520Paget%25E2%2580%2599s%2520disease%2520of%2520bone%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2003%26volume%3D18%26issue%3D8%26spage%3D1519%26epage%3D1524%26doi%3D10.1359%2Fjbmr.2003.18.8.1519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Layfield, R.</span></span> <span> </span><span class="NLM_article-title">The molecular pathogenesis of Paget disease of bone</span>. <i>Expert Rev. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">27</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1017/S1462399407000464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1017%2FS1462399407000464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=17903332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BD2srot1Cluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=1-13&issue=27&author=R.+Layfield&title=The+molecular+pathogenesis+of+Paget+disease+of+bone&doi=10.1017%2FS1462399407000464"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular pathogenesis of Paget disease of bone</span></div><div class="casAuthors">Layfield Robert</div><div class="citationInfo"><span class="NLM_cas:title">Expert reviews in molecular medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">1-13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Paget disease of bone (PDB) is a condition characterised by increased bone remodelling at discrete lesions throughout the skeleton.  The primary cellular abnormality in PDB involves a net increase in the activity of bone-resorbing osteoclasts, with a secondary increase in bone-forming osteoblast activity.  Genetic factors are known to play an important role, with mutations affecting different components of the RANK-NF-kappaB signalling pathway having been identified in patients with PDB and related disorders.  Whilst the disease mechanism in these cases is likely to involve aberrant RANK-mediated osteoclast NF-kappaB signalling, the precise relationship between other potential contributors, such as viruses and environmental factors, and the molecular pathogenesis of PDB is less clear.  This review considers the roles of these different factors in PDB, and concludes that a fuller understanding of their contributions to disease aetiology is likely to be central to future advances in the clinical management of this debilitating skeletal disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTeQpXPu1DwNEGy1nwu7K2mfW6udTcc2eY9yQcO64JG77ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srot1Cluw%253D%253D&md5=105d8c656459e9b8bc454e1ccf7afcd0</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1017%2FS1462399407000464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1462399407000464%26sid%3Dliteratum%253Aachs%26aulast%3DLayfield%26aufirst%3DR.%26atitle%3DThe%2520molecular%2520pathogenesis%2520of%2520Paget%2520disease%2520of%2520bone%26jtitle%3DExpert%2520Rev.%2520Mol.%2520Med.%26date%3D2007%26volume%3D9%26issue%3D27%26spage%3D1%26epage%3D13%26doi%3D10.1017%2FS1462399407000464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiruma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurihara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subler, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boykin, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishizuka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dempster, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roodman, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windle, J. J.</span></span> <span> </span><span class="NLM_article-title">A SQSTM1/p62 mutation linked to Paget’s disease increases the osteoclastogenic potential of the bone microenvironment</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">3708</span>– <span class="NLM_lpage">3719</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddn266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1093%2Fhmg%2Fddn266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18765443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlGis7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=3708-3719&issue=23&author=Y.+Hirumaauthor=N.+Kuriharaauthor=M.+A.+Sublerauthor=H.+Zhouauthor=C.+S.+Boykinauthor=H.+Zhangauthor=S.+Ishizukaauthor=D.+W.+Dempsterauthor=G.+D.+Roodmanauthor=J.+J.+Windle&title=A+SQSTM1%2Fp62+mutation+linked+to+Paget%E2%80%99s+disease+increases+the+osteoclastogenic+potential+of+the+bone+microenvironment&doi=10.1093%2Fhmg%2Fddn266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment</span></div><div class="casAuthors">Hiruma, Yuko; Kurihara, Noriyoshi; Subler, Mark A.; Zhou, Hua; Boykin, Christina S.; Zhang, Heju; Ishizuka, Seiichi; Dempster, David W.; Roodman, G. David; Windle, Jolene J.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3708-3719</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Paget's disease of bone (PDB) is the second most common bone disease and is characterized by focal bone lesions which contain large nos. of abnormal osteoclasts (OCLs) and very active normal osteoblasts in a highly osteoclastogenic marrow microenvironment.  The etiol. of PDB is not well understood and both environmental and genetic causes have been implicated in its pathogenesis.  Mutations in the SQSTM1/p62 gene have been identified in up to 30% of Paget's patients.  To det. if p62 mutation is sufficient to induce PDB, we generated mice harboring a mutation causing a P-to-L (proline-to-leucine) substitution at residue 394 (the murine equiv. of human p62P392L, the most common PDB-assocd. mutation).  Bone marrow cultures from p62P394L mice formed increased nos. of OCLs in response to receptor activator of NF-κB ligand (RANKL), tumor necrosis factor α (TNF-α) or 1α,25-(OH)2D3, similar to PDB patients.  However, purified p62P394L OCL precursors depleted of stromal cells were no longer hyper-responsive to 1α,25-(OH)2D3, suggesting effects of the p62P394L mutation on the marrow microenvironment in addn. to direct effects on OCLs.  Co-cultures of purified p62P394L stromal cells with either wild-type (WT) or p62P394L OCL precursors formed more OCLs than co-cultures contg. WT stromal cells due to increased RANKL prodn. by the mutant stromal cells.  However, despite the enhanced osteoclastogenic potential of both OCL precursors and marrow stromal cells, the p62P394L mice had histol. normal bones.  These results indicate that this PDB-assocd. p62 mutation is not sufficient to induce PDB and suggest that addnl. factors acting together with p62 mutation are necessary for the development of PDB in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi9LLaFx-4bLVg90H21EOLACvtfcHk0lhVEeLwaRNx6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlGis7%252FK&md5=9980806516366ea4ceaf90646cae2420</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddn266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddn266%26sid%3Dliteratum%253Aachs%26aulast%3DHiruma%26aufirst%3DY.%26aulast%3DKurihara%26aufirst%3DN.%26aulast%3DSubler%26aufirst%3DM.%2BA.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DBoykin%26aufirst%3DC.%2BS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DIshizuka%26aufirst%3DS.%26aulast%3DDempster%26aufirst%3DD.%2BW.%26aulast%3DRoodman%26aufirst%3DG.%2BD.%26aulast%3DWindle%26aufirst%3DJ.%2BJ.%26atitle%3DA%2520SQSTM1%252Fp62%2520mutation%2520linked%2520to%2520Paget%25E2%2580%2599s%2520disease%2520increases%2520the%2520osteoclastogenic%2520potential%2520of%2520the%2520bone%2520microenvironment%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2008%26volume%3D17%26issue%3D23%26spage%3D3708%26epage%3D3719%26doi%3D10.1093%2Fhmg%2Fddn266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rea, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layfield, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratajczak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. K.</span></span> <span> </span><span class="NLM_article-title">New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget’s disease of bone</span>. <i>Endocr. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">501</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1210/er.2012-1034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1210%2Fer.2012-1034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=23612225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVKgtrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=501-524&issue=4&author=S.+L.+Reaauthor=J.+P.+Walshauthor=R.+Layfieldauthor=T.+Ratajczakauthor=J.+K.+Xu&title=New+insights+into+the+role+of+sequestosome+1%2Fp62+mutant+proteins+in+the+pathogenesis+of+Paget%E2%80%99s+disease+of+bone&doi=10.1210%2Fer.2012-1034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget's Disease of bone</span></div><div class="casAuthors">Rea, Sarah L.; Walsh, John P.; Layfield, Robert; Ratajczak, Thomas; Xu, Jiake</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">501-524</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Paget's disease of bone (PDB) is characterized by focal areas of aberrant and excessive bone turnover, specifically increased bone resorption and disorganized bone formation.  Germline mutations in the sequestosome 1/p62 (SQSTM1/p62) gene are common in PDB patients, with most mutations affecting the ubiquitin-assocd. domain of the protein.  In vitro, osteoclast precursor cells expressing PDB-mutant SQSTM1/p62 protein are assocd. with increases in nuclear factor κB activation, osteoclast differentiation, and bone resorption.  Although the precise mechanisms by which SQSTM1/p62 mutations contribute to disease pathogenesis and progression are not well defined, it is apparent that as well as affecting nuclear factor κB signaling, SQSTM1/p62 is a master regulator of ubiquitinated protein turnover via autophagy and the ubiquitin-proteasome system.  Addnl. roles for SQSTM1/p62 in the oxidative stress-induced Keap1/Nrf2 pathway and in caspase-mediated apoptosis that were recently reported are potentially relevant to the pathogenesis of PDB.  Thus, SQSTM1/p62 may serve as a mol. link or switch between autophagy, apoptosis, and cell survival signaling.  The purpose of this review is to outline recent advances in understanding of the multiple pathophysiol. roles of SQSTM1/p62 protein, with particular emphasis on their relationship to PDB, including challenges assocd. with translating SQSTM1/p62 research into clin. diagnosis and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCNVd8lih1nLVg90H21EOLACvtfcHk0lhVEeLwaRNx6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVKgtrjF&md5=8e516a639bd6bbbf0b9c202c4b184f5b</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1210%2Fer.2012-1034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2012-1034%26sid%3Dliteratum%253Aachs%26aulast%3DRea%26aufirst%3DS.%2BL.%26aulast%3DWalsh%26aufirst%3DJ.%2BP.%26aulast%3DLayfield%26aufirst%3DR.%26aulast%3DRatajczak%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DJ.%2BK.%26atitle%3DNew%2520insights%2520into%2520the%2520role%2520of%2520sequestosome%25201%252Fp62%2520mutant%2520proteins%2520in%2520the%2520pathogenesis%2520of%2520Paget%25E2%2580%2599s%2520disease%2520of%2520bone%26jtitle%3DEndocr.%2520Rev.%26date%3D2013%26volume%3D34%26issue%3D4%26spage%3D501%26epage%3D524%26doi%3D10.1210%2Fer.2012-1034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kular, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tickner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chim, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. K.</span></span> <span> </span><span class="NLM_article-title">An overview of the regulation of bone remodelling at the cellular level</span>. <i>Clin. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">863</span>– <span class="NLM_lpage">873</span>, <span class="refDoi"> DOI: 10.1016/j.clinbiochem.2012.03.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.clinbiochem.2012.03.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22465238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38Xltl2rsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2012&pages=863-873&issue=12&author=J.+Kularauthor=J.+Ticknerauthor=S.+M.+Chimauthor=J.+K.+Xu&title=An+overview+of+the+regulation+of+bone+remodelling+at+the+cellular+level&doi=10.1016%2Fj.clinbiochem.2012.03.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of the regulation of bone remodelling at the cellular level</span></div><div class="casAuthors">Kular, Jasreen; Tickner, Jennifer; Chim, Shek Man; Xu, Jiake</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">863-873</span>CODEN:
                <span class="NLM_cas:coden">CLBIAS</span>;
        ISSN:<span class="NLM_cas:issn">0009-9120</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">To review the current literature on the regulation of bone remodelling at the cellular level.The cellular activities of the cells in the basic multicellular unit (BMU) were evaluated.Bone remodelling requires an intimate cross-talk between osteoclasts and osteoblasts and is tightly coordinated by regulatory proteins that interact through complex autocrine/paracrine mechanisms.  Osteocytes, bone lining cells, osteomacs, and vascular endothelial cells also regulate bone remodelling in the BMU via cell signalling networks of ligand-receptor complexes.  In addn., through secreted and membrane-bound factors in the bone microenvironment, T and B lymphocytes mediate bone homeostasis in osteoimmunol.Osteoporosis and other bone diseases occur because multicellular communication within the BMU is disrupted.  Understanding the cellular and mol. basis of bone remodelling and the discovery of novel paracrine or coupling factors, such as RANKL, sclerostin, EGFL6 and semaphorin 4D, will lay the foundation for drug development against bone diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5Zf7yUCbqU7Vg90H21EOLACvtfcHk0ljBYe58CC1E6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xltl2rsrg%253D&md5=28abc44dc0e76c03ee832c29e9c08a58</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1016%2Fj.clinbiochem.2012.03.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinbiochem.2012.03.021%26sid%3Dliteratum%253Aachs%26aulast%3DKular%26aufirst%3DJ.%26aulast%3DTickner%26aufirst%3DJ.%26aulast%3DChim%26aufirst%3DS.%2BM.%26aulast%3DXu%26aufirst%3DJ.%2BK.%26atitle%3DAn%2520overview%2520of%2520the%2520regulation%2520of%2520bone%2520remodelling%2520at%2520the%2520cellular%2520level%26jtitle%3DClin.%2520Biochem.%26date%3D2012%26volume%3D45%26issue%3D12%26spage%3D863%26epage%3D873%26doi%3D10.1016%2Fj.clinbiochem.2012.03.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takayanagi, H.</span></span> <span> </span><span class="NLM_article-title">Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">292</span>– <span class="NLM_lpage">304</span>, <span class="refDoi"> DOI: 10.1038/nri2062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fnri2062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=17380158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtlyhurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=292-304&issue=4&author=H.+Takayanagi&title=Osteoimmunology%3A+shared+mechanisms+and+crosstalk+between+the+immune+and+bone+systems&doi=10.1038%2Fnri2062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems</span></div><div class="casAuthors">Takayanagi, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">292-304</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Osteoimmunol. is an interdisciplinary research field focused on the mol. understanding of the interplay between the immune and skeletal systems.  Although osteoimmunol. started with the study of the immune regulation of osteoclasts, its scope has been extended to encompass a wide range of mol. and cellular interactions, including those between osteoblasts and osteoclasts, lymphocytes and osteoclasts, and osteoblasts and hematopoietic cells.  Therefore, the two systems should be understood to be integrated and operating in the context of the 'osteoimmune' system, a heuristic concept that provides not only a framework for obtaining new insights by basic research, but also a scientific basis for the discovery of novel treatments for diseases related to both systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZxVDBwUkq3rVg90H21EOLACvtfcHk0ljBYe58CC1E6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtlyhurc%253D&md5=61d02a7dac0ac2a0abddeda9ca6eab42</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1038%2Fnri2062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2062%26sid%3Dliteratum%253Aachs%26aulast%3DTakayanagi%26aufirst%3DH.%26atitle%3DOsteoimmunology%253A%2520shared%2520mechanisms%2520and%2520crosstalk%2520between%2520the%2520immune%2520and%2520bone%2520systems%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2007%26volume%3D7%26issue%3D4%26spage%3D292%26epage%3D304%26doi%3D10.1038%2Fnri2062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurihara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiruma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subler, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dempster, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singer, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruber, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windle, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roodman, G. D.</span></span> <span> </span><span class="NLM_article-title">Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>117</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1172/JCI28267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1172%2FJCI28267" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=17187080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmvV2qtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=133-142&issue=1&author=N.+Kuriharaauthor=Y.+Hirumaauthor=H.+Zhouauthor=M.+A.+Sublerauthor=D.+W.+Dempsterauthor=F.+R.+Singerauthor=S.+V.+Reddyauthor=H.+E.+Gruberauthor=J.+J.+Windleauthor=G.+D.+Roodman&title=Mutation+of+the+sequestosome+1+%28p62%29+gene+increases+osteoclastogenesis+but+does+not+induce+Paget+disease&doi=10.1172%2FJCI28267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease</span></div><div class="casAuthors">Kurihara, Noriyoshi; Hiruma, Yuko; Zhou, Hua; Subler, Mark A.; Dempster, David W.; Singer, Frederick R.; Reddy, Sakamuri V.; Gruber, Helen E.; Windle, Jolene J.; Roodman, G. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">133-142</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Paget disease is the most exaggerated example of abnormal bone remodeling, with the primary cellular abnormality in the osteoclast.  Mutations in the p62 (sequestosome 1) gene occur in one-third of patients with familial Paget disease and in a minority of patients with sporadic Paget disease, with the P392L amino acid substitution being the most commonly obsd. mutation.  However, it is unknown how p62P392L mutation contributes to the development of this disease.  To det. the effects of p62P392L expression on osteoclasts in vitro and in vivo, we introduced either the p62P392L or WT p62 gene into normal osteoclast precursors and targeted p62P392L expression to the osteoclast lineage in transgenic mice.  P62P392L-transduced osteoclast precursors were hyperresponsive to receptor activator of NF-κB ligand (RANKL) and TNF-α and showed increased NF-κB signaling but did not demonstrate increased 1,25-(OH)2D3 responsivity, TAFII-17 expression, or nuclear no. per osteoclast.  Mice expressing p62P392L developed increased osteoclast nos. and progressive bone loss, but osteoblast nos. were not coordinately increased, as is seen in Paget disease.  These results indicate that p62P392L expression on osteoclasts is not sufficient to induce the full pagetic phenotype but suggest that p62 mutations cause a predisposition to the development of Paget disease by increasing the sensitivity of osteoclast precursors to osteoclastogenic cytokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr38GlC3QrsqLVg90H21EOLACvtfcHk0ljBYe58CC1E6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmvV2qtw%253D%253D&md5=582802f6985afb9cd6d1c6e49670d66f</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1172%2FJCI28267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI28267%26sid%3Dliteratum%253Aachs%26aulast%3DKurihara%26aufirst%3DN.%26aulast%3DHiruma%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DSubler%26aufirst%3DM.%2BA.%26aulast%3DDempster%26aufirst%3DD.%2BW.%26aulast%3DSinger%26aufirst%3DF.%2BR.%26aulast%3DReddy%26aufirst%3DS.%2BV.%26aulast%3DGruber%26aufirst%3DH.%2BE.%26aulast%3DWindle%26aufirst%3DJ.%2BJ.%26aulast%3DRoodman%26aufirst%3DG.%2BD.%26atitle%3DMutation%2520of%2520the%2520sequestosome%25201%2520%2528p62%2529%2520gene%2520increases%2520osteoclastogenesis%2520but%2520does%2520not%2520induce%2520Paget%2520disease%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26issue%3D1%26spage%3D133%26epage%3D142%26doi%3D10.1172%2FJCI28267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daroszewska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van’t Hof, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layfield, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landao-Basonga, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ralston, S. H.</span></span> <span> </span><span class="NLM_article-title">A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget’s disease-like disorder in mice</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">2734</span>– <span class="NLM_lpage">2744</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddr172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1093%2Fhmg%2Fddr172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21515589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVeisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=2734-2744&issue=14&author=A.+Daroszewskaauthor=R.+J.+van%E2%80%99t+Hofauthor=J.+A.+Rojasauthor=R.+Layfieldauthor=E.+Landao-Basongaauthor=L.+Roseauthor=K.+Roseauthor=S.+H.+Ralston&title=A+point+mutation+in+the+ubiquitin-associated+domain+of+SQSMT1+is+sufficient+to+cause+a+Paget%E2%80%99s+disease-like+disorder+in+mice&doi=10.1093%2Fhmg%2Fddr172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice</span></div><div class="casAuthors">Daroszewska, Anna; van 't Hof, Robert J.; Rojas, Javier A.; Layfield, Robert; Landao-Basonga, Euphemie; Rose, Lorraine; Rose, Ken; Ralston, Stuart H.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2734-2744</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Mutations of SQSTM1 occur in about 10% of patients with Paget's disease of bone (PDB), but it is unclear whether they play a causal role or regulate susceptibility to an environmental trigger.  Here the authors show that mice with a proline to leucine mutation at codon 394 of mouse sqstm1 (P394L), equiv. to the P392L SQSTM1 mutation in humans, develop a bone disorder with remarkable similarity to PDB.  The P394L mutant mice developed focal bone lesions with increasing age and by 12 mo, 14/18 (77%) heterozygotes and 20/21 (95%) homozygotes had lesions, compared with 0/18 (0%) wild-type littermates (P< 0.001).  Lesions predominantly affected the lower limbs in an asym. manner and were characterized by focal increases in bone turnover, with increased bone resorption and formation, disruption of the normal bone architecture and accumulation of woven bone.  Osteoclasts within lesions were larger and more nucleated than normal and some contained nuclear inclusions similar to those obsd. in human PDB.  Osteoclast precursors from P394L mutant mice had increased sensitivity to RANKL in vitro resulting in the generation of osteoclasts that were larger and more nucleated than those generated from wild-type littermates.  There was increased expression of sqstm1, autophagy-related gene 5 (atg5) and light chain 3 gene (lc3) in osteoclast precursors and increased LC3-II protein levels in Bafilomycin-treated osteoclasts from P394L mutant mice compared with wild-type suggesting dysregulation of autophagy and enhanced autophagosome formation.  These studies demonstrate that SQSTM1 mutations can cause a PDB-like skeletal disorder in the absence of an addnl. trigger and provide a new disease model for PDB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Y1MJGsaoI7Vg90H21EOLACvtfcHk0lgz04Yfd7KdGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVeisLk%253D&md5=5e3024a87a9ec58ba408b01b9d04f59f</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddr172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddr172%26sid%3Dliteratum%253Aachs%26aulast%3DDaroszewska%26aufirst%3DA.%26aulast%3Dvan%25E2%2580%2599t%2BHof%26aufirst%3DR.%2BJ.%26aulast%3DRojas%26aufirst%3DJ.%2BA.%26aulast%3DLayfield%26aufirst%3DR.%26aulast%3DLandao-Basonga%26aufirst%3DE.%26aulast%3DRose%26aufirst%3DL.%26aulast%3DRose%26aufirst%3DK.%26aulast%3DRalston%26aufirst%3DS.%2BH.%26atitle%3DA%2520point%2520mutation%2520in%2520the%2520ubiquitin-associated%2520domain%2520of%2520SQSMT1%2520is%2520sufficient%2520to%2520cause%2520a%2520Paget%25E2%2580%2599s%2520disease-like%2520disorder%2520in%2520mice%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2011%26volume%3D20%26issue%3D14%26spage%3D2734%26epage%3D2744%26doi%3D10.1093%2Fhmg%2Fddr172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ralston, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langston, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, I. R.</span></span> <span> </span><span class="NLM_article-title">Pathogenesis and management of Paget’s disease of bone</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>372</i></span> (<span class="NLM_issue">9633</span>),  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">163</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(08)61035-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2FS0140-6736%2808%2961035-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18620951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVynurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2008&pages=155-163&issue=9633&author=S.+H.+Ralstonauthor=A.+L.+Langstonauthor=I.+R.+Reid&title=Pathogenesis+and+management+of+Paget%E2%80%99s+disease+of+bone&doi=10.1016%2FS0140-6736%2808%2961035-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenesis and management of Paget's disease of bone</span></div><div class="casAuthors">Ralston, Stuart H.; Langston, Anne L.; Reid, Ian R.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">9633</span>),
    <span class="NLM_cas:pages">155-163</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Paget's disease of bone is a common disease characterized by focal areas of increased bone turnover, affecting one or several bones throughout the skeleton.  Paget's disease is often asymptomatic but can be assocd. with bone pain and other complications such as osteoarthritis, pathol. fracture, bone deformity, deafness, and nerve compression syndromes.  Genetic factors have an important role in this disease, and mutations have been identified in four genes that cause Paget's disease and related syndromes.  The most important of these is Sequestosome 1 (SQSTM1), which is a scaffold protein in the nuclear factor κB (NFκB) signalling pathway.  Patients with SQSTM1 mutations have severe Paget's disease of bone and a high degree of penetrance with increasing age.  Environmental factors also contribute.  Most research has focused on paramyxovirus infection as a possible trigger, but evidence for this notion is conflicting.  Other potential triggers include deficiency of dietary calcium and repetitive mech. loading of the skeleton.  Medical management of Paget's disease of bone is based on giving inhibitors of osteoclastic bone resorption, and bisphosphonates are the treatment of first choice.  Bisphosphonate therapy is primarily indicated for patients who have bone pain arising from increased metabolic activity in affected bones.  Bisphosphonate therapy is highly effective at reducing bone turnover, and it has been shown to heal radiol. lesions and restore normal histol.; however, the long-term effects of bisphosphonates on disease progression have not been adequately studied.  No firm evidence as yet exists to show that bisphosphonates can prevent the development of complications of Paget's disease of bone, and further work is needed to address the effects of treatment on long-term clin. outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvexM1UZ6Hx7Vg90H21EOLACvtfcHk0lgz04Yfd7KdGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVynurc%253D&md5=8658ce77f45ae02132597f2491de080f</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2808%2961035-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252808%252961035-1%26sid%3Dliteratum%253Aachs%26aulast%3DRalston%26aufirst%3DS.%2BH.%26aulast%3DLangston%26aufirst%3DA.%2BL.%26aulast%3DReid%26aufirst%3DI.%2BR.%26atitle%3DPathogenesis%2520and%2520management%2520of%2520Paget%25E2%2580%2599s%2520disease%2520of%2520bone%26jtitle%3DLancet%26date%3D2008%26volume%3D372%26issue%3D9633%26spage%3D155%26epage%3D163%26doi%3D10.1016%2FS0140-6736%2808%2961035-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reid, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyles, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saidi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesenbrink, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, G. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zelenakas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosking, D.</span></span> <span> </span><span class="NLM_article-title">Comparison of a single infusion of zoledronic acid with risedronate for Paget’s disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>353</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">898</span>– <span class="NLM_lpage">908</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa044241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1056%2FNEJMoa044241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=16135834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFCht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=898-908&issue=9&author=I.+R.+Reidauthor=P.+Millerauthor=K.+Lylesauthor=W.+Fraserauthor=J.+P.+Brownauthor=Y.+Saidiauthor=P.+Mesenbrinkauthor=G.+Q.+Suauthor=J.+Pakauthor=K.+Zelenakasauthor=M.+Luchiauthor=P.+Richardsonauthor=D.+Hosking&title=Comparison+of+a+single+infusion+of+zoledronic+acid+with+risedronate+for+Paget%E2%80%99s+disease&doi=10.1056%2FNEJMoa044241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease</span></div><div class="casAuthors">Reid, Ian R.; Miller, Paul; Lyles, Kenneth; Fraser, William; Brown, Jacques P.; Saidi, Youssef; Mesenbrink, Peter; Su, Guoqin; Pak, Judy; Zelenakas, Ken; Luchi, Monica; Richardson, Peter; Hosking, David</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">898-908</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: The advent of bisphosphonates advanced therapy for Paget's disease, but more effective and convenient agents are needed to increase adherence.  Zoledronic acid, a bisphosphonate administered as a single i.v. infusion, might meet these needs.  METHODS: In two identical, randomized, double-blind, actively controlled trials of 6 mo duration, we compared one 15-min infusion of 5 mg of zoledronic acid with 60 days of oral risedronate (30 mg per day).  The primary efficacy end point was the rate of therapeutic response at six months, defined as a normalization of alk. phosphatase levels ora redn. of at least 75 % in the total alk. phosphatase excess.  The results of the studies were pooled.  RESULTS: At six months, 96.0 % of patients receiving zoledronic acid had a therapeutic response (169 of 176), as compared with 74.3 % of patients receiving risedronate (127 of 171, P < 0.001).  Alk. phosphatase levels normalized in 88.6 % of patients in the zoledronic acid group and 57.9 % of patients in the risedronate group (P < 0.001).  Zoledronic acid was assocd. with a shorter median time to a first therapeutic response (64 vs. 89 days, P < 0.001).  Higher response rates in the zoledronic acid group were consistent across all demog., disease-severity, and treatment-history subgroups and with changes in other bone-turnover markers.  The phys.-component summary score of the Medical Outcomes Study 36-item Short-Form General Health Survey, a measure of the quality of life, increased significantly from baseline at both three and six months in the zoledronic acid group and differed significantly from those in the risedronate group at three months.  Pain scores improved in both groups.  During post-trial follow-up (median, 190 days), 21 of 82 patients in the risedronate group had a loss of therapeutic response, as compared with 1 of 113 patients in the zoledronic acid group (P < 0.001).  CONCLUSIONS A single infusion of zoledronic acid produces more rapid, more complete, and more sustained responses in Paget's disease than does daily treatment with risedronate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiTng4toTvJrVg90H21EOLACvtfcHk0lgz04Yfd7KdGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFCht7g%253D&md5=5bd96393a52a837b3abef1839d196c3f</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa044241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa044241%26sid%3Dliteratum%253Aachs%26aulast%3DReid%26aufirst%3DI.%2BR.%26aulast%3DMiller%26aufirst%3DP.%26aulast%3DLyles%26aufirst%3DK.%26aulast%3DFraser%26aufirst%3DW.%26aulast%3DBrown%26aufirst%3DJ.%2BP.%26aulast%3DSaidi%26aufirst%3DY.%26aulast%3DMesenbrink%26aufirst%3DP.%26aulast%3DSu%26aufirst%3DG.%2BQ.%26aulast%3DPak%26aufirst%3DJ.%26aulast%3DZelenakas%26aufirst%3DK.%26aulast%3DLuchi%26aufirst%3DM.%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DHosking%26aufirst%3DD.%26atitle%3DComparison%2520of%2520a%2520single%2520infusion%2520of%2520zoledronic%2520acid%2520with%2520risedronate%2520for%2520Paget%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D353%26issue%3D9%26spage%3D898%26epage%3D908%26doi%3D10.1056%2FNEJMoa044241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woo, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellstein, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalmar, J. R.</span></span> <span> </span><span class="NLM_article-title">Bisphosphonates and osteonecrosis of the jaw-response</span>. <i>Ann. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>145</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">792</span>– <span class="NLM_lpage">792</span>, <span class="refDoi"> DOI: 10.7326/0003-4819-145-10-200611210-00023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.7326%2F0003-4819-145-10-200611210-00023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2006&pages=792-792&issue=10&author=S.+B.+Wooauthor=J.+W.+Hellsteinauthor=J.+R.+Kalmar&title=Bisphosphonates+and+osteonecrosis+of+the+jaw-response&doi=10.7326%2F0003-4819-145-10-200611210-00023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-145-10-200611210-00023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-145-10-200611210-00023%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DS.%2BB.%26aulast%3DHellstein%26aufirst%3DJ.%2BW.%26aulast%3DKalmar%26aufirst%3DJ.%2BR.%26atitle%3DBisphosphonates%2520and%2520osteonecrosis%2520of%2520the%2520jaw-response%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D2006%26volume%3D145%26issue%3D10%26spage%3D792%26epage%3D792%26doi%3D10.7326%2F0003-4819-145-10-200611210-00023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bava, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callon, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamble, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitto, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cundy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornish, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, I. R.</span></span> <span> </span><span class="NLM_article-title">Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget’s disease of bone</span>. <i>J. Bone Miner. Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">298</span>– <span class="NLM_lpage">309</span>, <span class="refDoi"> DOI: 10.1359/jbmr.061108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1359%2Fjbmr.061108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=17129176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFCgs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=298-309&issue=2&author=D.+Naotauthor=U.+Bavaauthor=B.+Matthewsauthor=K.+E.+Callonauthor=G.+D.+Gambleauthor=M.+Blackauthor=S.+Songauthor=R.+P.+Pittoauthor=T.+Cundyauthor=J.+Cornishauthor=I.+R.+Reid&title=Differential+gene+expression+in+cultured+osteoblasts+and+bone+marrow+stromal+cells+from+patients+with+Paget%E2%80%99s+disease+of+bone&doi=10.1359%2Fjbmr.061108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget's disease of bone</span></div><div class="casAuthors">Naot, Dorit; Bava, Usha; Matthews, Brya; Callon, Karen E.; Gamble, Gregory D.; Black, Michael; Song, Sarah; Pitto, Rocco P.; Cundy, Tim; Cornish, Jill; Reid, Ian R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">298-309</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">Paget's disease is a focal condition of bone.  To study changes in cells within pagetic lesions, we cultured osteoblasts and stromal cells from 22 patients and compared gene expression in these cells to cells from healthy bone.  We identified several differentially regulated genes, and we suggest that these changes could lead to the formation of the lesions.  Introduction: Paget's disease is a focal condition of bone of unknown cause.  Although it is regarded as primarily an osteoclast disorder, the tight coupling of the activity of osteoclasts and osteoblasts suggests that the osteoblast could play a key role in its pathogenesis.  The aim of the study was to identify possible changes in pagetic osteoblasts and stromal cells that might contribute to the development of pagetic lesions.  Materials and Methods: Candidate genes were identified based on known bone cell regulators, supplemented with microarray anal.  Gene expression was detd. by real-time PCR in primary cultures of osteoblasts and bone marrow stromal cells from pagetic patients and control subjects.  Concns. of secreted proteins were detd. by ELISA.  Results: Dickkopf1 mRNA and protein levels were increased in both pagetic osteoblast and stromal cell cultures, and interleukin (IL)-1 and IL-6 were overexpressed in pagetic osteoblasts.  These changes parallel recent findings in myeloma bone disease, which shares some clin. similarities with Paget's disease.  Alk. phosphatase was overexpressed, and bone sialoprotein and osteocalcin were underexpressed in pagetic osteoblasts, consistent with their circulating levels in pagetic patients.  It is hypothesized that overexpression of Dickkopf1, IL-1, and IL-6 would result in stimulation of osteoclast proliferation and inhibition of osteoblast growth, leading to the development of the characteristic lytic bone lesions.  By stimulating osteoblast differentiation, Dickkopf1 and IL-6 may also promote mineralization, leading to the conversion of lytic lesions to sclerotic.  Conclusions: These findings suggest that dysregulated gene expression in pagetic osteoblasts could cause the changes in bone cell no. and function characteristic of Paget's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfYHF9BEuTv7Vg90H21EOLACvtfcHk0lg3gjbw97WmFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvFCgs7k%253D&md5=5a48073432d70ba8d8cab504bd7d7907</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.061108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.061108%26sid%3Dliteratum%253Aachs%26aulast%3DNaot%26aufirst%3DD.%26aulast%3DBava%26aufirst%3DU.%26aulast%3DMatthews%26aufirst%3DB.%26aulast%3DCallon%26aufirst%3DK.%2BE.%26aulast%3DGamble%26aufirst%3DG.%2BD.%26aulast%3DBlack%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DS.%26aulast%3DPitto%26aufirst%3DR.%2BP.%26aulast%3DCundy%26aufirst%3DT.%26aulast%3DCornish%26aufirst%3DJ.%26aulast%3DReid%26aufirst%3DI.%2BR.%26atitle%3DDifferential%2520gene%2520expression%2520in%2520cultured%2520osteoblasts%2520and%2520bone%2520marrow%2520stromal%2520cells%2520from%2520patients%2520with%2520Paget%25E2%2580%2599s%2520disease%2520of%2520bone%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2007%26volume%3D22%26issue%3D2%26spage%3D298%26epage%3D309%26doi%3D10.1359%2Fjbmr.061108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himori, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omodaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiga, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakazawa, T.</span></span> <span> </span><span class="NLM_article-title">The novel Rho kinase (ROCK) inhibitor K-115: a new candidate drug for neuroprotective treatment in glaucoma</span>. <i>Invest. Ophthalmol. Visual Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">7126</span>– <span class="NLM_lpage">7136</span>, <span class="refDoi"> DOI: 10.1167/iovs.13-13842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1167%2Fiovs.13-13842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=25277230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVOltbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=7126-7136&issue=11&author=K.+Yamamotoauthor=K.+Maruyamaauthor=N.+Himoriauthor=K.+Omodakaauthor=Y.+Yokoyamaauthor=Y.+Shigaauthor=R.+Morinauthor=T.+Nakazawa&title=The+novel+Rho+kinase+%28ROCK%29+inhibitor+K-115%3A+a+new+candidate+drug+for+neuroprotective+treatment+in+glaucoma&doi=10.1167%2Fiovs.13-13842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">The novel Rho kinase (ROCK) inhibitor K-115: a new candidate drug for neuroprotective treatment in glaucoma</span></div><div class="casAuthors">Yamamoto, Kotaro; Maruyama, Kazuichi; Himori, Noriko; Omodaka, Kazuko; Yokoyama, Yu; Shiga, Yukihiro; Morin, Ryu; Nakazawa, Toru</div><div class="citationInfo"><span class="NLM_cas:title">Investigative Ophthalmology & Visual Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">7126-7136</span>CODEN:
                <span class="NLM_cas:coden">IOVSDA</span>;
        ISSN:<span class="NLM_cas:issn">1552-5783</span>.
    
            (<span class="NLM_cas:orgname">Association for Research in Vision and Ophthalmology</span>)
        </div><div class="casAbstract">To investigate the effect of K-115, a novel Rho kinase (ROCK) inhibitor, on retinal ganglion cell (RGC) survival in an optic nerve crush (NC) model.  Addnl., to det. the details of the mechanism of K-115's neuroprotective effect in vivo and in vitro.  ROCK inhibitors, including K-115 and fasudil (1 mg/kg/d), or vehicle were administered orally to C57BL/6 mice.  Retinal ganglion cell death was then induced with NC.  Retinal ganglion cell survival was evaluated by counting surviving retrogradely labeled cells and measuring RGC marker expression with quant. real-time polymerase chain reaction (qRT-PCR).  Total oxidized lipid levels were assessed with a thiobarbituric acid-reactive substances (TBARS) assay.  Reactive oxygen species (ROS) levels were assessed by co-labeling with CellROX and Fluorogold.  Expression of the NADPH oxidase (Nox) family of genes was evaluated with qRT-PCR.  The survival of RGCs after NC was increased 34 ± 3% with K-115, a significantly protective effect.  Moreover, a similar effect was revealed by the qRT-PCR anal. of Thy-1.2 and Brn3a, RGC markers.  Levels of oxidized lipids and ROS also increased with time after NC.  NC-induced oxidative stress, including oxidn. of lipids and prodn. of ROS, was significantly attenuated by K-115.  Furthermore, expression of the Nox gene family, esp. Nox1, which is involved in the NC-induced ROS prodn. pathway, was dramatically reduced by K-115.  The results indicated that oral K-115 administration delayed RGC death.  Although K-115 may be mediated through Nox1 downregulation, we found that it did not suppress ROS prodn. directly.  Our findings show that K-115 has a potential use in neuroprotective treatment for glaucoma and other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7y2j7EK2KoLVg90H21EOLACvtfcHk0lg3gjbw97WmFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVOltbfN&md5=f0db38d732b7244c73b3aeca80cf193a</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1167%2Fiovs.13-13842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.13-13842%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DMaruyama%26aufirst%3DK.%26aulast%3DHimori%26aufirst%3DN.%26aulast%3DOmodaka%26aufirst%3DK.%26aulast%3DYokoyama%26aufirst%3DY.%26aulast%3DShiga%26aufirst%3DY.%26aulast%3DMorin%26aufirst%3DR.%26aulast%3DNakazawa%26aufirst%3DT.%26atitle%3DThe%2520novel%2520Rho%2520kinase%2520%2528ROCK%2529%2520inhibitor%2520K-115%253A%2520a%2520new%2520candidate%2520drug%2520for%2520neuroprotective%2520treatment%2520in%2520glaucoma%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2014%26volume%3D55%26issue%3D11%26spage%3D7126%26epage%3D7136%26doi%3D10.1167%2Fiovs.13-13842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fogliatto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gianellini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brasca, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casale, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballinari, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciomei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degrassi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Ponti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guanci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paolucci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polucci, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valsasina, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccotto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesenti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantegani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isacchi, A.</span></span> <span> </span><span class="NLM_article-title">NMS-E973, a novel synthetic inhibitor of Hsp90 with activity against multiple models of drug resistance to targeted agents, including intracranial metastases</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">3520</span>– <span class="NLM_lpage">3532</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-3512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1158%2F1078-0432.CCR-12-3512" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=23674492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtValt7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=3520-3532&issue=13&author=G.+Fogliattoauthor=L.+Gianelliniauthor=M.+G.+Brascaauthor=E.+Casaleauthor=D.+Ballinariauthor=M.+Ciomeiauthor=A.+Degrassiauthor=A.+De+Pontiauthor=M.+Germaniauthor=M.+Guanciauthor=M.+Paolucciauthor=P.+Polucciauthor=M.+Russoauthor=F.+Solaauthor=B.+Valsasinaauthor=C.+Viscoauthor=F.+Zuccottoauthor=D.+Donatiauthor=E.+Felderauthor=E.+Pesentiauthor=A.+Galvaniauthor=S.+Manteganiauthor=A.+Isacchi&title=NMS-E973%2C+a+novel+synthetic+inhibitor+of+Hsp90+with+activity+against+multiple+models+of+drug+resistance+to+targeted+agents%2C+including+intracranial+metastases&doi=10.1158%2F1078-0432.CCR-12-3512"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">NMS-E973, a Novel Synthetic Inhibitor of Hsp90 with Activity against Multiple Models of Drug Resistance to Targeted Agents, Including Intracranial Metastases</span></div><div class="casAuthors">Fogliatto, Gianpaolo; Gianellini, Laura; Brasca, Maria G.; Casale, Elena; Ballinari, Dario; Ciomei, Marina; Degrassi, Anna; De Ponti, Anna; Germani, Massimiliano; Guanci, Marco; Paolucci, Mauro; Polucci, Paolo; Russo, Micaela; Sola, Francesco; Valsasina, Barbara; Visco, Carlo; Zuccotto, Fabio; Donati, Daniele; Felder, Eduard; Pesenti, Enrico; Galvani, Arturo; Mantegani, Sergio; Isacchi, Antonella</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3520-3532</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Recent developments of second generation Hsp90 inhibitors suggested a potential for development of this class of mols. also in tumors that have become resistant to mol. targeted agents.  Disease progression is often due to brain metastases, sometimes related to insufficient drug concns. within the brain.  Our objective was to identify and characterize a novel inhibitor of Hsp90 able to cross the blood-brain barrier (BBB).  Exptl. Design: Here is described a detailed biochem. and crystallog. characterization of NMS-E973.  Mechanism-based anticancer activity was described in cell models, including models of resistance to kinase inhibitors.  Pharmacokinetics properties were followed in plasma, tumor, liver, and brain.  In vivo activity and pharmacodynamics, as well as the pharmacokinetic/pharmacodynamic relationships, were evaluated in xenografts, including an intracranially implanted melanoma model.  Results: NMS-E973, representative of a novel isoxazole-derived class of Hsp90 inhibitors, binds Hsp90α with subnanomolar affinity and high selectivity towards kinases, as well as other ATPases.  It possesses potent antiproliferative activity against tumor cell lines and a favorable pharmacokinetic profile, with selective retention in tumor tissue and ability to cross the BBB.  NMS-E973 induces tumor shrinkage in different human tumor xenografts, and is highly active in models of resistance to kinase inhibitors.  Moreover, consistent with its brain penetration, NMS-E973 is active also in an intracranially implanted melanoma model.  Conclusions: Overall, the efficacy profile of NMS-E973 suggests a potential for development in different clin. settings, including tumors that have become resistant to mol. targeted agents, particularly in cases of tumors which reside beyond the BBB.  Clin Cancer Res; 19(13); 3520-32. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-27WeJC9bM7Vg90H21EOLACvtfcHk0lhB1iVIYhZ6GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtValt7bM&md5=fcf8b530e3581ba78e0c0668755ecfe6</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-3512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-3512%26sid%3Dliteratum%253Aachs%26aulast%3DFogliatto%26aufirst%3DG.%26aulast%3DGianellini%26aufirst%3DL.%26aulast%3DBrasca%26aufirst%3DM.%2BG.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DBallinari%26aufirst%3DD.%26aulast%3DCiomei%26aufirst%3DM.%26aulast%3DDegrassi%26aufirst%3DA.%26aulast%3DDe%2BPonti%26aufirst%3DA.%26aulast%3DGermani%26aufirst%3DM.%26aulast%3DGuanci%26aufirst%3DM.%26aulast%3DPaolucci%26aufirst%3DM.%26aulast%3DPolucci%26aufirst%3DP.%26aulast%3DRusso%26aufirst%3DM.%26aulast%3DSola%26aufirst%3DF.%26aulast%3DValsasina%26aufirst%3DB.%26aulast%3DVisco%26aufirst%3DC.%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DFelder%26aufirst%3DE.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DGalvani%26aufirst%3DA.%26aulast%3DMantegani%26aufirst%3DS.%26aulast%3DIsacchi%26aufirst%3DA.%26atitle%3DNMS-E973%252C%2520a%2520novel%2520synthetic%2520inhibitor%2520of%2520Hsp90%2520with%2520activity%2520against%2520multiple%2520models%2520of%2520drug%2520resistance%2520to%2520targeted%2520agents%252C%2520including%2520intracranial%2520metastases%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26issue%3D13%26spage%3D3520%26epage%3D3532%26doi%3D10.1158%2F1078-0432.CCR-12-3512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lundgren, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brekken, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huser, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timple, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busch, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neely, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sensintaffar, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scannevin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasibhatla, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, F. J.</span></span> <span> </span><span class="NLM_article-title">BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">921</span>– <span class="NLM_lpage">929</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-08-0758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1158%2F1535-7163.MCT-08-0758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19372565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1amt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=921-929&issue=4&author=K.+Lundgrenauthor=H.+Zhangauthor=J.+Brekkenauthor=N.+Huserauthor=R.+E.+Powellauthor=N.+Timpleauthor=D.+J.+Buschauthor=L.+Neelyauthor=J.+L.+Sensintaffarauthor=Y.+C.+Yangauthor=A.+McKenzieauthor=J.+Friedmanauthor=R.+Scannevinauthor=A.+Kamalauthor=K.+Hongauthor=S.+R.+Kasibhatlaauthor=M.+F.+Boehmauthor=F.+J.+Burrows&title=BIIB021%2C+an+orally+available%2C+fully+synthetic+small-molecule+inhibitor+of+the+heat+shock+protein+Hsp90&doi=10.1158%2F1535-7163.MCT-08-0758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90</span></div><div class="casAuthors">Lundgren, Karen; Zhang, Hong; Brekken, John; Huser, Nanni; Powell, Rachel E.; Timple, Noel; Busch, David J.; Neely, Laura; Sensintaffar, John L.; Yang, Yong-ching; McKenzie, Andres; Friedman, Jessica; Scannevin, Robert; Kamal, Adeela; Hong, Kevin; Kasibhatla, Srinivas R.; Boehm, Marcus F.; Burrows, Francis J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">921-929</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inhibition of heat shock protein 90 (Hsp90) results in the degrdn. of oncoproteins that drive malignant progression, inducing cell death, making Hsp90 a target of substantial interest for cancer therapy.  BIIB021 is a novel, fully synthetic inhibitor of Hsp90 that binds competitively with geldanamycin in the ATP-binding pocket of Hsp90.  In tumor cells, BIIB021 induced the degrdn. of Hsp90 client proteins including HER-2, AKT, and Raf-1 and up-regulated expression of the heat shock proteins Hsp70 and Hsp27.  BIIB021 treatment resulted in growth inhibition and cell death in cell lines from a variety of tumor types at nanomolar concns.  Oral administration of BIIB021 led to the degrdn. of Hsp90 client proteins measured in tumor tissue and resulted in the inhibition of tumor growth in several human tumor xenograft models.  Studies to investigate the antitumor effects of BIIB021 showed activity on both daily and intermittent dosing schedules, providing dose schedule flexibility for clin. studies.  Assays measuring the HER-2 protein in tumor tissue and the HER-2 extracellular domain in plasma were used to show interdiction of the Hsp90 pathway and utility as potential biomarkers in clin. trials for BIIB021.  Together, these data show that BIIB021 is a promising new oral inhibitor of Hsp90 with antitumor activity in preclin. models.[Mol Cancer Ther 2009;8(4):921-9].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSbI2RYG4aF7Vg90H21EOLACvtfcHk0lhB1iVIYhZ6GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1amt74%253D&md5=271e2311ab807bc74b2ac66b81e514e1</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0758%26sid%3Dliteratum%253Aachs%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBrekken%26aufirst%3DJ.%26aulast%3DHuser%26aufirst%3DN.%26aulast%3DPowell%26aufirst%3DR.%2BE.%26aulast%3DTimple%26aufirst%3DN.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DNeely%26aufirst%3DL.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DY.%2BC.%26aulast%3DMcKenzie%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DJ.%26aulast%3DScannevin%26aufirst%3DR.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26atitle%3DBIIB021%252C%2520an%2520orally%2520available%252C%2520fully%2520synthetic%2520small-molecule%2520inhibitor%2520of%2520the%2520heat%2520shock%2520protein%2520Hsp90%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26issue%3D4%26spage%3D921%26epage%3D929%26doi%3D10.1158%2F1535-7163.MCT-08-0758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mashino, T.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of the protein-protein interaction between phosphorylated p62 and Keap1 attenuate chemoresistance in a human hepatocellular carcinoma cell line</span>. <i>Free Radical Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1080/10715762.2020.1732955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1080%2F10715762.2020.1732955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=32075457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BB387jvVCmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=1-291&author=D.+Yasudaauthor=T.+Oheauthor=K.+Takahashiauthor=R.+Imamuraauthor=H.+Kojimaauthor=T.+Okabeauthor=Y.+Ichimuraauthor=M.+Komatsuauthor=M.+Yamamotoauthor=T.+Naganoauthor=T.+Mashino&title=Inhibitors+of+the+protein-protein+interaction+between+phosphorylated+p62+and+Keap1+attenuate+chemoresistance+in+a+human+hepatocellular+carcinoma+cell+line&doi=10.1080%2F10715762.2020.1732955"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of the protein-protein interaction between phosphorylated p62 and Keap1 attenuate chemoresistance in a human hepatocellular carcinoma cell line</span></div><div class="casAuthors">Yasuda Daisuke; Ohe Tomoyuki; Takahashi Kyoko; Mashino Tadahiko; Imamura Riyo; Kojima Hirotatsu; Okabe Takayoshi; Nagano Tetsuo; Ichimura Yoshinobu; Komatsu Masaaki; Yamamoto Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Free radical research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Resistance to anticancer agents has been an obstacle to developing therapeutics and reducing medical costs.  Whereas sorafenib is used for the treatment of human hepatocellular carcinoma (HCC), resistance limits its efficacy. p62, a multifunctional protein, is overexpressed in several HCC cell lines, such as Huh-1 cells.  Phosphorylated p62 (p-p62) inhibits the protein-protein interaction (PPI) between Keap1 and Nrf2, resulting in the Nrf2 overactivation that causes drug resistance.  We have found a unique Nrf2 inactivator, named K67, that inhibited the PPI between Keap1 and p-p62 and attenuated sorafenib resistance in Huh-1 cells.  Herein, we designed and synthesised novel K67 derivatives by modification of the substituent at the 4-position of the two benzenesulfonyl groups of K67.  Although these new derivatives inhibited the Keap1-p-p62 PPI to a level comparable to or weaker than that of K67, the isopropoxy derivative enhanced the sensitivity of Huh-1 cells to sorafenib to a greater extent than K67 without any influence on the viability of Huh-7 cells, which is a non-resistant HCC cell line.  The isopropoxy derivative also increased the sensitivity of Huh-1 cells to regorafenib, which suggests that this derivative has the potential to be used as an agent to overcome chemoresistance based on Nrf2 inactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCl4j53i96sv69nzq6467DfW6udTcc2ebOMOyrw9kFZrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB387jvVCmug%253D%253D&md5=02ebd4ea0c0d75e0d7324c2dcfdcd869</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1080%2F10715762.2020.1732955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10715762.2020.1732955%26sid%3Dliteratum%253Aachs%26aulast%3DYasuda%26aufirst%3DD.%26aulast%3DOhe%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DImamura%26aufirst%3DR.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DIchimura%26aufirst%3DY.%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DNagano%26aufirst%3DT.%26aulast%3DMashino%26aufirst%3DT.%26atitle%3DInhibitors%2520of%2520the%2520protein-protein%2520interaction%2520between%2520phosphorylated%2520p62%2520and%2520Keap1%2520attenuate%2520chemoresistance%2520in%2520a%2520human%2520hepatocellular%2520carcinoma%2520cell%2520line%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2020%26spage%3D1%26epage%3D291%26doi%3D10.1080%2F10715762.2020.1732955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuganezawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinohara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noda, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inagaki, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohsumi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, A.</span></span> <span> </span><span class="NLM_article-title">Two-colored fluorescence correlation spectroscopy screening for LC3-P62 interaction inhibitors</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1103</span>– <span class="NLM_lpage">1109</span>, <span class="refDoi"> DOI: 10.1177/1087057113492200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1177%2F1087057113492200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=23741014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslWjsLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=1103-1109&issue=9&author=K.+Tsuganezawaauthor=Y.+Shinoharaauthor=N.+Ogawaauthor=S.+Tsuboiauthor=N.+Okadaauthor=M.+Moriauthor=S.+Yokoyamaauthor=N.+N.+Nodaauthor=F.+Inagakiauthor=Y.+Ohsumiauthor=A.+Tanaka&title=Two-colored+fluorescence+correlation+spectroscopy+screening+for+LC3-P62+interaction+inhibitors&doi=10.1177%2F1087057113492200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Two-colored fluorescence correlation spectroscopy screening for LC3-P62 interaction inhibitors</span></div><div class="casAuthors">Tsuganezawa, Keiko; Shinohara, Yoshiyasu; Ogawa, Naoko; Tsuboi, Shun; Okada, Norihisa; Mori, Masumi; Yokoyama, Shigeyuki; Noda, Nobuo N.; Inagaki, Fuyuhiko; Ohsumi, Yoshinori; Tanaka, Akiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1103-1109, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The fluorescence correlation spectroscopy (FCS)-based competitive binding assay to screen for protein-protein interaction inhibitors is a highly sensitive method as compared with the fluorescent polarization assay used conventionally.  However, the FCS assay identifies many false-pos. compds., which requires specifically designed orthogonal screenings.  A two-colored application of the FCS-based screening was newly developed, and inhibitors of a protein-protein interaction, involving selective autophagy, were selected.  We focused on the interaction of LC3 with the adaptor protein p62, because the interaction is crucial to degrade the specific target proteins recruited by p62.  First, about 10,000 compds. were subjected to the FCS-based competitive assay using a TAMRA-labeled p62-derived probe, and 29 hit compds. were selected.  Next, the obtained hits were evaluated by the second FCS assay, using an Alexa647-labeled p62-derived probe to remove the false-pos. compds., and six hit compds. inhibited the interaction.  Finally, we tested all 29 compds. by surface plasmon resonance-based competitive binding assay to evaluate their inhibition of the LC3-p62 interaction and selected two inhibitors with IC50 values less than 2 μM.  The two-colored FCS-based screening was shown to be effective to screen for protein-protein interaction inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonqJany-BymLVg90H21EOLACvtfcHk0lhj0VD9983LmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslWjsLnE&md5=b1b6e7e4b385ea19dbcf0551a6236a66</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1177%2F1087057113492200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057113492200%26sid%3Dliteratum%253Aachs%26aulast%3DTsuganezawa%26aufirst%3DK.%26aulast%3DShinohara%26aufirst%3DY.%26aulast%3DOgawa%26aufirst%3DN.%26aulast%3DTsuboi%26aufirst%3DS.%26aulast%3DOkada%26aufirst%3DN.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DNoda%26aufirst%3DN.%2BN.%26aulast%3DInagaki%26aufirst%3DF.%26aulast%3DOhsumi%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DA.%26atitle%3DTwo-colored%2520fluorescence%2520correlation%2520spectroscopy%2520screening%2520for%2520LC3-P62%2520interaction%2520inhibitors%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2013%26volume%3D18%26issue%3D9%26spage%3D1103%26epage%3D1109%26doi%3D10.1177%2F1087057113492200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chung, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sontheimer, H.</span></span> <span> </span><span class="NLM_article-title">Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor-kappaB</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">193</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2009.06129.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1111%2Fj.1471-4159.2009.06129.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19457125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVCmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2009&pages=182-193&issue=1&author=W.+J.+Chungauthor=H.+Sontheimer&title=Sulfasalazine+inhibits+the+growth+of+primary+brain+tumors+independent+of+nuclear+factor-kappaB&doi=10.1111%2Fj.1471-4159.2009.06129.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor-κB</span></div><div class="casAuthors">Chung, W. Joon; Sontheimer, Harald</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">182-193</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Nuclear factor-κB (NF-κB) is a pleiotropic transcription factor that generally enhances cellular resistance to apoptotic cell death.  It has been shown to be constitutively active in some cancers and is being pursued as potential anticancer target.  Sulfasalazine which is used clin. to treat Crohn's disease has emerged as a potential inhibitor of NF-κB and has shown promising results in two pre-clin. studies to target primary brain tumors, gliomas.  Once digested, sulfasalazine is cleaved into sulfapyridine and 5-aminosalicylic acid (5-ASA; mesalamine) by colonic bacteria, and the latter, too, is reported to suppress NF-κB activity.  We now show that glioma cells obtained from patient biopsies or glioma cell lines do not show significant constitutive NF-κB activation, unless exposed to inflammatory cytokines.  This does not change when gliomas are implanted into the cerebrum of severe combined immundeficient mice.  Nevertheless, sulfasalazine but not its cleaved form 5-ASA caused a dose-dependent inhibition of glioma growth.  This effect was entirely attributable to the inhibition of cystine uptake via the system xc- cystine-glutamate transporter.  It could be mimicked by S-4-carboxy-phenylglycine (S-4-CPG) a more specific system xc- inhibitor, and lentiviral expression of a constitutively active form of IκB kinase b was unable to overcome the growth retarding effects of sulfasalazine or S-4-CPG.  Both drugs inhibited cystine uptake causing a chronic depletion of intracellular GSH and consequently compromised cellular redox defense which stymied tumor growth.  This data suggests that system xc- is a promising therapeutic target in gliomas and possibly other cancers and that it can be pharmacol. inhibited by Sulfasalazine, an FDA-approved drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRj_MjJmn6C7Vg90H21EOLACvtfcHk0lhj0VD9983LmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVCmtLo%253D&md5=dca393070e5e4fa0c16b61f53c99b7f1</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2009.06129.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2009.06129.x%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DW.%2BJ.%26aulast%3DSontheimer%26aufirst%3DH.%26atitle%3DSulfasalazine%2520inhibits%2520the%2520growth%2520of%2520primary%2520brain%2520tumors%2520independent%2520of%2520nuclear%2520factor-kappaB%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D110%26issue%3D1%26spage%3D182%26epage%3D193%26doi%3D10.1111%2Fj.1471-4159.2009.06129.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rangaraju, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verrier, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madorsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, W. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Notterpek, L.</span></span> <span> </span><span class="NLM_article-title">Rapamycin activates autophagy and improves myelination in explant cultures from neuropathic mice</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">34</span>),  <span class="NLM_fpage">11388</span>– <span class="NLM_lpage">11397</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.1356-10.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1523%2FJNEUROSCI.1356-10.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20739560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFens7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=11388-11397&issue=34&author=S.+Rangarajuauthor=J.+D.+Verrierauthor=I.+Madorskyauthor=J.+Nicksauthor=W.+A.+Dunnauthor=L.+Notterpek&title=Rapamycin+activates+autophagy+and+improves+myelination+in+explant+cultures+from+neuropathic+mice&doi=10.1523%2FJNEUROSCI.1356-10.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Rapamycin activates autophagy and improves myelination in explant cultures from neuropathic mice</span></div><div class="casAuthors">Rangaraju, Sunitha; Verrier, Jonathan D.; Madorsky, Irina; Nicks, Jessica; Dunn, William A., Jr.; Notterpek, Lucia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">11388-11397</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Misexpression and cytosolic retention of peripheral myelin protein 22 (PMP22) within Schwann cells (SCs) is assocd. with a genetically heterogeneous group of demyelinating peripheral neuropathies.  PMP22 overproducer C22 and spontaneous mutant Trembler J (TrJ) mice display neuropathic phenotypes and affected nerves contain abnormally localized PMP22.  Nutrient deprivation-induced autophagy is able to suppress the formation of PMP22 aggregates in a toxin-induced cellular model, and improve locomotor performance and myelination in TrJ mice.  As a step toward therapies, we assessed whether pharmacol. activation of autophagy by rapamycin (RM) could facilitate the processing of PMP22 within neuropathic SCs and enhance their capacity to myelinate peripheral axons.  Exposure of mouse SCs to RM induced autophagy in a dose- and time-dependent manner and decreased the accumulation of poly-ubiquitinated substrates.  The treatment of myelinating dorsal root ganglion (DRG) explant cultures from neuropathic mice with RM (25 nm) improved the processing of PMP22 and increased the abundance and length of myelin internodes, as well as the expression of myelin proteins.  Notably, RM is similarly effective in both the C22 and TrJ model, signifying that the benefit overlaps among distinct genetic models of PMP22 neuropathies.  Furthermore, lentivirus-mediated shRNA knockdown of the autophagy-related gene 12 (Atg12) abolished the activation of autophagy and the increase in myelin proteins, demonstrating that autophagy is crit. for the obsd. improvement.  Together, these results support the potential use of RM and other autophagy-enhancing compds. as therapeutic agents for PMP22-assocd. demyelinating neuropathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHJQBmoa_TPbVg90H21EOLACvtfcHk0lhlZI3vIYFZhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFens7bE&md5=dafa8368d10878b8a40aeab2917b5639</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1356-10.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1356-10.2010%26sid%3Dliteratum%253Aachs%26aulast%3DRangaraju%26aufirst%3DS.%26aulast%3DVerrier%26aufirst%3DJ.%2BD.%26aulast%3DMadorsky%26aufirst%3DI.%26aulast%3DNicks%26aufirst%3DJ.%26aulast%3DDunn%26aufirst%3DW.%2BA.%26aulast%3DNotterpek%26aufirst%3DL.%26atitle%3DRapamycin%2520activates%2520autophagy%2520and%2520improves%2520myelination%2520in%2520explant%2520cultures%2520from%2520neuropathic%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26issue%3D34%26spage%3D11388%26epage%3D11397%26doi%3D10.1523%2FJNEUROSCI.1356-10.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lane, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McSheehy, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allegrini, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boulay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brueggen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littlewood-Evans, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maira, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martiny-Baron, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnell, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, T.</span></span> <span> </span><span class="NLM_article-title">mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1612</span>– <span class="NLM_lpage">1622</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-08-2057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1158%2F1078-0432.CCR-08-2057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19223496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisVWrsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=1612-1622&issue=5&author=H.+A.+Laneauthor=J.+M.+Woodauthor=P.+M.+McSheehyauthor=P.+R.+Allegriniauthor=A.+Boulayauthor=J.+Brueggenauthor=A.+Littlewood-Evansauthor=S.+M.+Mairaauthor=G.+Martiny-Baronauthor=C.+R.+Schnellauthor=P.+Siniauthor=T.+O%E2%80%99Reilly&title=mTOR+inhibitor+RAD001+%28everolimus%29+has+antiangiogenic%2Fvascular+properties+distinct+from+a+VEGFR+tyrosine+kinase+inhibitor&doi=10.1158%2F1078-0432.CCR-08-2057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">mTOR Inhibitor RAD001 (Everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor</span></div><div class="casAuthors">Lane, Heidi A.; Wood, Jeanette M.; McSheehy, Paul M. J.; Allegrini, Peter R.; Boulay, Anne; Brueggen, Joseph; Littlewood-Evans, Amanda; Maira, Sauveur-Michel; Martiny-Baron, Georg; Schnell, Christian R.; Sini, Patrizia; O'Reilly, Terence</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1612-1622</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Comparison of the antiangiogenic/vascular properties of the oral mammalian target of rapamycin (mTOR) inhibitor RAD001 (everolimus) and the vascular endothelial growth factor receptor (VEGFR) inhibitor vatalanib (PTK/ZK).  Antiproliferative activity against various tumor histotypes and downstream effects on the mTOR pathway were measured in vitro.  In vivo, antitumor activity, plasma, and tumor RAD001 levels were measured.  Activity in several different angiogenic/vascular assays in vitro and in vivo was assessed and compared with PTK/ZK.  RAD001 inhibited proliferation in vitro (IC50 values <1 nmol/L to >1 μmol/L), and in sensitive and insensitive tumor cells, pS6 kinase and 4E-BP1 were inhibited.  Activity in vitro did not correlate with activity in vivo and significant responses were seen in tumors with IC50 values >10-fold higher than tumor RAD001 concns.  In vitro, RAD001 inhibited the proliferation of VEGF-stimulated and fibroblast growth factor-stimulated human endothelial cells but not dermal fibroblasts and impaired VEGF release from both sensitive and insensitive tumor cells but did not inhibit migration of human endothelial cells.  In vivo, in tumor models derived from either sensitive or insensitive cells, RAD001 reduced Tie-2 levels, the amt. of mature and immature vessels, total plasma, and tumor VEGF.  RAD001 did not affect blood vessel leakiness in normal vasculature acutely exposed to VEGF nor did it affect tumor vascular permeability (Ktrans) as measured by dynamic contrast-enhanced magnetic resonance imaging.  However, the pan-VEGFR inhibitor PTK/ZK inhibited endothelial cell migration and vascular permeability but had less effect on mature vessels compared with RAD001.  VEGFR and mTOR inhibitors show similar but also distinct effects on tumor vascular biol., which has implications for their clin. activity alone or in combination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9GnfDB23UtbVg90H21EOLACvtfcHk0lhlZI3vIYFZhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisVWrsr0%253D&md5=43e02b9eff78ab07e48cef6e1900bd11</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-2057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-2057%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DH.%2BA.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DMcSheehy%26aufirst%3DP.%2BM.%26aulast%3DAllegrini%26aufirst%3DP.%2BR.%26aulast%3DBoulay%26aufirst%3DA.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DLittlewood-Evans%26aufirst%3DA.%26aulast%3DMaira%26aufirst%3DS.%2BM.%26aulast%3DMartiny-Baron%26aufirst%3DG.%26aulast%3DSchnell%26aufirst%3DC.%2BR.%26aulast%3DSini%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DT.%26atitle%3DmTOR%2520inhibitor%2520RAD001%2520%2528everolimus%2529%2520has%2520antiangiogenic%252Fvascular%2520properties%2520distinct%2520from%2520a%2520VEGFR%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26issue%3D5%26spage%3D1612%26epage%3D1622%26doi%3D10.1158%2F1078-0432.CCR-08-2057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maira, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stauffer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brueggen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritsch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brachmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chene, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Pover, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoemaker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabbro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabriel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Echeverria, C.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1851</span>– <span class="NLM_lpage">1863</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-08-0017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1158%2F1535-7163.MCT-08-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18606717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1851-1863&issue=7&author=S.+M.+Mairaauthor=F.+Staufferauthor=J.+Brueggenauthor=P.+Furetauthor=C.+Schnellauthor=C.+Fritschauthor=S.+Brachmannauthor=P.+Cheneauthor=A.+De+Poverauthor=K.+Schoemakerauthor=D.+Fabbroauthor=D.+Gabrielauthor=M.+Simonenauthor=L.+Murphyauthor=P.+Finanauthor=W.+Sellersauthor=C.+Garcia-Echeverria&title=Identification+and+characterization+of+NVP-BEZ235%2C+a+new+orally+available+dual+phosphatidylinositol+3-kinase%2Fmammalian+target+of+rapamycin+inhibitor+with+potent+in+vivo+antitumor+activity&doi=10.1158%2F1535-7163.MCT-08-0017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span></div><div class="casAuthors">Maira, Sauveur-Michel; Stauffer, Frederic; Brueggen, Josef; Furet, Pascal; Schnell, Christian; Fritsch, Christine; Brachmann, Saskia; Chene, Patrick; De Pover, Alain; Schoemaker, Kevin; Fabbro, Doriano; Gabriel, Daniela; Simonen, Marjo; Murphy, Leon; Finan, Peter; Sellers, William; Garcia-Echeverria, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1851-1863</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin inhibitor (mTOR) pathway is often constitutively activated in human tumor cells, providing unique opportunities for anticancer therapeutic intervention.  NVP-BEZ235 is an imidazo[4,5-c]quinoline deriv. that inhibits PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes.  In cellular settings using human tumor cell lines, this mol. is able to effectively and specifically block the dysfunctional activation of the PI3K pathway, inducing G1 arrest.  The cellular activity of NVP-BEZ235 translates well in in vivo models of human cancer.  Thus, the compd. was well tolerated, displayed disease stasis when administered orally, and enhanced the efficacy of other anticancer agents when used in in vivo combination studies.  Ex vivo pharmacokinetic/pharmacodynamic analyses of tumor tissues showed a time-dependent correlation between compd. concn. and PI3K/Akt pathway inhibition.  Collectively, the preclin. data show that NVP-BEZ235 is a potent dual PI3K/mTOR modulator with favorable pharmaceutical properties.  NVP-BEZ235 is currently in phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyO784qv52vrVg90H21EOLACvtfcHk0lhYSiOw35paWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D&md5=5b1979e134dd12065198d86dbc11ce15</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0017%26sid%3Dliteratum%253Aachs%26aulast%3DMaira%26aufirst%3DS.%2BM.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DBrachmann%26aufirst%3DS.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DDe%2BPover%26aufirst%3DA.%26aulast%3DSchoemaker%26aufirst%3DK.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGabriel%26aufirst%3DD.%26aulast%3DSimonen%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520NVP-BEZ235%252C%2520a%2520new%2520orally%2520available%2520dual%2520phosphatidylinositol%25203-kinase%252Fmammalian%2520target%2520of%2520rapamycin%2520inhibitor%2520with%2520potent%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26issue%3D7%26spage%3D1851%26epage%3D1863%26doi%3D10.1158%2F1535-7163.MCT-08-0017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J. J.</span></span> <span> </span><span class="NLM_article-title">Induction of C/EBP homologous protein-mediated apoptosis and autophagy by licochalcone A in non-small cell lung cancer cells</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">26241</span>, <span class="refDoi"> DOI: 10.1038/srep26241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fsrep26241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27184816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28Xot1Gnsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=26241&author=Z.+H.+Tangauthor=X.+Chenauthor=Z.+Y.+Wangauthor=K.+Chaiauthor=Y.+F.+Wangauthor=X.+H.+Xuauthor=X.+W.+Wangauthor=J.+H.+Luauthor=Y.+T.+Wangauthor=X.+P.+Chenauthor=J.+J.+Lu&title=Induction+of+C%2FEBP+homologous+protein-mediated+apoptosis+and+autophagy+by+licochalcone+A+in+non-small+cell+lung+cancer+cells&doi=10.1038%2Fsrep26241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of C/EBP homologous protein-mediated apoptosis and autophagy by licochalcone A in non-small cell lung cancer cells</span></div><div class="casAuthors">Tang, Zheng-Hai; Chen, Xin; Wang, Zhao-Yu; Chai, Ke; Wang, Ya-Fang; Xu, Xiao-Huang; Wang, Xiao-Wen; Lu, Jia-Hong; Wang, Yi-Tao; Chen, Xiu-Ping; Lu, Jin-Jian</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26241</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Licochalcone A (LCA), a flavonoid isolated from the famous Chinese medicinal herb Glycyrrhiza uralensis Fisch, presents obvious anti-cancer effects.  In this study, the anti-cancer effects and potential mechanisms of LCA in non-small cell lung cancer (NSCLC) cells were studied.  LCA decreased cell viability, increased lactate dehydrogenase release, and induced apoptosis in a concn.-dependent manner in NSCLC cells while not in human embryonic lung fibroblast cells.  The expression of phosphatidylethanolamine-modified microtubule-assocd. protein light-chain 3 (LC3-II) and formation of GFP-LC3 punta, two autophagic markers, were increased after treatment with LCA.  LCA-induced LC3-II expression was increased when combined with chloroquine (CQ), while knock-down of autophagy related protein (ATG) 7 or ATG5 reversed LCA-induced LC3-II expression and GFP-LC3 punta formation, suggesting that LCA induced autophagy in NSCLC cells.  Inhibition of autophagy could not reverse the LCA-induced cell viability decrease and apoptosis.  In addn., LCA increased the expression of endoplasmic reticulum stress related proteins, such as binding Ig protein and C/EBP homologous protein (CHOP).  Knock-down of CHOP reversed LCA-induced cell viability decrease, apoptosis, and autophagy.  Taken together, LCA-induced autophagic effect is an accompanied phenomenon in NSCLC cells, and CHOP is crit. for LCA-induced cell viability decrease, apoptosis, and autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc5AMA8-m9D7Vg90H21EOLACvtfcHk0lhYSiOw35paWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xot1Gnsrw%253D&md5=4c971728c4abbc419da2b13a912638da</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1038%2Fsrep26241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep26241%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DZ.%2BH.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DZ.%2BY.%26aulast%3DChai%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.%2BF.%26aulast%3DXu%26aufirst%3DX.%2BH.%26aulast%3DWang%26aufirst%3DX.%2BW.%26aulast%3DLu%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DY.%2BT.%26aulast%3DChen%26aufirst%3DX.%2BP.%26aulast%3DLu%26aufirst%3DJ.%2BJ.%26atitle%3DInduction%2520of%2520C%252FEBP%2520homologous%2520protein-mediated%2520apoptosis%2520and%2520autophagy%2520by%2520licochalcone%2520A%2520in%2520non-small%2520cell%2520lung%2520cancer%2520cells%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D26241%26doi%3D10.1038%2Fsrep26241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundu, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surh, Y. J.</span></span> <span> </span><span class="NLM_article-title">Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">7449</span>– <span class="NLM_lpage">7458</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-1266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1158%2F0008-5472.CAN-09-1266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19738051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFaku7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=7449-7458&issue=18&author=M.+H.+Leeauthor=B.+Y.+Choiauthor=J.+K.+Kunduauthor=Y.+K.+Shinauthor=H.+K.+Naauthor=Y.+J.+Surh&title=Resveratrol+suppresses+growth+of+human+ovarian+cancer+cells+in+culture+and+in+a+murine+xenograft+model%3A+eukaryotic+elongation+factor+1A2+as+a+potential+target&doi=10.1158%2F0008-5472.CAN-09-1266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Resveratrol Suppresses Growth of Human Ovarian Cancer Cells in Culture and in a Murine Xenograft Model: Eukaryotic Elongation Factor 1A2 as a Potential Target</span></div><div class="casAuthors">Lee, Mee-Hyun; Choi, Bu Young; Kundu, Joydeb Kumar; Shin, Young Kee; Na, Hye-Kyung; Surh, Young-Joon</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7449-7458</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The eukaryotic elongation factor 1A2 (eEF1A2) is known to retain oncogenic potential and is recognized as a novel target for cancer prevention and therapy.  Resveratrol (trans-3,4',5-trihydroxystilbene), a phytoalexin present in grapes, has been reported to possess chemopreventive and chemotherapeutic activities.  In the present study, we examd. the growth-inhibitory effects of resveratrol in human ovarian cancer PA-1 cells, considering eEF1A2 as a potential mol. target.  Pretreatment with resveratrol attenuated proliferation of serum-starved PA-1 cells stimulated with insulin or serum.  Resveratrol also activated caspase-9, -7, and -3 and induced apoptosis in PA-1 cells in the presence of insulin or serum.  Insulin or serum stimulation of PA-1 cells resulted in the marked induction of eEF1A2, which was suppressed by pretreatment with resveratrol.  Moreover, resveratrol inhibited insulin- or serum-induced soft-agar colony formation in eEF1A2-transfected NIH3T3 cells.  An antibody array directed to assess the phosphorylation of protein kinases revealed that treatment with insulin or serum induced the phosphorylation of Akt in PA-1 cells.  Pharmacol. inhibition of Akt with LY294002 abrogated insulin- or serum-induced eEF1A2 expression and increased the caspase-3 activity.  In another expt., i.p. administration of resveratrol retarded the growth of PA-1 cell xenograft and the expression of eEF1A2 in athymic nude mice in assocn. with decreased bromodeoxyuridine positivity, reduced expression of proliferating cell nuclear antigen, increased the terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling and caspase-3 staining, and diminished CD31 positivity.  Taken together, eEF1A2 may be considered as a potential mol. target for the antiproliferative effects of resveratrol in PA-1 ovarian cancer cells. [Cancer Res 2009;69(18):7449-58].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonBbArTtNU87Vg90H21EOLACvtfcHk0lhYSiOw35paWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFaku7vE&md5=f252a9896a4a06e2292ac8beb2692bac</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-1266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-1266%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BH.%26aulast%3DChoi%26aufirst%3DB.%2BY.%26aulast%3DKundu%26aufirst%3DJ.%2BK.%26aulast%3DShin%26aufirst%3DY.%2BK.%26aulast%3DNa%26aufirst%3DH.%2BK.%26aulast%3DSurh%26aufirst%3DY.%2BJ.%26atitle%3DResveratrol%2520suppresses%2520growth%2520of%2520human%2520ovarian%2520cancer%2520cells%2520in%2520culture%2520and%2520in%2520a%2520murine%2520xenograft%2520model%253A%2520eukaryotic%2520elongation%2520factor%25201A2%2520as%2520a%2520potential%2520target%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26issue%3D18%26spage%3D7449%26epage%3D7458%26doi%3D10.1158%2F0008-5472.CAN-09-1266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somaiah, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, G.</span></span> <span> </span><span class="NLM_article-title">Antiangiogenic agents in the management of non-small cell lung cancer: where do we stand now and where are we headed?</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.4161/cbt.19594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.4161%2Fcbt.19594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22481432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFOiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=247-263&issue=5&author=C.+Aggarwalauthor=N.+Somaiahauthor=G.+Simon&title=Antiangiogenic+agents+in+the+management+of+non-small+cell+lung+cancer%3A+where+do+we+stand+now+and+where+are+we+headed%3F&doi=10.4161%2Fcbt.19594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Antiangiogenic agents in the management of non-small cell lung cancer: Where do we stand now and where are we headed?</span></div><div class="casAuthors">Aggarwal, Charu; Somaiah, Neeta; Simon, George R.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">247-263</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  Several therapies targeting angiogenesis are currently in development for non-small cell lung cancer (NSCLC).  This review discusses results of recent clin. trials evaluating chemotherapy plus antiangiogenic therapy for NSCLC.  Bevacizumab, an anti-VEGF antibody, is currently approved for the treatment of advanced NSCLC in combination with carboplatin and paclitaxel.  Completed phase III trials evaluating bevacizumab plus chemotherapy have shown prolonged progression-free survival; however, not all trials showed significant improvement in overall survival (OS).  Phase III trials of the tyrosine kinase inhibitors (TKIs) vandetanib and sorafenib and the vascular disrupting agent ASA404 also failed to improve OS compared with chemotherapy alone.  Clin. trials are ongoing involving several new antiangiogenic therapies, including ramucirumab, aflibercept, cediranib, nintedanib (BIBF 1120), sunitinib, pazopanib, brivanib, ABT-869, axitinib, ABT-751 and NPI-2358; several of these agents have shown promising phase I/II results.  Results from recently completed and ongoing phase III trials will det. if these newer antiangiogenic agents will be incorporated into clin. practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf7DKB8kq3hrVg90H21EOLACvtfcHk0lgCiNlXSev31A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFOiurg%253D&md5=3dfaacfa20c4170f4e8845152d2737d3</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.4161%2Fcbt.19594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.19594%26sid%3Dliteratum%253Aachs%26aulast%3DAggarwal%26aufirst%3DC.%26aulast%3DSomaiah%26aufirst%3DN.%26aulast%3DSimon%26aufirst%3DG.%26atitle%3DAntiangiogenic%2520agents%2520in%2520the%2520management%2520of%2520non-small%2520cell%2520lung%2520cancer%253A%2520where%2520do%2520we%2520stand%2520now%2520and%2520where%2520are%2520we%2520headed%253F%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2012%26volume%3D13%26issue%3D5%26spage%3D247%26epage%3D263%26doi%3D10.4161%2Fcbt.19594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anagnostopoulou, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pediaditakis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alkahtani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alarifi, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gravanis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charalampopoulos, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stournaras, C.</span></span> <span> </span><span class="NLM_article-title">Differential effects of dehydroepiandrosterone and testosterone in prostate and colon cancer cell apoptosis: the role of nerve growth factor (NGF) receptors</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>154</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2446</span>– <span class="NLM_lpage">2456</span>, <span class="refDoi"> DOI: 10.1210/en.2012-2249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1210%2Fen.2012-2249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=23696568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVart7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2013&pages=2446-2456&issue=7&author=V.+Anagnostopoulouauthor=I.+Pediaditakisauthor=S.+Alkahtaniauthor=S.+A.+Alarifiauthor=E.+M.+Schmidtauthor=F.+Langauthor=A.+Gravanisauthor=I.+Charalampopoulosauthor=C.+Stournaras&title=Differential+effects+of+dehydroepiandrosterone+and+testosterone+in+prostate+and+colon+cancer+cell+apoptosis%3A+the+role+of+nerve+growth+factor+%28NGF%29+receptors&doi=10.1210%2Fen.2012-2249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects of dehydroepiandrosterone and testosterone in prostate and colon cancer cell apoptosis: the role of nerve growth factor (NGF) receptors</span></div><div class="casAuthors">Anagnostopoulou, Vasilesia; Pediaditakis, Iosif; Alkahtani, Saad; Alarifi, Saud A.; Schmidt, Eva-Maria; Lang, Florian; Gravanis, Achille; Charalampopoulos, Ioannis; Stournaras, Christos</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2446-2456</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Tumor growth is fostered by inhibition of cell death, which involves the receptiveness of tumor to growth factors and hormones.  We have recently shown that testosterone exerts proapoptotic effects in prostate and colon cancer cells through a membrane-initiated mechanism.  In addn., we have recently reported that dehydroepiandrosterone (DHEA) can control cell fate, activating nerve growth factor (NGF) receptors, namely tropomyosin-related kinase (Trk)A and p75 neurotrophin receptor, in primary neurons and in PC12 tumoral cells.  NGF was recently involved in cancer cell proliferation and apoptosis.  In the present study, we explored the cross talk between androgens (testosterone and DHEA) and NGF in regulating apoptosis of prostate and colon cancer cells.  DHEA and NGF strongly blunted serum deprivation-induced apoptosis, whereas testosterone induced apoptosis of both cancer cell lines.  The antiapoptotic effect of both DHEA and NGF was completely reversed by testosterone.  In line with this, DHEA or NGF up-regulated, whereas testosterone down-regulated, the expression of TrkA receptor.  The effects of androgens were abolished in both cell lines in the presence of TrkA inhibitor.  DHEA induced the phosphorylation of TrkA and the interaction of p75 neurotrophin receptor with its effectors, Rho protein GDP dissocn. inhibitor and receptor interacting serine/threonine-protein kinase 2.  Conversely, testosterone was unable to activate both receptors.  Testosterone acted as a DHEA and NGF antagonist, by blocking the activation of both receptors by DHEA or NGF.  Our findings suggest that androgens may influence hormone-sensitive tumor cells via their cross talk with NGF receptors.  The interplay between steroid hormone and neurotrophins signaling in hormone-dependent tumors offers new insights in the pathophysiol. of these neoplasias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW9lWIKhVh6LVg90H21EOLACvtfcHk0lgCiNlXSev31A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVart7bF&md5=3618a632575a0a2fc148a0090a1af6a2</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1210%2Fen.2012-2249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2012-2249%26sid%3Dliteratum%253Aachs%26aulast%3DAnagnostopoulou%26aufirst%3DV.%26aulast%3DPediaditakis%26aufirst%3DI.%26aulast%3DAlkahtani%26aufirst%3DS.%26aulast%3DAlarifi%26aufirst%3DS.%2BA.%26aulast%3DSchmidt%26aufirst%3DE.%2BM.%26aulast%3DLang%26aufirst%3DF.%26aulast%3DGravanis%26aufirst%3DA.%26aulast%3DCharalampopoulos%26aufirst%3DI.%26aulast%3DStournaras%26aufirst%3DC.%26atitle%3DDifferential%2520effects%2520of%2520dehydroepiandrosterone%2520and%2520testosterone%2520in%2520prostate%2520and%2520colon%2520cancer%2520cell%2520apoptosis%253A%2520the%2520role%2520of%2520nerve%2520growth%2520factor%2520%2528NGF%2529%2520receptors%26jtitle%3DEndocrinology%26date%3D2013%26volume%3D154%26issue%3D7%26spage%3D2446%26epage%3D2456%26doi%3D10.1210%2Fen.2012-2249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roh, J. L.</span></span> <span> </span><span class="NLM_article-title">Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">454</span>– <span class="NLM_lpage">462</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2018.10.426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.freeradbiomed.2018.10.426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=30339884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFyrsbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2018&pages=454-462&author=D.+Shinauthor=E.+H.+Kimauthor=J.+Leeauthor=J.+L.+Roh&title=Nrf2+inhibition+reverses+resistance+to+GPX4+inhibitor-induced+ferroptosis+in+head+and+neck+cancer&doi=10.1016%2Fj.freeradbiomed.2018.10.426"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer</span></div><div class="casAuthors">Shin, Daiha; Kim, Eun Hye; Lee, Jaewang; Roh, Jong-Lyel</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">454-462</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glutathione peroxidase 4 (GPX4) is a regulator of ferroptosis (iron-dependent, non-apoptotic cell death); its inhibition can render therapy-resistant cancer cells susceptible to ferroptosis.  However, some cancer cells develop mechanisms protective against ferroptosis; understanding these mechanisms could help overcome chemoresistance.  In this study, we investigated the mol. mechanisms underlying resistance to ferroptosis induced by GPX4 inhibition in head and neck cancer (HNC).  The effects of two GPX4 inhibitors, (1S, 3R)-RSL3 and ML-162, and of trigonelline were tested in HNC cell lines, including cisplatin-resistant (HN3R) and acquired RSL3-resistant (HN3-rslR) cells.  The effects of the inhibitors and trigonelline, as well as of inhibition of the p62, Keap1, or Nrf2 genes, were assessed by cell viability, cell death, lipid ROS prodn., and protein expression, and in mouse tumor xenograft models.  Treatment with RSL3 or ML-162 induced the ferroptosis of HNC cells to varying degrees.  RSL3 or ML-162 treatment increased the expression of p62 and Nrf2 in chemoresistant HN3R and HN3-rslR cells, inactivated Keap1, and increased expression of the phospho-PERK-ATF4-SESN2 pathway.  Transcriptional activation of Nrf2 was assocd. with resistance to ferroptosis.  Overexpression of Nrf2 by inhibiting Keap1 or Nrf2 gene transfection rendered chemosensitive HN3 cells resistant to RSL3.  However, Nrf2 inhibition or p62 silencing sensitized HN3R cells to RSL3.  Trigonelline sensitized chemoresistant HNC cells to RSL3 treatment in a mouse model transplanted with HN3R.  Thus, activation of the Nrf2-ARE pathway contributed to the resistance of HNC cells to GPX4 inhibition, and inhibition of this pathway reversed the resistance to ferroptosis in HNC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCeKPEn4zW57Vg90H21EOLACvtfcHk0lgCiNlXSev31A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFyrsbbL&md5=6f54318c8ae274298ba17898b5b52832</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2018.10.426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2018.10.426%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DE.%2BH.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DRoh%26aufirst%3DJ.%2BL.%26atitle%3DNrf2%2520inhibition%2520reverses%2520resistance%2520to%2520GPX4%2520inhibitor-induced%2520ferroptosis%2520in%2520head%2520and%2520neck%2520cancer%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2018%26volume%3D129%26spage%3D454%26epage%3D462%26doi%3D10.1016%2Fj.freeradbiomed.2018.10.426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis: Death by lipid peroxidation</span>. <i>Trends Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1016/j.tcb.2015.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.tcb.2015.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=26653790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCisbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=165-176&issue=3&author=W.+S.+Yangauthor=B.+R.+Stockwell&title=Ferroptosis%3A+Death+by+lipid+peroxidation&doi=10.1016%2Fj.tcb.2015.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis: Death by Lipid Peroxidation</span></div><div class="casAuthors">Yang, Wan Seok; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">165-176</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ferroptosis is a regulated form of cell death driven by loss of activity of the lipid repair enzyme glutathione peroxidase 4 (GPX4) and subsequent accumulation of lipid-based reactive oxygen species (ROS), particularly lipid hydroperoxides.  This form of iron-dependent cell death is genetically, biochem., and morphol. distinct from other cell death modalities, including apoptosis, unregulated necrosis, and necroptosis.  Ferroptosis is regulated by specific pathways and is involved in diverse biol. contexts.  Here we summarize the discovery of ferroptosis, the mechanism of ferroptosis regulation, and its increasingly appreciated relevance to both normal and pathol. physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs1AaEhcSJa7Vg90H21EOLACvtfcHk0lhT27OSahghXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCisbfK&md5=6b46735835ccc4add329d40713a4b6cd</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2015.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2015.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%2BS.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DFerroptosis%253A%2520Death%2520by%2520lipid%2520peroxidation%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2016%26volume%3D26%26issue%3D3%26spage%3D165%26epage%3D176%26doi%3D10.1016%2Fj.tcb.2015.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dowdle, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyfeler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elling, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triantafellow, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantwell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornella-Taracido, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fekkes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Digan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burdick, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helliwell, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Aquin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastien, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiederschain, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuerth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwalb, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugwonali, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harbinski, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallarico, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myer, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bussiere, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labow, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamann, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valdez, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keaney, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, L. O.</span></span> <span> </span><span class="NLM_article-title">Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1069</span>– <span class="NLM_lpage">1079</span>, <span class="refDoi"> DOI: 10.1038/ncb3053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fncb3053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=25327288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOisrnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=1069-1079&issue=11&author=W.+E.+Dowdleauthor=B.+Nyfelerauthor=J.+Nagelauthor=R.+A.+Ellingauthor=S.+Liuauthor=E.+Triantafellowauthor=S.+Menonauthor=Z.+Wangauthor=A.+Hondaauthor=G.+Pardeeauthor=J.+Cantwellauthor=C.+Luuauthor=I.+Cornella-Taracidoauthor=E.+Harringtonauthor=P.+Fekkesauthor=H.+Leiauthor=Q.+Fangauthor=M.+E.+Diganauthor=D.+Burdickauthor=A.+F.+Powersauthor=S.+B.+Helliwellauthor=S.+D%E2%80%99Aquinauthor=J.+Bastienauthor=H.+Wangauthor=D.+Wiederschainauthor=J.+Kuerthauthor=P.+Bergmanauthor=D.+Schwalbauthor=J.+Thomasauthor=S.+Ugwonaliauthor=F.+Harbinskiauthor=J.+Tallaricoauthor=C.+J.+Wilsonauthor=V.+E.+Myerauthor=J.+A.+Porterauthor=D.+E.+Bussiereauthor=P.+M.+Finanauthor=M.+A.+Labowauthor=X.+Maoauthor=L.+G.+Hamannauthor=B.+D.+Manningauthor=R.+A.+Valdezauthor=T.+Nicholsonauthor=M.+Schirleauthor=M.+S.+Knappauthor=E.+P.+Keaneyauthor=L.+O.+Murphy&title=Selective+VPS34+inhibitor+blocks+autophagy+and+uncovers+a+role+for+NCOA4+in+ferritin+degradation+and+iron+homeostasis+in+vivo&doi=10.1038%2Fncb3053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo</span></div><div class="casAuthors">Dowdle, William E.; Nyfeler, Beat; Nagel, Jane; Elling, Robert A.; Liu, Shanming; Triantafellow, Ellen; Menon, Suchithra; Wang, Zuncai; Honda, Ayako; Pardee, Gwynn; Cantwell, John; Luu, Catherine; Cornella-Taracido, Ivan; Harrington, Edmund; Fekkes, Peter; Lei, Hong; Fang, Qing; Digan, Mary Ellen; Burdick, Debra; Powers, Andrew F.; Helliwell, Stephen B.; D'Aquin, Simon; Bastien, Julie; Wang, Henry; Wiederschain, Dmitri; Kuerth, Jenny; Bergman, Philip; Schwalb, David; Thomas, Jason; Ugwonali, Savuth; Harbinski, Fred; Tallarico, John; Wilson, Christopher J.; Myer, Vic E.; Porter, Jeffery A.; Bussiere, Dirksen E.; Finan, Peter M.; Labow, Mark A.; Mao, Xiaohong; Hamann, Lawrence G.; Manning, Brendan D.; Valdez, Reginald A.; Nicholson, Thomas; Schirle, Markus; Knapp, Mark S.; Keaney, Erin P.; Murphy, Leon O.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1069-1079</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cells rely on autophagy to clear misfolded proteins and damaged organelles to maintain cellular homeostasis.  In this study we use the new autophagy inhibitor PIK-III to screen for autophagy substrates.  PIK-III is a selective inhibitor of VPS34 that binds a unique hydrophobic pocket not present in related kinases such as PI(3)Kα.  PIK-III acutely inhibits autophagy and de novo lipidation of LC3, and leads to the stabilization of autophagy substrates.  By performing ubiquitin-affinity proteomics on PIK-III-treated cells we identified substrates including NCOA4, which accumulates in ATG7-deficient cells and co-localizes with autolysosomes.  NCOA4 directly binds ferritin heavy chain-1 (FTH1) to target the iron-binding ferritin complex with a relative mol. mass of 450,000 to autolysosomes following starvation or iron depletion.  Interestingly, Ncoa4-/- mice exhibit a profound accumulation of iron in splenic macrophages, which are crit. for the reutilization of iron from engulfed red blood cells.  Taken together, the results of this study provide a new mechanism for selective autophagy of ferritin and reveal a previously unappreciated role for autophagy and NCOA4 in the control of iron homeostasis in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRcQWjov109LVg90H21EOLACvtfcHk0lhT27OSahghXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOisrnE&md5=cca365c06b5342dafb9314a98cb698c4</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1038%2Fncb3053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb3053%26sid%3Dliteratum%253Aachs%26aulast%3DDowdle%26aufirst%3DW.%2BE.%26aulast%3DNyfeler%26aufirst%3DB.%26aulast%3DNagel%26aufirst%3DJ.%26aulast%3DElling%26aufirst%3DR.%2BA.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DTriantafellow%26aufirst%3DE.%26aulast%3DMenon%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DHonda%26aufirst%3DA.%26aulast%3DPardee%26aufirst%3DG.%26aulast%3DCantwell%26aufirst%3DJ.%26aulast%3DLuu%26aufirst%3DC.%26aulast%3DCornella-Taracido%26aufirst%3DI.%26aulast%3DHarrington%26aufirst%3DE.%26aulast%3DFekkes%26aufirst%3DP.%26aulast%3DLei%26aufirst%3DH.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DDigan%26aufirst%3DM.%2BE.%26aulast%3DBurdick%26aufirst%3DD.%26aulast%3DPowers%26aufirst%3DA.%2BF.%26aulast%3DHelliwell%26aufirst%3DS.%2BB.%26aulast%3DD%25E2%2580%2599Aquin%26aufirst%3DS.%26aulast%3DBastien%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWiederschain%26aufirst%3DD.%26aulast%3DKuerth%26aufirst%3DJ.%26aulast%3DBergman%26aufirst%3DP.%26aulast%3DSchwalb%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DJ.%26aulast%3DUgwonali%26aufirst%3DS.%26aulast%3DHarbinski%26aufirst%3DF.%26aulast%3DTallarico%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DC.%2BJ.%26aulast%3DMyer%26aufirst%3DV.%2BE.%26aulast%3DPorter%26aufirst%3DJ.%2BA.%26aulast%3DBussiere%26aufirst%3DD.%2BE.%26aulast%3DFinan%26aufirst%3DP.%2BM.%26aulast%3DLabow%26aufirst%3DM.%2BA.%26aulast%3DMao%26aufirst%3DX.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26aulast%3DManning%26aufirst%3DB.%2BD.%26aulast%3DValdez%26aufirst%3DR.%2BA.%26aulast%3DNicholson%26aufirst%3DT.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DKnapp%26aufirst%3DM.%2BS.%26aulast%3DKeaney%26aufirst%3DE.%2BP.%26aulast%3DMurphy%26aufirst%3DL.%2BO.%26atitle%3DSelective%2520VPS34%2520inhibitor%2520blocks%2520autophagy%2520and%2520uncovers%2520a%2520role%2520for%2520NCOA4%2520in%2520ferritin%2520degradation%2520and%2520iron%2520homeostasis%2520in%2520vivo%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2014%26volume%3D16%26issue%3D11%26spage%3D1069%26epage%3D1079%26doi%3D10.1038%2Fncb3053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Honda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornella-Taracido, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triantafellow, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowdle, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiedershain, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maniara, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamann, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keaney, E. P.</span></span> <span> </span><span class="NLM_article-title">Potent, selective, and orally bioavailable inhibitors of VPS34 provide chemical tools to modulate autophagy in vivo</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00335</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00335" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVaht7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=72-76&issue=1&author=A.+Hondaauthor=E.+Harringtonauthor=I.+Cornella-Taracidoauthor=P.+Furetauthor=M.+S.+Knappauthor=M.+Glickauthor=E.+Triantafellowauthor=W.+E.+Dowdleauthor=D.+Wiedershainauthor=W.+Maniaraauthor=C.+Mooreauthor=P.+M.+Finanauthor=L.+G.+Hamannauthor=B.+Firestoneauthor=L.+O.+Murphyauthor=E.+P.+Keaney&title=Potent%2C+selective%2C+and+orally+bioavailable+inhibitors+of+VPS34+provide+chemical+tools+to+modulate+autophagy+in+vivo&doi=10.1021%2Facsmedchemlett.5b00335"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">Potent, Selective, and Orally Bioavailable Inhibitors of VPS34 Provide Chemical Tools to Modulate Autophagy in Vivo</span></div><div class="casAuthors">Honda, Ayako; Harrington, Edmund; Cornella-Taracido, Ivan; Furet, Pascal; Knapp, Mark S.; Glick, Meir; Triantafellow, Ellen; Dowdle, William E.; Wiedershain, Dmitri; Maniara, Wieslawa; Moore, Christine; Finan, Peter M.; Hamann, Lawrence G.; Firestone, Brant; Murphy, Leon O.; Keaney, Erin P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-76</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Autophagy is a dynamic process that regulates lysosomal-dependent degrdn. of cellular components.  Until recently the study of autophagy has been hampered by the lack of reliable pharmacol. tools, but selective inhibitors are now available to modulate the PI 3-kinase VPS34, which is required for autophagy.  Here the authors describe the discovery of potent and selective VPS34 inhibitors, e.g. I, their pharmacokinetic (PK) properties, and ability to inhibit autophagy in cellular and mouse models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfNB0Fz4jh9rVg90H21EOLACvtfcHk0ljIHSLd-42YiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVaht7fF&md5=31ed3d118c705dfcf7ae94391c2f5701</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00335%26sid%3Dliteratum%253Aachs%26aulast%3DHonda%26aufirst%3DA.%26aulast%3DHarrington%26aufirst%3DE.%26aulast%3DCornella-Taracido%26aufirst%3DI.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DKnapp%26aufirst%3DM.%2BS.%26aulast%3DGlick%26aufirst%3DM.%26aulast%3DTriantafellow%26aufirst%3DE.%26aulast%3DDowdle%26aufirst%3DW.%2BE.%26aulast%3DWiedershain%26aufirst%3DD.%26aulast%3DManiara%26aufirst%3DW.%26aulast%3DMoore%26aufirst%3DC.%26aulast%3DFinan%26aufirst%3DP.%2BM.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DMurphy%26aufirst%3DL.%2BO.%26aulast%3DKeaney%26aufirst%3DE.%2BP.%26atitle%3DPotent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitors%2520of%2520VPS34%2520provide%2520chemical%2520tools%2520to%2520modulate%2520autophagy%2520in%2520vivo%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26issue%3D1%26spage%3D72%26epage%3D76%26doi%3D10.1021%2Facsmedchemlett.5b00335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robke, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laraia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carnero
Corrales, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konstantinidis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muroi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richters, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engbring, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomassi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J.</span></span> <span> </span><span class="NLM_article-title">Phenotypic identification of a novel autophagy inhibitor chemotype targeting lipid kinase VPS34</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">28</span>),  <span class="NLM_fpage">8153</span>– <span class="NLM_lpage">8157</span>, <span class="refDoi"> DOI: 10.1002/anie.201703738</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1002%2Fanie.201703738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2sXps1eht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=8153-8157&issue=28&author=L.+Robkeauthor=L.+Laraiaauthor=M.+A.+Carnero%0ACorralesauthor=G.+Konstantinidisauthor=M.+Muroiauthor=A.+Richtersauthor=M.+Winzkerauthor=T.+Engbringauthor=S.+Tomassiauthor=N.+Watanabeauthor=H.+Osadaauthor=D.+Rauhauthor=H.+Waldmannauthor=Y.+W.+Wuauthor=J.+Engel&title=Phenotypic+identification+of+a+novel+autophagy+inhibitor+chemotype+targeting+lipid+kinase+VPS34&doi=10.1002%2Fanie.201703738"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Phenotypic Identification of a Novel Autophagy Inhibitor Chemotype Targeting Lipid Kinase VPS34</span></div><div class="casAuthors">Robke, Lucas; Laraia, Luca; Carnero Corrales, Marjorie A.; Konstantinidis, Georgios; Muroi, Makoto; Richters, Andre; Winzker, Michael; Engbring, Tobias; Tomassi, Stefano; Watanabe, Nobumoto; Osada, Hiroyuki; Rauh, Daniel; Waldmann, Herbert; Wu, Yao-Wen; Engel, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">8153-8157</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Autophagy is a crit. regulator of cellular homeostasis and metab.  Interference with this process is considered a new approach for the treatment of disease, in particular cancer and neurol. disorders.  Therefore, novel small-mol. autophagy modulators are in high demand.  We describe the discovery of autophinib, a potent autophagy inhibitor with a novel chemotype.  Autophinib was identified by means of a phenotypic assay monitoring the formation of autophagy-induced puncta, indicating accumulation of the lipidated cytosolic protein LC3 on the autophagosomal membrane.  Target identification and validation revealed that autophinib inhibits autophagy induced by starvation or rapamycin by targeting the lipid kinase VPS34.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY54SF9Lnw9LVg90H21EOLACvtfcHk0ljIHSLd-42YiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXps1eht78%253D&md5=408a6a3ac7717b58b97a43a195979846</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1002%2Fanie.201703738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201703738%26sid%3Dliteratum%253Aachs%26aulast%3DRobke%26aufirst%3DL.%26aulast%3DLaraia%26aufirst%3DL.%26aulast%3DCarnero%2BCorrales%26aufirst%3DM.%2BA.%26aulast%3DKonstantinidis%26aufirst%3DG.%26aulast%3DMuroi%26aufirst%3DM.%26aulast%3DRichters%26aufirst%3DA.%26aulast%3DWinzker%26aufirst%3DM.%26aulast%3DEngbring%26aufirst%3DT.%26aulast%3DTomassi%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DN.%26aulast%3DOsada%26aufirst%3DH.%26aulast%3DRauh%26aufirst%3DD.%26aulast%3DWaldmann%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%2BW.%26aulast%3DEngel%26aufirst%3DJ.%26atitle%3DPhenotypic%2520identification%2520of%2520a%2520novel%2520autophagy%2520inhibitor%2520chemotype%2520targeting%2520lipid%2520kinase%2520VPS34%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26issue%3D28%26spage%3D8153%26epage%3D8157%26doi%3D10.1002%2Fanie.201703738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alton, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kath, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lingardo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span> <span> </span><span class="NLM_article-title">Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1)</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>431</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1042/BJ20101024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1042%2FBJ20101024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20704563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1ahu7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=431&publication_year=2010&pages=245-255&issue=2&author=L.+R.+Pearceauthor=G.+R.+Altonauthor=D.+T.+Richterauthor=J.+C.+Kathauthor=L.+Lingardoauthor=J.+Chapmanauthor=C.+Hwangauthor=D.+R.+Alessi&title=Characterization+of+PF-4708671%2C+a+novel+and+highly+specific+inhibitor+of+p70+ribosomal+S6+kinase+%28S6K1%29&doi=10.1042%2FBJ20101024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1)</span></div><div class="casAuthors">Pearce, Laura R.; Alton, Gordon R.; Richter, Daniel T.; Kath, John C.; Lingardo, Laura; Chapman, Justin; Hwang, Catherine; Alessi, Dario R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">431</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">245-255</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">S6K1 (p70 ribosomal S6 kinase 1) is activated by insulin and growth factors via the PI3K (phosphoinositide 3-kinase) and mTOR (mammalian target of rapamycin) signaling pathways.  S6K1 regulates numerous processes, such as protein synthesis, growth, proliferation and longevity, and its inhibition has been proposed as a strategy for the treatment of cancer and insulin resistance.  In the present paper we describe a novel cell-permeable inhibitor of S6K1, PF-4708671, which specifically inhibits the S6K1 isoform with a Ki of 20 nM and IC50 of 160 nM.  PF-4708671 prevents the S6K1-mediated phosphorylation of S6 protein in response to IGF-1 (insulin-like growth factor 1), while having no effect upon the PMA-induced phosphorylation of substrates of the highly related RSK (p90 ribosomal S6 kinase) and MSK (mitogen- and stress-activated kinase) kinases.  PF-4708671 was also found to induce phosphorylation of the T-loop and hydrophobic motif of S6K1, an effect that is dependent upon mTORC1 (mTOR complex 1).  PF-4708671 is the first S6K1-specific inhibitor to be reported and will be a useful tool for delineating S6K1-specific roles downstream of mTOR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcvyQDLNhsbbVg90H21EOLACvtfcHk0lhIOEV8Kgx-jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1ahu7rO&md5=50e4ca5dbe19b903836c1099c3b58e38</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1042%2FBJ20101024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20101024%26sid%3Dliteratum%253Aachs%26aulast%3DPearce%26aufirst%3DL.%2BR.%26aulast%3DAlton%26aufirst%3DG.%2BR.%26aulast%3DRichter%26aufirst%3DD.%2BT.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DLingardo%26aufirst%3DL.%26aulast%3DChapman%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DC.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DCharacterization%2520of%2520PF-4708671%252C%2520a%2520novel%2520and%2520highly%2520specific%2520inhibitor%2520of%2520p70%2520ribosomal%2520S6%2520kinase%2520%2528S6K1%2529%26jtitle%3DBiochem.%2520J.%26date%3D2010%26volume%3D431%26issue%3D2%26spage%3D245%26epage%3D255%26doi%3D10.1042%2FBJ20101024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marabita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baraldo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solagna, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceelen, J. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartori, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolte, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemazanyy, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyronnet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pende, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaauw, B.</span></span> <span> </span><span class="NLM_article-title">S6K1 is required for increasing skeletal muscle force during hypertrophy</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">501</span>– <span class="NLM_lpage">513</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2016.09.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.celrep.2016.09.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27705797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1aksb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=501-513&issue=2&author=M.+Marabitaauthor=M.+Baraldoauthor=F.+Solagnaauthor=J.+J.+M.+Ceelenauthor=R.+Sartoriauthor=H.+Nolteauthor=I.+Nemazanyyauthor=S.+Pyronnetauthor=M.+Krugerauthor=M.+Pendeauthor=B.+Blaauw&title=S6K1+is+required+for+increasing+skeletal+muscle+force+during+hypertrophy&doi=10.1016%2Fj.celrep.2016.09.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">S6K1 Is Required for Increasing Skeletal Muscle Force during Hypertrophy</span></div><div class="casAuthors">Marabita, Manuela; Baraldo, Martina; Solagna, Francesca; Ceelen, Judith Johanna Maria; Sartori, Roberta; Nolte, Hendrik; Nemazanyy, Ivan; Pyronnet, Stephane; Kruger, Marcus; Pende, Mario; Blaauw, Bert</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">501-513</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Loss of skeletal muscle mass and force aggravates age-related sarcopenia and numerous pathologies, such as cancer and diabetes.  The AKT-mTORC1 pathway plays a major role in stimulating adult muscle growth; however, the functional role of its downstream mediators in vivo is unknown.  Here, we show that simultaneous inhibition of mTOR signaling to both S6K1 and 4E-BP1 is sufficient to reduce AKT-induced muscle growth and render it insensitive to the mTORC1-inhibitor rapamycin.  Surprisingly, lack of mTOR signaling to 4E-BP1 only, or deletion of S6K1 alone, is not sufficient to reduce muscle hypertrophy or alter its sensitivity to rapamycin.  However, we report that, while not required for muscle growth, S6K1 is essential for maintaining muscle structure and force prodn.  Hypertrophy in the absence of S6K1 is characterized by compromised ribosome biogenesis and the formation of p62-pos. protein aggregates.  These findings identify S6K1 as a crucial player for maintaining muscle function during hypertrophy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohIRcc-lA1k7Vg90H21EOLACvtfcHk0lhIOEV8Kgx-jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1aksb7K&md5=07d45431eec5b605d0ab0e8a5d5bc51c</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2016.09.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2016.09.020%26sid%3Dliteratum%253Aachs%26aulast%3DMarabita%26aufirst%3DM.%26aulast%3DBaraldo%26aufirst%3DM.%26aulast%3DSolagna%26aufirst%3DF.%26aulast%3DCeelen%26aufirst%3DJ.%2BJ.%2BM.%26aulast%3DSartori%26aufirst%3DR.%26aulast%3DNolte%26aufirst%3DH.%26aulast%3DNemazanyy%26aufirst%3DI.%26aulast%3DPyronnet%26aufirst%3DS.%26aulast%3DKruger%26aufirst%3DM.%26aulast%3DPende%26aufirst%3DM.%26aulast%3DBlaauw%26aufirst%3DB.%26atitle%3DS6K1%2520is%2520required%2520for%2520increasing%2520skeletal%2520muscle%2520force%2520during%2520hypertrophy%26jtitle%3DCell%2520Rep.%26date%3D2016%26volume%3D17%26issue%3D2%26spage%3D501%26epage%3D513%26doi%3D10.1016%2Fj.celrep.2016.09.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perisic, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R. L.</span></span> <span> </span><span class="NLM_article-title">Finding a fitting shoe for Cinderella: searching for an autophagy inhibitor</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">805</span>– <span class="NLM_lpage">807</span>, <span class="refDoi"> DOI: 10.4161/auto.6.6.12577</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.4161%2Fauto.6.6.12577" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20574157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BC3cjkslersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=805-807&issue=6&author=S.+Millerauthor=A.+Oleksyauthor=O.+Perisicauthor=R.+L.+Williams&title=Finding+a+fitting+shoe+for+Cinderella%3A+searching+for+an+autophagy+inhibitor&doi=10.4161%2Fauto.6.6.12577"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Finding a fitting shoe for Cinderella: searching for an autophagy inhibitor</span></div><div class="casAuthors">Miller Simon; Oleksy Arkadiusz; Perisic Olga; Williams Roger L</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">805-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Vps34 is the ancestral phosphatidylinositol 3-kinase (PtdIns3K) isoform and is essential for endosomal trafficking of proteins to the vacuole/lysosome, autophagy and phagocytosis.  Vps34-containing complexes associate with specific cellular compartments to produce PtdIns(3)P.  Understanding the roles of Vps34 has been hampered by the lack of potent, specific inhibitors.  To boost development of Vps34 inhibitors, we determined the crystal structures of Vps34 alone and in complexes with multitargeted PtdIns3K inhibitors.  These structures provided a first glimpse into the uniquely constricted ATP-binding site of Vps34 and enabled us to model Vps34 regulation.  We showed that the substrate-binding "activation" loop and the flexibly attached amphipathic C-terminal helix are crucial for catalysis on membranes.  The C-terminal helix also suppresses ATP hydrolysis in the absence of membranes.  We propose that membrane binding shifts the C-terminal helix to orient the enzyme for catalysis, and the Vps15 regulatory subunit, which binds to this and the preceding helix, may facilitate this process.  This C-terminal region may also represent a target for specific, non-ATP-competitive PtdIns3K inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRCfWmsTtK3tx0LsK7uFuY7fW6udTcc2ebUlk_srPNxQ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjkslersw%253D%253D&md5=89ff222fe46103f0bcff0e4092dc5538</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.4161%2Fauto.6.6.12577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.6.6.12577%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DOleksy%26aufirst%3DA.%26aulast%3DPerisic%26aufirst%3DO.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26atitle%3DFinding%2520a%2520fitting%2520shoe%2520for%2520Cinderella%253A%2520searching%2520for%2520an%2520autophagy%2520inhibitor%26jtitle%3DAutophagy%26date%3D2010%26volume%3D6%26issue%3D6%26spage%3D805%26epage%3D807%26doi%3D10.4161%2Fauto.6.6.12577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morishita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayakawa, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwase, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naoe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiyoi, H.</span></span> <span> </span><span class="NLM_article-title">The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinib</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">35</span>),  <span class="NLM_fpage">56241</span>– <span class="NLM_lpage">56252</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.11025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.18632%2Foncotarget.11025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27494842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BC2s3otVeiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=56241-56252&issue=35&author=T.+Morishitaauthor=F.+Hayakawaauthor=K.+Sugimotoauthor=M.+Iwaseauthor=H.+Yamamotoauthor=D.+Hiranoauthor=Y.+Kojimaauthor=N.+Imotoauthor=T.+Naoeauthor=H.+Kiyoi&title=The+photosensitizer+verteporfin+has+light-independent+anti-leukemic+activity+for+Ph-positive+acute+lymphoblastic+leukemia+and+synergistically+works+with+dasatinib&doi=10.18632%2Foncotarget.11025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinib</span></div><div class="casAuthors">Morishita Takanobu; Hayakawa Fumihiko; Yamamoto Hideyuki; Hirano Daiki; Kojima Yuki; Imoto Naoto; Kiyoi Hitoshi; Sugimoto Keiki; Iwase Mizuho; Naoe Tomoki</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">56241-56252</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cell lines have been used for drug discovery as useful models of cancers; however, they do not recapitulate cancers faithfully, particularly from the viewpoints of microenvironmental independence.  Patient-derived xenografts (PDX) are established by the transfer of primary tumor cells directly from patients into immunodeficient mice and can provide primary-like tumor cells of the amount needed at the desired time.  We developed a high-throughput drug screening system using PDX cells and performed drug screening using the PDX cells of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).  We established four Ph+ ALL PDX mice and performed high-throughput screening of 3440 compounds using leukemia cells from the PDX mice (PDX-cell screening).  The profiles of drugs selected by PDX-cell screening were markedly different from those by screening using the Ph+ ALL cell line.  We found that verteporfin, an FDA-approved drug, exhibited strong PDX cell-specific cytotoxicity.  In the validation assay, its GI50 was 228 nM, 395 nM, and 538 nM in three PDX cells and 3.93 μM, 2.11 μM, and 5.61 μM in three cell lines.  Although verteporfin is a photosensitizer activated by photoirradiation, its cytotoxic effects were mediated by the light-independent production of reactive oxygen species; therefore, its anti-leukemic effects were also exerted in vivo without photoirradiation.  Furthermore, it exhibited synergistic effects with dasatinib, an ABL kinase inhibitor.  These results indicated the potential of verteporfin as a new anti-leukemic reagent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRjLbpvJwtLh3T4ugvCDgnZfW6udTcc2ea5Z4sc3xAKubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3otVeiuw%253D%253D&md5=c4e63cfed5f285b35da2b2edd9aa35c0</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.11025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.11025%26sid%3Dliteratum%253Aachs%26aulast%3DMorishita%26aufirst%3DT.%26aulast%3DHayakawa%26aufirst%3DF.%26aulast%3DSugimoto%26aufirst%3DK.%26aulast%3DIwase%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DHirano%26aufirst%3DD.%26aulast%3DKojima%26aufirst%3DY.%26aulast%3DImoto%26aufirst%3DN.%26aulast%3DNaoe%26aufirst%3DT.%26aulast%3DKiyoi%26aufirst%3DH.%26atitle%3DThe%2520photosensitizer%2520verteporfin%2520has%2520light-independent%2520anti-leukemic%2520activity%2520for%2520Ph-positive%2520acute%2520lymphoblastic%2520leukemia%2520and%2520synergistically%2520works%2520with%2520dasatinib%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26issue%3D35%26spage%3D56241%26epage%3D56252%26doi%3D10.18632%2Foncotarget.11025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doh-Ura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caughey, B.</span></span> <span> </span><span class="NLM_article-title">Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation</span>. <i>Journal of virology</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>74</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">4894</span>– <span class="NLM_lpage">4897</span>, <span class="refDoi"> DOI: 10.1128/JVI.74.10.4894-4897.2000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1128%2FJVI.74.10.4894-4897.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10775631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD3cXivFynsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=4894-4897&issue=10&author=K.+Doh-Uraauthor=T.+Iwakiauthor=B.+Caughey&title=Lysosomotropic+agents+and+cysteine+protease+inhibitors+inhibit+scrapie-associated+prion+protein+accumulation&doi=10.1128%2FJVI.74.10.4894-4897.2000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation</span></div><div class="casAuthors">Doh-Ura, Katsumi; Iwaki, Toru; Caughey, Byron</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4894-4897</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We report that lysosomotropic agents and cysteine protease inhibitors inhibited protease-resistant prion protein accumulation in scrapie-infected neuroblastoma cells.  The inhibition occurred without either apparent effects on normal prion protein biosynthesis or turnover or direct interactions with prion protein mols.  The findings introduce two new classes of inhibitors of the formation of protease-resistant prion protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3tW6UfovyjrVg90H21EOLACvtfcHk0ljGtiz4SRhuEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXivFynsLw%253D&md5=5878062596dd2f20f0deb17e905de4af</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1128%2FJVI.74.10.4894-4897.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.74.10.4894-4897.2000%26sid%3Dliteratum%253Aachs%26aulast%3DDoh-Ura%26aufirst%3DK.%26aulast%3DIwaki%26aufirst%3DT.%26aulast%3DCaughey%26aufirst%3DB.%26atitle%3DLysosomotropic%2520agents%2520and%2520cysteine%2520protease%2520inhibitors%2520inhibit%2520scrapie-associated%2520prion%2520protein%2520accumulation%26jtitle%3DJournal%2520of%2520virology%26date%3D2000%26volume%3D74%26issue%3D10%26spage%3D4894%26epage%3D4897%26doi%3D10.1128%2FJVI.74.10.4894-4897.2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref208"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref208'); return false;" data-citation="" class="refNumLink">208</a></strong><div class="NLM_citation" id="cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roh, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, K. C.</span></span> <span> </span><span class="NLM_article-title">Compound C independent of AMPK inhibits ICAM-1 and VCAM-1 expression in inflammatory stimulants-activated endothelial cells in vitro and in vivo</span>. <i>Atherosclerosis</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>219</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1016/j.atherosclerosis.2011.06.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.atherosclerosis.2011.06.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21764059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtl2ku7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=219&publication_year=2011&pages=57-64&issue=1&author=Y.+M.+Kimauthor=M.+Y.+Kimauthor=H.+J.+Kimauthor=G.+S.+Rohauthor=G.+H.+Koauthor=H.+G.+Seoauthor=J.+H.+Leeauthor=K.+C.+Chang&title=Compound+C+independent+of+AMPK+inhibits+ICAM-1+and+VCAM-1+expression+in+inflammatory+stimulants-activated+endothelial+cells+in+vitro+and+in+vivo&doi=10.1016%2Fj.atherosclerosis.2011.06.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Compound C independent of AMPK inhibits ICAM-1 and VCAM-1 expression in inflammatory stimulants-activated endothelial cells in vitro and in vivo</span></div><div class="casAuthors">Kim, Young Min; Kim, Min Young; Kim, Hye Jung; Roh, Gu Seob; Ko, Gyung Hyuck; Seo, Han Geuk; Lee, Jae Heun; Chang, Ki Churl</div><div class="citationInfo"><span class="NLM_cas:title">Atherosclerosis (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">219</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-64</span>CODEN:
                <span class="NLM_cas:coden">ATHSBL</span>;
        ISSN:<span class="NLM_cas:issn">0021-9150</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Activation of the NF-κB and mitogen activated protein (MAP) kinases plays an important role in the expression of inflammatory genes such as adhesion mols.  Although compd. C is known as an AMPK inhibitor, AMPK-independent action of it has been recognized.  Effects on the expression of ICAM-1 and VCAM-1 by compd. C were investigated in TNF-α-activated human umbilical vein endothelial cells (HUVECs) in vitro and in thoracic aorta of rats treated with lipopolysaccharide (LPS) in vivo.  Compd. C inhibited ICAM-1 and VCAM-1 expression at the transcriptional as well as translational level in TNF-α-activated HUVECs.  In both DN-AMPK- and AMPKα1-siRNA-transfected HUVECs, compd. C still inhibited TNF-α-induced VCAM-1 and ICAM-1 expression, indicating that this is AMPK-independent action.  Interestingly, compd. C significantly inhibited NF-κB activity and translocation of p65 to nucleus in HUVECs when activated with TNF-α.  Importantly, administration of compd. C (0.2 mg/kg) significantly reduced expression of both ICAM-1 and VCAM-1 in LPS-treated rat thoracic aortas.  In addn., compd. C significantly inhibited iNOS and prodn. of NO in both TNF-α- and LPS-activated RAW 264.7 cells.  Finally, compd. C significantly inhibited phosphorylation of Akt and p-38MAPK but not protein kinase c or ERK1/2 in HUVECs.  Taken together, we conclude that adhesion mols. (ICAM-1, VCAM-1) are to be the novel targets of compd. C in preventing inflammatory insult to endothelial cells independent of AMPK inhibition via inhibition of NF-κB activity along with inhibition of phosphorylation of PI3K and P38 MAPK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDVp8CMQ_6lLVg90H21EOLACvtfcHk0ljGtiz4SRhuEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtl2ku7vJ&md5=5f20177e9826434fba85a3909b340796</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1016%2Fj.atherosclerosis.2011.06.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.atherosclerosis.2011.06.043%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%2BM.%26aulast%3DKim%26aufirst%3DM.%2BY.%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DRoh%26aufirst%3DG.%2BS.%26aulast%3DKo%26aufirst%3DG.%2BH.%26aulast%3DSeo%26aufirst%3DH.%2BG.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DChang%26aufirst%3DK.%2BC.%26atitle%3DCompound%2520C%2520independent%2520of%2520AMPK%2520inhibits%2520ICAM-1%2520and%2520VCAM-1%2520expression%2520in%2520inflammatory%2520stimulants-activated%2520endothelial%2520cells%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DAtherosclerosis%26date%3D2011%26volume%3D219%26issue%3D1%26spage%3D57%26epage%3D64%26doi%3D10.1016%2Fj.atherosclerosis.2011.06.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref209"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref209'); return false;" data-citation="" class="refNumLink">209</a></strong><div class="NLM_citation" id="cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider-Poetsch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eyler, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrick, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. O.</span></span> <span> </span><span class="NLM_article-title">Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1038/nchembio.304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fnchembio.304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20118940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1ygu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=209-217&issue=3&author=T.+Schneider-Poetschauthor=J.+Juauthor=D.+E.+Eylerauthor=Y.+Dangauthor=S.+Bhatauthor=W.+C.+Merrickauthor=R.+Greenauthor=B.+Shenauthor=J.+O.+Liu&title=Inhibition+of+eukaryotic+translation+elongation+by+cycloheximide+and+lactimidomycin&doi=10.1038%2Fnchembio.304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit209R"><div class="casContent"><span class="casTitleNuber">209</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin</span></div><div class="casAuthors">Schneider-Poetsch, Tilman; Ju, Jianhua; Eyler, Daniel E.; Dang, Yongjun; Bhat, Shridhar; Merrick, William C.; Green, Rachel; Shen, Ben; Liu, Jun O.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">209-217</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although the protein synthesis inhibitor cycloheximide (CHX) has been known for decades, its precise mechanism of action remains incompletely understood.  The glutarimide portion of CHX is seen in a family of structurally related natural products including migrastatin, isomigrastatin, and lactimidomycin (LTM).  We found that LTM, isomigrastatin, and analogs have a potent antiproliferative effect on tumor cell lines and selectively inhibit translation.  A systematic comparative study of the effects of CHX and LTM on protein synthesis revealed both similarities and differences between the two inhibitors.  Both LTM and CHX were found to block the translocation step in elongation.  Footprinting expts. revealed protection of a single cytidine nucleotide (C3993) in the E-site of the 60S ribosomal subunit, thus defining a common binding pocket for the two inhibitors in the ribosome.  These results shed new light on the mol. mechanism of inhibition of translation elongation by both CHX and LTM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsVhn_TkyD-LVg90H21EOLACvtfcHk0lhjFUQqXNDYNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1ygu7w%253D&md5=77e621c87b496cd697f77299623b9f06</span></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.304%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider-Poetsch%26aufirst%3DT.%26aulast%3DJu%26aufirst%3DJ.%26aulast%3DEyler%26aufirst%3DD.%2BE.%26aulast%3DDang%26aufirst%3DY.%26aulast%3DBhat%26aufirst%3DS.%26aulast%3DMerrick%26aufirst%3DW.%2BC.%26aulast%3DGreen%26aufirst%3DR.%26aulast%3DShen%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DJ.%2BO.%26atitle%3DInhibition%2520of%2520eukaryotic%2520translation%2520elongation%2520by%2520cycloheximide%2520and%2520lactimidomycin%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26issue%3D3%26spage%3D209%26epage%3D217%26doi%3D10.1038%2Fnchembio.304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref210"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref210'); return false;" data-citation="" class="refNumLink">210</a></strong><div class="NLM_citation" id="cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Q.</span></span> <span> </span><span class="NLM_article-title">The cytochrome P450 inhibitor SKF-525A disrupts autophagy in primary rat hepatocytes</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>255</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1016/j.cbi.2016.03.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.cbi.2016.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=26964495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28XktFKhtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=2016&pages=55-62&author=Y.+Luoauthor=X.+Yangauthor=Q.+Shi&title=The+cytochrome+P450+inhibitor+SKF-525A+disrupts+autophagy+in+primary+rat+hepatocytes&doi=10.1016%2Fj.cbi.2016.03.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">The cytochrome P450 inhibitor SKF-525A disrupts autophagy in primary rat hepatocytes</span></div><div class="casAuthors">Luo, Yong; Yang, Xi; Shi, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">255</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">55-62</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">The cytochrome P 450 (CYP) inhibitor SKF-525A is commonly used to study drug metab. and toxicity, particularly hepatotoxicity.  By using Western blot and immunofluorescence staining, we unexpectedly found that SKF-525A at 2-20 μM caused remarkable accumulation of microtubule-assocd. protein light chain 3 II (LC3-II) in primary rat hepatocytes at 1, 4 and 24 h, indicating that autophagy was disrupted.  SKF-525A showed no effects on chloroquine induced LC3-II accumulation, suggesting that autophagic flux was blocked, which is further supported by the increased level of the p62 protein after SKF-525A treatment.  SKF-525A did not affect proteasome activities or gene expression of LC3-II or p62.  Immunofluorescence of green fluorescent protein fused lysosomal-assocd. membrane protein 1 (LAMP1, a specific protein marker for lysosomes) and LC3-II showed that co-localization of these two proteins was partially abolished by SKF-525A, indicating that autophagosome-lysosome fusion was blocked.  The other five CYP inhibitors, metyrapone, 1-aminobenzotriazole, alpha-naphthoflavone, ticlopidine, and ketoconazole, showed no effects in parallel expts.  These findings provide novel insights into the mechanisms by which various CYP inhibitors differentially affect a same drug's toxicity in hepatocytes.  The data also indicate that SKF-525A is not an ideal chem. inhibitor for probing the relation between CYP mediated metab. and toxicity in primary hepatocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn07o4W22s1bVg90H21EOLACvtfcHk0lhjFUQqXNDYNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktFKhtbY%253D&md5=e46d14ec3541f9ca6b13cc66a9072678</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2016.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2016.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DQ.%26atitle%3DThe%2520cytochrome%2520P450%2520inhibitor%2520SKF-525A%2520disrupts%2520autophagy%2520in%2520primary%2520rat%2520hepatocytes%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2016%26volume%3D255%26spage%3D55%26epage%3D62%26doi%3D10.1016%2Fj.cbi.2016.03.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref211"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref211'); return false;" data-citation="" class="refNumLink">211</a></strong><div class="NLM_citation" id="cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Said, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bock, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lajqi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weindl, G.</span></span> <span> </span><span class="NLM_article-title">Chloroquine promotes IL-17 production by CD4+ T cells via p38-dependent IL-23 release by monocyte-derived Langerhans-like cells</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>193</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">6135</span>– <span class="NLM_lpage">6143</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1303276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.4049%2Fjimmunol.1303276" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=25385822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVegu7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2014&pages=6135-6143&issue=12&author=A.+Saidauthor=S.+Bockauthor=T.+Lajqiauthor=G.+Mullerauthor=G.+Weindl&title=Chloroquine+promotes+IL-17+production+by+CD4%2B+T+cells+via+p38-dependent+IL-23+release+by+monocyte-derived+Langerhans-like+cells&doi=10.4049%2Fjimmunol.1303276"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Chloroquine Promotes IL-17 Production by CD4+ T Cells via p38-Dependent IL-23 Release by Monocyte-Derived Langerhans-like Cells</span></div><div class="casAuthors">Said, Andre; Bock, Stephanie; Lajqi, Trim; Mueller, Gerrit; Weindl, Guenther</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6135-6143</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Recent studies suggest a role for autophagy in the secretion of IL-1 cytokines regulating the development of inflammatory diseases.  The antimalarial drug and autophagy/lysosome inhibitor chloroquine (CHQ) is considered as potential trigger of drug-induced or drug-aggravated psoriasis, in which Th17 cells sustain a persistent inflammation.  In this study, we investigated the effect of CHQ on human monocyte-derived Langerhans-like cells (MoLC) and dendritic cells (MoDC) in response to IL-1β.  The presence of CHQ reduced IL-12p70 release in both subsets, but surprisingly increased IL-6 prodn. in MoDC and IL-23 in MoLC.  Importantly, CHQ-treated MoLC promoted IL-17A secretion by CD4+ T cells and elevated RORC mRNA levels, whereas IFN-γ release was reduced.  The dysregulation of IL-12 family cytokines in MoLC and MoDC occurred at the transcriptional level.  Similar effects were obtained with other late autophagy inhibitors, whereas PI3K inhibitor 3-methyladenine failed to increase IL-23 secretion.  The modulated cytokine release was dependent on IL-1 cytokine activation and abrogated by a specific IL-1R antagonist.  CHQ elevated expression of TNFR-assocd. factor 6, a common intermediate in IL-1R and TLR-dependent signaling.  Accordingly, treatment with Pam3CSK4 and CHQ enhanced IL-23 release in MoLC and MoDC.  CHQ inhibited autophagic flux, confirmed by increased LC3-II and p62 expression, and activated ERK, p38, and JNK MAPK, but only inhibition of p38 abrogated IL-23 release by MoLC.  Thus, our findings indicate that CHQ modulates cytokine release in a p38-dependent manner, suggesting an essential role of Langerhans cells and dendritic cells in CHQ-provoked psoriasis, possibly by promoting Th17 immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxgFQ_assfYLVg90H21EOLACvtfcHk0lhjFUQqXNDYNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVegu7zE&md5=41e06c27afa859687cd93353587fa7c1</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1303276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1303276%26sid%3Dliteratum%253Aachs%26aulast%3DSaid%26aufirst%3DA.%26aulast%3DBock%26aufirst%3DS.%26aulast%3DLajqi%26aufirst%3DT.%26aulast%3DMuller%26aufirst%3DG.%26aulast%3DWeindl%26aufirst%3DG.%26atitle%3DChloroquine%2520promotes%2520IL-17%2520production%2520by%2520CD4%252B%2520T%2520cells%2520via%2520p38-dependent%2520IL-23%2520release%2520by%2520monocyte-derived%2520Langerhans-like%2520cells%26jtitle%3DJ.%2520Immunol.%26date%3D2014%26volume%3D193%26issue%3D12%26spage%3D6135%26epage%3D6143%26doi%3D10.4049%2Fjimmunol.1303276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref212"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref212'); return false;" data-citation="" class="refNumLink">212</a></strong><div class="NLM_citation" id="cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bui, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obin, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, J.</span></span> <span> </span><span class="NLM_article-title">Assurance of mitochondrial integrity and mammalian longevity by the p62–Keap1-Nrf2-Nqo1 cascade</span>. <i>EMBO Rep.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">150</span>– <span class="NLM_lpage">156</span>, <span class="refDoi"> DOI: 10.1038/embor.2011.246</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fembor.2011.246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22222206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsF2juw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=150-156&issue=2&author=J.+Kwonauthor=E.+Hanauthor=C.+B.+Buiauthor=W.+Shinauthor=J.+Leeauthor=S.+Leeauthor=Y.+B.+Choiauthor=A.+H.+Leeauthor=K.+H.+Leeauthor=C.+Parkauthor=M.+S.+Obinauthor=S.+K.+Parkauthor=Y.+J.+Seoauthor=G.+T.+Ohauthor=H.+W.+Leeauthor=J.+Shin&title=Assurance+of+mitochondrial+integrity+and+mammalian+longevity+by+the+p62%E2%80%93Keap1-Nrf2-Nqo1+cascade&doi=10.1038%2Fembor.2011.246"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Assurance of mitochondrial integrity and mammalian longevity by the p62-Keap1-Nrf2-Nqo1 cascade</span></div><div class="casAuthors">Kwon, Jeongho; Han, Eunhye; Bui, Chi-Bao; Shin, Woochul; Lee, Junho; Lee, Sejeong; Choi, Young-Bong; Lee, Ann-Hwee; Lee, Kyong-Hoon; Park, Chankyu; Obin, Martin S.; Park, Sung Kyu; Seo, Yun Jeong; Oh, Goo Taeg; Lee, Han-Woong; Shin, Jaekyoon</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">150-156</span>CODEN:
                <span class="NLM_cas:coden">ERMEAX</span>;
        ISSN:<span class="NLM_cas:issn">1469-221X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sqstm1/p62 functions in the non-canonical activation of nuclear factor (erythroid-derived 2)-like 2 (Nrf2).  However, its physiol. relevance is not certain.  Here, we show that p62-/- mice exhibited an accelerated presentation of ageing phenotypes, and tissues from these mice created a pro-oxidative environment owing to compromised mitochondrial electron transport.  Accordingly, mitochondrial function rapidly declined with age in p62-/- mice.  In addn., p62 enhanced basal Nrf2 activity, conferring a higher steady-state expression of NAD(P)H dehydrogenase, quinone 1 (Nqo1) to maintain mitochondrial membrane potential and, thereby, restrict excess oxidant generation.  Together, the p62-Nrf2-Nqo1 cascade functions to assure mammalian longevity by stabilizing mitochondrial integrity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMFbRXLeikg7Vg90H21EOLACvtfcHk0ljIBBChYRvR0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsF2juw%253D%253D&md5=7584f546228bdcf159a9e3cf53809dbe</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1038%2Fembor.2011.246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fembor.2011.246%26sid%3Dliteratum%253Aachs%26aulast%3DKwon%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DE.%26aulast%3DBui%26aufirst%3DC.%2BB.%26aulast%3DShin%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DY.%2BB.%26aulast%3DLee%26aufirst%3DA.%2BH.%26aulast%3DLee%26aufirst%3DK.%2BH.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DObin%26aufirst%3DM.%2BS.%26aulast%3DPark%26aufirst%3DS.%2BK.%26aulast%3DSeo%26aufirst%3DY.%2BJ.%26aulast%3DOh%26aufirst%3DG.%2BT.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DShin%26aufirst%3DJ.%26atitle%3DAssurance%2520of%2520mitochondrial%2520integrity%2520and%2520mammalian%2520longevity%2520by%2520the%2520p62%25E2%2580%2593Keap1-Nrf2-Nqo1%2520cascade%26jtitle%3DEMBO%2520Rep.%26date%3D2012%26volume%3D13%26issue%3D2%26spage%3D150%26epage%3D156%26doi%3D10.1038%2Fembor.2011.246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref213"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref213'); return false;" data-citation="" class="refNumLink">213</a></strong><div class="NLM_citation" id="cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muto, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flex, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kupchinsky, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Primiano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galehdari, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehghani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecchetti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpentieri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizza, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazaheri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedaghat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vahidi Mehrjardi, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traversa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Nottia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kousi, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamshidi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciolfi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caputo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malamiri, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantaleoni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffries, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeighami, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherafat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Giuda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shariati, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrozzo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsanis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maroofian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Servidei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tartaglia, M.</span></span> <span> </span><span class="NLM_article-title">Biallelic SQSTM1 mutations in early-onset, variably progressive neurodegeneration</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>91</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">e319</span>– <span class="NLM_lpage">e330</span>, <span class="refDoi"> DOI: 10.1212/WNL.0000000000005869</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1212%2FWNL.0000000000005869" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=29959261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlGnsL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2018&pages=e319-e330&issue=4&author=V.+Mutoauthor=E.+Flexauthor=Z.+Kupchinskyauthor=G.+Primianoauthor=H.+Galehdariauthor=M.+Dehghaniauthor=S.+Cecchettiauthor=G.+Carpentieriauthor=T.+Rizzaauthor=N.+Mazaheriauthor=A.+Sedaghatauthor=M.+Y.+Vahidi+Mehrjardiauthor=A.+Traversaauthor=M.+Di+Nottiaauthor=M.+M.+Kousiauthor=Y.+Jamshidiauthor=A.+Ciolfiauthor=V.+Caputoauthor=R.+A.+Malamiriauthor=F.+Pantaleoniauthor=S.+Martinelliauthor=A.+R.+Jeffriesauthor=J.+Zeighamiauthor=A.+Sherafatauthor=D.+Di+Giudaauthor=G.+R.+Shariatiauthor=R.+Carrozzoauthor=N.+Katsanisauthor=R.+Maroofianauthor=S.+Servideiauthor=M.+Tartaglia&title=Biallelic+SQSTM1+mutations+in+early-onset%2C+variably+progressive+neurodegeneration&doi=10.1212%2FWNL.0000000000005869"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">Biallelic SQSTM1 mutations in early-onset, variably progressive neurodegeneration</span></div><div class="casAuthors">Muto, Valentina; Flex, Elisabetta; Kupchinsky, Zachary; Primiano, Guido; Galehdari, Hamid; Dehghani, Mohammadreza; Cecchetti, Serena; Carpentieri, Giovanna; Rizza, Teresa; Mazaheri, Neda; Sedaghat, Alireza; Vahidi Mehrjardi, Mohammad Yahya; Traversa, Alice; Di Nottia, Michela; Kousi, Maria M.; Jamshidi, Yalda; Ciolfi, Andrea; Caputo, Viviana; Malamiri, Reza Azizi; Pantaleoni, Francesca; Martinelli, Simone; Jeffries, Aaron R.; Zeighami, Jawaher; Sherafat, Amir; Di Giuda, Daniela; Shariati, Gholam Reza; Carrozzo, Rosalba; Katsanis, Nicholas; Maroofian, Reza; Servidei, Serenella; Tartaglia, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e319-e330</span>CODEN:
                <span class="NLM_cas:coden">NEURAI</span>;
        ISSN:<span class="NLM_cas:issn">0028-3878</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective: To characterize clin. and molecularly an early-onset, variably progressive neurodegenerative disorder characterized by a cerebellar syndrome with severe ataxia, gaze palsy, dyskinesia, dystonia, and cognitive decline affecting 11 individuals from 3 consanguineous families.  Methods: We used whole-exome sequencing (WES) (families 1 and 2) and a combined approach based on homozygosity mapping and WES (family 3).  We performed in vitro studies to explore the effect of the nontruncating SQSTM1 mutation on protein function and the effect of impaired SQSTM1 function on autophagy.  We analyzed the consequences of sqstm1 down-modulation on the structural integrity of the cerebellum in vivo using zebrafish as a model.  Results: We identified 3 homozygous inactivating variants, including a splice site substitution (c.301+2T>A) causing aberrant transcript processing and accelerated degrdn. of a resulting protein lacking exon 2, as well as 2 truncating changes (c.875_876insT and c.934_936delinsTGA).  We show that loss of SQSTM1 causes impaired prodn. of ubiquitin-pos. protein aggregates in response to misfolded protein stress and decelerated autophagic flux.  The consequences of sqstm1 down-modulation on the structural integrity of the cerebellum in zebrafish documented a variable but reproducible phenotype characterized by cerebellum anomalies ranging from depletion of axonal connections to complete atrophy.  We provide a detailed clin. characterization of the disorder; the natural history is reported for 2 siblings who have been followed up for >20 years.  Conclusions: This study offers an accurate clin. characterization of this recently recognized neurodegenerative disorder caused by biallelic inactivating mutations in SQSTM1 and links this phenotype to defective selective autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnLNHPSU0S47Vg90H21EOLACvtfcHk0ljIBBChYRvR0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlGnsL3N&md5=7e0028caf2c44a744c87bf0b1fc6c2af</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1212%2FWNL.0000000000005869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.0000000000005869%26sid%3Dliteratum%253Aachs%26aulast%3DMuto%26aufirst%3DV.%26aulast%3DFlex%26aufirst%3DE.%26aulast%3DKupchinsky%26aufirst%3DZ.%26aulast%3DPrimiano%26aufirst%3DG.%26aulast%3DGalehdari%26aufirst%3DH.%26aulast%3DDehghani%26aufirst%3DM.%26aulast%3DCecchetti%26aufirst%3DS.%26aulast%3DCarpentieri%26aufirst%3DG.%26aulast%3DRizza%26aufirst%3DT.%26aulast%3DMazaheri%26aufirst%3DN.%26aulast%3DSedaghat%26aufirst%3DA.%26aulast%3DVahidi%2BMehrjardi%26aufirst%3DM.%2BY.%26aulast%3DTraversa%26aufirst%3DA.%26aulast%3DDi%2BNottia%26aufirst%3DM.%26aulast%3DKousi%26aufirst%3DM.%2BM.%26aulast%3DJamshidi%26aufirst%3DY.%26aulast%3DCiolfi%26aufirst%3DA.%26aulast%3DCaputo%26aufirst%3DV.%26aulast%3DMalamiri%26aufirst%3DR.%2BA.%26aulast%3DPantaleoni%26aufirst%3DF.%26aulast%3DMartinelli%26aufirst%3DS.%26aulast%3DJeffries%26aufirst%3DA.%2BR.%26aulast%3DZeighami%26aufirst%3DJ.%26aulast%3DSherafat%26aufirst%3DA.%26aulast%3DDi%2BGiuda%26aufirst%3DD.%26aulast%3DShariati%26aufirst%3DG.%2BR.%26aulast%3DCarrozzo%26aufirst%3DR.%26aulast%3DKatsanis%26aufirst%3DN.%26aulast%3DMaroofian%26aufirst%3DR.%26aulast%3DServidei%26aufirst%3DS.%26aulast%3DTartaglia%26aufirst%3DM.%26atitle%3DBiallelic%2520SQSTM1%2520mutations%2520in%2520early-onset%252C%2520variably%2520progressive%2520neurodegeneration%26jtitle%3DNeurology%26date%3D2018%26volume%3D91%26issue%3D4%26spage%3De319%26epage%3De330%26doi%3D10.1212%2FWNL.0000000000005869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref214"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref214'); return false;" data-citation="" class="refNumLink">214</a></strong><div class="NLM_citation" id="cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selloum, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champy, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diez-Guerra, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auwerx, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span> <span> </span><span class="NLM_article-title">Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">222</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2006.01.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.cmet.2006.01.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=16517408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD28Xislyhtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=211-222&issue=3&author=A.+Rodriguezauthor=A.+Duranauthor=M.+Selloumauthor=M.+F.+Champyauthor=F.+J.+Diez-Guerraauthor=J.+M.+Floresauthor=M.+Serranoauthor=J.+Auwerxauthor=M.+T.+Diaz-Mecoauthor=J.+Moscat&title=Mature-onset+obesity+and+insulin+resistance+in+mice+deficient+in+the+signaling+adapter+p62&doi=10.1016%2Fj.cmet.2006.01.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62</span></div><div class="casAuthors">Rodriguez, Angelina; Duran, Angeles; Selloum, Mohammed; Champy, Marie-France; Diez-Guerra, Francisco J.; Flores, Juana Maria; Serrano, Manuel; Auwerx, Johan; Diaz-Meco, Maria T.; Moscat, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">211-222</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Signaling cascades that control adipogenesis are essential in the regulation of body wt. and obesity.  The adaptor p62 controls pathways that modulate cell differentiation.  The authors report that p62-/- mice develop mature-onset obesity, leptin resistance, as well as impaired glucose and insulin intolerance.  The metabolic rate was significantly reduced in p62-/- nonobese mice, which displayed increased mRNA levels of PPAR-γ and reduced levels of UCP-1 in adipose tissue.  Basal activity of ERK was enhanced in fat from nonobese mutant mice.  Embryo fibroblasts from p62-/- mice differentiated better than the wild-type controls into adipocytes, which was abrogated by pharmacol. inhibition of the ERK pathway.  The p62 is induced during adipocyte differentiation and inhibits ERK activation by direct interaction.  The authors propose that p62 normally antagonizes basal ERK activity and adipocyte differentiation and that its loss leads to the hyperactivation of ERK that favors adipogenesis and obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomuqtMEFK4TbVg90H21EOLACvtfcHk0lg5UYv_IzzlUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xislyhtrs%253D&md5=d6986162cf7ed08d9414c6eb5e304788</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2006.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2006.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DDuran%26aufirst%3DA.%26aulast%3DSelloum%26aufirst%3DM.%26aulast%3DChampy%26aufirst%3DM.%2BF.%26aulast%3DDiez-Guerra%26aufirst%3DF.%2BJ.%26aulast%3DFlores%26aufirst%3DJ.%2BM.%26aulast%3DSerrano%26aufirst%3DM.%26aulast%3DAuwerx%26aufirst%3DJ.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DMoscat%26aufirst%3DJ.%26atitle%3DMature-onset%2520obesity%2520and%2520insulin%2520resistance%2520in%2520mice%2520deficient%2520in%2520the%2520signaling%2520adapter%2520p62%26jtitle%3DCell%2520Metab.%26date%3D2006%26volume%3D3%26issue%3D3%26spage%3D211%26epage%3D222%26doi%3D10.1016%2Fj.cmet.2006.01.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref215"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref215'); return false;" data-citation="" class="refNumLink">215</a></strong><div class="NLM_citation" id="cit215"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh Babu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamar Seibenhener, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strom, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemppainen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, M. W.</span></span> <span> </span><span class="NLM_article-title">Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">120</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2008.05340.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1111%2Fj.1471-4159.2008.05340.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18346206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BD1cvitlSrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2008&pages=107-120&issue=1&author=J.+Ramesh+Babuauthor=M.+Lamar+Seibenhenerauthor=J.+Pengauthor=A.+L.+Stromauthor=R.+Kemppainenauthor=N.+Coxauthor=H.+Zhuauthor=M.+C.+Wootenauthor=M.+T.+Diaz-Mecoauthor=J.+Moscatauthor=M.+W.+Wooten&title=Genetic+inactivation+of+p62+leads+to+accumulation+of+hyperphosphorylated+tau+and+neurodegeneration&doi=10.1111%2Fj.1471-4159.2008.05340.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration</span></div><div class="casAuthors">Ramesh Babu J; Lamar Seibenhener M; Peng Junmin; Strom Anna-Lena; Kemppainen Robert; Cox Nancy; Zhu Haining; Wooten Michael C; Diaz-Meco Maria T; Moscat Jorge; Wooten Marie W</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">107-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The signaling adapter p62 plays a coordinating role in mediating phosphorylation and ubiquitin-dependent trafficking of interacting proteins.  However, there is little known about the physiologic role of this protein in brain.  Here, we report age-dependent constitutive activation of glycogen synthase kinase 3beta, protein kinase B, mitogen-activated protein kinase, and c-Jun-N-terminal kinase in adult p62(-/-) mice resulting in hyperphosphorylated tau, neurofibrillary tangles, and neurodegeneration.  Biochemical fractionation of p62(-/-) brain led to recovery of aggregated K63-ubiquitinated tau.  Loss of p62 was manifested by increased anxiety, depression, loss of working memory, and reduced serum brain-derived neurotrophic factor levels.  Our findings reveal a novel role for p62 as a chaperone that regulates tau solubility thereby preventing tau aggregation.  This study provides a clear demonstration of an Alzheimer-like phenotype in a mouse model in the absence of expression of human genes carrying mutations in amyloid-beta protein precursor, presenilin, or tau.  Thus, these findings provide new insight into manifestation of sporadic Alzheimer disease and the impact of obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTej33M0uF5Zf9pSBfyDvp7fW6udTcc2eYAUkaeTYyQ2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvitlSrtA%253D%253D&md5=a7fdc891414a454b800d8b8ed8cbfe42</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05340.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05340.x%26sid%3Dliteratum%253Aachs%26aulast%3DRamesh%2BBabu%26aufirst%3DJ.%26aulast%3DLamar%2BSeibenhener%26aufirst%3DM.%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DStrom%26aufirst%3DA.%2BL.%26aulast%3DKemppainen%26aufirst%3DR.%26aulast%3DCox%26aufirst%3DN.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DWooten%26aufirst%3DM.%2BC.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DWooten%26aufirst%3DM.%2BW.%26atitle%3DGenetic%2520inactivation%2520of%2520p62%2520leads%2520to%2520accumulation%2520of%2520hyperphosphorylated%2520tau%2520and%2520neurodegeneration%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D106%26issue%3D1%26spage%3D107%26epage%3D120%26doi%3D10.1111%2Fj.1471-4159.2008.05340.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref216"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref216'); return false;" data-citation="" class="refNumLink">216</a></strong><div class="NLM_citation" id="cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurosawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kino, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurosawa-Yamada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washizu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakaso, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanagawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warabi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimogori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nukina, N.</span></span> <span> </span><span class="NLM_article-title">Depletion of p62 reduces nuclear inclusions and paradoxically ameliorates disease phenotypes in Huntington’s model mice</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1092</span>– <span class="NLM_lpage">1105</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddu522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1093%2Fhmg%2Fddu522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=25305080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVyls73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=1092-1105&issue=4&author=M.+Kurosawaauthor=G.+Matsumotoauthor=Y.+Kinoauthor=M.+Okunoauthor=M.+Kurosawa-Yamadaauthor=C.+Washizuauthor=H.+Taniguchiauthor=K.+Nakasoauthor=T.+Yanagawaauthor=E.+Warabiauthor=T.+Shimogoriauthor=T.+Sakuraiauthor=N.+Hattoriauthor=N.+Nukina&title=Depletion+of+p62+reduces+nuclear+inclusions+and+paradoxically+ameliorates+disease+phenotypes+in+Huntington%E2%80%99s+model+mice&doi=10.1093%2Fhmg%2Fddu522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Depletion of p62 reduces nuclear inclusions and paradoxically ameliorates disease phenotypes in Huntington's model mice</span></div><div class="casAuthors">Kurosawa, Masaru; Matsumoto, Gen; Kino, Yoshihiro; Okuno, Misako; Kurosawa-Yamada, Mizuki; Washizu, Chika; Taniguchi, Harumi; Nakaso, Kazuhiro; Yanagawa, Toru; Warabi, Eiji; Shimogori, Tomomi; Sakurai, Takashi; Hattori, Nobutaka; Nukina, Nobuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1092-1105</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Huntington's disease (HD) is a dominantly inherited genetic disease caused by mutant huntingtin (htt) protein with expanded polyglutamine (polyQ) tracts.  A neuropathol. hallmark of HD is the presence of neuronal inclusions of mutant htt. p62 is an important regulatory protein in selective autophagy, a process by which aggregated proteins are degraded, and it is assocd. with several neurodegenerative disorders including HD.  Here, we investigated the effect of p62 depletion in three HD model mice: R6/2, HD190QG and HD120QG mice.  We found that loss of p62 in these models led to longer life spans and reduced nuclear inclusions, although cytoplasmic inclusions increased with polyQ length.  In mouse embryonic fibroblasts (MEFs) with or without p62, mutant htt with a nuclear localization signal (NLS) showed no difference in nuclear inclusion between the two MEF types.  In the case of mutant htt without NLS, however, p62 depletion increased cytoplasmic inclusions.  Furthermore, to examine the effect of impaired autophagy in HD model mice, we crossed R6/2 mice with Atg5 conditional knockout mice.  These mice also showed decreased nuclear inclusions and increased cytoplasmic inclusions, similar to HD mice lacking p62.  These data suggest that the genetic ablation of p62 in HD model mice enhances cytoplasmic inclusion formation by interrupting autophagic clearance of polyQ inclusions.  This reduces polyQ nuclear influx and paradoxically ameliorates disease phenotypes by decreasing toxic nuclear inclusions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopHG4Cy0wU_bVg90H21EOLACvtfcHk0lg5UYv_IzzlUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVyls73N&md5=2c2c6e585f6f96df06b258259b5d3a51</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddu522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddu522%26sid%3Dliteratum%253Aachs%26aulast%3DKurosawa%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DG.%26aulast%3DKino%26aufirst%3DY.%26aulast%3DOkuno%26aufirst%3DM.%26aulast%3DKurosawa-Yamada%26aufirst%3DM.%26aulast%3DWashizu%26aufirst%3DC.%26aulast%3DTaniguchi%26aufirst%3DH.%26aulast%3DNakaso%26aufirst%3DK.%26aulast%3DYanagawa%26aufirst%3DT.%26aulast%3DWarabi%26aufirst%3DE.%26aulast%3DShimogori%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DT.%26aulast%3DHattori%26aufirst%3DN.%26aulast%3DNukina%26aufirst%3DN.%26atitle%3DDepletion%2520of%2520p62%2520reduces%2520nuclear%2520inclusions%2520and%2520paradoxically%2520ameliorates%2520disease%2520phenotypes%2520in%2520Huntington%25E2%2580%2599s%2520model%2520mice%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2015%26volume%3D24%26issue%3D4%26spage%3D1092%26epage%3D1105%26doi%3D10.1093%2Fhmg%2Fddu522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207'],'ref208':['cit208'],'ref209':['cit209'],'ref210':['cit210'],'ref211':['cit211'],'ref212':['cit212'],'ref213':['cit213'],'ref214':['cit214'],'ref215':['cit215'],'ref216':['cit216']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 4 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoqian  Jia</span>, <span class="hlFld-ContribAuthor ">Anqi  Zhang</span>, <span class="hlFld-ContribAuthor ">Zheng  Li</span>, <span class="hlFld-ContribAuthor ">Xiaoling  Peng</span>, <span class="hlFld-ContribAuthor ">Xuebi  Tian</span>, <span class="hlFld-ContribAuthor ">Feng  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Activation of spinal PDGFRβ in microglia promotes neuronal autophagy via p38 MAPK pathway in morphine‐tolerant rats. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neurochemistry</span><span> <strong>2021,</strong> <em>158 </em>
                                    (2)
                                     , 373-390. <a href="https://doi.org/10.1111/jnc.15383" title="DOI URL">https://doi.org/10.1111/jnc.15383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jnc.15383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjnc.15383%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neurochemistry%26atitle%3DActivation%252Bof%252Bspinal%252BPDGFR%2525CE%2525B2%252Bin%252Bmicroglia%252Bpromotes%252Bneuronal%252Bautophagy%252Bvia%252Bp38%252BMAPK%252Bpathway%252Bin%252Bmorphine%2525E2%252580%252590tolerant%252Brats%26aulast%3DJia%26aufirst%3DXiaoqian%26date%3D2021%26date%3D2021%26volume%3D158%26issue%3D2%26spage%3D373%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hsin-Ling  Yang</span>, <span class="hlFld-ContribAuthor ">Hui-Wen  Liu</span>, <span class="hlFld-ContribAuthor ">Sirjana  Shrestha</span>, <span class="hlFld-ContribAuthor ">Varadharajan  Thiyagarajan</span>, <span class="hlFld-ContribAuthor ">Hui-Chi  Huang</span>, <span class="hlFld-ContribAuthor ">You-Cheng  Hseu</span>. </span><span class="cited-content_cbyCitation_article-title">Antrodia salmonea induces apoptosis and enhances cytoprotective autophagy in colon cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Aging</span><span> <strong>2021,</strong> <em>13 </em>
                                    (12)
                                     , 15964-15989. <a href="https://doi.org/10.18632/aging.203019" title="DOI URL">https://doi.org/10.18632/aging.203019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/aging.203019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Faging.203019%26sid%3Dliteratum%253Aachs%26jtitle%3DAging%26atitle%3DAntrodia%252Bsalmonea%252Binduces%252Bapoptosis%252Band%252Benhances%252Bcytoprotective%252Bautophagy%252Bin%252Bcolon%252Bcancer%252Bcells%26aulast%3DYang%26aufirst%3DHsin-Ling%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D12%26spage%3D15964%26epage%3D15989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongqi  Li</span>, <span class="hlFld-ContribAuthor ">Chuanchun  He</span>, <span class="hlFld-ContribAuthor ">Fan  Ye</span>, <span class="hlFld-ContribAuthor ">En  Ye</span>, <span class="hlFld-ContribAuthor ">Hao  He</span>, <span class="hlFld-ContribAuthor ">Gong  Chen</span>, <span class="hlFld-ContribAuthor ">Jing  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">p62 Overexpression Promotes Bone Metastasis of Lung Adenocarcinoma out of LC3-Dependent Autophagy. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fonc.2021.609548" title="DOI URL">https://doi.org/10.3389/fonc.2021.609548</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2021.609548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2021.609548%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3Dp62%252BOverexpression%252BPromotes%252BBone%252BMetastasis%252Bof%252BLung%252BAdenocarcinoma%252Bout%252Bof%252BLC3-Dependent%252BAutophagy%26aulast%3DLi%26aufirst%3DDongqi%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Evangelisti</span>, <span class="hlFld-ContribAuthor ">Helen  Butler</span>, <span class="hlFld-ContribAuthor ">Federica  del Monte</span>. </span><span class="cited-content_cbyCitation_article-title">The Heart of the Alzheimer's: A Mindful View of Heart Disease. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Physiology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphys.2020.625974" title="DOI URL">https://doi.org/10.3389/fphys.2020.625974</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphys.2020.625974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphys.2020.625974%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Physiology%26atitle%3DThe%252BHeart%252Bof%252Bthe%252BAlzheimer%252527s%25253A%252BA%252BMindful%252BView%252Bof%252BHeart%252BDisease%26aulast%3DEvangelisti%26aufirst%3DAlessandro%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/medium/jm9b02038_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/medium/jm9b02038_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Domains of p62. There are six domains on p62: N-terminal Phox1 and Bem1p (PB1) domain; zinc finger (ZZ) domain; tumor necrosis factor receptor-associated factor 6 (TRAF6)-binding (TB) motif; LC3-interacting region (LIR) domain; Keap1-interacting region (KIR) domain; C-terminal ubiquitin-associated (UBA) domain. The PB1 domain functions to promote p62 oligomerization and interaction with aPKCs and MEKK3. The ZZ domain and TB domain are associated with the NF-κB signaling pathway. The LIR domain is responsible for binding to LC3. The KIR domain is required for p62 to activate the Nrf2 pathway through competitive inhibition of Keap1. The UBA domain is responsible for the interaction between autophagosomes and ubiquitinated proteins. The UBA domain cooperates with the LIR domain to promote autophagy occurrence. NLS1/2 and NES are responsible for the nucleo-cytoplasmic shuttling of p62.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/medium/jm9b02038_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Process of p62-mediated selective autophagy. Misfolded protein aggregates are recruited to the UBA domain of p62. Once intracellular or extracellular stimulation signals are accepted, phagophores keep expanding and parceling cytoplasmic components. Then phagophores close the opening and form sealed spherical autophagosomes. p62 bodies interact with LC3 to promote the formation of autophagosomes. Autophagosomes combine with lysosomes to form autolysosomes and promote aggregated proteins to degradation in them.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/medium/jm9b02038_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Positive correlation between p62 and tumorigenesis in epithelium cells. p62 makes itself a central regulator of tumorigenesis through interacting with pathways responsible for controlling cell anabolism and catabolism. p62 accumulation contributes to cancer progression mainly associated with five approaches: (1) selective autophagy, (2) nuclear factor-κB (NF-κB) signaling pathway, (3) nuclear factor erythroid 2-related factor 2 (Nrf2) pathway, (4) mechanistic target of rapamycin (mTOR) pathway, (5) the oncogenic transcription factor Twist1 pathway.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/medium/jm9b02038_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Degradation of Nrf2 activated by Keap1. Keap1 is a substrate adaptor protein of a Cullin 3 (Cul3)-based ubiquitin ligase, and it functions to maintain a low level of Nrf2 by promoting its ubiquitination and degradation in 26S proteasome under normal conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/medium/jm9b02038_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Canonical and noncanonical pathways of Nrf2 activation. Canonical pathway induced by oxidative stress or electrophiles: Keap1/Cul3-mediated Nrf2 degradation is blocked through modification of cysteine residues in Keap1, resulting in Nrf2 escaping from Keap1-induced ubiquitination and activation of the Nrf2-dependent cytoprotective gene. In the noncanonical pathway, Nrf2 activation can also be achieved by several endogenous proteins p62, functioning as a noncanonical way to disturb the Nrf2–Keap1 interaction. The KIR domain of p62 competitively binds to the Kelch domain of Keap1, which is the same binding site of Nrf2, resulting in the dissociation of the Nrf2–Keap1 complex and activation of Nrf2 to induce the expression of ARE-bearing genes and the <i>SQSTM1</i> gene, which constitutes positive feedback between p62 accumulation and Nrf2 activation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/medium/jm9b02038_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Negative correlation between p62 and tumor stroma activation. Loss of p62 in stromal cells triggers inflammation and metabolism dysfunction, which are two critical factors contributing to the tumorigenic properties of the stroma.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/medium/jm9b02038_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. The relationship between p62 and AD pathologies. The decrease of p62 in AD brains is associated with β-amyloid neuritic plaques and NFTs. p62 inhibition leads to the decrease of proteasome activity and promotion of tau-hyperphosphorylation, which results in the accumulation of misfolded tau, a typical characteristic of NFTs. On the other hand, p62 absence can promote Aβ deposition by impacting the Nrf2 and mitophagy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/medium/jm9b02038_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. OCL formation activated by the RANKL–RANK pathway. Increased RANK activates polyubiquitinated TRAF-6 accumulation, which recruits p62 and aPKCs. Phosphorylation of the IKK complex leads to phosphorylation of IKB, which is degraded by the proteasome and activates NF-κB to transcribe genes beneficial to OCL formation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-18/acs.jmedchem.9b02038/20200918/images/large/jm9b02038_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02038&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i44">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25517" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25517" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 216 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vadlamudi, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, J.</span></span> <span> </span><span class="NLM_article-title">Genomic structure and promoter analysis of the p62 gene encoding a non-proteasomal multiubiquitin chain binding protein</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>435</i></span> (<span class="NLM_issue">2–3</span>),  <span class="NLM_fpage">138</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(98)01021-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2FS0014-5793%2898%2901021-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=9762895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADyaK1cXmt1emt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=435&publication_year=1998&pages=138-142&issue=2%E2%80%933&author=R.+K.+Vadlamudiauthor=J.+Shin&title=Genomic+structure+and+promoter+analysis+of+the+p62+gene+encoding+a+non-proteasomal+multiubiquitin+chain+binding+protein&doi=10.1016%2FS0014-5793%2898%2901021-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Genomic structure and promoter analysis of the p62 gene encoding a non-proteasomal multiubiquitin chain binding protein</span></div><div class="casAuthors">Vadlamudi, Ratna K.; Shin, Jaekyoon</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">435</span>
        (<span class="NLM_cas:issue">2,3</span>),
    <span class="NLM_cas:pages">138-142</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">P62 is a novel immediate early response gene encoding a ubiquitin chain binding protein.  To investigate the mechanism of p62 gene expression, we isolated and characterized the 20 kb long human p62 gene.  The p62 gene contains seven introns and eight exons.  The splice sites conformed to the GT/AG rule, except introns 6 and 7 which used the unusual GC dinucleotides.  The p62 promoter is TATA-less, and 357 nucleotides of the 5'-flanking region contain basic machineries for transcription.  A reporter gene linked to 1800 nucleotides of the 5'-flanking region was rapidly activated by various extracellular signals.  The presence of a CpG island as well as multiple binding sites for SP-1, AP-1, NF-κB, and Ets-1 family in the promoter region supports the regulated activation of the p62 gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrONVdfwR7D8rVg90H21EOLACvtfcHk0ljytjDc4eOzIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmt1emt70%253D&md5=c98a838ae8018c6fc0bfcfe5034d2f7d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2898%2901021-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252898%252901021-7%26sid%3Dliteratum%253Aachs%26aulast%3DVadlamudi%26aufirst%3DR.%2BK.%26aulast%3DShin%26aufirst%3DJ.%26atitle%3DGenomic%2520structure%2520and%2520promoter%2520analysis%2520of%2520the%2520p62%2520gene%2520encoding%2520a%2520non-proteasomal%2520multiubiquitin%2520chain%2520binding%2520protein%26jtitle%3DFEBS%2520Lett.%26date%3D1998%26volume%3D435%26issue%3D2%25E2%2580%25933%26spage%3D138%26epage%3D142%26doi%3D10.1016%2FS0014-5793%2898%2901021-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Joung, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strominger, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, J.</span></span> <span> </span><span class="NLM_article-title">Molecular cloning of a phosphotyrosine-independent ligand of the p56(lck) SH2 domain</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5991</span>– <span class="NLM_lpage">5995</span>, <span class="refDoi"> DOI: 10.1073/pnas.93.12.5991</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1073%2Fpnas.93.12.5991" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=8650207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADyaK28Xjs1Ojsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=5991-5995&issue=12&author=I.+Joungauthor=J.+L.+Stromingerauthor=J.+Shin&title=Molecular+cloning+of+a+phosphotyrosine-independent+ligand+of+the+p56%28lck%29+SH2+domain&doi=10.1073%2Fpnas.93.12.5991"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning of a phosphotyrosine-independent ligand of the p56lck SH2 domain</span></div><div class="casAuthors">Joung, Insil; Strominger, Jack L.; Shin, Jaekyoon</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5991-5995</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A novel human cDNA encoding a cytosolic 62-kDa protein (p62) that binds to the Src homol. 2 (SH2) domain of p56lck in a phosphotyrosine-independent manner has been cloned.  The cDNA is composed of 2074 nucleotides with an open reading frame encoding 440 amino acids.  Northern anal. suggests that p62 is expressed ubiquitously in all tissues examd.  P62 is not homologous to any known protein in the data base.  However, it contains a cysteine-rich region resembling a zinc finger motif, a potential G-protein-binding region, a PEST motif, and several potential phosphorylation sites.  Using T7-epitope tagged p62 expression in HeLa cells, the expressed protein was shown to bind to the lck SH2 domain.  Deletion of the N-terminal 50 amino acids abolished binding, but mutagenesis of the single tyrosine residue in this region had no effect on binding.  Thus, the cloned cDNA indeed encodes the p62 protein, which is a phosphotyrosine-independent ligand for the lck SH2 domain.  Its binding mechanism is unique with respect to binding modes of other known ligands for SH2 domains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplpLz4fO-ldLVg90H21EOLACvtfcHk0ljytjDc4eOzIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xjs1Ojsb8%253D&md5=6ffa8d26a71fbe0dc1f42355d0c5c293</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.12.5991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.12.5991%26sid%3Dliteratum%253Aachs%26aulast%3DJoung%26aufirst%3DI.%26aulast%3DStrominger%26aufirst%3DJ.%2BL.%26aulast%3DShin%26aufirst%3DJ.%26atitle%3DMolecular%2520cloning%2520of%2520a%2520phosphotyrosine-independent%2520ligand%2520of%2520the%2520p56%2528lck%2529%2520SH2%2520domain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26issue%3D12%26spage%3D5991%26epage%3D5995%26doi%3D10.1073%2Fpnas.93.12.5991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Carcer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandoval, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span> <span> </span><span class="NLM_article-title">Localization of atypical protein kinase C isoforms into lysosome-targeted endosomes through interaction with p62</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">3069</span>– <span class="NLM_lpage">3080</span>, <span class="refDoi"> DOI: 10.1128/MCB.18.5.3069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1128%2FMCB.18.5.3069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=9566925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADyaK1cXis1GmsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1998&pages=3069-3080&issue=5&author=P.+Sanchezauthor=G.+De+Carcerauthor=I.+V.+Sandovalauthor=J.+Moscatauthor=M.+T.+Diaz-Meco&title=Localization+of+atypical+protein+kinase+C+isoforms+into+lysosome-targeted+endosomes+through+interaction+with+p62&doi=10.1128%2FMCB.18.5.3069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Localization of atypical protein kinase C isoforms into lysosome-targeted endosomes through interaction with p62</span></div><div class="casAuthors">Sanchez, Pilar; De Carcer, Guillermo; Sandoval, Ignacio V.; Moscat, Jorge; Diaz-Meco, Maria T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">3069-3080</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">An increasing no. of independent studies indicate that the atypical protein kinase C (PKC) isoforms (aPKCs) are critically involved in the control of cell proliferation and survival.  The aPKCs are targets of important lipid mediators such as ceramide and the products of the PI 3-kinase.  In addn., the aPKCs have been shown to interact with Ras and with two novel proteins, LIP (lambda-interacting protein; a selective activator of λ/ιPKC) and the product of par-4 (a gene induced during apoptosis), which is an inhibitor of both λ/ιPKC and ζPKC.  LIP and Par-4 interact with the zinc finger domain of the aPKCs where the lipid mediators have been shown to bind.  Here we report the identification of p62, a previously described phosphotyrosine-independent p56lck SH2-interacting protein, as a mol. that interacts potently with the V1 domain of λ/ιPKC and, albeit with lower affinity, with ζPKC.  We also show in this study that ectopically expressed p62 colocalizes perfectly with both λ/ιPKC and ζPKC.  Interestingly, the endogenous p62, like the ectopically expressed protein, displays a punctate vesicular pattern and clearly colocalizes with endogenous λ/ιPKC and endogenous ζPKC.  P62 colocalizes with Rab7 and partially with lamp-1 and limp-II as well as with the epidermal growth factor (EGF) receptor in activated cells, but not with Rab5 or the transferrin receptor.  Of functional relevance, expression of dominant neg. λ/ιPKC, but not of the wild-type enzyme, severely impairs the endocytic membrane transport of the EGF receptor with no effect on the transferrin receptor.  These findings strongly suggest that the aPKCs are anchored by p62 in the lysosome-targeted endosomal compartment, which seems crit. for the control of the growth factor receptor trafficking.  This is particularly relevant in light of the role played by the aPKCs in mitogenic cell signaling events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9LrgrrgM2ObVg90H21EOLACvtfcHk0liYPcdjlsPApA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXis1GmsL4%253D&md5=3c5639bc44206a280e82433614e09099</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1128%2FMCB.18.5.3069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.18.5.3069%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez%26aufirst%3DP.%26aulast%3DDe%2BCarcer%26aufirst%3DG.%26aulast%3DSandoval%26aufirst%3DI.%2BV.%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26atitle%3DLocalization%2520of%2520atypical%2520protein%2520kinase%2520C%2520isoforms%2520into%2520lysosome-targeted%2520endosomes%2520through%2520interaction%2520with%2520p62%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1998%26volume%3D18%26issue%3D5%26spage%3D3069%26epage%3D3080%26doi%3D10.1128%2FMCB.18.5.3069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pikkarainen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartikainen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soininen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alafuzoff, I.</span></span> <span> </span><span class="NLM_article-title">Distribution and pattern of pathology in subjects with familial or sporadic late-onset cerebellar ataxia as assessed by p62/sequestosome immunohistochemistry</span>. <i>Cerebellum</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">720</span>– <span class="NLM_lpage">731</span>, <span class="refDoi"> DOI: 10.1007/s12311-011-0281-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1007%2Fs12311-011-0281-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21544590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVyrtrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=720-731&issue=4&author=M.+Pikkarainenauthor=P.+Hartikainenauthor=H.+Soininenauthor=I.+Alafuzoff&title=Distribution+and+pattern+of+pathology+in+subjects+with+familial+or+sporadic+late-onset+cerebellar+ataxia+as+assessed+by+p62%2Fsequestosome+immunohistochemistry&doi=10.1007%2Fs12311-011-0281-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution and Pattern of Pathology in Subjects with Familial or Sporadic Late-Onset Cerebellar Ataxia as Assessed by p62/Sequestosome Immunohistochemistry</span></div><div class="casAuthors">Pikkarainen, Maria; Hartikainen, Paeivi; Soininen, Hilkka; Alafuzoff, Irina</div><div class="citationInfo"><span class="NLM_cas:title">Cerebellum</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">720-731</span>CODEN:
                <span class="NLM_cas:coden">CERECF</span>;
        ISSN:<span class="NLM_cas:issn">1473-4222</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We investigated whether ubiquitin-binding protein p62/sequestosome-1 could be utilized to evaluate the pathol. seen in patients with a clin. diagnosis of progressive late-onset cerebellar ataxia (LOCA). p62-immunoreactive (IR) lesions were assessed by means of immunohistochem. in the brains of six LOCA cases, one with the spinocerebellar ataxia type 1 mutation (SCA1), ages at death ranging from 46 to 56 years.  All cases fulfilled the criteria of olivopontocerebellar atrophy (OPCA), i.e., displaying cell loss in the predilection brain areas.  One case, genetics unknown, exhibited p62-IR neuronal intranuclear inclusions (NIs).  Similar NIs were labeled with the 1C2 antibody that recognizes proteins contg. large polyglutamine stretches.  In this case, also fused in sarcoma-IR NIs were seen.  In the remaining LOCA cases, including the case with the SCA1 mutation, different kinds of nuclear and cytoplasmic p62 and 1C2 labeling but no NIs were seen.  The immunoreactivity and distribution of lesions while applying p62 and 1C2 immunohistochem. varied in our six LOCA cases fulfilling the criteria of OPCA.  In all cases except in the SCA1, diffuse nuclear p62 labeling was seen, not previously reported in SCA or other neurodegenerative disorders.  Due to the variability noted here as well as the limited no. of cases, no assessment of progression and distributional pattern of pathol. could be conducted.  Based on a literature search, it is apparent that there is a need for clinico-pathol.-genetical studies of LOCA, esp. to obtain a deeper understanding of the regional distribution and progression of pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqScYxAb8-UurVg90H21EOLACvtfcHk0liYPcdjlsPApA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVyrtrvK&md5=4fa0cac68d24f00173e85ce43c372ae0</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs12311-011-0281-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12311-011-0281-2%26sid%3Dliteratum%253Aachs%26aulast%3DPikkarainen%26aufirst%3DM.%26aulast%3DHartikainen%26aufirst%3DP.%26aulast%3DSoininen%26aufirst%3DH.%26aulast%3DAlafuzoff%26aufirst%3DI.%26atitle%3DDistribution%2520and%2520pattern%2520of%2520pathology%2520in%2520subjects%2520with%2520familial%2520or%2520sporadic%2520late-onset%2520cerebellar%2520ataxia%2520as%2520assessed%2520by%2520p62%252Fsequestosome%2520immunohistochemistry%26jtitle%3DCerebellum%26date%3D2011%26volume%3D10%26issue%3D4%26spage%3D720%26epage%3D731%26doi%3D10.1007%2Fs12311-011-0281-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamark, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isakson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brech, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overvatn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenmark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjorkoy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansen, T.</span></span> <span> </span><span class="NLM_article-title">p62/SQSTM1 and ALFY interact to facilitate the formation of p62 bodies/ALIS and their degradation by autophagy</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">330</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.4161/auto.6.3.11226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.4161%2Fauto.6.3.11226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20168092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1WjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=330-344&issue=3&author=T.+H.+Clausenauthor=T.+Lamarkauthor=P.+Isaksonauthor=K.+Finleyauthor=K.+B.+Larsenauthor=A.+Brechauthor=A.+Overvatnauthor=H.+Stenmarkauthor=G.+Bjorkoyauthor=A.+Simonsenauthor=T.+Johansen&title=p62%2FSQSTM1+and+ALFY+interact+to+facilitate+the+formation+of+p62+bodies%2FALIS+and+their+degradation+by+autophagy&doi=10.4161%2Fauto.6.3.11226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">P62/SQSTM1 and ALFY interact to facilitate the formation of p62 bodies/ALIS and their degradation by autophagy</span></div><div class="casAuthors">Clausen, Terje Hoeyvarde; Lamark, Trond; Isakson, Pauline; Finley, Kim; Larsen, Kenneth Bowitz; Brech, Andreas; Oevervatn, Aud; Stenmark, Harald; Bjoerkoey, Geir; Simonsen, Anne; Johansen, Terje</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">330-344</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8627</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Accumulation of ubiquitinated proteins in cytoplasmic and/or nuclear inclusions is a hallmark of several diseases assocd. with premature cell death.  SQSTM1/p62 is known to bind ubiquitinated substrates and aid their aggregation and degrdn. by macroautophagy.  We show here that p62 is required to recruit the large phosphoinositide-binding protein ALFY to cytoplasmic p62 bodies generated upon amino acid starvation or puromycin-treatment.  ALFY, as well as p62, is required for formation and autophagic degrdn. of cytoplasmic ubiquitin-pos. inclusions.  Moreover, both p62 and ALFY localize to nuclear promyleocytic leukemia (PML) bodies.  The Drosophila p62 homolog Ref(2) P accumulates in ubiquitinated inclusions in the brain of flies carrying mutations in the ALFY homolog Blue cheese, demonstrating that ALFY is required for autophagic degrdn. of p62-assocd. ubiquitinated proteins in vivo.  We conclude that p62 and ALFY interact to organize misfolded, ubiquitinated proteins into protein bodies that become degraded by autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa7Du1RQygUrVg90H21EOLACvtfcHk0liYPcdjlsPApA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1WjtLo%253D&md5=9e1a29fc05e68ab7f2e62f027b1cf026</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.4161%2Fauto.6.3.11226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.6.3.11226%26sid%3Dliteratum%253Aachs%26aulast%3DClausen%26aufirst%3DT.%2BH.%26aulast%3DLamark%26aufirst%3DT.%26aulast%3DIsakson%26aufirst%3DP.%26aulast%3DFinley%26aufirst%3DK.%26aulast%3DLarsen%26aufirst%3DK.%2BB.%26aulast%3DBrech%26aufirst%3DA.%26aulast%3DOvervatn%26aufirst%3DA.%26aulast%3DStenmark%26aufirst%3DH.%26aulast%3DBjorkoy%26aufirst%3DG.%26aulast%3DSimonsen%26aufirst%3DA.%26aulast%3DJohansen%26aufirst%3DT.%26atitle%3Dp62%252FSQSTM1%2520and%2520ALFY%2520interact%2520to%2520facilitate%2520the%2520formation%2520of%2520p62%2520bodies%252FALIS%2520and%2520their%2520degradation%2520by%2520autophagy%26jtitle%3DAutophagy%26date%3D2010%26volume%3D6%26issue%3D3%26spage%3D330%26epage%3D344%26doi%3D10.4161%2Fauto.6.3.11226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bjorkoy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamark, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brech, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Outzen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perander, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overvatn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenmark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansen, T.</span></span> <span> </span><span class="NLM_article-title">p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>171</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">603</span>– <span class="NLM_lpage">614</span>, <span class="refDoi"> DOI: 10.1083/jcb.200507002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1083%2Fjcb.200507002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=16286508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BD2MnitVWktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2005&pages=603-614&issue=4&author=G.+Bjorkoyauthor=T.+Lamarkauthor=A.+Brechauthor=H.+Outzenauthor=M.+Peranderauthor=A.+Overvatnauthor=H.+Stenmarkauthor=T.+Johansen&title=p62%2FSQSTM1+forms+protein+aggregates+degraded+by+autophagy+and+has+a+protective+effect+on+huntingtin-induced+cell+death&doi=10.1083%2Fjcb.200507002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death</span></div><div class="casAuthors">Bjorkoy Geir; Lamark Trond; Brech Andreas; Outzen Heidi; Perander Maria; Overvatn Aud; Stenmark Harald; Johansen Terje</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of cell biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">603-14</span>
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    </div><div class="casAbstract">Autophagic degradation of ubiquitinated protein aggregates is important for cell survival, but it is not known how the autophagic machinery recognizes such aggregates.  In this study, we report that polymerization of the polyubiquitin-binding protein p62/SQSTM1 yields protein bodies that either reside free in the cytosol and nucleus or occur within autophagosomes and lysosomal structures.  Inhibition of autophagy led to an increase in the size and number of p62 bodies and p62 protein levels.  The autophagic marker light chain 3 (LC3) colocalized with p62 bodies and co-immunoprecipitated with p62, suggesting that these two proteins participate in the same complexes.  The depletion of p62 inhibited recruitment of LC3 to autophagosomes under starvation conditions.  Strikingly, p62 and LC3 formed a shell surrounding aggregates of mutant huntingtin.  Reduction of p62 protein levels or interference with p62 function significantly increased cell death that was induced by the expression of mutant huntingtin.  We suggest that p62 may, via LC3, be involved in linking polyubiquitinated protein aggregates to the autophagy machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTI4TfVb2IG0H6oPH0mYWL1fW6udTcc2eapYVFhbThX1Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MnitVWktw%253D%253D&md5=458c088f5526eadc05be25594a183747</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200507002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200507002%26sid%3Dliteratum%253Aachs%26aulast%3DBjorkoy%26aufirst%3DG.%26aulast%3DLamark%26aufirst%3DT.%26aulast%3DBrech%26aufirst%3DA.%26aulast%3DOutzen%26aufirst%3DH.%26aulast%3DPerander%26aufirst%3DM.%26aulast%3DOvervatn%26aufirst%3DA.%26aulast%3DStenmark%26aufirst%3DH.%26aulast%3DJohansen%26aufirst%3DT.%26atitle%3Dp62%252FSQSTM1%2520forms%2520protein%2520aggregates%2520degraded%2520by%2520autophagy%2520and%2520has%2520a%2520protective%2520effect%2520on%2520huntingtin-induced%2520cell%2520death%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2005%26volume%3D171%26issue%3D4%26spage%3D603%26epage%3D614%26doi%3D10.1083%2Fjcb.200507002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dang, C. V.</span></span> <span> </span><span class="NLM_article-title">MYC on the path to cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>149</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.cell.2012.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22464321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVehu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2012&pages=22-35&issue=1&author=C.+V.+Dang&title=MYC+on+the+path+to+cancer&doi=10.1016%2Fj.cell.2012.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">MYC on the Path to Cancer</span></div><div class="casAuthors">Dang, Chi V.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-35</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The MYC oncogene contributes to the genesis of many human cancers.  Recent insights into its expression and function have led to therapeutic opportunities.  MYC's activation by bromodomain proteins could be inhibited by drug-like mols., resulting in tumor inhibition in vivo.  Tumor growth can also be curbed by pharmacol. uncoupling bioenergetic pathways involving glucose or glutamine metab. from Myc-induced cellular biomass accumulation.  Other approaches to halt Myc on the path to cancer involve targeting Myc-Max dimerization or Myc-induced microRNA expression.  Here the richness of our understanding of MYC is reviewed, highlighting new biol. insights and opportunities for cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8ebUAbjLhmbVg90H21EOLACvtfcHk0ljZhetfK-xyMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVehu78%253D&md5=5b0131f36c845e16dc9a736034483109</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DC.%2BV.%26atitle%3DMYC%2520on%2520the%2520path%2520to%2520cancer%26jtitle%3DCell%26date%3D2012%26volume%3D149%26issue%3D1%26spage%3D22%26epage%3D35%26doi%3D10.1016%2Fj.cell.2012.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hocking, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, G. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daroszewska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangion, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olavesen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cundy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wuyts, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Hul, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ralston, S. H.</span></span> <span> </span><span class="NLM_article-title">Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget’s disease</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">2735</span>– <span class="NLM_lpage">2739</span>, <span class="refDoi"> DOI: 10.1093/hmg/11.22.2735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1093%2Fhmg%2F11.22.2735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=12374763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVSjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2002&pages=2735-2739&issue=22&author=L.+J.+Hockingauthor=G.+J.+A.+Lucasauthor=A.+Daroszewskaauthor=J.+Mangionauthor=M.+Olavesenauthor=T.+Cundyauthor=G.+C.+Nicholsonauthor=L.+Wardauthor=S.+T.+Bennettauthor=W.+Wuytsauthor=W.+Van+Hulauthor=S.+H.+Ralston&title=Domain-specific+mutations+in+sequestosome+1+%28SQSTM1%29+cause+familial+and+sporadic+Paget%E2%80%99s+disease&doi=10.1093%2Fhmg%2F11.22.2735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease</span></div><div class="casAuthors">Hocking, Lynne J.; Lucas, Gavin J. A.; Daroszewska, Anna; Mangion, Jon; Olavesen, Mark; Cundy, Tim; Nicholson, Geoff C.; Ward, Lynley; Bennett, Simon T.; Wuyts, Wim; Van Hul, Wim; Ralston, Stuart H.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2735-2739</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Paget's disease of bone (PDB) is a common disorder characterized by focal abnormalities of increased and disorganized bone turnover.  Genetic factors are important in the pathogenesis of PDB, and in previous studies, the authors and others identified a locus for familial PDB by genome-wide search on 5q35-qter (PDB3).  The gene encoding sequestosome 1 (SQSTM1/p62) maps to within the PDB3 crit. region, and recent studies have identified a proline-leucine amino acid change at codon 392 of SQSTM1 (P392L) in French-Canadian patients with PDB.  The authors conducted mutation screening of positional candidate genes in the PDB3 locus in patients with PDB, and also identified mutations in the gene encoding SQSTM1 as a common cause of familial and sporadic PDB.  Three different mutations were found, all affecting the highly conserved ubiquitin-binding domain.  The most common mutation was the P392L change in exon 8, which was found in 13 of 68 families (19.1%).  Another mutation, a T insertion that introduces a stop codon at position 396 in exon 8, was found in four (5.8%) families.  A third mutation affecting the splice donor site in intron 7 was found in one (1.5%) family.  The P392L mutation was also found in 15 of 168 (8.9%) of patients with sporadic PDB and 0 of 160 of age- and sex-matched controls (P<0.0001).  These studies confirm that mutations affecting the ubiquitin-binding domain of SQSTM1 are a common cause of familial and sporadic Paget's disease of bone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIN4hRKTDlJLVg90H21EOLACvtfcHk0ljZhetfK-xyMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVSjsL8%253D&md5=d7af34ca6549df760787245bb6538c33</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F11.22.2735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F11.22.2735%26sid%3Dliteratum%253Aachs%26aulast%3DHocking%26aufirst%3DL.%2BJ.%26aulast%3DLucas%26aufirst%3DG.%2BJ.%2BA.%26aulast%3DDaroszewska%26aufirst%3DA.%26aulast%3DMangion%26aufirst%3DJ.%26aulast%3DOlavesen%26aufirst%3DM.%26aulast%3DCundy%26aufirst%3DT.%26aulast%3DNicholson%26aufirst%3DG.%2BC.%26aulast%3DWard%26aufirst%3DL.%26aulast%3DBennett%26aufirst%3DS.%2BT.%26aulast%3DWuyts%26aufirst%3DW.%26aulast%3DVan%2BHul%26aufirst%3DW.%26aulast%3DRalston%26aufirst%3DS.%2BH.%26atitle%3DDomain-specific%2520mutations%2520in%2520sequestosome%25201%2520%2528SQSTM1%2529%2520cause%2520familial%2520and%2520sporadic%2520Paget%25E2%2580%2599s%2520disease%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2002%26volume%3D11%26issue%3D22%26spage%3D2735%26epage%3D2739%26doi%3D10.1093%2Fhmg%2F11.22.2735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigneron, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labbe, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorca, T.</span></span> <span> </span><span class="NLM_article-title">The anaphase-promoting complex: a key factor in the regulation of cell cycle</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">314</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1207973</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fsj.onc.1207973" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=15678131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2MXnsFShsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=314-325&issue=3&author=A.+Castroauthor=C.+Bernisauthor=S.+Vigneronauthor=J.+C.+Labbeauthor=T.+Lorca&title=The+anaphase-promoting+complex%3A+a+key+factor+in+the+regulation+of+cell+cycle&doi=10.1038%2Fsj.onc.1207973"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The anaphase-promoting complex: a key factor in the regulation of cell cycle</span></div><div class="casAuthors">Castro, Anna; Bernis, Cyril; Vigneron, Suzanne; Labbe, Jean-Claude; Lorca, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">314-325</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Events controlling cell division are governed by the degrdn. of different regulatory proteins by the ubiquitin-dependent pathway.  In this pathway, the attachment of a polyubiquitin chain to a substrate by a ubiquitin ligase targets this substrate for degrdn. by the 26S proteasome.  Two different ubiquitin ligases play an important role in the cell cycle: the SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC).  Here, the authors describe the present knowledge about the APC.  The authors pay particular attention to the latest results concerning APC structure, APC regulation, and substrate recognition, and discuss the implications of these findings in an understanding of APC function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmv8lwu3_qbrVg90H21EOLACvtfcHk0lhV6zXc8tVWkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXnsFShsg%253D%253D&md5=c8c304a9928c3ba05cbd93b516f4fe77</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207973%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DBernis%26aufirst%3DC.%26aulast%3DVigneron%26aufirst%3DS.%26aulast%3DLabbe%26aufirst%3DJ.%2BC.%26aulast%3DLorca%26aufirst%3DT.%26atitle%3DThe%2520anaphase-promoting%2520complex%253A%2520a%2520key%2520factor%2520in%2520the%2520regulation%2520of%2520cell%2520cycle%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26issue%3D3%26spage%3D314%26epage%3D325%26doi%3D10.1038%2Fsj.onc.1207973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klionsky, D. J.</span></span> <span> </span><span class="NLM_article-title">Eaten alive: a history of macroautophagy</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">814</span>– <span class="NLM_lpage">822</span>, <span class="refDoi"> DOI: 10.1038/ncb0910-814</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fncb0910-814" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20811353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSju7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=814-822&issue=9&author=Z.+F.+Yangauthor=D.+J.+Klionsky&title=Eaten+alive%3A+a+history+of+macroautophagy&doi=10.1038%2Fncb0910-814"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Eaten alive: a history of macroautophagy</span></div><div class="casAuthors">Yang, Zhifen; Klionsky, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">814-822</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Macroautophagy (hereafter autophagy), or 'self-eating', is a conserved cellular pathway that controls protein and organelle degrdn., and has essential roles in survival, development and homeostasis.  Autophagy is also integral to human health and is involved in physiol., development, lifespan and a wide range of diseases, including cancer, neurodegeneration and microbial infection.  Although research on this topic began in the late 1950s, substantial progress in the mol. study of autophagy has taken place during only the past 15 years.  This review traces the key findings that led to our current mol. understanding of this complex process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ_iZJ3YUoHrVg90H21EOLACvtfcHk0lhV6zXc8tVWkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSju7zE&md5=a20abac7db3f20eac668c41052413397</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fncb0910-814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb0910-814%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%2BF.%26aulast%3DKlionsky%26aufirst%3DD.%2BJ.%26atitle%3DEaten%2520alive%253A%2520a%2520history%2520of%2520macroautophagy%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2010%26volume%3D12%26issue%3D9%26spage%3D814%26epage%3D822%26doi%3D10.1038%2Fncb0910-814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rusten, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenmark, H.</span></span> <span> </span><span class="NLM_article-title">p62, an autophagy hero or culprit?</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">209</span>, <span class="refDoi"> DOI: 10.1038/ncb0310-207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fncb0310-207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20190829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFemsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=207-209&issue=3&author=T.+E.+Rustenauthor=H.+Stenmark&title=p62%2C+an+autophagy+hero+or+culprit%3F&doi=10.1038%2Fncb0310-207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">p62, an autophagy hero or culprit?</span></div><div class="casAuthors">Rusten, Tor Erik; Stenmark, Harald</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207-209</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The p62 protein recognizes toxic cellular waste, which is then scavenged by a sequestration process known as self-eating or autophagy.  Lack of autophagy leads to accumulation of p62, which is not good for liver cells, as it induces a cellular stress response that leads to disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDTvJsqrkhz7Vg90H21EOLACvtfcHk0lhV6zXc8tVWkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFemsLo%253D&md5=8c8db4932b3c53a0e576e2cda62fcc20</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fncb0310-207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb0310-207%26sid%3Dliteratum%253Aachs%26aulast%3DRusten%26aufirst%3DT.%2BE.%26aulast%3DStenmark%26aufirst%3DH.%26atitle%3Dp62%252C%2520an%2520autophagy%2520hero%2520or%2520culprit%253F%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2010%26volume%3D12%26issue%3D3%26spage%3D207%26epage%3D209%26doi%3D10.1038%2Fncb0310-207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korolchuk, V. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansilla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menzies, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinsztein, D. C.</span></span> <span> </span><span class="NLM_article-title">Autophagy inhibition compromises degradation of ubiquitin–proteasome pathway substrates</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">517</span>– <span class="NLM_lpage">527</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2009.01.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.molcel.2009.01.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19250912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltFSnu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2009&pages=517-527&issue=4&author=V.+I.+Korolchukauthor=A.+Mansillaauthor=F.+M.+Menziesauthor=D.+C.+Rubinsztein&title=Autophagy+inhibition+compromises+degradation+of+ubiquitin%E2%80%93proteasome+pathway+substrates&doi=10.1016%2Fj.molcel.2009.01.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates</span></div><div class="casAuthors">Korolchuk, Viktor I.; Mansilla, Alicia; Menzies, Fiona M.; Rubinsztein, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">517-527</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The two main routes that cells use for degrading intracellular proteins are the ubiquitin-proteasome and autophagy-lysosome pathways, which have been thought to have largely distinct clients.  Here, we show that autophagy inhibition increases levels of proteasome substrates.  This is largely due to p62 (also called A170/SQSTM1) accumulation after autophagy inhibition.  Excess p62 inhibits the clearance of ubiquitinated proteins destined for proteasomal degrdn. by delaying their delivery to the proteasome's proteases.  Our data show that autophagy inhibition, which was previously believed to only affect long-lived proteins, will also compromise the ubiquitin-proteasome system.  This will lead to increased levels of short-lived regulatory proteins, like p53, as well as the accumulation of aggregation-prone proteins, with predicted deleterious consequences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw5rr6zXQN6bVg90H21EOLACvtfcHk0ljlFYMwBwr3pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltFSnu7Y%253D&md5=b184b0dedbf7b2cedea3f76687aebe85</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2009.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2009.01.021%26sid%3Dliteratum%253Aachs%26aulast%3DKorolchuk%26aufirst%3DV.%2BI.%26aulast%3DMansilla%26aufirst%3DA.%26aulast%3DMenzies%26aufirst%3DF.%2BM.%26aulast%3DRubinsztein%26aufirst%3DD.%2BC.%26atitle%3DAutophagy%2520inhibition%2520compromises%2520degradation%2520of%2520ubiquitin%25E2%2580%2593proteasome%2520pathway%2520substrates%26jtitle%3DMol.%2520Cell%26date%3D2009%26volume%3D33%26issue%3D4%26spage%3D517%26epage%3D527%26doi%3D10.1016%2Fj.molcel.2009.01.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachenmayer, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, Z.</span></span> <span> </span><span class="NLM_article-title">Proteotoxic stress induces phosphorylation of p62/SQSTM1 by ULK1 to regulate selective autophagic clearance of protein aggregates</span>. <i>PLoS Genet.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">e1004987</span>, <span class="refDoi"> DOI: 10.1371/journal.pgen.1004987</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1371%2Fjournal.pgen.1004987" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=25723488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28XltlCns74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=e1004987&issue=2&author=J.+Limauthor=M.+L.+Lachenmayerauthor=S.+Wuauthor=W.+Liuauthor=M.+Kunduauthor=R.+Wangauthor=M.+Komatsuauthor=Y.+J.+Ohauthor=Y.+Zhaoauthor=Z.+Yue&title=Proteotoxic+stress+induces+phosphorylation+of+p62%2FSQSTM1+by+ULK1+to+regulate+selective+autophagic+clearance+of+protein+aggregates&doi=10.1371%2Fjournal.pgen.1004987"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Proteotoxic stress induces phosphorylation of p62/SQSTM1 by ULK1 to regulate selective autophagic clearance of protein aggregates</span></div><div class="casAuthors">Lim, Junghyun; Lenard, Lachenmayer M.; Wu, Shuai; Liu, Wenchao; Kundu, Mondira; Wang, Rong; Komatsu, Masaaki; Oh, Young J.; Zhao, Yanxiang; Yue, Zhenyu</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Genetics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e1004987/1-e1004987/28</span>CODEN:
                <span class="NLM_cas:coden">PGLEB5</span>;
        ISSN:<span class="NLM_cas:issn">1553-7404</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Disruption of proteostasis, or protein homeostasis, is often assocd. with aberrant accumulation of misfolded proteins or protein aggregates.  Autophagy offers protection to cells by removing toxic protein aggregates and injured organelles in response to proteotoxic stress.  However, the exact mechanism whereby autophagy recognizes and degrades misfolded or aggregated proteins has yet to be elucidated.  Mounting evidence demonstrates the selectivity of autophagy, which is mediated through autophagy receptor proteins (e.g. p62/SQSTM1) linking autophagy cargos and autophagosomes.  Here we report that proteotoxic stress imposed by the proteasome inhibition or expression of polyglutamine expanded huntingtin (polyQ-Htt) induces p62 phosphorylation at its ubiquitin-assocn. (UBA) domain that regulates its binding to ubiquitinated proteins.We find that autophagy-related kinase ULK1 phosphorylates p62 at a novel phosphorylation site S409 in UBA domain.  Interestingly, phosphorylation of p62 by ULK1 does not occur upon nutrient starvation, in spite of its role in canonical autophagy signaling.  ULK1 also phosphorylates S405, while S409 phosphorylation critically regulates S405 phosphorylation.  We find that S409 phosphorylation destabilizes the UBA dimer interface, and increases binding affinity of p62 to ubiquitin.  Furthermore, lack of S409 phosphorylation causes accumulation of p62, aberrant localization of autophagy proteins and inhibition of the clearance of ubiquitinated proteins or polyQ-Htt.  Therefore, our data provide mechanistic insights into the regulation of selective autophagy by ULK1 and p62 upon proteotoxic stress.  Our study suggests a potential novel drug target in developing autophagy-based therapeutics for the treatment of proteinopathies including Huntington' disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGQyUcPSyWcrVg90H21EOLACvtfcHk0ljlFYMwBwr3pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltlCns74%253D&md5=ebbcdae749c70ff1b1ec31ee3a690fb8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pgen.1004987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pgen.1004987%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DJ.%26aulast%3DLachenmayer%26aufirst%3DM.%2BL.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DKundu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DOh%26aufirst%3DY.%2BJ.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DYue%26aufirst%3DZ.%26atitle%3DProteotoxic%2520stress%2520induces%2520phosphorylation%2520of%2520p62%252FSQSTM1%2520by%2520ULK1%2520to%2520regulate%2520selective%2520autophagic%2520clearance%2520of%2520protein%2520aggregates%26jtitle%3DPLoS%2520Genet.%26date%3D2015%26volume%3D11%26issue%3D2%26spage%3De1004987%26doi%3D10.1371%2Fjournal.pgen.1004987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibenhener, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderilla-Barbosa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, M. C.</span></span> <span> </span><span class="NLM_article-title">SQSTM1/p62 interacts with HDAC6 and regulates deacetylase activity</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">e76016</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0076016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1371%2Fjournal.pone.0076016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=24086678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOrsLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e76016&issue=9&author=J.+Yanauthor=M.+L.+Seibenhenerauthor=L.+Calderilla-Barbosaauthor=M.+T.+Diaz-Mecoauthor=J.+Moscatauthor=J.+X.+Jiangauthor=M.+W.+Wootenauthor=M.+C.+Wooten&title=SQSTM1%2Fp62+interacts+with+HDAC6+and+regulates+deacetylase+activity&doi=10.1371%2Fjournal.pone.0076016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">SQSTM1/p62 interacts with HDAC6 and regulates deacetylase activity</span></div><div class="casAuthors">Yan, Jin; Seibenhener, Michael Lamar; Calderilla-Barbosa, Luis; Diaz-Meco, Maria-Theresa; Moscat, Jorge; Jiang, Jianxiong; Wooten, Marie W.; Wooten, Michael C.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e76016</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Protein aggregates can form in the cytoplasm of the cell and are accumulated at aggresomes localized to the microtubule organizing center (MTOC) where they are subsequently degraded by autophagy.  In this process, aggregates are engulfed into autophagosomes which subsequently fuse with lysosomes for protein degrdn.  A member of the class II histone deacetylase family, histone deacetylase 6(HDAC6) has been shown to be involved in both aggresome formation and the fusion of autophagosomes with lysosomes making it an attractive target to regulate protein aggregation.  The scaffolding protein sequestosome 1(SQSTM1)/p62 has also been shown to regulate accumulation and autophagic clearance of protein aggregates.  Recent studies have revealed colocalization of HDAC6 and p62 to ubiquitinated mitochondria, as well as, ubiquitinated protein aggregates assocd. with the E3 ubiquitin ligase TRIM50.  HDAC6 deacetylase activity is required for aggresome formation and can be regulated by protein interaction with HDAC6.  Due to their colocalization at ubiquitinated protein aggregates, we sought to examine if p62 specifically interacted with HDAC6 and if so, if this interaction had any effect on HDAC6 activity and/or the physiol. function of cortactin-F-actin assembly.  We succeeded in identifying and mapping the direct interaction between HDAC6 and p62.  We further show that this interaction regulates HDAC6 deacetylase activity.  Data are presented demonstrating that the absence of p62 results in hyperactivation of HDAC6 and deacetylation of α-tubulin and cortactin.  Further, upon induction of protein misfolding we show that p62 is required for perinuclear co-localization of cortactin-F-actin assemblies.  Thus, our findings indicate that p62 plays a key role in regulating the recruitment of F-actin network assemblies to the MTOC, a crit. cellular function that is required for successful autophagic clearance of protein aggregates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpExnTVUcFzirVg90H21EOLACvtfcHk0ljlFYMwBwr3pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOrsLjE&md5=d9025bf2bb345b9300a728c6b492e456</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0076016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0076016%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DSeibenhener%26aufirst%3DM.%2BL.%26aulast%3DCalderilla-Barbosa%26aufirst%3DL.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DJ.%2BX.%26aulast%3DWooten%26aufirst%3DM.%2BW.%26aulast%3DWooten%26aufirst%3DM.%2BC.%26atitle%3DSQSTM1%252Fp62%2520interacts%2520with%2520HDAC6%2520and%2520regulates%2520deacetylase%2520activity%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D9%26spage%3De76016%26doi%3D10.1371%2Fjournal.pone.0076016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Long, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H. T.</span></span> <span> </span><span class="NLM_article-title">Multifunctional p62 effects underlie diverse metabolic diseases</span>. <i>Trends Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">818</span>– <span class="NLM_lpage">830</span>, <span class="refDoi"> DOI: 10.1016/j.tem.2017.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.tem.2017.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=28966079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFeqtr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=818-830&issue=11&author=M.+Longauthor=X.+Liauthor=L.+Liauthor=M.+Dodsonauthor=D.+D.+Zhangauthor=H.+T.+Zheng&title=Multifunctional+p62+effects+underlie+diverse+metabolic+diseases&doi=10.1016%2Fj.tem.2017.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional p62 Effects Underlie Diverse Metabolic Diseases</span></div><div class="casAuthors">Long, Min; Li, Xing; Li, Li; Dodson, Matthew; Zhang, Donna D.; Zheng, Hongting</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">818-830</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">P62, a protein capable of binding both ubiquitin and autophagy substrates, is well established as a key regulator in cancer and neurodegenerative diseases.  Recently, there has been accumulating evidence that p62 is also a pivotal regulator in metabolic diseases, such as obesity, T2DM, NAFLD, metabolic bone disease, gout and thyroid disease.  This review summarizes the emerging role of p62 on these diseases by considering its functional domains, phenotypes in genetically modified animals, clin. obsd. alterations, and its effects on downstream metabolic signaling pathways.  At the same time, we highlight the need to explore the roles played by p62 in the gastrointestinal environment and immune system, and the extent to which its elevated expression may confer protection against metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_BlrVQz9ZbrVg90H21EOLACvtfcHk0ljW79De7zZCkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFeqtr3E&md5=a1fabfc182d851f6283db0ed0caaa67a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2017.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2017.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DDodson%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26aulast%3DZheng%26aufirst%3DH.%2BT.%26atitle%3DMultifunctional%2520p62%2520effects%2520underlie%2520diverse%2520metabolic%2520diseases%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2017%26volume%3D28%26issue%3D11%26spage%3D818%26epage%3D830%26doi%3D10.1016%2Fj.tem.2017.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Martin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span> <span> </span><span class="NLM_article-title">p62/SQSTM1-steering the cell through health and disease</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>131</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">jcs222836</span>, <span class="refDoi"> DOI: 10.1242/jcs.222836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1242%2Fjcs.222836" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=30397181" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2018&pages=jcs222836&issue=21&author=P.+Sanchez-Martinauthor=M.+Komatsu&title=p62%2FSQSTM1-steering+the+cell+through+health+and+disease&doi=10.1242%2Fjcs.222836"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1242%2Fjcs.222836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.222836%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez-Martin%26aufirst%3DP.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3Dp62%252FSQSTM1-steering%2520the%2520cell%2520through%2520health%2520and%2520disease%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2018%26volume%3D131%26issue%3D21%26spage%3Djcs222836%26doi%3D10.1242%2Fjcs.222836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span> <span> </span><span class="NLM_article-title">The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway</span>. <i>EMBO journal</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1576</span>– <span class="NLM_lpage">1586</span>, <span class="refDoi"> DOI: 10.1093/emboj/19.7.1576</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1093%2Femboj%2F19.7.1576" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD3cXislymt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=1576-1586&issue=7&author=L.+Sanzauthor=M.+T.+Diaz-Mecoauthor=H.+Nakanoauthor=J.+Moscat&title=The+atypical+PKC-interacting+protein+p62+channels+NF-kappaB+activation+by+the+IL-1-TRAF6+pathway&doi=10.1093%2Femboj%2F19.7.1576"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The atypical PKC-interacting protein p62 channels NF-κB activation by the IL-1-TRAF6 pathway</span></div><div class="casAuthors">Sanz, Laura; Diaz-Meco, Maria T.; Nakano, Hiroyasu; Moscat, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1576-1586</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The atypical protein kinase C (aPKC)-interacting protein, p62, has previously been shown to interact with RIP, linking these kinases to NF-κB activation by tumor necrosis factor α (TNFα).  The aPKCs have been implicated in the activation of IKKβ in TNFα-stimulated cells and have been shown to be activated in response to interleukin-1 (IL-1).  Here the authors demonstrate that the inhibition of the aPKCs or the down-regulation of p62 severely abrogates NF-κB activation by IL-1 and TRAF6, suggesting that both proteins are crit. intermediaries in this pathway.  Consistent with this the authors show that p62 selectively interacts with the TRAF domain of TRAF6 but not that of TRAF5 or TRAF2 in co-transfection expts.  The binding of endogenous p62 to TRAF6 is stimulus dependent, reinforcing the notion that this is a physiol. relevant interaction.  Furthermore, the authors demonstrate that the N-terminal domain of TRAF6, which is required for signaling, interacts with ζPKC in a dimerization-dependent manner.  Together, these results indicate that p62 is an important intermediary not only in TNFα but also in IL-1 signaling to NF-κB via the specific adapters RIP and TRAF6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrytjcrhYe9zbVg90H21EOLACvtfcHk0ljW79De7zZCkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXislymt7s%253D&md5=dcfc651bfcb5c031a7058464fee50f62</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F19.7.1576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F19.7.1576%26sid%3Dliteratum%253Aachs%26aulast%3DSanz%26aufirst%3DL.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DNakano%26aufirst%3DH.%26aulast%3DMoscat%26aufirst%3DJ.%26atitle%3DThe%2520atypical%2520PKC-interacting%2520protein%2520p62%2520channels%2520NF-kappaB%2520activation%2520by%2520the%2520IL-1-TRAF6%2520pathway%26jtitle%3DEMBO%2520journal%26date%3D2000%26volume%3D19%26issue%3D7%26spage%3D1576%26epage%3D1586%26doi%3D10.1093%2Femboj%2F19.7.1576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumanomidou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sou, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ezaki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kominami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamane, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span> <span> </span><span class="NLM_article-title">Structural basis for sorting mechanism of p62 in selective autophagy</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span> (<span class="NLM_issue">33</span>),  <span class="NLM_fpage">22847</span>– <span class="NLM_lpage">22857</span>, <span class="refDoi"> DOI: 10.1074/jbc.M802182200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1074%2Fjbc.M802182200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18524774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsVKmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=22847-22857&issue=33&author=Y.+Ichimuraauthor=T.+Kumanomidouauthor=Y.+S.+Souauthor=T.+Mizushimaauthor=J.+Ezakiauthor=T.+Uenoauthor=E.+Kominamiauthor=T.+Yamaneauthor=K.+Tanakaauthor=M.+Komatsu&title=Structural+basis+for+sorting+mechanism+of+p62+in+selective+autophagy&doi=10.1074%2Fjbc.M802182200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Sorting Mechanism of p62 in Selective Autophagy</span></div><div class="casAuthors">Ichimura, Yoshinobu; Kumanomidou, Taichi; Sou, Yu-shin; Mizushima, Tsunehiro; Ezaki, Junji; Ueno, Takashi; Kominami, Eiki; Yamane, Takashi; Tanaka, Keiji; Komatsu, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">22847-22857</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Impairment of autophagic degrdn. of the ubiquitin- and LC3-binding protein "p62" leads to the formation of cytoplasmic inclusion bodies.  However, little is known about the sorting mechanism of p62 to autophagic degrdn.  Here we identified a motif of murine p62 consisting of 11 amino acids (Ser334-Ser344) contg. conserved acidic and hydrophobic residues across species, as an LC3 recognition sequence (LRS).  The crystal structure of the LC3-LRS complex at 1.56Å resoln. revealed interaction of Trp340 and Leu343 of p62 with different hydrophobic pockets on the ubiquitin fold of LC3.  In vivo analyses demonstrated that p62 mutants lacking LC3 binding ability accumulated without entrapping into autophagosomes in the cytoplasm and subsequently formed ubiquitin-pos. inclusion bodies as in autophagy-deficient cells.  These results demonstrate that the intracellular level of p62 is tightly regulated by autophagy through the direct interaction of LC3 with p62 and reveal that selective turnover of p62 via autophagy controls inclusion body formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqriqJXuar6ObVg90H21EOLACvtfcHk0ljF00C7ztgvPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsVKmt7o%253D&md5=6066759d89a4a3bd321c9ca77bae7c5b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M802182200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M802182200%26sid%3Dliteratum%253Aachs%26aulast%3DIchimura%26aufirst%3DY.%26aulast%3DKumanomidou%26aufirst%3DT.%26aulast%3DSou%26aufirst%3DY.%2BS.%26aulast%3DMizushima%26aufirst%3DT.%26aulast%3DEzaki%26aufirst%3DJ.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DKominami%26aufirst%3DE.%26aulast%3DYamane%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3DStructural%2520basis%2520for%2520sorting%2520mechanism%2520of%2520p62%2520in%2520selective%2520autophagy%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26issue%3D33%26spage%3D22847%26epage%3D22857%26doi%3D10.1074%2Fjbc.M802182200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimple, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siderovski, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, G. L.</span></span> <span> </span><span class="NLM_article-title">PB1 domain interaction of p62/sequestosome 1 and MEKK3 regulates NF-kappaB activation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">2077</span>– <span class="NLM_lpage">2089</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.065102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1074%2Fjbc.M109.065102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19903815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjsVSqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=2077-2089&issue=3&author=K.+Nakamuraauthor=A.+J.+Kimpleauthor=D.+P.+Siderovskiauthor=G.+L.+Johnson&title=PB1+domain+interaction+of+p62%2Fsequestosome+1+and+MEKK3+regulates+NF-kappaB+activation&doi=10.1074%2Fjbc.M109.065102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">PB1 Domain Interaction of p62/Sequestosome 1 and MEKK3 Regulates NF-κB Activation</span></div><div class="casAuthors">Nakamura, Kazuhiro; Kimple, Adam J.; Siderovski, David P.; Johnson, Gary L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">2077-2089</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">P62/Sequestosome 1 is a scaffold protein involved in the regulation of autophagy, trafficking of proteins to the proteasome, and activation of NF-κB.  P62 encodes an N-terminal PB1 domain in addn. to the ZZ domain, TRAF6-binding domain, LC3 interaction region, and ubiquitin-assocd. domain, each crit. for the physiol. function of p62.  PB1 domains have a β-grasp topol. where the front end of one PB1 domain binds the back end of a second PB1 domain.  The p62 PB1 domain homodimerizes as well as heterodimerizes with other PB1 domains.  The front end of the PB1 domain in p62 binds the PB1 domain of atypical protein kinases C, the MAPK kinase, MEK5, and the NBR1 protein.  Other than its role in homodimerization, the rear end acidic cluster region of the p62 PB1 domain had no previous defined binding partners.  Herein, we demonstrate that the rear end acidic cluster region of the p62 PB1 domain binds the front end basic region of the MAPK kinase kinase, MEKK3.  P62 and MEKK3 co-localize in speckles or aggregates that are centers for organizing TRAF6-regulated NF-κB signaling and the assembly of polyubiquinated proteins sorting to sequestosomes and proteasomes.  The p62-MEKK3 complex binds TRAF6, which regulates the ubiquitination of the IKK complex and NF-κB activation.  P62 is required for the assocn. of MEKK3 with TRAF6, and short hairpin RNA knockdown of p62 inhibits IL-1 and MEKK3 activation of NF-κB.  The rear end acidic cluster of the p62 PB1 domain is used to organize cytosolic aggregates or speckles-assocd. TRAF6-p62-MEKK3 complex for control of NF-κB activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS5Q3e_FG82rVg90H21EOLACvtfcHk0ljF00C7ztgvPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjsVSqsg%253D%253D&md5=dca7f975296dcfa2273d2845b20b0a8d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.065102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.065102%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DKimple%26aufirst%3DA.%2BJ.%26aulast%3DSiderovski%26aufirst%3DD.%2BP.%26aulast%3DJohnson%26aufirst%3DG.%2BL.%26atitle%3DPB1%2520domain%2520interaction%2520of%2520p62%252Fsequestosome%25201%2520and%2520MEKK3%2520regulates%2520NF-kappaB%2520activation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26issue%3D3%26spage%3D2077%26epage%3D2089%26doi%3D10.1074%2Fjbc.M109.065102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ofengeim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">736</span>, <span class="refDoi"> DOI: 10.1038/nrm3683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fnrm3683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=24129419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1WmsL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=727-736&issue=11&author=D.+Ofengeimauthor=J.+Yuan&title=Regulation+of+RIP1+kinase+signalling+at+the+crossroads+of+inflammation+and+cell+death&doi=10.1038%2Fnrm3683"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death</span></div><div class="casAuthors">Ofengeim, Dimitry; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">727-736</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Receptor-interacting protein 1 (RIP1) kinase has emerged as a key upstream regulator that controls inflammatory signaling as well as the activation of multiple cell death pathways, including apoptosis and necroptosis.  The ability of RIP1 to modulate these key cellular events is tightly controlled by ubiquitylation, deubiquitylation, and the interaction of RIP1 with a class of ubiquitin receptors.  The modification of RIP1 may thus provide a unique 'ubiquitin code' that dets. whether a cell activates nuclear factor-κB (NF-κB) to promote inflammatory signaling or induces cell death by apoptosis or necroptosis.  Targeting RIP1 might be a novel therapeutic strategy for the treatment of both acute and chronic human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEaxoFDmOcn7Vg90H21EOLACvtfcHk0ljF00C7ztgvPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1WmsL%252FE&md5=4a21fb85ca9c564082d2faedc1c60cf1</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrm3683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3683%26sid%3Dliteratum%253Aachs%26aulast%3DOfengeim%26aufirst%3DD.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DRegulation%2520of%2520RIP1%2520kinase%2520signalling%2520at%2520the%2520crossroads%2520of%2520inflammation%2520and%2520cell%2520death%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2013%26volume%3D14%26issue%3D11%26spage%3D727%26epage%3D736%26doi%3D10.1038%2Fnrm3683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L. K.</span></span> <span> </span><span class="NLM_article-title">p62/SQSTM1 as an oncotarget mediates cisplatin resistance through activating RIP1-NF-kappaB pathway in human ovarian cancer cells</span>. <i>Cancer science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>108</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1405</span>– <span class="NLM_lpage">1413</span>, <span class="refDoi"> DOI: 10.1111/cas.13276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1111%2Fcas.13276" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=28498503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVGntLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2017&pages=1405-1413&issue=7&author=X.+Y.+Yanauthor=Y.+Zhangauthor=J.+J.+Zhangauthor=L.+C.+Zhangauthor=Y.+N.+Liuauthor=Y.+Wuauthor=Y.+N.+Xueauthor=S.+Y.+Luauthor=J.+Suauthor=L.+K.+Sun&title=p62%2FSQSTM1+as+an+oncotarget+mediates+cisplatin+resistance+through+activating+RIP1-NF-kappaB+pathway+in+human+ovarian+cancer+cells&doi=10.1111%2Fcas.13276"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">p62/SQSTM1 as an oncotarget mediates cisplatin resistance through activating RIP1-NF-κB pathway in human ovarian cancer cells</span></div><div class="casAuthors">Yan, Xiao-Yu; Zhang, Yu; Zhang, Juan-Juan; Zhang, Li-Chao; Liu, Ya-Nan; Wu, Yao; Xue, Ya-Nan; Lu, Sheng-Yao; Su, Jing; Sun, Lian-Kun</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1405-1413</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Platinum-based therapeutic strategies have been widely used in ovarian cancer treatment.  However, drug resistance has greatly limited therapeutic efficacy.  Recently, tolerance to cisplatin has been attributed to other factors unrelated to DNA. p62 (also known as SQSTM1) functions as a multifunctional hub participating in tumorigenesis and may be a therapeutic target.  Our previous study showed that p62 was overexpressed in drug-resistant ovarian epithelial carcinoma and its inhibition increased the sensitivity to cisplatin.  In this study, we demonstrate that the activity of the NF-κB signaling pathway and K63-linked ubiquitination of RIP1 was higher in cisplatin-resistant ovarian (SKOV3/DDP) cells compared with parental cells.  In addn., cisplatin resistance could be reversed by inhibiting the expression of p62 using siRNA.  Furthermore, deletion of the ZZ domain of p62 that interacts with RIP1 in SKOV3 cells markedly decreased K63-linked ubiquitination of RIP1 and inhibited the activation of the NF-κB signaling pathway.  Moreover, loss of the ZZ domain from p62 led to poor proliferative capacity and high levels of apoptosis in SKOV3 cells and made them more sensitive to cisplatin treatment.  Collectively, we provide evidence that p62 is implicated in the activation of NF-κB signaling that is partly dependent on RIP1. p62 promotes cell proliferation and inhibits apoptosis thus mediating drug resistance in ovarian cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZvEM9J3RUg7Vg90H21EOLACvtfcHk0lj1v-Sj6bRYZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVGntLbL&md5=750746b2c920bb418afc86232741476c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fcas.13276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.13276%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DX.%2BY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DL.%2BC.%26aulast%3DLiu%26aufirst%3DY.%2BN.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DY.%2BN.%26aulast%3DLu%26aufirst%3DS.%2BY.%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DL.%2BK.%26atitle%3Dp62%252FSQSTM1%2520as%2520an%2520oncotarget%2520mediates%2520cisplatin%2520resistance%2520through%2520activating%2520RIP1-NF-kappaB%2520pathway%2520in%2520human%2520ovarian%2520cancer%2520cells%26jtitle%3DCancer%2520science%26date%3D2017%26volume%3D108%26issue%3D7%26spage%3D1405%26epage%3D1413%26doi%3D10.1111%2Fcas.13276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwok, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Belleroche, J. S.</span></span> <span> </span><span class="NLM_article-title">Sequestosome-1 (SQSTM1) sequence variants in ALS cases in the UK: prevalence and coexistence of SQSTM1 mutations in ALS kindred with PDB</span>. <i>Eur. J. Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">492</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1038/ejhg.2013.184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fejhg.2013.184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=23942205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktlGlt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=492-496&issue=4&author=C.+T.+Kwokauthor=A.+Morrisauthor=J.+S.+de+Belleroche&title=Sequestosome-1+%28SQSTM1%29+sequence+variants+in+ALS+cases+in+the+UK%3A+prevalence+and+coexistence+of+SQSTM1+mutations+in+ALS+kindred+with+PDB&doi=10.1038%2Fejhg.2013.184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Sequestosome-1 (SQSTM1) sequence variants in ALS cases in the UK: prevalence and coexistence of SQSTM1 mutations in ALS kindred with PDB</span></div><div class="casAuthors">Kwok, Chun T.; Morris, Alex; de Belleroche, Jacqueline S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">492-496</span>CODEN:
                <span class="NLM_cas:coden">EJHGEU</span>;
        ISSN:<span class="NLM_cas:issn">1018-4813</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in the SQSTM1 gene have been reported to be assocd. with amyotrophic lateral sclerosis (ALS).  We sought to det. the frequency of these mutations in a UK familial ALS (FALS) cohort.  Sequences of all eight exons of the SQSTM1 gene were analyzed in index cases from 61 different FALS kindred lacking known FALS mutations.  Six exonic variants c.463G>A, p.(Glu155Lys), c.822G>C, p.(Glu274Asp), c.888G>T, p.(=), c.954C>T, p.(=), c.1038G>A, p.(=) and c.1175C>T, p.  (Pro392Leu) were identified in five FALS index cases, three of which were non-synonymous and three were synonymous.  One index case harbored three variants (c.822G>C, c.888G>T and c.954C>T), and a second index case harbored two variants (c.822G>C and c.954C>T).  Only the p.(Pro392Leu) and p.(Glu155Lys) mutations were predicted to be pathogenic.  In one p.(Pro392Leu) kindred, the carrier developed both ALS and Paget's disease of bone (PDB), and, in the p.(Glu155Lys) kindred, the father of the proband developed PDB.  All p.(Pro392Leu) carriers were heterozygous for a previously reported founder haplotype for PDB, where this mutation has an established causal effect.  The frequency of the p.(Pro392Leu) mutation in this UK FALS cohort was 2.3% and 0.97% overall including three previously screened FALS cohorts.  Our results confirm the presence of the p.(Pro392Leu) SQSTM1 mutation in FALS.  This mutation is the most common SQSTM1 mutation found in ALS to date, and a likely pathogenicity is supported by having an established causal role in PDB.  The occurrence of the same mutation in ALS and PDB is indicative of a common pathogenic pathway that converges on protein homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozWZMgJFrGL7Vg90H21EOLACvtfcHk0lj1v-Sj6bRYZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktlGlt78%253D&md5=bb5e2764204efbae60ac1d9f64e91c25</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fejhg.2013.184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fejhg.2013.184%26sid%3Dliteratum%253Aachs%26aulast%3DKwok%26aufirst%3DC.%2BT.%26aulast%3DMorris%26aufirst%3DA.%26aulast%3Dde%2BBelleroche%26aufirst%3DJ.%2BS.%26atitle%3DSequestosome-1%2520%2528SQSTM1%2529%2520sequence%2520variants%2520in%2520ALS%2520cases%2520in%2520the%2520UK%253A%2520prevalence%2520and%2520coexistence%2520of%2520SQSTM1%2520mutations%2520in%2520ALS%2520kindred%2520with%2520PDB%26jtitle%3DEur.%2520J.%2520Hum.%2520Genet.%26date%3D2014%26volume%3D22%26issue%3D4%26spage%3D492%26epage%3D496%26doi%3D10.1038%2Fejhg.2013.184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Joazeiro, C. A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissman, A. M.</span></span> <span> </span><span class="NLM_article-title">RING finger proteins: mediators of ubiquitin ligase activity</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>102</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">549</span>– <span class="NLM_lpage">552</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)00077-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2FS0092-8674%2800%2900077-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=11007473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFWit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=549-552&issue=5&author=C.+A.+P.+Joazeiroauthor=A.+M.+Weissman&title=RING+finger+proteins%3A+mediators+of+ubiquitin+ligase+activity&doi=10.1016%2FS0092-8674%2800%2900077-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">RING finger proteins: mediators of ubiquitin ligase activity</span></div><div class="casAuthors">Joazeiro, Claudio A. P.; Weissman, Allan M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">549-552</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review with 20 refs.  Ubiquitination is a highly regulated and common cellular process with ubiquitin protein ligases (E3) as central players.  RING finger proteins represent the largest class of E3s to date.  Whether RING fingers are primarily modules that mediate ubiquitination and other protein modifications or if they have other discrete functions should soon become apparent.  Mammalian genomes encode hundreds of RING finger proteins.  Extrapolating from in vitro studies, we predict that many of these have the capacity to interact with E2s and to potentially mediate ubiquitination.  It remains to be detd. how many of these will be bona fide E3s for heterologous substrates, targets for ubiquitination, or both.  The no. of potential E3s is further enhanced by the combinatorial assocn. of certain RING finger proteins with other proteins that provide docking sites for substrates.  The field of intracellular protein degrdn. now leaves the era where mediators of substrate-specific ubiquitination were scarce and enters a new and exciting phase where databases provide us with a large no. of candidate E3s awaiting characterization.  Each has the potential to help us understand how cells orchestrate the complexities of rapidly regulating protein levels and activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGstCtpScUhrVg90H21EOLACvtfcHk0lj1v-Sj6bRYZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFWit7s%253D&md5=92fc04f47883e83d39cb491d6fa26834</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2900077-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252900077-5%26sid%3Dliteratum%253Aachs%26aulast%3DJoazeiro%26aufirst%3DC.%2BA.%2BP.%26aulast%3DWeissman%26aufirst%3DA.%2BM.%26atitle%3DRING%2520finger%2520proteins%253A%2520mediators%2520of%2520ubiquitin%2520ligase%2520activity%26jtitle%3DCell%26date%3D2000%26volume%3D102%26issue%3D5%26spage%3D549%26epage%3D552%26doi%3D10.1016%2FS0092-8674%2800%2900077-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geetha, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibenhener, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span> <span> </span><span class="NLM_article-title">The p62 scaffold regulates nerve growth factor-induced NF-kappa B activation by influencing TRAF6 polyubiquitination</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span> (<span class="NLM_issue">42</span>),  <span class="NLM_fpage">35625</span>– <span class="NLM_lpage">35629</span>, <span class="refDoi"> DOI: 10.1074/jbc.C500237200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1074%2Fjbc.C500237200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=16079148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFWmurrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=35625-35629&issue=42&author=M.+W.+Wootenauthor=T.+Geethaauthor=M.+L.+Seibenhenerauthor=J.+R.+Babuauthor=M.+T.+Diaz-Mecoauthor=J.+Moscat&title=The+p62+scaffold+regulates+nerve+growth+factor-induced+NF-kappa+B+activation+by+influencing+TRAF6+polyubiquitination&doi=10.1074%2Fjbc.C500237200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The p62 scaffold regulates nerve growth factor-induced NF-κB activation by influencing TRAF6 polyubiquitination</span></div><div class="casAuthors">Wooten, Marie W.; Geetha, Thangiah; Seibenhener, M. Lamar; Babu, J. Ramesh; Diaz-Meco, Maria T.; Moscat, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">35625-35629</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Sequestosome 1/p62 is a scaffolding protein with several interaction modules that include a PB1 dimerization domain, a TRAF6 (tumor necrosis factor receptor-assocd. factor 6) binding site, and a ubiquitin-assocg. (UBA) domain.  Here, we report that p62 functions to facilitate K63-polyubiquitination of TRAF6 and thereby mediates nerve growth factor-induced activation of the NF-κB pathway.  In brain of p62 knock-out mice we did not recover polyubiquitinated TRAF6.  The UBA domain binds polyubiquitin chains and deletion of p62-UBA domain or mutation of F406V within the ubiquitin binding pocket of the UBA domain abolished TRAF6 polyubiquitination.  Likewise, deletion of p62 N-terminal dimerization domain or the TRAF6 binding site had similar effects on both polyubiquitination and oligomerization of TRAF6.  Nerve growth factor treatment of PC12 cells induced TRAF6 polyubiquitination along with formation of a p62-TRAF6-IKKβ-PKCι signal complex, while inhibition of the p62/TRAF6 interaction had an opposite effect.  These results provide evidence for a mechanism whereby p62 serves to regulate the NF-κB pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhHtx2OlREorVg90H21EOLACvtfcHk0lgjMbDOn478vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFWmurrE&md5=b0b847082ba014a13bf74838eb5420db</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C500237200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C500237200%26sid%3Dliteratum%253Aachs%26aulast%3DWooten%26aufirst%3DM.%2BW.%26aulast%3DGeetha%26aufirst%3DT.%26aulast%3DSeibenhener%26aufirst%3DM.%2BL.%26aulast%3DBabu%26aufirst%3DJ.%2BR.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DMoscat%26aufirst%3DJ.%26atitle%3DThe%2520p62%2520scaffold%2520regulates%2520nerve%2520growth%2520factor-induced%2520NF-kappa%2520B%2520activation%2520by%2520influencing%2520TRAF6%2520polyubiquitination%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26issue%3D42%26spage%3D35625%26epage%3D35629%26doi%3D10.1074%2Fjbc.C500237200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chamoux, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McManus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laberge, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roux, S.</span></span> <span> </span><span class="NLM_article-title">Involvement of kinase PKC-zeta in the p62/p62(P392L)-driven activation of NF-kappaB in human osteoclasts</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1832</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">475</span>– <span class="NLM_lpage">484</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2012.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.bbadis.2012.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCgtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1832&publication_year=2013&pages=475-484&issue=3&author=E.+Chamouxauthor=S.+McManusauthor=G.+Labergeauthor=M.+Bissonauthor=S.+Roux&title=Involvement+of+kinase+PKC-zeta+in+the+p62%2Fp62%28P392L%29-driven+activation+of+NF-kappaB+in+human+osteoclasts&doi=10.1016%2Fj.bbadis.2012.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of kinase PKC-zeta in the p62/p62P392L-driven activation of NF-κB in human osteoclasts</span></div><div class="casAuthors">Chamoux, Estelle; McManus, Stephen; Laberge, Gino; Bisson, Martine; Roux, Sophie</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1832</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">475-484</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Mutations of the gene encoding sequestosome1 (SQSTM1/p62), clustering in or near the UBA domain, have been described in Paget's disease of bone (PDB); among these the P392L substitution is the most prevalent.  Protein p62 mediates several cell functions, including the control of NF-κB signaling, and autophagy.  This scaffolding protein interacts with atypical PKCζ in the RANKL-induced signaling complex.  We have previously shown that osteoclasts (OCs) overexpressing the p62P392L variant were in a constitutively activated state, presenting activated kinase p-PKCζ/λ and activated NF-κB prior to RANKL stimulation.  In the present study, we investigated the relationships between PKCζ and NF-κB activation in human OCs transfected with p62 variants.  We showed that PKCζ and p-PKCζ/λ colocalize with p62, and that PKCζ is involved in the RANKL-induced NF-κB activation and in the RANKL-independent activation of NF-κB obsd. in p62P392L-transfected cells.  We also obsd. a basal and RANKL-induced increase in IκBα levels in the presence of the p62P392L mutation that contrasted with the NF-κB activation.  In this study we propose that PKCζ plays a role in the activation of NF-κB by acting as a p65 (RelA) kinase at Ser536, independently of IκBα; this alternative pathway could be used preferentially in the presence of the p62P392L mutation, which may hinder the ubiquitin-proteasome pathway.  Overall, our results highlight the importance of p62-assocd. PKCζ in the overactive state of pagetic OCs and in the activation of NF-κB, particularly in the presence of the p62P392L mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoToi0wa789mrVg90H21EOLACvtfcHk0lgjMbDOn478vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCgtLk%253D&md5=c381b983a8c6e13aa85a5c28a411c0a6</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2012.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2012.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DChamoux%26aufirst%3DE.%26aulast%3DMcManus%26aufirst%3DS.%26aulast%3DLaberge%26aufirst%3DG.%26aulast%3DBisson%26aufirst%3DM.%26aulast%3DRoux%26aufirst%3DS.%26atitle%3DInvolvement%2520of%2520kinase%2520PKC-zeta%2520in%2520the%2520p62%252Fp62%2528P392L%2529-driven%2520activation%2520of%2520NF-kappaB%2520in%2520human%2520osteoclasts%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2013%26volume%3D1832%26issue%3D3%26spage%3D475%26epage%3D484%26doi%3D10.1016%2Fj.bbadis.2012.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bloom, G. S.</span></span> <span> </span><span class="NLM_article-title">Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis</span>. <i>JAMA neurology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">505</span>– <span class="NLM_lpage">508</span>, <span class="refDoi"> DOI: 10.1001/jamaneurol.2013.5847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1001%2Fjamaneurol.2013.5847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=24493463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BC2cvhslWmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=505-508&issue=4&author=G.+S.+Bloom&title=Amyloid-beta+and+tau%3A+the+trigger+and+bullet+in+Alzheimer+disease+pathogenesis&doi=10.1001%2Fjamaneurol.2013.5847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis</span></div><div class="casAuthors">Bloom George S</div><div class="citationInfo"><span class="NLM_cas:title">JAMA neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">505-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The defining features of Alzheimer disease (AD) include conspicuous changes in both brain histology and behavior.  The AD brain is characterized microscopically by the combined presence of 2 classes of abnormal structures, extracellular amyloid plaques and intraneuronal neurofibrillary tangles, both of which comprise highly insoluble, densely packed filaments.  The soluble building blocks of these structures are amyloid-β (Aβ) peptides for plaques and tau for tangles.  Amyloid-β peptides are proteolytic fragments of the transmembrane amyloid precursor protein, whereas tau is a brain-specific, axon-enriched microtubule-associated protein.  The behavioral symptoms of AD correlate with the accumulation of plaques and tangles, and they are a direct consequence of the damage and destruction of synapses that mediate memory and cognition.  Synapse loss can be caused by the failure of live neurons to maintain functional axons and dendrites or by neuron death.  During the past dozen years, a steadily accumulating body of evidence has indicated that soluble forms of Aβ and tau work together, independently of their accumulation into plaques and tangles, to drive healthy neurons into the diseased state and that hallmark toxic properties of Aβ require tau.  For instance, acute neuron death, delayed neuron death following ectopic cell cycle reentry, and synaptic dysfunction are triggered by soluble, extracellular Aβ species and depend on soluble, cytoplasmic tau.  Therefore, Aβ is upstream of tau in AD pathogenesis and triggers the conversion of tau from a normal to a toxic state, but there is also evidence that toxic tau enhances Aβ toxicity via a feedback loop.  Because soluble toxic aggregates of both Aβ and tau can self-propagate and spread throughout the brain by prionlike mechanisms, successful therapeutic intervention for AD would benefit from detecting these species before plaques, tangles, and cognitive impairment become evident and from interfering with the destructive biochemical pathways that they initiate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSz_gqDeA-SdD0O18WR3iAofW6udTcc2ebVCkTvrXs-P7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvhslWmsA%253D%253D&md5=a12c1fb9fb6f57c471009a3b30573fb3</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1001%2Fjamaneurol.2013.5847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjamaneurol.2013.5847%26sid%3Dliteratum%253Aachs%26aulast%3DBloom%26aufirst%3DG.%2BS.%26atitle%3DAmyloid-beta%2520and%2520tau%253A%2520the%2520trigger%2520and%2520bullet%2520in%2520Alzheimer%2520disease%2520pathogenesis%26jtitle%3DJAMA%2520neurology%26date%3D2014%26volume%3D71%26issue%3D4%26spage%3D505%26epage%3D508%26doi%3D10.1001%2Fjamaneurol.2013.5847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span> <span> </span><span class="NLM_article-title">TRAF6 promoted the metastasis of esophageal squamous cell carcinoma</span>. <i>Tumor Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">715</span>– <span class="NLM_lpage">721</span>, <span class="refDoi"> DOI: 10.1007/s13277-013-1098-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1007%2Fs13277-013-1098-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGjtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=715-721&issue=1&author=Q.+Hanauthor=F.+Yaoauthor=C.+Zhongauthor=H.+Zhao&title=TRAF6+promoted+the+metastasis+of+esophageal+squamous+cell+carcinoma&doi=10.1007%2Fs13277-013-1098-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">TRAF6 promoted the metastasis of esophageal squamous cell carcinoma</span></div><div class="casAuthors">Han, Qingqi; Yao, Feng; Zhong, Chenxi; Zhao, Heng</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">715-721</span>CODEN:
                <span class="NLM_cas:coden">TUMBEA</span>;
        ISSN:<span class="NLM_cas:issn">1010-4283</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Esophageal cancer is one of the most aggressive malignancies and has been ranked as the sixth leading cause of cancer-related death in the world.  It is very urgent to find new therapeutic targets.  Although tumor necrosis factor receptor-assocd. factor 6 (TRAF6) was initially identified as an adaptor for NF-κB signaling, recently it has been found to be involved in cancer by modulating various signaling pathways.  In the previous study, we have found that TRAF6 promoted the growth of esophageal squamous cell carcinoma (ESCC) cell in vitro and in vivo.  However, the effects of TRAF6 on the migration and metastasis of ESCC cells are poorly understood.  Here, we found that TRAF6 promoted migration and metastasis of ESCC cells through modulating Ras signaling.  Overexpression of TRAF6 promoted the migration of ESCC cells and immortalized esophageal epithelial cells, while knock down the expression of TRAF6 inhibited the migration and metastasis of ESCC cells in vitro and in vivo.  Mech., TRAF6 binds Ras with its N-terminal and activated Ras signaling.  Taken together, TRAF6 played an important role in the metastasis of ESCC and might be a promising therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9-0iCeZ1UwLVg90H21EOLACvtfcHk0lgfY1NHxxJdIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGjtbw%253D&md5=e5a133848689d41740042fdb8c540a6a</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs13277-013-1098-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13277-013-1098-z%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DQ.%26aulast%3DYao%26aufirst%3DF.%26aulast%3DZhong%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DH.%26atitle%3DTRAF6%2520promoted%2520the%2520metastasis%2520of%2520esophageal%2520squamous%2520cell%2520carcinoma%26jtitle%3DTumor%2520Biol.%26date%3D2014%26volume%3D35%26issue%3D1%26spage%3D715%26epage%3D721%26doi%3D10.1007%2Fs13277-013-1098-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Birgisdottir, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamark, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansen, T.</span></span> <span> </span><span class="NLM_article-title">The LIR motif-crucial for selective autophagy</span>. <i>Journal of cell science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>126</i></span> (<span class="NLM_issue">Pt 15</span>),  <span class="NLM_fpage">3237</span>– <span class="NLM_lpage">3247</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=23908376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFajur%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2013&pages=3237-3247&issue=Pt+15&author=A.+B.+Birgisdottirauthor=T.+Lamarkauthor=T.+Johansen&title=The+LIR+motif-crucial+for+selective+autophagy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The LIR motif - crucial for selective autophagy</span></div><div class="casAuthors">Birgisdottir, Aasa Birna; Lamark, Trond; Johansen, Terje</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3237-3247</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  (Macro)autophagy is a fundamental degrdn. process for macromols. and organelles of vital importance for cell and tissue homeostasis.  Autophagy research has gained a strong momentum in recent years because of its relevance to cancer, neurodegenerative diseases, muscular dystrophy, lipid storage disorders, development, ageing and innate immunity.  Autophagy has traditionally been thought of as a bulk degrdn. process that is mobilized upon nutritional starvation to replenish the cell with building blocks and keep up with the energy demand.  This view has recently changed dramatically following an array of papers describing various forms of selective autophagy.  A main driving force has been the discovery of specific autophagy receptors that sequester cargo into forming autophagosomes (phagophores).  At the heart of this selectivity lies the LC3-interacting region (LIR) motif, which ensures the targeting of autophagy receptors to LC3 (or other ATG8 family proteins) anchored in the phagophore membrane.  LIR-contg. proteins include cargo receptors, members of the basal autophagy app., proteins assocd. with vesicles and of their transport, Rab GTPase-activating proteins (GAPs) and specific signaling proteins that are degraded by selective autophagy.  Here, we comment on these new insights and focus on the interactions of LIR-contg. proteins with members of the ATG8 protein family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaWI8Ij9ZBkrVg90H21EOLACvtfcHk0lgfY1NHxxJdIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFajur%252FK&md5=37d7a374da7d515bc5cca5558261eb01</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBirgisdottir%26aufirst%3DA.%2BB.%26aulast%3DLamark%26aufirst%3DT.%26aulast%3DJohansen%26aufirst%3DT.%26atitle%3DThe%2520LIR%2520motif-crucial%2520for%2520selective%2520autophagy%26jtitle%3DJournal%2520of%2520cell%2520science%26date%3D2013%26volume%3D126%26issue%3DPt%252015%26spage%3D3237%26epage%3D3247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kominami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span> <span> </span><span class="NLM_article-title">Selective turnover of p62/A170/SQSTM1 by autophagy</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1063</span>– <span class="NLM_lpage">1066</span>, <span class="refDoi"> DOI: 10.4161/auto.6826</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.4161%2Fauto.6826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18776737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtlaktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=1063-1066&issue=8&author=Y.+Ichimuraauthor=E.+Kominamiauthor=K.+Tanakaauthor=M.+Komatsu&title=Selective+turnover+of+p62%2FA170%2FSQSTM1+by+autophagy&doi=10.4161%2Fauto.6826"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Selective turnover of p62/A170/SQSTM1 by autophagy</span></div><div class="casAuthors">Ichimura, Yoshinobu; Kominami, Eiki; Tanaka, Keiji; Komatsu, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1063-1066</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8627</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  Loss of autophagy causes liver injury, cardiomyopathy and neurodegeneration, assocd. with the formation of ubiquitin-pos. inclusion bodies.  However, the pathogenic mechanism and mol. machinery involved in inclusion formation are not fully understood.  We recently identified a ubiquitin-binding protein, p62/A170/SQSTM1, as a mol. involved in inclusion formation.  P62 interacts with LC3 which regulates autophagosome formation, through an 11 amino acid sequence rich in acidic and hydrophobic residues, named the LC3-recognition sequence (LRS), and the LC3-p62 complex is degraded by autophagy.  Furthermore, structural anal. reveals an interaction of Trp-340 and Leu-343 of p62 with different hydrophobic pockets in the ubiquitin-fold of LC3.  P62 mutants, defective in binding the LRS, escape efficient turnover by autophagy, forming ubiquitin- and p62-pos. inclusions.  Importantly, such ubiquitin- and p62-pos. inclusions are identified in various human diseases, implying the involvement of autophagy in their pathogenic mechanisms.  Our reports identify an important role for autophagy in the selective turnover of p62, and demonstrate that in addn. to the essential role of LC3 in autophagosome formation, LC3 is also involved in sorting autophagy-specific substrate(s).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLpHsCGMqL1rVg90H21EOLACvtfcHk0lgfY1NHxxJdIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtlaktQ%253D%253D&md5=1904742d6716c203b1c5093cd65628fa</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.4161%2Fauto.6826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.6826%26sid%3Dliteratum%253Aachs%26aulast%3DIchimura%26aufirst%3DY.%26aulast%3DKominami%26aufirst%3DE.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3DSelective%2520turnover%2520of%2520p62%252FA170%252FSQSTM1%2520by%2520autophagy%26jtitle%3DAutophagy%26date%3D2008%26volume%3D4%26issue%3D8%26spage%3D1063%26epage%3D1066%26doi%3D10.4161%2Fauto.6826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cha, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, J. S.</span></span> <span> </span><span class="NLM_article-title">Expression of autophagy-related proteins in hurthle cell neoplasm is different from that in follicular neoplasm</span>. <i>Dis. Markers</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1155/2017/1372387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1155%2F2017%2F1372387" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=1-8&author=Y.+J.+Chaauthor=H.+M.+Kimauthor=J.+S.+Koo&title=Expression+of+autophagy-related+proteins+in+hurthle+cell+neoplasm+is+different+from+that+in+follicular+neoplasm&doi=10.1155%2F2017%2F1372387"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1155%2F2017%2F1372387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2017%252F1372387%26sid%3Dliteratum%253Aachs%26aulast%3DCha%26aufirst%3DY.%2BJ.%26aulast%3DKim%26aufirst%3DH.%2BM.%26aulast%3DKoo%26aufirst%3DJ.%2BS.%26atitle%3DExpression%2520of%2520autophagy-related%2520proteins%2520in%2520hurthle%2520cell%2520neoplasm%2520is%2520different%2520from%2520that%2520in%2520follicular%2520neoplasm%26jtitle%3DDis.%2520Markers%26date%3D2017%26volume%3D2017%26spage%3D1%26epage%3D8%26doi%3D10.1155%2F2017%2F1372387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishayee, A.</span></span> <span> </span><span class="NLM_article-title">Nrf2-mediated redox signaling in arsenic carcinogenesis: a review</span>. <i>Arch. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>87</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1007/s00204-012-0920-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1007%2Fs00204-012-0920-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22914984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1emsbfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2013&pages=383-396&issue=2&author=D.+Sinhaauthor=J.+Biswasauthor=A.+Bishayee&title=Nrf2-mediated+redox+signaling+in+arsenic+carcinogenesis%3A+a+review&doi=10.1007%2Fs00204-012-0920-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2-mediated redox signaling in arsenic carcinogenesis: a review</span></div><div class="casAuthors">Sinha, Dona; Biswas, Jaydip; Bishayee, Anupam</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Toxicology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">383-396</span>CODEN:
                <span class="NLM_cas:coden">ARTODN</span>;
        ISSN:<span class="NLM_cas:issn">0340-5761</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Arsenic is a ubiquitous toxic metalloid whose natural leaching from geogenic resources of earth's crust into groundwater has become a dreadful health hazard to millions of people across the globe.  Arsenic has been documented as a top most potent human carcinogen by Agency of Toxic Substances and Disease Registry.  There have been a no. of schools of opinions regarding the underlying mechanism of arsenic-induced carcinogenicity, but the theory of oxidative stress generated by arsenic has gained much importance.  Imbalance in the cellular redox state and its assocd. complications have been closely assocd. with nuclear factor-erythroid 2-related factor 2 (Nrf2), a basic-leucine zipper transcription factor that activates the antioxidant responsive element and electrophilic responsive element, thereby upregulating the expression of a variety of downstream genes.  This review has been framed on the lines of differential mol. responses of Nrf2 on arsenic exposure as well as the chemopreventive strategy which may be improvised to regulate Nrf2 in order to combat arsenic-induced oxidative stress and its long-term carcinogenic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbBd2dQk9ac7Vg90H21EOLACvtfcHk0liOqIoBVZoRlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1emsbfP&md5=d3bdbb06e64c1ac797ff06d66743a180</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs00204-012-0920-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00204-012-0920-5%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DD.%26aulast%3DBiswas%26aufirst%3DJ.%26aulast%3DBishayee%26aufirst%3DA.%26atitle%3DNrf2-mediated%2520redox%2520signaling%2520in%2520arsenic%2520carcinogenesis%253A%2520a%2520review%26jtitle%3DArch.%2520Toxicol.%26date%3D2013%26volume%3D87%26issue%3D2%26spage%3D383%26epage%3D396%26doi%3D10.1007%2Fs00204-012-0920-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span> <span> </span><span class="NLM_article-title">Reasonably activating Nrf2: a long-term, effective and controllable strategy for neurodegenerative diseases</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>185</i></span>,  <span class="NLM_fpage">111862</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.111862</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.ejmech.2019.111862" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=31735576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFOlsL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2020&pages=111862&author=Q.+Liauthor=S.+Xingauthor=Y.+Chenauthor=Q.+Liaoauthor=Q.+Liauthor=Y.+Liuauthor=S.+Heauthor=F.+Fengauthor=Y.+Chenauthor=J.+Zhangauthor=W.+Liuauthor=Q.+Guoauthor=Y.+Sunauthor=H.+Sun&title=Reasonably+activating+Nrf2%3A+a+long-term%2C+effective+and+controllable+strategy+for+neurodegenerative+diseases&doi=10.1016%2Fj.ejmech.2019.111862"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Reasonably activating Nrf2: A long-term, effective and controllable strategy for neurodegenerative diseases</span></div><div class="casAuthors">Li, Qi; Xing, Shuaishuai; Chen, Ying; Liao, Qinghong; Li, Qihang; Liu, Yang; He, Siyu; Feng, Feng; Chen, Yao; Zhang, Jie; Liu, Wenyuan; Guo, Qinglong; Sun, Yuan; Sun, Haopeng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111862</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative diseases are a variety of debilitating and fatal disorder in central nervous system (CNS).  Besides targeting neuronal activity by influencing neurotransmitters or their corresponding receptors, modulating the underlying processes that lead to cell death, such as oxidative stress and mitochondrial dysfunction, should also be emphasized as an assistant strategy for neurodegeneration therapy.  Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) has been closely verified to be related to anti-inflammation and oxidative stress, rationally regulating its belonging pathway and activating Nrf2 is emphasized to be a potential treatment approach.  There have existed multiple Nrf2 activators with different mechanisms and diverse structures, but those applied for neuro-disorders are still limited.  On the basis of research arrangement and compd. summary, the authors put forward the limitations of existing Nrf2 activators for neurodegenerative diseases and their future developing directions in enhancing the blood-brain barrier permeability to make Nrf2 activators function in CNS and designing Nrf2-based multitarget-directed ligands to affect multiple nodes in pathol. of neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpaN0Pbk65J7Vg90H21EOLACvtfcHk0liOqIoBVZoRlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFOlsL%252FK&md5=c8062f0b9652b7fec2f6678f4f7378cb</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.111862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.111862%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DXing%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLiao%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DFeng%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DH.%26atitle%3DReasonably%2520activating%2520Nrf2%253A%2520a%2520long-term%252C%2520effective%2520and%2520controllable%2520strategy%2520for%2520neurodegenerative%2520diseases%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D185%26spage%3D111862%26doi%3D10.1016%2Fj.ejmech.2019.111862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamark, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjottem, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awuh, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overvatn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansen, T.</span></span> <span> </span><span class="NLM_article-title">p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span> (<span class="NLM_issue">29</span>),  <span class="NLM_fpage">22576</span>– <span class="NLM_lpage">22591</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.118976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1074%2Fjbc.M110.118976" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20452972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1WntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=22576-22591&issue=29&author=A.+Jainauthor=T.+Lamarkauthor=E.+Sjottemauthor=K.+B.+Larsenauthor=J.+A.+Awuhauthor=A.+Overvatnauthor=M.+McMahonauthor=J.+D.+Hayesauthor=T.+Johansen&title=p62%2FSQSTM1+is+a+target+gene+for+transcription+factor+NRF2+and+creates+a+positive+feedback+loop+by+inducing+antioxidant+response+element-driven+gene+transcription&doi=10.1074%2Fjbc.M110.118976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription</span></div><div class="casAuthors">Jain, Ashish; Lamark, Trond; Sjottem, Eva; Bowitz Larsen, Kenneth; Atesoh Awuh, Jane; Overvatn, Aud; McMahon, Michael; Hayes, John D.; Johansen, Terje</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">22576-22591</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The p62/SQSTM1 (sequestosome 1) protein, which acts as a cargo receptor for autophagic degrdn. of ubiquitinated targets, is up-regulated by various stressors.  Induction of the p62 gene by oxidative stress is mediated by NF-E2-related factor 2 (NRF2) and, at the same time, p62 protein contributes to the activation of NRF2, but hitherto the mechanisms involved were not known.  Herein, we have mapped an antioxidant response element (ARE) in the p62 promoter that is responsible for its induction by oxidative stress via NRF2.  Chromatin immunopptn. and gel mobility-shift assays verified that NRF2 binds to this cis-element in vivo and in vitro.  Also, p62 docks directly onto the Kelch-repeat domain of Kelch-like ECH-assocd. protein 1 (KEAP1), via a motif designated the KEAP1 interacting region (KIR), thereby blocking binding between KEAP1 and NRF2 that leads to ubiquitylation and degrdn. of the transcription factor.  The KIR motif in p62 is located immediately C-terminal to the LC3-interacting region (LIR) and resembles the ETGE motif utilized by NRF2 for its interaction with KEAP1.  KIR is required for p62 to stabilize NRF2, and inhibition of KEAP1 by p62 occurs from a cytoplasmic location within the cell.  The LIR and KIR motifs cannot be engaged simultaneously by LC3 and KEAP1, but because p62 is polymeric the interaction between KEAP1 and p62 leads to accumulation of KEAP1 in p62 bodies, which is followed by autophagic degrdn. of KEAP1.  Our data explain how p62 contributes to activation of NRF2 target genes in response to oxidative stress through creating a pos. feedback loop.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgqJXJvye3yrVg90H21EOLACvtfcHk0liOqIoBVZoRlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1WntLg%253D&md5=707de1a603fba64ec0d631b575bd6c99</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.118976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.118976%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DA.%26aulast%3DLamark%26aufirst%3DT.%26aulast%3DSjottem%26aufirst%3DE.%26aulast%3DLarsen%26aufirst%3DK.%2BB.%26aulast%3DAwuh%26aufirst%3DJ.%2BA.%26aulast%3DOvervatn%26aufirst%3DA.%26aulast%3DMcMahon%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DJohansen%26aufirst%3DT.%26atitle%3Dp62%252FSQSTM1%2520is%2520a%2520target%2520gene%2520for%2520transcription%2520factor%2520NRF2%2520and%2520creates%2520a%2520positive%2520feedback%2520loop%2520by%2520inducing%2520antioxidant%2520response%2520element-driven%2520gene%2520transcription%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26issue%3D29%26spage%3D22576%26epage%3D22591%26doi%3D10.1074%2Fjbc.M110.118976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span> <span> </span><span class="NLM_article-title">Activation of p62/SQSTM1-Keap1-nuclear factor erythroid 2-related factor 2 pathway in cancer</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">210</span>, <span class="refDoi"> DOI: 10.3389/fonc.2018.00210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.3389%2Ffonc.2018.00210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=29930914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252Fgs1GgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=210&author=Y.+Ichimuraauthor=M.+Komatsu&title=Activation+of+p62%2FSQSTM1-Keap1-nuclear+factor+erythroid+2-related+factor+2+pathway+in+cancer&doi=10.3389%2Ffonc.2018.00210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of p62/SQSTM1-Keap1-Nuclear Factor Erythroid 2-Related Factor 2 Pathway in Cancer</span></div><div class="casAuthors">Ichimura Yoshinobu; Komatsu Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">210</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">Autophagy and the Keap1-Nrf2 system are major cellular defense mechanisms against metabolic and oxidative stress.  These two systems are linked via phosphorylation of the ubiquitin binding autophagy receptor protein p62/SQSTM1 in the p62-Keap1-Nrf2 pathway.  The p62-Keap1-Nrf2 pathway plays a protective role in normal cells; however, recent studies indicate that this pathway induces tumorigenesis of pre-malignant cells, and promotes the growth and drug resistance of tumor cells via metabolic reprogramming mediated by Nrf2 activation.  These findings suggest that impairment of autophagy is involved in the acquisition of malignancy and maintenance of tumors, and furthermore, that p62/SQSTM1 could be a potential target for chemotherapy in cancers that harbor excess p62.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTviYn3QVqG6dHxxy173TfNfW6udTcc2eY03p0bteGC_7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252Fgs1GgsQ%253D%253D&md5=73a86b286e267b612bb101089809078b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2018.00210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2018.00210%26sid%3Dliteratum%253Aachs%26aulast%3DIchimura%26aufirst%3DY.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3DActivation%2520of%2520p62%252FSQSTM1-Keap1-nuclear%2520factor%2520erythroid%25202-related%2520factor%25202%2520pathway%2520in%2520cancer%26jtitle%3DFront.%2520Oncol.%26date%3D2018%26volume%3D8%26spage%3D210%26doi%3D10.3389%2Ffonc.2018.00210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sofola-Adesakin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatliff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez Perez-Nievas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snoeren, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocheme, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adcott, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khericha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo-Quan, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noble, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partridge, L.</span></span> <span> </span><span class="NLM_article-title">Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer’s disease</span>. <i>PLoS Genet.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">e1006593</span>, <span class="refDoi"> DOI: 10.1371/journal.pgen.1006593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1371%2Fjournal.pgen.1006593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=28253260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1aitrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=e1006593&issue=3&author=F.+Kerrauthor=O.+Sofola-Adesakinauthor=D.+K.+Ivanovauthor=J.+Gatliffauthor=B.+Gomez+Perez-Nievasauthor=H.+C.+Bertrandauthor=P.+Martinezauthor=R.+Callardauthor=I.+Snoerenauthor=H.+M.+Cochemeauthor=J.+Adcottauthor=M.+Kherichaauthor=J.+I.+Castillo-Quanauthor=G.+Wellsauthor=W.+Nobleauthor=J.+Thorntonauthor=L.+Partridge&title=Direct+Keap1-Nrf2+disruption+as+a+potential+therapeutic+target+for+Alzheimer%E2%80%99s+disease&doi=10.1371%2Fjournal.pgen.1006593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease</span></div><div class="casAuthors">Kerr, Fiona; Sofola-Adesakin, Oyinkan; Ivanov, Dobril K.; Gatliff, Jemma; Perez-Nievas, Beatriz Gomez; Bertrand, Helene C.; Martinez, Pedro; Callard, Rebecca; Snoeren, Inge; Cocheme, Helena M.; Adcott, Jennifer; Khericha, Mobina; Castillo-Quan, JorgeIvan; Wells, Geoffrey; Noble, Wendy; Thornton, Janet; Partridge, Linda</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Genetics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e1006593/1-e1006593/30</span>CODEN:
                <span class="NLM_cas:coden">PGLEB5</span>;
        ISSN:<span class="NLM_cas:issn">1553-7404</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Nrf2, a transcriptional activator of cell protection genes, is an attractive therapeutic target for the prevention of neurodegenerative diseases, including Alzheimer's disease (AD).  Current Nrf2 activators, however, may exert toxicity and pathway over-activation can induce detrimental effects.  An understanding of the mechanisms mediating Nrf2 inhibition in neurodegenerative conditions may therefore direct the design of drugs targeted for the prevention of these diseases with minimal side-effects.  Our study provides the first in vivo evidence that specific inhibition of Keap1, a neg. regulator of Nrf2, can prevent neuronal toxicity in response to the AD-initiating Aβ42 peptide, in correlation with Nrf2 activation.  Comparatively, lithium, an inhibitor of the Nrf2 suppressor GSK-3, prevented Aβ42 toxicity by mechanisms independent of Nrf2.  A new direct inhibitor of the Keap1-Nrf2 binding domain also prevented synaptotoxicity mediated by naturally-derived Aβ oligomers in mouse cortical neurons.  Overall, our findings highlight Keap1 specifically as an efficient target for the reactivation of Nrf2 in AD, and support the further investigation of direct Keap1 inhibitors for the prevention of neurodegeneration in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaPjD0cuk13rVg90H21EOLACvtfcHk0lihFVdbIh-kqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1aitrzO&md5=0bb45ee28b645cb153bcdb3a6758d489</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pgen.1006593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pgen.1006593%26sid%3Dliteratum%253Aachs%26aulast%3DKerr%26aufirst%3DF.%26aulast%3DSofola-Adesakin%26aufirst%3DO.%26aulast%3DIvanov%26aufirst%3DD.%2BK.%26aulast%3DGatliff%26aufirst%3DJ.%26aulast%3DGomez%2BPerez-Nievas%26aufirst%3DB.%26aulast%3DBertrand%26aufirst%3DH.%2BC.%26aulast%3DMartinez%26aufirst%3DP.%26aulast%3DCallard%26aufirst%3DR.%26aulast%3DSnoeren%26aufirst%3DI.%26aulast%3DCocheme%26aufirst%3DH.%2BM.%26aulast%3DAdcott%26aufirst%3DJ.%26aulast%3DKhericha%26aufirst%3DM.%26aulast%3DCastillo-Quan%26aufirst%3DJ.%2BI.%26aulast%3DWells%26aufirst%3DG.%26aulast%3DNoble%26aufirst%3DW.%26aulast%3DThornton%26aufirst%3DJ.%26aulast%3DPartridge%26aufirst%3DL.%26atitle%3DDirect%2520Keap1-Nrf2%2520disruption%2520as%2520a%2520potential%2520therapeutic%2520target%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPLoS%2520Genet.%26date%3D2017%26volume%3D13%26issue%3D3%26spage%3De1006593%26doi%3D10.1371%2Fjournal.pgen.1006593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cohen-Kaplan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livneh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabre, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziv, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciechanover, A.</span></span> <span> </span><span class="NLM_article-title">p62- and ubiquitin-dependent stress-induced autophagy of the mammalian 26S proteasome</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">47</span>),  <span class="NLM_fpage">E7490</span>– <span class="NLM_lpage">E7499</span>, <span class="refDoi"> DOI: 10.1073/pnas.1615455113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1073%2Fpnas.1615455113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27791183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1ykurjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=E7490-E7499&issue=47&author=V.+Cohen-Kaplanauthor=I.+Livnehauthor=N.+Avniauthor=B.+Fabreauthor=T.+Zivauthor=Y.+T.+Kwonauthor=A.+Ciechanover&title=p62-+and+ubiquitin-dependent+stress-induced+autophagy+of+the+mammalian+26S+proteasome&doi=10.1073%2Fpnas.1615455113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">p62- and ubiquitin-dependent stress-induced autophagy of the mammalian 26S proteasome</span></div><div class="casAuthors">Cohen-Kaplan, Victoria; Livneh, Ido; Avni, Noa; Fabre, Bertrand; Ziv, Tamar; Kwon, Yong Tae; Ciechanover, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">E7490-E7499</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The ubiquitin-proteasome system and autophagy are the two main proteolytic systems involved in, among other functions, the maintenance of cell integrity by eliminating misfolded and damaged proteins and organelles.  Both systems remove their targets after their conjugation with ubiquitin.  An interesting, yet incompletely understood problem relates to the fate of the components of the two systems.  Here we provide evidence that amino acid starvation enhances polyubiquitination on specific sites of the proteasome, a modification essential for its targeting to the autophagic machinery.  The uptake of the ubiquitinated proteasome is mediated by its interaction with the ubiquitin-assocd. domain of p62/SQSTM1, a process that also requires interaction with LC3.  Importantly, deletion of the PB1 domain of p62, which is important for the targeting of ubiquitinated substrates to the proteasome, has no effect on stress-induced autophagy of this proteolytic machinery, suggesting that the domain of p62 that binds to the proteasome dets. the function of p62 in either targeting substrates to the proteasome or targeting the proteasome to autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6eNef2mWtg7Vg90H21EOLACvtfcHk0lggqnFWtNZomA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1ykurjE&md5=7defe031e853828cc64fb0e88e1adde3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1615455113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1615455113%26sid%3Dliteratum%253Aachs%26aulast%3DCohen-Kaplan%26aufirst%3DV.%26aulast%3DLivneh%26aufirst%3DI.%26aulast%3DAvni%26aufirst%3DN.%26aulast%3DFabre%26aufirst%3DB.%26aulast%3DZiv%26aufirst%3DT.%26aulast%3DKwon%26aufirst%3DY.%2BT.%26aulast%3DCiechanover%26aufirst%3DA.%26atitle%3Dp62-%2520and%2520ubiquitin-dependent%2520stress-induced%2520autophagy%2520of%2520the%2520mammalian%252026S%2520proteasome%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26issue%3D47%26spage%3DE7490%26epage%3DE7499%26doi%3D10.1073%2Fpnas.1615455113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teyssou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebon, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boillee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doukoure, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bataillon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sazdovitch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cazeneuve, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meininger, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeGuern, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salachas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seilhean, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millecamps, S.</span></span> <span> </span><span class="NLM_article-title">Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>125</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">522</span>, <span class="refDoi"> DOI: 10.1007/s00401-013-1090-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1007%2Fs00401-013-1090-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=23417734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltFCmsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2013&pages=511-522&issue=4&author=E.+Teyssouauthor=T.+Takedaauthor=V.+Lebonauthor=S.+Boilleeauthor=B.+Doukoureauthor=G.+Bataillonauthor=V.+Sazdovitchauthor=C.+Cazeneuveauthor=V.+Meiningerauthor=E.+LeGuernauthor=F.+Salachasauthor=D.+Seilheanauthor=S.+Millecamps&title=Mutations+in+SQSTM1+encoding+p62+in+amyotrophic+lateral+sclerosis%3A+genetics+and+neuropathology&doi=10.1007%2Fs00401-013-1090-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology</span></div><div class="casAuthors">Teyssou, Elisa; Takeda, Takahiro; Lebon, Vincent; Boillee, Severine; Doukoure, Brahima; Bataillon, Guillaume; Sazdovitch, Veronique; Cazeneuve, Cecile; Meininger, Vincent; LeGuern, Eric; Salachas, Francois; Seilhean, Danielle; Millecamps, Stephanie</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">511-522</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Mutations in SQSTM1 encoding the sequestosome 1/p62 protein have recently been identified in familial and sporadic cases of amyotrophic lateral sclerosis (ALS). p62 is a component of the ubiquitin inclusions detected in degenerating neurons in ALS patients.  We sequenced SQSTM1 in 90 French patients with familial ALS (FALS) and 74 autopsied ALS cases with sporadic ALS (SALS).  We identified, at the heterozygote state, one missense c.1175C>T, p.Pro392Leu (exon 8) in one of our FALS and one substitution in intron 7 (the c.1165+1G>A, previously called IVS7+1 G-A, A390X) affecting the exon 7 splicing site in one SALS.  These mutations that are located in the ubiquitin-assocd. domain (UBA domain) of the p62 protein have already been described in Paget's disease and ALS patients carrying these mutations had both concomitant Paget's disease.  However, we also identified two novel missense mutations in two SALS: the c.259A>G, p.Met87Val in exon 2 and the c.304A>G, p.Lys102Glu in exon 3.  These mutations that were not detected in 360 control subjects are possibly pathogenic.  Neuropathol. anal. of three patients carrying SQSTM1 variants revealed the presence of large round p62 inclusions in motor neurons, and immunoblot anal. showed an increased p62 and TDP-43 protein levels in the spinal cord.  Our results confirm that SQSTM1 gene mutations could be the cause or genetic susceptibility factor of ALS in some patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4iSkSmw3nE7Vg90H21EOLACvtfcHk0lggqnFWtNZomA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltFCmsrs%253D&md5=005a974be4718f328aa965545387ee96</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs00401-013-1090-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-013-1090-0%26sid%3Dliteratum%253Aachs%26aulast%3DTeyssou%26aufirst%3DE.%26aulast%3DTakeda%26aufirst%3DT.%26aulast%3DLebon%26aufirst%3DV.%26aulast%3DBoillee%26aufirst%3DS.%26aulast%3DDoukoure%26aufirst%3DB.%26aulast%3DBataillon%26aufirst%3DG.%26aulast%3DSazdovitch%26aufirst%3DV.%26aulast%3DCazeneuve%26aufirst%3DC.%26aulast%3DMeininger%26aufirst%3DV.%26aulast%3DLeGuern%26aufirst%3DE.%26aulast%3DSalachas%26aufirst%3DF.%26aulast%3DSeilhean%26aufirst%3DD.%26aulast%3DMillecamps%26aufirst%3DS.%26atitle%3DMutations%2520in%2520SQSTM1%2520encoding%2520p62%2520in%2520amyotrophic%2520lateral%2520sclerosis%253A%2520genetics%2520and%2520neuropathology%26jtitle%3DActa%2520Neuropathol.%26date%3D2013%26volume%3D125%26issue%3D4%26spage%3D511%26epage%3D522%26doi%3D10.1007%2Fs00401-013-1090-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pankiv, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamark, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruun, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overvatn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjorkoy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansen, T.</span></span> <span> </span><span class="NLM_article-title">Nucleocytoplasmic shuttling of p62/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">5941</span>– <span class="NLM_lpage">5953</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.039925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1074%2Fjbc.M109.039925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20018885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFCqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=5941-5953&issue=8&author=S.+Pankivauthor=T.+Lamarkauthor=J.+A.+Bruunauthor=A.+Overvatnauthor=G.+Bjorkoyauthor=T.+Johansen&title=Nucleocytoplasmic+shuttling+of+p62%2FSQSTM1+and+its+role+in+recruitment+of+nuclear+polyubiquitinated+proteins+to+promyelocytic+leukemia+bodies&doi=10.1074%2Fjbc.M109.039925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleocytoplasmic Shuttling of p62/SQSTM1 and Its Role in Recruitment of Nuclear Polyubiquitinated Proteins to Promyelocytic Leukemia Bodies</span></div><div class="casAuthors">Pankiv, Serhiy; Lamark, Trond; Bruun, Jack-Ansgar; Overvatn, Aud; Bjorkoy, Geir; Johansen, Terje</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">5941-5953</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">P62, also known as sequestosome1 1 (SQSTM1), A170, or ZIP, is a multifunctional protein implicated in several signal transduction pathways.  P62 is induced by various forms of cellular stress, is degraded by autophagy, and acts as a cargo receptor for autophagic degrdn. of ubiquitinated targets.  It is also suggested to shuttle ubiquitinated proteins for proteasomal degrdn. p62 is commonly found in cytosolic protein inclusions in patients with protein aggregopathies, it is up-regulated in several forms of human tumors, and mutations in the gene are linked to classical adult onset Paget disease of the bone.  To this end, p62 has generally been considered to be a cytosolic protein, and little attention has been paid to possible nuclear roles of this protein.  Here, we present evidence that p62 shuttles continuously between nuclear and cytosolic compartments at a high rate.  The protein is also found in nuclear promyelocytic leukemia bodies.  We show that p62 contains two nuclear localization signals and a nuclear export signal.  Our data suggest that the nucleocytoplasmic shuttling of p62 is modulated by phosphorylations at or near the most important nuclear localization signal, NLS2.  The aggregation of p62 in cytosolic bodies also regulates the transport of p62 between the compartments.  We found p62 to be essential for accumulation of polyubiquitinated proteins in promyelocytic leukemia bodies upon inhibition of nuclear protein export.  Furthermore, p62 contributed to the assembly of proteasome-contg. degradative compartments in the vicinity of nuclear aggregates contg. polyglutamine-expanded Ataxin1Q84 and to the degrdn. of Ataxin1Q84.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptGR-BHB6FfrVg90H21EOLACvtfcHk0lggqnFWtNZomA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFCqs74%253D&md5=7aaa907fcd81f5b204b5ad0150dc42d9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.039925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.039925%26sid%3Dliteratum%253Aachs%26aulast%3DPankiv%26aufirst%3DS.%26aulast%3DLamark%26aufirst%3DT.%26aulast%3DBruun%26aufirst%3DJ.%2BA.%26aulast%3DOvervatn%26aufirst%3DA.%26aulast%3DBjorkoy%26aufirst%3DG.%26aulast%3DJohansen%26aufirst%3DT.%26atitle%3DNucleocytoplasmic%2520shuttling%2520of%2520p62%252FSQSTM1%2520and%2520its%2520role%2520in%2520recruitment%2520of%2520nuclear%2520polyubiquitinated%2520proteins%2520to%2520promyelocytic%2520leukemia%2520bodies%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26issue%3D8%26spage%3D5941%26epage%3D5953%26doi%3D10.1074%2Fjbc.M109.039925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yorimitsu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klionsky, D. J.</span></span> <span> </span><span class="NLM_article-title">Autophagy: molecular machinery for self-eating</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1542</span>– <span class="NLM_lpage">1552</span>, <span class="refDoi"> DOI: 10.1038/sj.cdd.4401765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fsj.cdd.4401765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=16247502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCjt7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=1542-1552&author=T.+Yorimitsuauthor=D.+J.+Klionsky&title=Autophagy%3A+molecular+machinery+for+self-eating&doi=10.1038%2Fsj.cdd.4401765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy: molecular machinery for self-eating</span></div><div class="casAuthors">Yorimitsu, T.; Klionsky, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">Suppl. 2</span>),
    <span class="NLM_cas:pages">1542-1552</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Autophagy is a highly conserved process in eukaryotes in which the cytoplasm, including excess or aberrant organelles, is sequestered into double-membrane vesicles and delivered to the degradative organelle, the lysosome/vacuole, for breakdown and eventual recycling of the resulting macromols.  This process has an important role in various biol. events such as adaptation to changing environmental conditions, cellular remodeling during development and differentiation, and detn. of lifespan.  Auto-phagy is also involved in preventing certain types of disease, although it may contribute to some pathologies.  Recent studies have identified many components that are required to drive this complicated cellular process.  Auto-phagy-related genes were first identified in yeast, but homologs are found in all eukaryotes.  Analyses in a range of model systems have provided huge advances toward understanding the mol. basis of autophagy.  Here we review our current knowledge on the machinery and mol. mechanism of autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgAFRsUOGNrbVg90H21EOLACvtfcHk0lhmm0mBOMDAXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCjt7%252FJ&md5=669805b0c9c4af98c9a6dd484ff81f1f</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4401765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4401765%26sid%3Dliteratum%253Aachs%26aulast%3DYorimitsu%26aufirst%3DT.%26aulast%3DKlionsky%26aufirst%3DD.%2BJ.%26atitle%3DAutophagy%253A%2520molecular%2520machinery%2520for%2520self-eating%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2005%26volume%3D12%26spage%3D1542%26epage%3D1552%26doi%3D10.1038%2Fsj.cdd.4401765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waguri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizushima, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwata, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ezaki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamazaki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iemura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natsume, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanagawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uwayama, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warabi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kominami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span> <span> </span><span class="NLM_article-title">Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>131</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1149</span>– <span class="NLM_lpage">1163</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.10.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.cell.2007.10.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18083104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksFGnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=1149-1163&issue=6&author=M.+Komatsuauthor=S.+Waguriauthor=M.+Koikeauthor=Y.+Souauthor=T.+Uenoauthor=T.+Haraauthor=N.+Mizushimaauthor=J.+Iwataauthor=J.+Ezakiauthor=S.+Murataauthor=J.+Hamazakiauthor=Y.+Nishitoauthor=S.+Iemuraauthor=T.+Natsumeauthor=T.+Yanagawaauthor=J.+Uwayamaauthor=E.+Warabiauthor=H.+Yoshidaauthor=T.+Ishiiauthor=A.+Kobayashiauthor=M.+Yamamotoauthor=Z.+Yueauthor=Y.+Uchiyamaauthor=E.+Kominamiauthor=K.+Tanaka&title=Homeostatic+levels+of+p62+control+cytoplasmic+inclusion+body+formation+in+autophagy-deficient+mice&doi=10.1016%2Fj.cell.2007.10.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice</span></div><div class="casAuthors">Komatsu, Masaaki; Waguri, Satoshi; Koike, Masato; Sou, Yu-shin; Ueno, Takashi; Hara, Taichi; Mizushima, Noboru; Iwata, Jun-ichi; Ezaki, Junji; Murata, Shigeo; Hamazaki, Jun; Nishito, Yasumasa; Iemura, Shun-ichiro; Natsume, Tohru; Yanagawa, Toru; Uwayama, Junya; Warabi, Eiji; Yoshida, Hiroshi; Ishii, Tetsuro; Kobayashi, Akira; Yamamoto, Masayuki; Yue, Zhenyu; Uchiyama, Yasuo; Kominami, Eiki; Tanaka, Keiji</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1149-1163</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Inactivation of constitutive autophagy results in formation of cytoplasmic protein inclusions and leads to liver injury and neurodegeneration, but the details of abnormalities related to impaired autophagy are largely unknown.  Here we used mouse genetic analyses to define the roles of autophagy in the aforementioned events.  We report that the ubiquitin- and LC3-binding protein "p62" regulates the formation of protein aggregates and is removed by autophagy.  Thus, genetic ablation of p62 suppressed the appearance of ubiquitin-pos. protein aggregates in hepatocytes and neurons, indicating that p62 plays an important role in inclusion body formation.  Moreover, loss of p62 markedly attenuated liver injury caused by autophagy deficiency, whereas it had little effect on neuronal degeneration.  Our findings highlight the unexpected role of homeostatic level of p62, which is regulated by autophagy, in controlling intracellular inclusion body formation, and indicate that the pathol. process assocd. with autophagic deficiency is cell-type specific.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRUqqGdziagrVg90H21EOLACvtfcHk0ljqZ1TY0QtLvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksFGnsg%253D%253D&md5=7b3e77dd70d33df65b4010d91a90fce9</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.10.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.10.035%26sid%3Dliteratum%253Aachs%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DWaguri%26aufirst%3DS.%26aulast%3DKoike%26aufirst%3DM.%26aulast%3DSou%26aufirst%3DY.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DMizushima%26aufirst%3DN.%26aulast%3DIwata%26aufirst%3DJ.%26aulast%3DEzaki%26aufirst%3DJ.%26aulast%3DMurata%26aufirst%3DS.%26aulast%3DHamazaki%26aufirst%3DJ.%26aulast%3DNishito%26aufirst%3DY.%26aulast%3DIemura%26aufirst%3DS.%26aulast%3DNatsume%26aufirst%3DT.%26aulast%3DYanagawa%26aufirst%3DT.%26aulast%3DUwayama%26aufirst%3DJ.%26aulast%3DWarabi%26aufirst%3DE.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DA.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DYue%26aufirst%3DZ.%26aulast%3DUchiyama%26aufirst%3DY.%26aulast%3DKominami%26aufirst%3DE.%26aulast%3DTanaka%26aufirst%3DK.%26atitle%3DHomeostatic%2520levels%2520of%2520p62%2520control%2520cytoplasmic%2520inclusion%2520body%2520formation%2520in%2520autophagy-deficient%2520mice%26jtitle%3DCell%26date%3D2007%26volume%3D131%26issue%3D6%26spage%3D1149%26epage%3D1163%26doi%3D10.1016%2Fj.cell.2007.10.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, E.</span></span> <span> </span><span class="NLM_article-title">Autophagy and metabolism</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>330</i></span> (<span class="NLM_issue">6009</span>),  <span class="NLM_fpage">1344</span>– <span class="NLM_lpage">1348</span>, <span class="refDoi"> DOI: 10.1126/science.1193497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1126%2Fscience.1193497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21127245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVyrsbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=1344-1348&issue=6009&author=J.+D.+Rabinowitzauthor=E.+White&title=Autophagy+and+metabolism&doi=10.1126%2Fscience.1193497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy and metabolism</span></div><div class="casAuthors">Rabinowitz, Joshua D.; White, Eileen</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">6009</span>),
    <span class="NLM_cas:pages">1344-1348</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Autophagy is a process of self-cannibalization.  Cells capture their own cytoplasm and organelles and consume them in lysosomes.  The resulting breakdown products are inputs to cellular metab., through which they are used to generate energy and to build new proteins and membranes.  Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones.  In starvation, it provides an internal source of nutrients for energy generation and, thus, survival.  A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases.  It does have a downside, however; cancer cells exploit it to survive in nutrient-poor tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpREWU_wFW6GLVg90H21EOLACvtfcHk0ljqZ1TY0QtLvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVyrsbbE&md5=4b6ed3a623cbef8df1241579e15632fa</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1126%2Fscience.1193497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1193497%26sid%3Dliteratum%253Aachs%26aulast%3DRabinowitz%26aufirst%3DJ.%2BD.%26aulast%3DWhite%26aufirst%3DE.%26atitle%3DAutophagy%2520and%2520metabolism%26jtitle%3DScience%26date%3D2010%26volume%3D330%26issue%3D6009%26spage%3D1344%26epage%3D1348%26doi%3D10.1126%2Fscience.1193497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mizushima, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span> <span> </span><span class="NLM_article-title">Autophagy: renovation of cells and tissues</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>147</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">728</span>– <span class="NLM_lpage">741</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.10.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.cell.2011.10.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22078875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVKgsLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2011&pages=728-741&issue=4&author=N.+Mizushimaauthor=M.+Komatsu&title=Autophagy%3A+renovation+of+cells+and+tissues&doi=10.1016%2Fj.cell.2011.10.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy: Renovation of Cells and Tissues</span></div><div class="casAuthors">Mizushima, Noboru; Komatsu, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">728-741</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Autophagy is the major intracellular degrdn. system by which cytoplasmic materials are delivered to and degraded in the lysosome.  However, the purpose of autophagy is not the simple elimination of materials, but instead, autophagy serves as a dynamic recycling system that produces new building blocks and energy for cellular renovation and homeostasis.  Here we provide a multidisciplinary review of our current understanding of autophagy's role in metabolic adaptation, intracellular quality control, and renovation during development and differentiation.  We also explore how recent mouse models in combination with advances in human genetics are providing key insights into how the impairment or activation of autophagy contributes to pathogenesis of diverse diseases, from neurodegenerative diseases such as Parkinson disease to inflammatory disorders such as Crohn disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphHJHJXZsr6bVg90H21EOLACvtfcHk0ljqZ1TY0QtLvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVKgsLnN&md5=c749750db767f05549db0b22ec5068c7</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.10.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.10.026%26sid%3Dliteratum%253Aachs%26aulast%3DMizushima%26aufirst%3DN.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3DAutophagy%253A%2520renovation%2520of%2520cells%2520and%2520tissues%26jtitle%3DCell%26date%3D2011%26volume%3D147%26issue%3D4%26spage%3D728%26epage%3D741%26doi%3D10.1016%2Fj.cell.2011.10.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ammar, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y.</span></span> <span> </span><span class="NLM_article-title">Crosstalk between macroautophagy and chaperone-mediated autophagy: implications for the treatment of neurological diseases</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1284</span>– <span class="NLM_lpage">1296</span>, <span class="refDoi"> DOI: 10.1007/s12035-014-8933-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1007%2Fs12035-014-8933-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=25330936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSqsLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2015&pages=1284-1296&issue=3&author=H.+J.+Wuauthor=S.+Chenauthor=A.+B.+Ammarauthor=J.+Xuauthor=Q.+Wuauthor=K.+Panauthor=J.+M.+Zhangauthor=Y.+Hong&title=Crosstalk+between+macroautophagy+and+chaperone-mediated+autophagy%3A+implications+for+the+treatment+of+neurological+diseases&doi=10.1007%2Fs12035-014-8933-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Crosstalk Between Macroautophagy and Chaperone-Mediated Autophagy: Implications for the Treatment of Neurological Diseases</span></div><div class="casAuthors">Wu, Haijian; Chen, Sheng; Ammar, Al-Baadani; Xu, Jie; Wu, Qun; Pan, Kum; Zhang, Jianmin; Hong, Yuan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1284-1296</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Macroautophagy and chaperone-mediated autophagy (CMA) are two important subtypes of autophagy that play a crit. role in cellular quality control under physiol. and pathol. conditions.  Despite the marked differences between these two autophagic pathways, macroautophagy and CMA are intimately connected with each other during the autophagy-lysosomal degrdn. process, in particular, in the setting of neurol. illness.  Macroautophagy serves as a backup mechanism to removal of malfunctioning proteins (i.e., aberrant α-synuclein) from the cytoplasm when CMA is compromised, and vice versa.  The mol. mechanisms underlying the conversation between macroautophagy and CMA are being clarified.  Herein, we survey current overviews concg. on the complex interactions between macroautophagy and CMA, and present therapeutic potentials through utilization and manipulation of macroautophagy-CMA crosstalk in the treatment of neurol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_Jt28FSSLy7Vg90H21EOLACvtfcHk0lgI8ejGvNevig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSqsLjJ&md5=239453df2be7fb599bf17f0d818d2db8</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1007%2Fs12035-014-8933-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-014-8933-0%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DH.%2BJ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DAmmar%26aufirst%3DA.%2BB.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DPan%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DJ.%2BM.%26aulast%3DHong%26aufirst%3DY.%26atitle%3DCrosstalk%2520between%2520macroautophagy%2520and%2520chaperone-mediated%2520autophagy%253A%2520implications%2520for%2520the%2520treatment%2520of%2520neurological%2520diseases%26jtitle%3DMol.%2520Neurobiol.%26date%3D2015%26volume%3D52%26issue%3D3%26spage%3D1284%26epage%3D1296%26doi%3D10.1007%2Fs12035-014-8933-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kunz, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, A.</span></span> <span> </span><span class="NLM_article-title">Determination of four sequential stages during microautophagy in vitro</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">9987</span>– <span class="NLM_lpage">9996</span>, <span class="refDoi"> DOI: 10.1074/jbc.M307905200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1074%2Fjbc.M307905200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=14679207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitlygsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=9987-9996&issue=11&author=J.+B.+Kunzauthor=H.+Schwarzauthor=A.+Mayer&title=Determination+of+four+sequential+stages+during+microautophagy+in+vitro&doi=10.1074%2Fjbc.M307905200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of four sequential stages during microautophagy in vitro</span></div><div class="casAuthors">Kunz, Joachim B.; Schwarz, Heinz; Mayer, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">9987-9996</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Microautophagy is the transfer of cytosolic components into the lysosome by direct invagination of the lysosomal membrane and subsequent budding of vesicles into the lysosomal lumen.  This process is topol. equiv. to membrane invagination during multivesicular body formation and to the budding of enveloped viruses.  Vacuoles are lysosomal compartments of yeasts.  Vacuolar membrane invagination can be reconstituted in vitro with purified yeast vacuoles, serving as a model system for budding of vesicles into the lumen of an organelle.  Using this in vitro system, we defined different reaction states.  We identified inhibitors of microautophagy in vitro and used them as tools for kinetic anal.  This allowed us to characterize 4 biochem. distinguishable steps of the reaction.  We propose that these correspond to sequential stages of vacuole invagination and vesicle scission.  Formation of vacuolar invaginations was slow and temp.-dependent, whereas the final scission of the vesicle from a preformed invagination was fast and proceeded even on ice.  Our observations suggest that the formation of invaginations rather than the scission of vesicles is the rate-limiting step of the overall reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJxw7fw4uIl7Vg90H21EOLACvtfcHk0lgI8ejGvNevig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitlygsr0%253D&md5=cd24c51cf20e31bcb3f917f634312377</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M307905200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M307905200%26sid%3Dliteratum%253Aachs%26aulast%3DKunz%26aufirst%3DJ.%2BB.%26aulast%3DSchwarz%26aufirst%3DH.%26aulast%3DMayer%26aufirst%3DA.%26atitle%3DDetermination%2520of%2520four%2520sequential%2520stages%2520during%2520microautophagy%2520in%2520vitro%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26issue%3D11%26spage%3D9987%26epage%3D9996%26doi%3D10.1074%2Fjbc.M307905200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terlecky, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plant, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dice, J. F.</span></span> <span> </span><span class="NLM_article-title">A role for a 70-kilodalton heat shock protein in lysosomal degradation of intracellular proteins</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>246</i></span> (<span class="NLM_issue">4928</span>),  <span class="NLM_fpage">382</span>– <span class="NLM_lpage">385</span>, <span class="refDoi"> DOI: 10.1126/science.2799391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1126%2Fscience.2799391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=2799391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADyaK3cXivFei" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=1989&pages=382-385&issue=4928&author=H.+L.+Chiangauthor=S.+R.+Terleckyauthor=C.+P.+Plantauthor=J.+F.+Dice&title=A+role+for+a+70-kilodalton+heat+shock+protein+in+lysosomal+degradation+of+intracellular+proteins&doi=10.1126%2Fscience.2799391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A role for a 70-kilodaton heat shock protein in lysosomal degradation of intracellular proteins</span></div><div class="casAuthors">Chiang, Hui Ling; Terlecky, Stanley R.; Plant, Charles P.; Dice, J. Fred</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">246</span>
        (<span class="NLM_cas:issue">4928</span>),
    <span class="NLM_cas:pages">382-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A 73-kilodalton (kD) intracellular protein was found to bind to peptide regions that target intracellular proteins for lysosomal degrdn. in response to serum withdrawal.  This protein crossreacted with a monoclonal antibody raised to a member of the 70-kD heat shock protein (hsp70) family, and sequences of 2 internal peptides of the 73-kD protein confirm that it is a member of this family.  In response to serum withdrawal, the intracellular concn. of the 73-kD protein increased severalfold.  In the presence of ATP and MgCl2 the 73-kD protein enhanced protein degrdn. in 2 different cell-free assays for lysosomal proteolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8lZiH72r-DrVg90H21EOLACvtfcHk0lgI8ejGvNevig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXivFei&md5=81aebe3c75135c1167ede6ba3ac2e12f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1126%2Fscience.2799391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.2799391%26sid%3Dliteratum%253Aachs%26aulast%3DChiang%26aufirst%3DH.%2BL.%26aulast%3DTerlecky%26aufirst%3DS.%2BR.%26aulast%3DPlant%26aufirst%3DC.%2BP.%26aulast%3DDice%26aufirst%3DJ.%2BF.%26atitle%3DA%2520role%2520for%2520a%252070-kilodalton%2520heat%2520shock%2520protein%2520in%2520lysosomal%2520degradation%2520of%2520intracellular%2520proteins%26jtitle%3DScience%26date%3D1989%26volume%3D246%26issue%3D4928%26spage%3D382%26epage%3D385%26doi%3D10.1126%2Fscience.2799391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinet, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Meyer, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andries, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kockx, M. M.</span></span> <span> </span><span class="NLM_article-title">In situ detection of starvation-induced autophagy</span>. <i>J. Histochem. Cytochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1369/jhc.5A6743.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1369%2Fjhc.5A6743.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=16148314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD28XitlOlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=85-96&issue=1&author=W.+Martinetauthor=G.+R.+De+Meyerauthor=L.+Andriesauthor=A.+G.+Hermanauthor=M.+M.+Kockx&title=In+situ+detection+of+starvation-induced+autophagy&doi=10.1369%2Fjhc.5A6743.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">In situ detection of starvation-induced autophagy</span></div><div class="casAuthors">Martinet, Wim; De Meyer, Guido R. Y.; Andries, Luc; Herman, Arnold G.; Kockx, Mark M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-96</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    
            (<span class="NLM_cas:orgname">Histochemical Society, Inc.</span>)
        </div><div class="casAbstract">Autophagy is a regulated bulk degrdn. process involved in many different human pathologies.  Transmission electron microscopy (TEM) is currently the only reliable method for monitoring autophagy in situ.  Because TEM is labor intensive, the authors questioned whether useful marker proteins can be found for unambiguous detection of autophagy in tissue via routinely used colorimetric, immunohistochem., or fluorescent techniques.  Starved Hep G2 hepatocytes and nutrient-deprived liver tissue were used as a model for the initiation of autophagy.  The findings indicate that starvation-induced autophagy in Hep G2 cells was assocd. neither with differential mRNA gene expression nor with changes in the expression level of known autophagy-related proteins.  On the contrary, both transcription and translation were inhibited, suggesting that the identification of autophagy-specific biomarkers for tissue is highly compromised.  Light chain 3 (LC3) protein, which is an attractive marker of autophagosomes, revealed a relatively low expression level in tissue and cultured cells, but could be detected via immunohistochem. in liver from GFP-LC3 transgenic mice.  The no. of LC3 immunopos. dot-like structures was significantly upregulated in liver tissue from nutrient-deprived GFP-LC3 mice as compared with nonstarved control tissue.  Apparently, LC3 immunostaining can be used as an alternative detection method for autophagy in situ, but only when this protein is overexpressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8_vy2GGsXXrVg90H21EOLACvtfcHk0ljqDcVIjnvSbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitlOlug%253D%253D&md5=d86097d1b1e7d6159cf4ee8902921a54</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1369%2Fjhc.5A6743.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1369%252Fjhc.5A6743.2005%26sid%3Dliteratum%253Aachs%26aulast%3DMartinet%26aufirst%3DW.%26aulast%3DDe%2BMeyer%26aufirst%3DG.%2BR.%26aulast%3DAndries%26aufirst%3DL.%26aulast%3DHerman%26aufirst%3DA.%2BG.%26aulast%3DKockx%26aufirst%3DM.%2BM.%26atitle%3DIn%2520situ%2520detection%2520of%2520starvation-induced%2520autophagy%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D2006%26volume%3D54%26issue%3D1%26spage%3D85%26epage%3D96%26doi%3D10.1369%2Fjhc.5A6743.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mizushima, N.</span></span> <span> </span><span class="NLM_article-title">Autophagy: process and function</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">2861</span>– <span class="NLM_lpage">2873</span>, <span class="refDoi"> DOI: 10.1101/gad.1599207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1101%2Fgad.1599207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18006683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmsrjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=2861-2873&issue=22&author=N.+Mizushima&title=Autophagy%3A+process+and+function&doi=10.1101%2Fgad.1599207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy: process and function</span></div><div class="casAuthors">Mizushima, Noboru</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2861-2873</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  Autophagy is an intracellular degrdn. system that delivers cytoplasmic constituents to the lysosome.  Despite its simplicity, recent progress has demonstrated that autophagy plays a wide variety of physiol. and pathophysiol. roles, which are sometimes complex.  Autophagy consists of several sequential steps-sequestration, transport to lysosomes, degrdn., and utilization of degrdn. products-and each step may exert different function.  In this review, the process of autophagy is summarized, and the role of autophagy is discussed in a process-based manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjLQ6AXbG19rVg90H21EOLACvtfcHk0ljqDcVIjnvSbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmsrjP&md5=a55a6956ae9fc41b7067753459f90ca5</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1101%2Fgad.1599207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1599207%26sid%3Dliteratum%253Aachs%26aulast%3DMizushima%26aufirst%3DN.%26atitle%3DAutophagy%253A%2520process%2520and%2520function%26jtitle%3DGenes%2520Dev.%26date%3D2007%26volume%3D21%26issue%3D22%26spage%3D2861%26epage%3D2873%26doi%3D10.1101%2Fgad.1599207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, Z.</span></span> <span> </span><span class="NLM_article-title">SQSTM1/p62 loss reverses the inhibitory effect of sunitinib on autophagy independent of AMPK signaling</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">11087</span>, <span class="refDoi"> DOI: 10.1038/s41598-019-47597-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fs41598-019-47597-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=31366950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BB3MvjsVemtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=11087&issue=1&author=B.+Houauthor=G.+Wangauthor=Q.+Gaoauthor=Y.+Weiauthor=C.+Zhangauthor=Y.+Wangauthor=Y.+Huoauthor=H.+Yangauthor=X.+Jiangauthor=Z.+Xi&title=SQSTM1%2Fp62+loss+reverses+the+inhibitory+effect+of+sunitinib+on+autophagy+independent+of+AMPK+signaling&doi=10.1038%2Fs41598-019-47597-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">SQSTM1/p62 loss reverses the inhibitory effect of sunitinib on autophagy independent of AMPK signaling</span></div><div class="casAuthors">Hou Bolin; Gao Quan; Wei Yanjie; Zhang Caining; Wang Yange; Jiang Xuejun; Hou Bolin; Gao Quan; Wei Yanjie; Zhang Caining; Wang Yange; Wang Gang; Xi Zhijun; Huo Yuqing; Yang Huaiyi</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11087</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Sunitinib (ST), a multitargeted receptor tyrosine kinase inhibitor, has been demonstrated to be effective for the treatment of renal carcinoma.  It has been reported that ST is involved in the mediation of autophagy; however, its regulatory role in the autophagic process remains controversial.  Furthermore, the mechanism by which activated AMP-activated protein kinase (AMPK) negatively regulates autophagy remains nearly unexplored.  In the present study, we revealed that ST inhibited AMPK activity and regulated autophagy in a cell type- and dose-dependent manner.  In a number of cell lines, ST was demonstrated to inhibit H2O2-induced autophagy and the phosphorylation of acetyl-CoA carboxylase (ACC), whereas alone it could block the autophagic flux concurrent with increased expression of p62.  An immunoprecipitation assay revealed that LC3 directly interacted with p62, whereas ST increased punctate LC3 staining, which was well colocalized with p62.  Taken together, we reveal a previously unnoticed pathway for ST to regulate the autophagic process, and p62, although often utilized as a substrate in autophagy, plays a critical role in regulating the inhibition of ST in both basal and induced autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwPdPrOAUoaR0LsK7uFuY7fW6udTcc2eYe5ZX-iuyos7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MvjsVemtQ%253D%253D&md5=5819caa869b4e944c1b4515f2239c475</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-47597-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-47597-4%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHuo%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DXi%26aufirst%3DZ.%26atitle%3DSQSTM1%252Fp62%2520loss%2520reverses%2520the%2520inhibitory%2520effect%2520of%2520sunitinib%2520on%2520autophagy%2520independent%2520of%2520AMPK%2520signaling%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26issue%3D1%26spage%3D11087%26doi%3D10.1038%2Fs41598-019-47597-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Youle, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narendra, D. P.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of mitophagy</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1038/nrm3028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fnrm3028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21179058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2murvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=9-14&issue=1&author=R.+J.+Youleauthor=D.+P.+Narendra&title=Mechanisms+of+mitophagy&doi=10.1038%2Fnrm3028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of mitophagy</span></div><div class="casAuthors">Youle, Richard J.; Narendra, Derek P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-14</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Autophagy not only recycles intracellular components to compensate for nutrient deprivation but also selectively eliminates organelles to regulate their no. and maintain quality control.  Mitophagy, the specific autophagic elimination of mitochondria, has been identified in yeast, mediated by autophagy-related 32 (Atg32), and in mammals during red blood cell differentiation, mediated by NIP3-like protein X (NIX; also known as BNIP3L).  Moreover, mitophagy is regulated in many metazoan cell types by parkin and PTEN-induced putative kinase protein 1 (PINK1), and mutations in the genes encoding these proteins have been linked to forms of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreUxmIhSOkeLVg90H21EOLACvtfcHk0lieInCL0hbEXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2murvF&md5=8b3cd10ebef89f08c561485c4b81caa1</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fnrm3028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3028%26sid%3Dliteratum%253Aachs%26aulast%3DYoule%26aufirst%3DR.%2BJ.%26aulast%3DNarendra%26aufirst%3DD.%2BP.%26atitle%3DMechanisms%2520of%2520mitophagy%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2011%26volume%3D12%26issue%3D1%26spage%3D9%26epage%3D14%26doi%3D10.1038%2Fnrm3028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, E.</span></span> <span> </span><span class="NLM_article-title">Kinetics of protein aggregates disposal by aggrephagy</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>588</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1016/bs.mie.2016.09.084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fbs.mie.2016.09.084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=28237105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmslSntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=588&publication_year=2017&pages=245-281&author=S.+Tanauthor=E.+Wong&title=Kinetics+of+protein+aggregates+disposal+by+aggrephagy&doi=10.1016%2Fbs.mie.2016.09.084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics of protein aggregates disposal by aggrephagy</span></div><div class="casAuthors">Tan, S.; Wong, E.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">588</span>
        (<span class="NLM_cas:issue">Molecular Characterization of Autophagic Responses, Part B</span>),
    <span class="NLM_cas:pages">245-281</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Macroautophagy has generated considerable interest because of its ability to recognize and target protein inclusions found prevalent in neurodegenerative diseases to lysosomes for elimination.  Pharmacol. upregulation of macroautophagy to remove disease-linked aggresomes has been reported to slow down disease progression and to improve survivability in many neurodegenerative models.  Despite its bulk removal mechanism, we now know that there are selective forms of autophagy.  Defect in selective autophagy represents a prominent cause of autophagic failures in many disorders.  Aggrephagy refers to the selective degrdn. of protein aggregates by macroautophagy.  In this chapter, we will review the mechanisms and factors that govern the selectivity of protein aggregates for disposal by macroautophagy.  This understanding is paramount for us to develop therapeutic approaches to enhance specific cargo targeting in addn. to general upregulation of macroautophagy for mitigating disease progression.  In addn., we will provide an overview of the different exptl. models of protein inclusions, as well as the microscopy and biochem. techniques used to quant. analyze the abundance of protein inclusions and the kinetics of their turnovers by macroautophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMs1xLraah8LVg90H21EOLACvtfcHk0lieInCL0hbEXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmslSntL0%253D&md5=4ad9e7ab5f18ac447b6c61d47246492c</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fbs.mie.2016.09.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.mie.2016.09.084%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DE.%26atitle%3DKinetics%2520of%2520protein%2520aggregates%2520disposal%2520by%2520aggrephagy%26jtitle%3DMethods%2520Enzymol.%26date%3D2017%26volume%3D588%26spage%3D245%26epage%3D281%26doi%3D10.1016%2Fbs.mie.2016.09.084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seranova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, D.</span></span> <span> </span><span class="NLM_article-title">Selective autophagy and xenophagy in infection and disease</span>. <i>Front. Cell Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">147</span>, <span class="refDoi"> DOI: 10.3389/fcell.2018.00147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.3389%2Ffcell.2018.00147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=30483501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BB3crlsV2ktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=147&author=V.+Sharmaauthor=S.+Vermaauthor=E.+Seranovaauthor=S.+Sarkarauthor=D.+Kumar&title=Selective+autophagy+and+xenophagy+in+infection+and+disease&doi=10.3389%2Ffcell.2018.00147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Autophagy and Xenophagy in Infection and Disease</span></div><div class="casAuthors">Sharma Vartika; Verma Surbhi; Kumar Dhiraj; Seranova Elena; Sarkar Sovan</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in cell and developmental biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">147</span>
        ISSN:<span class="NLM_cas:issn">2296-634X</span>.
    </div><div class="casAbstract">Autophagy, a cellular homeostatic process, which ensures cellular survival under various stress conditions, has catapulted to the forefront of innate defense mechanisms during intracellular infections.  The ability of autophagy to tag and target intracellular pathogens toward lysosomal degradation is central to this key defense function.  However, studies involving the role and regulation of autophagy during intracellular infections largely tend to ignore the housekeeping function of autophagy.  A growing number of evidences now suggest that the housekeeping function of autophagy, rather than the direct pathogen degradation function, may play a decisive role to determine the outcome of infection and immunological balance.  We discuss herein the studies that establish the homeostatic and anti-inflammatory function of autophagy, as well as role of bacterial effectors in modulating and coopting these functions.  Given that the core autophagy machinery remains largely the same across diverse cargos, how selectivity plays out during intracellular infection remains intriguing.  We explore here, the contrasting role of autophagy adaptors being both selective as well as pleotropic in functions and discuss whether E3 ligases could bring in the specificity to cargo selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQeDGPEbJxSCNyzdcP07UmufW6udTcc2eaZqH9S19P0J7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3crlsV2ktg%253D%253D&md5=9000fe59d94df8e1c00fd99e0247b1fa</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.3389%2Ffcell.2018.00147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffcell.2018.00147%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DV.%26aulast%3DVerma%26aufirst%3DS.%26aulast%3DSeranova%26aufirst%3DE.%26aulast%3DSarkar%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DD.%26atitle%3DSelective%2520autophagy%2520and%2520xenophagy%2520in%2520infection%2520and%2520disease%26jtitle%3DFront.%2520Cell%2520Dev.%2520Biol.%26date%3D2018%26volume%3D6%26spage%3D147%26doi%3D10.3389%2Ffcell.2018.00147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oku, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, Y.</span></span> <span> </span><span class="NLM_article-title">Pexophagy in Pichia pastoris</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>451</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">228</span>, <span class="refDoi"> DOI: 10.1016/S0076-6879(08)03215-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2FS0076-6879%2808%2903215-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19185723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1Wjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=451&publication_year=2008&pages=217-228&author=M.+Okuauthor=Y.+Sakai&title=Pexophagy+in+Pichia+pastoris&doi=10.1016%2FS0076-6879%2808%2903215-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Pexophagy in Pichia pastoris</span></div><div class="casAuthors">Oku, Masahide; Sakai, Yasuyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">451</span>
        (<span class="NLM_cas:issue">Autophagy: Lower Eukaryotes and Nonmammalian Systems, Part A</span>),
    <span class="NLM_cas:pages">217-228</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  The peroxisome is an organelle whose quantity is tightly regulated in response to changes in metabolic status, and much knowledge has been accumulated regarding its dynamics.  The turnover of peroxisomes through autophagic pathways, termed pexophagy, has been esp. studied in several methylotrophic yeast strains capable of growth on methanol as a sole carbon source, which led to the identification of factors involved in pexophagy.  In the methylotrophic yeast Pichia pastoris, several types of membrane dynamics during pexophagy can be visualized simultaneously under live cell imaging.  The decrease of abundant peroxisomal proteins in the cell lysate can be used as a convenient indicator of the completion of pexophagy.  In combination, these methods provide basic information for further anal. of pexophagy at the mol. level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryDxR5FNNS3LVg90H21EOLACvtfcHk0lhnLy1QXjHpFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1Wjt7w%253D&md5=089851473383cf304e845e210343e22e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2808%2903215-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252808%252903215-1%26sid%3Dliteratum%253Aachs%26aulast%3DOku%26aufirst%3DM.%26aulast%3DSakai%26aufirst%3DY.%26atitle%3DPexophagy%2520in%2520Pichia%2520pastoris%26jtitle%3DMethods%2520Enzymol.%26date%3D2008%26volume%3D451%26spage%3D217%26epage%3D228%26doi%3D10.1016%2FS0076-6879%2808%2903215-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MacIntosh, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassham, D. C.</span></span> <span> </span><span class="NLM_article-title">The connection between ribophagy, autophagy and ribosomal RNA decay</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">662</span>– <span class="NLM_lpage">663</span>, <span class="refDoi"> DOI: 10.4161/auto.7.6.15447</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.4161%2Fauto.7.6.15447" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21460615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38Xks1ymtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=662-663&issue=6&author=G.+C.+MacIntoshauthor=D.+C.+Bassham&title=The+connection+between+ribophagy%2C+autophagy+and+ribosomal+RNA+decay&doi=10.4161%2Fauto.7.6.15447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The connection between ribophagy, autophagy and ribosomal RNA decay</span></div><div class="casAuthors">MacIntosh, Gustavo C.; Bassham, Diane C.</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">662-663</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8627</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  Ribosomes are essential components of all cells.  A large body of knowledge has been accumulated regarding ribosome synthesis and assembly; however, the pathways of normal ribosome turnover, esp. rRNA decay, are not known.  Some information on ribosome recycling derives from studies on starved yeast cells that use a specialized type of autophagy, called ribophagy, to differentially target ribosomes for degrdn.  We found that Arabidopsis RNS2, a conserved RNase of the RNase T2 family, is necessary for normal decay of rRNA.  Mutants lacking RNS2 activity have longer-lived rRNA, accumulate RNA in the vacuole and show constitutive macroautophagy.  Thus, it is clear that normal rRNA decay is necessary to maintain cellular homeostasis.  These phenotypes and the subcellular localization of RNS2 in the endoplasmic reticulum and the vacuole suggest that RNS2 participates in a ribophagy-like mechanism that targets ribosomes for recycling under normal growth conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8pFmpYKJIxrVg90H21EOLACvtfcHk0lhnLy1QXjHpFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xks1ymtQ%253D%253D&md5=8a118f84e1f53c704dfe7fa9c6416d23</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.4161%2Fauto.7.6.15447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.7.6.15447%26sid%3Dliteratum%253Aachs%26aulast%3DMacIntosh%26aufirst%3DG.%2BC.%26aulast%3DBassham%26aufirst%3DD.%2BC.%26atitle%3DThe%2520connection%2520between%2520ribophagy%252C%2520autophagy%2520and%2520ribosomal%2520RNA%2520decay%26jtitle%3DAutophagy%26date%3D2011%26volume%3D7%26issue%3D6%26spage%3D662%26epage%3D663%26doi%3D10.4161%2Fauto.7.6.15447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamark, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dikic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansen, T.</span></span> <span> </span><span class="NLM_article-title">NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets</span>. <i>Cell Cycle</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">1986</span>– <span class="NLM_lpage">1990</span>, <span class="refDoi"> DOI: 10.4161/cc.8.13.8892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.4161%2Fcc.8.13.8892" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19502794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFykuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1986-1990&issue=13&author=T.+Lamarkauthor=V.+Kirkinauthor=I.+Dikicauthor=T.+Johansen&title=NBR1+and+p62+as+cargo+receptors+for+selective+autophagy+of+ubiquitinated+targets&doi=10.4161%2Fcc.8.13.8892"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets</span></div><div class="casAuthors">Lamark, Trond; Kirkin, Vladimir; Dikic, Ivan; Johansen, Terje</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1986-1990</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1538-4101</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  Autophagy is an evolutionary conserved cell survival process for the degrdn. of long-lived proteins, damaged organelles, and protein aggregates.  Mammalian proteins p62 and NBR1 are selectively degraded by autophagy and can act as cargo receptors or adaptors for the autophagic degrdn. of ubiquitinated substrates.  Despite differing in size and primary sequence, both proteins share a similar domain architecture contg. an N-terminal PB1 domain, a LIR motif interacting with ATG8 family proteins, and a C-terminal UBA domain interacting with ubiquitin.  The LIR motif is essential for their autophagic degrdn., indicating that ATG8 family proteins are responsible for the docking of p62 and NBR1 to nucleating autophagosomes.  Proteins p62 and NBR1 cooperate in the sequestration of misfolded and ubiquitinated proteins in p62 bodies and are both required for their degrdn. by autophagy.  Here, the authors discuss the role of p62 and NBR1 in degrdn. of ubiquitinated cargoes and the putative role of LIR as a general motif for docking of proteins to ATG8 family proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH9ltW91qxNrVg90H21EOLACvtfcHk0lhnLy1QXjHpFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFykuw%253D%253D&md5=325f743e80c3ce93415662822d1fc683</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.4161%2Fcc.8.13.8892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.8.13.8892%26sid%3Dliteratum%253Aachs%26aulast%3DLamark%26aufirst%3DT.%26aulast%3DKirkin%26aufirst%3DV.%26aulast%3DDikic%26aufirst%3DI.%26aulast%3DJohansen%26aufirst%3DT.%26atitle%3DNBR1%2520and%2520p62%2520as%2520cargo%2520receptors%2520for%2520selective%2520autophagy%2520of%2520ubiquitinated%2520targets%26jtitle%3DCell%2520Cycle%26date%3D2009%26volume%3D8%26issue%3D13%26spage%3D1986%26epage%3D1990%26doi%3D10.4161%2Fcc.8.13.8892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strnad, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zatloukal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stumptner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulaksiz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denk, H.</span></span> <span> </span><span class="NLM_article-title">Mallory-Denk-bodies: lessons from keratin-containing hepatic inclusion bodies</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>1782</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">764</span>– <span class="NLM_lpage">774</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2008.08.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.bbadis.2008.08.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCntb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1782&publication_year=2008&pages=764-774&issue=12&author=P.+Strnadauthor=K.+Zatloukalauthor=C.+Stumptnerauthor=H.+Kulaksizauthor=H.+Denk&title=Mallory-Denk-bodies%3A+lessons+from+keratin-containing+hepatic+inclusion+bodies&doi=10.1016%2Fj.bbadis.2008.08.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Mallory-Denk-bodies: Lessons from keratin-containing hepatic inclusion bodies</span></div><div class="casAuthors">Strnad, P.; Zatloukal, K.; Stumptner, C.; Kulaksiz, H.; Denk, H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1782</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">764-774</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Inclusion bodies are characteristic morphol. features of various neuronal, muscular and other human disorders.  They share common mol. constituents such as p62, chaperones and proteasome subunits.  The proteins within aggregates are misfolded with increased β-sheet structure, they are heavily phosphorylated, ubiquitinylated and partially degraded.  Furthermore, involvement of proteasomal system represents a common feature of virtually all inclusions.  Multiple aggregates contain intermediate filament proteins as their major constituents.  Among them, Mallory-Denk bodies (MDBs) are the best studied.  MDBs represent hepatic inclusions obsd. in diverse chronic liver diseases such as alc. and non-alc. steatohepatitis, chronic cholestasis, metabolic disorders and hepatocellular neoplasms.  MDBs are induced in mice fed griseofulvin or 3,5-diethoxycarbonyl-1,4-dihydrocollidine and resolve after discontinuation of toxin administration.  The availability of a drug-induced model makes MDBs a unique tool for studying inclusion formation.  Our review summarizes the recent advances gained from this model and shows how they relate to observations in other aggregates.  The MDB formation-underlying mechanisms include protein misfolding, chaperone alterations, disproportional protein expression with keratin 8 > keratin 18 levels and subsequent keratin 8 crosslinking via transglutaminase. p62 presence is crucial for MDB formation.  Proteasome inhibitors ppt. MDB formation, whereas stimulation of autophagy with rapamycin attenuates their formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG0R0PfzKloLVg90H21EOLACvtfcHk0ljQw7mqh4eKdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCntb%252FE&md5=a1230e0d263a507879b4de689026ff05</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2008.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2008.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DStrnad%26aufirst%3DP.%26aulast%3DZatloukal%26aufirst%3DK.%26aulast%3DStumptner%26aufirst%3DC.%26aulast%3DKulaksiz%26aufirst%3DH.%26aulast%3DDenk%26aufirst%3DH.%26atitle%3DMallory-Denk-bodies%253A%2520lessons%2520from%2520keratin-containing%2520hepatic%2520inclusion%2520bodies%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2008%26volume%3D1782%26issue%3D12%26spage%3D764%26epage%3D774%26doi%3D10.1016%2Fj.bbadis.2008.08.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aparicio, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espino, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bejarano, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallardo-Soler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salido, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pariente, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pena, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tapia, J. A.</span></span> <span> </span><span class="NLM_article-title">Autophagy-related proteins are functionally active in human spermatozoa and may be involved in the regulation of cell survival and motility</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">33647</span>, <span class="refDoi"> DOI: 10.1038/srep33647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fsrep33647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27633131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFentL3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=33647&author=I.+M.+Aparicioauthor=J.+Espinoauthor=I.+Bejaranoauthor=A.+Gallardo-Solerauthor=M.+L.+Campoauthor=G.+M.+Salidoauthor=J.+A.+Parienteauthor=F.+J.+Penaauthor=J.+A.+Tapia&title=Autophagy-related+proteins+are+functionally+active+in+human+spermatozoa+and+may+be+involved+in+the+regulation+of+cell+survival+and+motility&doi=10.1038%2Fsrep33647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy-related proteins are functionally active in human spermatozoa and may be involved in the regulation of cell survival and motility</span></div><div class="casAuthors">Aparicio, I. M.; Espino, J.; Bejarano, I.; Gallardo-Soler, A.; Campo, M. L.; Salido, G. M.; Pariente, J. A.; Pena, F. J.; Tapia, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">33647</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Macroautophagy (hereafter autophagy) is an evolutionarily highly conserved cellular process that participates in the maintenance of intracellular homeostasis through the degrdn. of most long-lived proteins and entire organelles.  Autophagy participates in some reproductive events; however, there are not reports regarding the role of autophagy in the regulation of sperm physiol.  Hence, the aim of this study was to investigate whether autophagy-related proteins are present and functionally active in human spermatozoa.  Proteins related to autophagy/mitophagy process (LC3, Atg5, Atg16, Beclin 1, p62, m-TOR, AMPKα 1/2, and PINK1) were present in human spermatozoa.  LC3 colocalized with p62 in the middle piece of the spermatozoa.  Autophagy activation induced a significant increase in motility and a decrease in PINK1, TOM20 expression and caspase 3/7 activation.  In contrast, autophagy inhibition resulted in decreased motility, viability, ATP and intracellular calcium concn. whereas PINK1, TOM20 expression, AMPK phosphorylation and caspase 3/7 activation were significantly increased.  In conclusion our results show that autophagy related proteins and upstream regulators are present and functional in human spermatozoa.  Modification of mitochondrial proteins expression after autophagy activation/inhibition may be indicating that a specialized form of autophagy named mitophagy may be regulating sperm function such as motility and viability and may be cooperating with apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3Mou1PHTnqrVg90H21EOLACvtfcHk0ljQw7mqh4eKdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFentL3J&md5=c347a38b4b4bc460dccb9f42942d3c8c</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fsrep33647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep33647%26sid%3Dliteratum%253Aachs%26aulast%3DAparicio%26aufirst%3DI.%2BM.%26aulast%3DEspino%26aufirst%3DJ.%26aulast%3DBejarano%26aufirst%3DI.%26aulast%3DGallardo-Soler%26aufirst%3DA.%26aulast%3DCampo%26aufirst%3DM.%2BL.%26aulast%3DSalido%26aufirst%3DG.%2BM.%26aulast%3DPariente%26aufirst%3DJ.%2BA.%26aulast%3DPena%26aufirst%3DF.%2BJ.%26aulast%3DTapia%26aufirst%3DJ.%2BA.%26atitle%3DAutophagy-related%2520proteins%2520are%2520functionally%2520active%2520in%2520human%2520spermatozoa%2520and%2520may%2520be%2520involved%2520in%2520the%2520regulation%2520of%2520cell%2520survival%2520and%2520motility%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D33647%26doi%3D10.1038%2Fsrep33647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamark, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overvatn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harneshaug, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjorkoy, G.</span></span> <span> </span><span class="NLM_article-title">A reporter cell system to monitor autophagy based on p62/SQSTM1</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">784</span>– <span class="NLM_lpage">793</span>, <span class="refDoi"> DOI: 10.4161/auto.6.6.12510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.4161%2Fauto.6.6.12510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20574168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFCqsrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=784-793&issue=6&author=K.+B.+Larsenauthor=T.+Lamarkauthor=A.+Overvatnauthor=I.+Harneshaugauthor=T.+Johansenauthor=G.+Bjorkoy&title=A+reporter+cell+system+to+monitor+autophagy+based+on+p62%2FSQSTM1&doi=10.4161%2Fauto.6.6.12510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">A reporter cell system to monitor autophagy based on p62/SQSTM1</span></div><div class="casAuthors">Larsen, Kenneth Bowitz; Lamark, Trond; Oevervam, Aud; Harneshaug, Ingvill; Johansen, Terje; Bjoerkoey, Geir</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">784-793</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8627</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Macroautophagy (hereafter referred to as autophagy) is a catabolic pathway to isolate and transport cytosolic components to the lysosome for degrdn.  Recently, autophagy receptors, like p62/SQSTM1 and NBR1, which phys. link autophagic cargo to ATG8/MAP1-LC3/GABARAP family members located on the forming autophagic membranes, have been identified.  To identify conditions or compds. that affect autophagy, cell systems that efficiently report on autophagic flux are required.  Here we describe reporter cell systems based on induced expression of GFP-p62, GFP-NBR1 or GFP-LC3B.  The degrdn. of the fusion proteins was followed after promoter shut-off by flow cytometry of live cells.  All three fusion proteins were degraded at a basal rate by autophagy.  Surprisingly, the basal degrdn. rate varied for the three reporter fusion proteins.  GFP-LC3B was the most stable protein.  GFP-NBR1 was most efficiently degraded under basal conditions while degrdn. of GFP-p62 displayed the strongest response to amino acid starvation.  GFP-p62 was found to perform the best of the tested reporters.  Single cell anal. of autophagic flux by flow cytometry allows ests. of heterogeneous cell populations.  The feasibility of this approach was demonstrated using transient overexpression of a dominant neg. ULK1 kinase and siRNA-mediated knockdown of LC3B to inhibit autophagic degrdn. of GFP-p62.  The inducible GFP-p62 cell system allows quantification by several approaches and will be useful in screening for compds. or conditions that affect the rate of autophagy.  Inducers of autophagy can be identified using rich medium whereas inhibitors are identified under starvation conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0X0ToS2A15LVg90H21EOLACvtfcHk0lhaUs9aEDC9RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFCqsrrI&md5=c8c9021cd2de1b7b1413de0766cad06f</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.4161%2Fauto.6.6.12510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.6.6.12510%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DK.%2BB.%26aulast%3DLamark%26aufirst%3DT.%26aulast%3DOvervatn%26aufirst%3DA.%26aulast%3DHarneshaug%26aufirst%3DI.%26aulast%3DJohansen%26aufirst%3DT.%26aulast%3DBjorkoy%26aufirst%3DG.%26atitle%3DA%2520reporter%2520cell%2520system%2520to%2520monitor%2520autophagy%2520based%2520on%2520p62%252FSQSTM1%26jtitle%3DAutophagy%26date%3D2010%26volume%3D6%26issue%3D6%26spage%3D784%26epage%3D793%26doi%3D10.4161%2Fauto.6.6.12510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rusten, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenmark, H.</span></span> <span> </span><span class="NLM_article-title">p62, an autophagy hero or culprit?</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">209</span>, <span class="refDoi"> DOI: 10.1038/ncb0310-207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fncb0310-207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20190829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFemsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=207-209&issue=3&author=T.+E.+Rustenauthor=H.+Stenmark&title=p62%2C+an+autophagy+hero+or+culprit%3F&doi=10.1038%2Fncb0310-207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">p62, an autophagy hero or culprit?</span></div><div class="casAuthors">Rusten, Tor Erik; Stenmark, Harald</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207-209</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The p62 protein recognizes toxic cellular waste, which is then scavenged by a sequestration process known as self-eating or autophagy.  Lack of autophagy leads to accumulation of p62, which is not good for liver cells, as it induces a cellular stress response that leads to disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDTvJsqrkhz7Vg90H21EOLACvtfcHk0lhaUs9aEDC9RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFemsLo%253D&md5=8c8db4932b3c53a0e576e2cda62fcc20</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fncb0310-207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb0310-207%26sid%3Dliteratum%253Aachs%26aulast%3DRusten%26aufirst%3DT.%2BE.%26aulast%3DStenmark%26aufirst%3DH.%26atitle%3Dp62%252C%2520an%2520autophagy%2520hero%2520or%2520culprit%253F%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2010%26volume%3D12%26issue%3D3%26spage%3D207%26epage%3D209%26doi%3D10.1038%2Fncb0310-207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choe, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. K.</span></span> <span> </span><span class="NLM_article-title">Enhanced p62 expression through impaired proteasomal degradation is involved in caspase-1 activation in monosodium urate crystal-induced interleukin-1b expression</span>. <i>Rheumatology (Oxford, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1043</span>– <span class="NLM_lpage">1053</span>, <span class="refDoi"> DOI: 10.1093/rheumatology/ket474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1093%2Frheumatology%2Fket474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=24587486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotF2qsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=1043-1053&issue=6&author=J.+Y.+Choeauthor=H.+Y.+Jungauthor=K.+Y.+Parkauthor=S.+K.+Kim&title=Enhanced+p62+expression+through+impaired+proteasomal+degradation+is+involved+in+caspase-1+activation+in+monosodium+urate+crystal-induced+interleukin-1b+expression&doi=10.1093%2Frheumatology%2Fket474"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced p62 expression through impaired proteasomal degradation is involved in caspase-1 activation in monosodium urate crystal-induced interleukin-1β expression</span></div><div class="casAuthors">Choe, Jung-Yoon; Jung, Hyun-Young; Park, Ki-Yeun; Kim, Seong-Kyu</div><div class="citationInfo"><span class="NLM_cas:title">Rheumatology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1043-1053</span>CODEN:
                <span class="NLM_cas:coden">RUMAFK</span>;
        ISSN:<span class="NLM_cas:issn">1462-0324</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objective. Evidence for the role of autophagy in the regulation of inflammation, esp. IL-1β expression in response to monosodium urate (MSU) crystals, is presented.  This study investigated the role of p62, a selective autophagy receptor in autophagy, in IL-1β prodn. in MSU crystal-induced inflammation.  Methods. IL-1β, TNF-α and IL-6 mRNA expression was measured by quant. real-time PCR (qRT-PCR).  Autophagy-related mols. such as p62, Cullin-3, microtubule-assocd. protein 1 light-chain 3 (LC3) I/II, ubiquitin, caspase-1 and mitogen-activated protein kinase (MAPK)-related proteins were measured by immunoblotting.  Small interfering RNAs (siRNAs) for Atg16L1, IL-1β and p62 were used to silence each target gene.  Results. MSU crystals accelerate the process of autophagosome formation and also induce impairment of proteasomal degrdn., resulting in p62 accumulation in autophagy.  Enhanced p62 accumulation by MSU crystals leads to IL-1β expression through activation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK), but not p38, of the MAPK pathway and is also involved in activation of caspase-1 in inflammasomes.  Impaired autophagosome formation by Atg16L1 siRNA significantly amplified p62 levels, thereby producing enhanced inflammatory responses, including overexpression of IL-1β under stimulation of MSU crystals.  IL-1β also induces p62 protein, and blocking IL-1β under stimulation of MSU crystals greatly reduced p62 levels.  Conclusion. This study demonstrates that enhanced p62 expression through impaired proteasomal degrdn. by MSU crystals plays a crucial role in caspase-1 activation in MSU crystal-induced IL-1β prodn. p62 is required for activation of inflammasomes during acute inflammation in gout.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolm2_Jdipsp7Vg90H21EOLACvtfcHk0lhaUs9aEDC9RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotF2qsLk%253D&md5=67a2fbcc23af60e5f63488a875fdfcdb</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2Fket474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252Fket474%26sid%3Dliteratum%253Aachs%26aulast%3DChoe%26aufirst%3DJ.%2BY.%26aulast%3DJung%26aufirst%3DH.%2BY.%26aulast%3DPark%26aufirst%3DK.%2BY.%26aulast%3DKim%26aufirst%3DS.%2BK.%26atitle%3DEnhanced%2520p62%2520expression%2520through%2520impaired%2520proteasomal%2520degradation%2520is%2520involved%2520in%2520caspase-1%2520activation%2520in%2520monosodium%2520urate%2520crystal-induced%2520interleukin-1b%2520expression%26jtitle%3DRheumatology%2520%2528Oxford%252C%2520U.%2520K.%2529%26date%3D2014%26volume%3D53%26issue%3D6%26spage%3D1043%26epage%3D1053%26doi%3D10.1093%2Frheumatology%2Fket474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Umemura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamachika, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Font-Burgada, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramaniam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghunandan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linares, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reina-Campos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umemura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valasek, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">p62, upregulated during preneoplasia, induces hepatocellular carcinogenesis by maintaining survival of stressed HCC-initiating cells</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">935</span>– <span class="NLM_lpage">948</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2016.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.ccell.2016.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27211490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28Xotlentro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2016&pages=935-948&issue=6&author=A.+Umemuraauthor=F.+Heauthor=K.+Taniguchiauthor=H.+Nakagawaauthor=S.+Yamachikaauthor=J.+Font-Burgadaauthor=Z.+Y.+Zhongauthor=S.+Subramaniamauthor=S.+Raghunandanauthor=A.+Duranauthor=J.+F.+Linaresauthor=M.+Reina-Camposauthor=S.+Umemuraauthor=M.+A.+Valasekauthor=E.+Sekiauthor=K.+Yamaguchiauthor=K.+Koikeauthor=Y.+Itohauthor=M.+T.+Diaz-Mecoauthor=J.+Moscatauthor=M.+Karin&title=p62%2C+upregulated+during+preneoplasia%2C+induces+hepatocellular+carcinogenesis+by+maintaining+survival+of+stressed+HCC-initiating+cells&doi=10.1016%2Fj.ccell.2016.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells</span></div><div class="casAuthors">Umemura, Atsushi; He, Feng; Taniguchi, Koji; Nakagawa, Hayato; Yamachika, Shinichiro; Font-Burgada, Joan; Zhong, Zhenyu; Subramaniam, Shankar; Raghunandan, Sindhu; Duran, Angeles; Linares, Juan F.; Reina-Campos, Miguel; Umemura, Shiori; Valasek, Mark A.; Seki, Ekihiro; Yamaguchi, Kanji; Koike, Kazuhiko; Itoh, Yoshito; Diaz-Meco, Maria T.; Moscat, Jorge; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">935-948</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">P62 is a ubiquitin-binding autophagy receptor and signaling protein that accumulates in premalignant liver diseases and most hepatocellular carcinomas (HCCs).  Although p62 was proposed to participate in the formation of benign adenomas in autophagy-deficient livers, its role in HCC initiation was not explored.  Here we show that p62 is necessary and sufficient for HCC induction in mice and that its high expression in non-tumor human liver predicts rapid HCC recurrence after curative ablation.  High p62 expression is needed for activation of NRF2 and mTORC1, induction of c-Myc, and protection of HCC-initiating cells from oxidative stress-induced death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG3PmjQwQ86bVg90H21EOLACvtfcHk0lghppmijUHcMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xotlentro%253D&md5=c8b15119ef52aacdc15ea7a9a3ee39e2</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2016.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2016.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DUmemura%26aufirst%3DA.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DTaniguchi%26aufirst%3DK.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DYamachika%26aufirst%3DS.%26aulast%3DFont-Burgada%26aufirst%3DJ.%26aulast%3DZhong%26aufirst%3DZ.%2BY.%26aulast%3DSubramaniam%26aufirst%3DS.%26aulast%3DRaghunandan%26aufirst%3DS.%26aulast%3DDuran%26aufirst%3DA.%26aulast%3DLinares%26aufirst%3DJ.%2BF.%26aulast%3DReina-Campos%26aufirst%3DM.%26aulast%3DUmemura%26aufirst%3DS.%26aulast%3DValasek%26aufirst%3DM.%2BA.%26aulast%3DSeki%26aufirst%3DE.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DKoike%26aufirst%3DK.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3Dp62%252C%2520upregulated%2520during%2520preneoplasia%252C%2520induces%2520hepatocellular%2520carcinogenesis%2520by%2520maintaining%2520survival%2520of%2520stressed%2520HCC-initiating%2520cells%26jtitle%3DCancer%2520Cell%26date%3D2016%26volume%3D29%26issue%3D6%26spage%3D935%26epage%3D948%26doi%3D10.1016%2Fj.ccell.2016.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linares, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvez, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wikenheiser, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span> <span> </span><span class="NLM_article-title">The signaling adaptor p62 is an important NF-kappa B mediator in tumorigenesis</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2008.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.ccr.2008.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18394557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkslSjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=343-354&issue=4&author=A.+Duranauthor=J.+F.+Linaresauthor=A.+S.+Galvezauthor=K.+Wikenheiserauthor=J.+M.+Floresauthor=M.+T.+Diaz-Mecoauthor=J.+Moscat&title=The+signaling+adaptor+p62+is+an+important+NF-kappa+B+mediator+in+tumorigenesis&doi=10.1016%2Fj.ccr.2008.02.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The signaling adaptor p62 is an important NF-κB mediator in tumorigenesis</span></div><div class="casAuthors">Duran, Angeles; Linares, Juan F.; Galvez, Anita S.; Wikenheiser, Kathryn; Flores, Juana M.; Diaz-Meco, Maria T.; Moscat, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">343-354</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The balance between cell death and survival, two crit. aspects of oncogenic transformation, dets. the outcome of tumorigenesis.  Nuclear factor-κB (NF-κB) is a crit. regulator of survival; it is induced by the oncogene Ras and, when inhibited, accounts for the cell death response of Ras-transformed cells.  Here, we show that the signaling adaptor p62 is induced by Ras, its levels are increased in human tumors, and it is required for Ras-induced survival and transformation.  P62-/- mice are resistant to Ras-induced lung adenocarcinomas.  P62 is necessary for Ras to trigger IκB kinase (IKK) through the polyubiquitination of tumor necrosis factor (TNF) receptor-assocd. factor 6 (TRAF6), and its deficiency produces increased reactive oxygen species (ROS) levels, which account for the enhanced cell death and reduced tumorigenicity of Ras in the absence of p62.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3t40xqHjHH7Vg90H21EOLACvtfcHk0lghppmijUHcMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkslSjtrY%253D&md5=a3557942b123db5fa13abd7a2b2a7713</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2008.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2008.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DDuran%26aufirst%3DA.%26aulast%3DLinares%26aufirst%3DJ.%2BF.%26aulast%3DGalvez%26aufirst%3DA.%2BS.%26aulast%3DWikenheiser%26aufirst%3DK.%26aulast%3DFlores%26aufirst%3DJ.%2BM.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DMoscat%26aufirst%3DJ.%26atitle%3DThe%2520signaling%2520adaptor%2520p62%2520is%2520an%2520important%2520NF-kappa%2520B%2520mediator%2520in%2520tumorigenesis%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D13%26issue%3D4%26spage%3D343%26epage%3D354%26doi%3D10.1016%2Fj.ccr.2008.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torigoe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asanuma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hisasue, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, N.</span></span> <span> </span><span class="NLM_article-title">Cytosolic overexpression of p62 sequestosome 1 in neoplastic prostate tissue</span>. <i>Histopathology</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2559.2005.02313.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1111%2Fj.1365-2559.2005.02313.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=16405664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FitVSqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2006&pages=157-161&issue=2&author=H.+Kitamuraauthor=T.+Torigoeauthor=H.+Asanumaauthor=S.+I.+Hisasueauthor=K.+Suzukiauthor=T.+Tsukamotoauthor=M.+Satohauthor=N.+Sato&title=Cytosolic+overexpression+of+p62+sequestosome+1+in+neoplastic+prostate+tissue&doi=10.1111%2Fj.1365-2559.2005.02313.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Cytosolic overexpression of p62 sequestosome 1 in neoplastic prostate tissue</span></div><div class="casAuthors">Kitamura H; Torigoe T; Asanuma H; Hisasue S-I; Suzuki K; Tsukamoto T; Satoh M; Sato N</div><div class="citationInfo"><span class="NLM_cas:title">Histopathology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-61</span>
        ISSN:<span class="NLM_cas:issn">0309-0167</span>.
    </div><div class="casAbstract">AIMS:  To investigate the expression of p62 in various prostatic tissues, and to demonstrate different immunohistochemical patterns of p62 expression in distinct pathological entities of the prostate.  The p62 sequestosome 1 (SQSTM1) gene product is a multifunctional protein with ubiquitous expression in normal adult tissue.  METHODS AND RESULTS:  Overexpression of p62 was detected in prostate cancer cell lines and tissues by reverse transcriptase-polymerase chain reaction.  Immunohistochemical staining for p62 was performed on 73 cases of paraffin-embedded prostatic tissue. p62 was negative or weakly positive only in the nucleus (pattern N) of prostatic gland epithelium in nine normal and hyperplastic prostate specimens, whilst most cancerous tissue showed intense, uniform staining for p62 in the cytoplasm (pattern C).  Of the prostate cancer specimens, 91% showed positive pattern C immunoreactivity.  Of the cases with high-grade prostatic intraepithelial neoplasia (PIN) around cancer, 77% showed pattern C.  However, in specimens from the patients without prostate cancer PIN displayed pattern C in only 32% of cases.  Western blot analysis showed that all cancer cell lines expressed p62 in the cytoplasm but there was little nuclear expression.  CONCLUSION:  Cytosolic overexpression of p62 is a novel immunohistochemical characteristic in prostatic adenocarcinoma and high-grade PIN, suggesting that p62 might be a novel marker for prostatic malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS4Q809cHSgjXl8icjszYl0fW6udTcc2eZkYWj2c-BGAbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FitVSqug%253D%253D&md5=6de7425cd1be440743ae5c76ffc17948</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2559.2005.02313.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2559.2005.02313.x%26sid%3Dliteratum%253Aachs%26aulast%3DKitamura%26aufirst%3DH.%26aulast%3DTorigoe%26aufirst%3DT.%26aulast%3DAsanuma%26aufirst%3DH.%26aulast%3DHisasue%26aufirst%3DS.%2BI.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DSatoh%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DN.%26atitle%3DCytosolic%2520overexpression%2520of%2520p62%2520sequestosome%25201%2520in%2520neoplastic%2520prostate%2520tissue%26jtitle%3DHistopathology%26date%3D2006%26volume%3D48%26issue%3D2%26spage%3D157%26epage%3D161%26doi%3D10.1111%2Fj.1365-2559.2005.02313.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signoretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beroukhim, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lizotte, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liberzon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bair, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamayo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsherniak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabak, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hakimi, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciriello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sander, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaelin, W. G.</span></span> <span> </span><span class="NLM_article-title">SQSTM1 is a pathogenic target of 5q copy number gains in kidney cancer</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">738</span>– <span class="NLM_lpage">750</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2013.10.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.ccr.2013.10.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=24332042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFyltrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=738-750&issue=6&author=L.+J.+Liauthor=C.+Shenauthor=E.+Nakamuraauthor=K.+Andoauthor=S.+Signorettiauthor=R.+Beroukhimauthor=G.+S.+Cowleyauthor=P.+Lizotteauthor=E.+Liberzonauthor=S.+Bairauthor=D.+E.+Rootauthor=P.+Tamayoauthor=A.+Tsherniakauthor=S.+C.+Chengauthor=B.+Tabakauthor=A.+Jacobsenauthor=A.+A.+Hakimiauthor=N.+Schultzauthor=G.+Cirielloauthor=C.+Sanderauthor=J.+J.+Hsiehauthor=W.+G.+Kaelin&title=SQSTM1+is+a+pathogenic+target+of+5q+copy+number+gains+in+kidney+cancer&doi=10.1016%2Fj.ccr.2013.10.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">SQSTM1 Is a Pathogenic Target of 5q Copy Number Gains in Kidney Cancer</span></div><div class="casAuthors">Li, Lianjie; Shen, Chuan; Nakamura, Eijiro; Ando, Kiyohiro; Signoretti, Sabina; Beroukhim, Rameen; Cowley, Glenn S.; Lizotte, Patrick; Liberzon, Ella; Bair, Steven; Root, David E.; Tamayo, Pablo; Tsherniak, Aviad; Cheng, Su-Chun; Tabak, Barbara; Jacobsen, Anders; Hakimi, A. Ari; Schultz, Nikolaus; Ciriello, Giovanni; Sander, Chris; Hsieh, James J.; Kaelin, William G., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">738-750</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Clear cell renal cell carcinoma (ccRCC) is the most common form of kidney cancer and is often linked to loss of chromosome 3p, which harbors the VHL tumor suppressor gene, loss of chromosome 14q, which includes HIF1A, and gain of chromosome 5q.  The relevant target(s) on chromosome 5q is not known.  Here, we show that 5q amplification leads to overexpression of the SQSTM1 oncogene in ccRCC lines and tumors.  Overexpression of SQSTM1 in ccRCC lines promoted resistance to redox stress and increased soft agar growth, while downregulation of SQSTM1 decreased resistance to redox stress, impaired cellular fitness, and decreased tumor formation.  Therefore, the selection pressure to amplify 5q in ccRCC is driven, at least partly, by SQSTM1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDLybjFnYTMrVg90H21EOLACvtfcHk0lj5PbxADZU9TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFyltrzM&md5=0d9e0bf2b9be24a33e2ecd7c082fa58f</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2013.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2013.10.025%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%2BJ.%26aulast%3DShen%26aufirst%3DC.%26aulast%3DNakamura%26aufirst%3DE.%26aulast%3DAndo%26aufirst%3DK.%26aulast%3DSignoretti%26aufirst%3DS.%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DCowley%26aufirst%3DG.%2BS.%26aulast%3DLizotte%26aufirst%3DP.%26aulast%3DLiberzon%26aufirst%3DE.%26aulast%3DBair%26aufirst%3DS.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DTamayo%26aufirst%3DP.%26aulast%3DTsherniak%26aufirst%3DA.%26aulast%3DCheng%26aufirst%3DS.%2BC.%26aulast%3DTabak%26aufirst%3DB.%26aulast%3DJacobsen%26aufirst%3DA.%26aulast%3DHakimi%26aufirst%3DA.%2BA.%26aulast%3DSchultz%26aufirst%3DN.%26aulast%3DCiriello%26aufirst%3DG.%26aulast%3DSander%26aufirst%3DC.%26aulast%3DHsieh%26aufirst%3DJ.%2BJ.%26aulast%3DKaelin%26aufirst%3DW.%2BG.%26atitle%3DSQSTM1%2520is%2520a%2520pathogenic%2520target%2520of%25205q%2520copy%2520number%2520gains%2520in%2520kidney%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2013%26volume%3D24%26issue%3D6%26spage%3D738%26epage%3D750%26doi%3D10.1016%2Fj.ccr.2013.10.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valencia, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu-Baker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat-Pardos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reina-Campos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castilla, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metallo, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span> <span> </span><span class="NLM_article-title">Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2014.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.ccr.2014.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=25002027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFans7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2014&pages=121-135&issue=1&author=T.+Valenciaauthor=J.+Y.+Kimauthor=S.+Abu-Bakerauthor=J.+Moscat-Pardosauthor=C.+S.+Ahnauthor=M.+Reina-Camposauthor=A.+Duranauthor=E.+A.+Castillaauthor=C.+M.+Metalloauthor=M.+T.+Diaz-Mecoauthor=J.+Moscat&title=Metabolic+reprogramming+of+stromal+fibroblasts+through+p62-mTORC1+signaling+promotes+inflammation+and+tumorigenesis&doi=10.1016%2Fj.ccr.2014.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic Reprogramming of Stromal Fibroblasts through p62-mTORC1 Signaling Promotes Inflammation and Tumorigenesis</span></div><div class="casAuthors">Valencia, Tania; Kim, Ji Young; Abu-Baker, Shadi; Moscat-Pardos, Jorge; Ahn, Christopher S.; Reina-Campos, Miguel; Duran, Angeles; Castilla, Elias A.; Metallo, Christian M.; Diaz-Meco, Maria T.; Moscat, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">121-135</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The tumor microenvironment plays a crit. role in cancer progression, but the precise mechanisms by which stromal cells influence the epithelium are poorly understood.  Here we show that p62 levels were reduced in the stroma of several tumors and that its loss in the tumor microenvironment or stromal fibroblasts resulted in increased tumorigenesis of epithelial prostate cancer cells.  The mechanism involves the regulation of cellular redox through an mTORC1/c-Myc pathway of stromal glucose and amino acid metab., resulting in increased stromal IL-6 prodn., which is required for tumor promotion in the epithelial compartment.  Thus, p62 is an anti-inflammatory tumor suppressor that acts through the modulation of metab. in the tumor stroma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFR7mW_cF9IbVg90H21EOLACvtfcHk0lj5PbxADZU9TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFans7rL&md5=8448e9f8c287d7db07c690150e5f1215</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2014.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2014.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DValencia%26aufirst%3DT.%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DAbu-Baker%26aufirst%3DS.%26aulast%3DMoscat-Pardos%26aufirst%3DJ.%26aulast%3DAhn%26aufirst%3DC.%2BS.%26aulast%3DReina-Campos%26aufirst%3DM.%26aulast%3DDuran%26aufirst%3DA.%26aulast%3DCastilla%26aufirst%3DE.%2BA.%26aulast%3DMetallo%26aufirst%3DC.%2BM.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DMoscat%26aufirst%3DJ.%26atitle%3DMetabolic%2520reprogramming%2520of%2520stromal%2520fibroblasts%2520through%2520p62-mTORC1%2520signaling%2520promotes%2520inflammation%2520and%2520tumorigenesis%26jtitle%3DCancer%2520Cell%26date%3D2014%26volume%3D26%26issue%3D1%26spage%3D121%26epage%3D135%26doi%3D10.1016%2Fj.ccr.2014.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span> <span> </span><span class="NLM_article-title">p62 in cancer: signaling adaptor beyond autophagy</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>167</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">606</span>– <span class="NLM_lpage">609</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.09.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.cell.2016.09.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27768885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslCrsrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2016&pages=606-609&issue=3&author=J.+Moscatauthor=M.+Karinauthor=M.+T.+Diaz-Meco&title=p62+in+cancer%3A+signaling+adaptor+beyond+autophagy&doi=10.1016%2Fj.cell.2016.09.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">p62 in Cancer: Signaling Adaptor Beyond Autophagy</span></div><div class="casAuthors">Moscat, Jorge; Karin, Michael; Diaz-Meco, Maria T.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">606-609</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Adaptor proteins participate in selective autophagy, which is crit. for cellular detoxification and stress relief.  However, new evidence supports an autophagy-independent key role of the adaptor p62 (encoded by the gene Sqstm1) in signaling functions central to tumor initiation in the epithelium and suppression of tumor progression in the stroma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfCL87hjyvcbVg90H21EOLACvtfcHk0lh605YLZeWmtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslCrsrjL&md5=cb962ea1adfd7935b4fbe0eba4b7049b</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.09.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.09.030%26sid%3Dliteratum%253Aachs%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DKarin%26aufirst%3DM.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26atitle%3Dp62%2520in%2520cancer%253A%2520signaling%2520adaptor%2520beyond%2520autophagy%26jtitle%3DCell%26date%3D2016%26volume%3D167%26issue%3D3%26spage%3D606%26epage%3D609%26doi%3D10.1016%2Fj.cell.2016.09.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eskelinen, E. L.</span></span> <span> </span><span class="NLM_article-title">The dual role of autophagy in cancer</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">294</span>– <span class="NLM_lpage">300</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2011.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.coph.2011.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21498118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVaisbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=294-300&issue=4&author=E.+L.+Eskelinen&title=The+dual+role+of+autophagy+in+cancer&doi=10.1016%2Fj.coph.2011.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">The dual role of autophagy in cancer</span></div><div class="casAuthors">Eskelinen, Eeva-Liisa</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">294-300</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Autophagy is a mechanism for the degrdn. of cytoplasmic material, damaged organelles and aggregate-prone proteins in lysosomes.  Recent evidence indicates that autophagy is a tumor suppressor mechanism, which is connected to its role in the clearance of the scaffold protein p62/SQSTM1 and prevention of oxidative stress and genomic instability.  However, since autophagy is a survival mechanism, cancer cells can also exploit it to survive nutrient limitation and hypoxia that often occur in solid tumors.  Tumor cells can also upregulate autophagy as a response to cancer treatment, and recent studies show that inhibition of autophagy can enhance the killing of tumor cells after treatment.  Interestingly, the FK506-binding protein 51 plays a role in the autophagy-linked radiation resistance of malignant melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqperDgYUp4kLVg90H21EOLACvtfcHk0lh605YLZeWmtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVaisbfF&md5=ff1fedd9f6f59b5cac7f594c65f87681</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2011.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2011.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DEskelinen%26aufirst%3DE.%2BL.%26atitle%3DThe%2520dual%2520role%2520of%2520autophagy%2520in%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2011%26volume%3D11%26issue%3D4%26spage%3D294%26epage%3D300%26doi%3D10.1016%2Fj.coph.2011.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debnath, J.</span></span> <span> </span><span class="NLM_article-title">Autophagy and tumorigenesis</span>. <i>Semin. Immunopathol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1007/s00281-010-0213-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1007%2Fs00281-010-0213-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20589500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FivVahsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2010&pages=383-396&issue=4&author=S.+Royauthor=J.+Debnath&title=Autophagy+and+tumorigenesis&doi=10.1007%2Fs00281-010-0213-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy and tumorigenesis</span></div><div class="casAuthors">Roy Srirupa; Debnath Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in immunopathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">383-96</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autophagy, a catabolic process involved in the sequestration and lysosomal degradation of cytoplasmic contents, is crucial for cellular homeostasis.  The current literature supports that autophagy plays diverse roles in the development, maintenance, and progression of tumors.  While genetic evidence indicates autophagy functions as a tumor suppressor mechanism, it is also apparent that autophagy can promote the survival of established tumors under stress conditions and in response to chemotherapy.  In this review, we discuss the mechanisms and the evidence underlying these multifaceted roles of autophagy in tumorigenesis, the prospects for targeting autophagy in cancer therapy, and overview the potential markers that may be utilized to reliably detect autophagy in clinical settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSRZ1BYMyXusI2y4bB4mnvYfW6udTcc2ebJ9nesSAVi6rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FivVahsg%253D%253D&md5=102223a7cdb6068f9431aef06e87c0cc</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1007%2Fs00281-010-0213-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00281-010-0213-0%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DDebnath%26aufirst%3DJ.%26atitle%3DAutophagy%2520and%2520tumorigenesis%26jtitle%3DSemin.%2520Immunopathol.%26date%3D2010%26volume%3D32%26issue%3D4%26spage%3D383%26epage%3D396%26doi%3D10.1007%2Fs00281-010-0213-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, T. D.</span></span> <span> </span><span class="NLM_article-title">Autophagy modulation: a prudent approach in cancer treatment?</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>82</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">913</span>– <span class="NLM_lpage">922</span>, <span class="refDoi"> DOI: 10.1007/s00280-018-3669-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1007%2Fs00280-018-3669-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=30182146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Gks7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2018&pages=913-922&issue=6&author=E.+Bishopauthor=T.+D.+Bradshaw&title=Autophagy+modulation%3A+a+prudent+approach+in+cancer+treatment%3F&doi=10.1007%2Fs00280-018-3669-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy modulation: a prudent approach in cancer treatment?</span></div><div class="casAuthors">Bishop, Eleanor; Bradshaw, Tracey D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">913-922</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Autophagy is a tightly controlled process comprising lysosomal degrdn. and recycling of cellular proteins and organelles.  In cancer, its paradoxical dual role of cytoprotection and cytotoxicity is context-dependent and controversial.  Autophagy primarily acts as a mechanism of tumor suppression, by maintenance of genomic integrity and prevention of proliferation and inflammation.  This, combined with immune-surveillance capabilities and autophagy's implicated role in cell death, acts to prevent tumor initiation.  However, established tumors exploit autophagy to survive cellular stresses in the hostile tumor microenvironment.  This can lead to therapy resistance, one of the biggest challenges facing current anti-cancer approaches.  Autophagy modulation is an exciting area of clin. development, attempting to harness this fundamental process as an anti-cancer strategy.  Autophagy induction could potentially prevent tumor formation and enhance anti-cancer immune responses.  In addn., drug-induced autophagy could be used to kill cancer cells, particularly those in which the apoptotic machinery is defective.  Conversely, autophagy inhibition may help to sensitize resistant cancer cells to conventional chemotherapies and specifically target autophagy-addicted tumors.  Currently, hydroxychloroquine is in phase I and II clin. trials in combination with several std. chemotherapies, whereas direct, deliberate autophagy induction remains to be tested clin.  More comprehensive understanding of the roles of autophagy throughout different stages of carcinogenesis has potential to guide development of novel therapeutic strategies to eradicate cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGIViCqA2AKLVg90H21EOLACvtfcHk0liKgnPYSq5Ncg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Gks7%252FE&md5=a1655951f3c69f959b2acc6b35fe00d4</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1007%2Fs00280-018-3669-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-018-3669-6%26sid%3Dliteratum%253Aachs%26aulast%3DBishop%26aufirst%3DE.%26aulast%3DBradshaw%26aufirst%3DT.%2BD.%26atitle%3DAutophagy%2520modulation%253A%2520a%2520prudent%2520approach%2520in%2520cancer%2520treatment%253F%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2018%26volume%3D82%26issue%3D6%26spage%3D913%26epage%3D922%26doi%3D10.1007%2Fs00280-018-3669-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fung, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lock, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debnath, J.</span></span> <span> </span><span class="NLM_article-title">Induction of autophagy during extracellular matrix detachment promotes cell survival</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">797</span>– <span class="NLM_lpage">806</span>, <span class="refDoi"> DOI: 10.1091/mbc.e07-10-1092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1091%2Fmbc.e07-10-1092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18094039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslemsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=797-806&issue=3&author=C.+Fungauthor=R.+Lockauthor=S.+Z.+Gaoauthor=E.+Salasauthor=J.+Debnath&title=Induction+of+autophagy+during+extracellular+matrix+detachment+promotes+cell+survival&doi=10.1091%2Fmbc.e07-10-1092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of autophagy during extracellular matrix detachment promotes cell survival</span></div><div class="casAuthors">Fung, Christopher; Lock, Rebecca; Gao, Sizhen; Salas, Eduardo; Debnath, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">797-806</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1939-4586</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Autophagy has been proposed to promote cell death during lumen formation in three-dimensional mammary epithelial acini because numerous autophagic vacuoles are obsd. in the dying central cells during morphogenesis.  Because these central cells die due to extracellular matrix (ECM) deprivation (anoikis), we have directly interrogated how matrix detachment regulates autophagy.  Detachment induces autophagy in both nontumorigenic epithelial lines and in primary epithelial cells.  RNA interference-mediated depletion of autophagy regulators (ATGs) inhibits detachment-induced autophagy, enhances apoptosis, and reduces clonogenic recovery after anoikis.  Remarkably, matrix-detached cells still exhibit autophagy when apoptosis is blocked by Bcl-2 overexpression, and ATG depletion reduces the clonogenic survival of Bcl-2-expressing cells after detachment.  Finally, stable redn. of ATG5 or ATG7 in MCF-10A acini enhances luminal apoptosis during morphogenesis and fails to elicit long-term luminal filling, even when combined with apoptotic inhibition mediated by Bcl-2 overexpression.  Thus, autophagy promotes epithelial cell survival during anoikis, including detached cells harboring antiapoptotic lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCt94oDcCXZLVg90H21EOLACvtfcHk0liKgnPYSq5Ncg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslemsr8%253D&md5=5480fd837a9490e92d80b9eeb2e5ec15</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1091%2Fmbc.e07-10-1092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.e07-10-1092%26sid%3Dliteratum%253Aachs%26aulast%3DFung%26aufirst%3DC.%26aulast%3DLock%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DS.%2BZ.%26aulast%3DSalas%26aufirst%3DE.%26aulast%3DDebnath%26aufirst%3DJ.%26atitle%3DInduction%2520of%2520autophagy%2520during%2520extracellular%2520matrix%2520detachment%2520promotes%2520cell%2520survival%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2008%26volume%3D19%26issue%3D3%26spage%3D797%26epage%3D806%26doi%3D10.1091%2Fmbc.e07-10-1092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amaravadi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimmelman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, E.</span></span> <span> </span><span class="NLM_article-title">Recent insights into the function of autophagy in cancer</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">1913</span>– <span class="NLM_lpage">1930</span>, <span class="refDoi"> DOI: 10.1101/gad.287524.116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1101%2Fgad.287524.116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27664235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlWiu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=1913-1930&issue=17&author=R.+Amaravadiauthor=A.+C.+Kimmelmanauthor=E.+White&title=Recent+insights+into+the+function+of+autophagy+in+cancer&doi=10.1101%2Fgad.287524.116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Recent insights into the function of autophagy in cancer</span></div><div class="casAuthors">Amaravadi, Ravi; Kimmelman, Alec C.; White, Eileen</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1913-1930</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Macroautophagy (referred to here as autophagy) is induced by starvation to capture and degrade intracellular proteins and organelles in lysosomes, which recycles intracellular components to sustain metab. and survival.  Autophagy also plays a major homeostatic role in controlling protein and organelle quality and quantity.  Dysfunctional autophagy contributes to many diseases.  In cancer, autophagy can be neutral, tumor-suppressive, or tumor-promoting in different contexts.  Large-scale genomic anal. of human cancers indicates that the loss or mutation of core autophagy genes is uncommon, whereas oncogenic events that activate autophagy and lysosomal biogenesis have been identified.  Autophagic flux, however, is difficult to measure in human tumor samples, making functional assessment of autophagy problematic in a clin. setting.  Autophagy impacts cellular metab., the proteome, and organelle nos. and quality, which alter cell functions in diverse ways.  Moreover, autophagy influences the interaction between the tumor and the host by promoting stress adaptation and suppressing activation of innate and adaptive immune responses.  Addnl., autophagy can promote a cross-talk between the tumor and the stroma, which can support tumor growth, particularly in a nutrient-limited microenvironment.  Thus, the role of autophagy in cancer is detd. by nutrient availability, microenvironment stress, and the presence of an immune system.  Here we discuss recent developments in the role of autophagy in cancer, in particular how autophagy can promote cancer through suppressing p53 and preventing energy crisis, cell death, senescence, and an anti-tumor immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZVHFFZf5sjbVg90H21EOLACvtfcHk0lgf16pUgRGb3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlWiu70%253D&md5=d0bbf76e801f31613d5e8f56f8d69d2b</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1101%2Fgad.287524.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.287524.116%26sid%3Dliteratum%253Aachs%26aulast%3DAmaravadi%26aufirst%3DR.%26aulast%3DKimmelman%26aufirst%3DA.%2BC.%26aulast%3DWhite%26aufirst%3DE.%26atitle%3DRecent%2520insights%2520into%2520the%2520function%2520of%2520autophagy%2520in%2520cancer%26jtitle%3DGenes%2520Dev.%26date%3D2016%26volume%3D30%26issue%3D17%26spage%3D1913%26epage%3D1930%26doi%3D10.1101%2Fgad.287524.116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bjorkoy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamark, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brech, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Outzen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perander, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overvatn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenmark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansen, T.</span></span> <span> </span><span class="NLM_article-title">p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>171</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">603</span>– <span class="NLM_lpage">614</span>, <span class="refDoi"> DOI: 10.1083/jcb.200507002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1083%2Fjcb.200507002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=16286508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BD2MnitVWktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2005&pages=603-614&issue=4&author=G.+Bjorkoyauthor=T.+Lamarkauthor=A.+Brechauthor=H.+Outzenauthor=M.+Peranderauthor=A.+Overvatnauthor=H.+Stenmarkauthor=T.+Johansen&title=p62%2FSQSTM1+forms+protein+aggregates+degraded+by+autophagy+and+has+a+protective+effect+on+huntingtin-induced+cell+death&doi=10.1083%2Fjcb.200507002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death</span></div><div class="casAuthors">Bjorkoy Geir; Lamark Trond; Brech Andreas; Outzen Heidi; Perander Maria; Overvatn Aud; Stenmark Harald; Johansen Terje</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of cell biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">603-14</span>
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    </div><div class="casAbstract">Autophagic degradation of ubiquitinated protein aggregates is important for cell survival, but it is not known how the autophagic machinery recognizes such aggregates.  In this study, we report that polymerization of the polyubiquitin-binding protein p62/SQSTM1 yields protein bodies that either reside free in the cytosol and nucleus or occur within autophagosomes and lysosomal structures.  Inhibition of autophagy led to an increase in the size and number of p62 bodies and p62 protein levels.  The autophagic marker light chain 3 (LC3) colocalized with p62 bodies and co-immunoprecipitated with p62, suggesting that these two proteins participate in the same complexes.  The depletion of p62 inhibited recruitment of LC3 to autophagosomes under starvation conditions.  Strikingly, p62 and LC3 formed a shell surrounding aggregates of mutant huntingtin.  Reduction of p62 protein levels or interference with p62 function significantly increased cell death that was induced by the expression of mutant huntingtin.  We suggest that p62 may, via LC3, be involved in linking polyubiquitinated protein aggregates to the autophagy machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTI4TfVb2IG0H6oPH0mYWL1fW6udTcc2eYuFo_MXQdzf7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MnitVWktw%253D%253D&md5=458c088f5526eadc05be25594a183747</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200507002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200507002%26sid%3Dliteratum%253Aachs%26aulast%3DBjorkoy%26aufirst%3DG.%26aulast%3DLamark%26aufirst%3DT.%26aulast%3DBrech%26aufirst%3DA.%26aulast%3DOutzen%26aufirst%3DH.%26aulast%3DPerander%26aufirst%3DM.%26aulast%3DOvervatn%26aufirst%3DA.%26aulast%3DStenmark%26aufirst%3DH.%26aulast%3DJohansen%26aufirst%3DT.%26atitle%3Dp62%252FSQSTM1%2520forms%2520protein%2520aggregates%2520degraded%2520by%2520autophagy%2520and%2520has%2520a%2520protective%2520effect%2520on%2520huntingtin-induced%2520cell%2520death%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2005%26volume%3D171%26issue%3D4%26spage%3D603%26epage%3D614%26doi%3D10.1083%2Fjcb.200507002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inami, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waguri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hino, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwadate, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span> <span> </span><span class="NLM_article-title">Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>193</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1083/jcb.201102031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1083%2Fjcb.201102031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21482715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltlGjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2011&pages=275-284&issue=2&author=Y.+Inamiauthor=S.+Waguriauthor=A.+Sakamotoauthor=T.+Kounoauthor=K.+Nakadaauthor=O.+Hinoauthor=S.+Watanabeauthor=J.+Andoauthor=M.+Iwadateauthor=M.+Yamamotoauthor=M.+S.+Leeauthor=K.+Tanakaauthor=M.+Komatsu&title=Persistent+activation+of+Nrf2+through+p62+in+hepatocellular+carcinoma+cells&doi=10.1083%2Fjcb.201102031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells</span></div><div class="casAuthors">Inami, Yoshihiro; Waguri, Satoshi; Sakamoto, Ayako; Kouno, Tsuguka; Nakada, Kazuto; Hino, Okio; Watanabe, Sumio; Ando, Jin; Iwadate, Manabu; Yamamoto, Masayuki; Lee, Myung-Shik; Tanaka, Keiji; Komatsu, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-284</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Suppression of autophagy is always accompanied by marked accumulation of p62, a selective autophagy substrate.  Because p62 interacts with the Nrf2-binding site on Keap1, which is a Cullin 3-based ubiquitin ligase adapter protein, autophagy deficiency causes competitive inhibition of the Nrf2-Keap1 interaction, resulting in stabilization of Nrf2 followed by transcriptional activation of Nrf2 target genes.  Herein, we show that liver-specific autophagy-deficient mice harbor adenomas linked to both the formation of p62- and Keap1-pos. cellular aggregates and induction of Nrf2 targets.  Importantly, similar aggregates were identified in more than 25% of human hepatocellular carcinomas (HCC), and induction of Nrf2 target genes was recognized in most of these tumors.  Gene targeting of p62 in an HCC cell line markedly abrogates the anchorage-independent growth, whereas forced expression of p62, but not a Keap1 interaction-defective mutant, resulted in recovery of the growth defect.  These results indicate the involvement of persistent activation of Nrf2 through the accumulation of p62 in hepatoma development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3R8QJbqjBu7Vg90H21EOLACvtfcHk0ljlQ9IRILGQow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltlGjtro%253D&md5=94996fb80dafd1637ce0299209a1db60</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201102031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201102031%26sid%3Dliteratum%253Aachs%26aulast%3DInami%26aufirst%3DY.%26aulast%3DWaguri%26aufirst%3DS.%26aulast%3DSakamoto%26aufirst%3DA.%26aulast%3DKouno%26aufirst%3DT.%26aulast%3DNakada%26aufirst%3DK.%26aulast%3DHino%26aufirst%3DO.%26aulast%3DWatanabe%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DJ.%26aulast%3DIwadate%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3DPersistent%2520activation%2520of%2520Nrf2%2520through%2520p62%2520in%2520hepatocellular%2520carcinoma%2520cells%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2011%26volume%3D193%26issue%3D2%26spage%3D275%26epage%3D284%26doi%3D10.1083%2Fjcb.201102031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waguri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eishi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hino, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizushima, N.</span></span> <span> </span><span class="NLM_article-title">Autophagy-deficient mice develop multiple liver tumors</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">795</span>– <span class="NLM_lpage">800</span>, <span class="refDoi"> DOI: 10.1101/gad.2016211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1101%2Fgad.2016211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21498569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltlKntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=795-800&issue=8&author=A.+Takamuraauthor=M.+Komatsuauthor=T.+Haraauthor=A.+Sakamotoauthor=C.+Kishiauthor=S.+Waguriauthor=Y.+Eishiauthor=O.+Hinoauthor=K.+Tanakaauthor=N.+Mizushima&title=Autophagy-deficient+mice+develop+multiple+liver+tumors&doi=10.1101%2Fgad.2016211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy-deficient mice develop multiple liver tumors</span></div><div class="casAuthors">Takamura, Akito; Komatsu, Masaaki; Hara, Taichi; Sakamoto, Ayako; Kishi, Chieko; Waguri, Satoshi; Eishi, Yoshinobu; Hino, Okio; Tanaka, Keiji; Mizushima, Noboru</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">795-800</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Autophagy is a major pathway for degrdn. of cytoplasmic proteins and organelles, and has been implicated in tumor suppression.  Here, we report that mice with systemic mosaic deletion of Atg5 and liver-specific Atg7-/- mice develop benign liver adenomas.  These tumor cells originate autophagy-deficient hepatocytes and show mitochondrial swelling, p62 accumulation, and oxidative stress and genomic damage responses.  The size of the Atg7-/- liver tumors is reduced by simultaneous deletion of p62.  These results suggest that autophagy is important for the suppression of spontaneous tumorigenesis through a cell-intrinsic mechanism, particularly in the liver, and that p62 accumulation contributes to tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDoU81LkM8lbVg90H21EOLACvtfcHk0ljlQ9IRILGQow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltlKntrY%253D&md5=5fff0dac8440745e12db5d1d53643cb3</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1101%2Fgad.2016211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.2016211%26sid%3Dliteratum%253Aachs%26aulast%3DTakamura%26aufirst%3DA.%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DA.%26aulast%3DKishi%26aufirst%3DC.%26aulast%3DWaguri%26aufirst%3DS.%26aulast%3DEishi%26aufirst%3DY.%26aulast%3DHino%26aufirst%3DO.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DMizushima%26aufirst%3DN.%26atitle%3DAutophagy-deficient%2520mice%2520develop%2520multiple%2520liver%2520tumors%26jtitle%3DGenes%2520Dev.%26date%3D2011%26volume%3D25%26issue%3D8%26spage%3D795%26epage%3D800%26doi%3D10.1101%2Fgad.2016211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span> <span> </span><span class="NLM_article-title">p62 at the crossroads of autophagy, apoptosis, and cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>137</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1001</span>– <span class="NLM_lpage">1004</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2009.05.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.cell.2009.05.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19524504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1eiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2009&pages=1001-1004&issue=6&author=J.+Moscatauthor=M.+T.+Diaz-Meco&title=p62+at+the+crossroads+of+autophagy%2C+apoptosis%2C+and+cancer&doi=10.1016%2Fj.cell.2009.05.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">p62 at the crossroads of autophagy, apoptosis, and cancer</span></div><div class="casAuthors">Moscat, Jorge; Diaz-Meco, Maria T.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1001-1004</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The signaling adaptor p62 is a multidomain protein implicated in the activation of the transcription factor NF-κB.  Recent findings link p62 activity to the extrinsic apoptosis pathway, and Mathew, R., et al. (2009) now show that the modulation of p62 by autophagy is a key factor in tumorigenesis.  These findings place p62 at crit. decision points that control cell death and survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohw1jilj8gS7Vg90H21EOLACvtfcHk0ljlQ9IRILGQow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1eiurs%253D&md5=e276456de2e89eadba0c222dce7091a1</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2009.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2009.05.023%26sid%3Dliteratum%253Aachs%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26atitle%3Dp62%2520at%2520the%2520crossroads%2520of%2520autophagy%252C%2520apoptosis%252C%2520and%2520cancer%26jtitle%3DCell%26date%3D2009%26volume%3D137%26issue%3D6%26spage%3D1001%26epage%3D1004%26doi%3D10.1016%2Fj.cell.2009.05.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strohecker, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karsli-Uzunbas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamphorst, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemons, J. M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karantza, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coller, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiPaola, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelinas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, E.</span></span> <span> </span><span class="NLM_article-title">Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">460</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1101/gad.2016311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1101%2Fgad.2016311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21317241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslCisbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=460-470&issue=5&author=J.+Y.+Guoauthor=H.+Y.+Chenauthor=R.+Mathewauthor=J.+Fanauthor=A.+M.+Stroheckerauthor=G.+Karsli-Uzunbasauthor=J.+J.+Kamphorstauthor=G.+H.+Chenauthor=J.+M.+S.+Lemonsauthor=V.+Karantzaauthor=H.+A.+Collerauthor=R.+S.+DiPaolaauthor=C.+Gelinasauthor=J.+D.+Rabinowitzauthor=E.+White&title=Activated+Ras+requires+autophagy+to+maintain+oxidative+metabolism+and+tumorigenesis&doi=10.1101%2Fgad.2016311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis</span></div><div class="casAuthors">Guo, Jessie Yanxiang; Chen, Hsin-Yi; Mathew, Robin; Fan, Jing; Strohecker, Anne M.; Karsli-Uzunbas, Gizem; Kamphorst, Jurre J.; Chen, Guanghua; Lemons, Johanna M. S.; Karantza, Vassiliki; Coller, Hilary A.; DiPaola, Robert S.; Gelinas, Celine; Rabinowitz, Joshua D.; White, Eileen</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">460-470</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Autophagy is a catabolic pathway used by cells to support metab. in response to starvation and to clear damaged proteins and organelles in response to stress.  We report here that expression of a H-rasV12 or K-rasV12 oncogene up-regulates basal autophagy, which is required for tumor cell survival in starvation and in tumorigenesis.  In Ras-expressing cells, defective autophagosome formation or cargo delivery causes accumulation of abnormal mitochondria and reduced oxygen consumption.  Autophagy defects also lead to tricarboxylic acid (TCA) cycle metabolite and energy depletion in starvation.  As mitochondria sustain viability of Ras-expressing cells in starvation, autophagy is required to maintain the pool of functional mitochondria necessary to support growth of Ras-driven tumors.  Human cancer cell lines bearing activating mutations in Ras commonly have high levels of basal autophagy, and, in a subset of these, down-regulating the expression of essential autophagy proteins impaired cell growth.  As cancers with Ras mutations have a poor prognosis, this "autophagy addiction" suggests that targeting autophagy and mitochondrial metab. are valuable new approaches to treat these aggressive cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqplDyIfMVeurVg90H21EOLACvtfcHk0liSo_fcL_Krgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslCisbg%253D&md5=bdebf93e1369906637436152bc11ea6e</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1101%2Fgad.2016311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.2016311%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DJ.%2BY.%26aulast%3DChen%26aufirst%3DH.%2BY.%26aulast%3DMathew%26aufirst%3DR.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DStrohecker%26aufirst%3DA.%2BM.%26aulast%3DKarsli-Uzunbas%26aufirst%3DG.%26aulast%3DKamphorst%26aufirst%3DJ.%2BJ.%26aulast%3DChen%26aufirst%3DG.%2BH.%26aulast%3DLemons%26aufirst%3DJ.%2BM.%2BS.%26aulast%3DKarantza%26aufirst%3DV.%26aulast%3DColler%26aufirst%3DH.%2BA.%26aulast%3DDiPaola%26aufirst%3DR.%2BS.%26aulast%3DGelinas%26aufirst%3DC.%26aulast%3DRabinowitz%26aufirst%3DJ.%2BD.%26aulast%3DWhite%26aufirst%3DE.%26atitle%3DActivated%2520Ras%2520requires%2520autophagy%2520to%2520maintain%2520oxidative%2520metabolism%2520and%2520tumorigenesis%26jtitle%3DGenes%2520Dev.%26date%3D2011%26volume%3D25%26issue%3D5%26spage%3D460%26epage%3D470%26doi%3D10.1101%2Fgad.2016311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mcafee, Q. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathanson, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaravadi, R. K.</span></span> <span> </span><span class="NLM_article-title">Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3478</span>– <span class="NLM_lpage">3489</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-10-2372</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1158%2F1078-0432.CCR-10-2372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21325076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtVGitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=3478-3489&issue=10&author=X.+H.+Maauthor=S.+Piaoauthor=D.+Wangauthor=Q.+W.+Mcafeeauthor=K.+L.+Nathansonauthor=J.+J.+Lumauthor=L.+Z.+Liauthor=R.+K.+Amaravadi&title=Measurements+of+tumor+cell+autophagy+predict+invasiveness%2C+resistance+to+chemotherapy%2C+and+survival+in+melanoma&doi=10.1158%2F1078-0432.CCR-10-2372"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma</span></div><div class="casAuthors">Ma, Xiao-Hong; Piao, Sheng-Fu; Wang, Dan; McAfee, Quentin W.; Nathanson, Katherine L.; Lum, Julian J.; Li, Lin Z.; Amaravadi, Ravi K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3478-3489</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Autophagy consists of lysosome-dependent degrdn. of cytoplasmic contents sequestered by autophagic vesicles (AV).  The role of autophagy in detg. tumor aggressiveness and response to therapy in melanoma was investigated.  Autophagy was measured in tumor biopsies obtained from metastatic melanoma patients enrolled on a phase II trial of temozolomide and sorafenib and correlated to clin. outcome.  These results were compared with autophagy measurements in aggressive and indolent melanoma cells grown in two- and three-dimensional (3D) culture and as xenograft tumors.  The effects of autophagy inhibition with either hydroxychloroquine or inducible shRNA (short hairpin RNA) against the autophagy gene ATG5 were assessed in three-dimensional spheroids.  Patients whose tumors had a high autophagic index were less likely to respond to treatment and had a shorter survival compared with those with a low autophagic index.  Differences in autophagy were less evident in aggressive and indolent melanoma cells grown in monolayer culture.  In contrast, autophagy was increased in aggressive compared with indolent melanoma xenograft tumors.  This difference was recapitulated when aggressive and indolent melanoma cells were grown as spheroids.  Autophagy inhibition with either hydroxychloroquine or inducible shRNA against ATG5 resulted in cell death in aggressive melanoma spheroids, and significantly augmented temozolomide-induced cell death.  Thus, autophagy is a potential prognostic factor and therapeutic target in melanoma.  Three-dimensional culture mimics the tumor microenvironment better than monolayer culture and is an appropriate model for studying therapeutic combinations involving autophagy modulators.  Autophagy inhibition should be tested clin. in patients with melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoUQqsbQHdbbVg90H21EOLACvtfcHk0liSo_fcL_Krgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtVGitLo%253D&md5=d12631fc7f68e0ba648c6f210ba9dc92</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-10-2372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-10-2372%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DX.%2BH.%26aulast%3DPiao%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DMcafee%26aufirst%3DQ.%2BW.%26aulast%3DNathanson%26aufirst%3DK.%2BL.%26aulast%3DLum%26aufirst%3DJ.%2BJ.%26aulast%3DLi%26aufirst%3DL.%2BZ.%26aulast%3DAmaravadi%26aufirst%3DR.%2BK.%26atitle%3DMeasurements%2520of%2520tumor%2520cell%2520autophagy%2520predict%2520invasiveness%252C%2520resistance%2520to%2520chemotherapy%252C%2520and%2520survival%2520in%2520melanoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26issue%3D10%26spage%3D3478%26epage%3D3489%26doi%3D10.1158%2F1078-0432.CCR-10-2372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amaravadi, R.</span></span> <span> </span><span class="NLM_article-title">Autophagy can contribute to cell death when combining targeted therapy</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">2097</span>– <span class="NLM_lpage">2098</span>, <span class="refDoi"> DOI: 10.4161/cbt.8.21.10416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.4161%2Fcbt.8.21.10416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotVWksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=2097-2098&issue=21&author=R.+Amaravadi&title=Autophagy+can+contribute+to+cell+death+when+combining+targeted+therapy&doi=10.4161%2Fcbt.8.21.10416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy can contribute to cell death when combining targeted therapy</span></div><div class="casAuthors">Amaravadi, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2097-2100</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  The research Martin et al. (2009) entitled, 'Inhibitin of MCL-1 enhances Lapatinib toxicity and overcomes Lapatinib resistance via BAK-dependent autophagy' is reviewed with commentary and refs.  The authors characterized the synergistic cell death found in colon and breast cancer cells treated with the ErbB1/2 inhibitor lapatinib and the BCL-2 family inhibitor obatoclax.  Surprisingly, they were unable to find evidence of caspase activation in cells treated with this combination and that inhibition of caspase function with z-VAD modestly enhanced cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq77Wbl1379bVg90H21EOLACvtfcHk0liSo_fcL_Krgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotVWksLo%253D&md5=29b65b45b5b988a2c0aaded0b9f57c35</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.4161%2Fcbt.8.21.10416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.8.21.10416%26sid%3Dliteratum%253Aachs%26aulast%3DAmaravadi%26aufirst%3DR.%26atitle%3DAutophagy%2520can%2520contribute%2520to%2520cell%2520death%2520when%2520combining%2520targeted%2520therapy%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2009%26volume%3D8%26issue%3D21%26spage%3D2097%26epage%3D2098%26doi%3D10.4161%2Fcbt.8.21.10416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sundaram, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugarajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S. V.</span></span> <span> </span><span class="NLM_article-title">Mutant p62(P392L) stimulation of osteoclast differentiation in Paget’s disease of bone</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>152</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4180</span>– <span class="NLM_lpage">4189</span>, <span class="refDoi"> DOI: 10.1210/en.2011-1225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1210%2Fen.2011-1225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21878516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOrtb%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2011&pages=4180-4189&issue=11&author=K.+Sundaramauthor=S.+Shanmugarajanauthor=D.+S.+Raoauthor=S.+V.+Reddy&title=Mutant+p62%28P392L%29+stimulation+of+osteoclast+differentiation+in+Paget%E2%80%99s+disease+of+bone&doi=10.1210%2Fen.2011-1225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone</span></div><div class="casAuthors">Sundaram, Kumaran; Shanmugarajan, Srinivasan; Rao, D. Sudhaker; Reddy, Sakamuri V.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4180-4189</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Paget's disease of the bone (PDB) is an autosomal dominant trait with genetic heterogeneity, characterized by abnormal osteoclastogenesis.  Sequestosome 1 (p62) is a scaffold protein that plays an important role in receptor activator of nuclear factor κB (RANK) signaling essential for osteoclast (OCL) differentiation.  P62P392L mutation in the ubiquitin-assocd. (UBA) domain is widely assocd. with PDB; however, the mechanisms by which p62P392L stimulate OCL differentiation in PDB are not completely understood.  Deubiquitinating enzyme cylindromatosis (CYLD) has been shown to neg. regulate RANK ligand-RANK signaling essential for OCL differentiation.  Here, we report that CYLD binds with the p62 wild-type (p62WT), non-UBA mutant (p62A381V) but not with the UBA mutant (p62P392L) in OCL progenitor cells.  Also, p62P392L induces expression of c-Fos (2.8-fold) and nuclear factor of activated T cells c1 (6.0-fold) transcription factors crit. for OCL differentiation.  Furthermore, p62P392L expression results in accumulation of polyubiquitinated TNF receptor-assocd. factor (TRAF)6 and elevated levels of phospho-IκB during OCL differentiation.  Retroviral transduction of p62P392L/CYLD short hairpin RNA significantly increased TRAP pos. multinucleated OCL formation/bone resorption activity in mouse bone marrow cultures.  Thus, the p62P392L mutation abolished CYLD interaction and enhanced OCL development/bone resorption activity in PDB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnCnqE4OKW37Vg90H21EOLACvtfcHk0ljK4iDUULR8tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOrtb%252FL&md5=a814ce703028c713f5d09e2c6499f006</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1210%2Fen.2011-1225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2011-1225%26sid%3Dliteratum%253Aachs%26aulast%3DSundaram%26aufirst%3DK.%26aulast%3DShanmugarajan%26aufirst%3DS.%26aulast%3DRao%26aufirst%3DD.%2BS.%26aulast%3DReddy%26aufirst%3DS.%2BV.%26atitle%3DMutant%2520p62%2528P392L%2529%2520stimulation%2520of%2520osteoclast%2520differentiation%2520in%2520Paget%25E2%2580%2599s%2520disease%2520of%2520bone%26jtitle%3DEndocrinology%26date%3D2011%26volume%3D152%26issue%3D11%26spage%3D4180%26epage%3D4189%26doi%3D10.1210%2Fen.2011-1225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benhar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levitzki, A.</span></span> <span> </span><span class="NLM_article-title">ROS, stress-activated kinases and stress signaling in cancer</span>. <i>EMBO Rep.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">420</span>– <span class="NLM_lpage">425</span>, <span class="refDoi"> DOI: 10.1093/embo-reports/kvf094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1093%2Fembo-reports%2Fkvf094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=11991946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD38Xkt1Srurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=420-425&issue=5&author=M.+Benharauthor=D.+Engelbergauthor=A.+Levitzki&title=ROS%2C+stress-activated+kinases+and+stress+signaling+in+cancer&doi=10.1093%2Fembo-reports%2Fkvf094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">ROS, stress-activated kinases and stress signaling in cancer</span></div><div class="casAuthors">Benhar, Moran; Engelberg, David; Levitzki, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Reports</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">420-425</span>CODEN:
                <span class="NLM_cas:coden">ERMEAX</span>;
        ISSN:<span class="NLM_cas:issn">1469-221X</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Anticancer therapy is frequently efficient in early stages of the disease, whereas advanced tumors are usually resistant to the same treatments.  The mol. basis for this change is not entirely understood.  Many anticancer agents are DNA- or cytoskeleton-damaging drugs that show some specificity towards dividing cells.  However, recent studies show that these agents also activate stress-signaling cascades that may play a role in eliciting the obsd. therapeutic effects.  We discuss recent findings that suggest that induction of stress signaling in oncogenically transformed cells is integrated into apoptotic pathways.  Reactive oxygen species (ROS) and stress-activated protein kinases (SAPKs), which are potentiated in recently transformed cells, emerge as key effectors of cell death.  In advanced tumors, however, these agents are down-regulated and, consequently, death signaling is suppressed.  Such changes in ROS and SAPK activity levels during the course of tumor development may underlie the changes in responsiveness to anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu2fW7Q64Nn7Vg90H21EOLACvtfcHk0ljK4iDUULR8tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xkt1Srurs%253D&md5=953ebe8ec80b47b51259187976f36c6f</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1093%2Fembo-reports%2Fkvf094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fembo-reports%252Fkvf094%26sid%3Dliteratum%253Aachs%26aulast%3DBenhar%26aufirst%3DM.%26aulast%3DEngelberg%26aufirst%3DD.%26aulast%3DLevitzki%26aufirst%3DA.%26atitle%3DROS%252C%2520stress-activated%2520kinases%2520and%2520stress%2520signaling%2520in%2520cancer%26jtitle%3DEMBO%2520Rep.%26date%3D2002%26volume%3D3%26issue%3D5%26spage%3D420%26epage%3D425%26doi%3D10.1093%2Fembo-reports%2Fkvf094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grivennikov, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greten, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">Immunity, inflammation, and cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>140</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">883</span>– <span class="NLM_lpage">899</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2010.01.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.cell.2010.01.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20303878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSgu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2010&pages=883-899&issue=6&author=S.+I.+Grivennikovauthor=F.+R.+Gretenauthor=M.+Karin&title=Immunity%2C+inflammation%2C+and+cancer&doi=10.1016%2Fj.cell.2010.01.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Immunity, inflammation, and cancer</span></div><div class="casAuthors">Grivennikov, Sergei I.; Greten, Florian R.; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">883-899</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Inflammatory responses play decisive roles at different stages of tumor development, including initiation, promotion, malignant conversion, invasion, and metastasis.  Inflammation also affects immune surveillance and responses to therapy.  Immune cells that infiltrate tumors engage in an extensive and dynamic crosstalk with cancer cells, and some of the mol. events that mediate this dialog have been revealed.  This review outlines the principal mechanisms that govern the effects of inflammation and immunity on tumor development and discusses attractive new targets for cancer therapy and prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSKC7HKir8HLVg90H21EOLACvtfcHk0ljK4iDUULR8tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSgu7g%253D&md5=5d554f70b26c479b72d934a462ac2086</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.01.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.01.025%26sid%3Dliteratum%253Aachs%26aulast%3DGrivennikov%26aufirst%3DS.%2BI.%26aulast%3DGreten%26aufirst%3DF.%2BR.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DImmunity%252C%2520inflammation%252C%2520and%2520cancer%26jtitle%3DCell%26date%3D2010%26volume%3D140%26issue%3D6%26spage%3D883%26epage%3D899%26doi%3D10.1016%2Fj.cell.2010.01.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, B. P.</span></span> <span> </span><span class="NLM_article-title">Inflammation: a driving force speeds cancer metastasis</span>. <i>Cell Cycle</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">3267</span>– <span class="NLM_lpage">3273</span>, <span class="refDoi"> DOI: 10.4161/cc.8.20.9699</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.4161%2Fcc.8.20.9699" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19770594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvVequ70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=3267-3273&issue=20&author=Y.+Wuauthor=B.+P.+Zhou&title=Inflammation%3A+a+driving+force+speeds+cancer+metastasis&doi=10.4161%2Fcc.8.20.9699"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation: a driving force speeds cancer metastasis</span></div><div class="casAuthors">Wu, Yadi; Zhou, Binhua P.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3267-3273</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1538-4101</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  It has been increasingly recognized that tumor microenvironment plays an important role in carcinogenesis.  Inflammatory component is present and contributes to tumor proliferation, angiogenesis, metastasis and resistance to hormonal and chemotherapy.  This review highlights the role of inflammation in the tumor metastasis.  We focus on the function of proinflammatory factors, particularly cytokines during tumor metastasis.  Understanding of the mechanisms by which inflammation contributes to metastasis will lead to innovative approach for treating cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroJxib1pSWH7Vg90H21EOLACvtfcHk0ljFPL7TM-T2jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvVequ70%253D&md5=910e480c0b4aca668d7e6f945c9fef01</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.4161%2Fcc.8.20.9699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.8.20.9699%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DB.%2BP.%26atitle%3DInflammation%253A%2520a%2520driving%2520force%2520speeds%2520cancer%2520metastasis%26jtitle%3DCell%2520Cycle%26date%3D2009%26volume%3D8%26issue%3D20%26spage%3D3267%26epage%3D3273%26doi%3D10.4161%2Fcc.8.20.9699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span> <span> </span><span class="NLM_article-title">The atypical PKC-interacting protein p62 channels NF-kappa B activation by the IL-1-TRAF6 pathway</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1576</span>– <span class="NLM_lpage">1586</span>, <span class="refDoi"> DOI: 10.1093/emboj/19.7.1576</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1093%2Femboj%2F19.7.1576" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10747026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD3cXislymt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=1576-1586&issue=7&author=L.+Sanzauthor=M.+T.+Diaz-Mecoauthor=H.+Nakanoauthor=J.+Moscat&title=The+atypical+PKC-interacting+protein+p62+channels+NF-kappa+B+activation+by+the+IL-1-TRAF6+pathway&doi=10.1093%2Femboj%2F19.7.1576"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">The atypical PKC-interacting protein p62 channels NF-κB activation by the IL-1-TRAF6 pathway</span></div><div class="casAuthors">Sanz, Laura; Diaz-Meco, Maria T.; Nakano, Hiroyasu; Moscat, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1576-1586</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The atypical protein kinase C (aPKC)-interacting protein, p62, has previously been shown to interact with RIP, linking these kinases to NF-κB activation by tumor necrosis factor α (TNFα).  The aPKCs have been implicated in the activation of IKKβ in TNFα-stimulated cells and have been shown to be activated in response to interleukin-1 (IL-1).  Here the authors demonstrate that the inhibition of the aPKCs or the down-regulation of p62 severely abrogates NF-κB activation by IL-1 and TRAF6, suggesting that both proteins are crit. intermediaries in this pathway.  Consistent with this the authors show that p62 selectively interacts with the TRAF domain of TRAF6 but not that of TRAF5 or TRAF2 in co-transfection expts.  The binding of endogenous p62 to TRAF6 is stimulus dependent, reinforcing the notion that this is a physiol. relevant interaction.  Furthermore, the authors demonstrate that the N-terminal domain of TRAF6, which is required for signaling, interacts with ζPKC in a dimerization-dependent manner.  Together, these results indicate that p62 is an important intermediary not only in TNFα but also in IL-1 signaling to NF-κB via the specific adapters RIP and TRAF6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrytjcrhYe9zbVg90H21EOLACvtfcHk0ljFPL7TM-T2jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXislymt7s%253D&md5=dcfc651bfcb5c031a7058464fee50f62</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F19.7.1576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F19.7.1576%26sid%3Dliteratum%253Aachs%26aulast%3DSanz%26aufirst%3DL.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DNakano%26aufirst%3DH.%26aulast%3DMoscat%26aufirst%3DJ.%26atitle%3DThe%2520atypical%2520PKC-interacting%2520protein%2520p62%2520channels%2520NF-kappa%2520B%2520activation%2520by%2520the%2520IL-1-TRAF6%2520pathway%26jtitle%3DEMBO%2520J.%26date%3D2000%26volume%3D19%26issue%3D7%26spage%3D1576%26epage%3D1586%26doi%3D10.1093%2Femboj%2F19.7.1576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ea, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Z. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pineda, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. J. J.</span></span> <span> </span><span class="NLM_article-title">Activation of IKK by TNF alpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2006.03.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.molcel.2006.03.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=16603398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkt1Gmtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2006&pages=245-257&issue=2&author=C.+K.+Eaauthor=L.+Dengauthor=Z.+P.+Xiaauthor=G.+Pinedaauthor=Z.+J.+J.+Chen&title=Activation+of+IKK+by+TNF+alpha+requires+site-specific+ubiquitination+of+RIP1+and+polyubiquitin+binding+by+NEMO&doi=10.1016%2Fj.molcel.2006.03.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO</span></div><div class="casAuthors">Ea, Chee-Kwee; Deng, Li; Xia, Zong-Ping; Pineda, Gabriel; Chen, Zhijian J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">245-257</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The receptor interacting protein kinase 1 (RIP1) is essential for the activation of nuclear factor κB (NF-κB) by tumor necrosis factor α (TNFα).  Here, we present evidence that TNFα induces the polyubiquitination of RIP1 at Lys-377 and that this polyubiquitination is required for the activation of IκB kinase (IKK) and NF-κB.  A point mutation of RIP1 at Lys-377 (K377R) abolishes its polyubiquitination as well as its ability to restore IKK activation in a RIP1-deficient cell line.  The K377R mutation of RIP1 also prevents the recruitment of TAK1 and IKK complexes to TNF receptor.  Interestingly, polyubiquitinated RIP1 recruits IKK through the binding between the polyubiquitin chains and NEMO, a regulatory subunit of the IKK complex.  Mutations of NEMO that disrupt its polyubiquitin binding also abolish IKK activation.  These results reveal the biochem. mechanism underlying the essential signaling function of NEMO and provide direct evidence that signal-induced site-specific ubiquitination of RIP1 is required for IKK activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXSt-Dp_VcZLVg90H21EOLACvtfcHk0ljFPL7TM-T2jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkt1Gmtb8%253D&md5=47308469a366c3b9f648e76f60702a3e</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2006.03.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2006.03.026%26sid%3Dliteratum%253Aachs%26aulast%3DEa%26aufirst%3DC.%2BK.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DXia%26aufirst%3DZ.%2BP.%26aulast%3DPineda%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DZ.%2BJ.%2BJ.%26atitle%3DActivation%2520of%2520IKK%2520by%2520TNF%2520alpha%2520requires%2520site-specific%2520ubiquitination%2520of%2520RIP1%2520and%2520polyubiquitin%2520binding%2520by%2520NEMO%26jtitle%3DMol.%2520Cell%26date%3D2006%26volume%3D22%26issue%3D2%26spage%3D245%26epage%3D257%26doi%3D10.1016%2Fj.molcel.2006.03.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ling, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Q. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemischka, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiao, P. J.</span></span> <span> </span><span class="NLM_article-title">Kras(G12D)-induced IKK2/beta/NF-kappa B activation by IL-1 alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">120</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2011.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.ccr.2011.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22264792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1SktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=105-120&issue=1&author=J.+H.+Lingauthor=Y.+A.+Kangauthor=R.+Y.+Zhaoauthor=Q.+H.+Xiaauthor=D.+F.+Leeauthor=Z.+Changauthor=J.+Liauthor=B.+L.+Pengauthor=J.+B.+Flemingauthor=H.+M.+Wangauthor=J.+S.+Liuauthor=I.+R.+Lemischkaauthor=M.+C.+Hungauthor=P.+J.+Chiao&title=Kras%28G12D%29-induced+IKK2%2Fbeta%2FNF-kappa+B+activation+by+IL-1+alpha+and+p62+feedforward+loops+is+required+for+development+of+pancreatic+ductal+adenocarcinoma&doi=10.1016%2Fj.ccr.2011.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">KrasG12D-Induced IKK2/β/NF-κB Activation by IL-1α and p62 Feedforward Loops Is Required for Development of Pancreatic Ductal Adenocarcinoma</span></div><div class="casAuthors">Ling, Jianhua; Kang, Ya-an; Zhao, Ruiying; Xia, Qianghua; Lee, Dung-Fang; Chang, Zhe; Li, Jin; Peng, Bailu; Fleming, Jason B.; Wang, Huamin; Liu, Jinsong; Lemischka, Ihor R.; Hung, Mien-Chie; Chiao, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-120</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Summary: Constitutive Kras and NF-κB activation is identified as signature alterations in pancreatic ductal adenocarcinoma (PDAC).  However, how NF-κB is activated in PDAC is not yet understood.  Here, we report that pancreas-targeted IKK2/β inactivation inhibited NF-κB activation and PDAC development in KrasG12D and KrasG12D;Ink4a/ArfF/F mice, demonstrating a mechanistic link between IKK2/β and KrasG12D in PDAC inception.  Our findings reveal that KrasG12D-activated AP-1 induces IL-1α, which, in turn, activates NF-κB and its target genes IL-1α and p62, to initiate IL-1α/p62 feedforward loops for inducing and sustaining NF-κB activity.  Furthermore, IL-1α overexpression correlates with Kras mutation, NF-κB activity, and poor survival in PDAC patients.  Therefore, our findings demonstrate the mechanism by which IKK2/β/NF-κB is activated by KrasG12D through dual feedforward loops of IL-1α/p62.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocWOU6Ouq2SbVg90H21EOLACvtfcHk0liaAZIitNWqhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1SktLY%253D&md5=7a739c3f1d43dfa62e31ce6af3bc2151</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2011.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2011.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DJ.%2BH.%26aulast%3DKang%26aufirst%3DY.%2BA.%26aulast%3DZhao%26aufirst%3DR.%2BY.%26aulast%3DXia%26aufirst%3DQ.%2BH.%26aulast%3DLee%26aufirst%3DD.%2BF.%26aulast%3DChang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DB.%2BL.%26aulast%3DFleming%26aufirst%3DJ.%2BB.%26aulast%3DWang%26aufirst%3DH.%2BM.%26aulast%3DLiu%26aufirst%3DJ.%2BS.%26aulast%3DLemischka%26aufirst%3DI.%2BR.%26aulast%3DHung%26aufirst%3DM.%2BC.%26aulast%3DChiao%26aufirst%3DP.%2BJ.%26atitle%3DKras%2528G12D%2529-induced%2520IKK2%252Fbeta%252FNF-kappa%2520B%2520activation%2520by%2520IL-1%2520alpha%2520and%2520p62%2520feedforward%2520loops%2520is%2520required%2520for%2520development%2520of%2520pancreatic%2520ductal%2520adenocarcinoma%26jtitle%3DCancer%2520Cell%26date%3D2012%26volume%3D21%26issue%3D1%26spage%3D105%26epage%3D120%26doi%3D10.1016%2Fj.ccr.2011.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mayo, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cogswell, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">RogersGraham, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Der, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, A. S.</span></span> <span> </span><span class="NLM_article-title">Requirement of NF-kappa B activation to suppress p53-independent apoptosis induced by oncogenic Ras</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>278</i></span> (<span class="NLM_issue">5344</span>),  <span class="NLM_fpage">1812</span>– <span class="NLM_lpage">1815</span>, <span class="refDoi"> DOI: 10.1126/science.278.5344.1812</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1126%2Fscience.278.5344.1812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=9388187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADyaK2sXnvFCksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=1997&pages=1812-1815&issue=5344&author=M.+W.+Mayoauthor=C.+Y.+Wangauthor=P.+C.+Cogswellauthor=K.+S.+RogersGrahamauthor=S.+W.+Loweauthor=C.+J.+Derauthor=A.+S.+Baldwin&title=Requirement+of+NF-kappa+B+activation+to+suppress+p53-independent+apoptosis+induced+by+oncogenic+Ras&doi=10.1126%2Fscience.278.5344.1812"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras</span></div><div class="casAuthors">Mayo, Marty W.; Wang, Cun-Yu; Cogswell, Patricia C.; Rogers-Graham, Kelley S.; Lowe, Scott W.; Der, Channing J.; Baldwin, Albert S., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">5344</span>),
    <span class="NLM_cas:pages">1812-1815</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The ras proto-oncogene is frequently mutated in human tumors and functions to chronically stimulate signal transduction cascades resulting in the synthesis or activation of specific transcription factors, including Ets, c-Myc, c-Jun, and nuclear factor kappa B (NF-κB).  These Ras-responsive transcription factors are required for transformation, but the mechanisms by which these proteins facilitate oncogenesis have not been fully established.  Oncogenic Ras was shown to initiate a p53-independent apoptotic response that was suppressed through the activation of NF-κB.  These results provide an explanation for the requirement of NF-κB for Ras-mediated oncogenesis and provide evidence that Ras-transformed cells are susceptible to apoptosis even if they do not express the p53 tumor-suppressor gene product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYP4VmisJ6cLVg90H21EOLACvtfcHk0liaAZIitNWqhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnvFCksLo%253D&md5=8334214d8287e8b744db9f9cf41dba36</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1126%2Fscience.278.5344.1812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.278.5344.1812%26sid%3Dliteratum%253Aachs%26aulast%3DMayo%26aufirst%3DM.%2BW.%26aulast%3DWang%26aufirst%3DC.%2BY.%26aulast%3DCogswell%26aufirst%3DP.%2BC.%26aulast%3DRogersGraham%26aufirst%3DK.%2BS.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26aulast%3DDer%26aufirst%3DC.%2BJ.%26aulast%3DBaldwin%26aufirst%3DA.%2BS.%26atitle%3DRequirement%2520of%2520NF-kappa%2520B%2520activation%2520to%2520suppress%2520p53-independent%2520apoptosis%2520induced%2520by%2520oncogenic%2520Ras%26jtitle%3DScience%26date%3D1997%26volume%3D278%26issue%3D5344%26spage%3D1812%26epage%3D1815%26doi%3D10.1126%2Fscience.278.5344.1812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teramoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikegawa, S.</span></span> <span> </span><span class="NLM_article-title">Truncating mutations of RB1CC1 in human breast cancer</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1038/ng911</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fng911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=12068296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvVGmtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2002&pages=285-288&issue=3&author=T.+Chanoauthor=K.+Kontaniauthor=K.+Teramotoauthor=H.+Okabeauthor=S.+Ikegawa&title=Truncating+mutations+of+RB1CC1+in+human+breast+cancer&doi=10.1038%2Fng911"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Truncating mutations of RB1CC1 in human breast cancer</span></div><div class="casAuthors">Chano, Tokuhiro; Kontani, Keiichi; Teramoto, Koji; Okabe, Hidetoshi; Ikegawa, Shiro</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">285-288</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The protein RB1CC1 (retinoblastoma 1 (RB1)-inducible coiled-coil 1) has been identified as a key regulator of the tumor-suppressor gene RB1.  RB1CC1 is localized in the nucleus and has been proposed to be a transcription factor because of its nuclear localization signal, leucine zipper motif and coiled-coil structure.  The gene RB1CC1 is localized to a region of chromosome 8q11 (ref. 2) contg. several loci of putative tumor-suppressor genes; however, its role in human cancers remains to be detd.  Here we report that 20% (7 of 35) of primary breast cancers examd. contained mutations in RB1CC1, including nine large interstitial deletions predicted to yield markedly truncated RB1CC1 proteins.  Wildtype RB1CC1 and RB1 were absent or significantly less abundant than normal in the seven cancers with mutations in RB1CC1, but were abundant in cancers without such mutations.  In all seven cancers, both RB1CC1 alleles were inactivated; two showed compd. heterozygous deletions.  Thus, RB1CC1 is frequently mutated in breast cancer and shows characteristics of a classical tumor-suppressor gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIEG9VJWui7rVg90H21EOLACvtfcHk0liaAZIitNWqhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvVGmtLg%253D&md5=2c02a1ccdaf8ce683a2f7d1396c5d56d</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1038%2Fng911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng911%26sid%3Dliteratum%253Aachs%26aulast%3DChano%26aufirst%3DT.%26aulast%3DKontani%26aufirst%3DK.%26aulast%3DTeramoto%26aufirst%3DK.%26aulast%3DOkabe%26aufirst%3DH.%26aulast%3DIkegawa%26aufirst%3DS.%26atitle%3DTruncating%2520mutations%2520of%2520RB1CC1%2520in%2520human%2520breast%2520cancer%26jtitle%3DNat.%2520Genet.%26date%3D2002%26volume%3D31%26issue%3D3%26spage%3D285%26epage%3D288%26doi%3D10.1038%2Fng911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croce, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, J. L.</span></span> <span> </span><span class="NLM_article-title">p62/SQSTM1 synergizes with autophagy for tumor growth in vivo</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1204</span>– <span class="NLM_lpage">1216</span>, <span class="refDoi"> DOI: 10.1101/gad.237354.113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1101%2Fgad.237354.113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=24888590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVSktLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=1204-1216&issue=11&author=H.+J.+Weiauthor=C.+R.+Wangauthor=C.+M.+Croceauthor=J.+L.+Guan&title=p62%2FSQSTM1+synergizes+with+autophagy+for+tumor+growth+in+vivo&doi=10.1101%2Fgad.237354.113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">p62/SQSTM1 synergizes with autophagy for tumor growth in vivo</span></div><div class="casAuthors">Wei, Huijun; Wang, Chenran; Croce, Carlo M.; Guan, Jun-Lin</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1204-1216</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Autophagy is crucial for cellular homeostasis and plays important roles in tumorigenesis.  FIP200 (FAK family-interacting protein of 200 kDa) is an essential autophagy gene required for autophagy induction, functioning in the ULK1-ATG13-FIP200 complex.  Our previous studies showed that conditional knockout of FIP200 significantly suppressed mammary tumorigenesis, which was accompanied by accumulation of p62 in tumor cells.  However, it is not clear whether FIP200 is also required for maintaining tumor growth and how the increased p62 level affects the growth in autophagy-deficient FIP200-null tumors in vivo.  Here, we describe a new system to delete FIP200 in transformed mouse embryonic fibroblasts as well as mammary tumor cells following their transplantation and show that ablation of FIP200 significantly reduced growth of established tumors in vivo.  Using similar strategies, we further showed that either p62 knockdown or p62 deficiency in established FIP200-null tumors dramatically impaired tumor growth.  The stimulation of tumor growth by p62 accumulation in FIP200-null tumors is assocd. with the up-regulated activation of the NF-κB pathway by p62.  Last, we showed that overexpression of the autophagy master regulator TFEBS142A increased the growth of established tumors, which correlated with the increased autophagy of the tumor cells.  Together, our studies demonstrate that p62 and autophagy synergize to promote tumor growth, suggesting that inhibition of both pathways could be more effective than targeting either alone for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIXxNl_tfXxbVg90H21EOLACvtfcHk0ljr9czZx5kDoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVSktLjO&md5=8a65e0ca2c7e220914196534b45e5d12</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1101%2Fgad.237354.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.237354.113%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DH.%2BJ.%26aulast%3DWang%26aufirst%3DC.%2BR.%26aulast%3DCroce%26aufirst%3DC.%2BM.%26aulast%3DGuan%26aufirst%3DJ.%2BL.%26atitle%3Dp62%252FSQSTM1%2520synergizes%2520with%2520autophagy%2520for%2520tumor%2520growth%2520in%2520vivo%26jtitle%3DGenes%2520Dev.%26date%3D2014%26volume%3D28%26issue%3D11%26spage%3D1204%26epage%3D1216%26doi%3D10.1101%2Fgad.237354.113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halliwell, B.</span></span> <span> </span><span class="NLM_article-title">Biochemistry of oxidative stress</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1147</span>– <span class="NLM_lpage">1150</span>, <span class="refDoi"> DOI: 10.1042/BST0351147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1042%2FBST0351147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=17956298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1eru7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=1147-1150&author=B.+Halliwell&title=Biochemistry+of+oxidative+stress&doi=10.1042%2FBST0351147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemistry of oxidative stress</span></div><div class="casAuthors">Halliwell, B.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1147-1150</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The terms 'antioxidant', 'oxidative stress' and 'oxidative damage' are widely used but rarely defined.  This brief review attempts to define them and to examine the ways in which oxidative stress and oxidative damage can affect cell behavior both in vivo and in cell culture, using cancer as an example.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLxO3HqpB1I7Vg90H21EOLACvtfcHk0ljr9czZx5kDoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1eru7vN&md5=5e4a8281ddbed9d2bc398df36eea4d6b</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1042%2FBST0351147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0351147%26sid%3Dliteratum%253Aachs%26aulast%3DHalliwell%26aufirst%3DB.%26atitle%3DBiochemistry%2520of%2520oxidative%2520stress%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2007%26volume%3D35%26spage%3D1147%26epage%3D1150%26doi%3D10.1042%2FBST0351147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1101/gad.13.1.76</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1101%2Fgad.13.1.76" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=9887101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADyaK1MXnvF2qsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=76-86&issue=1&author=K.+Itohauthor=N.+Wakabayashiauthor=Y.+Katohauthor=T.+Ishiiauthor=K.+Igarashiauthor=J.+D.+Engelauthor=M.+Yamamoto&title=Keap1+represses+nuclear+activation+of+antioxidant+responsive+elements+by+Nrf2+through+binding+to+the+amino-terminal+Neh2+domain&doi=10.1101%2Fgad.13.1.76"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain</span></div><div class="casAuthors">Itoh, Ken; Wakabayashi, Nobunao; Katoh, Yasutake; Ishii, Tetsuro; Igarashi, Kazuhiko; Engel, James Douglas; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">76-86</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Transcription factor Nrf2 is essential for the antioxidant responsive element 〈ARE〉-mediated induction of phase II detoxifying and oxidative stress enzyme genes.  Detailed anal. of differential Nrf2 activity displayed in transfected cell lines ultimately led to the identification of a new protein, which we named Keap1, that suppresses Nrf2 transcriptional activity by specific binding to its evolutionarily conserved amino-terminal regulatory domain.  The closest homolog of Keap1 is a Drosophila actin-binding protein called Kelch, implying that Keap1 might be a Nrf2 cytoplasmic effector.  We then showed that electrophilic agents antagonize Keap1 inhibition of Nrf2 activity in vivo, allowing Nrf2 to traverse from the cytoplasm to the nucleus and potentiate the ARE response.  We postulate that Keap1 and Nrf2 constitute a crucial cellular sensor for oxidative stress, and together mediate a key step in the signaling pathway that leads to transcriptional activation by this novel Nrf2 nuclear shuttling mechanism.  The activation of Nrf2 leads in turn to the induction of phase II enzyme and antioxidative stress genes in response to electrophiles and reactive oxygen species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQy--aOMXTI7Vg90H21EOLACvtfcHk0ljr9czZx5kDoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnvF2qsg%253D%253D&md5=1f6cdf6615b03719dedbffe01d0be2ec</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1101%2Fgad.13.1.76&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.13.1.76%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DWakabayashi%26aufirst%3DN.%26aulast%3DKatoh%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DIgarashi%26aufirst%3DK.%26aulast%3DEngel%26aufirst%3DJ.%2BD.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DKeap1%2520represses%2520nuclear%2520activation%2520of%2520antioxidant%2520responsive%2520elements%2520by%2520Nrf2%2520through%2520binding%2520to%2520the%2520amino-terminal%2520Neh2%2520domain%26jtitle%3DGenes%2520Dev.%26date%3D1999%26volume%3D13%26issue%3D1%26spage%3D76%26epage%3D86%26doi%3D10.1101%2Fgad.13.1.76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kern, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luesch, H.</span></span> <span> </span><span class="NLM_article-title">A genomic screen for activators of the antioxidant response element</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5205</span>– <span class="NLM_lpage">5210</span>, <span class="refDoi"> DOI: 10.1073/pnas.0700898104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1073%2Fpnas.0700898104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=17360324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=5205-5210&issue=12&author=Y.+X.+Liuauthor=J.+T.+Kernauthor=J.+R.+Walkerauthor=J.+A.+Johnsonauthor=P.+G.+Schultzauthor=H.+Luesch&title=A+genomic+screen+for+activators+of+the+antioxidant+response+element&doi=10.1073%2Fpnas.0700898104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">A genomic screen for activators of the antioxidant response element</span></div><div class="casAuthors">Liu, Yanxia; Kern, Jonathan T.; Walker, John R.; Johnson, Jeffrey A.; Schultz, Peter G.; Luesch, Hendrik</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5205-5210</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The antioxidant response element (ARE) is a cis-acting regulatory enhancer element found in the 5' flanking region of many phase II detoxification enzymes.  Up-regulation of ARE-dependent target genes is known to have neuroprotective effects; yet, the mechanism of activation is largely unknown.  By screening an arrayed collection of ≈15,000 full-length expression cDNAs in the human neuroblastoma cell line IMR-32 with an ARE-luciferase reporter, the authors have identified several cDNAs not previously assocd. with ARE activation.  A subset of cDNAs, encoding sequestosome 1 (SQSTM1) and dipeptidylpeptidase 3 (DPP3), activated the ARE in primary mouse-derived cortical neurons.  Overexpression of SQSTM1 and DPP3 in IMR-32 cells stimulated NF-E2-related factor 2 (NRF2) nuclear translocation and led to increased levels of NAD(P)H:quinone oxidoreductase 1, a protein which is transcriptionally regulated by the ARE.  When transfected into IMR-3z neuroblastoma cells that were depleted of transcription factor NRF2 by RNA interference, SQSTM1 and DPP3 were unable to activate the ARE or induce NAD(P)H:quinone oxidoreductase 1 expression, indicating that the ARE activation upon ectopic expression of these cDNAs is mediated by NRF2.  Studies with pharmacol. inhibitors indicated that 1-phosphatidylinositol 3-kinase and protein kinase C signaling are essential for activity.  Overexpression of these cDNAs conferred partial resistance to hydrogen peroxide or rotenone-induced toxicity, consistent with the induction of antioxidant and phase II detoxification enzymes, which can protect from oxidative stress.  This work and other such studies may provide mechanisms for activating the ARE in the absence of general oxidative stress and a yet-unexploited therapeutic approach to degenerative diseases and aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq85UPgBaWMfLVg90H21EOLACvtfcHk0lh8M5PGckgPrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFCgtb4%253D&md5=e2eca2643b63eaeb65478d69832dee48</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0700898104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0700898104%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%2BX.%26aulast%3DKern%26aufirst%3DJ.%2BT.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DJohnson%26aufirst%3DJ.%2BA.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DLuesch%26aufirst%3DH.%26atitle%3DA%2520genomic%2520screen%2520for%2520activators%2520of%2520the%2520antioxidant%2520response%2520element%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26issue%3D12%26spage%3D5205%26epage%3D5210%26doi%3D10.1073%2Fpnas.0700898104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">Mechanistic studies of the Nrf2–Keap1 signaling pathway</span>. <i>Drug Metab. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">769</span>– <span class="NLM_lpage">789</span>, <span class="refDoi"> DOI: 10.1080/03602530600971974</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1080%2F03602530600971974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=17145701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCnur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2006&pages=769-789&issue=4&author=D.+D.+Zhang&title=Mechanistic+studies+of+the+Nrf2%E2%80%93Keap1+signaling+pathway&doi=10.1080%2F03602530600971974"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic studies of the Nrf2-Keap1 signaling pathway</span></div><div class="casAuthors">Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">769-789</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A review.  Since eukaryotic cells constantly encounter various environmental insults, they have evolved defense mechanisms to cope with toxicant- and carcinogen-induced oxidative stress or electrophiles.  One of the most important cellular defense mechanisms against oxidative stress or electrophiles is mediated by the transcription factor Nrf2.  Under the basal condition, Nrf2-dependent transcription is repressed by a neg. regulator Keap1.  When cells are exposed to oxidative stress, electrophiles, or chemopreventive agents, Nrf2 escapes Keap1-mediated repression and activates antioxidant responsive element (ARE)-dependent gene expression to maintain cellular redox homeostasis.  Beyond its antioxidant function, Nrf2 has recently been recognized as a key factor regulating an array of genes that defend cells against the deleterious effects of environmental insults.  Since this Nrf2-dependent cellular defense response is able to protect multi-organs or multi-tissues, activation of Nrf2 has been implicated in conferring protection against many human diseases, including cancer, neurodegenerative diseases, cardiovascular diseases, acute and chronic lung injury, autoimmune diseases, and inflammation.  Therefore, understanding of Nrf2 regulation is crucial in the development of drugs for therapeutic intervention.  This review will discuss recent progress in the field of the Nrf2-Keap1 signaling pathway, with emphasis on the mechanistic studies of Nrf2 regulation by Keap1, oxidative stress, or chemopreventive compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5xfCSnwdvUrVg90H21EOLACvtfcHk0lh8M5PGckgPrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCnur%252FP&md5=7fc5c44bb9897739fe437679b6d21cf4</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1080%2F03602530600971974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F03602530600971974%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DMechanistic%2520studies%2520of%2520the%2520Nrf2%25E2%2580%2593Keap1%2520signaling%2520pathway%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2006%26volume%3D38%26issue%3D4%26spage%3D769%26epage%3D789%26doi%3D10.1080%2F03602530600971974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span> <span> </span><span class="NLM_article-title">Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">21592</span>– <span class="NLM_lpage">21600</span>, <span class="refDoi"> DOI: 10.1074/jbc.M300931200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1074%2Fjbc.M300931200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=12682069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksVems7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=21592-21600&issue=24&author=M.+McMahonauthor=K.+Itohauthor=M.+Yamamotoauthor=J.+D.+Hayes&title=Keap1-dependent+proteasomal+degradation+of+transcription+factor+Nrf2+contributes+to+the+negative+regulation+of+antioxidant+response+element-driven+gene+expression&doi=10.1074%2Fjbc.M300931200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression</span></div><div class="casAuthors">McMahon, Michael; Itoh, Ken; Yamamoto, Masayuki; Hayes, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">21592-21600</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Keap1 is a neg. regulator of Nrf2, a bZIP transcription factor that mediates adaptation to oxidative stress.  Previous studies suggested this neg. regulation is a consequence of Keap1 controlling the subcellular distribution of Nrf2.  We now report that Keap1 also controls the total cellular level of Nrf2 protein.  In the RL34 non-transformed rat liver cell line, Nrf2 was found to accumulate rapidly in response to oxidative stress caused by treatment with sulforaphane, and the accumulation resulted from inhibition of proteasomal-mediated degrdn. of the bZIP protein.  By heterologously expressing in COS1 cells epitope-tagged Nrf2 and an Nrf2ΔETGE mutant lacking the Keap1-binding site, in both the presence and absence of Keap1 we demonstrate that Nrf2 is subject to ubiquitination and proteasomal degrdn. independently of both Keap1 and the redox environment of the cell.  In oxidatively stressed cells, this is the sole mechanism responsible for Nrf2 degrdn.  However, under homeostatic conditions Nrf2 is subject to a substantially more rapid mode of proteasomal degrdn. than it is in oxidatively stressed cells, and this rapid turnover of Nrf2 requires it to interact with Keap1.  Within Nrf2, the N-terminal Neh2 domain is identified as the redox-sensitive degron.  These data suggest that Keap1 neg. regulates Nrf2 by both enhancing its rate of proteasomal degrdn. and altering its subcellular distribution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomAhRj4GOmc7Vg90H21EOLACvtfcHk0lh8M5PGckgPrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksVems7g%253D&md5=2810bf0fbf74c433b9fed9fa956a6f02</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M300931200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M300931200%26sid%3Dliteratum%253Aachs%26aulast%3DMcMahon%26aufirst%3DM.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26atitle%3DKeap1-dependent%2520proteasomal%2520degradation%2520of%2520transcription%2520factor%2520Nrf2%2520contributes%2520to%2520the%2520negative%2520regulation%2520of%2520antioxidant%2520response%2520element-driven%2520gene%2520expression%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26issue%3D24%26spage%3D21592%26epage%3D21600%26doi%3D10.1074%2Fjbc.M300931200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannink, M.</span></span> <span> </span><span class="NLM_article-title">Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">8137</span>– <span class="NLM_lpage">8151</span>, <span class="refDoi"> DOI: 10.1128/MCB.23.22.8137-8151.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1128%2FMCB.23.22.8137-8151.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=14585973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVKjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=8137-8151&issue=22&author=D.+D.+Zhangauthor=M.+Hannink&title=Distinct+cysteine+residues+in+Keap1+are+required+for+Keap1-dependent+ubiquitination+of+Nrf2+and+for+stabilization+of+Nrf2+by+chemopreventive+agents+and+oxidative+stress&doi=10.1128%2FMCB.23.22.8137-8151.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress</span></div><div class="casAuthors">Zhang, Donna D.; Hannink, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8137-8151</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A common feature of diverse chemopreventive agents is the ability to activate expression of a genetic program that protects cells from reactive chem. species that if left unchecked would cause mutagenic DNA damage.  The bZIP transcription factor Nrf2 has emerged as a key regulator of this cancer-preventive genetic program.  Nrf2 is normally sequestered in the cytoplasm by a protein known as Keap1.  Chemopreventive agents allow Nrf2 to escape from Keap1-mediated repression, although the mol. mechanism(s) responsible for activation of Nrf2 is not understood.  In this report, we demonstrate that Keap1 does not passively sequester Nrf2 in the cytoplasm but actively targets Nrf2 for ubiquitination and degrdn. by the proteasome under basal culture conditions.  We have identified two crit. cysteine residues in Keap1, C273 and C288, that are required for Keap1-dependent ubiquitination of Nrf2.  Both sulforaphane, a chemopreventive isothiocyanate, and oxidative stress enable Nrf2 to escape Keap1-dependent degrdn., leading to stabilization of Nrf2, increased nuclear localization of Nrf2, and activation of Nrf2-dependent cancer-protective genes.  We have identified a third cysteine residue in Keap1, C151, that is uniquely required for inhibition of Keap1-dependent degrdn. of Nrf2 by sulforaphane and oxidative stress.  This cysteine residue is also required for a novel posttranslational modification to Keap1 that is induced by oxidative stress.  We propose that Keap1 is a component of a novel E3 ubiquitin ligase complex that is specifically targeted for inhibition by both chemopreventive agents and oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqys54qQ6MlRLVg90H21EOLACvtfcHk0li8m1ZAUVUi7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVKjtr4%253D&md5=9287849578d0a6b7a6d52b67e3c65190</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1128%2FMCB.23.22.8137-8151.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.23.22.8137-8151.2003%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%2BD.%26aulast%3DHannink%26aufirst%3DM.%26atitle%3DDistinct%2520cysteine%2520residues%2520in%2520Keap1%2520are%2520required%2520for%2520Keap1-dependent%2520ubiquitination%2520of%2520Nrf2%2520and%2520for%2520stabilization%2520of%2520Nrf2%2520by%2520chemopreventive%2520agents%2520and%2520oxidative%2520stress%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2003%26volume%3D23%26issue%3D22%26spage%3D8137%26epage%3D8151%26doi%3D10.1128%2FMCB.23.22.8137-8151.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villeneuve, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">3275</span>– <span class="NLM_lpage">3285</span>, <span class="refDoi"> DOI: 10.1128/MCB.00248-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1128%2FMCB.00248-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20421418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptVegu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=3275-3285&issue=13&author=A.+Lauauthor=X.+J.+Wangauthor=F.+Zhaoauthor=N.+F.+Villeneuveauthor=T.+D.+Wuauthor=T.+Jiangauthor=Z.+Sunauthor=E.+Whiteauthor=D.+D.+Zhang&title=A+noncanonical+mechanism+of+Nrf2+activation+by+autophagy+deficiency%3A+direct+interaction+between+Keap1+and+p62&doi=10.1128%2FMCB.00248-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62</span></div><div class="casAuthors">Lau, Alexandria; Wang, Xiao-Jun; Zhao, Fei; Villeneuve, Nicole F.; Wu, Tongde; Jiang, Tao; Sun, Zheng; White, Eileen; Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3275-3285</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">In response to stress, cells can utilize several cellular processes, such as autophagy, which is a bulklysosomal degrdn. pathway, to mitigate damages and increase the chances of cell survival.  Deregulation of autophagy causes upregulation of p62 and the formation of p62-contg. aggregates, which are assocd. with neurodegenerative diseases and cancer.  The Nrf2-Keap1 pathway functions as a crit. regulator of the cell's defense mechanism against oxidative stress by controlling the expression of many cellular protective proteins.  Under basal conditions, Nrf2 is ubiquitinated by the Keap1-Cul3-E3 ubiquitin ligase complex and targeted to the 26S proteasome for degrdn.  Upon induction, the activity of the E3 ubiquitin ligase is inhibited through the modification of cysteine residues in Keap1, resulting in the stabilization and activation of Nrf2.  In this current study, we identified the direct interaction between p62 and Keap1 and the residues required for the interaction have been mapped to 349-DPSTGE-354 in p62 and three arginines in the Kelch domain of Keap1.  Accumulation of endogenous p62 or ectopic expression of p62 sequesters Keap1 into aggregates, resulting in the inhibition of Keap1-mediated Nrf2 ubiquitination and its subsequent degrdn. by the proteasome.  In contrast, overexpression of mutated p62, which loses its ability to interact with Keap1, had no effect on Nrf2 stability, demonstrating that p62-mediated Nrf2 upregulation is Keap1 dependent.  These findings demonstrate that autophagy deficiency activates the Nrf2 pathway in a noncanonical cysteine-independent mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBD8Dknwp7p7Vg90H21EOLACvtfcHk0ljbk-DcOgsKfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptVegu7k%253D&md5=fd52e7053b0fd9bbcb4c3c8d8df91ee4</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1128%2FMCB.00248-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00248-10%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DVilleneuve%26aufirst%3DN.%2BF.%26aulast%3DWu%26aufirst%3DT.%2BD.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DWhite%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DA%2520noncanonical%2520mechanism%2520of%2520Nrf2%2520activation%2520by%2520autophagy%2520deficiency%253A%2520direct%2520interaction%2520between%2520Keap1%2520and%2520p62%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2010%26volume%3D30%26issue%3D13%26spage%3D3275%26epage%3D3285%26doi%3D10.1128%2FMCB.00248-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirose, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagahashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukutomi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uemura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obata, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pi, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mashino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waguri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span> <span> </span><span class="NLM_article-title">p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">12030</span>, <span class="refDoi"> DOI: 10.1038/ncomms12030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fncomms12030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27345495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFSisLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12030&author=T.+Saitoauthor=Y.+Ichimuraauthor=K.+Taguchiauthor=T.+Suzukiauthor=T.+Mizushimaauthor=K.+Takagiauthor=Y.+Hiroseauthor=M.+Nagahashiauthor=T.+Isoauthor=T.+Fukutomiauthor=M.+Ohishiauthor=K.+Endoauthor=T.+Uemuraauthor=Y.+Nishitoauthor=S.+Okudaauthor=M.+Obataauthor=T.+Kounoauthor=R.+Imamuraauthor=Y.+Tadaauthor=R.+Obataauthor=D.+Yasudaauthor=K.+Takahashiauthor=T.+Fujimuraauthor=J.+B.+Piauthor=M.+S.+Leeauthor=T.+Uenoauthor=T.+Oheauthor=T.+Mashinoauthor=T.+Wakaiauthor=H.+Kojimaauthor=T.+Okabeauthor=T.+Naganoauthor=H.+Motohashiauthor=S.+Waguriauthor=T.+Sogaauthor=M.+Yamamotoauthor=K.+Tanakaauthor=M.+Komatsu&title=p62%2FSqstm1+promotes+malignancy+of+HCV-positive+hepatocellular+carcinoma+through+Nrf2-dependent+metabolic+reprogramming&doi=10.1038%2Fncomms12030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming</span></div><div class="casAuthors">Saito, Tetsuya; Ichimura, Yoshinobu; Taguchi, Keiko; Suzuki, Takafumi; Mizushima, Tsunehiro; Takagi, Kenji; Hirose, Yuki; Nagahashi, Masayuki; Iso, Tetsuro; Fukutomi, Toshiaki; Ohishi, Maki; Endo, Keiko; Uemura, Takefumi; Nishito, Yasumasa; Okuda, Shujiro; Obata, Miki; Kouno, Tsuguka; Imamura, Riyo; Tada, Yukio; Obata, Rika; Yasuda, Daisuke; Takahashi, Kyoko; Fujimura, Tsutomu; Pi, Jingbo; Lee, Myung-Shik; Ueno, Takashi; Ohe, Tomoyuki; Mashino, Tadahiko; Wakai, Toshifumi; Kojima, Hirotatsu; Okabe, Takayoshi; Nagano, Tetsuo; Motohashi, Hozumi; Waguri, Satoshi; Soga, Tomoyoshi; Yamamoto, Masayuki; Tanaka, Keiji; Komatsu, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12030</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">P62/Sqstm1 is a multifunctional protein involved in cell survival, growth and death, that is degraded by autophagy.  Amplification of the p62/Sqstm1 gene, and aberrant accumulation and phosphorylation of p62/Sqstm1, have been implicated in tumor development.  Herein, we reveal the mol. mechanism of p62/Sqstm1-dependent malignant progression, and suggest that mol. targeting of p62/Sqstm1 represents a potential chemotherapeutic approach against hepatocellular carcinoma (HCC).  Phosphorylation of p62/Sqstm1 at Ser349 directs glucose to the glucuronate pathway, and glutamine towards glutathione synthesis through activation of the transcription factor Nrf2.  These changes provide HCC cells with tolerance to anti-cancer drugs and proliferation potency.  Phosphorylated p62/Sqstm1 accumulates in tumor regions pos. for hepatitis C virus (HCV).  An inhibitor of phosphorylated p62-dependent Nrf2 activation suppresses the proliferation and anticancer agent tolerance of HCC.  Our data indicate that this Nrf2 inhibitor could be used to make cancer cells less resistant to anticancer drugs, esp. in HCV-pos. HCC patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWPpd-6mfs2rVg90H21EOLACvtfcHk0ljbk-DcOgsKfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFSisLzF&md5=859f788e0e5ac3e5ed46eeee9da47490</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1038%2Fncomms12030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12030%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DT.%26aulast%3DIchimura%26aufirst%3DY.%26aulast%3DTaguchi%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMizushima%26aufirst%3DT.%26aulast%3DTakagi%26aufirst%3DK.%26aulast%3DHirose%26aufirst%3DY.%26aulast%3DNagahashi%26aufirst%3DM.%26aulast%3DIso%26aufirst%3DT.%26aulast%3DFukutomi%26aufirst%3DT.%26aulast%3DOhishi%26aufirst%3DM.%26aulast%3DEndo%26aufirst%3DK.%26aulast%3DUemura%26aufirst%3DT.%26aulast%3DNishito%26aufirst%3DY.%26aulast%3DOkuda%26aufirst%3DS.%26aulast%3DObata%26aufirst%3DM.%26aulast%3DKouno%26aufirst%3DT.%26aulast%3DImamura%26aufirst%3DR.%26aulast%3DTada%26aufirst%3DY.%26aulast%3DObata%26aufirst%3DR.%26aulast%3DYasuda%26aufirst%3DD.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DFujimura%26aufirst%3DT.%26aulast%3DPi%26aufirst%3DJ.%2BB.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DOhe%26aufirst%3DT.%26aulast%3DMashino%26aufirst%3DT.%26aulast%3DWakai%26aufirst%3DT.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DNagano%26aufirst%3DT.%26aulast%3DMotohashi%26aufirst%3DH.%26aulast%3DWaguri%26aufirst%3DS.%26aulast%3DSoga%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3Dp62%252FSqstm1%2520promotes%2520malignancy%2520of%2520HCV-positive%2520hepatocellular%2520carcinoma%2520through%2520Nrf2-dependent%2520metabolic%2520reprogramming%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12030%26doi%3D10.1038%2Fncomms12030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wullschleger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loewith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, M. N.</span></span> <span> </span><span class="NLM_article-title">TOR signaling in growth and metabolism</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>124</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">471</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.01.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.cell.2006.01.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=16469695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslaqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2006&pages=471&issue=3&author=S.+Wullschlegerauthor=R.+Loewithauthor=M.+N.+Hall&title=TOR+signaling+in+growth+and+metabolism&doi=10.1016%2Fj.cell.2006.01.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">TOR signaling in growth and metabolism</span></div><div class="casAuthors">Wullschleger, Stephan; Loewith, Robbie; Hall, Michael N.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">471-484</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The target of rapamycin (TOR) is a conserved Ser/Thr kinase that regulates cell growth and metab. in response to environmental cues.  Here, highlighting contributions from studies in model organisms, we review mammalian TOR complexes and the signaling branches they mediate.  TOR is part of two distinct multiprotein complexes, TOR complex 1 (TORC1), which is sensitive to rapamycin, and TORC2, which is not.  The physiol. consequences of mammalian TORC1 dysregulation suggest that inhibitors of mammalian TOR may be useful in the treatment of cancer, cardiovascular disease, autoimmunity, and metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdwzZ5NGx9YrVg90H21EOLACvtfcHk0ljL4srv5k3t5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslaqs74%253D&md5=d8128a86651c824e725f56b90cafb88d</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DWullschleger%26aufirst%3DS.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DHall%26aufirst%3DM.%2BN.%26atitle%3DTOR%2520signaling%2520in%2520growth%2520and%2520metabolism%26jtitle%3DCell%26date%3D2006%26volume%3D124%26issue%3D3%26spage%3D471%26doi%3D10.1016%2Fj.cell.2006.01.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Martin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span> <span> </span><span class="NLM_article-title">p62/SQSTM1: ’Jack of all trades’ in health and cancer</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>286</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1111/febs.14712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1111%2Ffebs.14712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=30499183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFCit7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2019&pages=8-23&issue=1&author=P.+Sanchez-Martinauthor=T.+Saitoauthor=M.+Komatsu&title=p62%2FSQSTM1%3A+%E2%80%99Jack+of+all+trades%E2%80%99+in+health+and+cancer&doi=10.1111%2Ffebs.14712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">p62/SQSTM1: 'Jack of all trades' in health and cancer</span></div><div class="casAuthors">Sanchez-Martin, Pablo; Saito, Tetsuya; Komatsu, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-23</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  P62 is a stress-inducible protein able to change among binding partners, cellular localizations and form liq. droplet structures in a context-dependent manner.  This protein is mainly defined as a cargo receptor for selective autophagy, a process that allows the degrdn. of detrimental and unnecessary components through the lysosome.  Besides this role, its ability to interact with multiple binding partners allows p62 to act as a main regulator of the activation of the Nrf2, mTORC1, and NF-κB signaling pathways, linking p62 to the oxidative defense system, nutrient sensing, and inflammation, resp.  In the present review, we will present the mol. mechanisms behind the control p62 exerts over these pathways, their interconnection and how their deregulation contributes to cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprneSTDEcvP7Vg90H21EOLACvtfcHk0ljL4srv5k3t5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFCit7bE&md5=276c34df5107d61d4c837157725d09a2</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1111%2Ffebs.14712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.14712%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez-Martin%26aufirst%3DP.%26aulast%3DSaito%26aufirst%3DT.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3Dp62%252FSQSTM1%253A%2520%25E2%2580%2599Jack%2520of%2520all%2520trades%25E2%2580%2599%2520in%2520health%2520and%2520cancer%26jtitle%3DFEBS%2520J.%26date%3D2019%26volume%3D286%26issue%3D1%26spage%3D8%26epage%3D23%26doi%3D10.1111%2Ffebs.14712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amanchy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linares, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu-Baker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porollo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span> <span> </span><span class="NLM_article-title">p62 is a key regulator of nutrient sensing in the mTORC1 pathway</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">146</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2011.06.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.molcel.2011.06.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21981924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12gtrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2011&pages=134-146&issue=1&author=A.+Duranauthor=R.+Amanchyauthor=J.+F.+Linaresauthor=J.+Joshiauthor=S.+Abu-Bakerauthor=A.+Porolloauthor=M.+Hansenauthor=J.+Moscatauthor=M.+T.+Diaz-Meco&title=p62+is+a+key+regulator+of+nutrient+sensing+in+the+mTORC1+pathway&doi=10.1016%2Fj.molcel.2011.06.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">p62 is a key regulator of nutrient sensing in the mTORC1 pathway</span></div><div class="casAuthors">Duran, Angeles; Amanchy, Ramars; Linares, Juan F.; Joshi, Jayashree; Abu-Baker, Shadi; Porollo, Aleksey; Hansen, Malene; Moscat, Jorge; Diaz-Meco, Maria T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-146</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Signaling adaptor p62 is a crit. mediator of important cellular functions, owing to its ability to establish interactions with various signaling intermediaries.  Here, the authors identify raptor as an interacting partner of p62.  Thus, p62 is an integral part of the mTORC1 complex and is necessary to mediate amino acid signaling for the activation of S6K1 and 4EBP1.  Protein p62 interacted in an amino acid-dependent manner with mTOR and raptor.  In addn., p62 bound to Rags proteins and favored the formation of the active Rag heterodimer that was further stabilized by raptor.  Interestingly, p62 colocalized with Rags at the lysosomal compartment and was required for the interaction of mTOR with Rag GTPases in vivo and for translocation of the mTORC1 complex to the lysosome, a crucial step for mTOR activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr3IRKDm5MzbVg90H21EOLACvtfcHk0ljQcHTAz3L1dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12gtrrL&md5=a32a6d560b5c336a3fa7371145829a37</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2011.06.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2011.06.038%26sid%3Dliteratum%253Aachs%26aulast%3DDuran%26aufirst%3DA.%26aulast%3DAmanchy%26aufirst%3DR.%26aulast%3DLinares%26aufirst%3DJ.%2BF.%26aulast%3DJoshi%26aufirst%3DJ.%26aulast%3DAbu-Baker%26aufirst%3DS.%26aulast%3DPorollo%26aufirst%3DA.%26aulast%3DHansen%26aufirst%3DM.%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26atitle%3Dp62%2520is%2520a%2520key%2520regulator%2520of%2520nutrient%2520sensing%2520in%2520the%2520mTORC1%2520pathway%26jtitle%3DMol.%2520Cell%26date%3D2011%26volume%3D44%26issue%3D1%26spage%3D134%26epage%3D146%26doi%3D10.1016%2Fj.molcel.2011.06.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linares, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yajima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasparakis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span> <span> </span><span class="NLM_article-title">K63 polyubiquitination and activation of mTOR by the p62-TRAF6 complex in nutrient-activated cells</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2013.06.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.molcel.2013.06.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=23911927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1WrsbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2013&pages=283-296&issue=3&author=J.+F.+Linaresauthor=A.+Duranauthor=T.+Yajimaauthor=M.+Pasparakisauthor=J.+Moscatauthor=M.+T.+Diaz-Meco&title=K63+polyubiquitination+and+activation+of+mTOR+by+the+p62-TRAF6+complex+in+nutrient-activated+cells&doi=10.1016%2Fj.molcel.2013.06.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">K63 Polyubiquitination and Activation of mTOR by the p62-TRAF6 Complex in Nutrient-Activated Cells</span></div><div class="casAuthors">Linares, Juan F.; Duran, Angeles; Yajima, Tomoko; Pasparakis, Manolis; Moscat, Jorge; Diaz-Meco, Maria T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">283-296</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The ability of cells to respond to changes in nutrient availability is crit. for an adequate control of metabolic homeostasis.  Mammalian target of rapamycin complex 1 (mTORC1) is a central complex kinase in these processes.  The signaling adaptor p62 binds raptor, and integral component of the mTORC1 pathway. p62 interacts with TNF receptor assocd. factor 6 (TRAF6) and is required for mTORC1 translocation to the lysosome and its subsequent activation.  Here we show that TRAF6 is recruited to and activates mTORC1 through p62 in amino acid-stimulated cells.  We also show that TRAF6 is necessary for the translocation of mTORC1 to the lysosomes and that the TRAF6-catalyzed K63 ubiquitination of mTOR regulates mTORC1 activation by amino acids.  TRAF6, through its interaction with p62 and activation of mTORC1, modulates autophagy and is an important mediator in cancer cell proliferation.  Interfering with the p62-TRAF6 interaction serves to modulate autophagy and nutrient sensing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjV20DGgD_ArVg90H21EOLACvtfcHk0ljQcHTAz3L1dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1WrsbzM&md5=84ab95fe040ea47c6ca7fbcd10064ea6</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2013.06.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2013.06.020%26sid%3Dliteratum%253Aachs%26aulast%3DLinares%26aufirst%3DJ.%2BF.%26aulast%3DDuran%26aufirst%3DA.%26aulast%3DYajima%26aufirst%3DT.%26aulast%3DPasparakis%26aufirst%3DM.%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26atitle%3DK63%2520polyubiquitination%2520and%2520activation%2520of%2520mTOR%2520by%2520the%2520p62-TRAF6%2520complex%2520in%2520nutrient-activated%2520cells%26jtitle%3DMol.%2520Cell%26date%3D2013%26volume%3D51%26issue%3D3%26spage%3D283%26epage%3D296%26doi%3D10.1016%2Fj.molcel.2013.06.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linares, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reina-Campos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aza-Blanc, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span> <span> </span><span class="NLM_article-title">Amino acid activation of mTORC1 by a PB1-domain-driven kinase complex cascade</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1339</span>– <span class="NLM_lpage">1352</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2015.07.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.celrep.2015.07.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=26279575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCis7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=1339-1352&issue=8&author=J.+F.+Linaresauthor=A.+Duranauthor=M.+Reina-Camposauthor=P.+Aza-Blancauthor=A.+Camposauthor=J.+Moscatauthor=M.+T.+Diaz-Meco&title=Amino+acid+activation+of+mTORC1+by+a+PB1-domain-driven+kinase+complex+cascade&doi=10.1016%2Fj.celrep.2015.07.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Amino Acid Activation of mTORC1 by a PB1-Domain-Driven Kinase Complex Cascade</span></div><div class="casAuthors">Linares, Juan F.; Duran, Angeles; Reina-Campos, Miguel; Aza-Blanc, Pedro; Campos, Alex; Moscat, Jorge; Diaz-Meco, Maria T.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1339-1352</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The mTORC1 complex is central to the cellular response to changes in nutrient availability.  The signaling adaptor p62 contributes to mTORC1 activation in response to amino acids and interacts with TRAF6, which is required for the translocation of mTORC1 to the lysosome and the subsequent K63 polyubiquitination and activation of mTOR.  However, the signal initiating these p62-driven processes was previously unknown.  Here, we show that p62 is phosphorylated via a cascade that includes MEK3/6 and p38δ and is driven by the PB1-contg. kinase MEKK3.  This phosphorylation results in the recruitment of TRAF6 to p62, the ubiquitination and activation of mTOR, and the regulation of autophagy and cell proliferation.  Genetic inactivation of MEKK3 or p38δ mimics that of p62 in that it leads to inhibited growth of PTEN-deficient prostate organoids.  Anal. of human prostate cancer samples showed upregulation of these three components of the pathway, which correlated with enhanced mTORC1 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquKKMXLubHmrVg90H21EOLACvtfcHk0ljQcHTAz3L1dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCis7jK&md5=33e74d5f17399dc1b2576d836a28235b</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2015.07.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2015.07.045%26sid%3Dliteratum%253Aachs%26aulast%3DLinares%26aufirst%3DJ.%2BF.%26aulast%3DDuran%26aufirst%3DA.%26aulast%3DReina-Campos%26aufirst%3DM.%26aulast%3DAza-Blanc%26aufirst%3DP.%26aulast%3DCampos%26aufirst%3DA.%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26atitle%3DAmino%2520acid%2520activation%2520of%2520mTORC1%2520by%2520a%2520PB1-domain-driven%2520kinase%2520complex%2520cascade%26jtitle%3DCell%2520Rep.%26date%3D2015%26volume%3D12%26issue%3D8%26spage%3D1339%26epage%3D1352%26doi%3D10.1016%2Fj.celrep.2015.07.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Misra, U. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzo, S. V.</span></span> <span> </span><span class="NLM_article-title">Epac1-induced cellular proliferation in prostate cancer cells is mediated by B-Raf/ERK and mTOR signaling cascades</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>108</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">998</span>– <span class="NLM_lpage">1011</span>, <span class="refDoi"> DOI: 10.1002/jcb.22333</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1002%2Fjcb.22333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19725049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSqs7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2009&pages=998-1011&issue=4&author=U.+K.+Misraauthor=S.+V.+Pizzo&title=Epac1-induced+cellular+proliferation+in+prostate+cancer+cells+is+mediated+by+B-Raf%2FERK+and+mTOR+signaling+cascades&doi=10.1002%2Fjcb.22333"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Epac1-induced cellular proliferation in prostate cancer cells is mediated by B-Raf/ERK and mTOR signaling cascades</span></div><div class="casAuthors">Misra, Uma Kant; Pizzo, Salvatore Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">998-1011</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">CAMP-dependent, PKA-independent effects on cell proliferation are mediated by cAMP binding to EPAC and activation of Rap signaling.  In this report, we employed the analog 8-CPT-2-O-Me-cAMP to study binding to EPAC and subsequent activation of B-Raf/ERK and mTOR signaling in human cancer cells.  This compd. significantly stimulated DNA synthesis, protein synthesis, and cellular proliferation of human 1-LN prostate cancer cells.  By study of phosphorylation-dependent activation, we demonstrate that EPAC-mediated cellular effects require activation of the B-Raf/ERK and mTOR signaling cascades.  RNAi directed against EPAC gene expression as well as inhibitors of ERK, PI 3-kinase, and mTOR were employed to further demonstrate the role of these pathways in regulating prostate cancer cell proliferation.  These studies were then extended to several other human prostate cancer cell lines and melanoma cells with comparable results.  We conclude that B-Raf/ERK and mTOR signaling play an essential role in cAMP-dependent, but PKA-independent, proliferation of cancer cells.  © 2009 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXCJ8M-WxUq7Vg90H21EOLACvtfcHk0lhn1vtMfh1IJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSqs7rE&md5=93e02f2ef1411c1bf30ec209a9ff1e7f</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1002%2Fjcb.22333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.22333%26sid%3Dliteratum%253Aachs%26aulast%3DMisra%26aufirst%3DU.%2BK.%26aulast%3DPizzo%26aufirst%3DS.%2BV.%26atitle%3DEpac1-induced%2520cellular%2520proliferation%2520in%2520prostate%2520cancer%2520cells%2520is%2520mediated%2520by%2520B-Raf%252FERK%2520and%2520mTOR%2520signaling%2520cascades%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2009%26volume%3D108%26issue%3D4%26spage%3D998%26epage%3D1011%26doi%3D10.1002%2Fjcb.22333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donaher, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaswamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itzykson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Come, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savagner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gitelman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>117</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">927</span>– <span class="NLM_lpage">939</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2004.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.cell.2004.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=15210113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsFWnu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2004&pages=927-939&issue=7&author=J.+Yangauthor=S.+A.+Maniauthor=J.+L.+Donaherauthor=S.+Ramaswamyauthor=R.+A.+Itzyksonauthor=C.+Comeauthor=P.+Savagnerauthor=I.+Gitelmanauthor=A.+Richardsonauthor=R.+A.+Weinberg&title=Twist%2C+a+master+regulator+of+morphogenesis%2C+plays+an+essential+role+in+tumor+metastasis&doi=10.1016%2Fj.cell.2004.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis</span></div><div class="casAuthors">Yang, Jing; Mani, Sendurai A.; Donaher, Joana Liu; Ramaswamy, Sridhar; Itzykson, Raphael A.; Come, Christophe; Savagner, Pierre; Gitelman, Inna; Richardson, Andrea; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">927-939</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Metastasis is a multistep process during which cancer cells disseminate from the site of primary tumors and establish secondary tumors in distant organs.  In a search for key regulators of metastasis in a murine breast tumor model, the authors have found that the transcription factor Twist, a master regulator of embryonic morphogenesis, plays an essential role in metastasis.  Suppression of Twist expression in highly metastatic mammary carcinoma cells specifically inhibits their ability to metastasize from the mammary gland to the lung.  Ectopic expression of Twist results in loss of E-cadherin-mediated cell-cell adhesion, activation of mesenchymal markers, and induction of cell motility, suggesting that Twist contributes to metastasis by promoting an epithelial-mesenchymal transition (EMT).  In human breast cancers, high level of Twist expression is correlated with invasive lobular carcinoma, a highly infiltrating tumor type assocd. with loss of E-cadherin expression.  These results establish a mechanistic link between Twist, EMT, and tumor metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqPNT4BFZTkLVg90H21EOLACvtfcHk0lhn1vtMfh1IJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsFWnu7w%253D&md5=6a2f4793b4ba770f8bd08c8e5aa5a08e</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2004.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2004.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DMani%26aufirst%3DS.%2BA.%26aulast%3DDonaher%26aufirst%3DJ.%2BL.%26aulast%3DRamaswamy%26aufirst%3DS.%26aulast%3DItzykson%26aufirst%3DR.%2BA.%26aulast%3DCome%26aufirst%3DC.%26aulast%3DSavagner%26aufirst%3DP.%26aulast%3DGitelman%26aufirst%3DI.%26aulast%3DRichardson%26aufirst%3DA.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DTwist%252C%2520a%2520master%2520regulator%2520of%2520morphogenesis%252C%2520plays%2520an%2520essential%2520role%2520in%2520tumor%2520metastasis%26jtitle%3DCell%26date%3D2004%26volume%3D117%26issue%3D7%26spage%3D927%26epage%3D939%26doi%3D10.1016%2Fj.cell.2004.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Onder, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lander, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3645</span>– <span class="NLM_lpage">3654</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-2938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1158%2F0008-5472.CAN-07-2938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18483246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvVOitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=3645-3654&issue=10&author=T.+T.+Onderauthor=P.+B.+Guptaauthor=S.+A.+Maniauthor=J.+Yangauthor=E.+S.+Landerauthor=R.+A.+Weinberg&title=Loss+of+E-cadherin+promotes+metastasis+via+multiple+downstream+transcriptional+pathways&doi=10.1158%2F0008-5472.CAN-07-2938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional Pathways</span></div><div class="casAuthors">Onder, Tamer T.; Gupta, Piyush B.; Mani, Sendurai A.; Yang, Jing; Lander, Eric S.; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3645-3654</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Loss of the epithelial adhesion mol. E-cadherin is thought to enable metastasis by disrupting intercellular contacts-an early step in metastatic dissemination.  To further investigate the mol. basis of this notion, we use two methods to inhibit E-cadherin function that distinguish between E-cadherin's cell-cell adhesion and intracellular signaling functions.  Whereas the disruption of cell-cell contacts alone does not enable metastasis, the loss of E-cadherin protein does, through induction of an epithelial-to-mesenchymal transition, invasiveness, and anoikis resistance.  We find the E-cadherin binding partner β-catenin to be necessary, but not sufficient, for induction of these phenotypes.  In addn., gene expression anal. shows that E-cadherin loss results in the induction of multiple transcription factors, at least one of which, Twist, is necessary for E-cadherin loss-induced metastasis.  These findings indicate that E-cadherin loss in tumors contributes to metastatic dissemination by inducing wide-ranging transcriptional and functional changes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgx7f9E65UQbVg90H21EOLACvtfcHk0lhn1vtMfh1IJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvVOitLw%253D&md5=39cac4d757b2560460ffa04a19359624</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-2938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-2938%26sid%3Dliteratum%253Aachs%26aulast%3DOnder%26aufirst%3DT.%2BT.%26aulast%3DGupta%26aufirst%3DP.%2BB.%26aulast%3DMani%26aufirst%3DS.%2BA.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DLoss%2520of%2520E-cadherin%2520promotes%2520metastasis%2520via%2520multiple%2520downstream%2520transcriptional%2520pathways%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26issue%3D10%26spage%3D3645%26epage%3D3654%26doi%3D10.1158%2F0008-5472.CAN-07-2938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ming, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorburn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span> <span> </span><span class="NLM_article-title">Regulation of cell proliferation and migration by p62 through stabilization of Twist1</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">9241</span>– <span class="NLM_lpage">9246</span>, <span class="refDoi"> DOI: 10.1073/pnas.1322913111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1073%2Fpnas.1322913111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=24927592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVamurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=9241-9246&issue=25&author=L.+Qiangauthor=B.+Z.+Zhaoauthor=M.+Mingauthor=N.+Wangauthor=T.+C.+Heauthor=S.+Hwangauthor=A.+Thorburnauthor=Y.+He&title=Regulation+of+cell+proliferation+and+migration+by+p62+through+stabilization+of+Twist1&doi=10.1073%2Fpnas.1322913111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of cell proliferation and migration by p62 through stabilization of Twist1</span></div><div class="casAuthors">Qiang, Lei; Zhao, Baozhong; Ming, Mei; Wang, Ning; He, Tong-Chuan; Hwang, Seungmin; Thorburn, Andrew; He, Yu-Ying</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">9241-9246</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The selective autophagy substrate p62 serves as a mol. link between autophagy and cancer.  Suppression of autophagy causes p62 accumulation and thereby contributes to tumorigenesis.  Here we demonstrate that autophagy deficiency promotes cell proliferation and migration through p62-dependent stabilization of the oncogenic transcription factor Twist1.  P62 binds to Twist1 and inhibits degrdn. of Twist1.  In mice, p62 up-regulation promotes tumor cell growth and metastasis in a Twist1-dependent manner.  Our findings demonstrate that Twist1 is a key downstream effector of p62 in regulation of cell proliferation and migration and suggest that targeting p62-mediated Twist1 stabilization is a promising therapeutic strategy for prevention and treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXXGY8lVZUc7Vg90H21EOLACvtfcHk0lhMrnwhgPryVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVamurs%253D&md5=f791b236837c29b55739138da6f0d6fd</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1322913111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1322913111%26sid%3Dliteratum%253Aachs%26aulast%3DQiang%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DB.%2BZ.%26aulast%3DMing%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DT.%2BC.%26aulast%3DHwang%26aufirst%3DS.%26aulast%3DThorburn%26aufirst%3DA.%26aulast%3DHe%26aufirst%3DY.%26atitle%3DRegulation%2520of%2520cell%2520proliferation%2520and%2520migration%2520by%2520p62%2520through%2520stabilization%2520of%2520Twist1%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26issue%3D25%26spage%3D9241%26epage%3D9246%26doi%3D10.1073%2Fpnas.1322913111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ammirante, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grivennikov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nedospasov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">B-cell-derived lymphotoxin promotes castration-resistant prostate cancer</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>464</i></span> (<span class="NLM_issue">7286</span>),  <span class="NLM_fpage">302</span>– <span class="NLM_lpage">305</span>, <span class="refDoi"> DOI: 10.1038/nature08782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fnature08782" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20220849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFSnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=464&publication_year=2010&pages=302-305&issue=7286&author=M.+Ammiranteauthor=J.+L.+Luoauthor=S.+Grivennikovauthor=S.+Nedospasovauthor=M.+Karin&title=B-cell-derived+lymphotoxin+promotes+castration-resistant+prostate+cancer&doi=10.1038%2Fnature08782"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">B-cell-derived lymphotoxin promotes castration-resistant prostate cancer</span></div><div class="casAuthors">Ammirante, Massimo; Luo, Jun-Li; Grivennikov, Sergei; Nedospasov, Sergei; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">464</span>
        (<span class="NLM_cas:issue">7286</span>),
    <span class="NLM_cas:pages">302-305</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Prostate cancer (CaP) progresses from prostatic intraepithelial neoplasia through locally invasive adenocarcinoma to castration-resistant metastatic carcinoma.  Although radical prostatectomy, radiation and androgen ablation are effective therapies for androgen-dependent CaP, metastatic castration-resistant CaP is a major complication with high mortality.  Androgens stimulate growth and survival of prostate epithelium and early CaP.  Although most patients initially respond to androgen ablation, many develop castration-resistant CaP within 12-18 mo.  Despite extensive studies, the mechanisms underlying the emergence of castration-resistant CaP remain poorly understood and their elucidation is crit. for developing improved therapies.  Curiously, castration-resistant CaP remains androgen-receptor dependent, and potent androgen-receptor antagonists induce tumor regression in castrated mice.  The role of inflammation in castration-resistant CaP has not been addressed, although it was reported that intrinsic NF-κB activation supports its growth.  Inflammation is a localized protective reaction to injury or infection, but it also has a pathogenic role in many diseases, including cancer.  Whereas acute inflammation is crit. for host defense, chronic inflammation contributes to tumorigenesis and metastatic progression.  The inflammation-responsive IκB kinase (IKK)-β and its target NF-κB have important tumor-promoting functions within malignant cells and inflammatory cells.  The latter, including macrophages and lymphocytes, are important elements of the tumor microenvironment, but the mechanisms underlying their recruitment remain obscure, although they are thought to depend on chemokine and cytokine prodn.  We found that CaP progression is assocd. with inflammatory infiltration and activation of IKK-α, which stimulates metastasis by an NF-κB-independent, cell autonomous mechanism.  Here we show that androgen ablation causes infiltration of regressing androgen-dependent tumors with leukocytes, including B cells, in which IKK-β activation results in prodn. of cytokines that activate IKK-α and STAT3 in CaP cells to enhance hormone-free survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqYc1rD0xf_bVg90H21EOLACvtfcHk0lhMrnwhgPryVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFSnurs%253D&md5=17531b68980797adcf09a3a0eaed0694</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1038%2Fnature08782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08782%26sid%3Dliteratum%253Aachs%26aulast%3DAmmirante%26aufirst%3DM.%26aulast%3DLuo%26aufirst%3DJ.%2BL.%26aulast%3DGrivennikov%26aufirst%3DS.%26aulast%3DNedospasov%26aufirst%3DS.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DB-cell-derived%2520lymphotoxin%2520promotes%2520castration-resistant%2520prostate%2520cancer%26jtitle%3DNature%26date%3D2010%26volume%3D464%26issue%3D7286%26spage%3D302%26epage%3D305%26doi%3D10.1038%2Fnature08782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lisanti, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Outschoorn, U. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotgia, F.</span></span> <span> </span><span class="NLM_article-title">Oncogenes induce the cancer-associated fibroblast phenotype metabolic symbiosis and ″fibroblast addiction″ are new therapeutic targets for drug discovery</span>. <i>Cell Cycle</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">2723</span>– <span class="NLM_lpage">2732</span>, <span class="refDoi"> DOI: 10.4161/cc.25695</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.4161%2Fcc.25695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=23860382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlGiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=2723-2732&issue=17&author=M.+P.+Lisantiauthor=U.+E.+Martinez-Outschoornauthor=F.+Sotgia&title=Oncogenes+induce+the+cancer-associated+fibroblast+phenotype+metabolic+symbiosis+and+%E2%80%B3fibroblast+addiction%E2%80%B3+are+new+therapeutic+targets+for+drug+discovery&doi=10.4161%2Fcc.25695"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and "fibroblast addiction" are new therapeutic targets for drug discovery</span></div><div class="casAuthors">Lisanti, Michael P.; Martinez-Outschoorn, Ubaldo E.; Sotgia, Federica</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2723-2732</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1538-4101</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  Metabolic coupling, between mitochondria in cancer cells and catabolism in stromal fibroblasts, promotes tumor growth, recurrence, metastasis, and predicts anticancer drug resistance.  Catabolic fibroblasts donate the necessary fuels (such as L-lactate, ketones, glutamine, other amino acids, and fatty acids) to anabolic cancer cells, to metabolize via their TCA cycle and oxidative phosphorylation (OXPHOS).  This provides a simple mechanism by which metabolic energy and biomass are transferred from the host microenvironment to cancer cells.  Recently, we showed that catabolic metab. and "glycolytic reprogramming" in the tumor microenvironment are orchestrated by oncogene activation and inflammation, which originates in epithelial cancer cells.  Oncogenes drive the onset of the cancer-assocd. fibroblast phenotype in adjacent normal fibroblasts via paracrine oxidative stress.  This oncogene-induced transition to malignancy is "mirrored" by a loss of caveolin-1 (Cav-1) and an increase in MCT4 in adjacent stromal fibroblasts, functionally reflecting catabolic metab. in the tumor microenvironment.  Virtually identical findings were obtained using BRCA1-deficient breast and ovarian cancer cells.  Thus, oncogene activation (RAS, NFkB, TGF-β) and/or tumor suppressor loss (BRCA1) have similar functional effects on adjacent stromal fibroblasts, initiating "metabolic symbiosis" and the cancer-assocd. fibroblast phenotype.  New therapeutic strategies that metabolically uncouple oxidative cancer cells from their glycolytic stroma or modulate oxidative stress could be used to target this lethal subtype of cancers.  Targeting "fibroblast addiction" in primary and metastatic tumor cells may expose a crit. Achilles' heel, leading to disease regression in both sporadic and familial cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBKmBjE3IJ6rVg90H21EOLACvtfcHk0lhMrnwhgPryVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlGiu7k%253D&md5=186b118769295e05673196170e1a5aa2</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.4161%2Fcc.25695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.25695%26sid%3Dliteratum%253Aachs%26aulast%3DLisanti%26aufirst%3DM.%2BP.%26aulast%3DMartinez-Outschoorn%26aufirst%3DU.%2BE.%26aulast%3DSotgia%26aufirst%3DF.%26atitle%3DOncogenes%2520induce%2520the%2520cancer-associated%2520fibroblast%2520phenotype%2520metabolic%2520symbiosis%2520and%2520%25E2%2580%25B3fibroblast%2520addiction%25E2%2580%25B3%2520are%2520new%2520therapeutic%2520targets%2520for%2520drug%2520discovery%26jtitle%3DCell%2520Cycle%26date%3D2013%26volume%3D12%26issue%3D17%26spage%3D2723%26epage%3D2732%26doi%3D10.4161%2Fcc.25695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barron, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, D. R.</span></span> <span> </span><span class="NLM_article-title">The reactive stroma microenvironment and prostate cancer progression</span>. <i>Endocr.-Relat. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">R187</span>– <span class="NLM_lpage">R204</span>, <span class="refDoi"> DOI: 10.1530/ERC-12-0085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1530%2FERC-12-0085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22930558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=R187-R204&issue=6&author=D.+A.+Barronauthor=D.+R.+Rowley&title=The+reactive+stroma+microenvironment+and+prostate+cancer+progression&doi=10.1530%2FERC-12-0085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">The reactive stroma microenvironment and prostate cancer progression</span></div><div class="casAuthors">Barron, David A.; Rowley, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine-Related Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">R187-R204</span>CODEN:
                <span class="NLM_cas:coden">ERCAE9</span>;
        ISSN:<span class="NLM_cas:issn">1351-0088</span>.
    
            (<span class="NLM_cas:orgname">BioScientifica Ltd.</span>)
        </div><div class="casAbstract">A review.  Reactive stroma initiates during early prostate cancer development and coevolves with prostate cancer progression.  Previous studies have defined the key markers of reactive stroma and have established that reactive stroma biol. influences prostate tumorigenesis and progression.  The stem/progenitor cells of origin and the mechanisms that regulate their recruitment and activation to myofibroblasts or carcinoma-assocd. fibroblasts are essentially unknown.  Key regulatory factors have been identified, including transforming growth factor β, interleukin-8, fibroblast growth factors, connective tissue growth factor, wingless homologs-Wnts, and stromal cell-derived factor-1, among others.  The biol. of reactive stroma in cancer is similar to the more predictable biol. of the stroma compartment during wound repair at sites where the epithelial barrier function is breached and a stromal response is generated.  The coevolution of reactive stroma and the biol. of how reactive stroma-carcinoma interactions regulate cancer progression and metastasis are targets for new therapeutic approaches.  Such approaches are strategically designed to inhibit cancer progression by uncoupling the reactive stroma niche.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTdUu1u3Zar7Vg90H21EOLACvtfcHk0lg5CRjzHwETjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCitL4%253D&md5=758fd1a1ff0b2f4ca7f7e6cb642a3fd7</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1530%2FERC-12-0085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1530%252FERC-12-0085%26sid%3Dliteratum%253Aachs%26aulast%3DBarron%26aufirst%3DD.%2BA.%26aulast%3DRowley%26aufirst%3DD.%2BR.%26atitle%3DThe%2520reactive%2520stroma%2520microenvironment%2520and%2520prostate%2520cancer%2520progression%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D2012%26volume%3D19%26issue%3D6%26spage%3DR187%26epage%3DR204%26doi%3D10.1530%2FERC-12-0085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reina-Campos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valencia, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castilla, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschop, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span> <span> </span><span class="NLM_article-title">Adipocyte p62/SQSTM1 suppresses tumorigenesis through opposite regulations of metabolism in adipose tissue and tumor</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">770</span>– <span class="NLM_lpage">784</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2018.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.ccell.2018.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=29634950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntlCit7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=770-784&issue=4&author=J.+Huangauthor=A.+Duranauthor=M.+Reina-Camposauthor=T.+Valenciaauthor=E.+A.+Castillaauthor=T.+D.+Mullerauthor=M.+H.+Tschopauthor=J.+Moscatauthor=M.+T.+Diaz-Meco&title=Adipocyte+p62%2FSQSTM1+suppresses+tumorigenesis+through+opposite+regulations+of+metabolism+in+adipose+tissue+and+tumor&doi=10.1016%2Fj.ccell.2018.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Adipocyte p62/SQSTM1 Suppresses Tumorigenesis through Opposite Regulations of Metabolism in Adipose Tissue and Tumor</span></div><div class="casAuthors">Huang, Jianfeng; Duran, Angeles; Reina-Campos, Miguel; Valencia, Tania; Castilla, Elias A.; Muller, Timo D.; Tschop, Matthias H.; Moscat, Jorge; Diaz-Meco, Maria T.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">770-784.e6</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Obesity is a leading risk factor for cancer.  However, understanding the crosstalk between adipocytes and tumor cells in vivo, independently of dietary contributions, is a major gap in the field.  Here we used a prostate cancer (PCa) mouse model in which the signaling adaptor p62/Sqstm1 is selectively inactivated in adipocytes.  P62 loss in adipocytes results in increased osteopontin secretion, which mediates tumor fatty acid oxidn. and invasion, leading to aggressive metastatic PCa in vivo.  Furthermore, p62 deficiency triggers in adipocytes a general shutdown of energy-utilizing pathways through mTORC1 inhibition, which supports nutrient availability for cancer cells.  This reveals a central role of adipocyte's p62 in the symbiotic adipose tissue-tumor collaboration that enables cancer metabolic fitness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXV3tsNfRWPrVg90H21EOLACvtfcHk0lg5CRjzHwETjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntlCit7c%253D&md5=9415b6ef75ba3e64d6c5b99d13ad77f3</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2018.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2018.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DDuran%26aufirst%3DA.%26aulast%3DReina-Campos%26aufirst%3DM.%26aulast%3DValencia%26aufirst%3DT.%26aulast%3DCastilla%26aufirst%3DE.%2BA.%26aulast%3DMuller%26aufirst%3DT.%2BD.%26aulast%3DTschop%26aufirst%3DM.%2BH.%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26atitle%3DAdipocyte%2520p62%252FSQSTM1%2520suppresses%2520tumorigenesis%2520through%2520opposite%2520regulations%2520of%2520metabolism%2520in%2520adipose%2520tissue%2520and%2520tumor%26jtitle%3DCancer%2520Cell%26date%3D2018%26volume%3D33%26issue%3D4%26spage%3D770%26epage%3D784%26doi%3D10.1016%2Fj.ccell.2018.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iwadate, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirasawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inazawa, J.</span></span> <span> </span><span class="NLM_article-title">High expression of SQSTM1/p62 protein is associated with poor prognosis in epithelial ovarian cancer</span>. <i>Acta Histochem. Cytochem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">301</span>, <span class="refDoi"> DOI: 10.1267/ahc.14048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1267%2Fahc.14048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=25859063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BC2MjivVaiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2014&pages=295-301&issue=6&author=R.+Iwadateauthor=J.+Inoueauthor=H.+Tsudaauthor=M.+Takanoauthor=K.+Furuyaauthor=A.+Hirasawaauthor=D.+Aokiauthor=J.+Inazawa&title=High+expression+of+SQSTM1%2Fp62+protein+is+associated+with+poor+prognosis+in+epithelial+ovarian+cancer&doi=10.1267%2Fahc.14048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">High Expression of SQSTM1/p62 Protein Is Associated with Poor Prognosis in Epithelial Ovarian Cancer</span></div><div class="casAuthors">Iwadate Reiko; Inoue Jun; Tsuda Hitoshi; Takano Masashi; Furuya Kenichi; Hirasawa Akira; Aoki Daisuke; Inazawa Johji</div><div class="citationInfo"><span class="NLM_cas:title">Acta histochemica et cytochemica</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">295-301</span>
        ISSN:<span class="NLM_cas:issn">0044-5991</span>.
    </div><div class="casAbstract">High expression of SQSTM1/p62 (p62) protein, which functions as a hub for various cellular signaling pathways, has been detected in several human cancers.  However, the clinicopathological impact of high p62 expression is largely unknown in epithelial ovarian cancer (EOC).  Here, the expression level of p62 in primary EOCs (n=266) was assessed by immunohistochemistry, and its clinical significance was analyzed.  Univariate and multivariate analyses were used to determine the impact of p62 expression on overall survival. p62 was expressed in the cytoplasm (Cyto) and/or nucleus (Nuc) in primary EOCs, and an expression subtype (Cyto(High)/Nuc(Low)), showing high expression in the cytoplasm but low expression in the nucleus, was significantly correlated with serous carcinoma (P<0.001), advanced stage (P=0.005), presence of residual tumor (P<0.001), and low overall survival rate (P=0.013).  Furthermore, in serous carcinomas (n=107), the p62 Cyto(High)/Nuc(Low) subtype was significantly correlated with low overall survival rate (P=0.019) as an independent factor (P=0.044).  Thus, our findings suggest that high expression of cytoplasmic p62 may be a novel prognostic biomarker in EOC, particularly in serous carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS1SMGX3K8vvf69nzq6467DfW6udTcc2eY60Z_MO06QMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MjivVaiug%253D%253D&md5=aceb769a8f66b7a6948e04cd282d865b</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1267%2Fahc.14048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1267%252Fahc.14048%26sid%3Dliteratum%253Aachs%26aulast%3DIwadate%26aufirst%3DR.%26aulast%3DInoue%26aufirst%3DJ.%26aulast%3DTsuda%26aufirst%3DH.%26aulast%3DTakano%26aufirst%3DM.%26aulast%3DFuruya%26aufirst%3DK.%26aulast%3DHirasawa%26aufirst%3DA.%26aulast%3DAoki%26aufirst%3DD.%26aulast%3DInazawa%26aufirst%3DJ.%26atitle%3DHigh%2520expression%2520of%2520SQSTM1%252Fp62%2520protein%2520is%2520associated%2520with%2520poor%2520prognosis%2520in%2520epithelial%2520ovarian%2520cancer%26jtitle%3DActa%2520Histochem.%2520Cytochem.%26date%3D2014%26volume%3D47%26issue%3D6%26spage%3D295%26epage%3D301%26doi%3D10.1267%2Fahc.14048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choonara, Y. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillay, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">du Toit, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naidoo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ndesendo, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibambo, S. R.</span></span> <span> </span><span class="NLM_article-title">Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2510</span>– <span class="NLM_lpage">2557</span>, <span class="refDoi"> DOI: 10.3390/ijms10062510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.3390%2Fijms10062510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19582217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Sltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=2510-2557&issue=6&author=Y.+E.+Choonaraauthor=V.+Pillayauthor=L.+C.+du+Toitauthor=G.+Modiauthor=D.+Naidooauthor=V.+M.+Ndesendoauthor=S.+R.+Sibambo&title=Trends+in+the+molecular+pathogenesis+and+clinical+therapeutics+of+common+neurodegenerative+disorders&doi=10.3390%2Fijms10062510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders</span></div><div class="casAuthors">Choonara, Yahya E.; Pillay, Viness; du Toit, Lisa C.; Modi, Girish; Naidoo, Dinesh; Ndesendo, Valence M. K.; Sibambo, Sibongile R.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2510-2557</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  The term neurodegenerative disorders, encompasses a variety of underlying conditions, sporadic and/or familial and are characterized by the persistent loss of neuronal subtypes.  These disorders can disrupt mol. pathways, synapses, neuronal subpopulations and local circuits in specific brain regions, as well as higher-order neural networks.  Abnormal network activities may result in a vicious cycle, further impairing the integrity and functions of neurons and synapses, for example, through aberrant excitation or inhibition.  The most common neurodegenerative disorders are Alzheimer's disease, Parkinson's disease, Amyotrophic Lateral Sclerosis and Huntington's disease.  The mol. features of these disorders have been extensively researched and various unique neurotherapeutic interventions have been developed.  However, there is an enormous coercion to integrate the existing knowledge in order to intensify the reliability with which neurodegenerative disorders can be diagnosed and treated.  The objective of this review article is therefore to assimilate these disorders' in terms of their neuropathol., neurogenetics, etiol., trends in pharmacol. treatment, clin. management, and the use of innovative neurotherapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD3RZrWfcYerVg90H21EOLACvtfcHk0liNeC5aTfgSyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Sltbk%253D&md5=7717a9dee003850082028e1b10bc3910</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.3390%2Fijms10062510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms10062510%26sid%3Dliteratum%253Aachs%26aulast%3DChoonara%26aufirst%3DY.%2BE.%26aulast%3DPillay%26aufirst%3DV.%26aulast%3Ddu%2BToit%26aufirst%3DL.%2BC.%26aulast%3DModi%26aufirst%3DG.%26aulast%3DNaidoo%26aufirst%3DD.%26aulast%3DNdesendo%26aufirst%3DV.%2BM.%26aulast%3DSibambo%26aufirst%3DS.%2BR.%26atitle%3DTrends%2520in%2520the%2520molecular%2520pathogenesis%2520and%2520clinical%2520therapeutics%2520of%2520common%2520neurodegenerative%2520disorders%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2009%26volume%3D10%26issue%3D6%26spage%3D2510%26epage%3D2557%26doi%3D10.3390%2Fijms10062510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease is a synaptic failure</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>298</i></span> (<span class="NLM_issue">5594</span>),  <span class="NLM_fpage">789</span>– <span class="NLM_lpage">791</span>, <span class="refDoi"> DOI: 10.1126/science.1074069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1126%2Fscience.1074069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=12399581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD38XotFSnur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=789-791&issue=5594&author=D.+J.+Selkoe&title=Alzheimer%E2%80%99s+disease+is+a+synaptic+failure&doi=10.1126%2Fscience.1074069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's Disease Is a Synaptic Failure</span></div><div class="casAuthors">Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5594</span>),
    <span class="NLM_cas:pages">789-791</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  In its earliest clin. phase, Alzheimer's disease characteristically produces a remarkably pure impairment of memory.  Mounting evidence suggests that this syndrome begins with subtle alterations of hippocampal synaptic efficacy prior to frank neuronal degeneration, and that the synaptic dysfunction is caused by diffusible oligomeric assemblies of the amyloid β protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsFVFyrx-gM7Vg90H21EOLACvtfcHk0liNeC5aTfgSyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotFSnur0%253D&md5=5927195bd25a2d0fdf1663972f32a139</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1126%2Fscience.1074069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1074069%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520is%2520a%2520synaptic%2520failure%26jtitle%3DScience%26date%3D2002%26volume%3D298%26issue%3D5594%26spage%3D789%26epage%3D791%26doi%3D10.1126%2Fscience.1074069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bloom, G. S.</span></span> <span> </span><span class="NLM_article-title">Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis</span>. <i>Jama Neurol</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">505</span>– <span class="NLM_lpage">508</span>, <span class="refDoi"> DOI: 10.1001/jamaneurol.2013.5847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1001%2Fjamaneurol.2013.5847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=24493463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BC2cvhslWmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=505-508&issue=4&author=G.+S.+Bloom&title=Amyloid-beta+and+tau%3A+the+trigger+and+bullet+in+Alzheimer+disease+pathogenesis&doi=10.1001%2Fjamaneurol.2013.5847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis</span></div><div class="casAuthors">Bloom George S</div><div class="citationInfo"><span class="NLM_cas:title">JAMA neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">505-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The defining features of Alzheimer disease (AD) include conspicuous changes in both brain histology and behavior.  The AD brain is characterized microscopically by the combined presence of 2 classes of abnormal structures, extracellular amyloid plaques and intraneuronal neurofibrillary tangles, both of which comprise highly insoluble, densely packed filaments.  The soluble building blocks of these structures are amyloid-β (Aβ) peptides for plaques and tau for tangles.  Amyloid-β peptides are proteolytic fragments of the transmembrane amyloid precursor protein, whereas tau is a brain-specific, axon-enriched microtubule-associated protein.  The behavioral symptoms of AD correlate with the accumulation of plaques and tangles, and they are a direct consequence of the damage and destruction of synapses that mediate memory and cognition.  Synapse loss can be caused by the failure of live neurons to maintain functional axons and dendrites or by neuron death.  During the past dozen years, a steadily accumulating body of evidence has indicated that soluble forms of Aβ and tau work together, independently of their accumulation into plaques and tangles, to drive healthy neurons into the diseased state and that hallmark toxic properties of Aβ require tau.  For instance, acute neuron death, delayed neuron death following ectopic cell cycle reentry, and synaptic dysfunction are triggered by soluble, extracellular Aβ species and depend on soluble, cytoplasmic tau.  Therefore, Aβ is upstream of tau in AD pathogenesis and triggers the conversion of tau from a normal to a toxic state, but there is also evidence that toxic tau enhances Aβ toxicity via a feedback loop.  Because soluble toxic aggregates of both Aβ and tau can self-propagate and spread throughout the brain by prionlike mechanisms, successful therapeutic intervention for AD would benefit from detecting these species before plaques, tangles, and cognitive impairment become evident and from interfering with the destructive biochemical pathways that they initiate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSz_gqDeA-SdD0O18WR3iAofW6udTcc2eYHfAF-1hWQErntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvhslWmsA%253D%253D&md5=a12c1fb9fb6f57c471009a3b30573fb3</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1001%2Fjamaneurol.2013.5847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjamaneurol.2013.5847%26sid%3Dliteratum%253Aachs%26aulast%3DBloom%26aufirst%3DG.%2BS.%26atitle%3DAmyloid-beta%2520and%2520tau%253A%2520the%2520trigger%2520and%2520bullet%2520in%2520Alzheimer%2520disease%2520pathogenesis%26jtitle%3DJama%2520Neurol%26date%3D2014%26volume%3D71%26issue%3D4%26spage%3D505%26epage%3D508%26doi%3D10.1001%2Fjamaneurol.2013.5847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">East, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campanella, M.</span></span> <span> </span><span class="NLM_article-title">Mitophagy and the therapeutic clearance of damaged mitochondria for neuroprotection</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">382</span>– <span class="NLM_lpage">387</span>, <span class="refDoi"> DOI: 10.1016/j.biocel.2016.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.biocel.2016.08.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27586258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFWiur%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=382-387&author=D.+A.+Eastauthor=M.+Campanella&title=Mitophagy+and+the+therapeutic+clearance+of+damaged+mitochondria+for+neuroprotection&doi=10.1016%2Fj.biocel.2016.08.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Mitophagy and the therapeutic clearance of damaged mitochondria for neuroprotection</span></div><div class="casAuthors">East, Daniel A.; Campanella, Michelangelo</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">382-387</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Mitochondria are the foremost producers of the cellular energy currency ATP.  They are also a significant source of reactive oxygen species and an important buffer of intracellular calcium.  Mitochondrial retrograde signals regulate energy homeostasis and pro-survival elements whereas anterograde stimuli can trigger programmed cell death.  Maintenance of a healthy, functional mitochondria network is therefore essential, and several mechanisms of mitochondrial quality control have been described.  Mitochondrial dysfunction is linked to several neurodegenerative conditions including Parkinson, and Huntingdon diseases as well as Amyotrophic lateral sclerosis.  Understanding the mechanisms governing mitochondrial quality control may reveal novel strategies for pharmacol. intervention and disease therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRFDFcGXuZbbVg90H21EOLACvtfcHk0lhjpEAwC1cy6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFWiur%252FN&md5=1edd00e2b8fb1e55e005bace7931bf35</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2016.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2016.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DEast%26aufirst%3DD.%2BA.%26aulast%3DCampanella%26aufirst%3DM.%26atitle%3DMitophagy%2520and%2520the%2520therapeutic%2520clearance%2520of%2520damaged%2520mitochondria%2520for%2520neuroprotection%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2016%26volume%3D79%26spage%3D382%26epage%3D387%26doi%3D10.1016%2Fj.biocel.2016.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Babu, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibenhener, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strom, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemppainen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, M. W.</span></span> <span> </span><span class="NLM_article-title">Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">120</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2008.05340.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1111%2Fj.1471-4159.2008.05340.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18346206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1Ohu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2008&pages=107-120&issue=1&author=J.+R.+Babuauthor=M.+L.+Seibenhenerauthor=J.+M.+Pengauthor=A.+L.+Stromauthor=R.+Kemppainenauthor=N.+Coxauthor=H.+N.+Zhuauthor=M.+C.+Wootenauthor=M.+T.+Diaz-Mecoauthor=J.+Moscatauthor=M.+W.+Wooten&title=Genetic+inactivation+of+p62+leads+to+accumulation+of+hyperphosphorylated+tau+and+neurodegeneration&doi=10.1111%2Fj.1471-4159.2008.05340.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic inactivation of p62 leads to accumulation of hyper-phosphorylated tau and neurodegeneration</span></div><div class="casAuthors">Babu, J. Ramesh; Seibenhener, M. Lamar; Peng, Junmin; Strom, Anna-Lena; Kemppainen, Robert; Cox, Nancy; Zhu, Haining; Wooten, Michael C.; Diaz-Meco, Maria T.; Moscat, Jorge; Wooten, Marie W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">107-120</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The signaling adapter p62 plays a coordinating role in mediating phosphorylation and ubiquitin-dependent trafficking of interacting proteins.  However, there is little known about the physiol. role of this protein in brain.  Here, we report age-dependent constitutive activation of glycogen synthase kinase 3β, protein kinase B, mitogen-activated protein kinase, and c-Jun-N-terminal kinase in adult p62-/- mice resulting in hyperphosphorylated tau, neurofibrillary tangles, and neurodegeneration.  Biochem. fractionation of p62-/- brain led to recovery of aggregated K63-ubiquitinated tau.  Loss of p62 was manifested by increased anxiety, depression, loss of working memory, and reduced serum brain-derived neurotrophic factor levels.  Our findings reveal a novel role for p62 as a chaperone that regulates tau soly. thereby preventing tau aggregation.  This study provides a clear demonstration of an Alzheimer-like phenotype in a mouse model in the absence of expression of human genes carrying mutations in amyloid-beta protein precursor, presenilin 1, or tau.  Thus, these findings provide new insight into manifestation of sporadic Alzheimer disease and the impact of obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqctPwjnpXAg7Vg90H21EOLACvtfcHk0liCJkIYW4cHtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1Ohu7k%253D&md5=56d5b60e29220ad7fdcc50d7a698f6d2</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05340.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05340.x%26sid%3Dliteratum%253Aachs%26aulast%3DBabu%26aufirst%3DJ.%2BR.%26aulast%3DSeibenhener%26aufirst%3DM.%2BL.%26aulast%3DPeng%26aufirst%3DJ.%2BM.%26aulast%3DStrom%26aufirst%3DA.%2BL.%26aulast%3DKemppainen%26aufirst%3DR.%26aulast%3DCox%26aufirst%3DN.%26aulast%3DZhu%26aufirst%3DH.%2BN.%26aulast%3DWooten%26aufirst%3DM.%2BC.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DWooten%26aufirst%3DM.%2BW.%26atitle%3DGenetic%2520inactivation%2520of%2520p62%2520leads%2520to%2520accumulation%2520of%2520hyperphosphorylated%2520tau%2520and%2520neurodegeneration%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D106%26issue%3D1%26spage%3D107%26epage%3D120%26doi%3D10.1111%2Fj.1471-4159.2008.05340.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soto, C.</span></span> <span> </span><span class="NLM_article-title">Unfolding the role of protein misfolding in neurodegenerative diseases</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1038/nrn1007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fnrn1007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=12511861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=49-60&issue=1&author=C.+Soto&title=Unfolding+the+role+of+protein+misfolding+in+neurodegenerative+diseases&doi=10.1038%2Fnrn1007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Unfolding the role of protein misfolding in neurodegenerative diseases</span></div><div class="casAuthors">Soto, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-60</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recent evidence indicates that diverse neurodegenerative diseases might have a common cause and pathol. mechanism - the misfolding, aggregation and accumulation of proteins in the brain, resulting in neuronal apoptosis.  Studies from different disciplines strongly support this hypothesis and indicate that a common therapy for these devastating disorders might be possible.  The aim of this article is to review the literature on the mol. mechanism of protein misfolding and aggregation, its role in neurodegeneration and the potential targets for therapeutic intervention in neurodegenerative diseases.  Many questions still need to be answered and future research in this field will result in exciting new discoveries that might impact other areas of biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt-G4N2FMUNbVg90H21EOLACvtfcHk0liCJkIYW4cHtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlY%253D&md5=08a612ce6947fd846bb0d469fa747bef</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1038%2Fnrn1007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1007%26sid%3Dliteratum%253Aachs%26aulast%3DSoto%26aufirst%3DC.%26atitle%3DUnfolding%2520the%2520role%2520of%2520protein%2520misfolding%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2003%26volume%3D4%26issue%3D1%26spage%3D49%26epage%3D60%26doi%3D10.1038%2Fnrn1007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attarwala, I. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X. Q.</span></span> <span> </span><span class="NLM_article-title">SQSTM1/p62: a potential target for neurodegenerative disease</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2094</span>– <span class="NLM_lpage">2114</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00516</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00516" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtl2rur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=2094-2114&issue=5&author=S.+F.+Maauthor=I.+Y.+Attarwalaauthor=X.+Q.+Xie&title=SQSTM1%2Fp62%3A+a+potential+target+for+neurodegenerative+disease&doi=10.1021%2Facschemneuro.8b00516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">SQSTM1/p62: A Potential Target for Neurodegenerative Disease</span></div><div class="casAuthors">Ma, Shifan; Attarwala, Insiya; Xie, Xiangqun</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2094-2114</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative diseases, characterized by a progressive loss of brain function, affect the lives of millions of individuals worldwide.  The complexity of the brain poses a challenge for scientists who are trying to map the biochem. and physiol. pathways in order to identify areas of pathol. errors.  Brain samples of patients with neurodegenerative diseases have been shown to contain large amts. of misfolded and abnormally aggregated proteins, resulting in dysfunction in certain brain centers.  Removal of these abnormal mols. is essential in maintaining protein homeostasis and overall neuron health.  Macroautophagy is the major route by which cells achieve this.  Administration of certain autophagy-enhancing compds. has been shown to provide therapeutic effects for individuals with neurodegenerative conditions.  SQSTM1/p62 is a scaffold protein closely involved in the macroautophagy process.  P62 functions to anchor the ubiquitinated proteins to the autophagosome membrane, promoting degrdn. of unwanted mols.  Modulators targeting p62 to induce autophagy and promote its protective pathways for aggregate protein clearance have high potential in the treatment of these conditions.  Addnl., causal relationships have been found between errors in regulation of SQSTM1/p62 and the development of a variety of neurodegenerative disorders, including Alzheimer's, Parkinson's, Huntington's, Amyotrophic lateral sclerosis, and Frontotemporal lobar degeneration.  Furthermore, SQSTM1/p62 also serves as a signaling hub for multiple pathways assocd. with neurodegeneration, providing a potential therapeutic target in the treatment of neurodegenerative diseases.  However, rational design of a p62-oriented autophagy modulator that can balance the neg. and pos. functions of multiple domains in p62 requires further efforts in the exploration of the protein structure and pathol. basis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSNzt9o2QeTrVg90H21EOLACvtfcHk0lhPMbHYTDpKJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtl2rur4%253D&md5=719eb875d2f58b8e8156c06c3df90778</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00516%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DS.%2BF.%26aulast%3DAttarwala%26aufirst%3DI.%2BY.%26aulast%3DXie%26aufirst%3DX.%2BQ.%26atitle%3DSQSTM1%252Fp62%253A%2520a%2520potential%2520target%2520for%2520neurodegenerative%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26issue%3D5%26spage%3D2094%26epage%3D2114%26doi%3D10.1021%2Facschemneuro.8b00516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. F.</span></span> <span> </span><span class="NLM_article-title">p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation</span>. <i>Cell. Mol. Biol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">29</span>, <span class="refDoi"> DOI: 10.1186/s11658-016-0031-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1186%2Fs11658-016-0031-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=28536631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsVSmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=29&author=W.+J.+Liuauthor=L.+Yeauthor=W.+F.+Huangauthor=L.+J.+Guoauthor=Z.+G.+Xuauthor=H.+L.+Wuauthor=C.+Yangauthor=H.+F.+Liu&title=p62+links+the+autophagy+pathway+and+the+ubiqutin-proteasome+system+upon+ubiquitinated+protein+degradation&doi=10.1186%2Fs11658-016-0031-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">P62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation</span></div><div class="casAuthors">Liu, Wei Jing; Ye, Lin; Huang, Wei Fang; Guo, Lin Jie; Xu, Zi Gan; Wu, Hong Luan; Yang, Chen; Liu, Hua Feng</div><div class="citationInfo"><span class="NLM_cas:title">Cellular & Molecular Biology Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">29/1-29/14</span>CODEN:
                <span class="NLM_cas:coden">CMBLFF</span>;
        ISSN:<span class="NLM_cas:issn">1689-1392</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">The ubiquitin-proteasome system (UPS) and autophagy are two distinct and interacting proteolytic systems.  They play crit. roles in cell survival under normal conditions and during stress.  An increasing body of evidence indicates that ubiquitinated cargoes are important markers of degrdn. p62, a classical receptor of autophagy, is a multifunctional protein located throughout the cell and involved in many signal transduction pathways, including the Keap1-Nrf2 pathway.  It is involved in the proteasomal degrdn. of ubiquitinated proteins.  When the cellular p62 level is manipulated, the quantity and location pattern of ubiquitinated proteins change with a considerable impact on cell survival.  Altered p62 levels can even lead to some diseases.  The proteotoxic stress imposed by proteasome inhibition can activate autophagy through p62 phosphorylation.  A deficiency in autophagy may compromise the ubiquitin-proteasome system, since overabundant p62 delays delivery of the proteasomal substrate to the proteasome despite proteasomal catalytic activity being unchanged.  In addn., p62 and the proteasome can modulate the activity of HDAC6 deacetylase, thus influencing the autophagic degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9as-ehXGDY7Vg90H21EOLACvtfcHk0lhPMbHYTDpKJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsVSmsbk%253D&md5=50e9a4781bb48f49fe7b9d5943c5d618</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1186%2Fs11658-016-0031-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs11658-016-0031-z%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%2BJ.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DW.%2BF.%26aulast%3DGuo%26aufirst%3DL.%2BJ.%26aulast%3DXu%26aufirst%3DZ.%2BG.%26aulast%3DWu%26aufirst%3DH.%2BL.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DH.%2BF.%26atitle%3Dp62%2520links%2520the%2520autophagy%2520pathway%2520and%2520the%2520ubiqutin-proteasome%2520system%2520upon%2520ubiquitinated%2520protein%2520degradation%26jtitle%3DCell.%2520Mol.%2520Biol.%2520Lett.%26date%3D2016%26volume%3D21%26spage%3D29%26doi%3D10.1186%2Fs11658-016-0031-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Babu, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geetha, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, M. W.</span></span> <span> </span><span class="NLM_article-title">Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>94</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">192</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2005.03181.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1111%2Fj.1471-4159.2005.03181.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=15953362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvFCksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2005&pages=192-203&issue=1&author=J.+R.+Babuauthor=T.+Geethaauthor=M.+W.+Wooten&title=Sequestosome+1%2Fp62+shuttles+polyubiquitinated+tau+for+proteasomal+degradation&doi=10.1111%2Fj.1471-4159.2005.03181.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation</span></div><div class="casAuthors">Babu, Jeganathan Ramesh; Geetha, Thangiah; Wooten, Marie W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">192-203</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Inclusions isolated from several neurodegenerative diseases, including Alzheimer's disease (AD), are characterized by ubiquitin-pos. proteinaceous aggregates.  Employing confocal and immunoelectron microscopy, we find that the ubiquitin-assocg. protein sequestosome1/p62, co-localizes to aggregates isolated from AD but not control brain, along with the E3 ubiquitin ligase, TRAF6.  This interaction could be recapitulated by co-transfection in HEK293 cells.  Employing both in vitro and in vivo approaches, tau was found to be a substrate of the TRAF6, possessing lysine 63 polyubiquitin chains.  Moreover, tau recovered from brain of TRAF6 knockout mice, compared with wild type, was not ubiquitinated.  Tau degrdn. took place through the ubiquitin-proteasome pathway and was dependent upon either the K63-polyubiquitin chains or upon p62.  In brain lysates of p62 knockout mice, tau fails to co-interact with Rpt1, a proteasomal subunit, thereby indicating a requirement for p62 shuttling of tau to the proteasome.  Our results demonstrate that p62 interacts with K63-polyubiquitinated tau through its UBA domain and serves a novel role in regulating tau proteasomal degrdn.  We propose a model whereby either a decline in p62 expression or a decrease in proteasome activity may contribute to accumulation of insol./aggregated K63-polyubiquitinated tau.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxggL6oD-wILVg90H21EOLACvtfcHk0lhPMbHYTDpKJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvFCksbY%253D&md5=1cba213bc86a63595bd3c9ea92d7e34d</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2005.03181.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2005.03181.x%26sid%3Dliteratum%253Aachs%26aulast%3DBabu%26aufirst%3DJ.%2BR.%26aulast%3DGeetha%26aufirst%3DT.%26aulast%3DWooten%26aufirst%3DM.%2BW.%26atitle%3DSequestosome%25201%252Fp62%2520shuttles%2520polyubiquitinated%2520tau%2520for%2520proteasomal%2520degradation%26jtitle%3DJ.%2520Neurochem.%26date%3D2005%26volume%3D94%26issue%3D1%26spage%3D192%26epage%3D203%26doi%3D10.1111%2Fj.1471-4159.2005.03181.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaidi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundkeiqbal, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, K.</span></span> <span> </span><span class="NLM_article-title">Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer-disease</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>91</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5562</span>– <span class="NLM_lpage">5566</span>, <span class="refDoi"> DOI: 10.1073/pnas.91.12.5562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1073%2Fpnas.91.12.5562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=8202528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADyaK2c3mtFKhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=5562-5566&issue=12&author=A.+D.+Alonsoauthor=T.+Zaidiauthor=I.+Grundkeiqbalauthor=K.+Iqbal&title=Role+of+abnormally+phosphorylated+tau+in+the+breakdown+of+microtubules+in+Alzheimer-disease&doi=10.1073%2Fpnas.91.12.5562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease</span></div><div class="casAuthors">Alonso A C; Zaidi T; Grundke-Iqbal I; Iqbal K</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5562-6</span>
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The microtubule assembly-promoting activity of different pools of tau protein isolated from Alzheimer disease (AD) and control brains and the effect of dephosphorylation on this activity were studied.  Tau isolated from a 2.5% perchloric extract of AD brain had almost the same activity as that obtained from control brain, and this activity did not change significantly on dephosphorylation.  Abnormally phosphorylated tau (AD P-tau) isolated from brain homogenate of AD patients had little activity, and upon dephosphorylation with alkaline phosphatase, its activity increased to approximately the same level as the acid-soluble tau.  Addition of AD P-tau to a mixture of normal tau and tubulin inhibited microtubule assembly.  AD P-tau bound to normal tau but not to tubulin.  These studies suggest that the abnormal phosphorylation of tau might be responsible for the breakdown of microtubules in affected neurons in AD not only because the altered protein has little microtubule-promoting activity but also because it interacts with normal tau, making the latter unavailable for promoting the assembly of tubulin into microtubules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5nJ1wCLFdwrZpSb_XWfMrfW6udTcc2ea4PEcVcErPxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c3mtFKhtA%253D%253D&md5=4b73493ac98f48a1d5b6976104bd5ca3</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.12.5562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.12.5562%26sid%3Dliteratum%253Aachs%26aulast%3DAlonso%26aufirst%3DA.%2BD.%26aulast%3DZaidi%26aufirst%3DT.%26aulast%3DGrundkeiqbal%26aufirst%3DI.%26aulast%3DIqbal%26aufirst%3DK.%26atitle%3DRole%2520of%2520abnormally%2520phosphorylated%2520tau%2520in%2520the%2520breakdown%2520of%2520microtubules%2520in%2520Alzheimer-disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26issue%3D12%26spage%3D5562%26epage%3D5566%26doi%3D10.1073%2Fpnas.91.12.5562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">Medicine-the amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>297</i></span> (<span class="NLM_issue">5580</span>),  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1126/science.1072994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&issue=5580&author=J.+Hardyauthor=D.+J.+Selkoe&title=Medicine-the+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+progress+and+problems+on+the+road+to+therapeutics&doi=10.1126%2Fscience.1072994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0ljTtjHEriem3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DMedicine-the%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26issue%3D5580%26spage%3D353%26epage%3D356%26doi%3D10.1126%2Fscience.1072994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geetha, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGregor, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh, J.</span></span> <span> </span><span class="NLM_article-title">TRAF6 and p62 inhibit amyloid beta-induced neuronal death through p75 neurotrophin receptor</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1289</span>– <span class="NLM_lpage">1293</span>, <span class="refDoi"> DOI: 10.1016/j.neuint.2012.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.neuint.2012.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=23017601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs12ksbvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=1289-1293&issue=8&author=T.+Geethaauthor=C.+Zhengauthor=W.+C.+McGregorauthor=B.+D.+Whiteauthor=M.+T.+Diaz-Mecoauthor=J.+Moscatauthor=J.+Ramesh&title=TRAF6+and+p62+inhibit+amyloid+beta-induced+neuronal+death+through+p75+neurotrophin+receptor&doi=10.1016%2Fj.neuint.2012.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">TRAF6 and p62 inhibit amyloid β-induced neuronal death through p75 neurotrophin receptor</span></div><div class="casAuthors">Geetha, Thangiah; Zheng, Chen; McGregor, Wade C.; Douglas White, B.; Diaz-Meco, Maria T.; Moscat, Jorge; Babu, Jeganathan Ramesh</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1289-1293</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Amyloid β (Aβ) aggregates are the primary component of senile plaques in Alzheimer disease (AD) patient's brain.  Aβ is known to bind p75 neurotrophin receptor (p75NTR) and mediates Aβ-induced neuronal death.  Recently, we showed that NGF leads to p75NTR polyubiquitination, which promotes neuronal cell survival.  Here, we demonstrate that Aβ stimulation impaired the p75NTR polyubiquitination.  TRAF6 and p62 are required for polyubiquitination of p75NTR on NGF stimulation.  Interestingly, we found that overexpression of TRAF6/p62 restored p75NTR polyubiquitination upon Aβ/NGF treatment.  Aβ significantly reduced NF-κB activity by attenuating the interaction of p75NTR with IKKβ. p75NTR increased NF-κB activity by recruiting TRAF6/p62, which thereby mediated cell survival.  These findings indicate that TRAF6/p62 abrogated the Aβ-mediated inhibition of p75NTR polyubiquitination and restored neuronal cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbVMszTf9ngbVg90H21EOLACvtfcHk0ljTtjHEriem3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs12ksbvL&md5=e4060f807da58fbda95ad4c2afeecf64</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2012.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2012.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DGeetha%26aufirst%3DT.%26aulast%3DZheng%26aufirst%3DC.%26aulast%3DMcGregor%26aufirst%3DW.%2BC.%26aulast%3DWhite%26aufirst%3DB.%2BD.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DRamesh%26aufirst%3DJ.%26atitle%3DTRAF6%2520and%2520p62%2520inhibit%2520amyloid%2520beta-induced%2520neuronal%2520death%2520through%2520p75%2520neurotrophin%2520receptor%26jtitle%3DNeurochem.%2520Int.%26date%3D2012%26volume%3D61%26issue%3D8%26spage%3D1289%26epage%3D1293%26doi%3D10.1016%2Fj.neuint.2012.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brendza, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bales, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzman, D. M.</span></span> <span> </span><span class="NLM_article-title">Role of apoE/Abeta interactions in Alzheimer’s disease: insights from transgenic mouse models</span>. <i>Mol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.1038/sj.mp.4001006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fsj.mp.4001006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=11840304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BD387jvVaktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2002&pages=132-135&issue=2&author=R.+P.+Brendzaauthor=K.+R.+Balesauthor=S.+M.+Paulauthor=D.+M.+Holtzman&title=Role+of+apoE%2FAbeta+interactions+in+Alzheimer%E2%80%99s+disease%3A+insights+from+transgenic+mouse+models&doi=10.1038%2Fsj.mp.4001006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Role of apoE/Abeta interactions in Alzheimer's disease: insights from transgenic mouse models</span></div><div class="casAuthors">Brendza R P; Bales K R; Paul S M; Holtzman D M</div><div class="citationInfo"><span class="NLM_cas:title">Molecular psychiatry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">132-5</span>
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQvX8euXtprFOQ4Pl9hzjQhfW6udTcc2eYxP6tGKDpAobntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387jvVaktA%253D%253D&md5=f8b151eb9a16f6e74c60d3bfcb21a73f</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4001006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4001006%26sid%3Dliteratum%253Aachs%26aulast%3DBrendza%26aufirst%3DR.%2BP.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DPaul%26aufirst%3DS.%2BM.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26atitle%3DRole%2520of%2520apoE%252FAbeta%2520interactions%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520insights%2520from%2520transgenic%2520mouse%2520models%26jtitle%3DMol.%2520Psychiatry%26date%3D2002%26volume%3D7%26issue%3D2%26spage%3D132%26epage%3D135%26doi%3D10.1038%2Fsj.mp.4001006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whitfield, J. F.</span></span> <span> </span><span class="NLM_article-title">The road to load late-onset Alzheimer’s disease and a possible way to block it</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1257</span>– <span class="NLM_lpage">1260</span>, <span class="refDoi"> DOI: 10.1517/14728222.11.10.1257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1517%2F14728222.11.10.1257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=17907956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSgsbjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=1257-1260&issue=10&author=J.+F.+Whitfield&title=The+road+to+load+late-onset+Alzheimer%E2%80%99s+disease+and+a+possible+way+to+block+it&doi=10.1517%2F14728222.11.10.1257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">The road to load late-onset Alzheimer's disease and a possible way to block it</span></div><div class="casAuthors">Whitfield, James F.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1257-1260</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The ageing brain becomes increasingly less able to destroy or eject toxic amyloid (A) β42 peptide byproducts of normal neuronal activity that consequently accumulate to induce Alzheimer's disease (AD).  Therefore, the various components of the Aβ-clearing machinery are prime targets for AD therapeutics.  In this connection, there are reports that taking statins to lower circulating cholesterol to prevent cardiovascular disease can also prevent late-onset AD (LOAD) the most common form of the disease.  However, it seems unlikely that statins would prevent LOAD by lowering the very long-lived brain cholesterol that is controlled independently from the very much shorter-lived circulating cholesterol.  In fact, reducing the ability of the brain astrocytes to make cholesterol for their closely assocd. neuron clients' synaptogenesis could damage the brain rather than protect it.  However, a plausible way statins might prevent LOAD is to target a main component of the clearance machinery, low-d. lipoprotein receptor-related protein 1 (LRP1), the brain's powerful Aβ-efflux driver.  This is indicated by a reported ability of micromolar concns. of lovastatin and simvastatin to strongly stimulate brain vascular endothelial cells to make this Aβ ejector.  Therefore, if this holds up, taking a statin over the years would prevent the normal decline of LRP1 in the ageing brain and a LOAD-driving accumulation of Aβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVVpuLv-ZGHrVg90H21EOLACvtfcHk0lheDAoU0MA3CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSgsbjO&md5=0e60abd1ed0368305562bef0a541b213</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1517%2F14728222.11.10.1257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.11.10.1257%26sid%3Dliteratum%253Aachs%26aulast%3DWhitfield%26aufirst%3DJ.%2BF.%26atitle%3DThe%2520road%2520to%2520load%2520late-onset%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520a%2520possible%2520way%2520to%2520block%2520it%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2007%26volume%3D11%26issue%3D10%26spage%3D1257%26epage%3D1260%26doi%3D10.1517%2F14728222.11.10.1257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geetha, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unroe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sycheva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kluess, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, J. R.</span></span> <span> </span><span class="NLM_article-title">Polyubiquitination of the neurotrophin receptor p75 directs neuronal cell survival</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>421</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">286</span>– <span class="NLM_lpage">290</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2012.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.bbrc.2012.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22503986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFygur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2012&pages=286-290&issue=2&author=T.+Geethaauthor=C.+Zhengauthor=B.+Unroeauthor=M.+Sychevaauthor=H.+Kluessauthor=J.+R.+Babu&title=Polyubiquitination+of+the+neurotrophin+receptor+p75+directs+neuronal+cell+survival&doi=10.1016%2Fj.bbrc.2012.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Polyubiquitination of the neurotrophin receptor p75 directs neuronal cell survival</span></div><div class="casAuthors">Geetha, Thangiah; Zheng, Chen; Unroe, Bradford; Sycheva, Marina; Kluess, Heidi; Babu, Jeganathan Ramesh</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">421</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">286-290</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Specific binding of nerve growth factor (NGF) to p75 neurotrophin receptor (p75NTR) leads to p75NTR polyubiquitination and its subsequent interaction with TRAF6 resulting in neuronal cell survival.  However, when the binding of NGF to p75NTR was blocked with p75 antiserum, p75NTR polyubiquitination and neuronal cell survival were impaired.  Results showed that tyrosine phosphorylation of p75NTR increased the polyubiquitination of p75NTR and contributed to the obsd. apparent neuroprotective effects.  Similar to p75NTR polyubiquitination, interaction of TRAF6 with p75NTR was NGF/tyrosine phosphorylation dependent suggesting that TRAF6 might function as an E3 ubiquitin ligase.  In sum, the results show that specific binding of NGF to p75NTR mediates neuronal cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsFKFBdVd847Vg90H21EOLACvtfcHk0lheDAoU0MA3CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFygur8%253D&md5=01cd2f471fb0f884aa4cc51d93403a5e</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2012.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2012.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DGeetha%26aufirst%3DT.%26aulast%3DZheng%26aufirst%3DC.%26aulast%3DUnroe%26aufirst%3DB.%26aulast%3DSycheva%26aufirst%3DM.%26aulast%3DKluess%26aufirst%3DH.%26aulast%3DBabu%26aufirst%3DJ.%2BR.%26atitle%3DPolyubiquitination%2520of%2520the%2520neurotrophin%2520receptor%2520p75%2520directs%2520neuronal%2520cell%2520survival%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2012%26volume%3D421%26issue%3D2%26spage%3D286%26epage%3D290%26doi%3D10.1016%2Fj.bbrc.2012.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mamidipudi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, M. W.</span></span> <span> </span><span class="NLM_article-title">Identification of interleukin 1 receptor-associated kinase as a conserved component in the p75-neurotrophin receptor activation of nuclear factor-kappa B</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>277</i></span> (<span class="NLM_issue">31</span>),  <span class="NLM_fpage">28010</span>– <span class="NLM_lpage">28018</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109730200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1074%2Fjbc.M109730200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=12034707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvFKgtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=28010-28018&issue=31&author=V.+Mamidipudiauthor=X.+X.+Liauthor=M.+W.+Wooten&title=Identification+of+interleukin+1+receptor-associated+kinase+as+a+conserved+component+in+the+p75-neurotrophin+receptor+activation+of+nuclear+factor-kappa+B&doi=10.1074%2Fjbc.M109730200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of interleukin 1 receptor-associated kinase as a conserved component in the p75-neurotrophin receptor activation of nuclear factor-κB</span></div><div class="casAuthors">Mamidipudi, Vidya; Li, Xiaoxia; Wooten, Marie W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">28010-28018</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The neurotrophin nerve growth factor (NGF) supports neuronal survival by activating the transcription factor nuclear factor-κB (NF-κB).  The authors report here, for the first time, the identification of p75-assocd. kinase that mediates NGF-driven NF-κB activation.  Using co-immunopptn., they demonstrate an NGF-dependent assocn. of interleukin 1 receptor-assocd. kinase (IRAK) with the p75 neurotrophin receptor in PC12 cells.  The authors' results reveal that IRAK is recruited to the p75-NGF receptor leading to formation of a complex between IRAK, atypical protein kinase C interacting protein, p62, and TRAF6.  Activation of NF-κB occurs predominantly through the p75 receptor, and TrkA activity suppresses NF-κB activation and retards IκBβ degrdn.  In addn., the authors obsd. a requirement for the kinase activity of IRAK in mediating NGF-induced NF-κB activation, recruitment of the adapter protein p62 to the p75 receptor, and cell survival.  Moreover, p75-IRAK-mediated κB activation and the recruitment of IKKβ, but not IKKα, to the receptor require p62.  The authors' data thus provide novel information regarding the proximal components involved in p75 receptor signaling and underscore the importance of the atypical PKC interacting protein p62 in this process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPWw9vYNnG2LVg90H21EOLACvtfcHk0lhtWXri406NWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvFKgtLY%253D&md5=03ef477fadf5369c6e6535249a0a1daa</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109730200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109730200%26sid%3Dliteratum%253Aachs%26aulast%3DMamidipudi%26aufirst%3DV.%26aulast%3DLi%26aufirst%3DX.%2BX.%26aulast%3DWooten%26aufirst%3DM.%2BW.%26atitle%3DIdentification%2520of%2520interleukin%25201%2520receptor-associated%2520kinase%2520as%2520a%2520conserved%2520component%2520in%2520the%2520p75-neurotrophin%2520receptor%2520activation%2520of%2520nuclear%2520factor-kappa%2520B%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26issue%3D31%26spage%3D28010%26epage%3D28018%26doi%3D10.1074%2Fjbc.M109730200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adriaanse, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greig, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cader, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohr, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, E. F.</span></span> <span> </span><span class="NLM_article-title">Mitophagy and Alzheimer’s disease: cellular and molecular mechanisms</span>. <i>Trends Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1016/j.tins.2017.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.tins.2017.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=28190529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitFeitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2017&pages=151-166&issue=3&author=J.+S.+Kerrauthor=B.+A.+Adriaanseauthor=N.+H.+Greigauthor=M.+P.+Mattsonauthor=M.+Z.+Caderauthor=V.+A.+Bohrauthor=E.+F.+Fang&title=Mitophagy+and+Alzheimer%E2%80%99s+disease%3A+cellular+and+molecular+mechanisms&doi=10.1016%2Fj.tins.2017.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Mitophagy and Alzheimer's Disease: Cellular and Molecular Mechanisms</span></div><div class="casAuthors">Kerr, Jesse S.; Adriaanse, Bryan A.; Greig, Nigel H.; Mattson, Mark P.; Cader, M. Zameel; Bohr, Vilhelm A.; Fang, Evandro F.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Neurosciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">151-166</span>CODEN:
                <span class="NLM_cas:coden">TNSCDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-2236</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Neurons affected in Alzheimer's disease (AD) experience mitochondrial dysfunction and a bioenergetic deficit that occurs early and promotes the disease-defining amyloid beta peptide (Aβ) and Tau pathologies.  Emerging findings suggest that the autophagy/lysosome pathway that removes damaged mitochondria (mitophagy) is also compromised in AD, resulting in the accumulation of dysfunctional mitochondria.  Results in animal and cellular models of AD and in patients with sporadic late-onset AD suggest that impaired mitophagy contributes to synaptic dysfunction and cognitive deficits by triggering Aβ and Tau accumulation through increases in oxidative damage and cellular energy deficits; these, in turn, impair mitophagy.  Interventions that bolster mitochondrial health and/or stimulate mitophagy may therefore forestall the neurodegenerative process in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_-MRZbZ4Y1bVg90H21EOLACvtfcHk0lhtWXri406NWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitFeitb8%253D&md5=3365c23656a7890481e1553fd018808f</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2017.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2017.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DKerr%26aufirst%3DJ.%2BS.%26aulast%3DAdriaanse%26aufirst%3DB.%2BA.%26aulast%3DGreig%26aufirst%3DN.%2BH.%26aulast%3DMattson%26aufirst%3DM.%2BP.%26aulast%3DCader%26aufirst%3DM.%2BZ.%26aulast%3DBohr%26aufirst%3DV.%2BA.%26aulast%3DFang%26aufirst%3DE.%2BF.%26atitle%3DMitophagy%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520cellular%2520and%2520molecular%2520mechanisms%26jtitle%3DTrends%2520Neurosci.%26date%3D2017%26volume%3D40%26issue%3D3%26spage%3D151%26epage%3D166%26doi%3D10.1016%2Fj.tins.2017.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamat, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyles, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagi, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagi, N.</span></span> <span> </span><span class="NLM_article-title">Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease</span>. <i>Cell Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>70</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">707</span>– <span class="NLM_lpage">719</span>, <span class="refDoi"> DOI: 10.1007/s12013-014-0006-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1007%2Fs12013-014-0006-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=24807843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXns1aisrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2014&pages=707-719&issue=2&author=P.+K.+Kamatauthor=A.+Kalaniauthor=P.+Kylesauthor=S.+C.+Tyagiauthor=N.+Tyagi&title=Autophagy+of+mitochondria%3A+a+promising+therapeutic+target+for+neurodegenerative+disease&doi=10.1007%2Fs12013-014-0006-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy of Mitochondria: A Promising Therapeutic Target for Neurodegenerative Disease</span></div><div class="casAuthors">Kamat, Pradip K.; Kalani, Anuradha; Kyles, Philip; Tyagi, Suresh C.; Tyagi, Neetu</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">707-719</span>CODEN:
                <span class="NLM_cas:coden">CBBIFV</span>;
        ISSN:<span class="NLM_cas:issn">1085-9195</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The autophagic process is the only known mechanism for mitochondrial turnover and it has been speculated that dysfunction of autophagy may result in mitochondrial error and cellular stress.  Emerging investigations have provided new understanding of how autophagy of mitochondria (also known as mitophagy) is assocd. with cellular oxidative stress and its impact on neurodegeneration.  This impaired autophagic function may be considered as a possible mechanism in the pathogenesis of several neurodegenerative disorders including Parkinson's disease, Alzheimer's disease, multiple sclerosis, amyotrophic lateral sclerosis, and Huntington disease.  It can be suggested that autophagy dysfunction along with oxidative stress is considered main events in neurodegenerative disorders.  New therapeutic approaches have now begun to target mitochondria as a potential drug target.  This review discusses evidence supporting the notion that oxidative stress and autophagy are intimately assocd. with neurodegenerative disease pathogenesis.  This review also explores new approaches that can prevent mitochondrial dysfunction, improve neurodegenerative etiol., and also offer possible cures to the aforementioned neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoryIgB2Eg6l7Vg90H21EOLACvtfcHk0lhtWXri406NWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXns1aisrk%253D&md5=9961e5ffde3e6397bb21d1bd53a79271</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1007%2Fs12013-014-0006-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12013-014-0006-5%26sid%3Dliteratum%253Aachs%26aulast%3DKamat%26aufirst%3DP.%2BK.%26aulast%3DKalani%26aufirst%3DA.%26aulast%3DKyles%26aufirst%3DP.%26aulast%3DTyagi%26aufirst%3DS.%2BC.%26aulast%3DTyagi%26aufirst%3DN.%26atitle%3DAutophagy%2520of%2520mitochondria%253A%2520a%2520promising%2520therapeutic%2520target%2520for%2520neurodegenerative%2520disease%26jtitle%3DCell%2520Biochem.%2520Biophys.%26date%3D2014%26volume%3D70%26issue%3D2%26spage%3D707%26epage%3D719%26doi%3D10.1007%2Fs12013-014-0006-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleichmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A.</span></span> <span> </span><span class="NLM_article-title">Mitochondria in neuroplasticity and neurological disorders</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">748</span>– <span class="NLM_lpage">766</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2008.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.neuron.2008.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19081372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFahs7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=748-766&issue=5&author=M.+P.+Mattsonauthor=M.+Gleichmannauthor=A.+Cheng&title=Mitochondria+in+neuroplasticity+and+neurological+disorders&doi=10.1016%2Fj.neuron.2008.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria in neuroplasticity and neurological disorders</span></div><div class="casAuthors">Mattson, Mark P.; Gleichmann, Marc; Cheng, Aiwu</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">748-766</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Mitochondrial electron transport generates the ATP that is essential for the excitability and survival of neurons, and the protein phosphorylation reactions that mediate synaptic signaling and related long-term changes in neuronal structure and function.  Mitochondria are highly dynamic organelles that divide, fuse, and move purposefully within axons and dendrites.  Major functions of mitochondria in neurons include the regulation of Ca2+ and redox signaling, developmental and synaptic plasticity, and the arbitration of cell survival and death.  The importance of mitochondria in neurons is evident in the neurol. phenotypes in rare diseases caused by mutations in mitochondrial genes.  Mitochondria-mediated oxidative stress, perturbed Ca2+ homeostasis, and apoptosis may also contribute to the pathogenesis of prominent neurol. diseases including Alzheimer's, Parkinson's, and Huntington's diseases; stroke; amyotrophic lateral sclerosis; and psychiatric disorders.  Advances in understanding the mol. and cell biol. of mitochondria are leading to novel approaches for the prevention and treatment of neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVB5rd26j-rLVg90H21EOLACvtfcHk0lhQR2FnTc4ZfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFahs7rI&md5=66667579021bc8125d1b4796f44ff131</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2008.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2008.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DMattson%26aufirst%3DM.%2BP.%26aulast%3DGleichmann%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DA.%26atitle%3DMitochondria%2520in%2520neuroplasticity%2520and%2520neurological%2520disorders%26jtitle%3DNeuron%26date%3D2008%26volume%3D60%26issue%3D5%26spage%3D748%26epage%3D766%26doi%3D10.1016%2Fj.neuron.2008.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waeg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, K.</span></span> <span> </span><span class="NLM_article-title">4-hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau</span>. <i>NeuroReport</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">9–10</span>),  <span class="NLM_fpage">2275</span>– <span class="NLM_lpage">2281</span>, <span class="refDoi"> DOI: 10.1097/00001756-199707070-00036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1097%2F00001756-199707070-00036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=9243625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADyaK2sXlt1Wgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=2275-2281&issue=9%E2%80%9310&author=M.+P.+Mattsonauthor=W.+M.+Fuauthor=G.+Waegauthor=K.+Uchida&title=4-hydroxynonenal%2C+a+product+of+lipid+peroxidation%2C+inhibits+dephosphorylation+of+the+microtubule-associated+protein+tau&doi=10.1097%2F00001756-199707070-00036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">4-Hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau</span></div><div class="casAuthors">Mattson, Mark P.; Fu, Weiming; Waeg, Georg; Uchida, Koji</div><div class="citationInfo"><span class="NLM_cas:title">NeuroReport</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">2275-2281</span>CODEN:
                <span class="NLM_cas:coden">NERPEZ</span>;
        ISSN:<span class="NLM_cas:issn">0959-4965</span>.
    
            (<span class="NLM_cas:orgname">Rapid Science Publishers</span>)
        </div><div class="casAbstract">In Alzheimer's disease (AD) the microtubule-assocd. protein tau is excessively phosphorylated in degenerating neurons, but the mechanisms underlying the increased phosphorylation are unknown.  Recent findings suggest that oxidative stress, and membrane lipid peroxidn. in particular, contributes to the neurodegenerative process in AD.  The authors now report that following exposure of cultured rat hippocampal neurons to 4-hydroxynonenal (HNE), an aldehydic product of membrane lipid peroxidn., tau is resistant to dephosphorylation.  Immunocytochem. and Western blot analyses using phosphorylation-sensitive tau antibodies showed that HNE treatment causes a moderate increase in basal levels of tau phosphorylation, and prevents tau dephosphorylation by alk. phosphatase in neurons pretreated with the phosphatase inhibitor okadaic acid.  Studies with anti-HNE antibodies showed that HNE binds directly to tau, and that HNE immunoreactivity localizes to cell bodies and axons, cell compartments that contain tau.  These data suggest a role for HNE in altered tau phosphorylation and neurofibrillary degeneration in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmD64H-HG0A7Vg90H21EOLACvtfcHk0lhQR2FnTc4ZfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlt1Wgtro%253D&md5=0955162536d5897a86c1291ab9e338fc</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1097%2F00001756-199707070-00036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-199707070-00036%26sid%3Dliteratum%253Aachs%26aulast%3DMattson%26aufirst%3DM.%2BP.%26aulast%3DFu%26aufirst%3DW.%2BM.%26aulast%3DWaeg%26aufirst%3DG.%26aulast%3DUchida%26aufirst%3DK.%26atitle%3D4-hydroxynonenal%252C%2520a%2520product%2520of%2520lipid%2520peroxidation%252C%2520inhibits%2520dephosphorylation%2520of%2520the%2520microtubule-associated%2520protein%2520tau%26jtitle%3DNeuroReport%26date%3D1997%26volume%3D8%26issue%3D9%25E2%2580%259310%26spage%3D2275%26epage%3D2281%26doi%3D10.1097%2F00001756-199707070-00036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gwon, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arumugam, T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baik, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyun, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dann, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markesbery, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jo, D. G.</span></span> <span> </span><span class="NLM_article-title">Oxidative lipid modification of nicastrin enhances amyloidogenic γ-secretase activity in Alzheimer’s disease</span>. <i>Aging Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">559</span>– <span class="NLM_lpage">568</span>, <span class="refDoi"> DOI: 10.1111/j.1474-9726.2012.00817.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1111%2Fj.1474-9726.2012.00817.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22404891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OrtrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=559-568&issue=4&author=A.+R.+Gwonauthor=J.+S.+Parkauthor=T.+V.+Arumugamauthor=Y.+K.+Kwonauthor=S.+L.+Chanauthor=S.+H.+Kimauthor=S.+H.+Baikauthor=S.+Yangauthor=Y.+K.+Yunauthor=Y.+Choiauthor=S.+Kimauthor=S.+C.+Tangauthor=D.+H.+Hyunauthor=A.+W.+Chengauthor=C.+E.+Dannauthor=M.+Bernierauthor=J.+Leeauthor=W.+R.+Markesberyauthor=M.+P.+Mattsonauthor=D.+G.+Jo&title=Oxidative+lipid+modification+of+nicastrin+enhances+amyloidogenic+%CE%B3-secretase+activity+in+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fj.1474-9726.2012.00817.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative lipid modification of nicastrin enhances amyloidogenic γ-secretase activity in Alzheimer's disease</span></div><div class="casAuthors">Gwon, A.-Ryeong; Park, Jong-Sung; Arumugam, Thiruma V.; Kwon, Yong-Kook; Chan, Sic L.; Kim, Seol-Hee; Baik, Sang-Ha; Yang, Sunghee; Yun, Young-Kwang; Choi, Yuri; Kim, Saerom; Tang, Sung-Chun; Hyun, Dong-Hoon; Cheng, Aiwu; Dann, Charles E., III; Bernier, Michel; Lee, Jaewon; Markesbery, William R.; Mattson, Mark P.; Jo, Dong-Gyu</div><div class="citationInfo"><span class="NLM_cas:title">Aging Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">559-568</span>CODEN:
                <span class="NLM_cas:coden">ACGECQ</span>;
        ISSN:<span class="NLM_cas:issn">1474-9718</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The cause of elevated level of amyloid β-peptide (Aβ42) in common late-onset sporadic [Alzheimer's disease (AD)] has not been established.  Here, we show that the membrane lipid peroxidn. product 4-hydroxynonenal (HNE) is assocd. with amyloid and neurodegenerative pathologies in AD and that it enhances γ-secretase activity and Aβ42 prodn. in neurons.  The γ-secretase substrate receptor, nicastrin, was found to be modified by HNE in cultured neurons and in brain specimens from patients with AD, in which HNE-nicastrin levels were found to be correlated with increased γ-secretase activity and Aβ plaque burden.  Furthermore, HNE modification of nicastrin enhanced its binding to the γ-secretase substrate, amyloid precursor protein (APP) C99.  In addn., the stimulation of γ-secretase activity and Aβ42 prodn. by HNE were blocked by an HNE-scavenging histidine analog in a 3xTgAD mouse model of AD.  These findings suggest a specific mol. mechanism by which oxidative stress increases Aβ42 prodn. in AD and identify HNE as a novel therapeutic target upstream of the γ-secretase cleavage of APP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuYry6s13U0bVg90H21EOLACvtfcHk0lhQR2FnTc4ZfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OrtrvJ&md5=69a79fbdf10318113609622f5c1a566a</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1111%2Fj.1474-9726.2012.00817.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1474-9726.2012.00817.x%26sid%3Dliteratum%253Aachs%26aulast%3DGwon%26aufirst%3DA.%2BR.%26aulast%3DPark%26aufirst%3DJ.%2BS.%26aulast%3DArumugam%26aufirst%3DT.%2BV.%26aulast%3DKwon%26aufirst%3DY.%2BK.%26aulast%3DChan%26aufirst%3DS.%2BL.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DBaik%26aufirst%3DS.%2BH.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DYun%26aufirst%3DY.%2BK.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DS.%2BC.%26aulast%3DHyun%26aufirst%3DD.%2BH.%26aulast%3DCheng%26aufirst%3DA.%2BW.%26aulast%3DDann%26aufirst%3DC.%2BE.%26aulast%3DBernier%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMarkesbery%26aufirst%3DW.%2BR.%26aulast%3DMattson%26aufirst%3DM.%2BP.%26aulast%3DJo%26aufirst%3DD.%2BG.%26atitle%3DOxidative%2520lipid%2520modification%2520of%2520nicastrin%2520enhances%2520amyloidogenic%2520%25CE%25B3-secretase%2520activity%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAging%2520Cell%26date%3D2012%26volume%3D11%26issue%3D4%26spage%3D559%26epage%3D568%26doi%3D10.1111%2Fj.1474-9726.2012.00817.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eiyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, K.</span></span> <span> </span><span class="NLM_article-title">PINK1/Parkin-mediated mitophagy in mammalian cells</span>. <i>Curr. Opin. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1016/j.ceb.2015.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.ceb.2015.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=25697963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2msrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2015&pages=95-101&author=A.+Eiyamaauthor=K.+Okamoto&title=PINK1%2FParkin-mediated+mitophagy+in+mammalian+cells&doi=10.1016%2Fj.ceb.2015.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">PINK1/Parkin-mediated mitophagy in mammalian cells</span></div><div class="casAuthors">Eiyama, Akinori; Okamoto, Koji</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">95-101</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Mitochondria-specific autophagy (mitophagy) is a fundamental process crit. for maintaining mitochondrial fitness in a myriad of cell types.  Particularly, mitophagy contributes to mitochondrial quality control by selectively eliminating dysfunctional mitochondria.  In mammalian cells, the Ser/Thr kinase PINK1 and the E3 ubiquitin ligase Parkin act cooperatively in sensing mitochondrial functional state and marking damaged mitochondria for disposal via the autophagy pathway.  Notably, ubiquitin and deubiquitinases play vital roles in modulating Parkin activity and mitophagy efficiency.  In this review, we highlight recent breakthroughs addressing the key issues of how PINK1 activates Parkin in response to mitochondrial malfunction, how Parkin localizes specifically to impaired mitochondria, and how ubiquitination and deubiquitination regulate PINK1/Parkin-mediated mitophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5bIcK20R-CLVg90H21EOLACvtfcHk0ljqHvrx6vVeCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2msrg%253D&md5=6973e43c653a7c9b7f53fe6a5ddf7a6f</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2015.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2015.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DEiyama%26aufirst%3DA.%26aulast%3DOkamoto%26aufirst%3DK.%26atitle%3DPINK1%252FParkin-mediated%2520mitophagy%2520in%2520mammalian%2520cells%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2015%26volume%3D33%26spage%3D95%26epage%3D101%26doi%3D10.1016%2Fj.ceb.2015.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, W. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolz, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, G. W.,  2nd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, X. M.</span></span> <span> </span><span class="NLM_article-title">Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span> (<span class="NLM_issue">36</span>),  <span class="NLM_fpage">27879</span>– <span class="NLM_lpage">27890</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.119537</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1074%2Fjbc.M110.119537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20573959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVOnsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=27879-27890&issue=36&author=W.+X.+Dingauthor=H.+M.+Niauthor=M.+Liauthor=Y.+Liaoauthor=X.+Chenauthor=D.+B.+Stolzauthor=G.+W.+Dornauthor=X.+M.+Yin&title=Nix+is+critical+to+two+distinct+phases+of+mitophagy%2C+reactive+oxygen+species-mediated+autophagy+induction+and+Parkin-ubiquitin-p62-mediated+mitochondrial+priming&doi=10.1074%2Fjbc.M110.119537"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Nix Is Critical to Two Distinct Phases of Mitophagy, Reactive Oxygen Species-mediated Autophagy Induction and Parkin-Ubiquitin-p62-mediated Mitochondrial Priming</span></div><div class="casAuthors">Ding, Wen-Xing; Ni, Hong-Min; Li, Min; Liao, Yong; Chen, Xiaoyun; Stolz, Donna B.; Dorn, Gerald W., II; Yin, Xiao-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">27879-27890</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Damaged mitochondria can be eliminated by autophagy, i.e. mitophagy, which is important for cellular homeostasis and cell survival.  Despite the fact that a no. of factors have been found to be important for mitophagy in mammalian cells, their individual roles in the process had not been clearly defined.  Parkin is a ubiquitin-protein isopeptide ligase able to translocate to the mitochondria that are to be removed.  We showed here in a chem. hypoxia model of mitophagy induced by an uncoupler, carbonyl cyanide m-chlorophenylhydrazone (CCCP) that Parkin translocation resulted in mitochondrial ubiquitination and p62 recruitment to the mitochondria.  Small inhibitory RNA-mediated knockdown of p62 significantly diminished mitochondrial recognition by the autophagy machinery and the subsequent elimination.  Thus Parkin, ubiquitin, and p62 function in prepg. mitochondria for mitophagy, here referred to as mitochondrial priming.  However, these mols. were not required for the induction of autophagy machinery.  Neither Parkin nor p62 seemed to affect autophagy induction by CCCP.  Instead, we found that Nix was required for the autophagy induction.  Nix promoted CCCP-induced mitochondrial depolarization and reactive oxygen species generation, which inhibited mTOR signaling and activated autophagy.  Nix also contributed to mitochondrial priming by controlling the mitochondrial translocation of Parkin, although reactive oxygen species generation was not involved in this step.  Deletion of the C-terminal membrane targeting sequence but not mutations in the BH3 domain disabled Nix for these functions.  Our work thus distinguished the mol. events responsible for the different phases of mitophagy and placed Nix upstream of the events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRn-oM4221XbVg90H21EOLACvtfcHk0ljqHvrx6vVeCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVOnsL3L&md5=db8f958e70449e2f0ec670485ade07fe</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.119537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.119537%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DW.%2BX.%26aulast%3DNi%26aufirst%3DH.%2BM.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DStolz%26aufirst%3DD.%2BB.%26aulast%3DDorn%26aufirst%3DG.%2BW.%26aulast%3DYin%26aufirst%3DX.%2BM.%26atitle%3DNix%2520is%2520critical%2520to%2520two%2520distinct%2520phases%2520of%2520mitophagy%252C%2520reactive%2520oxygen%2520species-mediated%2520autophagy%2520induction%2520and%2520Parkin-ubiquitin-p62-mediated%2520mitochondrial%2520priming%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26issue%3D36%26spage%3D27879%26epage%3D27890%26doi%3D10.1074%2Fjbc.M110.119537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, J.</span></span> <span> </span><span class="NLM_article-title">PINK1 controls mitochondrial localization of Parkin through direct phosphorylation</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>377</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">975</span>– <span class="NLM_lpage">980</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2008.10.104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.bbrc.2008.10.104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18957282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVais7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2008&pages=975-980&issue=3&author=Y.+Kimauthor=J.+Parkauthor=S.+Kimauthor=S.+Songauthor=S.+K.+Kwonauthor=S.+H.+Leeauthor=T.+Kitadaauthor=J.+M.+Kimauthor=J.+Chung&title=PINK1+controls+mitochondrial+localization+of+Parkin+through+direct+phosphorylation&doi=10.1016%2Fj.bbrc.2008.10.104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">PINK1 controls mitochondrial localization of Parkin through direct phosphorylation</span></div><div class="casAuthors">Kim, Yongsung; Park, Jeehye; Kim, Sunhong; Song, Saera; Kwon, Seok-Kyu; Lee, Sang-Hee; Kitada, Tohru; Kim, Jin-Man; Chung, Jongkyeong</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">377</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">975-980</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">PTEN-induced putative kinase 1 (PINK1) and Parkin, encoded by their resp. genes assocd. with Parkinson's disease (PD), are linked in a common pathway involved in the protection of mitochondrial integrity and function.  However, the mechanism of their interaction at the biochem. level has not been investigated yet.  Using both mammalian and Drosophila systems, we here demonstrate that the PINK1 kinase activity is required for its function in mitochondria.  PINK1 regulates the localization of Parkin to the mitochondria in its kinase activity-dependent manner.  In detail, Parkin phosphorylation by PINK1 on its linker region promotes its mitochondrial translocation, and the RING1 domain of Parkin is crit. for this occurrence.  These results demonstrate the biochem. relationship between PINK1, Parkin, and the mitochondria and thereby suggest the possible mechanism of PINK-Parkin-assocd. PD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRqdn2wR6BKLVg90H21EOLACvtfcHk0liMOKt3ue64WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVais7jP&md5=3d3dee4bb7cc5f7f84821cf3509e0013</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2008.10.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2008.10.104%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DSong%26aufirst%3DS.%26aulast%3DKwon%26aufirst%3DS.%2BK.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DKitada%26aufirst%3DT.%26aulast%3DKim%26aufirst%3DJ.%2BM.%26aulast%3DChung%26aufirst%3DJ.%26atitle%3DPINK1%2520controls%2520mitochondrial%2520localization%2520of%2520Parkin%2520through%2520direct%2520phosphorylation%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2008%26volume%3D377%26issue%3D3%26spage%3D975%26epage%3D980%26doi%3D10.1016%2Fj.bbrc.2008.10.104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geisler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmstrom, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skujat, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiesel, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothfuss, O. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahle, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springer, W.</span></span> <span> </span><span class="NLM_article-title">PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">131</span>, <span class="refDoi"> DOI: 10.1038/ncb2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fncb2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20098416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=119-131&issue=2&author=S.+Geislerauthor=K.+M.+Holmstromauthor=D.+Skujatauthor=F.+C.+Fieselauthor=O.+C.+Rothfussauthor=P.+J.+Kahleauthor=W.+Springer&title=PINK1%2FParkin-mediated+mitophagy+is+dependent+on+VDAC1+and+p62%2FSQSTM1&doi=10.1038%2Fncb2012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1</span></div><div class="casAuthors">Geisler, Sven; Holmstroem, Kira M.; Skujat, Diana; Fiesel, Fabienne C.; Rothfuss, Oliver C.; Kahle, Philipp J.; Springer, Wolfdieter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-131</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Parkinson's disease is the most common neurodegenerative movement disorder.  Mutations in PINK1 and PARKIN are the most frequent causes of recessive Parkinson's disease.  However, their mol. contribution to pathogenesis remains unclear.  Here, we reveal important mechanistic steps of a PINK1/Parkin-directed pathway linking mitochondrial damage, ubiquitylation and autophagy in non-neuronal and neuronal cells.  PINK1 kinase activity and its mitochondrial localization sequence are prerequisites to induce translocation of the E3 ligase Parkin to depolarized mitochondria.  Subsequently, Parkin mediates the formation of two distinct poly-ubiquitin chains, linked through Lys 63 and Lys 27.  In addn., the autophagic adaptor p62/SQSTM1 is recruited to mitochondrial clusters and is essential for the clearance of mitochondria.  Strikingly, we identified VDAC1 (voltage-dependent anion channel 1) as a target for Parkin-mediated Lys 27 poly-ubiquitylation and mitophagy.  Moreover, pathogenic Parkin mutations interfere with distinct steps of mitochondrial translocation, ubiquitylation and/or final clearance through mitophagy.  Thus, our data provide functional links between PINK1, Parkin and the selective autophagy of mitochondria, which is implicated in the pathogenesis of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBWQl05xlFk7Vg90H21EOLACvtfcHk0liMOKt3ue64WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCqtbs%253D&md5=0f96bb285620e7c6852332b4cc5ca917</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1038%2Fncb2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2012%26sid%3Dliteratum%253Aachs%26aulast%3DGeisler%26aufirst%3DS.%26aulast%3DHolmstrom%26aufirst%3DK.%2BM.%26aulast%3DSkujat%26aufirst%3DD.%26aulast%3DFiesel%26aufirst%3DF.%2BC.%26aulast%3DRothfuss%26aufirst%3DO.%2BC.%26aulast%3DKahle%26aufirst%3DP.%2BJ.%26aulast%3DSpringer%26aufirst%3DW.%26atitle%3DPINK1%252FParkin-mediated%2520mitophagy%2520is%2520dependent%2520on%2520VDAC1%2520and%2520p62%252FSQSTM1%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2010%26volume%3D12%26issue%3D2%26spage%3D119%26epage%3D131%26doi%3D10.1038%2Fncb2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y. K.</span></span> <span> </span><span class="NLM_article-title">Choline dehydrogenase interacts with SQSTM1/p62 to recruit LC3 and stimulate mitophagy</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1906</span>– <span class="NLM_lpage">1920</span>, <span class="refDoi"> DOI: 10.4161/auto.32177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.4161%2Fauto.32177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=25483962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVKhsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=1906-1920&issue=11&author=S.+Parkauthor=S.+G.+Choiauthor=S.+M.+Yooauthor=J.+H.+Sonauthor=Y.+K.+Jung&title=Choline+dehydrogenase+interacts+with+SQSTM1%2Fp62+to+recruit+LC3+and+stimulate+mitophagy&doi=10.4161%2Fauto.32177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Choline dehydrogenase interacts with SQSTM1/p62 to recruit LC3 and stimulate mitophagy</span></div><div class="casAuthors">Park, Sungwoo; Choi, Seon-Guk; Yoo, Seung-Min; Son, Jin H.; Jung, Yong-Keun</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1906-1920, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8627</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">CHDH (choline dehydrogenase) is an enzyme catalyzing the dehydrogenation of choline to betaine aldehyde in mitochondria.  Apart from this well-known activity, we report here a pivotal role of CHDH in mitophagy.  Knockdown of CHDH expression impairs CCCP-induced mitophagy and PARK2/parkin-mediated clearance of mitochondria in mammalian cells, including HeLa cells and SN4741 dopaminergic neuronal cells.  Conversely, overexpression of CHDH accelerates PARK2-mediated mitophagy.  CHDH is found on both the outer and inner membranes of mitochondria in resting cells.  Interestingly, upon induction of mitophagy, CHDH accumulates on the outer membrane in a mitochondrial potential-dependent manner.  We found that CHDH is not a substrate of PARK2 but interacts with SQSTM1 independently of PARK2 to recruit SQSTM1 into depolarized mitochondria.  The FB1 domain of CHDH is exposed to the cytosol and is required for the interaction with SQSTM1, and overexpression of the FB1 domain only in cytosol reduces CCCP-induced mitochondrial degrdn. via competitive interaction with SQSTM1.  In addn., CHDH, but not the CHDH FB1 deletion mutant, forms a ternary protein complex with SQSTM1 and MAP1LC3 (LC3), leading to loading of LC3 onto the damaged mitochondria via SQSTM1.  Further, CHDH is crucial to the mitophagy induced by MPP+ in SN4741 cells.  Overall, our results suggest that CHDH is required for PARK2-mediated mitophagy for the recruitment of SQSTM1 and LC3 onto the mitochondria for cargo recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsh1_bUpx9H7Vg90H21EOLACvtfcHk0ljM99lEbWUSug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVKhsrw%253D&md5=04f8288cbfac5444cca641349382817b</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.4161%2Fauto.32177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.32177%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DS.%2BG.%26aulast%3DYoo%26aufirst%3DS.%2BM.%26aulast%3DSon%26aufirst%3DJ.%2BH.%26aulast%3DJung%26aufirst%3DY.%2BK.%26atitle%3DCholine%2520dehydrogenase%2520interacts%2520with%2520SQSTM1%252Fp62%2520to%2520recruit%2520LC3%2520and%2520stimulate%2520mitophagy%26jtitle%3DAutophagy%26date%3D2014%26volume%3D10%26issue%3D11%26spage%3D1906%26epage%3D1920%26doi%3D10.4161%2Fauto.32177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hollville, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullen, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. J.</span></span> <span> </span><span class="NLM_article-title">Bcl-2 family proteins participate in mitochondrial quality control by regulating Parkin/PINK1-dependent mitophagy</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">451</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2014.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.molcel.2014.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=24999239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFSgtLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=451-466&issue=3&author=E.+Hollvilleauthor=R.+G.+Carrollauthor=S.+P.+Cullenauthor=S.+J.+Martin&title=Bcl-2+family+proteins+participate+in+mitochondrial+quality+control+by+regulating+Parkin%2FPINK1-dependent+mitophagy&doi=10.1016%2Fj.molcel.2014.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Bcl-2 Family Proteins Participate in Mitochondrial Quality Control by Regulating Parkin/PINK1-Dependent Mitophagy</span></div><div class="casAuthors">Hollville, Emilie; Carroll, Richard G.; Cullen, Sean P.; Martin, Seamus J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">451-466</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Mitophagy facilitates the selective elimination of impaired or depolarized mitochondria through targeting the latter to autophagosomes.  Parkin becomes localized to depolarized mitochondria in a PINK1-dependent manner and polyubiquitinates multiple mitochondrial outer membrane proteins.  This permits ubiquitin-binding proteins (e.g., p62 and NBR1) to target impaired mitochondria to autophagosomes via Atg8/LC3II.  Bcl-2 family proteins regulate mitochondrial outer membrane permeabilization during apoptosis and can also influence macroautophagy via interactions with Beclin-1.  Here, we show that Parkin-dependent mitophagy is antagonized by prosurvival members of the Bcl-2 family (e.g., Bcl-xL and Mcl-1) in a Beclin-1-independent manner.  Bcl-2 proteins suppressed mitophagy through inhibition of Parkin translocation to depolarized mitochondria.  Consistent with this, Parkin translocation to mitochondria was enhanced by BH3-only proteins or a BH3-only mimetic.  Taken together with their role as regulators of apoptosis-assocd. mitochondrial permeabilization, as well as mitochondrial fission/fusion dynamics, this suggests that Bcl-2 family proteins act as global regulators of mitochondrial homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVoXI2PTy1U7Vg90H21EOLACvtfcHk0ljM99lEbWUSug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFSgtLzN&md5=9f9b9cabdeba877038feec258b168750</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2014.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2014.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DHollville%26aufirst%3DE.%26aulast%3DCarroll%26aufirst%3DR.%2BG.%26aulast%3DCullen%26aufirst%3DS.%2BP.%26aulast%3DMartin%26aufirst%3DS.%2BJ.%26atitle%3DBcl-2%2520family%2520proteins%2520participate%2520in%2520mitochondrial%2520quality%2520control%2520by%2520regulating%2520Parkin%252FPINK1-dependent%2520mitophagy%26jtitle%3DMol.%2520Cell%26date%3D2014%26volume%3D55%26issue%3D3%26spage%3D451%26epage%3D466%26doi%3D10.1016%2Fj.molcel.2014.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lazarou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sliter, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kane, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarraf, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sideris, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogel, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youle, R. J.</span></span> <span> </span><span class="NLM_article-title">The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>524</i></span> (<span class="NLM_issue">7565</span>),  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1038/nature14893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fnature14893" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=26266977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlaju73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=524&publication_year=2015&pages=309-314&issue=7565&author=M.+Lazarouauthor=D.+A.+Sliterauthor=L.+A.+Kaneauthor=S.+A.+Sarrafauthor=C.+Wangauthor=J.+L.+Burmanauthor=D.+P.+Siderisauthor=A.+I.+Fogelauthor=R.+J.+Youle&title=The+ubiquitin+kinase+PINK1+recruits+autophagy+receptors+to+induce+mitophagy&doi=10.1038%2Fnature14893"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy</span></div><div class="casAuthors">Lazarou, Michael; Sliter, Danielle A.; Kane, Lesley A.; Sarraf, Shireen A.; Wang, Chunxin; Burman, Jonathon L.; Sideris, Dionisia P.; Fogel, Adam I.; Youle, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">524</span>
        (<span class="NLM_cas:issue">7565</span>),
    <span class="NLM_cas:pages">309-314</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein aggregates and damaged organelles are tagged with ubiquitin chains to trigger selective autophagy.  To initiate mitophagy, the ubiquitin kinase PINK1 phosphorylates ubiquitin to activate the ubiquitin ligase parkin, which builds ubiquitin chains on mitochondrial outer membrane proteins, where they act to recruit autophagy receptors.  Using genome editing to knockout five autophagy receptors in HeLa cells, here we show that two receptors previously linked to xenophagy, NDP52 and optineurin, are the primary receptors for PINK1- and parkin-mediated mitophagy.  PINK1 recruits NDP52 and optineurin, but not p62, to mitochondria to activate mitophagy directly, independently of parkin.  Once recruited to mitochondria, NDP52 and optineurin recruit the autophagy factors ULK1, DFCP1 and WIPI1 to focal spots proximal to mitochondria, revealing a function for these autophagy receptors upstream of LC3.  This supports a new model in which PINK1-generated phospho-ubiquitin serves as the autophagy signal on mitochondria, and parkin then acts to amplify this signal.  This work also suggests direct and broader roles for ubiquitin phosphorylation in other autophagy pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6G4G5jmlFQLVg90H21EOLACvtfcHk0liZclEd_p0I4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlaju73P&md5=690c30ae72f33bec1622e7cc0686618a</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1038%2Fnature14893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14893%26sid%3Dliteratum%253Aachs%26aulast%3DLazarou%26aufirst%3DM.%26aulast%3DSliter%26aufirst%3DD.%2BA.%26aulast%3DKane%26aufirst%3DL.%2BA.%26aulast%3DSarraf%26aufirst%3DS.%2BA.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DBurman%26aufirst%3DJ.%2BL.%26aulast%3DSideris%26aufirst%3DD.%2BP.%26aulast%3DFogel%26aufirst%3DA.%2BI.%26aulast%3DYoule%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520ubiquitin%2520kinase%2520PINK1%2520recruits%2520autophagy%2520receptors%2520to%2520induce%2520mitophagy%26jtitle%3DNature%26date%3D2015%26volume%3D524%26issue%3D7565%26spage%3D309%26epage%3D314%26doi%3D10.1038%2Fnature14893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calvo-Garrido, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maffezzini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schober, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemente, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhlin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kele, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stranneheim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesko, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruhn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svenningsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wedell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freyer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wredenberg, A.</span></span> <span> </span><span class="NLM_article-title">SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation</span>. <i>Stem Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">696</span>– <span class="NLM_lpage">711</span>, <span class="refDoi"> DOI: 10.1016/j.stemcr.2019.01.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.stemcr.2019.01.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=30827875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktFOrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2019&pages=696-711&issue=4&author=J.+Calvo-Garridoauthor=C.+Maffezziniauthor=F.+A.+Schoberauthor=P.+Clementeauthor=E.+Uhlinauthor=M.+Keleauthor=H.+Stranneheimauthor=N.+Leskoauthor=H.+Bruhnauthor=P.+Svenningssonauthor=A.+Falkauthor=A.+Wedellauthor=C.+Freyerauthor=A.+Wredenberg&title=SQSTM1%2Fp62-directed+metabolic+reprogramming+is+essential+for+normal+neurodifferentiation&doi=10.1016%2Fj.stemcr.2019.01.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">SQSTM1/p62-Directed Metabolic Reprogramming Is Essential for Normal Neurodifferentiation</span></div><div class="casAuthors">Calvo-Garrido, Javier; Maffezzini, Camilla; Schober, Florian A.; Clemente, Paula; Uhlin, Elias; Kele, Malin; Stranneheim, Henrik; Lesko, Nicole; Bruhn, Helene; Svenningsson, Per; Falk, Anna; Wedell, Anna; Freyer, Christoph; Wredenberg, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Stem Cell Reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">696-711</span>CODEN:
                <span class="NLM_cas:coden">SCRTFL</span>;
        ISSN:<span class="NLM_cas:issn">2213-6711</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Neurodegenerative disorders are an increasingly common and irreversible burden on society, often affecting the aging population, but their etiol. and disease mechanisms are poorly understood.  Studying monogenic neurodegenerative diseases with known genetic cause provides an opportunity to understand cellular mechanisms also affected in more complex disorders.  We recently reported that loss-of-function mutations in the autophagy adaptor protein SQSTM1/p62 lead to a slowly progressive neurodegenerative disease presenting in childhood.  To further elucidate the neuronal involvement, we studied the cellular consequences of loss of p62 in a neuroepithelial stem cell (NESC) model and differentiated neurons derived from reprogrammed p62 patient cells or by CRISPR/Cas9-directed gene editing in NESCs.  Transcriptomic and proteomic analyses suggest that p62 is essential for neuronal differentiation by controlling the metabolic shift from aerobic glycolysis to oxidative phosphorylation required for neuronal maturation.  This shift is blocked by the failure to sufficiently downregulate lactate dehydrogenase expression due to the loss of p62, possibly through impaired Hif-1α downregulation and increased sensitivity to oxidative stress.  The findings imply an important role for p62 in neuronal energy metab. and particularly in the regulation of the shift between glycolysis and oxidative phosphorylation required for normal neurodifferentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq60DJCavx23rVg90H21EOLACvtfcHk0liZclEd_p0I4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktFOrsL8%253D&md5=123ef7ee5098f234a1ac3d143268624e</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.stemcr.2019.01.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stemcr.2019.01.023%26sid%3Dliteratum%253Aachs%26aulast%3DCalvo-Garrido%26aufirst%3DJ.%26aulast%3DMaffezzini%26aufirst%3DC.%26aulast%3DSchober%26aufirst%3DF.%2BA.%26aulast%3DClemente%26aufirst%3DP.%26aulast%3DUhlin%26aufirst%3DE.%26aulast%3DKele%26aufirst%3DM.%26aulast%3DStranneheim%26aufirst%3DH.%26aulast%3DLesko%26aufirst%3DN.%26aulast%3DBruhn%26aufirst%3DH.%26aulast%3DSvenningsson%26aufirst%3DP.%26aulast%3DFalk%26aufirst%3DA.%26aulast%3DWedell%26aufirst%3DA.%26aulast%3DFreyer%26aufirst%3DC.%26aulast%3DWredenberg%26aufirst%3DA.%26atitle%3DSQSTM1%252Fp62-directed%2520metabolic%2520reprogramming%2520is%2520essential%2520for%2520normal%2520neurodifferentiation%26jtitle%3DStem%2520Cell%2520Rep.%26date%3D2019%26volume%3D12%26issue%3D4%26spage%3D696%26epage%3D711%26doi%3D10.1016%2Fj.stemcr.2019.01.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haack, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignatius, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvo-Garrido, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iuso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isohanni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maffezzini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonnqvist, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suomalainen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kremer, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berutti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paucar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svenningsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stranneheim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandberg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wedell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurian, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayflick, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venco, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiranti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strom, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dichgans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvath, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holinski-Feder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freyer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meitinger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokisch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senderek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wredenberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klopstock, T.</span></span> <span> </span><span class="NLM_article-title">Absence of the autophagy adaptor SQSTM1/p62 causes childhood-onset neurodegeneration with ataxia, dystonia, and gaze palsy</span>. <i>Am. J. Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">743</span>, <span class="refDoi"> DOI: 10.1016/j.ajhg.2016.06.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.ajhg.2016.06.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27545679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlyjtLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2016&pages=735-743&issue=3&author=T.+B.+Haackauthor=E.+Ignatiusauthor=J.+Calvo-Garridoauthor=A.+Iusoauthor=P.+Isohanniauthor=C.+Maffezziniauthor=T.+Lonnqvistauthor=A.+Suomalainenauthor=M.+Gorzaauthor=L.+S.+Kremerauthor=E.+Grafauthor=M.+Hartigauthor=R.+Beruttiauthor=M.+Paucarauthor=P.+Svenningssonauthor=H.+Stranneheimauthor=G.+Brandbergauthor=A.+Wedellauthor=M.+A.+Kurianauthor=S.+A.+Hayflickauthor=P.+Vencoauthor=V.+Tirantiauthor=T.+M.+Stromauthor=M.+Dichgansauthor=R.+Horvathauthor=E.+Holinski-Federauthor=C.+Freyerauthor=T.+Meitingerauthor=H.+Prokischauthor=J.+Senderekauthor=A.+Wredenbergauthor=C.+J.+Carrollauthor=T.+Klopstock&title=Absence+of+the+autophagy+adaptor+SQSTM1%2Fp62+causes+childhood-onset+neurodegeneration+with+ataxia%2C+dystonia%2C+and+gaze+palsy&doi=10.1016%2Fj.ajhg.2016.06.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Absence of the Autophagy Adaptor SQSTM1/p62 Causes Childhood-Onset Neurodegeneration with Ataxia, Dystonia, and Gaze Palsy</span></div><div class="casAuthors">Haack, Tobias B.; Ignatius, Erika; Calvo-Garrido, Javier; Iuso, Arcangela; Isohanni, Pirjo; Maffezzini, Camilla; Loennqvist, Tuula; Suomalainen, Anu; Gorza, Matteo; Kremer, Laura S.; Graf, Elisabeth; Hartig, Monika; Berutti, Riccardo; Paucar, Martin; Svenningsson, Per; Stranneheim, Henrik; Brandberg, Goeran; Wedell, Anna; Kurian, Manju A.; Hayflick, Susan A.; Venco, Paola; Tiranti, Valeria; Strom, Tim M.; Dichgans, Martin; Horvath, Rita; Holinski-Feder, Elke; Freyer, Christoph; Meitinger, Thomas; Prokisch, Holger; Senderek, Jan; Wredenberg, Anna; Carroll, Christopher J.; Klopstock, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">735-743</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">SQSTM1 (sequestosome 1; also known as p62) encodes a multidomain scaffolding protein involved in various key cellular processes, including the removal of damaged mitochondria by its function as a selective autophagy receptor.  Heterozygous variants in SQSTM1 have been assocd. with Paget disease of the bone and might contribute to neurodegeneration in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).  Using exome sequencing, we identified three different biallelic loss-of-function variants in SQSTM1 in nine affected individuals from four families with a childhood- or adolescence-onset neurodegenerative disorder characterized by gait abnormalities, ataxia, dysarthria, dystonia, vertical gaze palsy, and cognitive decline.  We confirmed absence of the SQSTM1/p62 protein in affected individuals' fibroblasts and found evidence of a defect in the early response to mitochondrial depolarization and autophagosome formation.  Our findings expand the SQSTM1-assocd. phenotypic spectrum and lend further support to the concept of disturbed selective autophagy pathways in neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgFtjHBGoA77Vg90H21EOLACvtfcHk0ljnsDsbgv0ksQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlyjtLrJ&md5=91f1addb3e2ed8ae628a042db1337a4d</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.ajhg.2016.06.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajhg.2016.06.026%26sid%3Dliteratum%253Aachs%26aulast%3DHaack%26aufirst%3DT.%2BB.%26aulast%3DIgnatius%26aufirst%3DE.%26aulast%3DCalvo-Garrido%26aufirst%3DJ.%26aulast%3DIuso%26aufirst%3DA.%26aulast%3DIsohanni%26aufirst%3DP.%26aulast%3DMaffezzini%26aufirst%3DC.%26aulast%3DLonnqvist%26aufirst%3DT.%26aulast%3DSuomalainen%26aufirst%3DA.%26aulast%3DGorza%26aufirst%3DM.%26aulast%3DKremer%26aufirst%3DL.%2BS.%26aulast%3DGraf%26aufirst%3DE.%26aulast%3DHartig%26aufirst%3DM.%26aulast%3DBerutti%26aufirst%3DR.%26aulast%3DPaucar%26aufirst%3DM.%26aulast%3DSvenningsson%26aufirst%3DP.%26aulast%3DStranneheim%26aufirst%3DH.%26aulast%3DBrandberg%26aufirst%3DG.%26aulast%3DWedell%26aufirst%3DA.%26aulast%3DKurian%26aufirst%3DM.%2BA.%26aulast%3DHayflick%26aufirst%3DS.%2BA.%26aulast%3DVenco%26aufirst%3DP.%26aulast%3DTiranti%26aufirst%3DV.%26aulast%3DStrom%26aufirst%3DT.%2BM.%26aulast%3DDichgans%26aufirst%3DM.%26aulast%3DHorvath%26aufirst%3DR.%26aulast%3DHolinski-Feder%26aufirst%3DE.%26aulast%3DFreyer%26aufirst%3DC.%26aulast%3DMeitinger%26aufirst%3DT.%26aulast%3DProkisch%26aufirst%3DH.%26aulast%3DSenderek%26aufirst%3DJ.%26aulast%3DWredenberg%26aufirst%3DA.%26aulast%3DCarroll%26aufirst%3DC.%2BJ.%26aulast%3DKlopstock%26aufirst%3DT.%26atitle%3DAbsence%2520of%2520the%2520autophagy%2520adaptor%2520SQSTM1%252Fp62%2520causes%2520childhood-onset%2520neurodegeneration%2520with%2520ataxia%252C%2520dystonia%252C%2520and%2520gaze%2520palsy%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2016%26volume%3D99%26issue%3D3%26spage%3D735%26epage%3D743%26doi%3D10.1016%2Fj.ajhg.2016.06.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okatsu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saisho, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimanuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shitara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sou, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, N.</span></span> <span> </span><span class="NLM_article-title">p62/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria</span>. <i>Genes Cells</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">887</span>– <span class="NLM_lpage">900</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2443.2010.01426.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1111%2Fj.1365-2443.2010.01426.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20604804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVCltbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=887-900&issue=8&author=K.+Okatsuauthor=K.+Saishoauthor=M.+Shimanukiauthor=K.+Nakadaauthor=H.+Shitaraauthor=Y.+S.+Souauthor=M.+Kimuraauthor=S.+Satoauthor=N.+Hattoriauthor=M.+Komatsuauthor=K.+Tanakaauthor=N.+Matsuda&title=p62%2FSQSTM1+cooperates+with+Parkin+for+perinuclear+clustering+of+depolarized+mitochondria&doi=10.1111%2Fj.1365-2443.2010.01426.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">p62/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria</span></div><div class="casAuthors">Okatsu, Kei; Saisho, Keiko; Shimanuki, Midori; Nakada, Kazuto; Shitara, Hiroshi; Sou, Yu-shin; Kimura, Mayumi; Sato, Shigeto; Hattori, Nobutaka; Komatsu, Masaaki; Tanaka, Keiji; Matsuda, Noriyuki</div><div class="citationInfo"><span class="NLM_cas:title">Genes to Cells</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">887-900</span>CODEN:
                <span class="NLM_cas:coden">GECEFL</span>;
        ISSN:<span class="NLM_cas:issn">1356-9597</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">PINK1 and Parkin were first identified as the causal genes responsible for familial forms of early-onset Parkinson's disease (PD), a prevalent neurodegenerative disorder.  PINK1 encodes a mitochondrial serine/threonine protein kinase, whereas Parkin encodes an ubiquitin-protein ligase.  PINK1 and Parkin cooperate to maintain mitochondrial integrity; however, the detailed mol. mechanism of how Parkin-catalyzed ubiquitylation results in mitochondrial integrity remains an enigma.  In this study, we show that Parkin-catalyzed K63-linked polyubiquitylation of depolarized mitochondria resulted in ubiquitylated mitochondria being transported along microtubules to cluster in the perinuclear region, which was interfered by pathogenic mutations of Parkin.  In addn., p62/SQSTM1 (hereafter referred to as p62) was recruited to depolarized mitochondria after Parkin-directed ubiquitylation.  Intriguingly, deletion of p62 in mouse embryonic fibroblasts resulted in a gross loss of mitochondrial perinuclear clustering but did not hinder mitochondrial degrdn.  Thus, p62 is required for ubiquitylation-dependent clustering of damaged mitochondria, which resembles p62-mediated 'aggresome' formation of misfolded/unfolded proteins after ubiquitylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8c1s0HG6dqrVg90H21EOLACvtfcHk0ljnsDsbgv0ksQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVCltbrP&md5=f44a45c8f2cd33b365e00645c581c7ca</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2443.2010.01426.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2443.2010.01426.x%26sid%3Dliteratum%253Aachs%26aulast%3DOkatsu%26aufirst%3DK.%26aulast%3DSaisho%26aufirst%3DK.%26aulast%3DShimanuki%26aufirst%3DM.%26aulast%3DNakada%26aufirst%3DK.%26aulast%3DShitara%26aufirst%3DH.%26aulast%3DSou%26aufirst%3DY.%2BS.%26aulast%3DKimura%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DHattori%26aufirst%3DN.%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DMatsuda%26aufirst%3DN.%26atitle%3Dp62%252FSQSTM1%2520cooperates%2520with%2520Parkin%2520for%2520perinuclear%2520clustering%2520of%2520depolarized%2520mitochondria%26jtitle%3DGenes%2520Cells%26date%3D2010%26volume%3D15%26issue%3D8%26spage%3D887%26epage%3D900%26doi%3D10.1111%2Fj.1365-2443.2010.01426.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butterfield, D. A.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress in neurodegenerative disorders</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">11–12</span>),  <span class="NLM_fpage">1971</span>– <span class="NLM_lpage">1973</span>, <span class="refDoi"> DOI: 10.1089/ars.2006.8.1971</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1089%2Fars.2006.8.1971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=17034342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVKntb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=1971-1973&issue=11%E2%80%9312&author=D.+A.+Butterfield&title=Oxidative+stress+in+neurodegenerative+disorders&doi=10.1089%2Fars.2006.8.1971"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress in Neurodegenerative Disorders</span></div><div class="casAuthors">Butterfield, D. Allan</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11 & 12</span>),
    <span class="NLM_cas:pages">1971-1973</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  The topics discussed include: introduction and overview; causes and consequences of oxidative stress; and oxidative damage and neurodegenerative disorders.  Future studies and perspectives are also given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQeCr46_yPVrVg90H21EOLACvtfcHk0ljnsDsbgv0ksQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVKntb7P&md5=303629ed4cfc0e100d6339dbd2108aa9</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1089%2Fars.2006.8.1971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2006.8.1971%26sid%3Dliteratum%253Aachs%26aulast%3DButterfield%26aufirst%3DD.%2BA.%26atitle%3DOxidative%2520stress%2520in%2520neurodegenerative%2520disorders%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2006%26volume%3D8%26issue%3D11%25E2%2580%259312%26spage%3D1971%26epage%3D1973%26doi%3D10.1089%2Fars.2006.8.1971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butterfield, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perluigi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Marco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coccia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sultana, R.</span></span> <span> </span><span class="NLM_article-title">Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>397</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1016/j.neulet.2005.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.neulet.2005.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=16413966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD28XisFOqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=397&publication_year=2006&pages=170-173&issue=3&author=D.+A.+Butterfieldauthor=T.+Reedauthor=M.+Perluigiauthor=C.+De+Marcoauthor=R.+Cocciaauthor=C.+Ciniauthor=R.+Sultana&title=Elevated+protein-bound+levels+of+the+lipid+peroxidation+product%2C+4-hydroxy-2-nonenal%2C+in+brain+from+persons+with+mild+cognitive+impairment&doi=10.1016%2Fj.neulet.2005.12.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment</span></div><div class="casAuthors">Butterfield, D. Allan; Reed, Tanea; Perluigi, Marzia; De Marco, Carlo; Coccia, Raffaella; Cini, Chiara; Sultana, Rukhsana</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">397</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">170-173</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Oxidative damage is a feature of many age-related neurodegenerative diseases, including Alzheimer's disease (AD).  4-Hydroxy-2-nonenal (HNE) is a highly reactive product of the free radical-mediated lipid peroxidn. of unsatd. lipids, particularly arachidonic acid, in cellular membranes.  In the present study we show for the first time in brain obtained at short postmortem intervals that the levels of HNE are elevated in mild cognitive impairment (MCI) hippocampus and inferior parietal lobules compared to those of control brain.  Thus, increased levels of HNE in MCI brain implicate lipid peroxidn. as an early event in AD pathophysiol. and also suggest that the pharmacol. intervention to prevent lipid peroxidn. at the MCI stage or earlier may be a promising therapeutic strategy to delay or prevent progression to AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeee3vur7beLVg90H21EOLACvtfcHk0lj30Fc7WSzPRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisFOqsrk%253D&md5=ab2855b494f197c5831b68fc5b39317c</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2005.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2005.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DButterfield%26aufirst%3DD.%2BA.%26aulast%3DReed%26aufirst%3DT.%26aulast%3DPerluigi%26aufirst%3DM.%26aulast%3DDe%2BMarco%26aufirst%3DC.%26aulast%3DCoccia%26aufirst%3DR.%26aulast%3DCini%26aufirst%3DC.%26aulast%3DSultana%26aufirst%3DR.%26atitle%3DElevated%2520protein-bound%2520levels%2520of%2520the%2520lipid%2520peroxidation%2520product%252C%25204-hydroxy-2-nonenal%252C%2520in%2520brain%2520from%2520persons%2520with%2520mild%2520cognitive%2520impairment%26jtitle%3DNeurosci.%2520Lett.%26date%3D2006%26volume%3D397%26issue%3D3%26spage%3D170%26epage%3D173%26doi%3D10.1016%2Fj.neulet.2005.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mecocci, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macgarvey, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, M. F.</span></span> <span> </span><span class="NLM_article-title">Oxidative damage to mitochondrial-DNA is increased in Alzheimers-disease</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">747</span>– <span class="NLM_lpage">751</span>, <span class="refDoi"> DOI: 10.1002/ana.410360510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1002%2Fana.410360510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=7979220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADyaK2M%252FmvF2nsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1994&pages=747-751&issue=5&author=P.+Mecocciauthor=U.+Macgarveyauthor=M.+F.+Beal&title=Oxidative+damage+to+mitochondrial-DNA+is+increased+in+Alzheimers-disease&doi=10.1002%2Fana.410360510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease</span></div><div class="casAuthors">Mecocci P; MacGarvey U; Beal M F</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">747-51</span>
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">Oxidative damage to DNA may play a role in both normal aging and in neurodegenerative diseases.  We examined whether Alzheimer's disease (AD) is associated with increased oxidative damage to nDNA and mtDNA in postmortem brain tissue.  We measured the oxidized nucleoside, 8-hydroxy-2'-deoxyguanosine (OH8dG), in DNA isolated from three regions of cerebral cortex and cerebellum in 13 AD and 13 age-matched controls.  There was a significant threefold increase in the amount of OH8dG in mtDNA in parietal cortex of AD patients compared with controls.  In the entire group of samples there was a small significant increase in oxidative damage to nDNA and a highly significant threefold increase in oxidative damage to mtDNA in AD compared with age-matched controls.  These results confirm that mitochondrial DNA is particularly sensitive to oxidative damage, and they show that there is increased oxidative damage to DNA in AD, which may contribute to the neurodegenerative process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTIhMoEIAbG5Jp6t8nS6Nc3fW6udTcc2ebCEKTtNI8fKbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252FmvF2nsA%253D%253D&md5=f4708b4825a3eec3d86b1f1ab9884dca</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1002%2Fana.410360510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410360510%26sid%3Dliteratum%253Aachs%26aulast%3DMecocci%26aufirst%3DP.%26aulast%3DMacgarvey%26aufirst%3DU.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DOxidative%2520damage%2520to%2520mitochondrial-DNA%2520is%2520increased%2520in%2520Alzheimers-disease%26jtitle%3DAnn.%2520Neurol.%26date%3D1994%26volume%3D36%26issue%3D5%26spage%3D747%26epage%3D751%26doi%3D10.1002%2Fana.410360510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanagawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawane, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seita, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannai, S.</span></span> <span> </span><span class="NLM_article-title">Murine peritoneal macrophages induce a novel 60-kDa protein with structural similarity to a tyrosine kinase p56(lck)-associated protein in response to oxidative stress</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>226</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">456</span>– <span class="NLM_lpage">460</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1996.1377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1006%2Fbbrc.1996.1377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=8806656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADyaK28Xls1yit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=1996&pages=456-460&issue=2&author=T.+Ishiiauthor=T.+Yanagawaauthor=T.+Kawaneauthor=K.+Yukiauthor=J.+Seitaauthor=H.+Yoshidaauthor=S.+Bannai&title=Murine+peritoneal+macrophages+induce+a+novel+60-kDa+protein+with+structural+similarity+to+a+tyrosine+kinase+p56%28lck%29-associated+protein+in+response+to+oxidative+stress&doi=10.1006%2Fbbrc.1996.1377"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Murine peritoneal macrophages induce a novel 60-kDa protein with structural similarity to a tyrosine kinase p56lck-associated protein in response to oxidative stress</span></div><div class="casAuthors">Ishii, Tetsuro; Yanagawa, Yoru; Kawane, Tetsuya; Yuki, Koichi; Seita, Jun; Yoshida, Hiroshi; Bannai, Shiro</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">456-460</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Using differential screening we have cloned a cDNA encoding a novel oxidative stress protein designated A170 from murine peritoneal macrophages.  It has a Zn-finger domain, a PEST domain and several potential phosphorylation sites for kinases.  Treatments with oxidative stress agents such as di-Et maleate and paraquat increased a 2.0-kilobase A170 mRNA about twofold in the macrophages after 12 h in culture.  However, H2O2 or glucose/glucose oxidase did not increase the level of the A170 mRNA.  Using an A170-specific antibody we have detected in the macrophages a 60-kDa protein that was induced 5 to 10 h after the addn. of the oxidative stress agents.  A search of sequence databases revealed that the A170 protein is roughly 90% identical to a human protein that binds to the Src homol. 2 domain of the T-cell-specific tyrosine kinase p56lck.  These features suggest that the A170 protein plays a significant role in oxidative stress-responsive signal transduction in macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosnqKmPU_Ve7Vg90H21EOLACvtfcHk0ljVOJ9UdZgruw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xls1yit7o%253D&md5=de5965e2445982d0e146a905fb5c526b</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1996.1377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1996.1377%26sid%3Dliteratum%253Aachs%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DYanagawa%26aufirst%3DT.%26aulast%3DKawane%26aufirst%3DT.%26aulast%3DYuki%26aufirst%3DK.%26aulast%3DSeita%26aufirst%3DJ.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DBannai%26aufirst%3DS.%26atitle%3DMurine%2520peritoneal%2520macrophages%2520induce%2520a%2520novel%252060-kDa%2520protein%2520with%2520structural%2520similarity%2520to%2520a%2520tyrosine%2520kinase%2520p56%2528lck%2529-associated%2520protein%2520in%2520response%2520to%2520oxidative%2520stress%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1996%26volume%3D226%26issue%3D2%26spage%3D456%26epage%3D460%26doi%3D10.1006%2Fbbrc.1996.1377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M. P.</span></span> <span> </span><span class="NLM_article-title">Animal and human studies with the mitochondria-targeted antioxidant MitoQ</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1201</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1111/j.1749-6632.2010.05627.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1111%2Fj.1749-6632.2010.05627.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20649545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFegsLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1201&publication_year=2010&pages=96-103&author=R.+A.+J.+Smithauthor=M.+P.+Murphy&title=Animal+and+human+studies+with+the+mitochondria-targeted+antioxidant+MitoQ&doi=10.1111%2Fj.1749-6632.2010.05627.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Animal and human studies with the mitochondria-targeted antioxidant mitoQ</span></div><div class="casAuthors">Smith, Robin A. J.; Murphy, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1201</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">96-103</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  As mitochondrial oxidative damage contributes to a wide range of human diseases, antioxidants designed to be accumulated by mitochondria in vivo have been developed.  The most extensively studied of these mitochondria-targeted antioxidants is MitoQ, which contains the antioxidant quinone moiety covalently attached to a lipophilic triphenylphosphonium cation.  MitoQ has now been used in a range of in vivo studies in rats and mice and in two phase II human trials.  Here, we review what has been learned from these animal and human studies with MitoQ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN1QYo6EVyf7Vg90H21EOLACvtfcHk0ljVOJ9UdZgruw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFegsLrF&md5=e11dd288b96d56da2e229eb8052c8479</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.2010.05627.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.2010.05627.x%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DR.%2BA.%2BJ.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26atitle%3DAnimal%2520and%2520human%2520studies%2520with%2520the%2520mitochondria-targeted%2520antioxidant%2520MitoQ%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2010%26volume%3D1201%26spage%3D96%26epage%3D103%26doi%3D10.1111%2Fj.1749-6632.2010.05627.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baum, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, C. W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, S. K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwok, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lui, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsoh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, H. F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goggins, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zee, B. C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, C. Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mok, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, M. S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ip, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, C. Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, I. H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mok, V.</span></span> <span> </span><span class="NLM_article-title">Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease</span>. <i>J. Clin. Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">113</span>, <span class="refDoi"> DOI: 10.1097/jcp.0b013e318160862c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1097%2Fjcp.0b013e318160862c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18204357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BD1c7gtlansw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=110-113&issue=1&author=L.+Baumauthor=C.+W.+K.+Lamauthor=S.+K.+K.+Cheungauthor=T.+Kwokauthor=V.+Luiauthor=J.+Tsohauthor=L.+Lamauthor=V.+Leungauthor=E.+Huiauthor=C.+Ngauthor=J.+Wooauthor=H.+F.+K.+Chiuauthor=W.+B.+Gogginsauthor=B.+C.+Y.+Zeeauthor=K.+F.+Chengauthor=C.+Y.+S.+Fongauthor=A.+Wongauthor=H.+Mokauthor=M.+S.+S.+Chowauthor=P.+C.+Hoauthor=S.+P.+Ipauthor=C.+S.+Hoauthor=X.+W.+Yuauthor=C.+Y.+L.+Laiauthor=M.+H.+Chanauthor=S.+Szetoauthor=I.+H.+S.+Chanauthor=V.+Mok&title=Six-month+randomized%2C+placebo-controlled%2C+double-blind%2C+pilot+clinical+trial+of+curcumin+in+patients+with+Alzheimer+disease&doi=10.1097%2Fjcp.0b013e318160862c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease</span></div><div class="casAuthors">Baum Larry; Lam Christopher Wai Kei; Cheung Stanley Kwok-Kuen; Kwok Timothy; Lui Victor; Tsoh Joshua; Lam Linda; Leung Vivian; Hui Elsie; Ng Chelsia; Woo Jean; Chiu Helen Fung Kum; Goggins William B; Zee Benny Chung-Ying; Cheng King Fai; Fong Carmen Yuet Shim; Wong Adrian; Mok Hazel; Chow Moses Sing Sum; Ho Ping Chuen; Ip Siu Po; Ho Chung Shun; Yu Xiong Wen; Lai Caroline Yau Lin; Chan Ming-Houng; Szeto Samuel; Chan Iris Hiu Shuen; Mok Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical psychopharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">110-3</span>
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTPfhPvTevf1Ptos8R3JUhXfW6udTcc2ebpT2ov6RFvnLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7gtlansw%253D%253D&md5=b0b7fb02c9ec4f0213f6176415aa9a5d</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1097%2Fjcp.0b013e318160862c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252Fjcp.0b013e318160862c%26sid%3Dliteratum%253Aachs%26aulast%3DBaum%26aufirst%3DL.%26aulast%3DLam%26aufirst%3DC.%2BW.%2BK.%26aulast%3DCheung%26aufirst%3DS.%2BK.%2BK.%26aulast%3DKwok%26aufirst%3DT.%26aulast%3DLui%26aufirst%3DV.%26aulast%3DTsoh%26aufirst%3DJ.%26aulast%3DLam%26aufirst%3DL.%26aulast%3DLeung%26aufirst%3DV.%26aulast%3DHui%26aufirst%3DE.%26aulast%3DNg%26aufirst%3DC.%26aulast%3DWoo%26aufirst%3DJ.%26aulast%3DChiu%26aufirst%3DH.%2BF.%2BK.%26aulast%3DGoggins%26aufirst%3DW.%2BB.%26aulast%3DZee%26aufirst%3DB.%2BC.%2BY.%26aulast%3DCheng%26aufirst%3DK.%2BF.%26aulast%3DFong%26aufirst%3DC.%2BY.%2BS.%26aulast%3DWong%26aufirst%3DA.%26aulast%3DMok%26aufirst%3DH.%26aulast%3DChow%26aufirst%3DM.%2BS.%2BS.%26aulast%3DHo%26aufirst%3DP.%2BC.%26aulast%3DIp%26aufirst%3DS.%2BP.%26aulast%3DHo%26aufirst%3DC.%2BS.%26aulast%3DYu%26aufirst%3DX.%2BW.%26aulast%3DLai%26aufirst%3DC.%2BY.%2BL.%26aulast%3DChan%26aufirst%3DM.%2BH.%26aulast%3DSzeto%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DI.%2BH.%2BS.%26aulast%3DMok%26aufirst%3DV.%26atitle%3DSix-month%2520randomized%252C%2520placebo-controlled%252C%2520double-blind%252C%2520pilot%2520clinical%2520trial%2520of%2520curcumin%2520in%2520patients%2520with%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D2008%26volume%3D28%26issue%3D1%26spage%3D110%26epage%3D113%26doi%3D10.1097%2Fjcp.0b013e318160862c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, M. W.</span></span> <span> </span><span class="NLM_article-title">Oxidative damage to the promoter region of SQSTM1/p62 is common to neurodegenerative disease</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">302</span>– <span class="NLM_lpage">310</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2009.05.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.nbd.2009.05.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19481605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotFCgtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2009&pages=302-310&issue=2&author=Y.+F.+Duauthor=M.+C.+Wootenauthor=M.+W.+Wooten&title=Oxidative+damage+to+the+promoter+region+of+SQSTM1%2Fp62+is+common+to+neurodegenerative+disease&doi=10.1016%2Fj.nbd.2009.05.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative damage to the promoter region of SQSTM1/p62 is common to neurodegenerative disease</span></div><div class="casAuthors">Du, Yifeng; Wooten, Michael C.; Wooten, Marie W.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">302-310</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recently we reported that declined SQSTM1/p62 expression in Alzheimer disease brain was age-correlated with oxidative damage to the p62 promoter.  The objective of this study was to examine whether oxidative damage to the p62 promoter is common to DNA recovered from brain of individuals with neurodegenerative disease.  Increased 8-OHdG staining was obsd. in brain sections from Alzheimer's disease (AD), Parkinson disease (PD), Huntington disease (HD), Frontotemporal dementia (FTD), and Pick's disease compared to control subjects.  In parallel, the p62 promoter exhibited elevated oxidative damage in samples from various diseases compared to normal brain, and damage was neg. correlated with p62 expression in FTD samples.  Oxidative damage to the p62 promoter induced by H2O2 treatment decreased its transcriptional activity.  In keeping with this observation, the transcriptional activity of a Sp-1 element deletion mutant displayed reduced stimulus-induced activity.  These findings reveal that oxidative damage to the p62 promoter decreased its transcriptional activity and might therefore account for decreased expression of p62.  Altogether these results suggest that pharmacol. means to increase p62 expression may be beneficial in delaying the onset of neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA_-iE4eJ1l7Vg90H21EOLACvtfcHk0lhvKvYe4C-3vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotFCgtL0%253D&md5=96782e2b993c732f81a18d8a6655d6ab</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2009.05.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2009.05.015%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DY.%2BF.%26aulast%3DWooten%26aufirst%3DM.%2BC.%26aulast%3DWooten%26aufirst%3DM.%2BW.%26atitle%3DOxidative%2520damage%2520to%2520the%2520promoter%2520region%2520of%2520SQSTM1%252Fp62%2520is%2520common%2520to%2520neurodegenerative%2520disease%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2009%26volume%3D35%26issue%3D2%26spage%3D302%26epage%3D310%26doi%3D10.1016%2Fj.nbd.2009.05.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamark, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjottem, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awuh, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overvatn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansen, T.</span></span> <span> </span><span class="NLM_article-title">p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span> (<span class="NLM_issue">29</span>),  <span class="NLM_fpage">22576</span>– <span class="NLM_lpage">22591</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.118976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1074%2Fjbc.M110.118976" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20452972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1WntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=22576-22591&issue=29&author=A.+Jainauthor=T.+Lamarkauthor=E.+Sjottemauthor=K.+B.+Larsenauthor=J.+A.+Awuhauthor=A.+Overvatnauthor=M.+McMahonauthor=J.+D.+Hayesauthor=T.+Johansen&title=p62%2FSQSTM1+is+a+target+gene+for+transcription+factor+NRF2+and+creates+a+positive+feedback+loop+by+inducing+antioxidant+response+element-driven+gene+transcription&doi=10.1074%2Fjbc.M110.118976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription</span></div><div class="casAuthors">Jain, Ashish; Lamark, Trond; Sjottem, Eva; Bowitz Larsen, Kenneth; Atesoh Awuh, Jane; Overvatn, Aud; McMahon, Michael; Hayes, John D.; Johansen, Terje</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">22576-22591</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The p62/SQSTM1 (sequestosome 1) protein, which acts as a cargo receptor for autophagic degrdn. of ubiquitinated targets, is up-regulated by various stressors.  Induction of the p62 gene by oxidative stress is mediated by NF-E2-related factor 2 (NRF2) and, at the same time, p62 protein contributes to the activation of NRF2, but hitherto the mechanisms involved were not known.  Herein, we have mapped an antioxidant response element (ARE) in the p62 promoter that is responsible for its induction by oxidative stress via NRF2.  Chromatin immunopptn. and gel mobility-shift assays verified that NRF2 binds to this cis-element in vivo and in vitro.  Also, p62 docks directly onto the Kelch-repeat domain of Kelch-like ECH-assocd. protein 1 (KEAP1), via a motif designated the KEAP1 interacting region (KIR), thereby blocking binding between KEAP1 and NRF2 that leads to ubiquitylation and degrdn. of the transcription factor.  The KIR motif in p62 is located immediately C-terminal to the LC3-interacting region (LIR) and resembles the ETGE motif utilized by NRF2 for its interaction with KEAP1.  KIR is required for p62 to stabilize NRF2, and inhibition of KEAP1 by p62 occurs from a cytoplasmic location within the cell.  The LIR and KIR motifs cannot be engaged simultaneously by LC3 and KEAP1, but because p62 is polymeric the interaction between KEAP1 and p62 leads to accumulation of KEAP1 in p62 bodies, which is followed by autophagic degrdn. of KEAP1.  Our data explain how p62 contributes to activation of NRF2 target genes in response to oxidative stress through creating a pos. feedback loop.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgqJXJvye3yrVg90H21EOLACvtfcHk0lhvKvYe4C-3vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1WntLg%253D&md5=707de1a603fba64ec0d631b575bd6c99</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.118976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.118976%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DA.%26aulast%3DLamark%26aufirst%3DT.%26aulast%3DSjottem%26aufirst%3DE.%26aulast%3DLarsen%26aufirst%3DK.%2BB.%26aulast%3DAwuh%26aufirst%3DJ.%2BA.%26aulast%3DOvervatn%26aufirst%3DA.%26aulast%3DMcMahon%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DJohansen%26aufirst%3DT.%26atitle%3Dp62%252FSQSTM1%2520is%2520a%2520target%2520gene%2520for%2520transcription%2520factor%2520NRF2%2520and%2520creates%2520a%2520positive%2520feedback%2520loop%2520by%2520inducing%2520antioxidant%2520response%2520element-driven%2520gene%2520transcription%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26issue%3D29%26spage%3D22576%26epage%3D22591%26doi%3D10.1074%2Fjbc.M110.118976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otten, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manni, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanatos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menzies, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jurk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenneth, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passos, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attems, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veal, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teyssou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seilhean, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millecamps, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eskelinen, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronowska, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinsztein, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korolchuk, V. I.</span></span> <span> </span><span class="NLM_article-title">Oxidation of SQSTM1/p62 mediates the link between redox state and protein homeostasis</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">256</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02746-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fs41467-017-02746-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=29343728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BC1Mvhs12rsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=256&issue=1&author=B.+Carrollauthor=E.+G.+Ottenauthor=D.+Manniauthor=R.+Stefanatosauthor=F.+M.+Menziesauthor=G.+R.+Smithauthor=D.+Jurkauthor=N.+Kennethauthor=S.+Wilkinsonauthor=J.+F.+Passosauthor=J.+Attemsauthor=E.+A.+Vealauthor=E.+Teyssouauthor=D.+Seilheanauthor=S.+Millecampsauthor=E.+L.+Eskelinenauthor=A.+K.+Bronowskaauthor=D.+C.+Rubinszteinauthor=A.+Sanzauthor=V.+I.+Korolchuk&title=Oxidation+of+SQSTM1%2Fp62+mediates+the+link+between+redox+state+and+protein+homeostasis&doi=10.1038%2Fs41467-017-02746-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidation of SQSTM1/p62 mediates the link between redox state and protein homeostasis</span></div><div class="casAuthors">Carroll Bernadette; Otten Elsje G; Manni Diego; Stefanatos Rhoda; Smith Graham R; Jurk Diana; Kenneth Niall; Passos Joao F; Veal Elizabeth A; Sanz Alberto; Korolchuk Viktor I; Menzies Fiona M; Rubinsztein David C; Smith Graham R; Wilkinson Simon; Attems Johannes; Teyssou Elisa; Seilhean Danielle; Millecamps Stephanie; Seilhean Danielle; Eskelinen Eeva-Liisa; Bronowska Agnieszka K; Rubinsztein David C</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">256</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cellular homoeostatic pathways such as macroautophagy (hereinafter autophagy) are regulated by basic mechanisms that are conserved throughout the eukaryotic kingdom.  However, it remains poorly understood how these mechanisms further evolved in higher organisms.  Here we describe a modification in the autophagy pathway in vertebrates, which promotes its activity in response to oxidative stress.  We have identified two oxidation-sensitive cysteine residues in a prototypic autophagy receptor SQSTM1/p62, which allow activation of pro-survival autophagy in stress conditions.  The Drosophila p62 homologue, Ref(2)P, lacks these oxidation-sensitive cysteine residues and their introduction into the protein increases protein turnover and stress resistance of flies, whereas perturbation of p62 oxidation in humans may result in age-related pathology.  We propose that the redox-sensitivity of p62 may have evolved in vertebrates as a mechanism that allows activation of autophagy in response to oxidative stress to maintain cellular homoeostasis and increase cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7izekEYEuo9NTrvPZP1IpfW6udTcc2eb_CExWTQQ8Nrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mvhs12rsQ%253D%253D&md5=6fcf378990f79016d342f2be482191f3</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02746-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02746-z%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DB.%26aulast%3DOtten%26aufirst%3DE.%2BG.%26aulast%3DManni%26aufirst%3DD.%26aulast%3DStefanatos%26aufirst%3DR.%26aulast%3DMenzies%26aufirst%3DF.%2BM.%26aulast%3DSmith%26aufirst%3DG.%2BR.%26aulast%3DJurk%26aufirst%3DD.%26aulast%3DKenneth%26aufirst%3DN.%26aulast%3DWilkinson%26aufirst%3DS.%26aulast%3DPassos%26aufirst%3DJ.%2BF.%26aulast%3DAttems%26aufirst%3DJ.%26aulast%3DVeal%26aufirst%3DE.%2BA.%26aulast%3DTeyssou%26aufirst%3DE.%26aulast%3DSeilhean%26aufirst%3DD.%26aulast%3DMillecamps%26aufirst%3DS.%26aulast%3DEskelinen%26aufirst%3DE.%2BL.%26aulast%3DBronowska%26aufirst%3DA.%2BK.%26aulast%3DRubinsztein%26aufirst%3DD.%2BC.%26aulast%3DSanz%26aufirst%3DA.%26aulast%3DKorolchuk%26aufirst%3DV.%2BI.%26atitle%3DOxidation%2520of%2520SQSTM1%252Fp62%2520mediates%2520the%2520link%2520between%2520redox%2520state%2520and%2520protein%2520homeostasis%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26issue%3D1%26spage%3D256%26doi%3D10.1038%2Fs41467-017-02746-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rea, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majcher, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Searle, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layfield, R.</span></span> <span> </span><span class="NLM_article-title">SQSTM1 mutations-bridging Paget disease of bone and ALS/FTLD</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>325</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">37</span>, <span class="refDoi"> DOI: 10.1016/j.yexcr.2014.01.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.yexcr.2014.01.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=24486447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitlelsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2014&pages=27-37&issue=1&author=S.+L.+Reaauthor=V.+Majcherauthor=M.+S.+Searleauthor=R.+Layfield&title=SQSTM1+mutations-bridging+Paget+disease+of+bone+and+ALS%2FFTLD&doi=10.1016%2Fj.yexcr.2014.01.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">SQSTM1 mutations - Bridging Paget disease of bone and ALS/FTLD</span></div><div class="casAuthors">Rea, Sarah L.; Majcher, Veronika; Searle, Mark S.; Layfield, Rob</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-37</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Paget disease of bone (PDB) is a skeletal disorder common in Western Europe but extremely rare in the Indian subcontinent and Far East.  The condition has a strong genetic element with mutations affecting the SQSTM1 gene, encoding the p62 protein, frequently identified.  Recently SQSTM1 mutations have also been reported in a small no. of patients with amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD), neurodegenerative disorders in which significant coexistence with PDB has not been previously recognized.  Although several SQSTM1 mutations are common to both ALS/FTLD and PDB, many are ALS/FTLD-specific.  The p62 protein regulates various cellular processes including NF-κB signaling and autophagy pathways.  Here we consider how knowledge of the impact of PDB-assocd. SQSTM1 mutations (several of which are now known to be relevant for ALS/FTLD) on these pathways, as well as the locations of the mutations within the p62 primary sequence, may provide new insights into ALS/FTLD disease mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO-5Xu7HQbtLVg90H21EOLACvtfcHk0lifBwFrOu0diQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitlelsrg%253D&md5=3ee0dc16a76c9009d7994bdb48cb0c00</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2014.01.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2014.01.020%26sid%3Dliteratum%253Aachs%26aulast%3DRea%26aufirst%3DS.%2BL.%26aulast%3DMajcher%26aufirst%3DV.%26aulast%3DSearle%26aufirst%3DM.%2BS.%26aulast%3DLayfield%26aufirst%3DR.%26atitle%3DSQSTM1%2520mutations-bridging%2520Paget%2520disease%2520of%2520bone%2520and%2520ALS%252FFTLD%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2014%26volume%3D325%26issue%3D1%26spage%3D27%26epage%3D37%26doi%3D10.1016%2Fj.yexcr.2014.01.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sabatelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zollino, M.</span></span> <span> </span><span class="NLM_article-title">Clinical and genetic heterogeneity of amyotrophic lateral sclerosis</span>. <i>Clin. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>83</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">408</span>– <span class="NLM_lpage">416</span>, <span class="refDoi"> DOI: 10.1111/cge.12117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1111%2Fcge.12117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=23379621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosFKktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2013&pages=408-416&issue=5&author=M.+Sabatelliauthor=A.+Conteauthor=M.+Zollino&title=Clinical+and+genetic+heterogeneity+of+amyotrophic+lateral+sclerosis&doi=10.1111%2Fcge.12117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical and genetic heterogeneity of amyotrophic lateral sclerosis</span></div><div class="casAuthors">Sabatelli, M.; Conte, A.; Zollino, M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Genetics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">408-416</span>CODEN:
                <span class="NLM_cas:coden">CLGNAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-9163</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Although clin. picture of amyotrophic lateral sclerosis (ALS) is a stereotypical one, resulting from combination of signs secondary to dysfunction of both upper motor neuron (UMN) and lower motor neuron (LMN), clin. heterogeneity is a consistent feature of the disease.  Age of onset, relative mix of UMN and LMN signs, duration of the disease and assocn. with other conditions are major factors contributing to variable clin. phenotypes.  Genetically, familial forms of ALS are assocd. with a large no. of pleiotropic genes whose mutations impair different biochem. pathways, resulting in overlapping clin. and pathol. phenotypes.  Over the last few years contribution of large- and low-effect genes to sporadic ALS is increasingly recognized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptYRLkwkK7NbVg90H21EOLACvtfcHk0lifBwFrOu0diQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosFKktrg%253D&md5=d3dc82de3f58c7159bc05b31c9933610</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1111%2Fcge.12117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcge.12117%26sid%3Dliteratum%253Aachs%26aulast%3DSabatelli%26aufirst%3DM.%26aulast%3DConte%26aufirst%3DA.%26aulast%3DZollino%26aufirst%3DM.%26atitle%3DClinical%2520and%2520genetic%2520heterogeneity%2520of%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DClin.%2520Genet.%26date%3D2013%26volume%3D83%26issue%3D5%26spage%3D408%26epage%3D416%26doi%3D10.1111%2Fcge.12117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panegyres, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frencham, K.</span></span> <span> </span><span class="NLM_article-title">Course and causes of suspected dementia in young adults: a longitudinal study</span>. <i>American journal of Alzheimer’s disease and other dementias</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1177/1533317506295887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1177%2F1533317506295887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=17534002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BD2szit1KntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=48-56&issue=1&author=P.+K.+Panegyresauthor=K.+Frencham&title=Course+and+causes+of+suspected+dementia+in+young+adults%3A+a+longitudinal+study&doi=10.1177%2F1533317506295887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Course and causes of suspected dementia in young adults: a longitudinal study</span></div><div class="casAuthors">Panegyres Peter K; Frencham Kate</div><div class="citationInfo"><span class="NLM_cas:title">American journal of Alzheimer's disease and other dementias</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-56</span>
        ISSN:<span class="NLM_cas:issn">1533-3175</span>.
    </div><div class="casAbstract">The authors performed a prospective, unbiased analysis of a cohort of young patients assessed consecutively with the question of dementia.  The onset of patients' cognitive symptoms was prior to the age of 65 years.  A study group of 226 patients was followed for a mean duration of 4.59 +/- 2.23 years (1 SD; range, 0.04-7.86 years).  The diagnoses were established using published diagnostic criteria.  A diagnosis of dementia was made in 112 patients (49.56%).  Psychiatric disease was the most common diagnosis in those who did not have dementia (24.3%) followed by frontotemporal lobar degeneration (19.0%), Alzheimer's disease (11.9%), patients with cognitive symptoms who obtained normal neuropsychometric profiles (10.6%), nonneurological disorders (eg, obstructive sleep apnea [8.4%]), neurological disorders (eg, Parkinson's disease [4.9%]), and mild cognitive impairment (4.9%).  The frequencies of frontotemporal lobar degeneration and psychiatric disease were higher than Alzheimer's disease, unlike in older populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRIkI5T8Ht0zZPlX7E30qdzfW6udTcc2eaoIbUKQ_hTnLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2szit1KntQ%253D%253D&md5=7866ac4ecf15f5a9fd5c99780c51ed6e</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1177%2F1533317506295887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1533317506295887%26sid%3Dliteratum%253Aachs%26aulast%3DPanegyres%26aufirst%3DP.%2BK.%26aulast%3DFrencham%26aufirst%3DK.%26atitle%3DCourse%2520and%2520causes%2520of%2520suspected%2520dementia%2520in%2520young%2520adults%253A%2520a%2520longitudinal%2520study%26jtitle%3DAmerican%2520journal%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520other%2520dementias%26date%3D2007%26volume%3D22%26issue%3D1%26spage%3D48%26epage%3D56%26doi%3D10.1177%2F1533317506295887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanji, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakita, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, K.</span></span> <span> </span><span class="NLM_article-title">p62/sequestosome 1 binds to TDP-43 in brains with frontotemporal lobar degeneration with TDP-43 inclusions</span>. <i>J. Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>90</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2034</span>– <span class="NLM_lpage">2042</span>, <span class="refDoi"> DOI: 10.1002/jnr.23081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1002%2Fjnr.23081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22674379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvFOqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2012&pages=2034-2042&issue=10&author=K.+Tanjiauthor=H.+X.+Zhangauthor=F.+Moriauthor=A.+Kakitaauthor=H.+Takahashiauthor=K.+Wakabayashi&title=p62%2Fsequestosome+1+binds+to+TDP-43+in+brains+with+frontotemporal+lobar+degeneration+with+TDP-43+inclusions&doi=10.1002%2Fjnr.23081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">p62/sequestosome 1 binds to TDP-43 in brains with frontotemporal lobar degeneration with TDP-43 inclusions</span></div><div class="casAuthors">Tanji, Kunikazu; Zhang, Hai-Xin; Mori, Fumiaki; Kakita, Akiyoshi; Takahashi, Hitoshi; Wakabayashi, Koichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2034-2042</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Ubiquitin-pos. cytoplasmic inclusions are consistently found in various neurodegenerative diseases.  As with ubiquitin, anti-p62/SQSTM1 (referred to as p62) antibody clearly immunostains these inclusions.  P62 has a ubiquitin-assocd. domain at the carboxyl terminus and thereby interacts with ubiquitinated and misfolded proteins.  Here we immunopptd. endogenous p62 in the cerebral cortex from patients with frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) and found that p62 coimmunopptd. several proteins, including TDP-43, which is a major disease protein in FTLD-TDP.  Unexpectedly, p62 immunopptd. a smaller amt. of TDP-43 in FTLD-TDP compared with controls.  Further analyses showed that p62 physiol. binds to TDP-43 and likely is involved in degrdn. of TDP-43 with 35-kDa, but not full-length TDP-43.  Our results suggest that the interaction of TDP-43 and p62 is disrupted and may participate in the pathogenesis of TDP-43 proteinopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcIxUxWxvmBbVg90H21EOLACvtfcHk0lgi4nbAb4O00Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvFOqs74%253D&md5=3c8535b5959d73d8b7ad0cebb4a8ab83</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1002%2Fjnr.23081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.23081%26sid%3Dliteratum%253Aachs%26aulast%3DTanji%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DH.%2BX.%26aulast%3DMori%26aufirst%3DF.%26aulast%3DKakita%26aufirst%3DA.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DWakabayashi%26aufirst%3DK.%26atitle%3Dp62%252Fsequestosome%25201%2520binds%2520to%2520TDP-43%2520in%2520brains%2520with%2520frontotemporal%2520lobar%2520degeneration%2520with%2520TDP-43%2520inclusions%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2012%26volume%3D90%26issue%3D10%26spage%3D2034%26epage%3D2042%26doi%3D10.1002%2Fjnr.23081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alegre-Abarrategui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade-Martins, R.</span></span> <span> </span><span class="NLM_article-title">RNA dysfunction and aggrephagy at the centre of an amyotrophic lateral sclerosis/frontotemporal dementia disease continuum</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>136</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1345</span>– <span class="NLM_lpage">1360</span>, <span class="refDoi"> DOI: 10.1093/brain/awt030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1093%2Fbrain%2Fawt030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=23474849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BC3svks1aitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2013&pages=1345-1360&issue=5&author=M.+Thomasauthor=J.+Alegre-Abarrateguiauthor=R.+Wade-Martins&title=RNA+dysfunction+and+aggrephagy+at+the+centre+of+an+amyotrophic+lateral+sclerosis%2Ffrontotemporal+dementia+disease+continuum&doi=10.1093%2Fbrain%2Fawt030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">RNA dysfunction and aggrephagy at the centre of an amyotrophic lateral sclerosis/frontotemporal dementia disease continuum</span></div><div class="casAuthors">Thomas Matthew; Alegre-Abarrategui Javier; Wade-Martins Richard</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">Pt 5</span>),
    <span class="NLM_cas:pages">1345-60</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Amyotrophic lateral sclerosis and frontotemporal dementia form two poles of a genetically, pathologically and clinically-related disease continuum.  Analysis of the genes and proteins at the heart of this continuum highlights dysfunction of RNA processing and aggrephagy as crucial disease-associated pathways.  TAR DNA binding protein and fused in sarcoma (FUS) are both RNA processing proteins whose dysfunction impacts on global cellular RNA regulation.  The recent discovery that expression of repeat expansions in the C9orf72 gene may induce RNA foci that could sequester RNA binding proteins such as TAR DNA binding protein and FUS highlights a further possibly important mechanism of RNA dysfunction in disease.  Furthermore, sequestration of key RNA binding proteins may also play an important role in sporadic disease due to the association of TAR DNA binding protein and FUS with stress granules.  In a further functional convergence, ubiquilin 2, p62, valosin-containing protein and optineurin are all linked to aggrephagy, a cargo-specific subtype of autophagy important for degrading ubiquitinated target proteins through the lysosome.  Notably these two key pathways interact; TAR DNA binding protein and FUS bind and regulate key aggrephagy-related genes whereas dysfunction of aggrephagy leads to cytoplasmic relocalization and aggregation of TAR DNA binding protein.  The convergence of amyotrophic lateral sclerosis and frontotemporal dementia linked genes into these two pathways highlights RNA dysfunction and aggrephagy as promising areas for drug discovery.  In this review we discuss the importance of each of these pathways and suggest mechanisms by which they may cause both sporadic and familial disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSss4OwtmZ9cO2mnZh2OgS0fW6udTcc2eaoIbUKQ_hTnLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svks1aitg%253D%253D&md5=63a673f902456b6437deb417b0f21846</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawt030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawt030%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DAlegre-Abarrategui%26aufirst%3DJ.%26aulast%3DWade-Martins%26aufirst%3DR.%26atitle%3DRNA%2520dysfunction%2520and%2520aggrephagy%2520at%2520the%2520centre%2520of%2520an%2520amyotrophic%2520lateral%2520sclerosis%252Ffrontotemporal%2520dementia%2520disease%2520continuum%26jtitle%3DBrain%26date%3D2013%26volume%3D136%26issue%3D5%26spage%3D1345%26epage%3D1360%26doi%3D10.1093%2Fbrain%2Fawt030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goode, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rea, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sultana, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Searle, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layfield, R.</span></span> <span> </span><span class="NLM_article-title">ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling</span>. <i>Mol. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1016/j.mcn.2016.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.mcn.2016.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27554286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVeltbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=52-58&author=A.+Goodeauthor=S.+Reaauthor=M.+Sultanaauthor=B.+Shawauthor=M.+S.+Searleauthor=R.+Layfield&title=ALS-FTLD+associated+mutations+of+SQSTM1+impact+on+Keap1-Nrf2+signalling&doi=10.1016%2Fj.mcn.2016.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling</span></div><div class="casAuthors">Goode, Alice; Rea, Sarah; Sultana, Melanie; Shaw, Barry; Searle, Mark S.; Layfield, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">52-58</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The transcription factor Nrf2 and its repressor protein Keap1 play key roles in the regulation of antioxidant stress responses and both Keap1-Nrf2 signalling and oxidative stress have been implicated in the pathogenesis of the ALS-FTLD spectrum of neurodegenerative disorders.  The Keap1-binding partner and autophagy receptor SQSTM1/p62 has also recently been linked genetically to ALS-FTLD, with some missense mutations identified in patients mapping within or close to its Keap1-interacting region (KIR, residues 347-352).  Here we report the effects on protein function of four different disease assocd. mutations of SQSTM1/p62 which affect the KIR region.  Only mutations mapping precisely to the KIR (P348L and G351A) were assocd. with a loss of Keap1 binding in co-immunopptns. comparable to wild-type SQSTM1/p62.  These selective effects on Keap1 recognition were entirely rational based on protein structural models.  Consistent with impaired Keap1 binding, the P348L and G351A KIR mutants showed reduced ability to activate Nrf2 signalling compared to wild-type SQSTM1/p62 in antioxidant response element (ARE)-luciferase reporter assays.  The results suggest that SQSTM1 mutations within the KIR of SQSTM1/p62 contribute to etiol. of some cases of ALS-FTLD through a mechanism involving aberrant expression or regulation of oxidative response genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2W4RjD3vbDbVg90H21EOLACvtfcHk0lgDkZ0g3epJQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVeltbrE&md5=2dba8b692d85da668b6ab80b78833a59</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2Fj.mcn.2016.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcn.2016.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DGoode%26aufirst%3DA.%26aulast%3DRea%26aufirst%3DS.%26aulast%3DSultana%26aufirst%3DM.%26aulast%3DShaw%26aufirst%3DB.%26aulast%3DSearle%26aufirst%3DM.%2BS.%26aulast%3DLayfield%26aufirst%3DR.%26atitle%3DALS-FTLD%2520associated%2520mutations%2520of%2520SQSTM1%2520impact%2520on%2520Keap1-Nrf2%2520signalling%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2016%26volume%3D76%26spage%3D52%26epage%3D58%26doi%3D10.1016%2Fj.mcn.2016.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarlette, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krampfl, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grothe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhoff, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dengler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petri, S.</span></span> <span> </span><span class="NLM_article-title">Nuclear erythroid 2-related factor 2-antioxidative response element signaling pathway in motor cortex and spinal cord in amyotrophic lateral sclerosis</span>. <i>J. Neuropathol. Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1055</span>– <span class="NLM_lpage">1062</span>, <span class="refDoi"> DOI: 10.1097/NEN.0b013e31818b4906</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1097%2FNEN.0b013e31818b4906" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18957896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVeqtLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2008&pages=1055-1062&issue=11&author=A.+Sarletteauthor=K.+Krampflauthor=C.+Grotheauthor=N.+Neuhoffauthor=R.+Denglerauthor=S.+Petri&title=Nuclear+erythroid+2-related+factor+2-antioxidative+response+element+signaling+pathway+in+motor+cortex+and+spinal+cord+in+amyotrophic+lateral+sclerosis&doi=10.1097%2FNEN.0b013e31818b4906"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear erythroid 2-related factor 2-antioxidative response element signaling pathway in motor cortex and spinal cord in amyotrophic lateral sclerosis</span></div><div class="casAuthors">Sarlette, Alexander; Krampfl, Klaus; Grothe, Claudia; von Neuhoff, Nils; Dengler, Reinhard; Petri, Susanne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuropathology & Experimental Neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1055-1062</span>CODEN:
                <span class="NLM_cas:coden">JNENAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Oxidative stress and inflammation are important pathogenetic mechanisms in amyotrophic lateral sclerosis (ALS).  Nuclear erythroid 2-related factor 2 (Nrf2) is a basic region leucine-zipper transcription factor that binds to the antioxidant response element, thereby regulating the expression of many genes that are involved in cellular antioxidant and anti-inflammatory defense.  Under normal conditions, Nrf2 activation is inhibited by Kelch-like ECH-assocd. protein 1 (Keap1).  We investigated the potential involvement of the Nrf2/antioxidant response element signaling pathway in the selective degeneration of motor neurons in ALS.  Nrf2 and Keap1 expression was analyzed in primary motor cortex and spinal cord postmortem tissue samples from ALS patients and controls by in situ hybridization histochem., quant. real-time polymerase chain reaction, immunohistochem., and Western blot anal.  In ALS samples, there was a redn. of Nrf2 mRNA and protein expression in neurons, whereas Keap1 mRNA expression was increased in the motor cortex.  These results suggest that alterations in this signaling cascade occur in motor neurons in ALS and that they may contribute to chronic motor neuron degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM5tN7GW_yB7Vg90H21EOLACvtfcHk0lgDkZ0g3epJQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVeqtLbL&md5=aa15024d516b888e48107915db34be09</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1097%2FNEN.0b013e31818b4906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FNEN.0b013e31818b4906%26sid%3Dliteratum%253Aachs%26aulast%3DSarlette%26aufirst%3DA.%26aulast%3DKrampfl%26aufirst%3DK.%26aulast%3DGrothe%26aufirst%3DC.%26aulast%3DNeuhoff%26aufirst%3DN.%26aulast%3DDengler%26aufirst%3DR.%26aulast%3DPetri%26aufirst%3DS.%26atitle%3DNuclear%2520erythroid%25202-related%2520factor%25202-antioxidative%2520response%2520element%2520signaling%2520pathway%2520in%2520motor%2520cortex%2520and%2520spinal%2520cord%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D2008%26volume%3D67%26issue%3D11%26spage%3D1055%26epage%3D1062%26doi%3D10.1097%2FNEN.0b013e31818b4906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ning, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, X. R.</span></span> <span> </span><span class="NLM_article-title">Oxidized low-density lipoprotein-induced p62/SQSTM1 accumulation in THP-1-derived macrophages promotes IL-18 secretion and cell death</span>. <i>Exp. Ther. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">5417</span>– <span class="NLM_lpage">5423</span>, <span class="refDoi"> DOI: 10.3892/etm.2017.5221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.3892%2Fetm.2017.5221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=29285070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitV2jsb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=5417-5423&issue=6&author=H.+F.+Ningauthor=D.+Liuauthor=X.+C.+Yuauthor=X.+R.+Guan&title=Oxidized+low-density+lipoprotein-induced+p62%2FSQSTM1+accumulation+in+THP-1-derived+macrophages+promotes+IL-18+secretion+and+cell+death&doi=10.3892%2Fetm.2017.5221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidized low-density lipoprotein-induced p62/SQSTM1 accumulation in THP-1-derived macrophages promotes IL-18 secretion and cell death</span></div><div class="casAuthors">Ning, Haofeng; Liu, Dan; Yu, Xiaochen; Guan, Xiuru</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Therapeutic Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">5417-5423</span>CODEN:
                <span class="NLM_cas:coden">ETMXA2</span>;
        ISSN:<span class="NLM_cas:issn">1792-1015</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Macrophage autophagy has a protective role in the development of atherosclerosis; however, it turns dysfunctional in advanced lesions with an increase in p62/sequestosome-1 protein.  Little is known about the role and significance of p62 accumulation in atherosclerosis.  The present study investigated the assocn. between p62 expression and the process of foam cell formation.  Foam cell models were established through incubation of THP-1-derived macrophages with oxidized low-d. lipoprotein, and the process of foam cell formation was detected by Oil red O staining.  Furthermore, the dynamic change of p62 expression was detected by western blotting and quant. polymerase chain reaction.  Addnl., using gene silencing techniques, the roles of p62 in foam cells were investigated with ELISA, MTT and flow cytometry.  The results indicated that besides serving as a marker of autophagy deficiency, the p62 protein could also mediate inflammation and cytotoxicity in advanced foam cells.  Addnl., the implication of p62 in autophagy inhibition and foam cell formation makes it a key atherogenic factor under autophagy-deficient conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6Fx8df4TqDLVg90H21EOLACvtfcHk0lgskh-dEXOmCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitV2jsb3F&md5=1ad88ded2c113b39222a8ae88e127fa6</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.3892%2Fetm.2017.5221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fetm.2017.5221%26sid%3Dliteratum%253Aachs%26aulast%3DNing%26aufirst%3DH.%2BF.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DX.%2BC.%26aulast%3DGuan%26aufirst%3DX.%2BR.%26atitle%3DOxidized%2520low-density%2520lipoprotein-induced%2520p62%252FSQSTM1%2520accumulation%2520in%2520THP-1-derived%2520macrophages%2520promotes%2520IL-18%2520secretion%2520and%2520cell%2520death%26jtitle%3DExp.%2520Ther.%2520Med.%26date%3D2017%26volume%3D14%26issue%3D6%26spage%3D5417%26epage%3D5423%26doi%3D10.3892%2Fetm.2017.5221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Razani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ting, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virgin, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenkovich, C. F.</span></span> <span> </span><span class="NLM_article-title">Autophagy links inflammasomes to atherosclerotic progression</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">534</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2012.02.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.cmet.2012.02.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22440612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38Xkt1ynurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=534-544&issue=4&author=B.+Razaniauthor=C.+Fengauthor=T.+Colemanauthor=R.+Emanuelauthor=H.+T.+Wenauthor=S.+Hwangauthor=J.+P.+Tingauthor=H.+W.+Virginauthor=M.+B.+Kastanauthor=C.+F.+Semenkovich&title=Autophagy+links+inflammasomes+to+atherosclerotic+progression&doi=10.1016%2Fj.cmet.2012.02.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy Links Inflammasomes to Atherosclerotic Progression</span></div><div class="casAuthors">Razani, Babak; Feng, Chu; Coleman, Trey; Emanuel, Roy; Wen, Haitao; Hwang, Seungmin; Ting, Jenny P.; Virgin, Herbert W.; Kastan, Michael B.; Semenkovich, Clay F.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">534-544</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">We investigated the role of autophagy in atherosclerosis.  During plaque formation in mice, autophagic markers colocalized predominantly with macrophages (m.vphi.).  Atherosclerotic aortas had elevated levels of p62, suggesting that dysfunctional autophagy is characteristic of plaques.  To det. whether autophagy directly influences atherogenesis, we characterized Beclin-1 heterozygous-null and m.vphi.-specific ATG5-null (ATG5-m.vphi.KO) mice, commonly used models of autophagy haploinsufficiency and deficiency, resp.  Haploinsufficent Beclin-1 mice had no atherosclerotic phenotype, but ATG5-m.vphi.KO mice had increased plaques, suggesting an essential role for basal levels of autophagy in atheroprotection.  Defective autophagy is assocd. with proatherogenic inflammasome activation.  Classic inflammasome markers were robustly induced in ATG5-null m.vphi., esp. when coincubated with cholesterol crystals.  Moreover, cholesterol crystals appear to be increased in ATG5-m.vphi.KO plaques, suggesting a potentially vicious cycle of crystal formation and inflammasome activation in autophagy-deficient plaques.  These results show that autophagy becomes dysfunctional in atherosclerosis and its deficiency promotes atherosclerosis in part through inflammasome hyperactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_L9XEDatPTrVg90H21EOLACvtfcHk0lgskh-dEXOmCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xkt1ynurc%253D&md5=605c29c85e01000b894ea8bcecb428ff</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2012.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2012.02.011%26sid%3Dliteratum%253Aachs%26aulast%3DRazani%26aufirst%3DB.%26aulast%3DFeng%26aufirst%3DC.%26aulast%3DColeman%26aufirst%3DT.%26aulast%3DEmanuel%26aufirst%3DR.%26aulast%3DWen%26aufirst%3DH.%2BT.%26aulast%3DHwang%26aufirst%3DS.%26aulast%3DTing%26aufirst%3DJ.%2BP.%26aulast%3DVirgin%26aufirst%3DH.%2BW.%26aulast%3DKastan%26aufirst%3DM.%2BB.%26aulast%3DSemenkovich%26aufirst%3DC.%2BF.%26atitle%3DAutophagy%2520links%2520inflammasomes%2520to%2520atherosclerotic%2520progression%26jtitle%3DCell%2520Metab.%26date%3D2012%26volume%3D15%26issue%3D4%26spage%3D534%26epage%3D544%26doi%3D10.1016%2Fj.cmet.2012.02.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span> <span> </span><span class="NLM_article-title">Green tea polyphenol treatment attenuates atherosclerosis in high-fat diet-fed apolipoprotein E-knockout mice via alleviating dyslipidemia and up-regulating autophagy</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">e0181666</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0181666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1371%2Fjournal.pone.0181666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=28777810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1cXps1GgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0181666&issue=8&author=S.+Dingauthor=J.+Jiangauthor=P.+Yuauthor=G.+Zhangauthor=G.+Zhangauthor=X.+Liu&title=Green+tea+polyphenol+treatment+attenuates+atherosclerosis+in+high-fat+diet-fed+apolipoprotein+E-knockout+mice+via+alleviating+dyslipidemia+and+up-regulating+autophagy&doi=10.1371%2Fjournal.pone.0181666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Green tea polyphenol treatment attenuates atherosclerosis in high-fat diet-fed apolipoprotein E-knockout mice via alleviating dyslipidemia and up-regulating autophagy</span></div><div class="casAuthors">Ding, Shibin; Jiang, Jinjin; Yu, Pengxin; Zhang, Guofu; Zhang, Guanghui; Liu, Xiaoting</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e0181666/1-e0181666/18</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Green tea polyphenol (GTP) is a polyphenol source from green tea that has drawn wide attention owing to epidemiol. evidence of its beneficial effects in the prevention of cardiovascular disease; the underlying mol. mechanisms of these effects are not well understood.  This study aimed to investigate the effects of GTP treatment on autophagy regulation in the vessel wall and lipid metab. of HFD-fed male ApoE-knockout mice.  Methods: Adult male ApoE-knockout mice (n = 30) fed with a high-fat diet (HFD) were treated with either vehicle or GTP (3.2 or 6.4 g/L) administered via drinking water for 15 wk, and C57BL/6J mice fed with std. chow diet (STD) were used as the control group.  Metabolic parameters, expression of key mRNAs and proteins of hepatic lipid metab. and autophagy in the vessel wall of mice were detd. after the 15-wk treatment.  Results: A HFD induced atherosclerosis formation and lipid metab. disorders as well as reduced autophagy expression in the vessel wall of ApoE-knockout mice, but GTP treatment alleviated the lipid metab. disorders, decreased the oxLDL levels in serum, and increased the mRNA and protein expressions of hepatic PPARa and autophagy markers (LC3, Beclin1 and p62) in the vessel wall of ApoE-knockout mice.  Conclusions: Our findings suggest that GTP supplementation showed marked suppression of atherogenesis through improved lipid metab. as well as through a direct impact on oxLDL and autophagy flux in the vessel wall.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUsHEVkvw0uLVg90H21EOLACvtfcHk0lgskh-dEXOmCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXps1GgsQ%253D%253D&md5=428489c6aef52110f077cb1184652cd1</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0181666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0181666%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DGreen%2520tea%2520polyphenol%2520treatment%2520attenuates%2520atherosclerosis%2520in%2520high-fat%2520diet-fed%2520apolipoprotein%2520E-knockout%2520mice%2520via%2520alleviating%2520dyslipidemia%2520and%2520up-regulating%2520autophagy%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26issue%3D8%26spage%3De0181666%26doi%3D10.1371%2Fjournal.pone.0181666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bravo-San Pedro, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span> <span> </span><span class="NLM_article-title">Autophagy and mitophagy in cardiovascular disease</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>120</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1812</span>– <span class="NLM_lpage">1824</span>, <span class="refDoi"> DOI: 10.1161/CIRCRESAHA.117.311082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1161%2FCIRCRESAHA.117.311082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=28546358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotlOku74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2017&pages=1812-1824&issue=11&author=J.+M.+Bravo-San+Pedroauthor=G.+Kroemerauthor=L.+Galluzzi&title=Autophagy+and+mitophagy+in+cardiovascular+disease&doi=10.1161%2FCIRCRESAHA.117.311082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy and Mitophagy in Cardiovascular Disease</span></div><div class="casAuthors">Bravo-San Pedro, Jose Manuel; Kroemer, Guido; Galluzzi, Lorenzo</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1812-1824</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Autophagy contributes to the maintenance of intracellular homeostasis in most cells of cardiovascular origin, including cardiomyocytes, endothelial cells, and arterial smooth muscle cells.  Mitophagy is an autophagic response that specifically targets damaged, and hence potentially cytotoxic, mitochondria.  As these organelles occupy a crit. position in the bioenergetics of the cardiovascular system, mitophagy is particularly important for cardiovascular homeostasis in health and disease.  Consistent with this notion, genetic defects in autophagy or mitophagy have been shown to exacerbate the propensity of lab. animals to spontaneously develop cardiodegenerative disorders.  Moreover, pharmacol. or genetic maneuvers that alter the autophagic or mitophagic flux have been shown to influence disease outcome in rodent models of several cardiovascular conditions, such as myocardial infarction, various types of cardiomyopathy, and atherosclerosis.  In this review, we discuss the intimate connection between autophagy, mitophagy, and cardiovascular disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDOFBCqUaNi7Vg90H21EOLACvtfcHk0lg7RCzfyKnu9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotlOku74%253D&md5=f8dda092f990b5e9163c6e04688def9f</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.117.311082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.117.311082%26sid%3Dliteratum%253Aachs%26aulast%3DBravo-San%2BPedro%26aufirst%3DJ.%2BM.%26aulast%3DKroemer%26aufirst%3DG.%26aulast%3DGalluzzi%26aufirst%3DL.%26atitle%3DAutophagy%2520and%2520mitophagy%2520in%2520cardiovascular%2520disease%26jtitle%3DCirc.%2520Res.%26date%3D2017%26volume%3D120%26issue%3D11%26spage%3D1812%26epage%3D1824%26doi%3D10.1161%2FCIRCRESAHA.117.311082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sergin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokes, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehestani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micevych, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javaheri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballabio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epelman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weihl, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diwan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zayed, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Razani, B.</span></span> <span> </span><span class="NLM_article-title">Exploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">15750</span>, <span class="refDoi"> DOI: 10.1038/ncomms15750</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fncomms15750" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=28589926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpsVCltbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=15750&author=I.+Serginauthor=T.+D.+Evansauthor=X.+Y.+Zhangauthor=S.+Bhattacharyaauthor=C.+J.+Stokesauthor=E.+Songauthor=S.+Aliauthor=B.+Dehestaniauthor=K.+B.+Hollowayauthor=P.+S.+Micevychauthor=A.+Javaheriauthor=J.+R.+Crowleyauthor=A.+Ballabioauthor=J.+D.+Schillingauthor=S.+Epelmanauthor=C.+C.+Weihlauthor=A.+Diwanauthor=D.+P.+Fanauthor=M.+A.+Zayedauthor=B.+Razani&title=Exploiting+macrophage+autophagy-lysosomal+biogenesis+as+a+therapy+for+atherosclerosis&doi=10.1038%2Fncomms15750"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis</span></div><div class="casAuthors">Sergin, Ismail; Evans, Trent D.; Zhang, Xiangyu; Bhattacharya, Somashubhra; Stokes, Carl J.; Song, Eric; Ali, Sahl; Dehestani, Babak; Holloway, Karyn B.; Micevych, Paul S.; Javaheri, Ali; Crowley, Jan R.; Ballabio, Andrea; Schilling, Joel D.; Epelman, Slava; Weihl, Conrad C.; Diwan, Abhinav; Fan, Daping; Zayed, Mohamed A.; Razani, Babak</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15750</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Macrophages specialize in removing lipids and debris present in the atherosclerotic plaque.  However, plaque progression renders macrophages unable to degrade exogenous atherogenic material and endogenous cargo including dysfunctional proteins and organelles.  Here we show that a decline in the autophagy-lysosome system contributes to this as evidenced by a derangement in key autophagy markers in both mouse and human atherosclerotic plaques.  By augmenting macrophage TFEB, the master transcriptional regulator of autophagy-lysosomal biogenesis, we can reverse the autophagy dysfunction of plaques, enhance aggrephagy of p62-enriched protein aggregates and blunt macrophage apoptosis and pro-inflammatory IL-1β levels, leading to reduced atherosclerosis.  In order to harness this degradative response therapeutically, we also describe a natural sugar called trehalose as an inducer of macrophage autophagy-lysosomal biogenesis and show trehalose's ability to recapitulate the atheroprotective properties of macrophage TFEB overexpression.  Our data support this practical method of enhancing the degradative capacity of macrophages as a therapy for atherosclerotic vascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGy35mHMN5J7Vg90H21EOLACvtfcHk0lg7RCzfyKnu9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpsVCltbc%253D&md5=68f279a21821f7abb8fd7688061f84c2</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1038%2Fncomms15750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms15750%26sid%3Dliteratum%253Aachs%26aulast%3DSergin%26aufirst%3DI.%26aulast%3DEvans%26aufirst%3DT.%2BD.%26aulast%3DZhang%26aufirst%3DX.%2BY.%26aulast%3DBhattacharya%26aufirst%3DS.%26aulast%3DStokes%26aufirst%3DC.%2BJ.%26aulast%3DSong%26aufirst%3DE.%26aulast%3DAli%26aufirst%3DS.%26aulast%3DDehestani%26aufirst%3DB.%26aulast%3DHolloway%26aufirst%3DK.%2BB.%26aulast%3DMicevych%26aufirst%3DP.%2BS.%26aulast%3DJavaheri%26aufirst%3DA.%26aulast%3DCrowley%26aufirst%3DJ.%2BR.%26aulast%3DBallabio%26aufirst%3DA.%26aulast%3DSchilling%26aufirst%3DJ.%2BD.%26aulast%3DEpelman%26aufirst%3DS.%26aulast%3DWeihl%26aufirst%3DC.%2BC.%26aulast%3DDiwan%26aufirst%3DA.%26aulast%3DFan%26aufirst%3DD.%2BP.%26aulast%3DZayed%26aufirst%3DM.%2BA.%26aulast%3DRazani%26aufirst%3DB.%26atitle%3DExploiting%2520macrophage%2520autophagy-lysosomal%2520biogenesis%2520as%2520a%2520therapy%2520for%2520atherosclerosis%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D15750%26doi%3D10.1038%2Fncomms15750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Settembre, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Malta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polito, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Arencibia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetrini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdin, S. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huynh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colella, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sardiello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinsztein, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballabio, A.</span></span> <span> </span><span class="NLM_article-title">TFEB links autophagy to lysosomal biogenesis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>332</i></span> (<span class="NLM_issue">6036</span>),  <span class="NLM_fpage">1429</span>– <span class="NLM_lpage">1433</span>, <span class="refDoi"> DOI: 10.1126/science.1204592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1126%2Fscience.1204592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21617040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntlOltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2011&pages=1429-1433&issue=6036&author=C.+Settembreauthor=C.+Di+Maltaauthor=V.+A.+Politoauthor=M.+Garcia-Arencibiaauthor=F.+Vetriniauthor=S.+Erdinauthor=S.+U.+Erdinauthor=T.+Huynhauthor=D.+Medinaauthor=P.+Colellaauthor=M.+Sardielloauthor=D.+C.+Rubinszteinauthor=A.+Ballabio&title=TFEB+links+autophagy+to+lysosomal+biogenesis&doi=10.1126%2Fscience.1204592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">TFEB Links Autophagy to Lysosomal Biogenesis</span></div><div class="casAuthors">Settembre, Carmine; Di Malta, Chiara; Polito, Vinicia Assunta; Arencibia, Moises Garcia; Vetrini, Francesco; Erdin, Serkan; Erdin, Serpil Uckac; Huynh, Tuong; Medina, Diego; Colella, Pasqualina; Sardiello, Marco; Rubinsztein, David C.; Ballabio, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">6036</span>),
    <span class="NLM_cas:pages">1429-1433</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Autophagy is a cellular catabolic process that relies on the cooperation of autophagosomes and lysosomes.  During starvation, the cell expands both compartments to enhance degrdn. processes.  We found that starvation activates a transcriptional program that controls major steps of the autophagic pathway, including autophagosome formation, autophagosome-lysosome fusion, and substrate degrdn.  The transcription factor EB (TFEB), a master gene for lysosomal biogenesis, coordinated this program by driving expression of autophagy and lysosomal genes.  Nuclear localization and activity of TFEB were regulated by serine phosphorylation mediated by the extracellular signal-regulated kinase 2, whose activity was tuned by the levels of extracellular nutrients.  Thus, a mitogen-activated protein kinase-dependent mechanism regulates autophagy by controlling the biogenesis and partnership of two distinct cellular organelles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAFC-etIDsorVg90H21EOLACvtfcHk0lgV9dk8C4IPcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntlOltLw%253D&md5=ee36a38543a0f2fd156f6ba49d81fc04</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1126%2Fscience.1204592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1204592%26sid%3Dliteratum%253Aachs%26aulast%3DSettembre%26aufirst%3DC.%26aulast%3DDi%2BMalta%26aufirst%3DC.%26aulast%3DPolito%26aufirst%3DV.%2BA.%26aulast%3DGarcia-Arencibia%26aufirst%3DM.%26aulast%3DVetrini%26aufirst%3DF.%26aulast%3DErdin%26aufirst%3DS.%26aulast%3DErdin%26aufirst%3DS.%2BU.%26aulast%3DHuynh%26aufirst%3DT.%26aulast%3DMedina%26aufirst%3DD.%26aulast%3DColella%26aufirst%3DP.%26aulast%3DSardiello%26aufirst%3DM.%26aulast%3DRubinsztein%26aufirst%3DD.%2BC.%26aulast%3DBallabio%26aufirst%3DA.%26atitle%3DTFEB%2520links%2520autophagy%2520to%2520lysosomal%2520biogenesis%26jtitle%3DScience%26date%3D2011%26volume%3D332%26issue%3D6036%26spage%3D1429%26epage%3D1433%26doi%3D10.1126%2Fscience.1204592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sergin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Razani, B.</span></span> <span> </span><span class="NLM_article-title">TFEB and trehalose drive the macrophage autophagy-lysosome system to protect against atherosclerosis</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">724</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1080/15548627.2018.1434373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1080%2F15548627.2018.1434373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=29394113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1cXks1Khur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=724-726&issue=4&author=T.+D.+Evansauthor=S.+J.+Jeongauthor=X.+Y.+Zhangauthor=I.+Serginauthor=B.+Razani&title=TFEB+and+trehalose+drive+the+macrophage+autophagy-lysosome+system+to+protect+against+atherosclerosis&doi=10.1080%2F15548627.2018.1434373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">TFEB and trehalose drive the macrophage autophagy-lysosome system to protect against atherosclerosis</span></div><div class="casAuthors">Evans, Trent D.; Jeong, Se-Jin; Zhang, Xiangyu; Sergin, Ismail; Razani, Babak</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">724-726</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8635</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">In the atherosclerotic plaque, macrophages are the key catabolic workhorse responsible for clearing lipid and dead cell debris.  To survive the highly proinflammatory and lipotoxic plaque environment, macrophages must adopt strategies for maintaining tight homeostasis and self-renewal.  Macroautophagy/autophagy is a pro-survival cellular pathway wherein damaged or excess cellular cargoes are encapsulated by a double-membrane compartment and delivered to the lysosome for hydrolysis.  Previously, macrophage-specific autophagy deficiency has been shown to be atherogenic through several complementary mechanisms including hyperactivation of the inflammasome, defective efferocytosis, accumulation of cytotoxic protein aggregates, and impaired lipid degrdn.  Conversely, in a recent study we hypothesized that enhancing the macrophage autophagy-lysosomal system through genetic or pharmacol. means could protect against atherosclerosis.  We demonstrated that TFEB, a transcription factor master regulator of autophagy and lysosome biogenesis, coordinately enhances the function of this system to reduce atherosclerotic plaque burden.  Further, we characterized the disaccharide trehalose as a novel inducer of TFEB with similar atheroprotective effects.  Overall, these findings mechanistically interrogate the importance and therapeutic promise of a functional autophagy-lysosome degrdn. system in plaque macrophage biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOmCFOsPwqEbVg90H21EOLACvtfcHk0lgV9dk8C4IPcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXks1Khur0%253D&md5=144ab8c714b1d83bc8595ccf96bb907e</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1080%2F15548627.2018.1434373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15548627.2018.1434373%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DT.%2BD.%26aulast%3DJeong%26aufirst%3DS.%2BJ.%26aulast%3DZhang%26aufirst%3DX.%2BY.%26aulast%3DSergin%26aufirst%3DI.%26aulast%3DRazani%26aufirst%3DB.%26atitle%3DTFEB%2520and%2520trehalose%2520drive%2520the%2520macrophage%2520autophagy-lysosome%2520system%2520to%2520protect%2520against%2520atherosclerosis%26jtitle%3DAutophagy%26date%3D2018%26volume%3D14%26issue%3D4%26spage%3D724%26epage%3D726%26doi%3D10.1080%2F15548627.2018.1434373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L. F.</span></span> <span> </span><span class="NLM_article-title">mTOR enhances foam cell formation by suppressing the autophagy pathway</span>. <i>DNA Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">198</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1089/dna.2013.2164</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1089%2Fdna.2013.2164" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=24512183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltVSlsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=198-204&issue=4&author=X.+C.+Wangauthor=L.+X.+Liauthor=X.+L.+Niuauthor=X.+Y.+Dangauthor=P.+Liauthor=L.+Quauthor=X.+J.+Biauthor=Y.+X.+Gaoauthor=Y.+F.+Huauthor=M.+X.+Liauthor=W.+H.+Qiaoauthor=Z.+Pengauthor=L.+F.+Pan&title=mTOR+enhances+foam+cell+formation+by+suppressing+the+autophagy+pathway&doi=10.1089%2Fdna.2013.2164"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">mTOR enhances foam cell formation by suppressing the autophagy pathway</span></div><div class="casAuthors">Wang, Xiaochuang; Li, Lingxia; Niu, Xiaolin; Dang, Xiaoyan; Li, Ping; Qu, Li; Bi, Xiaoju; Gao, Yanxia; Hu, Yanfen; Li, Manxiang; Qiao, Wanhai; Peng, Zhuo; Pan, Longfei</div><div class="citationInfo"><span class="NLM_cas:title">DNA and Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">198-204</span>CODEN:
                <span class="NLM_cas:coden">DCEBE8</span>;
        ISSN:<span class="NLM_cas:issn">1044-5498</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Recently, autophagy has drawn more attention in cardiovascular disease as it has important roles in lipid metab.  Mammalian target of rapamycin (mTOR) is a key regulator of autophagy; however, its effect on atherosclerosis and the underlying mechanism remains undefined.  In this study, an obvious upregulation of mTOR and p-mTOR protein was obsd. in macrophage-derived foam cells.  Blocking mTOR expression with specific small interference RNA (siRNA) dramatically suppressed foam cell formation, accompanied by a decrease of lipid deposition.  Further mechanistic anal. indicated that suppressing mTOR expression significantly upregulated autophagic marker LC3 expression and downregulated autophagy substrate p62 levels, indicating that mTOR silencing triggered autophagosome formation.  Moreover, blocking mTOR expression obviously accelerated neutral lipid delivery to lysosome and cholesterol efflux from foam cells, implying that mTOR could induce macrophage foam cell formation by suppressing autophagic pathway.  Further, mTOR silencing significantly upregulated ULK1 expression, which was accounted for mTOR-induced foam cell formation via autophagic pathway as treatment with ULK1 siRNA dampened LC3-II levels and increased p62 expression, concomitant with lipid accumulation and decreased cholesterol efflux from foam cells.  Together, our data provide an insight into how mTOR accelerates the pathol. process of atherosclerosis.  Accordingly, blocking mTOR levels may be a promising therapeutic agent against atherosclerotic complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo31-E62U1vhLVg90H21EOLACvtfcHk0lg5se3Bv97YDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltVSlsro%253D&md5=b10be0dca1b74a0469570e026731c498</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1089%2Fdna.2013.2164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fdna.2013.2164%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BC.%26aulast%3DLi%26aufirst%3DL.%2BX.%26aulast%3DNiu%26aufirst%3DX.%2BL.%26aulast%3DDang%26aufirst%3DX.%2BY.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DQu%26aufirst%3DL.%26aulast%3DBi%26aufirst%3DX.%2BJ.%26aulast%3DGao%26aufirst%3DY.%2BX.%26aulast%3DHu%26aufirst%3DY.%2BF.%26aulast%3DLi%26aufirst%3DM.%2BX.%26aulast%3DQiao%26aufirst%3DW.%2BH.%26aulast%3DPeng%26aufirst%3DZ.%26aulast%3DPan%26aufirst%3DL.%2BF.%26atitle%3DmTOR%2520enhances%2520foam%2520cell%2520formation%2520by%2520suppressing%2520the%2520autophagy%2520pathway%26jtitle%3DDNA%2520Cell%2520Biol.%26date%3D2014%26volume%3D33%26issue%3D4%26spage%3D198%26epage%3D204%26doi%3D10.1089%2Fdna.2013.2164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yancey, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerome, W. G.</span></span> <span> </span><span class="NLM_article-title">Lysosomal sequestration of free and esterified cholesterol from oxidized low density lipoprotein in macrophages of different species</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1349</span>– <span class="NLM_lpage">1361</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=9684737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADyaK1cXkslOqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=1349-1361&issue=7&author=P.+G.+Yanceyauthor=W.+G.+Jerome&title=Lysosomal+sequestration+of+free+and+esterified+cholesterol+from+oxidized+low+density+lipoprotein+in+macrophages+of+different+species"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomal sequestration of free and esterified cholesterol from oxidized low density lipoprotein in macrophages of different species</span></div><div class="casAuthors">Yancey, Patricia G.; Jerome, W. Gray</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1349-1361</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">Lipid Research, Inc.</span>)
        </div><div class="casAbstract">Macrophage foam cells of atherosclerotic lesions store lipid in lysosomes and cytoplasmic inclusions.  Oxidized low d. lipoprotein (oxLDL) has been proposed to be the atherogenic particle responsible for the free and esterified cholesterol stores in macrophages.  Currently, however, there is a paucity of data showing that oxLDL can induce much cholesterol accumulation in cells.  The present studies compare the ability of mildly oxLDL (TBARS = 5 to 10 nmols/mg LDL protein) with acetylated LDL (acLDL) to induce free cholesterol (FC) and esterified cholesterol (EC) accumulation in pigeon, THP-1, and mouse macrophages.  Mildly oxLDL stimulated high levels of loading comparable to acLDL where the cellular cholesterol concns. ranged from 160 to 420 μg/mg cell protein with EC accounting for 52-80% of the cholesterol.  Pigeon and THP-1 macrophages stored most (60-90%) of oxLDL cholesterol (both FC and EC) in lysosomes, and the bulk (64-88%) of acLDL cholesterol in cytoplasmic inclusions.  Consistent with lysosomal accumulation, cholesterol esterification was 75% less in THP-1 macrophages enriched with oxLDL cholesterol compared with acLDL.  Furthermore, addn. of an acyl-CoA:cholesterol acyltransferase inhibitor did not significantly affect either cholesterol loading or the percent distribution of FC and EC in THP-1 and pigeon cells incubated with oxLDL.  Surprisingly, mouse macrophages stored most of oxLDL (71%) and acLDL (83%) cholesterol within cytoplasmic inclusions.  Also, in mouse macrophages, esterification paralleled cholesterol loading, and was 3-fold more in oxLDL treated cells compared with acLDL treated cells.  Inhibition of ACAT led to a 62% and 90% redn. in the %EC in oxLDL and acLDL treated mouse macrophages, resp.  The results demonstrate that mildly oxidized low d. lipoprotein (oxLDL) stimulates macrophage foam cell formation and lipid engorgement of lysosomes.  However, the fate of oxLDL cholesterol markedly differs in macrophages of different species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGGYIi9_eGOrVg90H21EOLACvtfcHk0lg5se3Bv97YDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkslOqtLY%253D&md5=9a4bd00b731395b8aa2d3c35c0a480c3</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYancey%26aufirst%3DP.%2BG.%26aulast%3DJerome%26aufirst%3DW.%2BG.%26atitle%3DLysosomal%2520sequestration%2520of%2520free%2520and%2520esterified%2520cholesterol%2520from%2520oxidized%2520low%2520density%2520lipoprotein%2520in%2520macrophages%2520of%2520different%2520species%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D1998%26volume%3D39%26issue%3D7%26spage%3D1349%26epage%3D1361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adamik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silbermann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roodman, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galson, D. L.</span></span> <span> </span><span class="NLM_article-title">XRK3F2 inhibition of p62-ZZ domain signaling rescues myeloma-induced GFI1-driven epigenetic repression of the Runx2 gene in pre-osteoblasts to overcome differentiation suppression</span>. <i>Front. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">344</span>, <span class="refDoi"> DOI: 10.3389/fendo.2018.00344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.3389%2Ffendo.2018.00344" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=30008697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252Fot1Ggsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=344&author=J.+Adamikauthor=R.+Silbermannauthor=S.+Marinoauthor=Q.+Sunauthor=J.+L.+Andersonauthor=D.+Zhouauthor=X.+Q.+Xieauthor=G.+D.+Roodmanauthor=D.+L.+Galson&title=XRK3F2+inhibition+of+p62-ZZ+domain+signaling+rescues+myeloma-induced+GFI1-driven+epigenetic+repression+of+the+Runx2+gene+in+pre-osteoblasts+to+overcome+differentiation+suppression&doi=10.3389%2Ffendo.2018.00344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">XRK3F2 Inhibition of p62-ZZ Domain Signaling Rescues Myeloma-Induced GFI1-Driven Epigenetic Repression of the Runx2 Gene in Pre-osteoblasts to Overcome Differentiation Suppression</span></div><div class="casAuthors">Adamik Juraj; Sun Quanhong; Galson Deborah L; Silbermann Rebecca; Marino Silvia; Anderson Judith L; Zhou Dan; Roodman G David; Silbermann Rebecca; Xie Xiang-Qun; Roodman G David</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in endocrinology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">344</span>
        ISSN:<span class="NLM_cas:issn">1664-2392</span>.
    </div><div class="casAbstract">Multiple myeloma bone disease (MMBD) is characterized by non-healing lytic bone lesions that persist even after a patient has achieved a hematologic remission.  We previously reported that p62 (sequestosome-1) in bone marrow stromal cells (BMSC) is critical for the formation of MM-induced signaling complexes that mediate OB suppression.  Importantly, XRK3F2, an inhibitor of the p62-ZZ domain, blunted MM-induced Runx2 suppression in vitro, and induced new bone formation and remodeling in the presence of tumor in vivo.  Additionally, we reported that MM cells induce the formation of repressive chromatin on the Runx2 gene in BMSC via direct binding of the transcriptional repressor GFI1, which recruits the histone modifiers, histone deacetylase 1 (HDAC1) and Enhancer of zeste homolog 2 (EZH2).  In this study we investigated the mechanism by which blocking p62-ZZ domain-dependent signaling prevents MM-induced suppression of Runx2 in BMSC.  XRK3F2 prevented MM-induced upregulation of Gfi1 and repression of the Runx2 gene when present in MM-preOB co-cultures.  We also show that p62-ZZ-domain blocking by XRK3F2 also prevented MM conditioned media and TNF plus IL7-mediated Gfi1 mRNA upregulation and the concomitant Runx2 repression, indicating that XRK3F2's prevention of p62-ZZ domain signaling within preOB is involved in the response.  Chromatin immunoprecipitation (ChIP) analyses revealed that XRK3F2 decreased MM-induced GFI1 occupancy at the Runx2-P1 promoter and prevented recruitment of HDAC1, thus preserving the transcriptionally permissive chromatin mark H3K9ac on Runx2 and allowing osteogenic differentiation.  Furthermore, treatment of MM-exposed preOB with XRK3F2 after MM removal decreased GFI1 enrichment at Runx2-P1 and rescued MM-induced suppression of Runx2 mRNA and its downstream osteogenic gene targets together with increased osteogenic differentiation.  Further, primary BMSC (hBMSC) from MM patients (MM-hBMSC) had little ability to increase H3K9ac on the Runx2 promoter in osteogenic conditions when compared to hBMSC from healthy donors (HD).  XRK3F2 treatment enriched Runx2 gene H3K9ac levels in MM-hBMSC to the level observed in HD-hBMSC, but did not alter HD-hBMSC H3K9ac.  Importantly, XRK3F2 treatment of long-term MM-hBMSC cultures rescued osteogenic differentiation and mineralization.  Our data show that blocking p62-ZZ domain-dependent signaling with XRK3F2 can reverse epigenetic-based mechanisms of MM-induced Runx2 suppression and promote osteogenic differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRGlHTC1_71lyA3UY9EwTNrfW6udTcc2ebAFHAPjO6Jkrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252Fot1Ggsg%253D%253D&md5=f1463cc7140b5b7ac5400a676e902e14</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.3389%2Ffendo.2018.00344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffendo.2018.00344%26sid%3Dliteratum%253Aachs%26aulast%3DAdamik%26aufirst%3DJ.%26aulast%3DSilbermann%26aufirst%3DR.%26aulast%3DMarino%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DAnderson%26aufirst%3DJ.%2BL.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DXie%26aufirst%3DX.%2BQ.%26aulast%3DRoodman%26aufirst%3DG.%2BD.%26aulast%3DGalson%26aufirst%3DD.%2BL.%26atitle%3DXRK3F2%2520inhibition%2520of%2520p62-ZZ%2520domain%2520signaling%2520rescues%2520myeloma-induced%2520GFI1-driven%2520epigenetic%2520repression%2520of%2520the%2520Runx2%2520gene%2520in%2520pre-osteoblasts%2520to%2520overcome%2520differentiation%2520suppression%26jtitle%3DFront.%2520Endocrinol.%26date%3D2018%26volume%3D9%26spage%3D344%26doi%3D10.3389%2Ffendo.2018.00344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouchiroud, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreux, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsyuba, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moullan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolet-dit-Felix, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jha, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo Sasso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huzard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aebischer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rinsch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auwerx, J.</span></span> <span> </span><span class="NLM_article-title">Urolithin A induces mitophagy and prolongs lifespan in C-elegans and increases muscle function in rodents</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">879</span>– <span class="NLM_lpage">888</span>, <span class="refDoi"> DOI: 10.1038/nm.4132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fnm.4132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27400265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Klsr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=879-888&issue=8&author=D.+Ryuauthor=L.+Mouchiroudauthor=P.+A.+Andreuxauthor=E.+Katsyubaauthor=N.+Moullanauthor=A.+A.+Nicolet-dit-Felixauthor=E.+G.+Williamsauthor=P.+Jhaauthor=G.+Lo+Sassoauthor=D.+Huzardauthor=P.+Aebischerauthor=C.+Sandiauthor=C.+Rinschauthor=J.+Auwerx&title=Urolithin+A+induces+mitophagy+and+prolongs+lifespan+in+C-elegans+and+increases+muscle+function+in+rodents&doi=10.1038%2Fnm.4132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents</span></div><div class="casAuthors">Ryu, Dongryeol; Mouchiroud, Laurent; Andreux, Penelope A.; Katsyuba, Elena; Moullan, Norman; Nicolet-dit-Felix, Amandine A.; Williams, Evan G.; Jha, Pooja; Lo Sasso, Giuseppe; Huzard, Damien; Aebischer, Patrick; Sandi, Carmen; Rinsch, Chris; Auwerx, Johan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">879-888</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The biol. effects of urolithins remain poorly characterized, despite wide-spread human exposure via the dietary consumption of their metabolic precursors, the ellagitannins, which are found in the pomegranate fruit, as well as in nuts and berries.  We identified urolithin A (UA) as a first-in-class natural compd. that induces mitophagy both in vitro and in vivo following oral consumption.  In C. elegans, UA prevented the accumulation of dysfunctional mitochondria with age and extended lifespan.  Likewise, UA prolonged normal activity during aging in C. elegans, including mobility and pharyngeal pumping, while maintaining mitochondrial respiratory capacity.  These effects translated to rodents, where UA improved exercise capacity in two different mouse models of age-related decline of muscle function, as well as in young rats.  Our findings highlight the health benefits of urolithin A and its potential application in strategies to improve mitochondrial and muscle function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcwLkJYGaEsbVg90H21EOLACvtfcHk0li1WNIB8rMAKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Klsr7F&md5=d74556b7cf4106974fff66f9508d39c0</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1038%2Fnm.4132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4132%26sid%3Dliteratum%253Aachs%26aulast%3DRyu%26aufirst%3DD.%26aulast%3DMouchiroud%26aufirst%3DL.%26aulast%3DAndreux%26aufirst%3DP.%2BA.%26aulast%3DKatsyuba%26aufirst%3DE.%26aulast%3DMoullan%26aufirst%3DN.%26aulast%3DNicolet-dit-Felix%26aufirst%3DA.%2BA.%26aulast%3DWilliams%26aufirst%3DE.%2BG.%26aulast%3DJha%26aufirst%3DP.%26aulast%3DLo%2BSasso%26aufirst%3DG.%26aulast%3DHuzard%26aufirst%3DD.%26aulast%3DAebischer%26aufirst%3DP.%26aulast%3DSandi%26aufirst%3DC.%26aulast%3DRinsch%26aufirst%3DC.%26aulast%3DAuwerx%26aufirst%3DJ.%26atitle%3DUrolithin%2520A%2520induces%2520mitophagy%2520and%2520prolongs%2520lifespan%2520in%2520C-elegans%2520and%2520increases%2520muscle%2520function%2520in%2520rodents%26jtitle%3DNat.%2520Med.%26date%3D2016%26volume%3D22%26issue%3D8%26spage%3D879%26epage%3D888%26doi%3D10.1038%2Fnm.4132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morselli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennetzen, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Megalou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benit, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rustin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Criollo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepp, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malik, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiuri, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horio, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Otin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavernarakis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madeo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span> <span> </span><span class="NLM_article-title">Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>192</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">615</span>– <span class="NLM_lpage">629</span>, <span class="refDoi"> DOI: 10.1083/jcb.201008167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1083%2Fjcb.201008167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21339330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXislGjs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2011&pages=615-629&issue=4&author=E.+Morselliauthor=G.+Marinoauthor=M.+V.+Bennetzenauthor=T.+Eisenbergauthor=E.+Megalouauthor=S.+Schroederauthor=S.+Cabreraauthor=P.+Benitauthor=P.+Rustinauthor=A.+Criolloauthor=O.+Keppauthor=L.+Galluzziauthor=S.+S.+Shenauthor=S.+A.+Malikauthor=M.+C.+Maiuriauthor=Y.+Horioauthor=C.+Lopez-Otinauthor=J.+S.+Andersenauthor=N.+Tavernarakisauthor=F.+Madeoauthor=G.+Kroemer&title=Spermidine+and+resveratrol+induce+autophagy+by+distinct+pathways+converging+on+the+acetylproteome&doi=10.1083%2Fjcb.201008167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome</span></div><div class="casAuthors">Morselli, Eugenia; Marino, Guillermo; Bennetzen, Martin V.; Eisenberg, Tobias; Megalou, Evgenia; Schroeder, Sabrina; Cabrera, Sandra; Benit, Paule; Rustin, Pierre; Criollo, Alfredo; Kepp, Oliver; Galluzzi, Lorenzo; Shen, Shensi; Malik, Shoaib Ahmad; Maiuri, Maria Chiara; Horio, Yoshiyuki; Lopez-Otin, Carlos; Andersen, Jens S.; Tavernarakis, Nektarios; Madeo, Frank; Kroemer, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">615-629</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Autophagy protects organelles, cells, and organisms against several stress conditions.  Induction of autophagy by resveratrol requires the NAD-dependent deacetylase sirtuin 1 (SIRT1).  In this paper, it is shown that the acetylase inhibitor spermidine stimulates autophagy independent of SIRT1 in human and yeast cells as well as in nematodes.  Although resveratrol and spermidine ignite autophagy through distinct mechanisms, these compds. stimulate convergent pathways that culminate in concordant modifications of the acetylproteome.  Both agents favor convergent deacetylation and acetylation reactions in the cytosol and in the nucleus, resp.  Both resveratrol and spermidine were able to induce autophagy in cytoplasts (enucleated cells).  Moreover, a cytoplasm-restricted mutant of SIRT1 could stimulate autophagy, suggesting that cytoplasmic deacetylation reactions dictate the autophagic cascade.  At doses at which neither resveratrol nor spermidine stimulated autophagy alone, these agents synergistically induced autophagy.  Altogether, these data underscore the importance of an autophagy regulatory network of antagonistic deacetylases and acetylases that can be pharmacol. manipulated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_JpR-msDh9rVg90H21EOLACvtfcHk0li1WNIB8rMAKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXislGjs7c%253D&md5=1bb33c4b97898af83c744a9d7078672b</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201008167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201008167%26sid%3Dliteratum%253Aachs%26aulast%3DMorselli%26aufirst%3DE.%26aulast%3DMarino%26aufirst%3DG.%26aulast%3DBennetzen%26aufirst%3DM.%2BV.%26aulast%3DEisenberg%26aufirst%3DT.%26aulast%3DMegalou%26aufirst%3DE.%26aulast%3DSchroeder%26aufirst%3DS.%26aulast%3DCabrera%26aufirst%3DS.%26aulast%3DBenit%26aufirst%3DP.%26aulast%3DRustin%26aufirst%3DP.%26aulast%3DCriollo%26aufirst%3DA.%26aulast%3DKepp%26aufirst%3DO.%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DS.%2BS.%26aulast%3DMalik%26aufirst%3DS.%2BA.%26aulast%3DMaiuri%26aufirst%3DM.%2BC.%26aulast%3DHorio%26aufirst%3DY.%26aulast%3DLopez-Otin%26aufirst%3DC.%26aulast%3DAndersen%26aufirst%3DJ.%2BS.%26aulast%3DTavernarakis%26aufirst%3DN.%26aulast%3DMadeo%26aufirst%3DF.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DSpermidine%2520and%2520resveratrol%2520induce%2520autophagy%2520by%2520distinct%2520pathways%2520converging%2520on%2520the%2520acetylproteome%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2011%26volume%3D192%26issue%3D4%26spage%3D615%26epage%3D629%26doi%3D10.1083%2Fjcb.201008167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dai, C. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. Y.</span></span> <span> </span><span class="NLM_article-title">p53 and mitochondrial dysfunction: novel insight of neurodegenerative diseases</span>. <i>J. Bioenerg. Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">337</span>– <span class="NLM_lpage">347</span>, <span class="refDoi"> DOI: 10.1007/s10863-016-9669-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1007%2Fs10863-016-9669-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27422544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFyntr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2016&pages=337-347&issue=4&author=C.+Q.+Daiauthor=T.+T.+Luoauthor=S.+C.+Luoauthor=J.+Q.+Wangauthor=S.+M.+Wangauthor=Y.+H.+Baiauthor=Y.+L.+Yangauthor=Y.+Y.+Wang&title=p53+and+mitochondrial+dysfunction%3A+novel+insight+of+neurodegenerative+diseases&doi=10.1007%2Fs10863-016-9669-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">p53 and mitochondrial dysfunction: novel insight of neurodegenerative diseases</span></div><div class="casAuthors">Dai, Chun-Qiu; Luo, Ting-Ting; Luo, Shi-Cheng; Wang, Jia-Qi; Wang, Sheng-Ming; Bai, Yun-Hu; Yang, Yan-Ling; Wang, Ya-Yun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bioenergetics and Biomembranes</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">337-347</span>CODEN:
                <span class="NLM_cas:coden">JBBID4</span>;
        ISSN:<span class="NLM_cas:issn">0145-479X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Mitochondria are organelles responsible for vital cell functions. p53 is a transcription factor that regulates the DNA stability and cell growth normality.  Recent studies revealed that p53 can influence mitochondrial function changing from normal condition to abnormal condition under different stress levels.  In normal state, p53 can maintain mitochondrial respiration through transactivation of SCO2.  When stress stimuli presents, SCO2 overexpresses and leads to ROS generation.  ROS promotes p53 inducing MALM (Mieap-induced accumulation of lysosome-like organelles within mitochondria) to repair dysfunctional mitochondria and MIV (Mieap-induced vacuole) to accomplish damaged mitochondria degrdn.  If stress or damage is irreversible, p53 will translocate to mitochondria, leading into apoptosis or necrosis.  Neurodegenerative diseases including Parkinson's disease, Huntington's disease and Alzheimer's disease are still lack of clear explanations of mechanisms, but more studies have revealed the functional relationship between mitochondria and p53 towards the pathol. development of these diseases.  In this review, we discuss that p53 plays the vital role in the function of mitochondria in the aspect of pathol. change metab.  We also analyze these diseases with novel targeted treating mols. which are related to p53 and mitochondria, hoping to present novel therapies in future clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQrS3qP7UaOLVg90H21EOLACvtfcHk0li-PV6fnGbQmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFyntr3E&md5=120cf7df72c9fdd26bf21f474a8fa69e</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1007%2Fs10863-016-9669-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10863-016-9669-5%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DC.%2BQ.%26aulast%3DLuo%26aufirst%3DT.%2BT.%26aulast%3DLuo%26aufirst%3DS.%2BC.%26aulast%3DWang%26aufirst%3DJ.%2BQ.%26aulast%3DWang%26aufirst%3DS.%2BM.%26aulast%3DBai%26aufirst%3DY.%2BH.%26aulast%3DYang%26aufirst%3DY.%2BL.%26aulast%3DWang%26aufirst%3DY.%2BY.%26atitle%3Dp53%2520and%2520mitochondrial%2520dysfunction%253A%2520novel%2520insight%2520of%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Bioenerg.%2520Biomembr.%26date%3D2016%26volume%3D48%26issue%3D4%26spage%3D337%26epage%3D347%26doi%3D10.1007%2Fs10863-016-9669-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodolfo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campello, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecconi, F.</span></span> <span> </span><span class="NLM_article-title">Mitophagy in neurodegenerative diseases</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">156</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1016/j.neuint.2017.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.neuint.2017.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=28797885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlegsL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2018&pages=156-166&author=C.+Rodolfoauthor=S.+Campelloauthor=F.+Cecconi&title=Mitophagy+in+neurodegenerative+diseases&doi=10.1016%2Fj.neuint.2017.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Mitophagy in neurodegenerative diseases</span></div><div class="casAuthors">Rodolfo, Carlo; Campello, Silvia; Cecconi, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">156-166</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neurodegenerative diseases, such as Parkinson's disease (PD), Alzheimer's disease (AD), Huntington's disease (HD), and Amyotrophic Lateral Sclerosis (ALS), are a complex "family" of pathologies, characterised by the progressive loss of neurons and/or neuronal functions, leading to severe phys. and cognitive inabilities in affected patients.  These syndromes, despite differences in the causative events, the onset, and the progression of the disease, share as common features the presence of aggregate-prone neuro-toxic proteins, in the form of aggresomes and/or inclusion bodies, perturbing cellular homeostasis and neuronal function (Popovic et al., 2014), and the presence of dysfunctional mitochondria.  The removal of protein aggregates and of damaged organelles, through the ubiquitin-proteasome system (UPS) and/or the autophagy/lysosome machinery, is a crucial step for the maintenance of neuronal homeostasis.  Indeed, their impairment has been reported as assocd. with the development of these diseases.  In this review, we focus on the role played by mitophagy, a specialised form of autophagy, in the onset and progression of major neurodegenerative diseases, as well as on possible therapeutic approaches involving mitophagy modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMll-LZSDLzbVg90H21EOLACvtfcHk0li-PV6fnGbQmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlegsL7O&md5=0ec4f311ea91b69f187ef039d51b1f0e</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2017.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2017.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DRodolfo%26aufirst%3DC.%26aulast%3DCampello%26aufirst%3DS.%26aulast%3DCecconi%26aufirst%3DF.%26atitle%3DMitophagy%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNeurochem.%2520Int.%26date%3D2018%26volume%3D117%26spage%3D156%26epage%3D166%26doi%3D10.1016%2Fj.neuint.2017.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paget, J.</span></span> <span> </span><span class="NLM_article-title">An address on certain points in the pathology of syphilis</span>. <i>British medical journal</i> <span class="NLM_year" style="font-weight: bold;">1876</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">790</span>),  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1136/bmj.1.790.215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1136%2Fbmj.1.790.215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20748114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BC3MzgvFersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1876&pages=215-217&issue=790&author=J.+Paget&title=An+address+on+certain+points+in+the+pathology+of+syphilis&doi=10.1136%2Fbmj.1.790.215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">An Address on Certain Points in the Pathology of Syphilis</span></div><div class="casAuthors">Paget J</div><div class="citationInfo"><span class="NLM_cas:title">British medical journal</span>
        (<span class="NLM_cas:date">1876</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">790</span>),
    <span class="NLM_cas:pages">215-7</span>
        ISSN:<span class="NLM_cas:issn">0007-1447</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR2ftheHkOrAVWTCLT8lX9SfW6udTcc2eYxJAyuYUsavrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MzgvFersw%253D%253D&md5=bb7c59f8663ff73808af3d1dc543d3e2</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1136%2Fbmj.1.790.215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.1.790.215%26sid%3Dliteratum%253Aachs%26aulast%3DPaget%26aufirst%3DJ.%26atitle%3DAn%2520address%2520on%2520certain%2520points%2520in%2520the%2520pathology%2520of%2520syphilis%26jtitle%3DBritish%2520medical%2520journal%26date%3D1876%26volume%3D1%26issue%3D790%26spage%3D215%26epage%3D217%26doi%3D10.1136%2Fbmj.1.790.215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cundy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, I. R.</span></span> <span> </span><span class="NLM_article-title">Paget’s disease of bone</span>. <i>Clin. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.clinbiochem.2011.09.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.clinbiochem.2011.09.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22024254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFaktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2012&pages=43-48&issue=1%E2%80%932&author=T.+Cundyauthor=I.+R.+Reid&title=Paget%E2%80%99s+disease+of+bone&doi=10.1016%2Fj.clinbiochem.2011.09.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Paget's disease of bone</span></div><div class="casAuthors">Cundy, Tim; Reid, Ian R.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">43-48</span>CODEN:
                <span class="NLM_cas:coden">CLBIAS</span>;
        ISSN:<span class="NLM_cas:issn">0009-9120</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Objectives: To review recent advance in understanding the causation and management of Paget's disease.  Design and methods: We review recent publications concerning the etiol. of the disease and the use of biochem. markers of bone turnover in diagnosis and treatment.  Results: Epidemiol. studies suggest that Paget's disease is decreasing in prevalence and severity (implying that environmental factors are important) but there is also strong evidence of a genetic predisposition particularly through the SQSTM1 gene.  Genome-wide assocn. studies have identified polymorphisms at several other loci that are assocd. with the disease.  Plasma alk. phosphatase activity (ALP) is widely used, but less helpful in patients with disease of limited extent.  Of the newer markers, plasma procollagen-1 N-peptide (PINP) performs best.  Treatment with potent bisphosphonates usually produces long-term remission.  Conclusions: Both genetic and environmental factors appear to be important in the etiol. of Paget's disease.  Effective long-term disease suppression can be achieved with bisphosphonate treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9whOwKtg6b7Vg90H21EOLACvtfcHk0li-PV6fnGbQmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFaktw%253D%253D&md5=a91cc54a42ca40e5656daeb8103648aa</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1016%2Fj.clinbiochem.2011.09.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinbiochem.2011.09.026%26sid%3Dliteratum%253Aachs%26aulast%3DCundy%26aufirst%3DT.%26aulast%3DReid%26aufirst%3DI.%2BR.%26atitle%3DPaget%25E2%2580%2599s%2520disease%2520of%2520bone%26jtitle%3DClin.%2520Biochem.%26date%3D2012%26volume%3D45%26issue%3D1%25E2%2580%25932%26spage%3D43%26epage%3D48%26doi%3D10.1016%2Fj.clinbiochem.2011.09.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebaldt, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C.</span></span> <span> </span><span class="NLM_article-title">Analysis of environmental factors in familial versus sporadic Paget’s disease of bone-the new England registry for Paget’s disease of bone</span>. <i>J. Bone Miner. Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1519</span>– <span class="NLM_lpage">1524</span>, <span class="refDoi"> DOI: 10.1359/jbmr.2003.18.8.1519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1359%2Fjbmr.2003.18.8.1519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=12929942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BD3szpt1GjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=1519-1524&issue=8&author=M.+Setonauthor=H.+K.+Choiauthor=M.+F.+Hansenauthor=R.+J.+Sebaldtauthor=C.+Cooper&title=Analysis+of+environmental+factors+in+familial+versus+sporadic+Paget%E2%80%99s+disease+of+bone-the+new+England+registry+for+Paget%E2%80%99s+disease+of+bone&doi=10.1359%2Fjbmr.2003.18.8.1519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of environmental factors in familial versus sporadic Paget's disease of bone--the New England Registry for Paget's Disease of Bone</span></div><div class="casAuthors">Seton Margaret; Choi Hyon K; Hansen Marc F; Sebaldt Rolf J; Cooper Cyrus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1519-24</span>
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    </div><div class="casAbstract">UNLABELLED:  A registry for Paget's Disease (PD) was created to study the environmental and familial features of this disorder.  This study examines the first 202 people enrolled.  Those with a family history of PD (20%) suffered earlier deformity and fracture, and tended to have grandparents born abroad.  These findings suggest heritage is important in PD; the role of environment remains unclear.  INTRODUCTION:  The New England Registry for Paget's Disease of Bone is a database that was created to explore the distribution and determinants of disease frequency.  METHODS:  Using a case-series design, we explored the association of environmental factors in expression of the disease, comparing those patients with familial Paget's disease to those with sporadic Paget's disease (PD).  RESULTS AND CONCLUSIONS:  Analysis of the first 202 patients enrolled in the registry revealed a positive family history (FH) in 41 (20%).  Significant findings in this cohort included an earlier age of onset (51 years FH+ versus 59 years FH-, p < 0.05), a trend to a higher incidence of bone deformity (49% versus 33%, p < 0.1), and an increased fracture rate (27% versus 11%, p < 0.05).  Persons with a FH of PD were less likely to record the United States or Canada as their grandparents' birthplace (p < 0.01), and sibships tended to be larger (p < 0.05).  A history of measles infection, childhood exposure to pets, milk ingestion, year of immigration to the United States, birth order, level of education, and functional status did not distinguish the two groups.  The database confirms the high prevalence of familial PD and supports the theory that heritable factors are important in the pathogenesis of this focal disorder of bone metabolism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTaViPOWMEqbJp6t8nS6Nc3fW6udTcc2eYi3byOQ3UzxLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3szpt1GjsA%253D%253D&md5=79c909a047dab313c2828b45bac567de</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.2003.18.8.1519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.2003.18.8.1519%26sid%3Dliteratum%253Aachs%26aulast%3DSeton%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DH.%2BK.%26aulast%3DHansen%26aufirst%3DM.%2BF.%26aulast%3DSebaldt%26aufirst%3DR.%2BJ.%26aulast%3DCooper%26aufirst%3DC.%26atitle%3DAnalysis%2520of%2520environmental%2520factors%2520in%2520familial%2520versus%2520sporadic%2520Paget%25E2%2580%2599s%2520disease%2520of%2520bone-the%2520new%2520England%2520registry%2520for%2520Paget%25E2%2580%2599s%2520disease%2520of%2520bone%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2003%26volume%3D18%26issue%3D8%26spage%3D1519%26epage%3D1524%26doi%3D10.1359%2Fjbmr.2003.18.8.1519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Layfield, R.</span></span> <span> </span><span class="NLM_article-title">The molecular pathogenesis of Paget disease of bone</span>. <i>Expert Rev. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">27</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1017/S1462399407000464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1017%2FS1462399407000464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=17903332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BD2srot1Cluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=1-13&issue=27&author=R.+Layfield&title=The+molecular+pathogenesis+of+Paget+disease+of+bone&doi=10.1017%2FS1462399407000464"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular pathogenesis of Paget disease of bone</span></div><div class="casAuthors">Layfield Robert</div><div class="citationInfo"><span class="NLM_cas:title">Expert reviews in molecular medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">1-13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Paget disease of bone (PDB) is a condition characterised by increased bone remodelling at discrete lesions throughout the skeleton.  The primary cellular abnormality in PDB involves a net increase in the activity of bone-resorbing osteoclasts, with a secondary increase in bone-forming osteoblast activity.  Genetic factors are known to play an important role, with mutations affecting different components of the RANK-NF-kappaB signalling pathway having been identified in patients with PDB and related disorders.  Whilst the disease mechanism in these cases is likely to involve aberrant RANK-mediated osteoclast NF-kappaB signalling, the precise relationship between other potential contributors, such as viruses and environmental factors, and the molecular pathogenesis of PDB is less clear.  This review considers the roles of these different factors in PDB, and concludes that a fuller understanding of their contributions to disease aetiology is likely to be central to future advances in the clinical management of this debilitating skeletal disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTeQpXPu1DwNEGy1nwu7K2mfW6udTcc2eYi3byOQ3UzxLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srot1Cluw%253D%253D&md5=105d8c656459e9b8bc454e1ccf7afcd0</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1017%2FS1462399407000464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1462399407000464%26sid%3Dliteratum%253Aachs%26aulast%3DLayfield%26aufirst%3DR.%26atitle%3DThe%2520molecular%2520pathogenesis%2520of%2520Paget%2520disease%2520of%2520bone%26jtitle%3DExpert%2520Rev.%2520Mol.%2520Med.%26date%3D2007%26volume%3D9%26issue%3D27%26spage%3D1%26epage%3D13%26doi%3D10.1017%2FS1462399407000464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiruma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurihara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subler, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boykin, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishizuka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dempster, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roodman, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windle, J. J.</span></span> <span> </span><span class="NLM_article-title">A SQSTM1/p62 mutation linked to Paget’s disease increases the osteoclastogenic potential of the bone microenvironment</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">3708</span>– <span class="NLM_lpage">3719</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddn266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1093%2Fhmg%2Fddn266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18765443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlGis7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=3708-3719&issue=23&author=Y.+Hirumaauthor=N.+Kuriharaauthor=M.+A.+Sublerauthor=H.+Zhouauthor=C.+S.+Boykinauthor=H.+Zhangauthor=S.+Ishizukaauthor=D.+W.+Dempsterauthor=G.+D.+Roodmanauthor=J.+J.+Windle&title=A+SQSTM1%2Fp62+mutation+linked+to+Paget%E2%80%99s+disease+increases+the+osteoclastogenic+potential+of+the+bone+microenvironment&doi=10.1093%2Fhmg%2Fddn266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment</span></div><div class="casAuthors">Hiruma, Yuko; Kurihara, Noriyoshi; Subler, Mark A.; Zhou, Hua; Boykin, Christina S.; Zhang, Heju; Ishizuka, Seiichi; Dempster, David W.; Roodman, G. David; Windle, Jolene J.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3708-3719</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Paget's disease of bone (PDB) is the second most common bone disease and is characterized by focal bone lesions which contain large nos. of abnormal osteoclasts (OCLs) and very active normal osteoblasts in a highly osteoclastogenic marrow microenvironment.  The etiol. of PDB is not well understood and both environmental and genetic causes have been implicated in its pathogenesis.  Mutations in the SQSTM1/p62 gene have been identified in up to 30% of Paget's patients.  To det. if p62 mutation is sufficient to induce PDB, we generated mice harboring a mutation causing a P-to-L (proline-to-leucine) substitution at residue 394 (the murine equiv. of human p62P392L, the most common PDB-assocd. mutation).  Bone marrow cultures from p62P394L mice formed increased nos. of OCLs in response to receptor activator of NF-κB ligand (RANKL), tumor necrosis factor α (TNF-α) or 1α,25-(OH)2D3, similar to PDB patients.  However, purified p62P394L OCL precursors depleted of stromal cells were no longer hyper-responsive to 1α,25-(OH)2D3, suggesting effects of the p62P394L mutation on the marrow microenvironment in addn. to direct effects on OCLs.  Co-cultures of purified p62P394L stromal cells with either wild-type (WT) or p62P394L OCL precursors formed more OCLs than co-cultures contg. WT stromal cells due to increased RANKL prodn. by the mutant stromal cells.  However, despite the enhanced osteoclastogenic potential of both OCL precursors and marrow stromal cells, the p62P394L mice had histol. normal bones.  These results indicate that this PDB-assocd. p62 mutation is not sufficient to induce PDB and suggest that addnl. factors acting together with p62 mutation are necessary for the development of PDB in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi9LLaFx-4bLVg90H21EOLACvtfcHk0ljb0I-_bAVHwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlGis7%252FK&md5=9980806516366ea4ceaf90646cae2420</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddn266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddn266%26sid%3Dliteratum%253Aachs%26aulast%3DHiruma%26aufirst%3DY.%26aulast%3DKurihara%26aufirst%3DN.%26aulast%3DSubler%26aufirst%3DM.%2BA.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DBoykin%26aufirst%3DC.%2BS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DIshizuka%26aufirst%3DS.%26aulast%3DDempster%26aufirst%3DD.%2BW.%26aulast%3DRoodman%26aufirst%3DG.%2BD.%26aulast%3DWindle%26aufirst%3DJ.%2BJ.%26atitle%3DA%2520SQSTM1%252Fp62%2520mutation%2520linked%2520to%2520Paget%25E2%2580%2599s%2520disease%2520increases%2520the%2520osteoclastogenic%2520potential%2520of%2520the%2520bone%2520microenvironment%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2008%26volume%3D17%26issue%3D23%26spage%3D3708%26epage%3D3719%26doi%3D10.1093%2Fhmg%2Fddn266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rea, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layfield, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratajczak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. K.</span></span> <span> </span><span class="NLM_article-title">New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget’s disease of bone</span>. <i>Endocr. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">501</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1210/er.2012-1034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1210%2Fer.2012-1034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=23612225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVKgtrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=501-524&issue=4&author=S.+L.+Reaauthor=J.+P.+Walshauthor=R.+Layfieldauthor=T.+Ratajczakauthor=J.+K.+Xu&title=New+insights+into+the+role+of+sequestosome+1%2Fp62+mutant+proteins+in+the+pathogenesis+of+Paget%E2%80%99s+disease+of+bone&doi=10.1210%2Fer.2012-1034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget's Disease of bone</span></div><div class="casAuthors">Rea, Sarah L.; Walsh, John P.; Layfield, Robert; Ratajczak, Thomas; Xu, Jiake</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">501-524</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Paget's disease of bone (PDB) is characterized by focal areas of aberrant and excessive bone turnover, specifically increased bone resorption and disorganized bone formation.  Germline mutations in the sequestosome 1/p62 (SQSTM1/p62) gene are common in PDB patients, with most mutations affecting the ubiquitin-assocd. domain of the protein.  In vitro, osteoclast precursor cells expressing PDB-mutant SQSTM1/p62 protein are assocd. with increases in nuclear factor κB activation, osteoclast differentiation, and bone resorption.  Although the precise mechanisms by which SQSTM1/p62 mutations contribute to disease pathogenesis and progression are not well defined, it is apparent that as well as affecting nuclear factor κB signaling, SQSTM1/p62 is a master regulator of ubiquitinated protein turnover via autophagy and the ubiquitin-proteasome system.  Addnl. roles for SQSTM1/p62 in the oxidative stress-induced Keap1/Nrf2 pathway and in caspase-mediated apoptosis that were recently reported are potentially relevant to the pathogenesis of PDB.  Thus, SQSTM1/p62 may serve as a mol. link or switch between autophagy, apoptosis, and cell survival signaling.  The purpose of this review is to outline recent advances in understanding of the multiple pathophysiol. roles of SQSTM1/p62 protein, with particular emphasis on their relationship to PDB, including challenges assocd. with translating SQSTM1/p62 research into clin. diagnosis and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCNVd8lih1nLVg90H21EOLACvtfcHk0ljb0I-_bAVHwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVKgtrjF&md5=8e516a639bd6bbbf0b9c202c4b184f5b</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1210%2Fer.2012-1034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2012-1034%26sid%3Dliteratum%253Aachs%26aulast%3DRea%26aufirst%3DS.%2BL.%26aulast%3DWalsh%26aufirst%3DJ.%2BP.%26aulast%3DLayfield%26aufirst%3DR.%26aulast%3DRatajczak%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DJ.%2BK.%26atitle%3DNew%2520insights%2520into%2520the%2520role%2520of%2520sequestosome%25201%252Fp62%2520mutant%2520proteins%2520in%2520the%2520pathogenesis%2520of%2520Paget%25E2%2580%2599s%2520disease%2520of%2520bone%26jtitle%3DEndocr.%2520Rev.%26date%3D2013%26volume%3D34%26issue%3D4%26spage%3D501%26epage%3D524%26doi%3D10.1210%2Fer.2012-1034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kular, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tickner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chim, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. K.</span></span> <span> </span><span class="NLM_article-title">An overview of the regulation of bone remodelling at the cellular level</span>. <i>Clin. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">863</span>– <span class="NLM_lpage">873</span>, <span class="refDoi"> DOI: 10.1016/j.clinbiochem.2012.03.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.clinbiochem.2012.03.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22465238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38Xltl2rsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2012&pages=863-873&issue=12&author=J.+Kularauthor=J.+Ticknerauthor=S.+M.+Chimauthor=J.+K.+Xu&title=An+overview+of+the+regulation+of+bone+remodelling+at+the+cellular+level&doi=10.1016%2Fj.clinbiochem.2012.03.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of the regulation of bone remodelling at the cellular level</span></div><div class="casAuthors">Kular, Jasreen; Tickner, Jennifer; Chim, Shek Man; Xu, Jiake</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">863-873</span>CODEN:
                <span class="NLM_cas:coden">CLBIAS</span>;
        ISSN:<span class="NLM_cas:issn">0009-9120</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">To review the current literature on the regulation of bone remodelling at the cellular level.The cellular activities of the cells in the basic multicellular unit (BMU) were evaluated.Bone remodelling requires an intimate cross-talk between osteoclasts and osteoblasts and is tightly coordinated by regulatory proteins that interact through complex autocrine/paracrine mechanisms.  Osteocytes, bone lining cells, osteomacs, and vascular endothelial cells also regulate bone remodelling in the BMU via cell signalling networks of ligand-receptor complexes.  In addn., through secreted and membrane-bound factors in the bone microenvironment, T and B lymphocytes mediate bone homeostasis in osteoimmunol.Osteoporosis and other bone diseases occur because multicellular communication within the BMU is disrupted.  Understanding the cellular and mol. basis of bone remodelling and the discovery of novel paracrine or coupling factors, such as RANKL, sclerostin, EGFL6 and semaphorin 4D, will lay the foundation for drug development against bone diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5Zf7yUCbqU7Vg90H21EOLACvtfcHk0ljb0I-_bAVHwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xltl2rsrg%253D&md5=28abc44dc0e76c03ee832c29e9c08a58</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1016%2Fj.clinbiochem.2012.03.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinbiochem.2012.03.021%26sid%3Dliteratum%253Aachs%26aulast%3DKular%26aufirst%3DJ.%26aulast%3DTickner%26aufirst%3DJ.%26aulast%3DChim%26aufirst%3DS.%2BM.%26aulast%3DXu%26aufirst%3DJ.%2BK.%26atitle%3DAn%2520overview%2520of%2520the%2520regulation%2520of%2520bone%2520remodelling%2520at%2520the%2520cellular%2520level%26jtitle%3DClin.%2520Biochem.%26date%3D2012%26volume%3D45%26issue%3D12%26spage%3D863%26epage%3D873%26doi%3D10.1016%2Fj.clinbiochem.2012.03.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takayanagi, H.</span></span> <span> </span><span class="NLM_article-title">Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">292</span>– <span class="NLM_lpage">304</span>, <span class="refDoi"> DOI: 10.1038/nri2062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fnri2062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=17380158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtlyhurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=292-304&issue=4&author=H.+Takayanagi&title=Osteoimmunology%3A+shared+mechanisms+and+crosstalk+between+the+immune+and+bone+systems&doi=10.1038%2Fnri2062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems</span></div><div class="casAuthors">Takayanagi, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">292-304</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Osteoimmunol. is an interdisciplinary research field focused on the mol. understanding of the interplay between the immune and skeletal systems.  Although osteoimmunol. started with the study of the immune regulation of osteoclasts, its scope has been extended to encompass a wide range of mol. and cellular interactions, including those between osteoblasts and osteoclasts, lymphocytes and osteoclasts, and osteoblasts and hematopoietic cells.  Therefore, the two systems should be understood to be integrated and operating in the context of the 'osteoimmune' system, a heuristic concept that provides not only a framework for obtaining new insights by basic research, but also a scientific basis for the discovery of novel treatments for diseases related to both systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZxVDBwUkq3rVg90H21EOLACvtfcHk0ljXGWgbopry6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtlyhurc%253D&md5=61d02a7dac0ac2a0abddeda9ca6eab42</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1038%2Fnri2062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2062%26sid%3Dliteratum%253Aachs%26aulast%3DTakayanagi%26aufirst%3DH.%26atitle%3DOsteoimmunology%253A%2520shared%2520mechanisms%2520and%2520crosstalk%2520between%2520the%2520immune%2520and%2520bone%2520systems%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2007%26volume%3D7%26issue%3D4%26spage%3D292%26epage%3D304%26doi%3D10.1038%2Fnri2062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurihara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiruma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subler, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dempster, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singer, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruber, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windle, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roodman, G. D.</span></span> <span> </span><span class="NLM_article-title">Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>117</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1172/JCI28267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1172%2FJCI28267" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=17187080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmvV2qtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=133-142&issue=1&author=N.+Kuriharaauthor=Y.+Hirumaauthor=H.+Zhouauthor=M.+A.+Sublerauthor=D.+W.+Dempsterauthor=F.+R.+Singerauthor=S.+V.+Reddyauthor=H.+E.+Gruberauthor=J.+J.+Windleauthor=G.+D.+Roodman&title=Mutation+of+the+sequestosome+1+%28p62%29+gene+increases+osteoclastogenesis+but+does+not+induce+Paget+disease&doi=10.1172%2FJCI28267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease</span></div><div class="casAuthors">Kurihara, Noriyoshi; Hiruma, Yuko; Zhou, Hua; Subler, Mark A.; Dempster, David W.; Singer, Frederick R.; Reddy, Sakamuri V.; Gruber, Helen E.; Windle, Jolene J.; Roodman, G. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">133-142</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Paget disease is the most exaggerated example of abnormal bone remodeling, with the primary cellular abnormality in the osteoclast.  Mutations in the p62 (sequestosome 1) gene occur in one-third of patients with familial Paget disease and in a minority of patients with sporadic Paget disease, with the P392L amino acid substitution being the most commonly obsd. mutation.  However, it is unknown how p62P392L mutation contributes to the development of this disease.  To det. the effects of p62P392L expression on osteoclasts in vitro and in vivo, we introduced either the p62P392L or WT p62 gene into normal osteoclast precursors and targeted p62P392L expression to the osteoclast lineage in transgenic mice.  P62P392L-transduced osteoclast precursors were hyperresponsive to receptor activator of NF-κB ligand (RANKL) and TNF-α and showed increased NF-κB signaling but did not demonstrate increased 1,25-(OH)2D3 responsivity, TAFII-17 expression, or nuclear no. per osteoclast.  Mice expressing p62P392L developed increased osteoclast nos. and progressive bone loss, but osteoblast nos. were not coordinately increased, as is seen in Paget disease.  These results indicate that p62P392L expression on osteoclasts is not sufficient to induce the full pagetic phenotype but suggest that p62 mutations cause a predisposition to the development of Paget disease by increasing the sensitivity of osteoclast precursors to osteoclastogenic cytokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr38GlC3QrsqLVg90H21EOLACvtfcHk0ljXGWgbopry6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmvV2qtw%253D%253D&md5=582802f6985afb9cd6d1c6e49670d66f</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1172%2FJCI28267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI28267%26sid%3Dliteratum%253Aachs%26aulast%3DKurihara%26aufirst%3DN.%26aulast%3DHiruma%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DSubler%26aufirst%3DM.%2BA.%26aulast%3DDempster%26aufirst%3DD.%2BW.%26aulast%3DSinger%26aufirst%3DF.%2BR.%26aulast%3DReddy%26aufirst%3DS.%2BV.%26aulast%3DGruber%26aufirst%3DH.%2BE.%26aulast%3DWindle%26aufirst%3DJ.%2BJ.%26aulast%3DRoodman%26aufirst%3DG.%2BD.%26atitle%3DMutation%2520of%2520the%2520sequestosome%25201%2520%2528p62%2529%2520gene%2520increases%2520osteoclastogenesis%2520but%2520does%2520not%2520induce%2520Paget%2520disease%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26issue%3D1%26spage%3D133%26epage%3D142%26doi%3D10.1172%2FJCI28267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daroszewska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van’t Hof, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layfield, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landao-Basonga, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ralston, S. H.</span></span> <span> </span><span class="NLM_article-title">A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget’s disease-like disorder in mice</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">2734</span>– <span class="NLM_lpage">2744</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddr172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1093%2Fhmg%2Fddr172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21515589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVeisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=2734-2744&issue=14&author=A.+Daroszewskaauthor=R.+J.+van%E2%80%99t+Hofauthor=J.+A.+Rojasauthor=R.+Layfieldauthor=E.+Landao-Basongaauthor=L.+Roseauthor=K.+Roseauthor=S.+H.+Ralston&title=A+point+mutation+in+the+ubiquitin-associated+domain+of+SQSMT1+is+sufficient+to+cause+a+Paget%E2%80%99s+disease-like+disorder+in+mice&doi=10.1093%2Fhmg%2Fddr172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice</span></div><div class="casAuthors">Daroszewska, Anna; van 't Hof, Robert J.; Rojas, Javier A.; Layfield, Robert; Landao-Basonga, Euphemie; Rose, Lorraine; Rose, Ken; Ralston, Stuart H.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2734-2744</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Mutations of SQSTM1 occur in about 10% of patients with Paget's disease of bone (PDB), but it is unclear whether they play a causal role or regulate susceptibility to an environmental trigger.  Here the authors show that mice with a proline to leucine mutation at codon 394 of mouse sqstm1 (P394L), equiv. to the P392L SQSTM1 mutation in humans, develop a bone disorder with remarkable similarity to PDB.  The P394L mutant mice developed focal bone lesions with increasing age and by 12 mo, 14/18 (77%) heterozygotes and 20/21 (95%) homozygotes had lesions, compared with 0/18 (0%) wild-type littermates (P< 0.001).  Lesions predominantly affected the lower limbs in an asym. manner and were characterized by focal increases in bone turnover, with increased bone resorption and formation, disruption of the normal bone architecture and accumulation of woven bone.  Osteoclasts within lesions were larger and more nucleated than normal and some contained nuclear inclusions similar to those obsd. in human PDB.  Osteoclast precursors from P394L mutant mice had increased sensitivity to RANKL in vitro resulting in the generation of osteoclasts that were larger and more nucleated than those generated from wild-type littermates.  There was increased expression of sqstm1, autophagy-related gene 5 (atg5) and light chain 3 gene (lc3) in osteoclast precursors and increased LC3-II protein levels in Bafilomycin-treated osteoclasts from P394L mutant mice compared with wild-type suggesting dysregulation of autophagy and enhanced autophagosome formation.  These studies demonstrate that SQSTM1 mutations can cause a PDB-like skeletal disorder in the absence of an addnl. trigger and provide a new disease model for PDB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Y1MJGsaoI7Vg90H21EOLACvtfcHk0ljXGWgbopry6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVeisLk%253D&md5=5e3024a87a9ec58ba408b01b9d04f59f</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddr172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddr172%26sid%3Dliteratum%253Aachs%26aulast%3DDaroszewska%26aufirst%3DA.%26aulast%3Dvan%25E2%2580%2599t%2BHof%26aufirst%3DR.%2BJ.%26aulast%3DRojas%26aufirst%3DJ.%2BA.%26aulast%3DLayfield%26aufirst%3DR.%26aulast%3DLandao-Basonga%26aufirst%3DE.%26aulast%3DRose%26aufirst%3DL.%26aulast%3DRose%26aufirst%3DK.%26aulast%3DRalston%26aufirst%3DS.%2BH.%26atitle%3DA%2520point%2520mutation%2520in%2520the%2520ubiquitin-associated%2520domain%2520of%2520SQSMT1%2520is%2520sufficient%2520to%2520cause%2520a%2520Paget%25E2%2580%2599s%2520disease-like%2520disorder%2520in%2520mice%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2011%26volume%3D20%26issue%3D14%26spage%3D2734%26epage%3D2744%26doi%3D10.1093%2Fhmg%2Fddr172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ralston, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langston, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, I. R.</span></span> <span> </span><span class="NLM_article-title">Pathogenesis and management of Paget’s disease of bone</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>372</i></span> (<span class="NLM_issue">9633</span>),  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">163</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(08)61035-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2FS0140-6736%2808%2961035-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18620951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVynurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2008&pages=155-163&issue=9633&author=S.+H.+Ralstonauthor=A.+L.+Langstonauthor=I.+R.+Reid&title=Pathogenesis+and+management+of+Paget%E2%80%99s+disease+of+bone&doi=10.1016%2FS0140-6736%2808%2961035-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenesis and management of Paget's disease of bone</span></div><div class="casAuthors">Ralston, Stuart H.; Langston, Anne L.; Reid, Ian R.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">9633</span>),
    <span class="NLM_cas:pages">155-163</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Paget's disease of bone is a common disease characterized by focal areas of increased bone turnover, affecting one or several bones throughout the skeleton.  Paget's disease is often asymptomatic but can be assocd. with bone pain and other complications such as osteoarthritis, pathol. fracture, bone deformity, deafness, and nerve compression syndromes.  Genetic factors have an important role in this disease, and mutations have been identified in four genes that cause Paget's disease and related syndromes.  The most important of these is Sequestosome 1 (SQSTM1), which is a scaffold protein in the nuclear factor κB (NFκB) signalling pathway.  Patients with SQSTM1 mutations have severe Paget's disease of bone and a high degree of penetrance with increasing age.  Environmental factors also contribute.  Most research has focused on paramyxovirus infection as a possible trigger, but evidence for this notion is conflicting.  Other potential triggers include deficiency of dietary calcium and repetitive mech. loading of the skeleton.  Medical management of Paget's disease of bone is based on giving inhibitors of osteoclastic bone resorption, and bisphosphonates are the treatment of first choice.  Bisphosphonate therapy is primarily indicated for patients who have bone pain arising from increased metabolic activity in affected bones.  Bisphosphonate therapy is highly effective at reducing bone turnover, and it has been shown to heal radiol. lesions and restore normal histol.; however, the long-term effects of bisphosphonates on disease progression have not been adequately studied.  No firm evidence as yet exists to show that bisphosphonates can prevent the development of complications of Paget's disease of bone, and further work is needed to address the effects of treatment on long-term clin. outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvexM1UZ6Hx7Vg90H21EOLACvtfcHk0lgeQ4kowuJ4tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVynurc%253D&md5=8658ce77f45ae02132597f2491de080f</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2808%2961035-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252808%252961035-1%26sid%3Dliteratum%253Aachs%26aulast%3DRalston%26aufirst%3DS.%2BH.%26aulast%3DLangston%26aufirst%3DA.%2BL.%26aulast%3DReid%26aufirst%3DI.%2BR.%26atitle%3DPathogenesis%2520and%2520management%2520of%2520Paget%25E2%2580%2599s%2520disease%2520of%2520bone%26jtitle%3DLancet%26date%3D2008%26volume%3D372%26issue%3D9633%26spage%3D155%26epage%3D163%26doi%3D10.1016%2FS0140-6736%2808%2961035-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reid, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyles, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saidi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesenbrink, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, G. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zelenakas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosking, D.</span></span> <span> </span><span class="NLM_article-title">Comparison of a single infusion of zoledronic acid with risedronate for Paget’s disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>353</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">898</span>– <span class="NLM_lpage">908</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa044241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1056%2FNEJMoa044241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=16135834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFCht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=898-908&issue=9&author=I.+R.+Reidauthor=P.+Millerauthor=K.+Lylesauthor=W.+Fraserauthor=J.+P.+Brownauthor=Y.+Saidiauthor=P.+Mesenbrinkauthor=G.+Q.+Suauthor=J.+Pakauthor=K.+Zelenakasauthor=M.+Luchiauthor=P.+Richardsonauthor=D.+Hosking&title=Comparison+of+a+single+infusion+of+zoledronic+acid+with+risedronate+for+Paget%E2%80%99s+disease&doi=10.1056%2FNEJMoa044241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease</span></div><div class="casAuthors">Reid, Ian R.; Miller, Paul; Lyles, Kenneth; Fraser, William; Brown, Jacques P.; Saidi, Youssef; Mesenbrink, Peter; Su, Guoqin; Pak, Judy; Zelenakas, Ken; Luchi, Monica; Richardson, Peter; Hosking, David</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">898-908</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: The advent of bisphosphonates advanced therapy for Paget's disease, but more effective and convenient agents are needed to increase adherence.  Zoledronic acid, a bisphosphonate administered as a single i.v. infusion, might meet these needs.  METHODS: In two identical, randomized, double-blind, actively controlled trials of 6 mo duration, we compared one 15-min infusion of 5 mg of zoledronic acid with 60 days of oral risedronate (30 mg per day).  The primary efficacy end point was the rate of therapeutic response at six months, defined as a normalization of alk. phosphatase levels ora redn. of at least 75 % in the total alk. phosphatase excess.  The results of the studies were pooled.  RESULTS: At six months, 96.0 % of patients receiving zoledronic acid had a therapeutic response (169 of 176), as compared with 74.3 % of patients receiving risedronate (127 of 171, P < 0.001).  Alk. phosphatase levels normalized in 88.6 % of patients in the zoledronic acid group and 57.9 % of patients in the risedronate group (P < 0.001).  Zoledronic acid was assocd. with a shorter median time to a first therapeutic response (64 vs. 89 days, P < 0.001).  Higher response rates in the zoledronic acid group were consistent across all demog., disease-severity, and treatment-history subgroups and with changes in other bone-turnover markers.  The phys.-component summary score of the Medical Outcomes Study 36-item Short-Form General Health Survey, a measure of the quality of life, increased significantly from baseline at both three and six months in the zoledronic acid group and differed significantly from those in the risedronate group at three months.  Pain scores improved in both groups.  During post-trial follow-up (median, 190 days), 21 of 82 patients in the risedronate group had a loss of therapeutic response, as compared with 1 of 113 patients in the zoledronic acid group (P < 0.001).  CONCLUSIONS A single infusion of zoledronic acid produces more rapid, more complete, and more sustained responses in Paget's disease than does daily treatment with risedronate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiTng4toTvJrVg90H21EOLACvtfcHk0ljZ29rxESSZ1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFCht7g%253D&md5=5bd96393a52a837b3abef1839d196c3f</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa044241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa044241%26sid%3Dliteratum%253Aachs%26aulast%3DReid%26aufirst%3DI.%2BR.%26aulast%3DMiller%26aufirst%3DP.%26aulast%3DLyles%26aufirst%3DK.%26aulast%3DFraser%26aufirst%3DW.%26aulast%3DBrown%26aufirst%3DJ.%2BP.%26aulast%3DSaidi%26aufirst%3DY.%26aulast%3DMesenbrink%26aufirst%3DP.%26aulast%3DSu%26aufirst%3DG.%2BQ.%26aulast%3DPak%26aufirst%3DJ.%26aulast%3DZelenakas%26aufirst%3DK.%26aulast%3DLuchi%26aufirst%3DM.%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DHosking%26aufirst%3DD.%26atitle%3DComparison%2520of%2520a%2520single%2520infusion%2520of%2520zoledronic%2520acid%2520with%2520risedronate%2520for%2520Paget%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D353%26issue%3D9%26spage%3D898%26epage%3D908%26doi%3D10.1056%2FNEJMoa044241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woo, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellstein, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalmar, J. R.</span></span> <span> </span><span class="NLM_article-title">Bisphosphonates and osteonecrosis of the jaw-response</span>. <i>Ann. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>145</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">792</span>– <span class="NLM_lpage">792</span>, <span class="refDoi"> DOI: 10.7326/0003-4819-145-10-200611210-00023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.7326%2F0003-4819-145-10-200611210-00023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2006&pages=792-792&issue=10&author=S.+B.+Wooauthor=J.+W.+Hellsteinauthor=J.+R.+Kalmar&title=Bisphosphonates+and+osteonecrosis+of+the+jaw-response&doi=10.7326%2F0003-4819-145-10-200611210-00023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-145-10-200611210-00023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-145-10-200611210-00023%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DS.%2BB.%26aulast%3DHellstein%26aufirst%3DJ.%2BW.%26aulast%3DKalmar%26aufirst%3DJ.%2BR.%26atitle%3DBisphosphonates%2520and%2520osteonecrosis%2520of%2520the%2520jaw-response%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D2006%26volume%3D145%26issue%3D10%26spage%3D792%26epage%3D792%26doi%3D10.7326%2F0003-4819-145-10-200611210-00023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bava, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callon, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamble, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitto, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cundy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornish, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, I. R.</span></span> <span> </span><span class="NLM_article-title">Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget’s disease of bone</span>. <i>J. Bone Miner. Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">298</span>– <span class="NLM_lpage">309</span>, <span class="refDoi"> DOI: 10.1359/jbmr.061108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1359%2Fjbmr.061108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=17129176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFCgs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=298-309&issue=2&author=D.+Naotauthor=U.+Bavaauthor=B.+Matthewsauthor=K.+E.+Callonauthor=G.+D.+Gambleauthor=M.+Blackauthor=S.+Songauthor=R.+P.+Pittoauthor=T.+Cundyauthor=J.+Cornishauthor=I.+R.+Reid&title=Differential+gene+expression+in+cultured+osteoblasts+and+bone+marrow+stromal+cells+from+patients+with+Paget%E2%80%99s+disease+of+bone&doi=10.1359%2Fjbmr.061108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget's disease of bone</span></div><div class="casAuthors">Naot, Dorit; Bava, Usha; Matthews, Brya; Callon, Karen E.; Gamble, Gregory D.; Black, Michael; Song, Sarah; Pitto, Rocco P.; Cundy, Tim; Cornish, Jill; Reid, Ian R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">298-309</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">Paget's disease is a focal condition of bone.  To study changes in cells within pagetic lesions, we cultured osteoblasts and stromal cells from 22 patients and compared gene expression in these cells to cells from healthy bone.  We identified several differentially regulated genes, and we suggest that these changes could lead to the formation of the lesions.  Introduction: Paget's disease is a focal condition of bone of unknown cause.  Although it is regarded as primarily an osteoclast disorder, the tight coupling of the activity of osteoclasts and osteoblasts suggests that the osteoblast could play a key role in its pathogenesis.  The aim of the study was to identify possible changes in pagetic osteoblasts and stromal cells that might contribute to the development of pagetic lesions.  Materials and Methods: Candidate genes were identified based on known bone cell regulators, supplemented with microarray anal.  Gene expression was detd. by real-time PCR in primary cultures of osteoblasts and bone marrow stromal cells from pagetic patients and control subjects.  Concns. of secreted proteins were detd. by ELISA.  Results: Dickkopf1 mRNA and protein levels were increased in both pagetic osteoblast and stromal cell cultures, and interleukin (IL)-1 and IL-6 were overexpressed in pagetic osteoblasts.  These changes parallel recent findings in myeloma bone disease, which shares some clin. similarities with Paget's disease.  Alk. phosphatase was overexpressed, and bone sialoprotein and osteocalcin were underexpressed in pagetic osteoblasts, consistent with their circulating levels in pagetic patients.  It is hypothesized that overexpression of Dickkopf1, IL-1, and IL-6 would result in stimulation of osteoclast proliferation and inhibition of osteoblast growth, leading to the development of the characteristic lytic bone lesions.  By stimulating osteoblast differentiation, Dickkopf1 and IL-6 may also promote mineralization, leading to the conversion of lytic lesions to sclerotic.  Conclusions: These findings suggest that dysregulated gene expression in pagetic osteoblasts could cause the changes in bone cell no. and function characteristic of Paget's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfYHF9BEuTv7Vg90H21EOLACvtfcHk0ljZ29rxESSZ1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvFCgs7k%253D&md5=5a48073432d70ba8d8cab504bd7d7907</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.061108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.061108%26sid%3Dliteratum%253Aachs%26aulast%3DNaot%26aufirst%3DD.%26aulast%3DBava%26aufirst%3DU.%26aulast%3DMatthews%26aufirst%3DB.%26aulast%3DCallon%26aufirst%3DK.%2BE.%26aulast%3DGamble%26aufirst%3DG.%2BD.%26aulast%3DBlack%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DS.%26aulast%3DPitto%26aufirst%3DR.%2BP.%26aulast%3DCundy%26aufirst%3DT.%26aulast%3DCornish%26aufirst%3DJ.%26aulast%3DReid%26aufirst%3DI.%2BR.%26atitle%3DDifferential%2520gene%2520expression%2520in%2520cultured%2520osteoblasts%2520and%2520bone%2520marrow%2520stromal%2520cells%2520from%2520patients%2520with%2520Paget%25E2%2580%2599s%2520disease%2520of%2520bone%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2007%26volume%3D22%26issue%3D2%26spage%3D298%26epage%3D309%26doi%3D10.1359%2Fjbmr.061108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himori, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omodaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiga, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakazawa, T.</span></span> <span> </span><span class="NLM_article-title">The novel Rho kinase (ROCK) inhibitor K-115: a new candidate drug for neuroprotective treatment in glaucoma</span>. <i>Invest. Ophthalmol. Visual Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">7126</span>– <span class="NLM_lpage">7136</span>, <span class="refDoi"> DOI: 10.1167/iovs.13-13842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1167%2Fiovs.13-13842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=25277230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVOltbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=7126-7136&issue=11&author=K.+Yamamotoauthor=K.+Maruyamaauthor=N.+Himoriauthor=K.+Omodakaauthor=Y.+Yokoyamaauthor=Y.+Shigaauthor=R.+Morinauthor=T.+Nakazawa&title=The+novel+Rho+kinase+%28ROCK%29+inhibitor+K-115%3A+a+new+candidate+drug+for+neuroprotective+treatment+in+glaucoma&doi=10.1167%2Fiovs.13-13842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">The novel Rho kinase (ROCK) inhibitor K-115: a new candidate drug for neuroprotective treatment in glaucoma</span></div><div class="casAuthors">Yamamoto, Kotaro; Maruyama, Kazuichi; Himori, Noriko; Omodaka, Kazuko; Yokoyama, Yu; Shiga, Yukihiro; Morin, Ryu; Nakazawa, Toru</div><div class="citationInfo"><span class="NLM_cas:title">Investigative Ophthalmology & Visual Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">7126-7136</span>CODEN:
                <span class="NLM_cas:coden">IOVSDA</span>;
        ISSN:<span class="NLM_cas:issn">1552-5783</span>.
    
            (<span class="NLM_cas:orgname">Association for Research in Vision and Ophthalmology</span>)
        </div><div class="casAbstract">To investigate the effect of K-115, a novel Rho kinase (ROCK) inhibitor, on retinal ganglion cell (RGC) survival in an optic nerve crush (NC) model.  Addnl., to det. the details of the mechanism of K-115's neuroprotective effect in vivo and in vitro.  ROCK inhibitors, including K-115 and fasudil (1 mg/kg/d), or vehicle were administered orally to C57BL/6 mice.  Retinal ganglion cell death was then induced with NC.  Retinal ganglion cell survival was evaluated by counting surviving retrogradely labeled cells and measuring RGC marker expression with quant. real-time polymerase chain reaction (qRT-PCR).  Total oxidized lipid levels were assessed with a thiobarbituric acid-reactive substances (TBARS) assay.  Reactive oxygen species (ROS) levels were assessed by co-labeling with CellROX and Fluorogold.  Expression of the NADPH oxidase (Nox) family of genes was evaluated with qRT-PCR.  The survival of RGCs after NC was increased 34 ± 3% with K-115, a significantly protective effect.  Moreover, a similar effect was revealed by the qRT-PCR anal. of Thy-1.2 and Brn3a, RGC markers.  Levels of oxidized lipids and ROS also increased with time after NC.  NC-induced oxidative stress, including oxidn. of lipids and prodn. of ROS, was significantly attenuated by K-115.  Furthermore, expression of the Nox gene family, esp. Nox1, which is involved in the NC-induced ROS prodn. pathway, was dramatically reduced by K-115.  The results indicated that oral K-115 administration delayed RGC death.  Although K-115 may be mediated through Nox1 downregulation, we found that it did not suppress ROS prodn. directly.  Our findings show that K-115 has a potential use in neuroprotective treatment for glaucoma and other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7y2j7EK2KoLVg90H21EOLACvtfcHk0lgWhHKoO1QAjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVOltbfN&md5=f0db38d732b7244c73b3aeca80cf193a</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1167%2Fiovs.13-13842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.13-13842%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DMaruyama%26aufirst%3DK.%26aulast%3DHimori%26aufirst%3DN.%26aulast%3DOmodaka%26aufirst%3DK.%26aulast%3DYokoyama%26aufirst%3DY.%26aulast%3DShiga%26aufirst%3DY.%26aulast%3DMorin%26aufirst%3DR.%26aulast%3DNakazawa%26aufirst%3DT.%26atitle%3DThe%2520novel%2520Rho%2520kinase%2520%2528ROCK%2529%2520inhibitor%2520K-115%253A%2520a%2520new%2520candidate%2520drug%2520for%2520neuroprotective%2520treatment%2520in%2520glaucoma%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2014%26volume%3D55%26issue%3D11%26spage%3D7126%26epage%3D7136%26doi%3D10.1167%2Fiovs.13-13842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fogliatto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gianellini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brasca, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casale, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballinari, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciomei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degrassi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Ponti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guanci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paolucci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polucci, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valsasina, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccotto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesenti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantegani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isacchi, A.</span></span> <span> </span><span class="NLM_article-title">NMS-E973, a novel synthetic inhibitor of Hsp90 with activity against multiple models of drug resistance to targeted agents, including intracranial metastases</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">3520</span>– <span class="NLM_lpage">3532</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-3512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1158%2F1078-0432.CCR-12-3512" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=23674492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtValt7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=3520-3532&issue=13&author=G.+Fogliattoauthor=L.+Gianelliniauthor=M.+G.+Brascaauthor=E.+Casaleauthor=D.+Ballinariauthor=M.+Ciomeiauthor=A.+Degrassiauthor=A.+De+Pontiauthor=M.+Germaniauthor=M.+Guanciauthor=M.+Paolucciauthor=P.+Polucciauthor=M.+Russoauthor=F.+Solaauthor=B.+Valsasinaauthor=C.+Viscoauthor=F.+Zuccottoauthor=D.+Donatiauthor=E.+Felderauthor=E.+Pesentiauthor=A.+Galvaniauthor=S.+Manteganiauthor=A.+Isacchi&title=NMS-E973%2C+a+novel+synthetic+inhibitor+of+Hsp90+with+activity+against+multiple+models+of+drug+resistance+to+targeted+agents%2C+including+intracranial+metastases&doi=10.1158%2F1078-0432.CCR-12-3512"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">NMS-E973, a Novel Synthetic Inhibitor of Hsp90 with Activity against Multiple Models of Drug Resistance to Targeted Agents, Including Intracranial Metastases</span></div><div class="casAuthors">Fogliatto, Gianpaolo; Gianellini, Laura; Brasca, Maria G.; Casale, Elena; Ballinari, Dario; Ciomei, Marina; Degrassi, Anna; De Ponti, Anna; Germani, Massimiliano; Guanci, Marco; Paolucci, Mauro; Polucci, Paolo; Russo, Micaela; Sola, Francesco; Valsasina, Barbara; Visco, Carlo; Zuccotto, Fabio; Donati, Daniele; Felder, Eduard; Pesenti, Enrico; Galvani, Arturo; Mantegani, Sergio; Isacchi, Antonella</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3520-3532</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Recent developments of second generation Hsp90 inhibitors suggested a potential for development of this class of mols. also in tumors that have become resistant to mol. targeted agents.  Disease progression is often due to brain metastases, sometimes related to insufficient drug concns. within the brain.  Our objective was to identify and characterize a novel inhibitor of Hsp90 able to cross the blood-brain barrier (BBB).  Exptl. Design: Here is described a detailed biochem. and crystallog. characterization of NMS-E973.  Mechanism-based anticancer activity was described in cell models, including models of resistance to kinase inhibitors.  Pharmacokinetics properties were followed in plasma, tumor, liver, and brain.  In vivo activity and pharmacodynamics, as well as the pharmacokinetic/pharmacodynamic relationships, were evaluated in xenografts, including an intracranially implanted melanoma model.  Results: NMS-E973, representative of a novel isoxazole-derived class of Hsp90 inhibitors, binds Hsp90α with subnanomolar affinity and high selectivity towards kinases, as well as other ATPases.  It possesses potent antiproliferative activity against tumor cell lines and a favorable pharmacokinetic profile, with selective retention in tumor tissue and ability to cross the BBB.  NMS-E973 induces tumor shrinkage in different human tumor xenografts, and is highly active in models of resistance to kinase inhibitors.  Moreover, consistent with its brain penetration, NMS-E973 is active also in an intracranially implanted melanoma model.  Conclusions: Overall, the efficacy profile of NMS-E973 suggests a potential for development in different clin. settings, including tumors that have become resistant to mol. targeted agents, particularly in cases of tumors which reside beyond the BBB.  Clin Cancer Res; 19(13); 3520-32. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-27WeJC9bM7Vg90H21EOLACvtfcHk0lgWhHKoO1QAjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtValt7bM&md5=fcf8b530e3581ba78e0c0668755ecfe6</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-3512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-3512%26sid%3Dliteratum%253Aachs%26aulast%3DFogliatto%26aufirst%3DG.%26aulast%3DGianellini%26aufirst%3DL.%26aulast%3DBrasca%26aufirst%3DM.%2BG.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DBallinari%26aufirst%3DD.%26aulast%3DCiomei%26aufirst%3DM.%26aulast%3DDegrassi%26aufirst%3DA.%26aulast%3DDe%2BPonti%26aufirst%3DA.%26aulast%3DGermani%26aufirst%3DM.%26aulast%3DGuanci%26aufirst%3DM.%26aulast%3DPaolucci%26aufirst%3DM.%26aulast%3DPolucci%26aufirst%3DP.%26aulast%3DRusso%26aufirst%3DM.%26aulast%3DSola%26aufirst%3DF.%26aulast%3DValsasina%26aufirst%3DB.%26aulast%3DVisco%26aufirst%3DC.%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DFelder%26aufirst%3DE.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DGalvani%26aufirst%3DA.%26aulast%3DMantegani%26aufirst%3DS.%26aulast%3DIsacchi%26aufirst%3DA.%26atitle%3DNMS-E973%252C%2520a%2520novel%2520synthetic%2520inhibitor%2520of%2520Hsp90%2520with%2520activity%2520against%2520multiple%2520models%2520of%2520drug%2520resistance%2520to%2520targeted%2520agents%252C%2520including%2520intracranial%2520metastases%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26issue%3D13%26spage%3D3520%26epage%3D3532%26doi%3D10.1158%2F1078-0432.CCR-12-3512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lundgren, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brekken, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huser, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timple, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busch, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neely, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sensintaffar, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scannevin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasibhatla, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, F. J.</span></span> <span> </span><span class="NLM_article-title">BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">921</span>– <span class="NLM_lpage">929</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-08-0758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1158%2F1535-7163.MCT-08-0758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19372565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1amt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=921-929&issue=4&author=K.+Lundgrenauthor=H.+Zhangauthor=J.+Brekkenauthor=N.+Huserauthor=R.+E.+Powellauthor=N.+Timpleauthor=D.+J.+Buschauthor=L.+Neelyauthor=J.+L.+Sensintaffarauthor=Y.+C.+Yangauthor=A.+McKenzieauthor=J.+Friedmanauthor=R.+Scannevinauthor=A.+Kamalauthor=K.+Hongauthor=S.+R.+Kasibhatlaauthor=M.+F.+Boehmauthor=F.+J.+Burrows&title=BIIB021%2C+an+orally+available%2C+fully+synthetic+small-molecule+inhibitor+of+the+heat+shock+protein+Hsp90&doi=10.1158%2F1535-7163.MCT-08-0758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90</span></div><div class="casAuthors">Lundgren, Karen; Zhang, Hong; Brekken, John; Huser, Nanni; Powell, Rachel E.; Timple, Noel; Busch, David J.; Neely, Laura; Sensintaffar, John L.; Yang, Yong-ching; McKenzie, Andres; Friedman, Jessica; Scannevin, Robert; Kamal, Adeela; Hong, Kevin; Kasibhatla, Srinivas R.; Boehm, Marcus F.; Burrows, Francis J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">921-929</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inhibition of heat shock protein 90 (Hsp90) results in the degrdn. of oncoproteins that drive malignant progression, inducing cell death, making Hsp90 a target of substantial interest for cancer therapy.  BIIB021 is a novel, fully synthetic inhibitor of Hsp90 that binds competitively with geldanamycin in the ATP-binding pocket of Hsp90.  In tumor cells, BIIB021 induced the degrdn. of Hsp90 client proteins including HER-2, AKT, and Raf-1 and up-regulated expression of the heat shock proteins Hsp70 and Hsp27.  BIIB021 treatment resulted in growth inhibition and cell death in cell lines from a variety of tumor types at nanomolar concns.  Oral administration of BIIB021 led to the degrdn. of Hsp90 client proteins measured in tumor tissue and resulted in the inhibition of tumor growth in several human tumor xenograft models.  Studies to investigate the antitumor effects of BIIB021 showed activity on both daily and intermittent dosing schedules, providing dose schedule flexibility for clin. studies.  Assays measuring the HER-2 protein in tumor tissue and the HER-2 extracellular domain in plasma were used to show interdiction of the Hsp90 pathway and utility as potential biomarkers in clin. trials for BIIB021.  Together, these data show that BIIB021 is a promising new oral inhibitor of Hsp90 with antitumor activity in preclin. models.[Mol Cancer Ther 2009;8(4):921-9].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSbI2RYG4aF7Vg90H21EOLACvtfcHk0lgZHDHKi35gAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1amt74%253D&md5=271e2311ab807bc74b2ac66b81e514e1</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0758%26sid%3Dliteratum%253Aachs%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBrekken%26aufirst%3DJ.%26aulast%3DHuser%26aufirst%3DN.%26aulast%3DPowell%26aufirst%3DR.%2BE.%26aulast%3DTimple%26aufirst%3DN.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DNeely%26aufirst%3DL.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DY.%2BC.%26aulast%3DMcKenzie%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DJ.%26aulast%3DScannevin%26aufirst%3DR.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26atitle%3DBIIB021%252C%2520an%2520orally%2520available%252C%2520fully%2520synthetic%2520small-molecule%2520inhibitor%2520of%2520the%2520heat%2520shock%2520protein%2520Hsp90%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26issue%3D4%26spage%3D921%26epage%3D929%26doi%3D10.1158%2F1535-7163.MCT-08-0758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mashino, T.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of the protein-protein interaction between phosphorylated p62 and Keap1 attenuate chemoresistance in a human hepatocellular carcinoma cell line</span>. <i>Free Radical Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1080/10715762.2020.1732955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1080%2F10715762.2020.1732955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=32075457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BB387jvVCmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=1-291&author=D.+Yasudaauthor=T.+Oheauthor=K.+Takahashiauthor=R.+Imamuraauthor=H.+Kojimaauthor=T.+Okabeauthor=Y.+Ichimuraauthor=M.+Komatsuauthor=M.+Yamamotoauthor=T.+Naganoauthor=T.+Mashino&title=Inhibitors+of+the+protein-protein+interaction+between+phosphorylated+p62+and+Keap1+attenuate+chemoresistance+in+a+human+hepatocellular+carcinoma+cell+line&doi=10.1080%2F10715762.2020.1732955"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of the protein-protein interaction between phosphorylated p62 and Keap1 attenuate chemoresistance in a human hepatocellular carcinoma cell line</span></div><div class="casAuthors">Yasuda Daisuke; Ohe Tomoyuki; Takahashi Kyoko; Mashino Tadahiko; Imamura Riyo; Kojima Hirotatsu; Okabe Takayoshi; Nagano Tetsuo; Ichimura Yoshinobu; Komatsu Masaaki; Yamamoto Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Free radical research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Resistance to anticancer agents has been an obstacle to developing therapeutics and reducing medical costs.  Whereas sorafenib is used for the treatment of human hepatocellular carcinoma (HCC), resistance limits its efficacy. p62, a multifunctional protein, is overexpressed in several HCC cell lines, such as Huh-1 cells.  Phosphorylated p62 (p-p62) inhibits the protein-protein interaction (PPI) between Keap1 and Nrf2, resulting in the Nrf2 overactivation that causes drug resistance.  We have found a unique Nrf2 inactivator, named K67, that inhibited the PPI between Keap1 and p-p62 and attenuated sorafenib resistance in Huh-1 cells.  Herein, we designed and synthesised novel K67 derivatives by modification of the substituent at the 4-position of the two benzenesulfonyl groups of K67.  Although these new derivatives inhibited the Keap1-p-p62 PPI to a level comparable to or weaker than that of K67, the isopropoxy derivative enhanced the sensitivity of Huh-1 cells to sorafenib to a greater extent than K67 without any influence on the viability of Huh-7 cells, which is a non-resistant HCC cell line.  The isopropoxy derivative also increased the sensitivity of Huh-1 cells to regorafenib, which suggests that this derivative has the potential to be used as an agent to overcome chemoresistance based on Nrf2 inactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCl4j53i96sv69nzq6467DfW6udTcc2eZ6w-HsliQplbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB387jvVCmug%253D%253D&md5=02ebd4ea0c0d75e0d7324c2dcfdcd869</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1080%2F10715762.2020.1732955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10715762.2020.1732955%26sid%3Dliteratum%253Aachs%26aulast%3DYasuda%26aufirst%3DD.%26aulast%3DOhe%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DImamura%26aufirst%3DR.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DIchimura%26aufirst%3DY.%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DNagano%26aufirst%3DT.%26aulast%3DMashino%26aufirst%3DT.%26atitle%3DInhibitors%2520of%2520the%2520protein-protein%2520interaction%2520between%2520phosphorylated%2520p62%2520and%2520Keap1%2520attenuate%2520chemoresistance%2520in%2520a%2520human%2520hepatocellular%2520carcinoma%2520cell%2520line%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2020%26spage%3D1%26epage%3D291%26doi%3D10.1080%2F10715762.2020.1732955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuganezawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinohara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noda, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inagaki, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohsumi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, A.</span></span> <span> </span><span class="NLM_article-title">Two-colored fluorescence correlation spectroscopy screening for LC3-P62 interaction inhibitors</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1103</span>– <span class="NLM_lpage">1109</span>, <span class="refDoi"> DOI: 10.1177/1087057113492200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1177%2F1087057113492200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=23741014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslWjsLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=1103-1109&issue=9&author=K.+Tsuganezawaauthor=Y.+Shinoharaauthor=N.+Ogawaauthor=S.+Tsuboiauthor=N.+Okadaauthor=M.+Moriauthor=S.+Yokoyamaauthor=N.+N.+Nodaauthor=F.+Inagakiauthor=Y.+Ohsumiauthor=A.+Tanaka&title=Two-colored+fluorescence+correlation+spectroscopy+screening+for+LC3-P62+interaction+inhibitors&doi=10.1177%2F1087057113492200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Two-colored fluorescence correlation spectroscopy screening for LC3-P62 interaction inhibitors</span></div><div class="casAuthors">Tsuganezawa, Keiko; Shinohara, Yoshiyasu; Ogawa, Naoko; Tsuboi, Shun; Okada, Norihisa; Mori, Masumi; Yokoyama, Shigeyuki; Noda, Nobuo N.; Inagaki, Fuyuhiko; Ohsumi, Yoshinori; Tanaka, Akiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1103-1109, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The fluorescence correlation spectroscopy (FCS)-based competitive binding assay to screen for protein-protein interaction inhibitors is a highly sensitive method as compared with the fluorescent polarization assay used conventionally.  However, the FCS assay identifies many false-pos. compds., which requires specifically designed orthogonal screenings.  A two-colored application of the FCS-based screening was newly developed, and inhibitors of a protein-protein interaction, involving selective autophagy, were selected.  We focused on the interaction of LC3 with the adaptor protein p62, because the interaction is crucial to degrade the specific target proteins recruited by p62.  First, about 10,000 compds. were subjected to the FCS-based competitive assay using a TAMRA-labeled p62-derived probe, and 29 hit compds. were selected.  Next, the obtained hits were evaluated by the second FCS assay, using an Alexa647-labeled p62-derived probe to remove the false-pos. compds., and six hit compds. inhibited the interaction.  Finally, we tested all 29 compds. by surface plasmon resonance-based competitive binding assay to evaluate their inhibition of the LC3-p62 interaction and selected two inhibitors with IC50 values less than 2 μM.  The two-colored FCS-based screening was shown to be effective to screen for protein-protein interaction inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonqJany-BymLVg90H21EOLACvtfcHk0lgZHDHKi35gAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslWjsLnE&md5=b1b6e7e4b385ea19dbcf0551a6236a66</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1177%2F1087057113492200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057113492200%26sid%3Dliteratum%253Aachs%26aulast%3DTsuganezawa%26aufirst%3DK.%26aulast%3DShinohara%26aufirst%3DY.%26aulast%3DOgawa%26aufirst%3DN.%26aulast%3DTsuboi%26aufirst%3DS.%26aulast%3DOkada%26aufirst%3DN.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DNoda%26aufirst%3DN.%2BN.%26aulast%3DInagaki%26aufirst%3DF.%26aulast%3DOhsumi%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DA.%26atitle%3DTwo-colored%2520fluorescence%2520correlation%2520spectroscopy%2520screening%2520for%2520LC3-P62%2520interaction%2520inhibitors%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2013%26volume%3D18%26issue%3D9%26spage%3D1103%26epage%3D1109%26doi%3D10.1177%2F1087057113492200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chung, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sontheimer, H.</span></span> <span> </span><span class="NLM_article-title">Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor-kappaB</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">193</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2009.06129.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1111%2Fj.1471-4159.2009.06129.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19457125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVCmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2009&pages=182-193&issue=1&author=W.+J.+Chungauthor=H.+Sontheimer&title=Sulfasalazine+inhibits+the+growth+of+primary+brain+tumors+independent+of+nuclear+factor-kappaB&doi=10.1111%2Fj.1471-4159.2009.06129.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor-κB</span></div><div class="casAuthors">Chung, W. Joon; Sontheimer, Harald</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">182-193</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Nuclear factor-κB (NF-κB) is a pleiotropic transcription factor that generally enhances cellular resistance to apoptotic cell death.  It has been shown to be constitutively active in some cancers and is being pursued as potential anticancer target.  Sulfasalazine which is used clin. to treat Crohn's disease has emerged as a potential inhibitor of NF-κB and has shown promising results in two pre-clin. studies to target primary brain tumors, gliomas.  Once digested, sulfasalazine is cleaved into sulfapyridine and 5-aminosalicylic acid (5-ASA; mesalamine) by colonic bacteria, and the latter, too, is reported to suppress NF-κB activity.  We now show that glioma cells obtained from patient biopsies or glioma cell lines do not show significant constitutive NF-κB activation, unless exposed to inflammatory cytokines.  This does not change when gliomas are implanted into the cerebrum of severe combined immundeficient mice.  Nevertheless, sulfasalazine but not its cleaved form 5-ASA caused a dose-dependent inhibition of glioma growth.  This effect was entirely attributable to the inhibition of cystine uptake via the system xc- cystine-glutamate transporter.  It could be mimicked by S-4-carboxy-phenylglycine (S-4-CPG) a more specific system xc- inhibitor, and lentiviral expression of a constitutively active form of IκB kinase b was unable to overcome the growth retarding effects of sulfasalazine or S-4-CPG.  Both drugs inhibited cystine uptake causing a chronic depletion of intracellular GSH and consequently compromised cellular redox defense which stymied tumor growth.  This data suggests that system xc- is a promising therapeutic target in gliomas and possibly other cancers and that it can be pharmacol. inhibited by Sulfasalazine, an FDA-approved drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRj_MjJmn6C7Vg90H21EOLACvtfcHk0lgszyXs50UzpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVCmtLo%253D&md5=dca393070e5e4fa0c16b61f53c99b7f1</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2009.06129.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2009.06129.x%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DW.%2BJ.%26aulast%3DSontheimer%26aufirst%3DH.%26atitle%3DSulfasalazine%2520inhibits%2520the%2520growth%2520of%2520primary%2520brain%2520tumors%2520independent%2520of%2520nuclear%2520factor-kappaB%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D110%26issue%3D1%26spage%3D182%26epage%3D193%26doi%3D10.1111%2Fj.1471-4159.2009.06129.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rangaraju, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verrier, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madorsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, W. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Notterpek, L.</span></span> <span> </span><span class="NLM_article-title">Rapamycin activates autophagy and improves myelination in explant cultures from neuropathic mice</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">34</span>),  <span class="NLM_fpage">11388</span>– <span class="NLM_lpage">11397</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.1356-10.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1523%2FJNEUROSCI.1356-10.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20739560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFens7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=11388-11397&issue=34&author=S.+Rangarajuauthor=J.+D.+Verrierauthor=I.+Madorskyauthor=J.+Nicksauthor=W.+A.+Dunnauthor=L.+Notterpek&title=Rapamycin+activates+autophagy+and+improves+myelination+in+explant+cultures+from+neuropathic+mice&doi=10.1523%2FJNEUROSCI.1356-10.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Rapamycin activates autophagy and improves myelination in explant cultures from neuropathic mice</span></div><div class="casAuthors">Rangaraju, Sunitha; Verrier, Jonathan D.; Madorsky, Irina; Nicks, Jessica; Dunn, William A., Jr.; Notterpek, Lucia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">11388-11397</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Misexpression and cytosolic retention of peripheral myelin protein 22 (PMP22) within Schwann cells (SCs) is assocd. with a genetically heterogeneous group of demyelinating peripheral neuropathies.  PMP22 overproducer C22 and spontaneous mutant Trembler J (TrJ) mice display neuropathic phenotypes and affected nerves contain abnormally localized PMP22.  Nutrient deprivation-induced autophagy is able to suppress the formation of PMP22 aggregates in a toxin-induced cellular model, and improve locomotor performance and myelination in TrJ mice.  As a step toward therapies, we assessed whether pharmacol. activation of autophagy by rapamycin (RM) could facilitate the processing of PMP22 within neuropathic SCs and enhance their capacity to myelinate peripheral axons.  Exposure of mouse SCs to RM induced autophagy in a dose- and time-dependent manner and decreased the accumulation of poly-ubiquitinated substrates.  The treatment of myelinating dorsal root ganglion (DRG) explant cultures from neuropathic mice with RM (25 nm) improved the processing of PMP22 and increased the abundance and length of myelin internodes, as well as the expression of myelin proteins.  Notably, RM is similarly effective in both the C22 and TrJ model, signifying that the benefit overlaps among distinct genetic models of PMP22 neuropathies.  Furthermore, lentivirus-mediated shRNA knockdown of the autophagy-related gene 12 (Atg12) abolished the activation of autophagy and the increase in myelin proteins, demonstrating that autophagy is crit. for the obsd. improvement.  Together, these results support the potential use of RM and other autophagy-enhancing compds. as therapeutic agents for PMP22-assocd. demyelinating neuropathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHJQBmoa_TPbVg90H21EOLACvtfcHk0lgszyXs50UzpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFens7bE&md5=dafa8368d10878b8a40aeab2917b5639</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1356-10.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1356-10.2010%26sid%3Dliteratum%253Aachs%26aulast%3DRangaraju%26aufirst%3DS.%26aulast%3DVerrier%26aufirst%3DJ.%2BD.%26aulast%3DMadorsky%26aufirst%3DI.%26aulast%3DNicks%26aufirst%3DJ.%26aulast%3DDunn%26aufirst%3DW.%2BA.%26aulast%3DNotterpek%26aufirst%3DL.%26atitle%3DRapamycin%2520activates%2520autophagy%2520and%2520improves%2520myelination%2520in%2520explant%2520cultures%2520from%2520neuropathic%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26issue%3D34%26spage%3D11388%26epage%3D11397%26doi%3D10.1523%2FJNEUROSCI.1356-10.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lane, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McSheehy, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allegrini, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boulay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brueggen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littlewood-Evans, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maira, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martiny-Baron, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnell, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, T.</span></span> <span> </span><span class="NLM_article-title">mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1612</span>– <span class="NLM_lpage">1622</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-08-2057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1158%2F1078-0432.CCR-08-2057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19223496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisVWrsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=1612-1622&issue=5&author=H.+A.+Laneauthor=J.+M.+Woodauthor=P.+M.+McSheehyauthor=P.+R.+Allegriniauthor=A.+Boulayauthor=J.+Brueggenauthor=A.+Littlewood-Evansauthor=S.+M.+Mairaauthor=G.+Martiny-Baronauthor=C.+R.+Schnellauthor=P.+Siniauthor=T.+O%E2%80%99Reilly&title=mTOR+inhibitor+RAD001+%28everolimus%29+has+antiangiogenic%2Fvascular+properties+distinct+from+a+VEGFR+tyrosine+kinase+inhibitor&doi=10.1158%2F1078-0432.CCR-08-2057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">mTOR Inhibitor RAD001 (Everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor</span></div><div class="casAuthors">Lane, Heidi A.; Wood, Jeanette M.; McSheehy, Paul M. J.; Allegrini, Peter R.; Boulay, Anne; Brueggen, Joseph; Littlewood-Evans, Amanda; Maira, Sauveur-Michel; Martiny-Baron, Georg; Schnell, Christian R.; Sini, Patrizia; O'Reilly, Terence</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1612-1622</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Comparison of the antiangiogenic/vascular properties of the oral mammalian target of rapamycin (mTOR) inhibitor RAD001 (everolimus) and the vascular endothelial growth factor receptor (VEGFR) inhibitor vatalanib (PTK/ZK).  Antiproliferative activity against various tumor histotypes and downstream effects on the mTOR pathway were measured in vitro.  In vivo, antitumor activity, plasma, and tumor RAD001 levels were measured.  Activity in several different angiogenic/vascular assays in vitro and in vivo was assessed and compared with PTK/ZK.  RAD001 inhibited proliferation in vitro (IC50 values <1 nmol/L to >1 μmol/L), and in sensitive and insensitive tumor cells, pS6 kinase and 4E-BP1 were inhibited.  Activity in vitro did not correlate with activity in vivo and significant responses were seen in tumors with IC50 values >10-fold higher than tumor RAD001 concns.  In vitro, RAD001 inhibited the proliferation of VEGF-stimulated and fibroblast growth factor-stimulated human endothelial cells but not dermal fibroblasts and impaired VEGF release from both sensitive and insensitive tumor cells but did not inhibit migration of human endothelial cells.  In vivo, in tumor models derived from either sensitive or insensitive cells, RAD001 reduced Tie-2 levels, the amt. of mature and immature vessels, total plasma, and tumor VEGF.  RAD001 did not affect blood vessel leakiness in normal vasculature acutely exposed to VEGF nor did it affect tumor vascular permeability (Ktrans) as measured by dynamic contrast-enhanced magnetic resonance imaging.  However, the pan-VEGFR inhibitor PTK/ZK inhibited endothelial cell migration and vascular permeability but had less effect on mature vessels compared with RAD001.  VEGFR and mTOR inhibitors show similar but also distinct effects on tumor vascular biol., which has implications for their clin. activity alone or in combination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9GnfDB23UtbVg90H21EOLACvtfcHk0lgszyXs50UzpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisVWrsr0%253D&md5=43e02b9eff78ab07e48cef6e1900bd11</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-2057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-2057%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DH.%2BA.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DMcSheehy%26aufirst%3DP.%2BM.%26aulast%3DAllegrini%26aufirst%3DP.%2BR.%26aulast%3DBoulay%26aufirst%3DA.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DLittlewood-Evans%26aufirst%3DA.%26aulast%3DMaira%26aufirst%3DS.%2BM.%26aulast%3DMartiny-Baron%26aufirst%3DG.%26aulast%3DSchnell%26aufirst%3DC.%2BR.%26aulast%3DSini%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DT.%26atitle%3DmTOR%2520inhibitor%2520RAD001%2520%2528everolimus%2529%2520has%2520antiangiogenic%252Fvascular%2520properties%2520distinct%2520from%2520a%2520VEGFR%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26issue%3D5%26spage%3D1612%26epage%3D1622%26doi%3D10.1158%2F1078-0432.CCR-08-2057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maira, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stauffer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brueggen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritsch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brachmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chene, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Pover, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoemaker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabbro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabriel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Echeverria, C.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1851</span>– <span class="NLM_lpage">1863</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-08-0017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1158%2F1535-7163.MCT-08-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18606717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1851-1863&issue=7&author=S.+M.+Mairaauthor=F.+Staufferauthor=J.+Brueggenauthor=P.+Furetauthor=C.+Schnellauthor=C.+Fritschauthor=S.+Brachmannauthor=P.+Cheneauthor=A.+De+Poverauthor=K.+Schoemakerauthor=D.+Fabbroauthor=D.+Gabrielauthor=M.+Simonenauthor=L.+Murphyauthor=P.+Finanauthor=W.+Sellersauthor=C.+Garcia-Echeverria&title=Identification+and+characterization+of+NVP-BEZ235%2C+a+new+orally+available+dual+phosphatidylinositol+3-kinase%2Fmammalian+target+of+rapamycin+inhibitor+with+potent+in+vivo+antitumor+activity&doi=10.1158%2F1535-7163.MCT-08-0017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span></div><div class="casAuthors">Maira, Sauveur-Michel; Stauffer, Frederic; Brueggen, Josef; Furet, Pascal; Schnell, Christian; Fritsch, Christine; Brachmann, Saskia; Chene, Patrick; De Pover, Alain; Schoemaker, Kevin; Fabbro, Doriano; Gabriel, Daniela; Simonen, Marjo; Murphy, Leon; Finan, Peter; Sellers, William; Garcia-Echeverria, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1851-1863</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin inhibitor (mTOR) pathway is often constitutively activated in human tumor cells, providing unique opportunities for anticancer therapeutic intervention.  NVP-BEZ235 is an imidazo[4,5-c]quinoline deriv. that inhibits PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes.  In cellular settings using human tumor cell lines, this mol. is able to effectively and specifically block the dysfunctional activation of the PI3K pathway, inducing G1 arrest.  The cellular activity of NVP-BEZ235 translates well in in vivo models of human cancer.  Thus, the compd. was well tolerated, displayed disease stasis when administered orally, and enhanced the efficacy of other anticancer agents when used in in vivo combination studies.  Ex vivo pharmacokinetic/pharmacodynamic analyses of tumor tissues showed a time-dependent correlation between compd. concn. and PI3K/Akt pathway inhibition.  Collectively, the preclin. data show that NVP-BEZ235 is a potent dual PI3K/mTOR modulator with favorable pharmaceutical properties.  NVP-BEZ235 is currently in phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyO784qv52vrVg90H21EOLACvtfcHk0lgOaTPr6M1AMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D&md5=5b1979e134dd12065198d86dbc11ce15</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0017%26sid%3Dliteratum%253Aachs%26aulast%3DMaira%26aufirst%3DS.%2BM.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DBrachmann%26aufirst%3DS.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DDe%2BPover%26aufirst%3DA.%26aulast%3DSchoemaker%26aufirst%3DK.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGabriel%26aufirst%3DD.%26aulast%3DSimonen%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520NVP-BEZ235%252C%2520a%2520new%2520orally%2520available%2520dual%2520phosphatidylinositol%25203-kinase%252Fmammalian%2520target%2520of%2520rapamycin%2520inhibitor%2520with%2520potent%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26issue%3D7%26spage%3D1851%26epage%3D1863%26doi%3D10.1158%2F1535-7163.MCT-08-0017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J. J.</span></span> <span> </span><span class="NLM_article-title">Induction of C/EBP homologous protein-mediated apoptosis and autophagy by licochalcone A in non-small cell lung cancer cells</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">26241</span>, <span class="refDoi"> DOI: 10.1038/srep26241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fsrep26241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27184816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28Xot1Gnsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=26241&author=Z.+H.+Tangauthor=X.+Chenauthor=Z.+Y.+Wangauthor=K.+Chaiauthor=Y.+F.+Wangauthor=X.+H.+Xuauthor=X.+W.+Wangauthor=J.+H.+Luauthor=Y.+T.+Wangauthor=X.+P.+Chenauthor=J.+J.+Lu&title=Induction+of+C%2FEBP+homologous+protein-mediated+apoptosis+and+autophagy+by+licochalcone+A+in+non-small+cell+lung+cancer+cells&doi=10.1038%2Fsrep26241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of C/EBP homologous protein-mediated apoptosis and autophagy by licochalcone A in non-small cell lung cancer cells</span></div><div class="casAuthors">Tang, Zheng-Hai; Chen, Xin; Wang, Zhao-Yu; Chai, Ke; Wang, Ya-Fang; Xu, Xiao-Huang; Wang, Xiao-Wen; Lu, Jia-Hong; Wang, Yi-Tao; Chen, Xiu-Ping; Lu, Jin-Jian</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26241</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Licochalcone A (LCA), a flavonoid isolated from the famous Chinese medicinal herb Glycyrrhiza uralensis Fisch, presents obvious anti-cancer effects.  In this study, the anti-cancer effects and potential mechanisms of LCA in non-small cell lung cancer (NSCLC) cells were studied.  LCA decreased cell viability, increased lactate dehydrogenase release, and induced apoptosis in a concn.-dependent manner in NSCLC cells while not in human embryonic lung fibroblast cells.  The expression of phosphatidylethanolamine-modified microtubule-assocd. protein light-chain 3 (LC3-II) and formation of GFP-LC3 punta, two autophagic markers, were increased after treatment with LCA.  LCA-induced LC3-II expression was increased when combined with chloroquine (CQ), while knock-down of autophagy related protein (ATG) 7 or ATG5 reversed LCA-induced LC3-II expression and GFP-LC3 punta formation, suggesting that LCA induced autophagy in NSCLC cells.  Inhibition of autophagy could not reverse the LCA-induced cell viability decrease and apoptosis.  In addn., LCA increased the expression of endoplasmic reticulum stress related proteins, such as binding Ig protein and C/EBP homologous protein (CHOP).  Knock-down of CHOP reversed LCA-induced cell viability decrease, apoptosis, and autophagy.  Taken together, LCA-induced autophagic effect is an accompanied phenomenon in NSCLC cells, and CHOP is crit. for LCA-induced cell viability decrease, apoptosis, and autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc5AMA8-m9D7Vg90H21EOLACvtfcHk0lgOaTPr6M1AMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xot1Gnsrw%253D&md5=4c971728c4abbc419da2b13a912638da</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1038%2Fsrep26241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep26241%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DZ.%2BH.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DZ.%2BY.%26aulast%3DChai%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.%2BF.%26aulast%3DXu%26aufirst%3DX.%2BH.%26aulast%3DWang%26aufirst%3DX.%2BW.%26aulast%3DLu%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DY.%2BT.%26aulast%3DChen%26aufirst%3DX.%2BP.%26aulast%3DLu%26aufirst%3DJ.%2BJ.%26atitle%3DInduction%2520of%2520C%252FEBP%2520homologous%2520protein-mediated%2520apoptosis%2520and%2520autophagy%2520by%2520licochalcone%2520A%2520in%2520non-small%2520cell%2520lung%2520cancer%2520cells%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D26241%26doi%3D10.1038%2Fsrep26241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundu, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surh, Y. J.</span></span> <span> </span><span class="NLM_article-title">Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">7449</span>– <span class="NLM_lpage">7458</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-1266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1158%2F0008-5472.CAN-09-1266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=19738051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFaku7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=7449-7458&issue=18&author=M.+H.+Leeauthor=B.+Y.+Choiauthor=J.+K.+Kunduauthor=Y.+K.+Shinauthor=H.+K.+Naauthor=Y.+J.+Surh&title=Resveratrol+suppresses+growth+of+human+ovarian+cancer+cells+in+culture+and+in+a+murine+xenograft+model%3A+eukaryotic+elongation+factor+1A2+as+a+potential+target&doi=10.1158%2F0008-5472.CAN-09-1266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Resveratrol Suppresses Growth of Human Ovarian Cancer Cells in Culture and in a Murine Xenograft Model: Eukaryotic Elongation Factor 1A2 as a Potential Target</span></div><div class="casAuthors">Lee, Mee-Hyun; Choi, Bu Young; Kundu, Joydeb Kumar; Shin, Young Kee; Na, Hye-Kyung; Surh, Young-Joon</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7449-7458</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The eukaryotic elongation factor 1A2 (eEF1A2) is known to retain oncogenic potential and is recognized as a novel target for cancer prevention and therapy.  Resveratrol (trans-3,4',5-trihydroxystilbene), a phytoalexin present in grapes, has been reported to possess chemopreventive and chemotherapeutic activities.  In the present study, we examd. the growth-inhibitory effects of resveratrol in human ovarian cancer PA-1 cells, considering eEF1A2 as a potential mol. target.  Pretreatment with resveratrol attenuated proliferation of serum-starved PA-1 cells stimulated with insulin or serum.  Resveratrol also activated caspase-9, -7, and -3 and induced apoptosis in PA-1 cells in the presence of insulin or serum.  Insulin or serum stimulation of PA-1 cells resulted in the marked induction of eEF1A2, which was suppressed by pretreatment with resveratrol.  Moreover, resveratrol inhibited insulin- or serum-induced soft-agar colony formation in eEF1A2-transfected NIH3T3 cells.  An antibody array directed to assess the phosphorylation of protein kinases revealed that treatment with insulin or serum induced the phosphorylation of Akt in PA-1 cells.  Pharmacol. inhibition of Akt with LY294002 abrogated insulin- or serum-induced eEF1A2 expression and increased the caspase-3 activity.  In another expt., i.p. administration of resveratrol retarded the growth of PA-1 cell xenograft and the expression of eEF1A2 in athymic nude mice in assocn. with decreased bromodeoxyuridine positivity, reduced expression of proliferating cell nuclear antigen, increased the terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling and caspase-3 staining, and diminished CD31 positivity.  Taken together, eEF1A2 may be considered as a potential mol. target for the antiproliferative effects of resveratrol in PA-1 ovarian cancer cells. [Cancer Res 2009;69(18):7449-58].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonBbArTtNU87Vg90H21EOLACvtfcHk0liL_NitLUGRFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFaku7vE&md5=f252a9896a4a06e2292ac8beb2692bac</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-1266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-1266%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BH.%26aulast%3DChoi%26aufirst%3DB.%2BY.%26aulast%3DKundu%26aufirst%3DJ.%2BK.%26aulast%3DShin%26aufirst%3DY.%2BK.%26aulast%3DNa%26aufirst%3DH.%2BK.%26aulast%3DSurh%26aufirst%3DY.%2BJ.%26atitle%3DResveratrol%2520suppresses%2520growth%2520of%2520human%2520ovarian%2520cancer%2520cells%2520in%2520culture%2520and%2520in%2520a%2520murine%2520xenograft%2520model%253A%2520eukaryotic%2520elongation%2520factor%25201A2%2520as%2520a%2520potential%2520target%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26issue%3D18%26spage%3D7449%26epage%3D7458%26doi%3D10.1158%2F0008-5472.CAN-09-1266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somaiah, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, G.</span></span> <span> </span><span class="NLM_article-title">Antiangiogenic agents in the management of non-small cell lung cancer: where do we stand now and where are we headed?</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.4161/cbt.19594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.4161%2Fcbt.19594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22481432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFOiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=247-263&issue=5&author=C.+Aggarwalauthor=N.+Somaiahauthor=G.+Simon&title=Antiangiogenic+agents+in+the+management+of+non-small+cell+lung+cancer%3A+where+do+we+stand+now+and+where+are+we+headed%3F&doi=10.4161%2Fcbt.19594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Antiangiogenic agents in the management of non-small cell lung cancer: Where do we stand now and where are we headed?</span></div><div class="casAuthors">Aggarwal, Charu; Somaiah, Neeta; Simon, George R.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">247-263</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  Several therapies targeting angiogenesis are currently in development for non-small cell lung cancer (NSCLC).  This review discusses results of recent clin. trials evaluating chemotherapy plus antiangiogenic therapy for NSCLC.  Bevacizumab, an anti-VEGF antibody, is currently approved for the treatment of advanced NSCLC in combination with carboplatin and paclitaxel.  Completed phase III trials evaluating bevacizumab plus chemotherapy have shown prolonged progression-free survival; however, not all trials showed significant improvement in overall survival (OS).  Phase III trials of the tyrosine kinase inhibitors (TKIs) vandetanib and sorafenib and the vascular disrupting agent ASA404 also failed to improve OS compared with chemotherapy alone.  Clin. trials are ongoing involving several new antiangiogenic therapies, including ramucirumab, aflibercept, cediranib, nintedanib (BIBF 1120), sunitinib, pazopanib, brivanib, ABT-869, axitinib, ABT-751 and NPI-2358; several of these agents have shown promising phase I/II results.  Results from recently completed and ongoing phase III trials will det. if these newer antiangiogenic agents will be incorporated into clin. practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf7DKB8kq3hrVg90H21EOLACvtfcHk0liL_NitLUGRFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFOiurg%253D&md5=3dfaacfa20c4170f4e8845152d2737d3</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.4161%2Fcbt.19594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.19594%26sid%3Dliteratum%253Aachs%26aulast%3DAggarwal%26aufirst%3DC.%26aulast%3DSomaiah%26aufirst%3DN.%26aulast%3DSimon%26aufirst%3DG.%26atitle%3DAntiangiogenic%2520agents%2520in%2520the%2520management%2520of%2520non-small%2520cell%2520lung%2520cancer%253A%2520where%2520do%2520we%2520stand%2520now%2520and%2520where%2520are%2520we%2520headed%253F%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2012%26volume%3D13%26issue%3D5%26spage%3D247%26epage%3D263%26doi%3D10.4161%2Fcbt.19594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anagnostopoulou, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pediaditakis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alkahtani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alarifi, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gravanis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charalampopoulos, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stournaras, C.</span></span> <span> </span><span class="NLM_article-title">Differential effects of dehydroepiandrosterone and testosterone in prostate and colon cancer cell apoptosis: the role of nerve growth factor (NGF) receptors</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>154</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2446</span>– <span class="NLM_lpage">2456</span>, <span class="refDoi"> DOI: 10.1210/en.2012-2249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1210%2Fen.2012-2249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=23696568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVart7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2013&pages=2446-2456&issue=7&author=V.+Anagnostopoulouauthor=I.+Pediaditakisauthor=S.+Alkahtaniauthor=S.+A.+Alarifiauthor=E.+M.+Schmidtauthor=F.+Langauthor=A.+Gravanisauthor=I.+Charalampopoulosauthor=C.+Stournaras&title=Differential+effects+of+dehydroepiandrosterone+and+testosterone+in+prostate+and+colon+cancer+cell+apoptosis%3A+the+role+of+nerve+growth+factor+%28NGF%29+receptors&doi=10.1210%2Fen.2012-2249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects of dehydroepiandrosterone and testosterone in prostate and colon cancer cell apoptosis: the role of nerve growth factor (NGF) receptors</span></div><div class="casAuthors">Anagnostopoulou, Vasilesia; Pediaditakis, Iosif; Alkahtani, Saad; Alarifi, Saud A.; Schmidt, Eva-Maria; Lang, Florian; Gravanis, Achille; Charalampopoulos, Ioannis; Stournaras, Christos</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2446-2456</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Tumor growth is fostered by inhibition of cell death, which involves the receptiveness of tumor to growth factors and hormones.  We have recently shown that testosterone exerts proapoptotic effects in prostate and colon cancer cells through a membrane-initiated mechanism.  In addn., we have recently reported that dehydroepiandrosterone (DHEA) can control cell fate, activating nerve growth factor (NGF) receptors, namely tropomyosin-related kinase (Trk)A and p75 neurotrophin receptor, in primary neurons and in PC12 tumoral cells.  NGF was recently involved in cancer cell proliferation and apoptosis.  In the present study, we explored the cross talk between androgens (testosterone and DHEA) and NGF in regulating apoptosis of prostate and colon cancer cells.  DHEA and NGF strongly blunted serum deprivation-induced apoptosis, whereas testosterone induced apoptosis of both cancer cell lines.  The antiapoptotic effect of both DHEA and NGF was completely reversed by testosterone.  In line with this, DHEA or NGF up-regulated, whereas testosterone down-regulated, the expression of TrkA receptor.  The effects of androgens were abolished in both cell lines in the presence of TrkA inhibitor.  DHEA induced the phosphorylation of TrkA and the interaction of p75 neurotrophin receptor with its effectors, Rho protein GDP dissocn. inhibitor and receptor interacting serine/threonine-protein kinase 2.  Conversely, testosterone was unable to activate both receptors.  Testosterone acted as a DHEA and NGF antagonist, by blocking the activation of both receptors by DHEA or NGF.  Our findings suggest that androgens may influence hormone-sensitive tumor cells via their cross talk with NGF receptors.  The interplay between steroid hormone and neurotrophins signaling in hormone-dependent tumors offers new insights in the pathophysiol. of these neoplasias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW9lWIKhVh6LVg90H21EOLACvtfcHk0ljNq0vgWkmv7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVart7bF&md5=3618a632575a0a2fc148a0090a1af6a2</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1210%2Fen.2012-2249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2012-2249%26sid%3Dliteratum%253Aachs%26aulast%3DAnagnostopoulou%26aufirst%3DV.%26aulast%3DPediaditakis%26aufirst%3DI.%26aulast%3DAlkahtani%26aufirst%3DS.%26aulast%3DAlarifi%26aufirst%3DS.%2BA.%26aulast%3DSchmidt%26aufirst%3DE.%2BM.%26aulast%3DLang%26aufirst%3DF.%26aulast%3DGravanis%26aufirst%3DA.%26aulast%3DCharalampopoulos%26aufirst%3DI.%26aulast%3DStournaras%26aufirst%3DC.%26atitle%3DDifferential%2520effects%2520of%2520dehydroepiandrosterone%2520and%2520testosterone%2520in%2520prostate%2520and%2520colon%2520cancer%2520cell%2520apoptosis%253A%2520the%2520role%2520of%2520nerve%2520growth%2520factor%2520%2528NGF%2529%2520receptors%26jtitle%3DEndocrinology%26date%3D2013%26volume%3D154%26issue%3D7%26spage%3D2446%26epage%3D2456%26doi%3D10.1210%2Fen.2012-2249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roh, J. L.</span></span> <span> </span><span class="NLM_article-title">Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">454</span>– <span class="NLM_lpage">462</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2018.10.426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.freeradbiomed.2018.10.426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=30339884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFyrsbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2018&pages=454-462&author=D.+Shinauthor=E.+H.+Kimauthor=J.+Leeauthor=J.+L.+Roh&title=Nrf2+inhibition+reverses+resistance+to+GPX4+inhibitor-induced+ferroptosis+in+head+and+neck+cancer&doi=10.1016%2Fj.freeradbiomed.2018.10.426"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer</span></div><div class="casAuthors">Shin, Daiha; Kim, Eun Hye; Lee, Jaewang; Roh, Jong-Lyel</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">454-462</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glutathione peroxidase 4 (GPX4) is a regulator of ferroptosis (iron-dependent, non-apoptotic cell death); its inhibition can render therapy-resistant cancer cells susceptible to ferroptosis.  However, some cancer cells develop mechanisms protective against ferroptosis; understanding these mechanisms could help overcome chemoresistance.  In this study, we investigated the mol. mechanisms underlying resistance to ferroptosis induced by GPX4 inhibition in head and neck cancer (HNC).  The effects of two GPX4 inhibitors, (1S, 3R)-RSL3 and ML-162, and of trigonelline were tested in HNC cell lines, including cisplatin-resistant (HN3R) and acquired RSL3-resistant (HN3-rslR) cells.  The effects of the inhibitors and trigonelline, as well as of inhibition of the p62, Keap1, or Nrf2 genes, were assessed by cell viability, cell death, lipid ROS prodn., and protein expression, and in mouse tumor xenograft models.  Treatment with RSL3 or ML-162 induced the ferroptosis of HNC cells to varying degrees.  RSL3 or ML-162 treatment increased the expression of p62 and Nrf2 in chemoresistant HN3R and HN3-rslR cells, inactivated Keap1, and increased expression of the phospho-PERK-ATF4-SESN2 pathway.  Transcriptional activation of Nrf2 was assocd. with resistance to ferroptosis.  Overexpression of Nrf2 by inhibiting Keap1 or Nrf2 gene transfection rendered chemosensitive HN3 cells resistant to RSL3.  However, Nrf2 inhibition or p62 silencing sensitized HN3R cells to RSL3.  Trigonelline sensitized chemoresistant HNC cells to RSL3 treatment in a mouse model transplanted with HN3R.  Thus, activation of the Nrf2-ARE pathway contributed to the resistance of HNC cells to GPX4 inhibition, and inhibition of this pathway reversed the resistance to ferroptosis in HNC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCeKPEn4zW57Vg90H21EOLACvtfcHk0ljNq0vgWkmv7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFyrsbbL&md5=6f54318c8ae274298ba17898b5b52832</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2018.10.426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2018.10.426%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DE.%2BH.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DRoh%26aufirst%3DJ.%2BL.%26atitle%3DNrf2%2520inhibition%2520reverses%2520resistance%2520to%2520GPX4%2520inhibitor-induced%2520ferroptosis%2520in%2520head%2520and%2520neck%2520cancer%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2018%26volume%3D129%26spage%3D454%26epage%3D462%26doi%3D10.1016%2Fj.freeradbiomed.2018.10.426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis: Death by lipid peroxidation</span>. <i>Trends Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1016/j.tcb.2015.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.tcb.2015.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=26653790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCisbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=165-176&issue=3&author=W.+S.+Yangauthor=B.+R.+Stockwell&title=Ferroptosis%3A+Death+by+lipid+peroxidation&doi=10.1016%2Fj.tcb.2015.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis: Death by Lipid Peroxidation</span></div><div class="casAuthors">Yang, Wan Seok; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">165-176</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ferroptosis is a regulated form of cell death driven by loss of activity of the lipid repair enzyme glutathione peroxidase 4 (GPX4) and subsequent accumulation of lipid-based reactive oxygen species (ROS), particularly lipid hydroperoxides.  This form of iron-dependent cell death is genetically, biochem., and morphol. distinct from other cell death modalities, including apoptosis, unregulated necrosis, and necroptosis.  Ferroptosis is regulated by specific pathways and is involved in diverse biol. contexts.  Here we summarize the discovery of ferroptosis, the mechanism of ferroptosis regulation, and its increasingly appreciated relevance to both normal and pathol. physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs1AaEhcSJa7Vg90H21EOLACvtfcHk0lgdBip-NFE29w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCisbfK&md5=6b46735835ccc4add329d40713a4b6cd</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2015.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2015.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%2BS.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DFerroptosis%253A%2520Death%2520by%2520lipid%2520peroxidation%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2016%26volume%3D26%26issue%3D3%26spage%3D165%26epage%3D176%26doi%3D10.1016%2Fj.tcb.2015.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dowdle, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyfeler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elling, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triantafellow, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantwell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornella-Taracido, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fekkes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Digan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burdick, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helliwell, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Aquin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastien, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiederschain, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuerth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwalb, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugwonali, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harbinski, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallarico, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myer, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bussiere, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labow, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamann, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valdez, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keaney, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, L. O.</span></span> <span> </span><span class="NLM_article-title">Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1069</span>– <span class="NLM_lpage">1079</span>, <span class="refDoi"> DOI: 10.1038/ncb3053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fncb3053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=25327288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOisrnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=1069-1079&issue=11&author=W.+E.+Dowdleauthor=B.+Nyfelerauthor=J.+Nagelauthor=R.+A.+Ellingauthor=S.+Liuauthor=E.+Triantafellowauthor=S.+Menonauthor=Z.+Wangauthor=A.+Hondaauthor=G.+Pardeeauthor=J.+Cantwellauthor=C.+Luuauthor=I.+Cornella-Taracidoauthor=E.+Harringtonauthor=P.+Fekkesauthor=H.+Leiauthor=Q.+Fangauthor=M.+E.+Diganauthor=D.+Burdickauthor=A.+F.+Powersauthor=S.+B.+Helliwellauthor=S.+D%E2%80%99Aquinauthor=J.+Bastienauthor=H.+Wangauthor=D.+Wiederschainauthor=J.+Kuerthauthor=P.+Bergmanauthor=D.+Schwalbauthor=J.+Thomasauthor=S.+Ugwonaliauthor=F.+Harbinskiauthor=J.+Tallaricoauthor=C.+J.+Wilsonauthor=V.+E.+Myerauthor=J.+A.+Porterauthor=D.+E.+Bussiereauthor=P.+M.+Finanauthor=M.+A.+Labowauthor=X.+Maoauthor=L.+G.+Hamannauthor=B.+D.+Manningauthor=R.+A.+Valdezauthor=T.+Nicholsonauthor=M.+Schirleauthor=M.+S.+Knappauthor=E.+P.+Keaneyauthor=L.+O.+Murphy&title=Selective+VPS34+inhibitor+blocks+autophagy+and+uncovers+a+role+for+NCOA4+in+ferritin+degradation+and+iron+homeostasis+in+vivo&doi=10.1038%2Fncb3053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo</span></div><div class="casAuthors">Dowdle, William E.; Nyfeler, Beat; Nagel, Jane; Elling, Robert A.; Liu, Shanming; Triantafellow, Ellen; Menon, Suchithra; Wang, Zuncai; Honda, Ayako; Pardee, Gwynn; Cantwell, John; Luu, Catherine; Cornella-Taracido, Ivan; Harrington, Edmund; Fekkes, Peter; Lei, Hong; Fang, Qing; Digan, Mary Ellen; Burdick, Debra; Powers, Andrew F.; Helliwell, Stephen B.; D'Aquin, Simon; Bastien, Julie; Wang, Henry; Wiederschain, Dmitri; Kuerth, Jenny; Bergman, Philip; Schwalb, David; Thomas, Jason; Ugwonali, Savuth; Harbinski, Fred; Tallarico, John; Wilson, Christopher J.; Myer, Vic E.; Porter, Jeffery A.; Bussiere, Dirksen E.; Finan, Peter M.; Labow, Mark A.; Mao, Xiaohong; Hamann, Lawrence G.; Manning, Brendan D.; Valdez, Reginald A.; Nicholson, Thomas; Schirle, Markus; Knapp, Mark S.; Keaney, Erin P.; Murphy, Leon O.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1069-1079</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cells rely on autophagy to clear misfolded proteins and damaged organelles to maintain cellular homeostasis.  In this study we use the new autophagy inhibitor PIK-III to screen for autophagy substrates.  PIK-III is a selective inhibitor of VPS34 that binds a unique hydrophobic pocket not present in related kinases such as PI(3)Kα.  PIK-III acutely inhibits autophagy and de novo lipidation of LC3, and leads to the stabilization of autophagy substrates.  By performing ubiquitin-affinity proteomics on PIK-III-treated cells we identified substrates including NCOA4, which accumulates in ATG7-deficient cells and co-localizes with autolysosomes.  NCOA4 directly binds ferritin heavy chain-1 (FTH1) to target the iron-binding ferritin complex with a relative mol. mass of 450,000 to autolysosomes following starvation or iron depletion.  Interestingly, Ncoa4-/- mice exhibit a profound accumulation of iron in splenic macrophages, which are crit. for the reutilization of iron from engulfed red blood cells.  Taken together, the results of this study provide a new mechanism for selective autophagy of ferritin and reveal a previously unappreciated role for autophagy and NCOA4 in the control of iron homeostasis in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRcQWjov109LVg90H21EOLACvtfcHk0lgdBip-NFE29w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOisrnE&md5=cca365c06b5342dafb9314a98cb698c4</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1038%2Fncb3053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb3053%26sid%3Dliteratum%253Aachs%26aulast%3DDowdle%26aufirst%3DW.%2BE.%26aulast%3DNyfeler%26aufirst%3DB.%26aulast%3DNagel%26aufirst%3DJ.%26aulast%3DElling%26aufirst%3DR.%2BA.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DTriantafellow%26aufirst%3DE.%26aulast%3DMenon%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DHonda%26aufirst%3DA.%26aulast%3DPardee%26aufirst%3DG.%26aulast%3DCantwell%26aufirst%3DJ.%26aulast%3DLuu%26aufirst%3DC.%26aulast%3DCornella-Taracido%26aufirst%3DI.%26aulast%3DHarrington%26aufirst%3DE.%26aulast%3DFekkes%26aufirst%3DP.%26aulast%3DLei%26aufirst%3DH.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DDigan%26aufirst%3DM.%2BE.%26aulast%3DBurdick%26aufirst%3DD.%26aulast%3DPowers%26aufirst%3DA.%2BF.%26aulast%3DHelliwell%26aufirst%3DS.%2BB.%26aulast%3DD%25E2%2580%2599Aquin%26aufirst%3DS.%26aulast%3DBastien%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWiederschain%26aufirst%3DD.%26aulast%3DKuerth%26aufirst%3DJ.%26aulast%3DBergman%26aufirst%3DP.%26aulast%3DSchwalb%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DJ.%26aulast%3DUgwonali%26aufirst%3DS.%26aulast%3DHarbinski%26aufirst%3DF.%26aulast%3DTallarico%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DC.%2BJ.%26aulast%3DMyer%26aufirst%3DV.%2BE.%26aulast%3DPorter%26aufirst%3DJ.%2BA.%26aulast%3DBussiere%26aufirst%3DD.%2BE.%26aulast%3DFinan%26aufirst%3DP.%2BM.%26aulast%3DLabow%26aufirst%3DM.%2BA.%26aulast%3DMao%26aufirst%3DX.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26aulast%3DManning%26aufirst%3DB.%2BD.%26aulast%3DValdez%26aufirst%3DR.%2BA.%26aulast%3DNicholson%26aufirst%3DT.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DKnapp%26aufirst%3DM.%2BS.%26aulast%3DKeaney%26aufirst%3DE.%2BP.%26aulast%3DMurphy%26aufirst%3DL.%2BO.%26atitle%3DSelective%2520VPS34%2520inhibitor%2520blocks%2520autophagy%2520and%2520uncovers%2520a%2520role%2520for%2520NCOA4%2520in%2520ferritin%2520degradation%2520and%2520iron%2520homeostasis%2520in%2520vivo%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2014%26volume%3D16%26issue%3D11%26spage%3D1069%26epage%3D1079%26doi%3D10.1038%2Fncb3053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Honda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornella-Taracido, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triantafellow, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowdle, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiedershain, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maniara, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamann, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keaney, E. P.</span></span> <span> </span><span class="NLM_article-title">Potent, selective, and orally bioavailable inhibitors of VPS34 provide chemical tools to modulate autophagy in vivo</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00335</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00335" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVaht7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=72-76&issue=1&author=A.+Hondaauthor=E.+Harringtonauthor=I.+Cornella-Taracidoauthor=P.+Furetauthor=M.+S.+Knappauthor=M.+Glickauthor=E.+Triantafellowauthor=W.+E.+Dowdleauthor=D.+Wiedershainauthor=W.+Maniaraauthor=C.+Mooreauthor=P.+M.+Finanauthor=L.+G.+Hamannauthor=B.+Firestoneauthor=L.+O.+Murphyauthor=E.+P.+Keaney&title=Potent%2C+selective%2C+and+orally+bioavailable+inhibitors+of+VPS34+provide+chemical+tools+to+modulate+autophagy+in+vivo&doi=10.1021%2Facsmedchemlett.5b00335"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">Potent, Selective, and Orally Bioavailable Inhibitors of VPS34 Provide Chemical Tools to Modulate Autophagy in Vivo</span></div><div class="casAuthors">Honda, Ayako; Harrington, Edmund; Cornella-Taracido, Ivan; Furet, Pascal; Knapp, Mark S.; Glick, Meir; Triantafellow, Ellen; Dowdle, William E.; Wiedershain, Dmitri; Maniara, Wieslawa; Moore, Christine; Finan, Peter M.; Hamann, Lawrence G.; Firestone, Brant; Murphy, Leon O.; Keaney, Erin P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-76</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Autophagy is a dynamic process that regulates lysosomal-dependent degrdn. of cellular components.  Until recently the study of autophagy has been hampered by the lack of reliable pharmacol. tools, but selective inhibitors are now available to modulate the PI 3-kinase VPS34, which is required for autophagy.  Here the authors describe the discovery of potent and selective VPS34 inhibitors, e.g. I, their pharmacokinetic (PK) properties, and ability to inhibit autophagy in cellular and mouse models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfNB0Fz4jh9rVg90H21EOLACvtfcHk0lgOb4_p6GKhLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVaht7fF&md5=31ed3d118c705dfcf7ae94391c2f5701</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00335%26sid%3Dliteratum%253Aachs%26aulast%3DHonda%26aufirst%3DA.%26aulast%3DHarrington%26aufirst%3DE.%26aulast%3DCornella-Taracido%26aufirst%3DI.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DKnapp%26aufirst%3DM.%2BS.%26aulast%3DGlick%26aufirst%3DM.%26aulast%3DTriantafellow%26aufirst%3DE.%26aulast%3DDowdle%26aufirst%3DW.%2BE.%26aulast%3DWiedershain%26aufirst%3DD.%26aulast%3DManiara%26aufirst%3DW.%26aulast%3DMoore%26aufirst%3DC.%26aulast%3DFinan%26aufirst%3DP.%2BM.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DMurphy%26aufirst%3DL.%2BO.%26aulast%3DKeaney%26aufirst%3DE.%2BP.%26atitle%3DPotent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitors%2520of%2520VPS34%2520provide%2520chemical%2520tools%2520to%2520modulate%2520autophagy%2520in%2520vivo%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26issue%3D1%26spage%3D72%26epage%3D76%26doi%3D10.1021%2Facsmedchemlett.5b00335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robke, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laraia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carnero
Corrales, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konstantinidis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muroi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richters, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engbring, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomassi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J.</span></span> <span> </span><span class="NLM_article-title">Phenotypic identification of a novel autophagy inhibitor chemotype targeting lipid kinase VPS34</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">28</span>),  <span class="NLM_fpage">8153</span>– <span class="NLM_lpage">8157</span>, <span class="refDoi"> DOI: 10.1002/anie.201703738</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1002%2Fanie.201703738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2sXps1eht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=8153-8157&issue=28&author=L.+Robkeauthor=L.+Laraiaauthor=M.+A.+Carnero%0ACorralesauthor=G.+Konstantinidisauthor=M.+Muroiauthor=A.+Richtersauthor=M.+Winzkerauthor=T.+Engbringauthor=S.+Tomassiauthor=N.+Watanabeauthor=H.+Osadaauthor=D.+Rauhauthor=H.+Waldmannauthor=Y.+W.+Wuauthor=J.+Engel&title=Phenotypic+identification+of+a+novel+autophagy+inhibitor+chemotype+targeting+lipid+kinase+VPS34&doi=10.1002%2Fanie.201703738"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Phenotypic Identification of a Novel Autophagy Inhibitor Chemotype Targeting Lipid Kinase VPS34</span></div><div class="casAuthors">Robke, Lucas; Laraia, Luca; Carnero Corrales, Marjorie A.; Konstantinidis, Georgios; Muroi, Makoto; Richters, Andre; Winzker, Michael; Engbring, Tobias; Tomassi, Stefano; Watanabe, Nobumoto; Osada, Hiroyuki; Rauh, Daniel; Waldmann, Herbert; Wu, Yao-Wen; Engel, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">8153-8157</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Autophagy is a crit. regulator of cellular homeostasis and metab.  Interference with this process is considered a new approach for the treatment of disease, in particular cancer and neurol. disorders.  Therefore, novel small-mol. autophagy modulators are in high demand.  We describe the discovery of autophinib, a potent autophagy inhibitor with a novel chemotype.  Autophinib was identified by means of a phenotypic assay monitoring the formation of autophagy-induced puncta, indicating accumulation of the lipidated cytosolic protein LC3 on the autophagosomal membrane.  Target identification and validation revealed that autophinib inhibits autophagy induced by starvation or rapamycin by targeting the lipid kinase VPS34.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY54SF9Lnw9LVg90H21EOLACvtfcHk0lixac7XbDnz8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXps1eht78%253D&md5=408a6a3ac7717b58b97a43a195979846</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1002%2Fanie.201703738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201703738%26sid%3Dliteratum%253Aachs%26aulast%3DRobke%26aufirst%3DL.%26aulast%3DLaraia%26aufirst%3DL.%26aulast%3DCarnero%2BCorrales%26aufirst%3DM.%2BA.%26aulast%3DKonstantinidis%26aufirst%3DG.%26aulast%3DMuroi%26aufirst%3DM.%26aulast%3DRichters%26aufirst%3DA.%26aulast%3DWinzker%26aufirst%3DM.%26aulast%3DEngbring%26aufirst%3DT.%26aulast%3DTomassi%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DN.%26aulast%3DOsada%26aufirst%3DH.%26aulast%3DRauh%26aufirst%3DD.%26aulast%3DWaldmann%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%2BW.%26aulast%3DEngel%26aufirst%3DJ.%26atitle%3DPhenotypic%2520identification%2520of%2520a%2520novel%2520autophagy%2520inhibitor%2520chemotype%2520targeting%2520lipid%2520kinase%2520VPS34%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26issue%3D28%26spage%3D8153%26epage%3D8157%26doi%3D10.1002%2Fanie.201703738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alton, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kath, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lingardo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span> <span> </span><span class="NLM_article-title">Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1)</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>431</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1042/BJ20101024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1042%2FBJ20101024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20704563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1ahu7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=431&publication_year=2010&pages=245-255&issue=2&author=L.+R.+Pearceauthor=G.+R.+Altonauthor=D.+T.+Richterauthor=J.+C.+Kathauthor=L.+Lingardoauthor=J.+Chapmanauthor=C.+Hwangauthor=D.+R.+Alessi&title=Characterization+of+PF-4708671%2C+a+novel+and+highly+specific+inhibitor+of+p70+ribosomal+S6+kinase+%28S6K1%29&doi=10.1042%2FBJ20101024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1)</span></div><div class="casAuthors">Pearce, Laura R.; Alton, Gordon R.; Richter, Daniel T.; Kath, John C.; Lingardo, Laura; Chapman, Justin; Hwang, Catherine; Alessi, Dario R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">431</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">245-255</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">S6K1 (p70 ribosomal S6 kinase 1) is activated by insulin and growth factors via the PI3K (phosphoinositide 3-kinase) and mTOR (mammalian target of rapamycin) signaling pathways.  S6K1 regulates numerous processes, such as protein synthesis, growth, proliferation and longevity, and its inhibition has been proposed as a strategy for the treatment of cancer and insulin resistance.  In the present paper we describe a novel cell-permeable inhibitor of S6K1, PF-4708671, which specifically inhibits the S6K1 isoform with a Ki of 20 nM and IC50 of 160 nM.  PF-4708671 prevents the S6K1-mediated phosphorylation of S6 protein in response to IGF-1 (insulin-like growth factor 1), while having no effect upon the PMA-induced phosphorylation of substrates of the highly related RSK (p90 ribosomal S6 kinase) and MSK (mitogen- and stress-activated kinase) kinases.  PF-4708671 was also found to induce phosphorylation of the T-loop and hydrophobic motif of S6K1, an effect that is dependent upon mTORC1 (mTOR complex 1).  PF-4708671 is the first S6K1-specific inhibitor to be reported and will be a useful tool for delineating S6K1-specific roles downstream of mTOR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcvyQDLNhsbbVg90H21EOLACvtfcHk0lixac7XbDnz8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1ahu7rO&md5=50e4ca5dbe19b903836c1099c3b58e38</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1042%2FBJ20101024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20101024%26sid%3Dliteratum%253Aachs%26aulast%3DPearce%26aufirst%3DL.%2BR.%26aulast%3DAlton%26aufirst%3DG.%2BR.%26aulast%3DRichter%26aufirst%3DD.%2BT.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DLingardo%26aufirst%3DL.%26aulast%3DChapman%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DC.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DCharacterization%2520of%2520PF-4708671%252C%2520a%2520novel%2520and%2520highly%2520specific%2520inhibitor%2520of%2520p70%2520ribosomal%2520S6%2520kinase%2520%2528S6K1%2529%26jtitle%3DBiochem.%2520J.%26date%3D2010%26volume%3D431%26issue%3D2%26spage%3D245%26epage%3D255%26doi%3D10.1042%2FBJ20101024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marabita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baraldo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solagna, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceelen, J. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartori, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolte, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemazanyy, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyronnet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pende, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaauw, B.</span></span> <span> </span><span class="NLM_article-title">S6K1 is required for increasing skeletal muscle force during hypertrophy</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">501</span>– <span class="NLM_lpage">513</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2016.09.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.celrep.2016.09.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27705797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1aksb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=501-513&issue=2&author=M.+Marabitaauthor=M.+Baraldoauthor=F.+Solagnaauthor=J.+J.+M.+Ceelenauthor=R.+Sartoriauthor=H.+Nolteauthor=I.+Nemazanyyauthor=S.+Pyronnetauthor=M.+Krugerauthor=M.+Pendeauthor=B.+Blaauw&title=S6K1+is+required+for+increasing+skeletal+muscle+force+during+hypertrophy&doi=10.1016%2Fj.celrep.2016.09.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">S6K1 Is Required for Increasing Skeletal Muscle Force during Hypertrophy</span></div><div class="casAuthors">Marabita, Manuela; Baraldo, Martina; Solagna, Francesca; Ceelen, Judith Johanna Maria; Sartori, Roberta; Nolte, Hendrik; Nemazanyy, Ivan; Pyronnet, Stephane; Kruger, Marcus; Pende, Mario; Blaauw, Bert</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">501-513</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Loss of skeletal muscle mass and force aggravates age-related sarcopenia and numerous pathologies, such as cancer and diabetes.  The AKT-mTORC1 pathway plays a major role in stimulating adult muscle growth; however, the functional role of its downstream mediators in vivo is unknown.  Here, we show that simultaneous inhibition of mTOR signaling to both S6K1 and 4E-BP1 is sufficient to reduce AKT-induced muscle growth and render it insensitive to the mTORC1-inhibitor rapamycin.  Surprisingly, lack of mTOR signaling to 4E-BP1 only, or deletion of S6K1 alone, is not sufficient to reduce muscle hypertrophy or alter its sensitivity to rapamycin.  However, we report that, while not required for muscle growth, S6K1 is essential for maintaining muscle structure and force prodn.  Hypertrophy in the absence of S6K1 is characterized by compromised ribosome biogenesis and the formation of p62-pos. protein aggregates.  These findings identify S6K1 as a crucial player for maintaining muscle function during hypertrophy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohIRcc-lA1k7Vg90H21EOLACvtfcHk0lixac7XbDnz8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1aksb7K&md5=07d45431eec5b605d0ab0e8a5d5bc51c</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2016.09.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2016.09.020%26sid%3Dliteratum%253Aachs%26aulast%3DMarabita%26aufirst%3DM.%26aulast%3DBaraldo%26aufirst%3DM.%26aulast%3DSolagna%26aufirst%3DF.%26aulast%3DCeelen%26aufirst%3DJ.%2BJ.%2BM.%26aulast%3DSartori%26aufirst%3DR.%26aulast%3DNolte%26aufirst%3DH.%26aulast%3DNemazanyy%26aufirst%3DI.%26aulast%3DPyronnet%26aufirst%3DS.%26aulast%3DKruger%26aufirst%3DM.%26aulast%3DPende%26aufirst%3DM.%26aulast%3DBlaauw%26aufirst%3DB.%26atitle%3DS6K1%2520is%2520required%2520for%2520increasing%2520skeletal%2520muscle%2520force%2520during%2520hypertrophy%26jtitle%3DCell%2520Rep.%26date%3D2016%26volume%3D17%26issue%3D2%26spage%3D501%26epage%3D513%26doi%3D10.1016%2Fj.celrep.2016.09.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perisic, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R. L.</span></span> <span> </span><span class="NLM_article-title">Finding a fitting shoe for Cinderella: searching for an autophagy inhibitor</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">805</span>– <span class="NLM_lpage">807</span>, <span class="refDoi"> DOI: 10.4161/auto.6.6.12577</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.4161%2Fauto.6.6.12577" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20574157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BC3cjkslersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=805-807&issue=6&author=S.+Millerauthor=A.+Oleksyauthor=O.+Perisicauthor=R.+L.+Williams&title=Finding+a+fitting+shoe+for+Cinderella%3A+searching+for+an+autophagy+inhibitor&doi=10.4161%2Fauto.6.6.12577"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Finding a fitting shoe for Cinderella: searching for an autophagy inhibitor</span></div><div class="casAuthors">Miller Simon; Oleksy Arkadiusz; Perisic Olga; Williams Roger L</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">805-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Vps34 is the ancestral phosphatidylinositol 3-kinase (PtdIns3K) isoform and is essential for endosomal trafficking of proteins to the vacuole/lysosome, autophagy and phagocytosis.  Vps34-containing complexes associate with specific cellular compartments to produce PtdIns(3)P.  Understanding the roles of Vps34 has been hampered by the lack of potent, specific inhibitors.  To boost development of Vps34 inhibitors, we determined the crystal structures of Vps34 alone and in complexes with multitargeted PtdIns3K inhibitors.  These structures provided a first glimpse into the uniquely constricted ATP-binding site of Vps34 and enabled us to model Vps34 regulation.  We showed that the substrate-binding "activation" loop and the flexibly attached amphipathic C-terminal helix are crucial for catalysis on membranes.  The C-terminal helix also suppresses ATP hydrolysis in the absence of membranes.  We propose that membrane binding shifts the C-terminal helix to orient the enzyme for catalysis, and the Vps15 regulatory subunit, which binds to this and the preceding helix, may facilitate this process.  This C-terminal region may also represent a target for specific, non-ATP-competitive PtdIns3K inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRCfWmsTtK3tx0LsK7uFuY7fW6udTcc2ea-hnEgKcsT5rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjkslersw%253D%253D&md5=89ff222fe46103f0bcff0e4092dc5538</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.4161%2Fauto.6.6.12577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.6.6.12577%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DOleksy%26aufirst%3DA.%26aulast%3DPerisic%26aufirst%3DO.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26atitle%3DFinding%2520a%2520fitting%2520shoe%2520for%2520Cinderella%253A%2520searching%2520for%2520an%2520autophagy%2520inhibitor%26jtitle%3DAutophagy%26date%3D2010%26volume%3D6%26issue%3D6%26spage%3D805%26epage%3D807%26doi%3D10.4161%2Fauto.6.6.12577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morishita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayakawa, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwase, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naoe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiyoi, H.</span></span> <span> </span><span class="NLM_article-title">The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinib</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">35</span>),  <span class="NLM_fpage">56241</span>– <span class="NLM_lpage">56252</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.11025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.18632%2Foncotarget.11025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=27494842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BC2s3otVeiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=56241-56252&issue=35&author=T.+Morishitaauthor=F.+Hayakawaauthor=K.+Sugimotoauthor=M.+Iwaseauthor=H.+Yamamotoauthor=D.+Hiranoauthor=Y.+Kojimaauthor=N.+Imotoauthor=T.+Naoeauthor=H.+Kiyoi&title=The+photosensitizer+verteporfin+has+light-independent+anti-leukemic+activity+for+Ph-positive+acute+lymphoblastic+leukemia+and+synergistically+works+with+dasatinib&doi=10.18632%2Foncotarget.11025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinib</span></div><div class="casAuthors">Morishita Takanobu; Hayakawa Fumihiko; Yamamoto Hideyuki; Hirano Daiki; Kojima Yuki; Imoto Naoto; Kiyoi Hitoshi; Sugimoto Keiki; Iwase Mizuho; Naoe Tomoki</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">56241-56252</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cell lines have been used for drug discovery as useful models of cancers; however, they do not recapitulate cancers faithfully, particularly from the viewpoints of microenvironmental independence.  Patient-derived xenografts (PDX) are established by the transfer of primary tumor cells directly from patients into immunodeficient mice and can provide primary-like tumor cells of the amount needed at the desired time.  We developed a high-throughput drug screening system using PDX cells and performed drug screening using the PDX cells of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).  We established four Ph+ ALL PDX mice and performed high-throughput screening of 3440 compounds using leukemia cells from the PDX mice (PDX-cell screening).  The profiles of drugs selected by PDX-cell screening were markedly different from those by screening using the Ph+ ALL cell line.  We found that verteporfin, an FDA-approved drug, exhibited strong PDX cell-specific cytotoxicity.  In the validation assay, its GI50 was 228 nM, 395 nM, and 538 nM in three PDX cells and 3.93 μM, 2.11 μM, and 5.61 μM in three cell lines.  Although verteporfin is a photosensitizer activated by photoirradiation, its cytotoxic effects were mediated by the light-independent production of reactive oxygen species; therefore, its anti-leukemic effects were also exerted in vivo without photoirradiation.  Furthermore, it exhibited synergistic effects with dasatinib, an ABL kinase inhibitor.  These results indicated the potential of verteporfin as a new anti-leukemic reagent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRjLbpvJwtLh3T4ugvCDgnZfW6udTcc2ea-hnEgKcsT5rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3otVeiuw%253D%253D&md5=c4e63cfed5f285b35da2b2edd9aa35c0</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.11025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.11025%26sid%3Dliteratum%253Aachs%26aulast%3DMorishita%26aufirst%3DT.%26aulast%3DHayakawa%26aufirst%3DF.%26aulast%3DSugimoto%26aufirst%3DK.%26aulast%3DIwase%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DHirano%26aufirst%3DD.%26aulast%3DKojima%26aufirst%3DY.%26aulast%3DImoto%26aufirst%3DN.%26aulast%3DNaoe%26aufirst%3DT.%26aulast%3DKiyoi%26aufirst%3DH.%26atitle%3DThe%2520photosensitizer%2520verteporfin%2520has%2520light-independent%2520anti-leukemic%2520activity%2520for%2520Ph-positive%2520acute%2520lymphoblastic%2520leukemia%2520and%2520synergistically%2520works%2520with%2520dasatinib%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26issue%3D35%26spage%3D56241%26epage%3D56252%26doi%3D10.18632%2Foncotarget.11025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doh-Ura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caughey, B.</span></span> <span> </span><span class="NLM_article-title">Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation</span>. <i>Journal of virology</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>74</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">4894</span>– <span class="NLM_lpage">4897</span>, <span class="refDoi"> DOI: 10.1128/JVI.74.10.4894-4897.2000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1128%2FJVI.74.10.4894-4897.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10775631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD3cXivFynsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=4894-4897&issue=10&author=K.+Doh-Uraauthor=T.+Iwakiauthor=B.+Caughey&title=Lysosomotropic+agents+and+cysteine+protease+inhibitors+inhibit+scrapie-associated+prion+protein+accumulation&doi=10.1128%2FJVI.74.10.4894-4897.2000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation</span></div><div class="casAuthors">Doh-Ura, Katsumi; Iwaki, Toru; Caughey, Byron</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4894-4897</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We report that lysosomotropic agents and cysteine protease inhibitors inhibited protease-resistant prion protein accumulation in scrapie-infected neuroblastoma cells.  The inhibition occurred without either apparent effects on normal prion protein biosynthesis or turnover or direct interactions with prion protein mols.  The findings introduce two new classes of inhibitors of the formation of protease-resistant prion protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3tW6UfovyjrVg90H21EOLACvtfcHk0liP3uV-mrdkmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXivFynsLw%253D&md5=5878062596dd2f20f0deb17e905de4af</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1128%2FJVI.74.10.4894-4897.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.74.10.4894-4897.2000%26sid%3Dliteratum%253Aachs%26aulast%3DDoh-Ura%26aufirst%3DK.%26aulast%3DIwaki%26aufirst%3DT.%26aulast%3DCaughey%26aufirst%3DB.%26atitle%3DLysosomotropic%2520agents%2520and%2520cysteine%2520protease%2520inhibitors%2520inhibit%2520scrapie-associated%2520prion%2520protein%2520accumulation%26jtitle%3DJournal%2520of%2520virology%26date%3D2000%26volume%3D74%26issue%3D10%26spage%3D4894%26epage%3D4897%26doi%3D10.1128%2FJVI.74.10.4894-4897.2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref208"><div class="reference"><strong class="refLabel"><a href="#ref208" class="rightTabRefNumLink">208</a></strong><div class="NLM_citation" id="rightTab-cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roh, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, K. C.</span></span> <span> </span><span class="NLM_article-title">Compound C independent of AMPK inhibits ICAM-1 and VCAM-1 expression in inflammatory stimulants-activated endothelial cells in vitro and in vivo</span>. <i>Atherosclerosis</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>219</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1016/j.atherosclerosis.2011.06.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.atherosclerosis.2011.06.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=21764059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtl2ku7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=219&publication_year=2011&pages=57-64&issue=1&author=Y.+M.+Kimauthor=M.+Y.+Kimauthor=H.+J.+Kimauthor=G.+S.+Rohauthor=G.+H.+Koauthor=H.+G.+Seoauthor=J.+H.+Leeauthor=K.+C.+Chang&title=Compound+C+independent+of+AMPK+inhibits+ICAM-1+and+VCAM-1+expression+in+inflammatory+stimulants-activated+endothelial+cells+in+vitro+and+in+vivo&doi=10.1016%2Fj.atherosclerosis.2011.06.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Compound C independent of AMPK inhibits ICAM-1 and VCAM-1 expression in inflammatory stimulants-activated endothelial cells in vitro and in vivo</span></div><div class="casAuthors">Kim, Young Min; Kim, Min Young; Kim, Hye Jung; Roh, Gu Seob; Ko, Gyung Hyuck; Seo, Han Geuk; Lee, Jae Heun; Chang, Ki Churl</div><div class="citationInfo"><span class="NLM_cas:title">Atherosclerosis (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">219</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-64</span>CODEN:
                <span class="NLM_cas:coden">ATHSBL</span>;
        ISSN:<span class="NLM_cas:issn">0021-9150</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Activation of the NF-κB and mitogen activated protein (MAP) kinases plays an important role in the expression of inflammatory genes such as adhesion mols.  Although compd. C is known as an AMPK inhibitor, AMPK-independent action of it has been recognized.  Effects on the expression of ICAM-1 and VCAM-1 by compd. C were investigated in TNF-α-activated human umbilical vein endothelial cells (HUVECs) in vitro and in thoracic aorta of rats treated with lipopolysaccharide (LPS) in vivo.  Compd. C inhibited ICAM-1 and VCAM-1 expression at the transcriptional as well as translational level in TNF-α-activated HUVECs.  In both DN-AMPK- and AMPKα1-siRNA-transfected HUVECs, compd. C still inhibited TNF-α-induced VCAM-1 and ICAM-1 expression, indicating that this is AMPK-independent action.  Interestingly, compd. C significantly inhibited NF-κB activity and translocation of p65 to nucleus in HUVECs when activated with TNF-α.  Importantly, administration of compd. C (0.2 mg/kg) significantly reduced expression of both ICAM-1 and VCAM-1 in LPS-treated rat thoracic aortas.  In addn., compd. C significantly inhibited iNOS and prodn. of NO in both TNF-α- and LPS-activated RAW 264.7 cells.  Finally, compd. C significantly inhibited phosphorylation of Akt and p-38MAPK but not protein kinase c or ERK1/2 in HUVECs.  Taken together, we conclude that adhesion mols. (ICAM-1, VCAM-1) are to be the novel targets of compd. C in preventing inflammatory insult to endothelial cells independent of AMPK inhibition via inhibition of NF-κB activity along with inhibition of phosphorylation of PI3K and P38 MAPK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDVp8CMQ_6lLVg90H21EOLACvtfcHk0lhRq9Ul10FAOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtl2ku7vJ&md5=5f20177e9826434fba85a3909b340796</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1016%2Fj.atherosclerosis.2011.06.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.atherosclerosis.2011.06.043%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%2BM.%26aulast%3DKim%26aufirst%3DM.%2BY.%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DRoh%26aufirst%3DG.%2BS.%26aulast%3DKo%26aufirst%3DG.%2BH.%26aulast%3DSeo%26aufirst%3DH.%2BG.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DChang%26aufirst%3DK.%2BC.%26atitle%3DCompound%2520C%2520independent%2520of%2520AMPK%2520inhibits%2520ICAM-1%2520and%2520VCAM-1%2520expression%2520in%2520inflammatory%2520stimulants-activated%2520endothelial%2520cells%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DAtherosclerosis%26date%3D2011%26volume%3D219%26issue%3D1%26spage%3D57%26epage%3D64%26doi%3D10.1016%2Fj.atherosclerosis.2011.06.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref209"><div class="reference"><strong class="refLabel"><a href="#ref209" class="rightTabRefNumLink">209</a></strong><div class="NLM_citation" id="rightTab-cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider-Poetsch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eyler, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrick, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. O.</span></span> <span> </span><span class="NLM_article-title">Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1038/nchembio.304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fnchembio.304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=20118940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1ygu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=209-217&issue=3&author=T.+Schneider-Poetschauthor=J.+Juauthor=D.+E.+Eylerauthor=Y.+Dangauthor=S.+Bhatauthor=W.+C.+Merrickauthor=R.+Greenauthor=B.+Shenauthor=J.+O.+Liu&title=Inhibition+of+eukaryotic+translation+elongation+by+cycloheximide+and+lactimidomycin&doi=10.1038%2Fnchembio.304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit209R"><div class="casContent"><span class="casTitleNuber">209</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin</span></div><div class="casAuthors">Schneider-Poetsch, Tilman; Ju, Jianhua; Eyler, Daniel E.; Dang, Yongjun; Bhat, Shridhar; Merrick, William C.; Green, Rachel; Shen, Ben; Liu, Jun O.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">209-217</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although the protein synthesis inhibitor cycloheximide (CHX) has been known for decades, its precise mechanism of action remains incompletely understood.  The glutarimide portion of CHX is seen in a family of structurally related natural products including migrastatin, isomigrastatin, and lactimidomycin (LTM).  We found that LTM, isomigrastatin, and analogs have a potent antiproliferative effect on tumor cell lines and selectively inhibit translation.  A systematic comparative study of the effects of CHX and LTM on protein synthesis revealed both similarities and differences between the two inhibitors.  Both LTM and CHX were found to block the translocation step in elongation.  Footprinting expts. revealed protection of a single cytidine nucleotide (C3993) in the E-site of the 60S ribosomal subunit, thus defining a common binding pocket for the two inhibitors in the ribosome.  These results shed new light on the mol. mechanism of inhibition of translation elongation by both CHX and LTM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsVhn_TkyD-LVg90H21EOLACvtfcHk0lhRq9Ul10FAOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1ygu7w%253D&md5=77e621c87b496cd697f77299623b9f06</span></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.304%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider-Poetsch%26aufirst%3DT.%26aulast%3DJu%26aufirst%3DJ.%26aulast%3DEyler%26aufirst%3DD.%2BE.%26aulast%3DDang%26aufirst%3DY.%26aulast%3DBhat%26aufirst%3DS.%26aulast%3DMerrick%26aufirst%3DW.%2BC.%26aulast%3DGreen%26aufirst%3DR.%26aulast%3DShen%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DJ.%2BO.%26atitle%3DInhibition%2520of%2520eukaryotic%2520translation%2520elongation%2520by%2520cycloheximide%2520and%2520lactimidomycin%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26issue%3D3%26spage%3D209%26epage%3D217%26doi%3D10.1038%2Fnchembio.304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref210"><div class="reference"><strong class="refLabel"><a href="#ref210" class="rightTabRefNumLink">210</a></strong><div class="NLM_citation" id="rightTab-cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Q.</span></span> <span> </span><span class="NLM_article-title">The cytochrome P450 inhibitor SKF-525A disrupts autophagy in primary rat hepatocytes</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>255</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1016/j.cbi.2016.03.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.cbi.2016.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=26964495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC28XktFKhtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=2016&pages=55-62&author=Y.+Luoauthor=X.+Yangauthor=Q.+Shi&title=The+cytochrome+P450+inhibitor+SKF-525A+disrupts+autophagy+in+primary+rat+hepatocytes&doi=10.1016%2Fj.cbi.2016.03.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">The cytochrome P450 inhibitor SKF-525A disrupts autophagy in primary rat hepatocytes</span></div><div class="casAuthors">Luo, Yong; Yang, Xi; Shi, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">255</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">55-62</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">The cytochrome P 450 (CYP) inhibitor SKF-525A is commonly used to study drug metab. and toxicity, particularly hepatotoxicity.  By using Western blot and immunofluorescence staining, we unexpectedly found that SKF-525A at 2-20 μM caused remarkable accumulation of microtubule-assocd. protein light chain 3 II (LC3-II) in primary rat hepatocytes at 1, 4 and 24 h, indicating that autophagy was disrupted.  SKF-525A showed no effects on chloroquine induced LC3-II accumulation, suggesting that autophagic flux was blocked, which is further supported by the increased level of the p62 protein after SKF-525A treatment.  SKF-525A did not affect proteasome activities or gene expression of LC3-II or p62.  Immunofluorescence of green fluorescent protein fused lysosomal-assocd. membrane protein 1 (LAMP1, a specific protein marker for lysosomes) and LC3-II showed that co-localization of these two proteins was partially abolished by SKF-525A, indicating that autophagosome-lysosome fusion was blocked.  The other five CYP inhibitors, metyrapone, 1-aminobenzotriazole, alpha-naphthoflavone, ticlopidine, and ketoconazole, showed no effects in parallel expts.  These findings provide novel insights into the mechanisms by which various CYP inhibitors differentially affect a same drug's toxicity in hepatocytes.  The data also indicate that SKF-525A is not an ideal chem. inhibitor for probing the relation between CYP mediated metab. and toxicity in primary hepatocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn07o4W22s1bVg90H21EOLACvtfcHk0lhRq9Ul10FAOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktFKhtbY%253D&md5=e46d14ec3541f9ca6b13cc66a9072678</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2016.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2016.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DQ.%26atitle%3DThe%2520cytochrome%2520P450%2520inhibitor%2520SKF-525A%2520disrupts%2520autophagy%2520in%2520primary%2520rat%2520hepatocytes%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2016%26volume%3D255%26spage%3D55%26epage%3D62%26doi%3D10.1016%2Fj.cbi.2016.03.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref211"><div class="reference"><strong class="refLabel"><a href="#ref211" class="rightTabRefNumLink">211</a></strong><div class="NLM_citation" id="rightTab-cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Said, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bock, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lajqi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weindl, G.</span></span> <span> </span><span class="NLM_article-title">Chloroquine promotes IL-17 production by CD4+ T cells via p38-dependent IL-23 release by monocyte-derived Langerhans-like cells</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>193</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">6135</span>– <span class="NLM_lpage">6143</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1303276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.4049%2Fjimmunol.1303276" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=25385822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVegu7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2014&pages=6135-6143&issue=12&author=A.+Saidauthor=S.+Bockauthor=T.+Lajqiauthor=G.+Mullerauthor=G.+Weindl&title=Chloroquine+promotes+IL-17+production+by+CD4%2B+T+cells+via+p38-dependent+IL-23+release+by+monocyte-derived+Langerhans-like+cells&doi=10.4049%2Fjimmunol.1303276"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Chloroquine Promotes IL-17 Production by CD4+ T Cells via p38-Dependent IL-23 Release by Monocyte-Derived Langerhans-like Cells</span></div><div class="casAuthors">Said, Andre; Bock, Stephanie; Lajqi, Trim; Mueller, Gerrit; Weindl, Guenther</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6135-6143</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Recent studies suggest a role for autophagy in the secretion of IL-1 cytokines regulating the development of inflammatory diseases.  The antimalarial drug and autophagy/lysosome inhibitor chloroquine (CHQ) is considered as potential trigger of drug-induced or drug-aggravated psoriasis, in which Th17 cells sustain a persistent inflammation.  In this study, we investigated the effect of CHQ on human monocyte-derived Langerhans-like cells (MoLC) and dendritic cells (MoDC) in response to IL-1β.  The presence of CHQ reduced IL-12p70 release in both subsets, but surprisingly increased IL-6 prodn. in MoDC and IL-23 in MoLC.  Importantly, CHQ-treated MoLC promoted IL-17A secretion by CD4+ T cells and elevated RORC mRNA levels, whereas IFN-γ release was reduced.  The dysregulation of IL-12 family cytokines in MoLC and MoDC occurred at the transcriptional level.  Similar effects were obtained with other late autophagy inhibitors, whereas PI3K inhibitor 3-methyladenine failed to increase IL-23 secretion.  The modulated cytokine release was dependent on IL-1 cytokine activation and abrogated by a specific IL-1R antagonist.  CHQ elevated expression of TNFR-assocd. factor 6, a common intermediate in IL-1R and TLR-dependent signaling.  Accordingly, treatment with Pam3CSK4 and CHQ enhanced IL-23 release in MoLC and MoDC.  CHQ inhibited autophagic flux, confirmed by increased LC3-II and p62 expression, and activated ERK, p38, and JNK MAPK, but only inhibition of p38 abrogated IL-23 release by MoLC.  Thus, our findings indicate that CHQ modulates cytokine release in a p38-dependent manner, suggesting an essential role of Langerhans cells and dendritic cells in CHQ-provoked psoriasis, possibly by promoting Th17 immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxgFQ_assfYLVg90H21EOLACvtfcHk0ljWYbantJdQNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVegu7zE&md5=41e06c27afa859687cd93353587fa7c1</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1303276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1303276%26sid%3Dliteratum%253Aachs%26aulast%3DSaid%26aufirst%3DA.%26aulast%3DBock%26aufirst%3DS.%26aulast%3DLajqi%26aufirst%3DT.%26aulast%3DMuller%26aufirst%3DG.%26aulast%3DWeindl%26aufirst%3DG.%26atitle%3DChloroquine%2520promotes%2520IL-17%2520production%2520by%2520CD4%252B%2520T%2520cells%2520via%2520p38-dependent%2520IL-23%2520release%2520by%2520monocyte-derived%2520Langerhans-like%2520cells%26jtitle%3DJ.%2520Immunol.%26date%3D2014%26volume%3D193%26issue%3D12%26spage%3D6135%26epage%3D6143%26doi%3D10.4049%2Fjimmunol.1303276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref212"><div class="reference"><strong class="refLabel"><a href="#ref212" class="rightTabRefNumLink">212</a></strong><div class="NLM_citation" id="rightTab-cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bui, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obin, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, J.</span></span> <span> </span><span class="NLM_article-title">Assurance of mitochondrial integrity and mammalian longevity by the p62–Keap1-Nrf2-Nqo1 cascade</span>. <i>EMBO Rep.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">150</span>– <span class="NLM_lpage">156</span>, <span class="refDoi"> DOI: 10.1038/embor.2011.246</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1038%2Fembor.2011.246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=22222206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsF2juw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=150-156&issue=2&author=J.+Kwonauthor=E.+Hanauthor=C.+B.+Buiauthor=W.+Shinauthor=J.+Leeauthor=S.+Leeauthor=Y.+B.+Choiauthor=A.+H.+Leeauthor=K.+H.+Leeauthor=C.+Parkauthor=M.+S.+Obinauthor=S.+K.+Parkauthor=Y.+J.+Seoauthor=G.+T.+Ohauthor=H.+W.+Leeauthor=J.+Shin&title=Assurance+of+mitochondrial+integrity+and+mammalian+longevity+by+the+p62%E2%80%93Keap1-Nrf2-Nqo1+cascade&doi=10.1038%2Fembor.2011.246"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Assurance of mitochondrial integrity and mammalian longevity by the p62-Keap1-Nrf2-Nqo1 cascade</span></div><div class="casAuthors">Kwon, Jeongho; Han, Eunhye; Bui, Chi-Bao; Shin, Woochul; Lee, Junho; Lee, Sejeong; Choi, Young-Bong; Lee, Ann-Hwee; Lee, Kyong-Hoon; Park, Chankyu; Obin, Martin S.; Park, Sung Kyu; Seo, Yun Jeong; Oh, Goo Taeg; Lee, Han-Woong; Shin, Jaekyoon</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">150-156</span>CODEN:
                <span class="NLM_cas:coden">ERMEAX</span>;
        ISSN:<span class="NLM_cas:issn">1469-221X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sqstm1/p62 functions in the non-canonical activation of nuclear factor (erythroid-derived 2)-like 2 (Nrf2).  However, its physiol. relevance is not certain.  Here, we show that p62-/- mice exhibited an accelerated presentation of ageing phenotypes, and tissues from these mice created a pro-oxidative environment owing to compromised mitochondrial electron transport.  Accordingly, mitochondrial function rapidly declined with age in p62-/- mice.  In addn., p62 enhanced basal Nrf2 activity, conferring a higher steady-state expression of NAD(P)H dehydrogenase, quinone 1 (Nqo1) to maintain mitochondrial membrane potential and, thereby, restrict excess oxidant generation.  Together, the p62-Nrf2-Nqo1 cascade functions to assure mammalian longevity by stabilizing mitochondrial integrity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMFbRXLeikg7Vg90H21EOLACvtfcHk0ljWYbantJdQNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsF2juw%253D%253D&md5=7584f546228bdcf159a9e3cf53809dbe</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1038%2Fembor.2011.246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fembor.2011.246%26sid%3Dliteratum%253Aachs%26aulast%3DKwon%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DE.%26aulast%3DBui%26aufirst%3DC.%2BB.%26aulast%3DShin%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DY.%2BB.%26aulast%3DLee%26aufirst%3DA.%2BH.%26aulast%3DLee%26aufirst%3DK.%2BH.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DObin%26aufirst%3DM.%2BS.%26aulast%3DPark%26aufirst%3DS.%2BK.%26aulast%3DSeo%26aufirst%3DY.%2BJ.%26aulast%3DOh%26aufirst%3DG.%2BT.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DShin%26aufirst%3DJ.%26atitle%3DAssurance%2520of%2520mitochondrial%2520integrity%2520and%2520mammalian%2520longevity%2520by%2520the%2520p62%25E2%2580%2593Keap1-Nrf2-Nqo1%2520cascade%26jtitle%3DEMBO%2520Rep.%26date%3D2012%26volume%3D13%26issue%3D2%26spage%3D150%26epage%3D156%26doi%3D10.1038%2Fembor.2011.246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref213"><div class="reference"><strong class="refLabel"><a href="#ref213" class="rightTabRefNumLink">213</a></strong><div class="NLM_citation" id="rightTab-cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muto, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flex, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kupchinsky, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Primiano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galehdari, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehghani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecchetti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpentieri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizza, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazaheri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedaghat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vahidi Mehrjardi, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traversa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Nottia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kousi, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamshidi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciolfi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caputo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malamiri, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantaleoni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffries, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeighami, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherafat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Giuda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shariati, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrozzo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsanis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maroofian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Servidei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tartaglia, M.</span></span> <span> </span><span class="NLM_article-title">Biallelic SQSTM1 mutations in early-onset, variably progressive neurodegeneration</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>91</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">e319</span>– <span class="NLM_lpage">e330</span>, <span class="refDoi"> DOI: 10.1212/WNL.0000000000005869</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1212%2FWNL.0000000000005869" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=29959261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlGnsL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2018&pages=e319-e330&issue=4&author=V.+Mutoauthor=E.+Flexauthor=Z.+Kupchinskyauthor=G.+Primianoauthor=H.+Galehdariauthor=M.+Dehghaniauthor=S.+Cecchettiauthor=G.+Carpentieriauthor=T.+Rizzaauthor=N.+Mazaheriauthor=A.+Sedaghatauthor=M.+Y.+Vahidi+Mehrjardiauthor=A.+Traversaauthor=M.+Di+Nottiaauthor=M.+M.+Kousiauthor=Y.+Jamshidiauthor=A.+Ciolfiauthor=V.+Caputoauthor=R.+A.+Malamiriauthor=F.+Pantaleoniauthor=S.+Martinelliauthor=A.+R.+Jeffriesauthor=J.+Zeighamiauthor=A.+Sherafatauthor=D.+Di+Giudaauthor=G.+R.+Shariatiauthor=R.+Carrozzoauthor=N.+Katsanisauthor=R.+Maroofianauthor=S.+Servideiauthor=M.+Tartaglia&title=Biallelic+SQSTM1+mutations+in+early-onset%2C+variably+progressive+neurodegeneration&doi=10.1212%2FWNL.0000000000005869"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">Biallelic SQSTM1 mutations in early-onset, variably progressive neurodegeneration</span></div><div class="casAuthors">Muto, Valentina; Flex, Elisabetta; Kupchinsky, Zachary; Primiano, Guido; Galehdari, Hamid; Dehghani, Mohammadreza; Cecchetti, Serena; Carpentieri, Giovanna; Rizza, Teresa; Mazaheri, Neda; Sedaghat, Alireza; Vahidi Mehrjardi, Mohammad Yahya; Traversa, Alice; Di Nottia, Michela; Kousi, Maria M.; Jamshidi, Yalda; Ciolfi, Andrea; Caputo, Viviana; Malamiri, Reza Azizi; Pantaleoni, Francesca; Martinelli, Simone; Jeffries, Aaron R.; Zeighami, Jawaher; Sherafat, Amir; Di Giuda, Daniela; Shariati, Gholam Reza; Carrozzo, Rosalba; Katsanis, Nicholas; Maroofian, Reza; Servidei, Serenella; Tartaglia, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e319-e330</span>CODEN:
                <span class="NLM_cas:coden">NEURAI</span>;
        ISSN:<span class="NLM_cas:issn">0028-3878</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective: To characterize clin. and molecularly an early-onset, variably progressive neurodegenerative disorder characterized by a cerebellar syndrome with severe ataxia, gaze palsy, dyskinesia, dystonia, and cognitive decline affecting 11 individuals from 3 consanguineous families.  Methods: We used whole-exome sequencing (WES) (families 1 and 2) and a combined approach based on homozygosity mapping and WES (family 3).  We performed in vitro studies to explore the effect of the nontruncating SQSTM1 mutation on protein function and the effect of impaired SQSTM1 function on autophagy.  We analyzed the consequences of sqstm1 down-modulation on the structural integrity of the cerebellum in vivo using zebrafish as a model.  Results: We identified 3 homozygous inactivating variants, including a splice site substitution (c.301+2T>A) causing aberrant transcript processing and accelerated degrdn. of a resulting protein lacking exon 2, as well as 2 truncating changes (c.875_876insT and c.934_936delinsTGA).  We show that loss of SQSTM1 causes impaired prodn. of ubiquitin-pos. protein aggregates in response to misfolded protein stress and decelerated autophagic flux.  The consequences of sqstm1 down-modulation on the structural integrity of the cerebellum in zebrafish documented a variable but reproducible phenotype characterized by cerebellum anomalies ranging from depletion of axonal connections to complete atrophy.  We provide a detailed clin. characterization of the disorder; the natural history is reported for 2 siblings who have been followed up for >20 years.  Conclusions: This study offers an accurate clin. characterization of this recently recognized neurodegenerative disorder caused by biallelic inactivating mutations in SQSTM1 and links this phenotype to defective selective autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnLNHPSU0S47Vg90H21EOLACvtfcHk0lisj5Jroc1Sbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlGnsL3N&md5=7e0028caf2c44a744c87bf0b1fc6c2af</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1212%2FWNL.0000000000005869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.0000000000005869%26sid%3Dliteratum%253Aachs%26aulast%3DMuto%26aufirst%3DV.%26aulast%3DFlex%26aufirst%3DE.%26aulast%3DKupchinsky%26aufirst%3DZ.%26aulast%3DPrimiano%26aufirst%3DG.%26aulast%3DGalehdari%26aufirst%3DH.%26aulast%3DDehghani%26aufirst%3DM.%26aulast%3DCecchetti%26aufirst%3DS.%26aulast%3DCarpentieri%26aufirst%3DG.%26aulast%3DRizza%26aufirst%3DT.%26aulast%3DMazaheri%26aufirst%3DN.%26aulast%3DSedaghat%26aufirst%3DA.%26aulast%3DVahidi%2BMehrjardi%26aufirst%3DM.%2BY.%26aulast%3DTraversa%26aufirst%3DA.%26aulast%3DDi%2BNottia%26aufirst%3DM.%26aulast%3DKousi%26aufirst%3DM.%2BM.%26aulast%3DJamshidi%26aufirst%3DY.%26aulast%3DCiolfi%26aufirst%3DA.%26aulast%3DCaputo%26aufirst%3DV.%26aulast%3DMalamiri%26aufirst%3DR.%2BA.%26aulast%3DPantaleoni%26aufirst%3DF.%26aulast%3DMartinelli%26aufirst%3DS.%26aulast%3DJeffries%26aufirst%3DA.%2BR.%26aulast%3DZeighami%26aufirst%3DJ.%26aulast%3DSherafat%26aufirst%3DA.%26aulast%3DDi%2BGiuda%26aufirst%3DD.%26aulast%3DShariati%26aufirst%3DG.%2BR.%26aulast%3DCarrozzo%26aufirst%3DR.%26aulast%3DKatsanis%26aufirst%3DN.%26aulast%3DMaroofian%26aufirst%3DR.%26aulast%3DServidei%26aufirst%3DS.%26aulast%3DTartaglia%26aufirst%3DM.%26atitle%3DBiallelic%2520SQSTM1%2520mutations%2520in%2520early-onset%252C%2520variably%2520progressive%2520neurodegeneration%26jtitle%3DNeurology%26date%3D2018%26volume%3D91%26issue%3D4%26spage%3De319%26epage%3De330%26doi%3D10.1212%2FWNL.0000000000005869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref214"><div class="reference"><strong class="refLabel"><a href="#ref214" class="rightTabRefNumLink">214</a></strong><div class="NLM_citation" id="rightTab-cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selloum, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champy, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diez-Guerra, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auwerx, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span> <span> </span><span class="NLM_article-title">Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">222</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2006.01.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1016%2Fj.cmet.2006.01.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=16517408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BD28Xislyhtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=211-222&issue=3&author=A.+Rodriguezauthor=A.+Duranauthor=M.+Selloumauthor=M.+F.+Champyauthor=F.+J.+Diez-Guerraauthor=J.+M.+Floresauthor=M.+Serranoauthor=J.+Auwerxauthor=M.+T.+Diaz-Mecoauthor=J.+Moscat&title=Mature-onset+obesity+and+insulin+resistance+in+mice+deficient+in+the+signaling+adapter+p62&doi=10.1016%2Fj.cmet.2006.01.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62</span></div><div class="casAuthors">Rodriguez, Angelina; Duran, Angeles; Selloum, Mohammed; Champy, Marie-France; Diez-Guerra, Francisco J.; Flores, Juana Maria; Serrano, Manuel; Auwerx, Johan; Diaz-Meco, Maria T.; Moscat, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">211-222</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Signaling cascades that control adipogenesis are essential in the regulation of body wt. and obesity.  The adaptor p62 controls pathways that modulate cell differentiation.  The authors report that p62-/- mice develop mature-onset obesity, leptin resistance, as well as impaired glucose and insulin intolerance.  The metabolic rate was significantly reduced in p62-/- nonobese mice, which displayed increased mRNA levels of PPAR-γ and reduced levels of UCP-1 in adipose tissue.  Basal activity of ERK was enhanced in fat from nonobese mutant mice.  Embryo fibroblasts from p62-/- mice differentiated better than the wild-type controls into adipocytes, which was abrogated by pharmacol. inhibition of the ERK pathway.  The p62 is induced during adipocyte differentiation and inhibits ERK activation by direct interaction.  The authors propose that p62 normally antagonizes basal ERK activity and adipocyte differentiation and that its loss leads to the hyperactivation of ERK that favors adipogenesis and obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomuqtMEFK4TbVg90H21EOLACvtfcHk0lisj5Jroc1Sbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xislyhtrs%253D&md5=d6986162cf7ed08d9414c6eb5e304788</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2006.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2006.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DDuran%26aufirst%3DA.%26aulast%3DSelloum%26aufirst%3DM.%26aulast%3DChampy%26aufirst%3DM.%2BF.%26aulast%3DDiez-Guerra%26aufirst%3DF.%2BJ.%26aulast%3DFlores%26aufirst%3DJ.%2BM.%26aulast%3DSerrano%26aufirst%3DM.%26aulast%3DAuwerx%26aufirst%3DJ.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DMoscat%26aufirst%3DJ.%26atitle%3DMature-onset%2520obesity%2520and%2520insulin%2520resistance%2520in%2520mice%2520deficient%2520in%2520the%2520signaling%2520adapter%2520p62%26jtitle%3DCell%2520Metab.%26date%3D2006%26volume%3D3%26issue%3D3%26spage%3D211%26epage%3D222%26doi%3D10.1016%2Fj.cmet.2006.01.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref215"><div class="reference"><strong class="refLabel"><a href="#ref215" class="rightTabRefNumLink">215</a></strong><div class="NLM_citation" id="rightTab-cit215"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh Babu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamar Seibenhener, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strom, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemppainen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Meco, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moscat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, M. W.</span></span> <span> </span><span class="NLM_article-title">Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">120</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2008.05340.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1111%2Fj.1471-4159.2008.05340.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=18346206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A280%3ADC%252BD1cvitlSrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2008&pages=107-120&issue=1&author=J.+Ramesh+Babuauthor=M.+Lamar+Seibenhenerauthor=J.+Pengauthor=A.+L.+Stromauthor=R.+Kemppainenauthor=N.+Coxauthor=H.+Zhuauthor=M.+C.+Wootenauthor=M.+T.+Diaz-Mecoauthor=J.+Moscatauthor=M.+W.+Wooten&title=Genetic+inactivation+of+p62+leads+to+accumulation+of+hyperphosphorylated+tau+and+neurodegeneration&doi=10.1111%2Fj.1471-4159.2008.05340.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration</span></div><div class="casAuthors">Ramesh Babu J; Lamar Seibenhener M; Peng Junmin; Strom Anna-Lena; Kemppainen Robert; Cox Nancy; Zhu Haining; Wooten Michael C; Diaz-Meco Maria T; Moscat Jorge; Wooten Marie W</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">107-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The signaling adapter p62 plays a coordinating role in mediating phosphorylation and ubiquitin-dependent trafficking of interacting proteins.  However, there is little known about the physiologic role of this protein in brain.  Here, we report age-dependent constitutive activation of glycogen synthase kinase 3beta, protein kinase B, mitogen-activated protein kinase, and c-Jun-N-terminal kinase in adult p62(-/-) mice resulting in hyperphosphorylated tau, neurofibrillary tangles, and neurodegeneration.  Biochemical fractionation of p62(-/-) brain led to recovery of aggregated K63-ubiquitinated tau.  Loss of p62 was manifested by increased anxiety, depression, loss of working memory, and reduced serum brain-derived neurotrophic factor levels.  Our findings reveal a novel role for p62 as a chaperone that regulates tau solubility thereby preventing tau aggregation.  This study provides a clear demonstration of an Alzheimer-like phenotype in a mouse model in the absence of expression of human genes carrying mutations in amyloid-beta protein precursor, presenilin, or tau.  Thus, these findings provide new insight into manifestation of sporadic Alzheimer disease and the impact of obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTej33M0uF5Zf9pSBfyDvp7fW6udTcc2eaiR2exHaJVcrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvitlSrtA%253D%253D&md5=a7fdc891414a454b800d8b8ed8cbfe42</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05340.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05340.x%26sid%3Dliteratum%253Aachs%26aulast%3DRamesh%2BBabu%26aufirst%3DJ.%26aulast%3DLamar%2BSeibenhener%26aufirst%3DM.%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DStrom%26aufirst%3DA.%2BL.%26aulast%3DKemppainen%26aufirst%3DR.%26aulast%3DCox%26aufirst%3DN.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DWooten%26aufirst%3DM.%2BC.%26aulast%3DDiaz-Meco%26aufirst%3DM.%2BT.%26aulast%3DMoscat%26aufirst%3DJ.%26aulast%3DWooten%26aufirst%3DM.%2BW.%26atitle%3DGenetic%2520inactivation%2520of%2520p62%2520leads%2520to%2520accumulation%2520of%2520hyperphosphorylated%2520tau%2520and%2520neurodegeneration%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D106%26issue%3D1%26spage%3D107%26epage%3D120%26doi%3D10.1111%2Fj.1471-4159.2008.05340.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref216"><div class="reference"><strong class="refLabel"><a href="#ref216" class="rightTabRefNumLink">216</a></strong><div class="NLM_citation" id="rightTab-cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurosawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kino, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurosawa-Yamada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washizu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakaso, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanagawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warabi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimogori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nukina, N.</span></span> <span> </span><span class="NLM_article-title">Depletion of p62 reduces nuclear inclusions and paradoxically ameliorates disease phenotypes in Huntington’s model mice</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1092</span>– <span class="NLM_lpage">1105</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddu522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=10.1093%2Fhmg%2Fddu522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=25305080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVyls73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=1092-1105&issue=4&author=M.+Kurosawaauthor=G.+Matsumotoauthor=Y.+Kinoauthor=M.+Okunoauthor=M.+Kurosawa-Yamadaauthor=C.+Washizuauthor=H.+Taniguchiauthor=K.+Nakasoauthor=T.+Yanagawaauthor=E.+Warabiauthor=T.+Shimogoriauthor=T.+Sakuraiauthor=N.+Hattoriauthor=N.+Nukina&title=Depletion+of+p62+reduces+nuclear+inclusions+and+paradoxically+ameliorates+disease+phenotypes+in+Huntington%E2%80%99s+model+mice&doi=10.1093%2Fhmg%2Fddu522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Depletion of p62 reduces nuclear inclusions and paradoxically ameliorates disease phenotypes in Huntington's model mice</span></div><div class="casAuthors">Kurosawa, Masaru; Matsumoto, Gen; Kino, Yoshihiro; Okuno, Misako; Kurosawa-Yamada, Mizuki; Washizu, Chika; Taniguchi, Harumi; Nakaso, Kazuhiro; Yanagawa, Toru; Warabi, Eiji; Shimogori, Tomomi; Sakurai, Takashi; Hattori, Nobutaka; Nukina, Nobuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1092-1105</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Huntington's disease (HD) is a dominantly inherited genetic disease caused by mutant huntingtin (htt) protein with expanded polyglutamine (polyQ) tracts.  A neuropathol. hallmark of HD is the presence of neuronal inclusions of mutant htt. p62 is an important regulatory protein in selective autophagy, a process by which aggregated proteins are degraded, and it is assocd. with several neurodegenerative disorders including HD.  Here, we investigated the effect of p62 depletion in three HD model mice: R6/2, HD190QG and HD120QG mice.  We found that loss of p62 in these models led to longer life spans and reduced nuclear inclusions, although cytoplasmic inclusions increased with polyQ length.  In mouse embryonic fibroblasts (MEFs) with or without p62, mutant htt with a nuclear localization signal (NLS) showed no difference in nuclear inclusion between the two MEF types.  In the case of mutant htt without NLS, however, p62 depletion increased cytoplasmic inclusions.  Furthermore, to examine the effect of impaired autophagy in HD model mice, we crossed R6/2 mice with Atg5 conditional knockout mice.  These mice also showed decreased nuclear inclusions and increased cytoplasmic inclusions, similar to HD mice lacking p62.  These data suggest that the genetic ablation of p62 in HD model mice enhances cytoplasmic inclusion formation by interrupting autophagic clearance of polyQ inclusions.  This reduces polyQ nuclear influx and paradoxically ameliorates disease phenotypes by decreasing toxic nuclear inclusions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopHG4Cy0wU_bVg90H21EOLACvtfcHk0lieM4TSBSa0PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVyls73N&md5=2c2c6e585f6f96df06b258259b5d3a51</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddu522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddu522%26sid%3Dliteratum%253Aachs%26aulast%3DKurosawa%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DG.%26aulast%3DKino%26aufirst%3DY.%26aulast%3DOkuno%26aufirst%3DM.%26aulast%3DKurosawa-Yamada%26aufirst%3DM.%26aulast%3DWashizu%26aufirst%3DC.%26aulast%3DTaniguchi%26aufirst%3DH.%26aulast%3DNakaso%26aufirst%3DK.%26aulast%3DYanagawa%26aufirst%3DT.%26aulast%3DWarabi%26aufirst%3DE.%26aulast%3DShimogori%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DT.%26aulast%3DHattori%26aufirst%3DN.%26aulast%3DNukina%26aufirst%3DN.%26atitle%3DDepletion%2520of%2520p62%2520reduces%2520nuclear%2520inclusions%2520and%2520paradoxically%2520ameliorates%2520disease%2520phenotypes%2520in%2520Huntington%25E2%2580%2599s%2520model%2520mice%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2015%26volume%3D24%26issue%3D4%26spage%3D1092%26epage%3D1105%26doi%3D10.1093%2Fhmg%2Fddu522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b02038&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-18%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b02038%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b02038" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b7beba29227f","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
